{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Benchmarks"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Initialize"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2021-01-05T11:03:09.852316Z",
     "start_time": "2021-01-05T11:03:07.701Z"
    },
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "── \u001b[1mAttaching packages\u001b[22m ─────────────────────────────────────── tidyverse 1.3.2 ──\n",
      "\u001b[32m✔\u001b[39m \u001b[34mggplot2\u001b[39m 3.4.1     \u001b[32m✔\u001b[39m \u001b[34mpurrr  \u001b[39m 1.0.1\n",
      "\u001b[32m✔\u001b[39m \u001b[34mtibble \u001b[39m 3.1.8     \u001b[32m✔\u001b[39m \u001b[34mdplyr  \u001b[39m 1.1.0\n",
      "\u001b[32m✔\u001b[39m \u001b[34mtidyr  \u001b[39m 1.3.0     \u001b[32m✔\u001b[39m \u001b[34mstringr\u001b[39m 1.5.0\n",
      "\u001b[32m✔\u001b[39m \u001b[34mreadr  \u001b[39m 2.1.3     \u001b[32m✔\u001b[39m \u001b[34mforcats\u001b[39m 0.5.2\n",
      "── \u001b[1mConflicts\u001b[22m ────────────────────────────────────────── tidyverse_conflicts() ──\n",
      "\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mfilter()\u001b[39m masks \u001b[34mstats\u001b[39m::filter()\n",
      "\u001b[31m✖\u001b[39m \u001b[34mdplyr\u001b[39m::\u001b[32mlag()\u001b[39m    masks \u001b[34mstats\u001b[39m::lag()\n",
      "Some features are not enabled in this build of Arrow. Run `arrow_info()` for more information.\n",
      "\n",
      "\n",
      "Attaching package: ‘arrow’\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:utils’:\n",
      "\n",
      "    timestamp\n",
      "\n",
      "\n",
      "\n",
      "Attaching package: ‘data.table’\n",
      "\n",
      "\n",
      "The following objects are masked from ‘package:dplyr’:\n",
      "\n",
      "    between, first, last\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:purrr’:\n",
      "\n",
      "    transpose\n",
      "\n",
      "\n",
      "\n",
      "Attaching package: ‘jsonlite’\n",
      "\n",
      "\n",
      "The following object is masked from ‘package:purrr’:\n",
      "\n",
      "    flatten\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "#library(Rmisc)\n",
    "library(dtplyr)\n",
    "library(tidyverse)\n",
    "library(glue)\n",
    "library(arrow)\n",
    "library(patchwork)\n",
    "library(data.table)\n",
    "library(\"jsonlite\")\n",
    "library(ggthemes)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {
    "ExecuteTime": {
     "end_time": "2021-01-05T11:03:10.491477Z",
     "start_time": "2021-01-05T11:03:10.445Z"
    },
    "tags": []
   },
   "outputs": [],
   "source": [
    "base_path = \"/home/jakobs\"\n",
    "\n",
    "project_path = glue(\"{base_path}/data\")\n",
    "experiment = '230323'\n",
    "experiment_path = glue(\"{project_path}/{experiment}\")\n",
    "\n",
    "endpoints_md = endpoint_defs = arrow::read_feather(glue(\"{base_path}/data/endpoints_epic_md.feather\")) %>% filter(n_epic>=100)\n",
    "endpoints = endpoint_defs$endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "base_size = 8\n",
    "title_size = 10\n",
    "facet_size = 9\n",
    "geom_text_size=3\n",
    "theme_set(theme_classic(base_size = base_size) + \n",
    "          theme(strip.background = element_blank(), plot.title=element_text(size=title_size, hjust=0), \n",
    "                strip.text.x = element_text(size = facet_size),axis.title=element_text(size=10), axis.text=element_text(size=8, color=\"black\"),\n",
    "                legend.position=\"bottom\", axis.line = element_line(size = 0.2), axis.ticks=element_line(size=0.2), panel.grid.major.y=element_line()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_map = endpoint_defs$phecode_string\n",
    "names(endpoint_map) =  endpoint_defs$endpoint\n",
    "endpoint_order = (endpoint_defs %>% arrange(as.numeric(phecode)))$endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_selection = c(\n",
    "    # generally very important\n",
    "    \"phecode_202\", # Diabetes mellitus\n",
    "    \"phecode_401\",\t#Hypertension\"  \n",
    "    \"phecode_404\", # Ischemic heart disease   \n",
    "    \"phecode_404-1\", # Myocardial infarction [Heart attack]\n",
    "    \"phecode_431-11\", # Cerebral infarction [Ischemic stroke]\n",
    "    \"phecode_424\", # Heart failure\n",
    "\n",
    "    \n",
    "    \"phecode_059-1\", # COVID 19\n",
    "    \"phecode_468\", # Pneumonia\n",
    "    \"phecode_474\", # Chronic obstructive pulmonary disease [COPD]\n",
    "      \n",
    "    \"phecode_286-2\", #\tMajor depressive disorder\n",
    "    \"phecode_324-11\", #Parkinson's Disease\n",
    "    \"phecode_328\", # Dementias and cerebral degeneration\n",
    "\n",
    "    \n",
    "    \"phecode_164\", # Anemia\n",
    "    \"phecode_726-1\", # Osteoporosis\n",
    "    \"phecode_371\", # Cataract\n",
    "    \"phecode_374-42\", # Diabetic retinopathy\n",
    "    \"phecode_374-5\", # Macular degeneration\n",
    "    \"phecode_375-1\", # Glaucoma\n",
    "    \n",
    "    \n",
    "    \"phecode_103\", # Malignant neoplasm of the skin\n",
    "    \"phecode_101\", # Malignant neoplasm of the digestive organs\n",
    "    \"phecode_102\", # LUNG CANCER\n",
    "    \n",
    "    \"phecode_583\", # Chronic kidney disease    \n",
    "    \"phecode_542\", # Chronic liver disease and sequelae    \n",
    "    \"OMOP_4306655\" # All-Cause Death\n",
    "    \n",
    "    # also generally important and relevant\n",
    "    #\"phecode_440-3\", # Pulmonary embolism\n",
    "    #\"phecode_468-1\",\t#Viral pneumonia\n",
    "#     \"phecode_460-2\",\t#Acute lower respiratory infection\n",
    "    #\"phecode_388\" # Blindness and low vision\n",
    "      # generally important and fun to check\n",
    "   # \"phecode_374-3\", # Retinal vascular changes and occlusions\n",
    "    #\"phecode_665\", # Psoriasis\n",
    "#     \"phecode_121\", # Leukemia\n",
    "    # important for eye\n",
    "#     \"phecode_705-1\", # Rheumatoid arthritis\n",
    ")\n",
    "\n",
    "endpoints_common = c(\n",
    "   'phecode_164', #Anemia\n",
    " 'phecode_705-1', #Rheumatoid arthritis\n",
    " 'phecode_328', #Dementias and cerebral degeneration\n",
    " 'phecode_328-1', #Alzheimer's disease\n",
    " 'phecode_401', #Hypertension\n",
    " 'phecode_202', #Diabetes mellitus\n",
    " 'phecode_416-21', #Atrial fibrillation\n",
    " 'phecode_404-1', #Myocardial infarction [Heart attack]\n",
    " 'phecode_424', #Heart failure\n",
    " 'phecode_468', #Pneumonia\n",
    " 'phecode_474', #Chronic obstructive pulmonary disease [COPD]\n",
    " 'phecode_583', #Chronic kidney disease\n",
    " 'OMOP_4306655' #All-Cause Death\n",
    "    )\n",
    "    \n",
    "endpoints_cardio = c(\n",
    "    'phecode_438-11',   #  \"Abdominal aortic aneurysm\",\n",
    "    'phecode_440-3',#  \"Pulmonary embolism\", # intervention\n",
    "    'phecode_413-21',#  \"Aortic stenosis\", # intervention\n",
    "    'phecode_400'#  \"Rheumatic fever and chronic rheumatic heart diseases\",\t\n",
    ")\n",
    "\n",
    "endpoints_eye= c(\n",
    "    'phecode_374-5', #Macular degeneration\n",
    " 'phecode_374-51', #Age-related macular degeneration\n",
    " 'phecode_374-42', #Diabetic retinopathy\n",
    " 'phecode_371', #Cataract\n",
    " 'phecode_388', #Blindness and low vision\n",
    " 'phecode_367-5', #Uveitis\n",
    " 'phecode_389-1' #Ocular pain\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "endpoint_defs = endpoint_defs %>% \n",
    "    mutate(name = phecode_string) %>%\n",
    "    mutate(name = \n",
    "           case_when( \n",
    "               phecode_string == \"Myocardial infarction [Heart attack]\"~\"Myocardial infarction\",\n",
    "               phecode_string == \"Cerebral infarction [Ischemic stroke]\"~\"Ischemic stroke\",\n",
    "               phecode_string == \"Chronic obstructive pulmonary disease [COPD]\"~\"Chronic obstructive pulmonary disease\",\n",
    "               phecode_string == \"Mitral valve insufficiency\"~\"Mitral insufficiency\",\n",
    "               phecode_string == \"Parkinson's disease (Primary)\"~\"Parkinson's disease\",\n",
    "               phecode_string == \"Suicide ideation and attempt or self harm\"~\"Suicide attempt\",\n",
    "               phecode_string == \"Ischemic heart disease\"~\"Coronary heart disease\",\n",
    "               phecode_string == \"Chronic kidney disease\"~\"Chronic kidney disease\",\n",
    "               phecode_string == \"Rheumatic fever and chronic rheumatic heart diseases\"~\"Rheumatic heart disease\",\n",
    "               phecode_string == \"Abdominal aortic aneurysm\"~\"Abdominal aortic aneurysm\",\n",
    "                  TRUE ~ name)\n",
    "           )\n",
    "            \n",
    "endpoint_map = endpoint_defs$name\n",
    "names(endpoint_map) =  endpoint_defs$endpoint\n",
    "#endpoint_order = (endpoint_defs %>% arrange(as.numeric(phecode)))$endpoint\n",
    "endpoint_order = endpoint_selection"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Load data"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Load Benchmarks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mJoining with `by = join_by(endpoint)`\n"
     ]
    }
   ],
   "source": [
    "#today = substr(Sys.time(), 0, 10) # YYYY-MM-DD\n",
    "today = '230323'\n",
    "name = glue(\"benchmarks_{today}\")\n",
    "benchmark_endpoints = arrow::read_feather(glue(\"{experiment_path}/{name}.feather\")) %>% left_join(endpoints_md) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint'. You can override using the\n",
      "`.groups` argument.\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 7 × 2</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>score</th><th scope=col>mean(cindex)</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>Retina        </td><td>0.5588917</td></tr>\n",
       "\t<tr><td>SCORE2        </td><td>0.5917204</td></tr>\n",
       "\t<tr><td>Age+Sex       </td><td>0.5928119</td></tr>\n",
       "\t<tr><td>ASCVD         </td><td>0.5937363</td></tr>\n",
       "\t<tr><td>Age+Sex+Retina</td><td>0.6003185</td></tr>\n",
       "\t<tr><td>SCORE2+Retina </td><td>0.6007473</td></tr>\n",
       "\t<tr><td>ASCVD+Retina  </td><td>0.6022785</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 7 × 2\n",
       "\\begin{tabular}{ll}\n",
       " score & mean(cindex)\\\\\n",
       " <chr> & <dbl>\\\\\n",
       "\\hline\n",
       "\t Retina         & 0.5588917\\\\\n",
       "\t SCORE2         & 0.5917204\\\\\n",
       "\t Age+Sex        & 0.5928119\\\\\n",
       "\t ASCVD          & 0.5937363\\\\\n",
       "\t Age+Sex+Retina & 0.6003185\\\\\n",
       "\t SCORE2+Retina  & 0.6007473\\\\\n",
       "\t ASCVD+Retina   & 0.6022785\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 7 × 2\n",
       "\n",
       "| score &lt;chr&gt; | mean(cindex) &lt;dbl&gt; |\n",
       "|---|---|\n",
       "| Retina         | 0.5588917 |\n",
       "| SCORE2         | 0.5917204 |\n",
       "| Age+Sex        | 0.5928119 |\n",
       "| ASCVD          | 0.5937363 |\n",
       "| Age+Sex+Retina | 0.6003185 |\n",
       "| SCORE2+Retina  | 0.6007473 |\n",
       "| ASCVD+Retina   | 0.6022785 |\n",
       "\n"
      ],
      "text/plain": [
       "  score          mean(cindex)\n",
       "1 Retina         0.5588917   \n",
       "2 SCORE2         0.5917204   \n",
       "3 Age+Sex        0.5928119   \n",
       "4 ASCVD          0.5937363   \n",
       "5 Age+Sex+Retina 0.6003185   \n",
       "6 SCORE2+Retina  0.6007473   \n",
       "7 ASCVD+Retina   0.6022785   "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "benchmark_endpoints %>% group_by(endpoint, score)  %>% summarise(cindex=mean(cindex)) %>% group_by(score) %>% summarise(mean(cindex)) %>% arrange(`mean(cindex)`)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint'. You can override using the\n",
      "`.groups` argument.\n"
     ]
    }
   ],
   "source": [
    "endpoints_sorted = (benchmark_endpoints %>% \n",
    "    filter(score == \"Age+Sex+Retina\") %>% \n",
    "    group_by(endpoint, score) %>% \n",
    "    summarise(cindex=mean(cindex, na.rm=TRUE)) %>% \n",
    "    arrange(cindex) %>% ungroup())$endpoint"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "categories_sorted = (endpoint_defs %>% distinct(phecode_category))$phecode_category"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# CALCULATE THE FREQ of significant!"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "plot_width = 10; plot_height=2.5; plot_res = 320\n",
    "options(repr.plot.width = plot_width, repr.plot.height = plot_height, repr.plot.res=plot_res)\n",
    "\n",
    "scores_plot = c(\"Age+Sex\", \"Age+Sex+Retina\")#, \"AgeSexRetina\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "options(repr.matrix.max.rows=1500, repr.matrix.max.cols=200)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "library(ggdist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[1] 172\n",
      "nrows with positive lower q of delta: 55\n",
      "nrows with negative lower q of delta: 117\n",
      "nrows with positive delta: 109\n",
      "nrows with negative delta: 63"
     ]
    }
   ],
   "source": [
    "table_2_pre = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    group_by(endpoint, score, phecode_string, phecode_category) %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    median_qi(delta) %>% filter(endpoint %in% endpoints_md$endpoint)\n",
    "    #mutate(posdelta = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\"))\n",
    "#table_2_pre %>% head()\n",
    "print(nrow(table_2_pre))\n",
    "\n",
    "cat(\"nrows with positive lower q of delta:\", nrow(table_2_pre %>% filter(.lower > 0)))\n",
    "cat(\"\\nnrows with negative lower q of delta:\", nrow(table_2_pre %>% filter(.lower <= 0)))\n",
    "cat(\"\\nnrows with positive delta:\", nrow(table_2_pre %>% filter(delta > 0)))\n",
    "cat(\"\\nnrows with negative delta:\", nrow(table_2_pre %>% filter(delta <= 0)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "table_2_significant = table_2_pre %>%\n",
    "    filter(delta > 0) %>%\n",
    "    filter(.lower > 0) %>%\n",
    "    arrange(endpoint)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "tags": []
   },
   "source": [
    "table_2_pre %>%\n",
    "    filter(delta > 0) %>%\n",
    "    filter(.lower > 0) %>%\n",
    "    arrange(endpoint) %>% \n",
    "    mutate_if(is.numeric, round, 3) %>%\n",
    "    write_csv(glue(\"outputs/SupplTable2_SignificantEndpoints_CropRatio-{crop_ratio}.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2022-11-30T14:21:35.048497Z",
     "iopub.status.busy": "2022-11-30T14:21:35.047303Z",
     "iopub.status.idle": "2022-11-30T14:21:35.089659Z",
     "shell.execute_reply": "2022-11-30T14:21:35.088017Z"
    },
    "tags": []
   },
   "source": [
    "table_2_pre %>%\n",
    "    arrange(endpoint) %>% \n",
    "    mutate_if(is.numeric, round, 3) %>%\n",
    "    write_csv(glue(\"outputs/SupplTable2_DeltasAllEndpoints_CropRatio-{crop_ratio}.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "execution": {
     "iopub.execute_input": "2022-11-30T14:21:35.093105Z",
     "iopub.status.busy": "2022-11-30T14:21:35.091887Z",
     "iopub.status.idle": "2022-11-30T14:21:35.106192Z",
     "shell.execute_reply": "2022-11-30T14:21:35.104788Z"
    }
   },
   "source": [
    "glue(\"outputs/SupplTable2_SignificantEndpoints_CropRatio-{crop_ratio}.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mJoining with `by = join_by(phecode_category)`\n",
      "\u001b[1m\u001b[22m`mutate_if()` ignored the following grouping variables:\n",
      "\u001b[36m•\u001b[39m Column `phecode_category`\n"
     ]
    },
    {
     "ename": "ERROR",
     "evalue": "Error in eval(parse(text = text, keep.source = FALSE), envir): object 'crop_ratio' not found\n",
     "output_type": "error",
     "traceback": [
      "Error in eval(parse(text = text, keep.source = FALSE), envir): object 'crop_ratio' not found\nTraceback:\n",
      "1. tmp %>% mutate_if(is.numeric, round, 3) %>% write_csv(glue(\"outputs/SupplTable2_RatioOfSignificantEndpoints-{crop_ratio}.csv\"))",
      "2. write_csv(., glue(\"outputs/SupplTable2_RatioOfSignificantEndpoints-{crop_ratio}.csv\"))",
      "3. write_delim(x, file, delim = \",\", na = na, append = append, col_names = col_names, \n .     quote = quote, escape = escape, eol = eol, num_threads = num_threads, \n .     progress = progress)",
      "4. vroom::vroom_write(x, file, delim = delim, col_names = col_names, \n .     append = append, na = na, eol = eol, quote = quote, escape = escape, \n .     num_threads = num_threads, progress = progress)",
      "5. standardise_one_path(file, write = TRUE)",
      "6. glue(\"outputs/SupplTable2_RatioOfSignificantEndpoints-{crop_ratio}.csv\")",
      "7. glue_data(.x = NULL, ..., .sep = .sep, .envir = .envir, .open = .open, \n .     .close = .close, .na = .na, .null = .null, .comment = .comment, \n .     .literal = .literal, .transformer = .transformer, .trim = .trim)",
      "8. (function (expr) \n . {\n .     eval_func <- .transformer(expr, env) %||% .null\n .     tryCatch(if (is.null(eval_func)) \n .         NULL\n .     else as.character(eval_func), error = function(e) {\n .         if (is.function(eval_func)) {\n .             message <- paste0(\"glue cannot interpolate functions into strings.\\n\", \n .                 \"* object '\", expr, \"' is a function.\")\n .             stop(message, call. = FALSE)\n .         }\n .         stop(e)\n .     })\n . })(\"crop_ratio\")",
      "9. .transformer(expr, env) %||% .null",
      "10. .transformer(expr, env)",
      "11. eval(parse(text = text, keep.source = FALSE), envir)",
      "12. eval(parse(text = text, keep.source = FALSE), envir)"
     ]
    }
   ],
   "source": [
    "og_counts = table_2_pre %>% group_by(phecode_category) %>% count() %>% select(phecode_category, n) %>% rename(N_total = n)\n",
    "tmp = table_2_significant %>% group_by(phecode_category) %>% count() %>% left_join(og_counts) %>% mutate(Percent_Significant=n/ N_total) \n",
    "#%>%        unite(s, n, N_total, sep = \"/\", remove=FALSE)\n",
    "tmp %>%  \n",
    "mutate_if(is.numeric, round, 3) %>%\n",
    "write_csv(glue(\"outputs/SupplTable2_RatioOfSignificantEndpoints-{crop_ratio}.csv\"))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "tags": []
   },
   "source": [
    "## delta c-idx with negative values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint', 'phecode_string'. You can\n",
      "override using the `.groups` argument.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAClAAAAKACAIAAABmfTB4AAAABmJLR0QA/wD/AP+gvaeTAAAg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\nAAAAAACguSmKwpbmANB0/x8U4019xGaK6wAAAABJRU5ErkJggg==",
      "text/plain": [
       "plot without title"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 320,
       "width": 1320
      }
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "geom.text.size = 1\n",
    "\n",
    "temp = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    ungroup() %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    summarise(delta = median(delta)) %>%\n",
    "    mutate(pos = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\")) %>%\n",
    "    mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "    mutate(highlight = case_when(endpoint %in% endpoint_selection ~ \"YES\", TRUE ~ \"NO\")) %>%# %>% filter(endpoint %in% endpoint_sample)\n",
    "    mutate(phecode_category = factor(phecode_category, levels=categories_sorted))\n",
    "\n",
    "endpoint_order = (temp %>% arrange(delta))$endpoint\n",
    "\n",
    "temp = temp %>% mutate(endpoint = factor(endpoint, levels=endpoint_order)) %>% ungroup() %>% arrange(endpoint) %>% group_by(phecode_category) %>% mutate(endpoint = row_number())\n",
    "\n",
    "ggplot(temp) +\n",
    "    geom_ribbon(aes(x=endpoint, ymin=0, ymax=delta), fill=\"black\", alpha=0.2)+\n",
    "    geom_point(aes(x=endpoint, y=delta, color=highlight, size=highlight, alpha=highlight)) +\n",
    "    geom_text(data=temp %>% filter(highlight==\"YES\"), aes(x=endpoint, y=delta+0.045, label=\"↓\"), color=\"black\", size=5, alpha=0.7) +\n",
    "#     geom_text(data=tmp,\n",
    "#               mapping = aes(x = -Inf, y = -Inf, label =s),\n",
    "#               hjust   = -0.1, \n",
    "#               vjust   = -13) + \n",
    "    #geom_segment(aes(x=endpoint, xend=endpoint, y=0, yend=delta, color=highlight, size=highlight), alpha=0.5)+#+\n",
    "    labs(x=\"Endpoints\", y=glue(\"Delta C-Index\"))+\n",
    "    scale_color_manual(values=c(\"NO\"=\"black\", \"YES\"=\"firebrick\"))+\n",
    "    scale_alpha_manual(values=c(\"NO\"=0.1, \"YES\"=1))+\n",
    "    scale_size_manual(values=c(\"NO\"=0.01, \"YES\"=1))+\n",
    "    #scale_colour_manual(values = c(\"pos\"=\"forestgreen\", \"neg\" = \"firebrick\")) + \n",
    "    #coord_polar() +\n",
    "    coord_cartesian(ylim=c(-0.1, 0.1), clip = \"off\")+\n",
    "    scale_y_continuous(expand=c(0, 0))+\n",
    "    scale_x_discrete(expand=expansion(add=20))+\n",
    "    facet_grid(~phecode_category, scales=\"free_x\", space=\"free_x\")+#, switch=TRUE)+\n",
    "    #facet_grid2(~phecode_category, scales = \"free\", independent = \"all\") + \n",
    "    theme(axis.title.x=element_blank(),\n",
    "        axis.text.x=element_blank(),\n",
    "        axis.ticks.x=element_blank(),\n",
    "        panel.grid.major=element_blank(), \n",
    "         strip.text = element_text(angle=270)) + \n",
    "    theme(legend.position=\"none\") \n",
    "    \n",
    "    #geom_ribbon(aes(x=id, ymin=AgeSex, ymax=`Age+Sex+Retina`), fill=\"red\", alpha=0.2)\n",
    "#geom_violin(size=0.1)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## delta c-idx with positive values (negative set to 0)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22m`summarise()` has grouped output by 'endpoint', 'phecode_string'. You can\n",
      "override using the `.groups` argument.\n"
     ]
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAADIAAAAMgCAIAAABusm8oAAAABmJLR0QA/wD/AP+gvaeTAAAg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\nAAAAAAAAlvQ/eg+4nYb3VzkAAAAASUVORK5CYII=",
      "text/plain": [
       "plot without title"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 400,
       "width": 1600
      }
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_width = 10; plot_height=2.5; plot_res = 320\n",
    "options(repr.plot.width = plot_width, repr.plot.height = plot_height, repr.plot.res=plot_res)\n",
    "\n",
    "scores_plot = c(\"Age+Sex\", \"Age+Sex+Retina\")#, \"AgeSexRetina\")\n",
    "\n",
    "temp_pos = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    ungroup() %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>% filter(endpoint %in% endpoints_md$endpoint)\n",
    "\n",
    "temp_pos = temp_pos %>%\n",
    "    group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "    summarise(delta = median(delta)) %>%\n",
    "    mutate(pos = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\")) %>%\n",
    "    mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "    mutate(highlight = case_when(endpoint %in% endpoint_selection ~ \"YES\", TRUE ~ \"NO\")) %>%# %>% filter(endpoint %in% endpoint_sample)\n",
    "    mutate(phecode_category = factor(phecode_category, levels=categories_sorted))\n",
    "\n",
    "endpoint_order = (temp_pos %>% arrange(delta))$endpoint\n",
    "\n",
    "temp_pos = temp_pos %>% mutate(endpoint = factor(endpoint, levels=endpoint_order)) %>% ungroup() %>% arrange(endpoint) %>% group_by(phecode_category) %>% mutate(endpoint = row_number())\n",
    "\n",
    "fig3a = ggplot(temp_pos) +\n",
    "    geom_ribbon(aes(x=endpoint, ymin=0, ymax=delta), fill=\"black\", alpha=0.2)+\n",
    "    geom_point(aes(x=endpoint, y=delta, color=highlight, size=highlight, alpha=highlight)) +\n",
    "    geom_text(data=temp_pos %>% filter(highlight==\"YES\"), aes(x=endpoint, y=delta+0.015, label=\"↓\"), color=\"black\", size=5, alpha=0.7) +\n",
    "    #geom_segment(aes(x=endpoint, xend=endpoint, y=0, yend=delta, color=highlight, size=highlight), alpha=0.5)+#+\n",
    "    labs(x=\"Endpoints\", y=glue(\"Delta C-Index\"))+\n",
    "    scale_color_manual(values=c(\"NO\"=\"black\", \"YES\"=\"firebrick\"))+\n",
    "    scale_alpha_manual(values=c(\"NO\"=0.1, \"YES\"=1))+\n",
    "    scale_size_manual(values=c(\"NO\"=0.01, \"YES\"=1))+\n",
    "    #scale_colour_manual(values = c(\"pos\"=\"forestgreen\", \"neg\" = \"firebrick\")) + \n",
    "    #coord_polar() +\n",
    "    coord_cartesian(ylim=c(NA, 0.1), clip = \"off\")+\n",
    "    scale_y_continuous(expand=c(0, 0))+\n",
    "    scale_x_discrete(expand=expansion(add=2))+\n",
    "    facet_grid(~phecode_category, scales=\"free_x\", space=\"free_x\")+#, switch=TRUE)+\n",
    "    #facet_grid2(~phecode_category, scales = \"free\", independent = \"all\") + \n",
    "    theme(axis.title.x=element_blank(),\n",
    "        axis.text.x=element_blank(),\n",
    "        axis.ticks.x=element_blank(),\n",
    "        panel.grid.major=element_blank(), \n",
    "         strip.text = element_text(angle=270)) + \n",
    "    theme(legend.position=\"none\") \n",
    "    \n",
    "fig3a    \n",
    "#geom_ribbon(aes(x=id, ymin=AgeSex, ymax=`Age+Sex+Retina`), fill=\"red\", alpha=0.2)\n",
    "#geom_violin(size=0.1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <e2>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <86>”\n",
      "Warning message in grid.Call.graphics(C_text, as.graphicsAnnot(x$label), x$x, x$y, :\n",
      "“conversion failure on '↓' in 'mbcsToSbcs': dot substituted for <93>”\n"
     ]
    }
   ],
   "source": [
    "plot_name = \"SupplFigure3a_EPIC_Discrimination_PhenomeWide\"\n",
    "fig3a %>% ggsave(filename=glue(\"outputs/{plot_name}.pdf\"), device=\"pdf\", width=plot_width, height=plot_height, dpi=plot_res, limitsize=FALSE)\n",
    "fig3a %>% ggsave(filename=glue(\"outputs/{plot_name}.png\"), device=\"png\", width=plot_width, height=plot_height, dpi=plot_res, limitsize=FALSE)\n",
    "temp_pos %>% write_csv(glue(\"outputs/SupplFigure3a.csv\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "ukb = fread(\"SupplTables - ST4_ DiscriminativePerformaceAllEndpoints.csv\")\n",
    "ukb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {},
   "outputs": [],
   "source": [
    "epic_agg <- benchmark_endpoints %>%\n",
    "  filter(score %in% scores_plot) %>%\n",
    "  mutate(score = factor(score, levels = scores_plot)) %>%\n",
    "  mutate(endpoint = factor(endpoint, levels = endpoints_sorted)) %>%\n",
    "  ungroup() %>%\n",
    "  pivot_wider(names_from = score, values_from = cindex) %>% \n",
    "  mutate(id = row_number()) %>%\n",
    "  mutate(delta = `Age+Sex+Retina` - `Age+Sex`) %>%\n",
    "  filter(endpoint %in% endpoints_md$endpoint) %>%\n",
    "  group_by(endpoint, phecode_string, phecode_category) %>%\n",
    "  median_qi(`Age+Sex`, `Age+Sex+Retina`, delta) %>%\n",
    "  mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "  mutate(phecode_category = factor(phecode_category, levels = categories_sorted))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "\u001b[1m\u001b[22mAdding missing grouping variables: `endpoint`, `phecode_string`\n"
     ]
    }
   ],
   "source": [
    "epic <- epic_agg %>%\n",
    "  mutate(epic_agesex = glue(\"{round(`Age+Sex`, 3)} ({round(`Age+Sex.lower`, 3)}, {round(`Age+Sex.upper`, 3)})\"),\n",
    "         epic_agesexretina = glue(\"{round(`Age+Sex+Retina`, 3)} ({round(`Age+Sex+Retina.lower`, 3)}, {round(`Age+Sex+Retina.upper`, 3)})\"),\n",
    "         epic_delta = glue(\"{round(delta, 3)} ({round(`delta.lower`, 3)}, {round(`delta.upper`, 3)})\")\n",
    "        ) %>%\n",
    "  select(epic_agesex, epic_agesexretina, epic_delta)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4 = ukb %>% left_join(epic, by=c(\"endpoint\", \"phecode_string\")) %>% as_tibble()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4_clean <- st4 %>%\n",
    "  mutate(across(everything(), ~ replace_na(., \"\"), .names = \"{col}\"))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 1171 × 9</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>phecode_category</th><th scope=col>endpoint</th><th scope=col>phecode_string</th><th scope=col>ukb_agesex</th><th scope=col>ukb_agesexretina</th><th scope=col>ukb_delta</th><th scope=col>epic_agesex</th><th scope=col>epic_agesexretina</th><th scope=col>epic_delta</th></tr>\n",
       "\t<tr><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;glue&gt;</th><th scope=col>&lt;glue&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>Blood         </td><td>phecode_165    </td><td>Hemoglobinopathies                                                                                      </td><td>0.612 (0.575, 0.655)</td><td>0.872 (0.85, 0.905) </td><td>0.259 (0.214, 0.312)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387-2  </td><td>Myopia                                                                                                  </td><td>0.585 (0.565, 0.603)</td><td>0.818 (0.803, 0.833)</td><td>0.232 (0.213, 0.26)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_688-1  </td><td>Sarcoidosis                                                                                             </td><td>0.29 (0.255, 0.319) </td><td>0.5 (0.457, 0.543)  </td><td>0.207 (0.161, 0.263)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_665-3  </td><td>Other psoriasis                                                                                         </td><td>0.373 (0.328, 0.41) </td><td>0.547 (0.506, 0.579)</td><td>0.175 (0.12, 0.23)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_373    </td><td>Noninflammatory disorders of choroid                                                                    </td><td>0.582 (0.547, 0.613)</td><td>0.753 (0.712, 0.783)</td><td>0.173 (0.139, 0.203)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_665-2  </td><td>Psoriatic arthropathy                                                                                   </td><td>0.37 (0.324, 0.405) </td><td>0.537 (0.5, 0.572)  </td><td>0.169 (0.122, 0.214)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_005    </td><td>Mycobacteria                                                                                            </td><td>0.485 (0.447, 0.532)</td><td>0.651 (0.602, 0.695)</td><td>0.169 (0.117, 0.225)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-3  </td><td>Benign neoplasm of other connective and soft tissue                                                     </td><td>0.4 (0.352, 0.446)  </td><td>0.551 (0.502, 0.592)</td><td>0.149 (0.096, 0.188)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_377-5  </td><td>Vitreous hemorrhage                                                                                     </td><td>0.546 (0.507, 0.577)</td><td>0.684 (0.645, 0.732)</td><td>0.143 (0.094, 0.184)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-71 </td><td>Long term (current) use of insulin                                                                      </td><td>0.595 (0.576, 0.616)</td><td>0.735 (0.715, 0.755)</td><td>0.139 (0.12, 0.161)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-11 </td><td>Mallet finger                                                                                           </td><td>0.396 (0.369, 0.43) </td><td>0.535 (0.498, 0.56) </td><td>0.138 (0.081, 0.173)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_096    </td><td>Contact or exposure to infectious agent                                                                 </td><td>0.429 (0.405, 0.451)</td><td>0.563 (0.536, 0.593)</td><td>0.135 (0.099, 0.165)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_008    </td><td>Helicobacter [H. pylori]                                                                                </td><td>0.442 (0.421, 0.471)</td><td>0.574 (0.548, 0.602)</td><td>0.132 (0.1, 0.168)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_370    </td><td>Disorders of iris and ciliary body                                                                      </td><td>0.622 (0.595, 0.648)</td><td>0.745 (0.725, 0.774)</td><td>0.127 (0.1, 0.152)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369-5  </td><td>Hereditary corneal dystrophies                                                                          </td><td>0.64 (0.611, 0.675) </td><td>0.766 (0.735, 0.804)</td><td>0.126 (0.092, 0.162)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-6  </td><td>Halitosis*                                                                                              </td><td>0.406 (0.355, 0.442)</td><td>0.529 (0.493, 0.567)</td><td>0.125 (0.086, 0.168)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-1  </td><td>Amblyopia                                                                                               </td><td>0.599 (0.576, 0.622)</td><td>0.712 (0.688, 0.738)</td><td>0.114 (0.086, 0.136)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_337-8  </td><td>Polyneuropathy in diseases classified elsewhere                                                         </td><td>0.645 (0.613, 0.681)</td><td>0.756 (0.726, 0.8)  </td><td>0.111 (0.065, 0.155)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-52 </td><td>Lipoma of intrathoracic organs                                                                          </td><td>0.431 (0.383, 0.465)</td><td>0.537 (0.495, 0.569)</td><td>0.109 (0.061, 0.16)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_110    </td><td>Malignant neoplasm of the endocrine glands                                                              </td><td>0.458 (0.417, 0.492)</td><td>0.564 (0.513, 0.611)</td><td>0.109 (0.047, 0.158)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-8  </td><td>Retinal edema                                                                                           </td><td>0.652 (0.628, 0.682)</td><td>0.758 (0.732, 0.785)</td><td>0.107 (0.089, 0.126)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387    </td><td>Disorders of refraction and accommodation                                                               </td><td>0.656 (0.643, 0.666)</td><td>0.761 (0.751, 0.772)</td><td>0.106 (0.093, 0.119)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_059-1  </td><td>COVID-19*                                                                                               </td><td>0.504 (0.468, 0.542)</td><td>0.61 (0.57, 0.651)  </td><td>0.106 (0.06, 0.17)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977    </td><td>Long term (current) drug therapy                                                                        </td><td>0.489 (0.481, 0.494)</td><td>0.593 (0.588, 0.599)</td><td>0.105 (0.098, 0.112)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-11 </td><td>Serous retinal detachment                                                                               </td><td>0.59 (0.568, 0.615) </td><td>0.696 (0.675, 0.723)</td><td>0.105 (0.076, 0.131)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_676-1  </td><td>Hypertrophic scar [Keloid scar]                                                                         </td><td>0.507 (0.478, 0.542)</td><td>0.613 (0.576, 0.647)</td><td>0.103 (0.065, 0.143)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712-1  </td><td>Loose body in joint                                                                                     </td><td>0.444 (0.412, 0.485)</td><td>0.546 (0.511, 0.583)</td><td>0.102 (0.058, 0.138)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-512</td><td>Exuadative (wet) age-related macular degeneration                                                       </td><td>0.751 (0.722, 0.78) </td><td>0.85 (0.826, 0.88)  </td><td>0.101 (0.071, 0.127)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387-1  </td><td>Hypermetropia                                                                                           </td><td>0.707 (0.671, 0.741)</td><td>0.803 (0.777, 0.828)</td><td>0.097 (0.063, 0.125)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-21 </td><td>Pallor                                                                                                  </td><td>0.462 (0.419, 0.508)</td><td>0.558 (0.512, 0.606)</td><td>0.097 (0.038, 0.143)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-6  </td><td>Episcleritis                                                                                            </td><td>0.478 (0.446, 0.509)</td><td>0.572 (0.543, 0.61) </td><td>0.096 (0.066, 0.13)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_205    </td><td>Hypoglycemia                                                                                            </td><td>0.656 (0.639, 0.68) </td><td>0.75 (0.728, 0.769) </td><td>0.094 (0.07, 0.119)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-1  </td><td>Retinal detachments and breaks                                                                          </td><td>0.582 (0.567, 0.599)</td><td>0.676 (0.661, 0.688)</td><td>0.093 (0.078, 0.111)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_385    </td><td>Abnormal results of function studies of eye                                                             </td><td>0.587 (0.557, 0.622)</td><td>0.678 (0.646, 0.708)</td><td>0.093 (0.057, 0.115)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504-1  </td><td>Gingivitis                                                                                              </td><td>0.422 (0.389, 0.454)</td><td>0.515 (0.478, 0.554)</td><td>0.093 (0.055, 0.141)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_236-11 </td><td>Morbid obesity                                                                                          </td><td>0.577 (0.553, 0.605)</td><td>0.666 (0.646, 0.69) </td><td>0.088 (0.068, 0.111)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_059    </td><td>Coronavirus                                                                                             </td><td>0.501 (0.465, 0.541)</td><td>0.59 (0.536, 0.641) </td><td>0.088 (0.041, 0.135)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_352-1  </td><td>Anosmia*                                                                                                </td><td>0.455 (0.418, 0.488)</td><td>0.544 (0.503, 0.574)</td><td>0.088 (0.039, 0.135)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202-4  </td><td>Other specified diabetes*                                                                               </td><td>0.613 (0.607, 0.619)</td><td>0.698 (0.693, 0.704)</td><td>0.086 (0.08, 0.091)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-7  </td><td>Long term (current) use of insulin or oral hypoglycemic drugs                                           </td><td>0.61 (0.601, 0.618) </td><td>0.696 (0.687, 0.703)</td><td>0.086 (0.078, 0.094)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-12 </td><td>Alcohol dependence                                                                                      </td><td>0.535 (0.518, 0.553)</td><td>0.622 (0.605, 0.637)</td><td>0.086 (0.066, 0.105)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-4  </td><td>Retinal disorders in diseases classified elsewhere                                                      </td><td>0.629 (0.622, 0.64) </td><td>0.714 (0.705, 0.725)</td><td>0.085 (0.074, 0.093)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-51 </td><td>Calcaneal spur                                                                                          </td><td>0.43 (0.389, 0.457) </td><td>0.517 (0.486, 0.551)</td><td>0.084 (0.047, 0.138)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-2  </td><td>Hyper-coagulability                                                                                     </td><td>0.446 (0.4, 0.487)  </td><td>0.528 (0.485, 0.563)</td><td>0.084 (0.034, 0.13)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-51 </td><td>Age-related macular degeneration                                                                        </td><td>0.752 (0.738, 0.766)</td><td>0.834 (0.819, 0.844)</td><td>0.083 (0.071, 0.094)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-5  </td><td>Uveitis                                                                                                 </td><td>0.526 (0.505, 0.551)</td><td>0.61 (0.59, 0.636)  </td><td>0.083 (0.059, 0.11)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_498    </td><td>Asphyxia and hypoxemia                                                                                  </td><td>0.616 (0.576, 0.656)</td><td>0.7 (0.666, 0.741)  </td><td>0.083 (0.045, 0.114)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_097-1  </td><td>Methicillin resistant Staphylococcus aureus                                                             </td><td>0.458 (0.421, 0.492)</td><td>0.541 (0.502, 0.583)</td><td>0.083 (0.033, 0.125)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-72 </td><td>Long term (current) use of oral hypoglycemic drugs                                                      </td><td>0.614 (0.606, 0.623)</td><td>0.695 (0.688, 0.704)</td><td>0.082 (0.073, 0.089)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202-1  </td><td>Type 1 diabetes                                                                                         </td><td>0.615 (0.596, 0.638)</td><td>0.698 (0.679, 0.719)</td><td>0.082 (0.06, 0.11)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-52 </td><td>Iridocyclitis                                                                                           </td><td>0.523 (0.504, 0.549)</td><td>0.608 (0.59, 0.628) </td><td>0.082 (0.058, 0.105)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_366-1  </td><td>Pterygium of eye                                                                                        </td><td>0.498 (0.458, 0.536)</td><td>0.576 (0.543, 0.631)</td><td>0.081 (0.035, 0.136)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-42 </td><td>Diabetic retinopathy                                                                                    </td><td>0.63 (0.621, 0.637) </td><td>0.708 (0.697, 0.714)</td><td>0.079 (0.071, 0.086)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-72 </td><td>Iron deficiency                                                                                         </td><td>0.545 (0.536, 0.554)</td><td>0.624 (0.617, 0.631)</td><td>0.079 (0.069, 0.086)   </td><td>0.62 (0.606, 0.644) </td><td>0.631 (0.617, 0.652)</td><td>0.012 (0.007, 0.017)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_501    </td><td>Dental caries                                                                                           </td><td>0.482 (0.465, 0.498)</td><td>0.56 (0.538, 0.579) </td><td>0.079 (0.053, 0.104)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_211    </td><td>Disorders of adrenal glands                                                                             </td><td>0.553 (0.516, 0.592)</td><td>0.634 (0.6, 0.673)  </td><td>0.079 (0.042, 0.123)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325-1  </td><td>Abnormal involuntary movements                                                                          </td><td>0.382 (0.339, 0.427)</td><td>0.459 (0.421, 0.503)</td><td>0.079 (0.029, 0.133)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160-1  </td><td>Iron deficiency anemia                                                                                  </td><td>0.554 (0.545, 0.565)</td><td>0.632 (0.621, 0.639)</td><td>0.077 (0.066, 0.085)   </td><td>0.607 (0.594, 0.62) </td><td>0.619 (0.6, 0.634)  </td><td>0.011 (0.005, 0.016)   </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-1  </td><td>Microcytic anemia                                                                                       </td><td>0.555 (0.544, 0.563)</td><td>0.631 (0.62, 0.639) </td><td>0.076 (0.068, 0.084)   </td><td>0.62 (0.598, 0.641) </td><td>0.632 (0.607, 0.647)</td><td>0.009 (0.005, 0.016)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369    </td><td>Noninflammatory disorders of the cornea                                                                 </td><td>0.633 (0.617, 0.648)</td><td>0.709 (0.685, 0.728)</td><td>0.076 (0.061, 0.09)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_546-3  </td><td>Hepatomegaly                                                                                            </td><td>0.538 (0.504, 0.585)</td><td>0.616 (0.574, 0.67) </td><td>0.076 (0.023, 0.134)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-1  </td><td>Acquired deformities of fingers                                                                         </td><td>0.445 (0.424, 0.476)</td><td>0.523 (0.499, 0.549)</td><td>0.075 (0.043, 0.109)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-3  </td><td>Mixed hyperlipidemia                                                                                    </td><td>0.48 (0.455, 0.51)  </td><td>0.56 (0.528, 0.595) </td><td>0.075 (0.041, 0.123)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_236-1  </td><td>Obesity                                                                                                 </td><td>0.511 (0.506, 0.516)</td><td>0.585 (0.58, 0.589) </td><td>0.074 (0.067, 0.08)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283-4  </td><td>Patient's noncompliance with medical treatment and regimen                                              </td><td>0.497 (0.489, 0.505)</td><td>0.572 (0.564, 0.579)</td><td>0.074 (0.062, 0.087)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-4  </td><td>Demoralization and apathy                                                                               </td><td>0.548 (0.521, 0.575)</td><td>0.622 (0.594, 0.649)</td><td>0.074 (0.038, 0.107)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674-11 </td><td>Vitiligo                                                                                                </td><td>0.516 (0.476, 0.558)</td><td>0.587 (0.539, 0.638)</td><td>0.074 (0.011, 0.13)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_097    </td><td>Drug resistant microorganisms                                                                           </td><td>0.479 (0.441, 0.514)</td><td>0.55 (0.517, 0.587) </td><td>0.073 (0.039, 0.109)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_236    </td><td>Overweight and obesity                                                                                  </td><td>0.512 (0.506, 0.517)</td><td>0.584 (0.58, 0.59)  </td><td>0.072 (0.066, 0.079)   </td><td>0.462 (0.429, 0.496)</td><td>0.503 (0.483, 0.535)</td><td>0.048 (0.018, 0.063)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-7  </td><td>Disorders of iron metabolism                                                                            </td><td>0.546 (0.538, 0.554)</td><td>0.618 (0.61, 0.625) </td><td>0.072 (0.063, 0.078)   </td><td>0.619 (0.6, 0.624)  </td><td>0.626 (0.613, 0.641)</td><td>0.012 (0.004, 0.019)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542    </td><td>Chronic liver disease and sequelae                                                                      </td><td>0.517 (0.509, 0.528)</td><td>0.589 (0.579, 0.598)</td><td>0.072 (0.057, 0.084)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_829-2  </td><td>Abnormal level of blood mineral*                                                                        </td><td>0.498 (0.481, 0.513)</td><td>0.571 (0.552, 0.591)</td><td>0.072 (0.055, 0.097)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202-2  </td><td>Type 2 diabetes                                                                                         </td><td>0.591 (0.585, 0.599)</td><td>0.662 (0.657, 0.667)</td><td>0.071 (0.063, 0.077)   </td><td>0.604 (0.595, 0.621)</td><td>0.637 (0.625, 0.643)</td><td>0.029 (0.018, 0.041)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-1  </td><td>Fibrosis and cirrhosis of liver                                                                         </td><td>0.636 (0.603, 0.66) </td><td>0.705 (0.678, 0.737)</td><td>0.071 (0.05, 0.1)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333-4  </td><td>Circadian rhythm sleep disorder                                                                         </td><td>0.438 (0.398, 0.481)</td><td>0.508 (0.468, 0.55) </td><td>0.071 (0.022, 0.119)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_202    </td><td>Diabetes mellitus                                                                                       </td><td>0.593 (0.586, 0.597)</td><td>0.662 (0.657, 0.668)</td><td>0.07 (0.063, 0.076)    </td><td>0.608 (0.591, 0.627)</td><td>0.635 (0.622, 0.654)</td><td>0.028 (0.013, 0.04)    </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_821    </td><td>Abnormality of red blood cells                                                                          </td><td>0.515 (0.485, 0.542)</td><td>0.587 (0.551, 0.611)</td><td>0.07 (0.044, 0.099)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-51 </td><td>Hypocalcemia                                                                                            </td><td>0.49 (0.449, 0.531) </td><td>0.564 (0.512, 0.597)</td><td>0.07 (0.016, 0.113)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232    </td><td>Vitamin deficiencies                                                                                    </td><td>0.549 (0.543, 0.556)</td><td>0.619 (0.613, 0.624)</td><td>0.069 (0.062, 0.077)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160    </td><td>Nutritional anemias                                                                                     </td><td>0.564 (0.556, 0.575)</td><td>0.633 (0.625, 0.641)</td><td>0.069 (0.061, 0.076)   </td><td>0.625 (0.61, 0.635) </td><td>0.634 (0.622, 0.65) </td><td>0.011 (0.008, 0.016)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-13 </td><td>Alcoholic liver disease                                                                                 </td><td>0.635 (0.601, 0.66) </td><td>0.702 (0.669, 0.733)</td><td>0.069 (0.041, 0.095)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-54 </td><td>Abscess or ulceration of vulva                                                                          </td><td>0.418 (0.369, 0.452)</td><td>0.484 (0.439, 0.535)</td><td>0.069 (0.018, 0.118)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-4  </td><td>Portal hypertension                                                                                     </td><td>0.646 (0.601, 0.681)</td><td>0.713 (0.672, 0.749)</td><td>0.068 (0.038, 0.098)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674-1  </td><td>Hypopigmentation                                                                                        </td><td>0.537 (0.498, 0.571)</td><td>0.603 (0.562, 0.642)</td><td>0.068 (0.021, 0.099)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_135-1  </td><td>Benign neoplasm of the oral cavity                                                                      </td><td>0.503 (0.466, 0.541)</td><td>0.57 (0.533, 0.606) </td><td>0.067 (0.015, 0.1)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281-2  </td><td>Substance dependence                                                                                    </td><td>0.538 (0.53, 0.545) </td><td>0.605 (0.596, 0.613)</td><td>0.066 (0.058, 0.074)   </td><td>0.541 (0.517, 0.563)</td><td>0.634 (0.609, 0.664)</td><td>0.095 (0.062, 0.134)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-511</td><td>Nonexuadative (dry) age-related macular degeneration                                                    </td><td>0.759 (0.736, 0.784)</td><td>0.824 (0.806, 0.846)</td><td>0.064 (0.045, 0.086)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_287    </td><td>Psychotic disorder                                                                                      </td><td>0.531 (0.497, 0.559)</td><td>0.592 (0.554, 0.631)</td><td>0.064 (0.015, 0.1)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_540-1  </td><td>Chronic hepatitis                                                                                       </td><td>0.535 (0.498, 0.585)</td><td>0.598 (0.567, 0.634)</td><td>0.063 (0.029, 0.102)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371-3  </td><td>Nuclear cataract                                                                                        </td><td>0.744 (0.736, 0.754)</td><td>0.805 (0.799, 0.814)</td><td>0.062 (0.054, 0.067)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-2  </td><td>Vitamin B group deficiency                                                                              </td><td>0.568 (0.558, 0.581)</td><td>0.63 (0.618, 0.643) </td><td>0.062 (0.048, 0.072)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_292    </td><td>Somatoform disorders                                                                                    </td><td>0.487 (0.449, 0.526)</td><td>0.546 (0.494, 0.598)</td><td>0.062 (0.016, 0.096)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371-31 </td><td>Age-related nuclear cataract                                                                            </td><td>0.745 (0.735, 0.751)</td><td>0.806 (0.799, 0.812)</td><td>0.061 (0.055, 0.069)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-4  </td><td>Vitamin D deficiency                                                                                    </td><td>0.571 (0.565, 0.578)</td><td>0.631 (0.624, 0.64) </td><td>0.06 (0.052, 0.067)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-2  </td><td>Fatty liver disease (FLD)                                                                               </td><td>0.525 (0.513, 0.535)</td><td>0.585 (0.573, 0.596)</td><td>0.06 (0.043, 0.072)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_380-2  </td><td>Disorders of optic disc                                                                                 </td><td>0.551 (0.513, 0.581)</td><td>0.611 (0.574, 0.645)</td><td>0.06 (0.023, 0.091)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-5  </td><td>Macular degeneration                                                                                    </td><td>0.715 (0.707, 0.725)</td><td>0.775 (0.769, 0.784)</td><td>0.059 (0.052, 0.066)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_343    </td><td>Disorders of autonomic nervous system                                                                   </td><td>0.52 (0.495, 0.546) </td><td>0.579 (0.544, 0.616)</td><td>0.059 (0.029, 0.093)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369-1  </td><td>Corneal scars and opacities                                                                             </td><td>0.631 (0.587, 0.674)</td><td>0.692 (0.655, 0.736)</td><td>0.058 (0.023, 0.107)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-2  </td><td>Pallor and flushing                                                                                     </td><td>0.516 (0.491, 0.542)</td><td>0.573 (0.551, 0.602)</td><td>0.057 (0.036, 0.084)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_251-1  </td><td>Gilbert syndrome*                                                                                       </td><td>0.551 (0.523, 0.59) </td><td>0.61 (0.575, 0.639) </td><td>0.056 (0.038, 0.071)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-5  </td><td>Noninfectious dermatoses of eyelid                                                                      </td><td>0.595 (0.568, 0.622)</td><td>0.652 (0.621, 0.677)</td><td>0.056 (0.034, 0.079)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_237    </td><td>Abnormal weight gain                                                                                    </td><td>0.504 (0.477, 0.523)</td><td>0.559 (0.541, 0.583)</td><td>0.056 (0.03, 0.081)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705-5  </td><td>Rheumatism, unspecified                                                                                 </td><td>0.457 (0.422, 0.49) </td><td>0.512 (0.473, 0.552)</td><td>0.056 (0.005, 0.102)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374    </td><td>Disorders of the retina                                                                                 </td><td>0.632 (0.624, 0.637)</td><td>0.687 (0.68, 0.693) </td><td>0.055 (0.051, 0.06)    </td><td>0.685 (0.67, 0.696) </td><td>0.741 (0.721, 0.763)</td><td>0.059 (0.037, 0.069)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351-2  </td><td>Hypoesthesia of skin*                                                                                   </td><td>0.701 (0.688, 0.717)</td><td>0.755 (0.741, 0.768)</td><td>0.055 (0.041, 0.067)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_098    </td><td>Carrier or suspected carrier of infectious diseases                                                     </td><td>0.59 (0.56, 0.622)  </td><td>0.645 (0.621, 0.681)</td><td>0.055 (0.03, 0.082)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281    </td><td>Substance abuse, dependence, and withdrawl                                                              </td><td>0.546 (0.537, 0.551)</td><td>0.6 (0.594, 0.607)  </td><td>0.054 (0.049, 0.063)   </td><td>0.549 (0.502, 0.569)</td><td>0.63 (0.61, 0.647)  </td><td>0.089 (0.064, 0.111)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_380    </td><td>Disorders of optic nerve and visual pathways                                                            </td><td>0.582 (0.554, 0.603)</td><td>0.637 (0.613, 0.658)</td><td>0.054 (0.032, 0.081)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_086    </td><td>Pediculosis, acariasis and other infestations                                                           </td><td>0.455 (0.432, 0.488)</td><td>0.51 (0.48, 0.541)  </td><td>0.054 (0.023, 0.087)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_812-2  </td><td>Angioneurotic edema                                                                                     </td><td>0.473 (0.427, 0.5)  </td><td>0.525 (0.485, 0.561)</td><td>0.054 (0.021, 0.101)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_371    </td><td>Cataract                                                                                                </td><td>0.732 (0.728, 0.736)</td><td>0.784 (0.781, 0.789)</td><td>0.053 (0.049, 0.055)   </td><td>0.711 (0.708, 0.72) </td><td>0.762 (0.755, 0.765)</td><td>0.049 (0.042, 0.054)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247    </td><td>Disorders of mineral metabolism and mineral deficiencies                                                </td><td>0.563 (0.556, 0.571)</td><td>0.616 (0.608, 0.625)</td><td>0.053 (0.046, 0.06)    </td><td>0.621 (0.6, 0.636)  </td><td>0.629 (0.608, 0.642)</td><td>0.007 (0.005, 0.012)   </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-3  </td><td>Mixed disorder of acid-base balance                                                                     </td><td>0.653 (0.635, 0.672)</td><td>0.708 (0.691, 0.727)</td><td>0.053 (0.036, 0.068)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_251    </td><td>Disorders of bilirubin excretion                                                                        </td><td>0.553 (0.52, 0.584) </td><td>0.606 (0.569, 0.633)</td><td>0.053 (0.033, 0.072)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_824    </td><td>Other abnormalities of plasma proteins*                                                                 </td><td>0.513 (0.495, 0.527)</td><td>0.566 (0.546, 0.585)</td><td>0.053 (0.032, 0.077)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_175    </td><td>Polycythemias                                                                                           </td><td>0.618 (0.585, 0.655)</td><td>0.673 (0.639, 0.701)</td><td>0.053 (0.023, 0.093)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_114    </td><td>Neuroendocrine tumors                                                                                   </td><td>0.579 (0.551, 0.614)</td><td>0.632 (0.589, 0.674)</td><td>0.052 (0.016, 0.095)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_831    </td><td>Glycosuria                                                                                              </td><td>0.595 (0.582, 0.605)</td><td>0.646 (0.632, 0.656)</td><td>0.051 (0.041, 0.062)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_684-11 </td><td>Alopecia Areata                                                                                         </td><td>0.624 (0.601, 0.64) </td><td>0.676 (0.653, 0.693)</td><td>0.051 (0.035, 0.069)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_809-1  </td><td>Acute pain                                                                                              </td><td>0.494 (0.457, 0.527)</td><td>0.545 (0.496, 0.586)</td><td>0.051 (0.014, 0.092)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504    </td><td>Periodontal diseases                                                                                    </td><td>0.508 (0.487, 0.531)</td><td>0.559 (0.539, 0.577)</td><td>0.05 (0.023, 0.073)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488-6  </td><td>Wheezing                                                                                                </td><td>0.519 (0.512, 0.531)</td><td>0.569 (0.56, 0.581) </td><td>0.049 (0.039, 0.061)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-11 </td><td>Open angle glaucoma                                                                                     </td><td>0.67 (0.655, 0.685) </td><td>0.719 (0.703, 0.734)</td><td>0.049 (0.037, 0.062)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-12 </td><td>Ulcerative colitis                                                                                      </td><td>0.482 (0.45, 0.512) </td><td>0.532 (0.499, 0.562)</td><td>0.049 (0.012, 0.085)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164    </td><td>Anemia                                                                                                  </td><td>0.588 (0.58, 0.595) </td><td>0.635 (0.628, 0.643)</td><td>0.048 (0.041, 0.053)   </td><td>0.636 (0.622, 0.653)</td><td>0.645 (0.631, 0.659)</td><td>0.008 (0.005, 0.01)    </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-55 </td><td>Puckering of macula                                                                                     </td><td>0.66 (0.637, 0.673) </td><td>0.706 (0.684, 0.721)</td><td>0.048 (0.031, 0.066)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_973    </td><td>Adverse effect of other drug                                                                            </td><td>0.645 (0.617, 0.675)</td><td>0.698 (0.663, 0.726)</td><td>0.048 (0.023, 0.08)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_537-1  </td><td>Peritonitis                                                                                             </td><td>0.508 (0.486, 0.54) </td><td>0.557 (0.532, 0.577)</td><td>0.048 (0.015, 0.073)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-5  </td><td>Neuromuscular dysfunction of bladder                                                                    </td><td>0.564 (0.532, 0.611)</td><td>0.618 (0.584, 0.654)</td><td>0.048 (0.012, 0.089)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_805    </td><td>Fever of unknown origin                                                                                 </td><td>0.527 (0.515, 0.539)</td><td>0.574 (0.563, 0.584)</td><td>0.047 (0.035, 0.059)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_170-19 </td><td>Neutropenia NOS                                                                                         </td><td>0.555 (0.524, 0.582)</td><td>0.599 (0.578, 0.631)</td><td>0.047 (0.013, 0.068)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_282-1  </td><td>Current tobacco use and nicotine dependence                                                             </td><td>0.568 (0.559, 0.576)</td><td>0.614 (0.608, 0.622)</td><td>0.046 (0.039, 0.055)   </td><td>0.548 (0.52, 0.572) </td><td>0.633 (0.615, 0.661)</td><td>0.088 (0.075, 0.103)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_503    </td><td>Diseases of pulp and periapical tissues                                                                 </td><td>0.509 (0.494, 0.525)</td><td>0.557 (0.54, 0.569) </td><td>0.046 (0.033, 0.064)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_449    </td><td>Other disorders of the circulatory system                                                               </td><td>0.633 (0.604, 0.668)</td><td>0.679 (0.643, 0.723)</td><td>0.046 (0.021, 0.075)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-6  </td><td>Anemia secondary to chronic diseases and conditions                                                     </td><td>0.648 (0.618, 0.688)</td><td>0.697 (0.662, 0.726)</td><td>0.046 (0.013, 0.08)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_666-2  </td><td>Idiopathic urticaria                                                                                    </td><td>0.557 (0.515, 0.604)</td><td>0.603 (0.558, 0.643)</td><td>0.046 (0.001, 0.088)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-1  </td><td>Hyperosmolality and/or hypernatremia                                                                    </td><td>0.502 (0.475, 0.531)</td><td>0.547 (0.523, 0.568)</td><td>0.044 (0.021, 0.074)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396-1  </td><td>Conductive hearing loss                                                                                 </td><td>0.537 (0.501, 0.572)</td><td>0.579 (0.548, 0.615)</td><td>0.044 (0.011, 0.076)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_474-1  </td><td>Emphysema                                                                                               </td><td>0.697 (0.677, 0.712)</td><td>0.738 (0.719, 0.755)</td><td>0.043 (0.026, 0.055)   </td><td>0.689 (0.671, 0.741)</td><td>0.714 (0.701, 0.754)</td><td>0.027 (0.01, 0.04)     </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-21 </td><td>Bell's palsy                                                                                            </td><td>0.527 (0.501, 0.557)</td><td>0.57 (0.544, 0.59)  </td><td>0.043 (0.012, 0.069)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_826-3  </td><td>Raised antibody titer*                                                                                  </td><td>0.517 (0.491, 0.555)</td><td>0.562 (0.531, 0.588)</td><td>0.042 (0.012, 0.068)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_387-3  </td><td>Astigmatism                                                                                             </td><td>0.717 (0.702, 0.739)</td><td>0.759 (0.741, 0.779)</td><td>0.041 (0.028, 0.055)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-4  </td><td>Disorders of magnesium metabolism                                                                       </td><td>0.67 (0.649, 0.691) </td><td>0.712 (0.69, 0.735) </td><td>0.041 (0.024, 0.058)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719-3  </td><td>Separation of muscle (nontraumatic)                                                                     </td><td>0.672 (0.643, 0.697)</td><td>0.71 (0.684, 0.735) </td><td>0.041 (0.02, 0.057)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_540-3  </td><td>Viral hepatitits                                                                                        </td><td>0.544 (0.506, 0.584)</td><td>0.587 (0.535, 0.622)</td><td>0.041 (0.011, 0.077)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_054    </td><td>Hepatovirus                                                                                             </td><td>0.555 (0.507, 0.603)</td><td>0.594 (0.559, 0.642)</td><td>0.041 (0.011, 0.07)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_204-2  </td><td>Impaired glucose tolerance (oral)                                                                       </td><td>0.581 (0.57, 0.59)  </td><td>0.621 (0.613, 0.629)</td><td>0.04 (0.031, 0.048)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-12 </td><td>Radial styloid tenosynovitis [de Quervain]                                                              </td><td>0.544 (0.524, 0.563)</td><td>0.584 (0.566, 0.602)</td><td>0.04 (0.026, 0.057)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-4  </td><td>Hyperkalemia [Hyperpotassemia]                                                                          </td><td>0.667 (0.651, 0.687)</td><td>0.708 (0.691, 0.724)</td><td>0.04 (0.025, 0.052)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_706-1  </td><td>Sacroiliitis NEC                                                                                        </td><td>0.559 (0.531, 0.597)</td><td>0.598 (0.567, 0.633)</td><td>0.04 (0.014, 0.07)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712-6  </td><td>Instability of joint                                                                                    </td><td>0.475 (0.437, 0.499)</td><td>0.513 (0.481, 0.558)</td><td>0.04 (0.014, 0.068)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_175-2  </td><td>Secondary polycythemia                                                                                  </td><td>0.627 (0.587, 0.671)</td><td>0.668 (0.627, 0.712)</td><td>0.04 (-0.01, 0.081)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840-8  </td><td>Allergies related to other diseases/symptoms                                                            </td><td>0.508 (0.5, 0.517)  </td><td>0.547 (0.54, 0.556) </td><td>0.039 (0.031, 0.047)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-3  </td><td>Postmenopausal atrophic vaginitis                                                                       </td><td>0.513 (0.504, 0.522)</td><td>0.552 (0.54, 0.56)  </td><td>0.039 (0.027, 0.051)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-3  </td><td>Retinal vascular changes and occlusions                                                                 </td><td>0.668 (0.656, 0.683)</td><td>0.707 (0.693, 0.72) </td><td>0.039 (0.027, 0.048)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_443-1  </td><td>Stricture of artery [Arterial stenosis]                                                                 </td><td>0.726 (0.697, 0.76) </td><td>0.764 (0.739, 0.795)</td><td>0.039 (0.015, 0.057)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-2  </td><td>Facial nerve disorders and weakness                                                                     </td><td>0.527 (0.5, 0.546)  </td><td>0.565 (0.541, 0.591)</td><td>0.039 (0.014, 0.066)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_299    </td><td>Mental disorder, not otherwise specified                                                                </td><td>0.532 (0.501, 0.559)</td><td>0.568 (0.542, 0.596)</td><td>0.039 (0.013, 0.058)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286-1  </td><td>Bipolar disorder                                                                                        </td><td>0.512 (0.458, 0.55) </td><td>0.554 (0.505, 0.585)</td><td>0.039 (-0.001, 0.092)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_474    </td><td>Chronic obstructive pulmonary disease [COPD]                                                            </td><td>0.666 (0.658, 0.674)</td><td>0.704 (0.697, 0.711)</td><td>0.038 (0.033, 0.046)   </td><td>0.696 (0.661, 0.711)</td><td>0.719 (0.694, 0.736)</td><td>0.027 (0.017, 0.038)   </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333-1  </td><td>Sleep apnea                                                                                             </td><td>0.598 (0.587, 0.611)</td><td>0.637 (0.627, 0.649)</td><td>0.038 (0.029, 0.05)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_662    </td><td>Rosacea                                                                                                 </td><td>0.53 (0.52, 0.542)  </td><td>0.567 (0.559, 0.576)</td><td>0.038 (0.029, 0.045)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-2  </td><td>Allergic rhinitis                                                                                       </td><td>0.501 (0.493, 0.51) </td><td>0.539 (0.532, 0.548)</td><td>0.038 (0.028, 0.048)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686-2  </td><td>Non-pressure chronic ulcer                                                                              </td><td>0.683 (0.667, 0.699)</td><td>0.72 (0.707, 0.737) </td><td>0.038 (0.027, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_388    </td><td>Blindness and low vision                                                                                </td><td>0.681 (0.666, 0.697)</td><td>0.72 (0.705, 0.735) </td><td>0.038 (0.027, 0.048)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_469-2  </td><td>Chronic bronchitis                                                                                      </td><td>0.651 (0.626, 0.676)</td><td>0.689 (0.668, 0.712)</td><td>0.038 (0.016, 0.064)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-11 </td><td>Intestinal e.coli                                                                                       </td><td>0.504 (0.466, 0.538)</td><td>0.543 (0.514, 0.58) </td><td>0.038 (0.008, 0.074)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_204    </td><td>Elevated blood glucose level                                                                            </td><td>0.581 (0.575, 0.587)</td><td>0.618 (0.612, 0.624)</td><td>0.037 (0.031, 0.044)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_503-5  </td><td>Periapical abscess                                                                                      </td><td>0.512 (0.497, 0.526)</td><td>0.548 (0.533, 0.563)</td><td>0.037 (0.022, 0.055)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_665    </td><td>Psoriasis                                                                                               </td><td>0.512 (0.498, 0.528)</td><td>0.549 (0.537, 0.562)</td><td>0.037 (0.022, 0.054)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_542-3  </td><td>Hepatic failure                                                                                         </td><td>0.654 (0.622, 0.692)</td><td>0.694 (0.66, 0.724) </td><td>0.037 (0.008, 0.072)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-1  </td><td>Glaucoma                                                                                                </td><td>0.653 (0.643, 0.661)</td><td>0.689 (0.678, 0.697)</td><td>0.036 (0.028, 0.043)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-8  </td><td>Hyperhidrosis                                                                                           </td><td>0.54 (0.528, 0.554) </td><td>0.577 (0.565, 0.59) </td><td>0.036 (0.025, 0.05)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_733-62 </td><td>Arthralgia of temporomandibular joint                                                                   </td><td>0.594 (0.57, 0.623) </td><td>0.629 (0.604, 0.664)</td><td>0.036 (0.016, 0.059)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-38 </td><td>Retinal vein occlusions                                                                                 </td><td>0.67 (0.649, 0.691) </td><td>0.703 (0.688, 0.724)</td><td>0.036 (0.016, 0.05)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-11 </td><td>Acute pyelonephritis                                                                                    </td><td>0.559 (0.533, 0.585)</td><td>0.595 (0.568, 0.616)</td><td>0.036 (0.012, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-82 </td><td>Generalized hyperhidrosis                                                                               </td><td>0.542 (0.527, 0.558)</td><td>0.578 (0.565, 0.591)</td><td>0.035 (0.022, 0.051)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-14 </td><td>Low-tension glaucoma (Normal-tension glaucoma)                                                          </td><td>0.682 (0.657, 0.717)</td><td>0.72 (0.683, 0.749) </td><td>0.035 (0.009, 0.061)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_356-1  </td><td>Dysarthria                                                                                              </td><td>0.646 (0.604, 0.683)</td><td>0.684 (0.646, 0.721)</td><td>0.035 (0.007, 0.089)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_384    </td><td>Anomalies of pupillary function                                                                         </td><td>0.558 (0.528, 0.598)</td><td>0.592 (0.555, 0.647)</td><td>0.035 (-0.013, 0.078)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351    </td><td>Disturbances of skin sensation                                                                          </td><td>0.535 (0.529, 0.54) </td><td>0.568 (0.563, 0.573)</td><td>0.034 (0.027, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-21 </td><td>Seasonal allergic rhinitis                                                                              </td><td>0.51 (0.499, 0.52)  </td><td>0.545 (0.532, 0.555)</td><td>0.034 (0.019, 0.048)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-113</td><td>Primary open angle glaucoma                                                                             </td><td>0.661 (0.636, 0.684)</td><td>0.694 (0.666, 0.714)</td><td>0.034 (0.016, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376-1  </td><td>Vitreous degeneration                                                                                   </td><td>0.606 (0.598, 0.615)</td><td>0.638 (0.631, 0.647)</td><td>0.033 (0.022, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_102-1  </td><td>Malignant neoplasm of the of bronchus and lung                                                          </td><td>0.679 (0.665, 0.697)</td><td>0.714 (0.697, 0.726)</td><td>0.033 (0.021, 0.045)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-19 </td><td>Spontaneous ecchymoses                                                                                  </td><td>0.533 (0.507, 0.558)</td><td>0.566 (0.536, 0.591)</td><td>0.033 (0.004, 0.064)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375    </td><td>Abnormal intraocular pressure                                                                           </td><td>0.619 (0.61, 0.629) </td><td>0.651 (0.641, 0.66) </td><td>0.032 (0.026, 0.038)   </td><td>0.633 (0.622, 0.638)</td><td>0.696 (0.69, 0.701) </td><td>0.065 (0.057, 0.073)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-11 </td><td>Alcohol abuse                                                                                           </td><td>0.616 (0.603, 0.631)</td><td>0.648 (0.636, 0.66) </td><td>0.032 (0.023, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-55 </td><td>Lesion of plantar nerve                                                                                 </td><td>0.599 (0.581, 0.611)</td><td>0.631 (0.613, 0.647)</td><td>0.032 (0.021, 0.047)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_680-3  </td><td>Xerosis cutis*                                                                                          </td><td>0.592 (0.578, 0.606)</td><td>0.622 (0.609, 0.638)</td><td>0.032 (0.019, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_164-2  </td><td>Macrocytic anemia                                                                                       </td><td>0.624 (0.599, 0.643)</td><td>0.656 (0.632, 0.675)</td><td>0.032 (0.017, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-4  </td><td>Carbuncle and furuncle                                                                                  </td><td>0.524 (0.511, 0.541)</td><td>0.557 (0.543, 0.573)</td><td>0.032 (0.014, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401-3  </td><td>Hypertensive chronic kidney disease                                                                     </td><td>0.7 (0.67, 0.737)   </td><td>0.732 (0.699, 0.768)</td><td>0.032 (0.009, 0.059)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-4  </td><td>Visual field defects                                                                                    </td><td>0.608 (0.585, 0.63) </td><td>0.639 (0.611, 0.662)</td><td>0.032 (0.005, 0.054)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_486-2  </td><td>Other diseases of bronchus                                                                              </td><td>0.506 (0.477, 0.538)</td><td>0.54 (0.499, 0.57)  </td><td>0.032 (-0.009, 0.078)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351-3  </td><td>Paresthesia of skin*                                                                                    </td><td>0.488 (0.477, 0.497)</td><td>0.52 (0.51, 0.53)   </td><td>0.031 (0.023, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_664    </td><td>Papulosquamous disorders                                                                                </td><td>0.532 (0.512, 0.55) </td><td>0.564 (0.544, 0.577)</td><td>0.031 (0.018, 0.049)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_680-1  </td><td>Corns and callosities                                                                                   </td><td>0.557 (0.542, 0.57) </td><td>0.587 (0.575, 0.602)</td><td>0.031 (0.018, 0.044)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_502    </td><td>Other diseases of teeth and supporting structures                                                       </td><td>0.505 (0.491, 0.521)</td><td>0.535 (0.52, 0.549) </td><td>0.031 (0.012, 0.05)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_730    </td><td>Other disorders and symptoms of the musculoskeletal system                                              </td><td>0.519 (0.498, 0.538)</td><td>0.55 (0.532, 0.567) </td><td>0.031 (0.008, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_347    </td><td>Other disorders of the brain and CNS                                                                    </td><td>0.574 (0.547, 0.593)</td><td>0.603 (0.569, 0.631)</td><td>0.031 (0.006, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_702-3  </td><td>Enteropathic arthropathies                                                                              </td><td>0.508 (0.466, 0.556)</td><td>0.54 (0.502, 0.574) </td><td>0.031 (-0.006, 0.071)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686    </td><td>Chronic ulcer of skin                                                                                   </td><td>0.695 (0.685, 0.708)</td><td>0.726 (0.716, 0.737)</td><td>0.03 (0.024, 0.041)    </td><td>0.771 (0.749, 0.787)</td><td>0.781 (0.761, 0.797)</td><td>0.01 (0.008, 0.012)    </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333    </td><td>Sleep disorders                                                                                         </td><td>0.521 (0.514, 0.528)</td><td>0.551 (0.545, 0.557)</td><td>0.03 (0.023, 0.037)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_676    </td><td>Hypertrophic conditions of skin                                                                         </td><td>0.482 (0.474, 0.491)</td><td>0.514 (0.504, 0.523)</td><td>0.03 (0.021, 0.043)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471-5  </td><td>Nasal polyps                                                                                            </td><td>0.546 (0.528, 0.565)</td><td>0.577 (0.558, 0.596)</td><td>0.03 (0.017, 0.049)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-12 </td><td>Allergic [atopic] conjunctivitis                                                                        </td><td>0.567 (0.545, 0.586)</td><td>0.598 (0.578, 0.617)</td><td>0.03 (0.015, 0.048)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_244    </td><td>Disorders of lipoprotein metabolism and other lipidemias                                                </td><td>0.594 (0.577, 0.617)</td><td>0.625 (0.602, 0.643)</td><td>0.03 (0.01, 0.045)     </td><td>0.588 (0.576, 0.6)  </td><td>0.586 (0.573, 0.597)</td><td>-0.003 (-0.003, -0.002)</td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-51 </td><td>Eczematous dermatitis of eyelid                                                                         </td><td>0.619 (0.591, 0.645)</td><td>0.647 (0.618, 0.673)</td><td>0.03 (0.007, 0.053)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-2  </td><td>Lesion of median, ulnar, radial nerve                                                                   </td><td>0.52 (0.501, 0.541) </td><td>0.55 (0.528, 0.572) </td><td>0.03 (0.007, 0.047)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-2  </td><td>Hyperglyceridemia                                                                                       </td><td>0.541 (0.511, 0.564)</td><td>0.567 (0.546, 0.598)</td><td>0.03 (0.003, 0.061)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_525-3  </td><td>Disorders of intestinal carbohydrate absorption                                                         </td><td>0.55 (0.5, 0.589)   </td><td>0.581 (0.546, 0.622)</td><td>0.03 (-0.004, 0.075)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283    </td><td>Other behavioral problems                                                                               </td><td>0.506 (0.502, 0.511)</td><td>0.536 (0.532, 0.542)</td><td>0.029 (0.024, 0.035)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_722    </td><td>Fasciopathy                                                                                             </td><td>0.505 (0.499, 0.512)</td><td>0.534 (0.529, 0.541)</td><td>0.029 (0.023, 0.036)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280    </td><td>Substance related disorders                                                                             </td><td>0.573 (0.563, 0.582)</td><td>0.602 (0.593, 0.611)</td><td>0.029 (0.021, 0.037)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448-9  </td><td>Peripheral vascular disease NOS [includes PAD]                                                          </td><td>0.73 (0.717, 0.744) </td><td>0.759 (0.745, 0.773)</td><td>0.029 (0.019, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-29 </td><td>Folate deficiency [Vitamin B9]                                                                          </td><td>0.72 (0.69, 0.745)  </td><td>0.748 (0.712, 0.773)</td><td>0.029 (0.011, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-6  </td><td>Impingement syndrome of shoulder*                                                                       </td><td>0.5 (0.489, 0.51)   </td><td>0.528 (0.517, 0.537)</td><td>0.029 (0.011, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-41 </td><td>Long term (current) use of inhaled steroids*                                                            </td><td>0.547 (0.523, 0.566)</td><td>0.576 (0.554, 0.596)</td><td>0.029 (0.01, 0.055)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-31 </td><td>Acidosis                                                                                                </td><td>0.647 (0.624, 0.673)</td><td>0.678 (0.658, 0.697)</td><td>0.029 (0.008, 0.05)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_232-27 </td><td>Vitamin B12 deficiency                                                                                  </td><td>0.576 (0.552, 0.603)</td><td>0.604 (0.58, 0.629) </td><td>0.029 (0.004, 0.053)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_666    </td><td>Urticaria                                                                                               </td><td>0.55 (0.54, 0.56)   </td><td>0.578 (0.569, 0.589)</td><td>0.028 (0.019, 0.037)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_102    </td><td>Malignant neoplasm of the thoracic and respiratory organs                                               </td><td>0.677 (0.657, 0.689)</td><td>0.704 (0.689, 0.714)</td><td>0.028 (0.013, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-4  </td><td>Long term (current) use of steroids                                                                     </td><td>0.545 (0.528, 0.563)</td><td>0.575 (0.552, 0.594)</td><td>0.028 (0.011, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_369-4  </td><td>Corneal degenerations                                                                                   </td><td>0.676 (0.651, 0.708)</td><td>0.705 (0.682, 0.738)</td><td>0.028 (0.009, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-1  </td><td>Pyelonephritis                                                                                          </td><td>0.542 (0.518, 0.562)</td><td>0.568 (0.539, 0.592)</td><td>0.028 (0.005, 0.044)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_352    </td><td>Disturbances of sensation of smell and taste                                                            </td><td>0.502 (0.484, 0.522)</td><td>0.531 (0.508, 0.548)</td><td>0.028 (0.004, 0.047)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_344    </td><td>Disorders of the circulation of the cerebrospinal fluid                                                 </td><td>0.566 (0.533, 0.602)</td><td>0.595 (0.564, 0.629)</td><td>0.028 (0, 0.07)        </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_727-1  </td><td>Osteonecrosis                                                                                           </td><td>0.525 (0.476, 0.568)</td><td>0.549 (0.518, 0.595)</td><td>0.028 (-0.03, 0.077)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719-11 </td><td>Spasm of muscle                                                                                         </td><td>0.472 (0.442, 0.512)</td><td>0.501 (0.461, 0.532)</td><td>0.028 (-0.024, 0.066)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_204-4  </td><td>Prediabetes*                                                                                            </td><td>0.544 (0.509, 0.589)</td><td>0.57 (0.535, 0.611) </td><td>0.028 (-0.014, 0.063)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_281-1  </td><td>Substance abuse                                                                                         </td><td>0.622 (0.608, 0.633)</td><td>0.648 (0.636, 0.658)</td><td>0.027 (0.019, 0.036)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_337    </td><td>Polyneuropathies                                                                                        </td><td>0.597 (0.583, 0.609)</td><td>0.624 (0.608, 0.64) </td><td>0.027 (0.018, 0.037)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_475    </td><td>Asthma                                                                                                  </td><td>0.52 (0.512, 0.53)  </td><td>0.548 (0.537, 0.556)</td><td>0.027 (0.018, 0.035)   </td><td>0.501 (0.49, 0.525) </td><td>0.532 (0.518, 0.547)</td><td>0.032 (0.02, 0.038)    </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177-2  </td><td>Enlargement of lymph nodes [Lymphadenopathy]                                                            </td><td>0.531 (0.52, 0.541) </td><td>0.558 (0.547, 0.569)</td><td>0.027 (0.014, 0.038)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_160-2  </td><td>Megaloblastic anemia                                                                                    </td><td>0.624 (0.605, 0.652)</td><td>0.651 (0.631, 0.671)</td><td>0.027 (0.013, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479-3  </td><td>Respiratory failure                                                                                     </td><td>0.672 (0.653, 0.695)</td><td>0.701 (0.679, 0.722)</td><td>0.027 (0.012, 0.042)   </td><td>0.66 (0.636, 0.7)   </td><td>0.69 (0.663, 0.721) </td><td>0.026 (0.009, 0.046)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-2  </td><td>Bacterial pneumonia                                                                                     </td><td>0.619 (0.599, 0.644)</td><td>0.647 (0.624, 0.671)</td><td>0.027 (0.011, 0.047)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_341    </td><td>Cerebral palsy and other paralytic syndromes                                                            </td><td>0.65 (0.626, 0.674) </td><td>0.675 (0.655, 0.695)</td><td>0.027 (0.011, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_377-4  </td><td>Retinal hemorrhage                                                                                      </td><td>0.641 (0.611, 0.675)</td><td>0.668 (0.633, 0.702)</td><td>0.027 (0.01, 0.046)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_411-2  </td><td>Pericardial effusion (noninflammatory)*                                                                 </td><td>0.635 (0.608, 0.663)</td><td>0.662 (0.635, 0.693)</td><td>0.027 (0.004, 0.049)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_257    </td><td>Polydipsia                                                                                              </td><td>0.512 (0.483, 0.545)</td><td>0.537 (0.509, 0.57) </td><td>0.027 (0, 0.049)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284-2  </td><td>Suicide and self-inflicted harm                                                                         </td><td>0.566 (0.533, 0.597)</td><td>0.594 (0.563, 0.63) </td><td>0.027 (-0.005, 0.066)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_486    </td><td>Other respiratory disorders                                                                             </td><td>0.544 (0.54, 0.55)  </td><td>0.571 (0.565, 0.576)</td><td>0.026 (0.021, 0.03)    </td><td>0.613 (0.595, 0.635)</td><td>0.619 (0.6, 0.644)  </td><td>0.006 (0.001, 0.014)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800    </td><td>Chest pain                                                                                              </td><td>0.513 (0.508, 0.519)</td><td>0.539 (0.533, 0.543)</td><td>0.026 (0.02, 0.031)    </td><td>0.546 (0.512, 0.561)</td><td>0.559 (0.532, 0.577)</td><td>0.015 (0.006, 0.028)   </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_390-1  </td><td>Otitis externa                                                                                          </td><td>0.502 (0.496, 0.508)</td><td>0.529 (0.523, 0.536)</td><td>0.026 (0.019, 0.034)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-1  </td><td>Alcohol use disorders                                                                                   </td><td>0.578 (0.568, 0.585)</td><td>0.604 (0.595, 0.614)</td><td>0.026 (0.018, 0.034)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333-11 </td><td>Obstructive sleep apnea                                                                                 </td><td>0.612 (0.593, 0.629)</td><td>0.638 (0.622, 0.654)</td><td>0.026 (0.015, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_535    </td><td>Intestinal or peritoneal adhesions                                                                      </td><td>0.554 (0.539, 0.569)</td><td>0.579 (0.566, 0.601)</td><td>0.026 (0.012, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487-3  </td><td>Hemoptysis                                                                                              </td><td>0.585 (0.566, 0.602)</td><td>0.611 (0.594, 0.627)</td><td>0.026 (0.012, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_686-1  </td><td>Pressure ulcer                                                                                          </td><td>0.721 (0.705, 0.737)</td><td>0.746 (0.733, 0.761)</td><td>0.026 (0.011, 0.038)   </td><td>0.787 (0.766, 0.814)</td><td>0.792 (0.766, 0.822)</td><td>0.004 (-0.003, 0.012)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-21 </td><td>Impetigo                                                                                                </td><td>0.513 (0.493, 0.534)</td><td>0.537 (0.522, 0.563)</td><td>0.026 (0.01, 0.04)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840-9  </td><td>Anaphylactic reaction                                                                                   </td><td>0.496 (0.455, 0.552)</td><td>0.524 (0.476, 0.566)</td><td>0.026 (-0.021, 0.073)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-6  </td><td>Prurigo                                                                                                 </td><td>0.528 (0.497, 0.565)</td><td>0.556 (0.523, 0.589)</td><td>0.026 (-0.009, 0.061)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_248    </td><td>Disorders of plasma-protein metabolism, NEC                                                             </td><td>0.601 (0.56, 0.653) </td><td>0.629 (0.573, 0.676)</td><td>0.026 (-0.003, 0.056)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284-29 </td><td>Intentional self-harm*                                                                                  </td><td>0.566 (0.531, 0.599)</td><td>0.595 (0.563, 0.632)</td><td>0.026 (-0.003, 0.052)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_683-2  </td><td>Nail dystrophy*                                                                                         </td><td>0.593 (0.56, 0.623) </td><td>0.618 (0.585, 0.651)</td><td>0.026 (-0.002, 0.051)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_804    </td><td>Other symptoms and signs involving the circulatory and respiratory system                               </td><td>0.533 (0.527, 0.54) </td><td>0.558 (0.553, 0.564)</td><td>0.025 (0.02, 0.031)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_469    </td><td>Bronchitis                                                                                              </td><td>0.543 (0.534, 0.553)</td><td>0.568 (0.561, 0.578)</td><td>0.025 (0.016, 0.034)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-2  </td><td>Bacterial infection of the skin                                                                         </td><td>0.503 (0.486, 0.52) </td><td>0.53 (0.506, 0.545) </td><td>0.025 (0.012, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800-2  </td><td>Precordial pain                                                                                         </td><td>0.536 (0.521, 0.551)</td><td>0.561 (0.545, 0.576)</td><td>0.025 (0.012, 0.037)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_832-5  </td><td>Acetonuria                                                                                              </td><td>0.547 (0.529, 0.563)</td><td>0.572 (0.556, 0.586)</td><td>0.025 (0.011, 0.038)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-6  </td><td>Fluid overload                                                                                          </td><td>0.721 (0.697, 0.74) </td><td>0.744 (0.725, 0.766)</td><td>0.025 (0.008, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_507-11 </td><td>Recurrent oral aphthae [Recurrent aphthous stomatitis]                                                  </td><td>0.559 (0.53, 0.584) </td><td>0.583 (0.55, 0.61)  </td><td>0.025 (0.001, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-12 </td><td>Partial epilepsy                                                                                        </td><td>0.587 (0.559, 0.62) </td><td>0.612 (0.573, 0.656)</td><td>0.025 (-0.017, 0.057)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_525-1  </td><td>Celiac disease                                                                                          </td><td>0.508 (0.482, 0.537)</td><td>0.534 (0.506, 0.563)</td><td>0.025 (-0.016, 0.055)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-52 </td><td>Meralgia paresthetica                                                                                   </td><td>0.472 (0.441, 0.5)  </td><td>0.496 (0.471, 0.524)</td><td>0.025 (-0.01, 0.057)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_666-1  </td><td>Allergic urticaria                                                                                      </td><td>0.599 (0.575, 0.627)</td><td>0.621 (0.587, 0.654)</td><td>0.025 (-0.007, 0.054)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-1  </td><td>Bacterial infections                                                                                    </td><td>0.552 (0.546, 0.559)</td><td>0.577 (0.57, 0.582) </td><td>0.024 (0.017, 0.029)   </td><td>0.715 (0.694, 0.733)</td><td>0.716 (0.695, 0.734)</td><td>0.001 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-1  </td><td>Carpal tunnel syndrome                                                                                  </td><td>0.542 (0.534, 0.552)</td><td>0.566 (0.555, 0.577)</td><td>0.024 (0.013, 0.034)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_341-2  </td><td>Hemiplegia and hemiparesis                                                                              </td><td>0.667 (0.65, 0.685) </td><td>0.692 (0.669, 0.712)</td><td>0.024 (0.01, 0.041)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-4  </td><td>Acquired deformities of the ankle and foot                                                              </td><td>0.582 (0.563, 0.597)</td><td>0.605 (0.586, 0.621)</td><td>0.024 (0.009, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-3  </td><td>Ptosis of eyelid                                                                                        </td><td>0.627 (0.606, 0.648)</td><td>0.652 (0.628, 0.673)</td><td>0.024 (0.009, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-1  </td><td>Hypo-coagulability                                                                                      </td><td>0.592 (0.566, 0.617)</td><td>0.614 (0.594, 0.64) </td><td>0.024 (0.008, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_355-2  </td><td>Alteration of consciousness                                                                             </td><td>0.621 (0.603, 0.646)</td><td>0.647 (0.625, 0.668)</td><td>0.024 (0.008, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_351-1  </td><td>Anesthesia of skin*                                                                                     </td><td>0.5 (0.487, 0.513)  </td><td>0.524 (0.512, 0.537)</td><td>0.024 (0.008, 0.038)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-12 </td><td>Familial hypercholesterolemia*                                                                          </td><td>0.598 (0.571, 0.624)</td><td>0.625 (0.594, 0.646)</td><td>0.024 (0.006, 0.045)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_366    </td><td>Noninflammatory disorders of conjunctiva                                                                </td><td>0.536 (0.52, 0.554) </td><td>0.559 (0.539, 0.58) </td><td>0.024 (0.003, 0.044)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_588-2  </td><td>Abnormal results of function study of kidney                                                            </td><td>0.687 (0.653, 0.712)</td><td>0.71 (0.676, 0.739) </td><td>0.024 (0.002, 0.047)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_810    </td><td>Shock                                                                                                   </td><td>0.722 (0.687, 0.754)</td><td>0.745 (0.71, 0.781) </td><td>0.024 (-0.004, 0.048)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-2  </td><td>Eustachian tube disorders                                                                               </td><td>0.53 (0.52, 0.538)  </td><td>0.553 (0.543, 0.563)</td><td>0.023 (0.016, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376-2  </td><td>Vitreous opacities                                                                                      </td><td>0.612 (0.604, 0.618)</td><td>0.634 (0.626, 0.643)</td><td>0.023 (0.016, 0.028)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-5  </td><td>Lichen simplex chronicus                                                                                </td><td>0.566 (0.542, 0.596)</td><td>0.591 (0.558, 0.617)</td><td>0.023 (0.002, 0.049)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_366-42 </td><td>Conjunctival hyperemia                                                                                  </td><td>0.516 (0.473, 0.552)</td><td>0.538 (0.502, 0.576)</td><td>0.023 (-0.008, 0.061)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376    </td><td>Disorders of vitreous body                                                                              </td><td>0.612 (0.604, 0.619)</td><td>0.635 (0.627, 0.642)</td><td>0.022 (0.017, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_283-8  </td><td>Other problems related to lifestyle                                                                     </td><td>0.513 (0.508, 0.518)</td><td>0.535 (0.529, 0.538)</td><td>0.022 (0.017, 0.027)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_733    </td><td>Dentofacial anomalies, including malocclusion                                                           </td><td>0.587 (0.572, 0.605)</td><td>0.607 (0.591, 0.624)</td><td>0.022 (0.012, 0.032)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_376-21 </td><td>Crystalline deposits in vitreous body                                                                   </td><td>0.592 (0.571, 0.608)</td><td>0.614 (0.601, 0.629)</td><td>0.022 (0.01, 0.035)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_733-6  </td><td>Temporomandibular joint disorders                                                                       </td><td>0.587 (0.575, 0.599)</td><td>0.609 (0.595, 0.621)</td><td>0.022 (0.01, 0.031)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_335    </td><td>Nerve root and plexus disorders                                                                         </td><td>0.543 (0.527, 0.558)</td><td>0.565 (0.553, 0.578)</td><td>0.022 (0.009, 0.035)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_135-5  </td><td>Benign neoplasm of the paranasal sinus and nasal cavity                                                 </td><td>0.555 (0.535, 0.569)</td><td>0.577 (0.559, 0.597)</td><td>0.022 (0.008, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550-2  </td><td>Cholecystitis                                                                                           </td><td>0.535 (0.52, 0.55)  </td><td>0.559 (0.539, 0.577)</td><td>0.022 (0.006, 0.045)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_061    </td><td>Influenza virus                                                                                         </td><td>0.56 (0.538, 0.586) </td><td>0.582 (0.559, 0.611)</td><td>0.022 (0.004, 0.041)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_588    </td><td>Disorders and findings from impaired renal function                                                     </td><td>0.655 (0.624, 0.692)</td><td>0.678 (0.647, 0.716)</td><td>0.022 (0.002, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-4  </td><td>Blepharochalasis                                                                                        </td><td>0.623 (0.59, 0.653) </td><td>0.643 (0.603, 0.68) </td><td>0.022 (-0.01, 0.052)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_149-3  </td><td>Benign neoplasm of the parathyroid gland                                                                </td><td>0.64 (0.61, 0.671)  </td><td>0.661 (0.633, 0.694)</td><td>0.022 (-0.009, 0.047)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-6  </td><td>Cellulitis and abscess                                                                                  </td><td>0.538 (0.533, 0.543)</td><td>0.559 (0.554, 0.564)</td><td>0.021 (0.016, 0.026)   </td><td>0.668 (0.64, 0.684) </td><td>0.667 (0.642, 0.678)</td><td>0 (-0.006, 0.004)      </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_582    </td><td>Acute kidney failure                                                                                    </td><td>0.705 (0.696, 0.711)</td><td>0.725 (0.718, 0.731)</td><td>0.021 (0.014, 0.028)   </td><td>0.74 (0.727, 0.749) </td><td>0.748 (0.734, 0.752)</td><td>0.007 (0.004, 0.009)   </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-9  </td><td>Abnormal thyroid function studies                                                                       </td><td>0.593 (0.57, 0.616) </td><td>0.614 (0.587, 0.638)</td><td>0.021 (0.005, 0.033)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_731    </td><td>Symptoms involving musculoskeletal systems                                                              </td><td>0.496 (0.485, 0.507)</td><td>0.516 (0.503, 0.526)</td><td>0.021 (0.004, 0.032)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530-2  </td><td>Anorectal abscess                                                                                       </td><td>0.596 (0.566, 0.632)</td><td>0.615 (0.58, 0.652) </td><td>0.021 (-0.007, 0.046)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-52 </td><td>Macular cyst, hole, or pseudohole                                                                       </td><td>0.663 (0.643, 0.685)</td><td>0.686 (0.663, 0.707)</td><td>0.021 (-0.002, 0.045)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_462-2  </td><td>Chronic sinusitis                                                                                       </td><td>0.54 (0.531, 0.547) </td><td>0.559 (0.551, 0.567)</td><td>0.02 (0.015, 0.025)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719-1  </td><td>Cramp and spasm                                                                                         </td><td>0.577 (0.567, 0.588)</td><td>0.598 (0.587, 0.608)</td><td>0.02 (0.012, 0.028)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-1  </td><td>Adhesive capsulitis of shoulder                                                                         </td><td>0.536 (0.527, 0.548)</td><td>0.557 (0.546, 0.567)</td><td>0.02 (0.011, 0.033)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_684-1  </td><td>Alopecia                                                                                                </td><td>0.687 (0.677, 0.697)</td><td>0.708 (0.697, 0.717)</td><td>0.02 (0.011, 0.029)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_333-2  </td><td>Insomnia                                                                                                </td><td>0.541 (0.531, 0.551)</td><td>0.561 (0.551, 0.569)</td><td>0.02 (0.01, 0.029)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_585    </td><td>Kidney stone disease                                                                                    </td><td>0.592 (0.58, 0.604) </td><td>0.612 (0.598, 0.624)</td><td>0.02 (0.01, 0.027)     </td><td>0.59 (0.566, 0.617) </td><td>0.6 (0.578, 0.636)  </td><td>0.01 (0.004, 0.019)    </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_495    </td><td>Abnormal findings on diagnostic imaging of lung                                                         </td><td>0.645 (0.634, 0.658)</td><td>0.666 (0.655, 0.678)</td><td>0.02 (0.009, 0.031)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-2  </td><td>Gastric ulcer                                                                                           </td><td>0.589 (0.572, 0.603)</td><td>0.608 (0.591, 0.623)</td><td>0.02 (0.003, 0.033)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_002-1  </td><td>Staphylococcus aureus                                                                                   </td><td>0.581 (0.561, 0.606)</td><td>0.601 (0.577, 0.621)</td><td>0.02 (0.002, 0.041)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-1  </td><td>Viral pneumonia                                                                                         </td><td>0.632 (0.596, 0.666)</td><td>0.652 (0.617, 0.685)</td><td>0.02 (-0.009, 0.055)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-1  </td><td>Epilepsy                                                                                                </td><td>0.563 (0.543, 0.584)</td><td>0.584 (0.558, 0.606)</td><td>0.02 (-0.009, 0.042)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148-1  </td><td>Benign neoplasm of eye                                                                                  </td><td>0.572 (0.539, 0.603)</td><td>0.594 (0.565, 0.617)</td><td>0.02 (-0.006, 0.046)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-61 </td><td>Hemangioma                                                                                              </td><td>0.498 (0.48, 0.516) </td><td>0.516 (0.496, 0.537)</td><td>0.02 (-0.006, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_056    </td><td>Human papillomavirus                                                                                    </td><td>0.492 (0.482, 0.5)  </td><td>0.511 (0.501, 0.518)</td><td>0.019 (0.007, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-9  </td><td>Delirium                                                                                                </td><td>0.75 (0.732, 0.763) </td><td>0.769 (0.753, 0.783)</td><td>0.019 (0.007, 0.029)   </td><td>0.802 (0.783, 0.817)</td><td>0.802 (0.784, 0.818)</td><td>0 (-0.002, 0.004)      </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_664-1  </td><td>Lichen planus, nitidus, or striatus                                                                     </td><td>0.579 (0.56, 0.596) </td><td>0.597 (0.58, 0.612) </td><td>0.019 (0.002, 0.031)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-11 </td><td>Candidiasis of skin and nails                                                                           </td><td>0.543 (0.527, 0.559)</td><td>0.563 (0.545, 0.575)</td><td>0.019 (0.001, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719-7  </td><td>Muscle weakness (generalized)                                                                           </td><td>0.55 (0.524, 0.575) </td><td>0.568 (0.545, 0.599)</td><td>0.019 (-0.01, 0.048)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-34 </td><td>Torticollis                                                                                             </td><td>0.53 (0.511, 0.546) </td><td>0.549 (0.528, 0.567)</td><td>0.019 (-0.001, 0.038)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_719    </td><td>Disorders of muscle                                                                                     </td><td>0.565 (0.554, 0.573)</td><td>0.583 (0.575, 0.593)</td><td>0.018 (0.011, 0.027)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713-2  </td><td>Effusion of joint                                                                                       </td><td>0.578 (0.57, 0.586) </td><td>0.596 (0.587, 0.604)</td><td>0.018 (0.011, 0.026)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_402    </td><td>Elevated blood pressure reading without diagnosis of hypertension                                       </td><td>0.536 (0.529, 0.543)</td><td>0.554 (0.546, 0.561)</td><td>0.018 (0.01, 0.025)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_545    </td><td>Nonspecific abnormal results of function study of liver                                                 </td><td>0.544 (0.533, 0.553)</td><td>0.561 (0.553, 0.572)</td><td>0.018 (0.008, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_706    </td><td>Other inflammatory spondylopathies                                                                      </td><td>0.585 (0.565, 0.603)</td><td>0.604 (0.586, 0.62) </td><td>0.018 (0.006, 0.032)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_349-13 </td><td>Abnormal findings on diagnostic imaging of skull and head                                               </td><td>0.627 (0.607, 0.65) </td><td>0.647 (0.622, 0.672)</td><td>0.018 (0.004, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-2  </td><td>Tachycardia                                                                                             </td><td>0.596 (0.583, 0.613)</td><td>0.615 (0.602, 0.628)</td><td>0.018 (0.004, 0.03)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-3  </td><td>Changes in skin texture                                                                                 </td><td>0.581 (0.57, 0.596) </td><td>0.599 (0.585, 0.614)</td><td>0.018 (0.003, 0.03)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_555    </td><td>Ascites                                                                                                 </td><td>0.642 (0.622, 0.66) </td><td>0.66 (0.635, 0.679) </td><td>0.018 (0.002, 0.037)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_349-1  </td><td>Abnormal findings on diagnostic test of central nervous system                                          </td><td>0.612 (0.594, 0.638)</td><td>0.633 (0.609, 0.654)</td><td>0.018 (0.001, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_826    </td><td>Other abnormal immunological findings in serum                                                          </td><td>0.521 (0.499, 0.55) </td><td>0.537 (0.507, 0.562)</td><td>0.018 (-0.016, 0.045)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-4  </td><td>Low back pain                                                                                           </td><td>0.517 (0.512, 0.522)</td><td>0.534 (0.529, 0.538)</td><td>0.017 (0.011, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_003    </td><td>Escherichia coli                                                                                        </td><td>0.599 (0.588, 0.611)</td><td>0.617 (0.601, 0.63) </td><td>0.017 (0.008, 0.027)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_204-1  </td><td>Impaired fasting glucose                                                                                </td><td>0.608 (0.591, 0.618)</td><td>0.625 (0.609, 0.641)</td><td>0.017 (0.006, 0.028)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-6  </td><td>Ocular hypertension                                                                                     </td><td>0.591 (0.577, 0.604)</td><td>0.607 (0.594, 0.624)</td><td>0.017 (0.003, 0.03)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_516    </td><td>Other diseases of stomach and duodenum                                                                  </td><td>0.586 (0.566, 0.601)</td><td>0.602 (0.589, 0.62) </td><td>0.017 (0.003, 0.029)   </td><td>0.527 (0.51, 0.538) </td><td>0.524 (0.507, 0.535)</td><td>-0.003 (-0.005, -0.001)</td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_348    </td><td>Other diseases of spinal cord                                                                           </td><td>0.563 (0.548, 0.582)</td><td>0.58 (0.562, 0.603) </td><td>0.017 (0.002, 0.033)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_179    </td><td>Immunodeficiencies                                                                                      </td><td>0.465 (0.437, 0.497)</td><td>0.483 (0.455, 0.51) </td><td>0.017 (-0.019, 0.051)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-12 </td><td>Hordeolum internum                                                                                      </td><td>0.544 (0.513, 0.57) </td><td>0.56 (0.525, 0.586) </td><td>0.017 (-0.015, 0.041)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148-16 </td><td>Benign neoplasm of choroid                                                                              </td><td>0.58 (0.557, 0.613) </td><td>0.596 (0.569, 0.626)</td><td>0.017 (-0.011, 0.044)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_480    </td><td>Pulmonary edema                                                                                         </td><td>0.709 (0.681, 0.737)</td><td>0.726 (0.696, 0.759)</td><td>0.017 (-0.002, 0.04)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_002    </td><td>Staphylococcus                                                                                          </td><td>0.605 (0.583, 0.623)</td><td>0.622 (0.601, 0.639)</td><td>0.017 (-0.002, 0.036)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401    </td><td>Hypertension                                                                                            </td><td>0.626 (0.623, 0.63) </td><td>0.642 (0.638, 0.646)</td><td>0.016 (0.014, 0.019)   </td><td>0.639 (0.631, 0.647)</td><td>0.648 (0.64, 0.656) </td><td>0.009 (0.006, 0.01)    </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401-1  </td><td>Essential hypertension                                                                                  </td><td>0.626 (0.622, 0.63) </td><td>0.642 (0.638, 0.647)</td><td>0.016 (0.014, 0.019)   </td><td>0.641 (0.631, 0.648)</td><td>0.648 (0.642, 0.653)</td><td>0.009 (0.005, 0.011)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488    </td><td>Abnormalities of breathing                                                                              </td><td>0.57 (0.565, 0.575) </td><td>0.586 (0.581, 0.591)</td><td>0.016 (0.013, 0.02)    </td><td>0.596 (0.564, 0.629)</td><td>0.627 (0.589, 0.649)</td><td>0.019 (0.002, 0.041)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460-2  </td><td>Acute lower respiratory infection                                                                       </td><td>0.559 (0.555, 0.563)</td><td>0.575 (0.572, 0.579)</td><td>0.016 (0.013, 0.02)    </td><td>0.717 (0.7, 0.736)  </td><td>0.724 (0.704, 0.741)</td><td>0.006 (0.004, 0.01)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718    </td><td>Back pain                                                                                               </td><td>0.518 (0.513, 0.522)</td><td>0.534 (0.529, 0.537)</td><td>0.016 (0.012, 0.02)    </td><td>0.572 (0.556, 0.602)</td><td>0.573 (0.557, 0.605)</td><td>0.001 (-0.001, 0.003)  </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386    </td><td>Visual disturbances                                                                                     </td><td>0.588 (0.579, 0.595)</td><td>0.605 (0.596, 0.613)</td><td>0.016 (0.011, 0.024)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_138    </td><td>Benign neoplasm of the skin                                                                             </td><td>0.528 (0.522, 0.535)</td><td>0.544 (0.537, 0.55) </td><td>0.016 (0.01, 0.021)    </td><td>0.475 (0.452, 0.5)  </td><td>0.474 (0.448, 0.51) </td><td>0.004 (-0.011, 0.016)  </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_684    </td><td>Diseases of hair and hair follicles                                                                     </td><td>0.695 (0.684, 0.704)</td><td>0.711 (0.7, 0.721)  </td><td>0.016 (0.009, 0.025)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325-2  </td><td>Abnormality of gait and mobility                                                                        </td><td>0.647 (0.639, 0.656)</td><td>0.662 (0.655, 0.671)</td><td>0.016 (0.009, 0.023)   </td><td>0.778 (0.75, 0.795) </td><td>0.774 (0.747, 0.793)</td><td>-0.002 (-0.005, -0.001)</td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336    </td><td>Mononeuropathies                                                                                        </td><td>0.544 (0.537, 0.552)</td><td>0.56 (0.554, 0.567) </td><td>0.016 (0.009, 0.022)   </td><td>0.512 (0.494, 0.527)</td><td>0.526 (0.506, 0.538)</td><td>0.012 (-0.002, 0.02)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_486-5  </td><td>Abnormal sputum                                                                                         </td><td>0.555 (0.547, 0.562)</td><td>0.571 (0.563, 0.58) </td><td>0.016 (0.009, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_496    </td><td>Abnormal results of pulmonary function studies                                                          </td><td>0.58 (0.57, 0.591)  </td><td>0.597 (0.587, 0.608)</td><td>0.016 (0.008, 0.024)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_524-1  </td><td>Irritable bowel syndrome                                                                                </td><td>0.606 (0.595, 0.617)</td><td>0.621 (0.611, 0.635)</td><td>0.016 (0.007, 0.026)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-5  </td><td>Hypokalemia [Hypopotassemia]                                                                            </td><td>0.638 (0.624, 0.655)</td><td>0.655 (0.643, 0.668)</td><td>0.016 (0.005, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_464-1  </td><td>Acute nasopharyngitis                                                                                   </td><td>0.534 (0.523, 0.543)</td><td>0.55 (0.538, 0.563) </td><td>0.016 (0.005, 0.027)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_464    </td><td>Nasopharyngitis                                                                                         </td><td>0.534 (0.521, 0.547)</td><td>0.549 (0.539, 0.562)</td><td>0.016 (0.003, 0.028)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_012    </td><td>Proteus                                                                                                 </td><td>0.675 (0.627, 0.723)</td><td>0.689 (0.64, 0.742) </td><td>0.016 (-0.034, 0.061)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-11 </td><td>Acute otitis media                                                                                      </td><td>0.506 (0.474, 0.536)</td><td>0.521 (0.491, 0.552)</td><td>0.016 (-0.017, 0.053)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-22 </td><td>Flushing                                                                                                </td><td>0.562 (0.535, 0.592)</td><td>0.578 (0.556, 0.602)</td><td>0.016 (-0.004, 0.04)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_515    </td><td>Heartburn and epigastric pain                                                                           </td><td>0.553 (0.545, 0.563)</td><td>0.569 (0.562, 0.578)</td><td>0.015 (0.01, 0.023)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468    </td><td>Pneumonia                                                                                               </td><td>0.665 (0.657, 0.671)</td><td>0.68 (0.672, 0.687) </td><td>0.015 (0.01, 0.021)    </td><td>0.73 (0.719, 0.748) </td><td>0.735 (0.722, 0.752)</td><td>0.004 (0.001, 0.005)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-4  </td><td>Pruritus                                                                                                </td><td>0.554 (0.547, 0.562)</td><td>0.57 (0.562, 0.576) </td><td>0.015 (0.01, 0.02)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448    </td><td>Peripheral vascular disease                                                                             </td><td>0.613 (0.601, 0.628)</td><td>0.629 (0.616, 0.643)</td><td>0.015 (0.009, 0.024)   </td><td>0.715 (0.68, 0.735) </td><td>0.715 (0.686, 0.732)</td><td>0.003 (-0.009, 0.012)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-4  </td><td>Allergy to analgesic agent                                                                              </td><td>0.624 (0.612, 0.633)</td><td>0.638 (0.626, 0.648)</td><td>0.015 (0.009, 0.021)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-9  </td><td>Lobar pneumonia*                                                                                        </td><td>0.675 (0.667, 0.683)</td><td>0.689 (0.681, 0.699)</td><td>0.015 (0.008, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361    </td><td>Disorders of eyelid function                                                                            </td><td>0.64 (0.629, 0.655) </td><td>0.655 (0.642, 0.672)</td><td>0.015 (0.004, 0.026)   </td><td>0.641 (0.621, 0.671)</td><td>0.639 (0.621, 0.673)</td><td>0 (-0.007, 0.003)      </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685    </td><td>Disorders of sweat glands                                                                               </td><td>0.55 (0.536, 0.561) </td><td>0.565 (0.553, 0.578)</td><td>0.015 (0.003, 0.028)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_355    </td><td>Coma and other alteration of consciousness                                                              </td><td>0.61 (0.593, 0.631) </td><td>0.626 (0.61, 0.641) </td><td>0.015 (0.001, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716-2  </td><td>Degenerative disc disease                                                                               </td><td>0.525 (0.508, 0.539)</td><td>0.54 (0.524, 0.551) </td><td>0.015 (0, 0.03)        </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_688    </td><td>Granulomatous disorder of the skin                                                                      </td><td>0.507 (0.478, 0.527)</td><td>0.522 (0.501, 0.543)</td><td>0.015 (-0.005, 0.034)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_138-1  </td><td>Nevus, non-neoplastic                                                                                   </td><td>0.532 (0.508, 0.552)</td><td>0.546 (0.527, 0.564)</td><td>0.015 (-0.005, 0.034)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556-3  </td><td>Abdominal or pelvic swelling, mass, or lump                                                             </td><td>0.543 (0.53, 0.559) </td><td>0.559 (0.542, 0.572)</td><td>0.015 (-0.001, 0.029)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724    </td><td>Other symptoms and disorders of the soft tissue                                                         </td><td>0.55 (0.543, 0.555) </td><td>0.565 (0.56, 0.57)  </td><td>0.014 (0.01, 0.019)    </td><td>0.541 (0.523, 0.556)</td><td>0.542 (0.523, 0.56) </td><td>0.004 (-0.01, 0.012)   </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840    </td><td>Allergy                                                                                                 </td><td>0.541 (0.534, 0.545)</td><td>0.554 (0.547, 0.56) </td><td>0.014 (0.009, 0.017)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_138-2  </td><td>Melanocytic nevi*                                                                                       </td><td>0.544 (0.537, 0.553)</td><td>0.559 (0.551, 0.567)</td><td>0.014 (0.008, 0.019)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177    </td><td>Abnormality of the lymph nodes                                                                          </td><td>0.555 (0.547, 0.565)</td><td>0.57 (0.56, 0.58)   </td><td>0.014 (0.006, 0.024)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-2  </td><td>Seborrheic dermatitis                                                                                   </td><td>0.541 (0.53, 0.551) </td><td>0.555 (0.544, 0.566)</td><td>0.014 (0.006, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716    </td><td>Intervertebral disc disorder                                                                            </td><td>0.535 (0.527, 0.544)</td><td>0.548 (0.539, 0.556)</td><td>0.014 (0.005, 0.02)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_680    </td><td>Epidermal thickening                                                                                    </td><td>0.586 (0.576, 0.595)</td><td>0.598 (0.589, 0.61) </td><td>0.014 (0.005, 0.019)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674    </td><td>Disorders of pigmentation                                                                               </td><td>0.545 (0.533, 0.556)</td><td>0.558 (0.548, 0.57) </td><td>0.014 (0.003, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_209    </td><td>Disorders of the pituitary gland and its hypothalamic control                                           </td><td>0.609 (0.582, 0.648)</td><td>0.621 (0.584, 0.657)</td><td>0.014 (-0.022, 0.038)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_007-1  </td><td>Hemophilus influenzae                                                                                   </td><td>0.595 (0.552, 0.627)</td><td>0.611 (0.566, 0.659)</td><td>0.014 (-0.012, 0.056)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_559    </td><td>Other disease of digestive system, NOS                                                                  </td><td>0.523 (0.493, 0.548)</td><td>0.537 (0.508, 0.561)</td><td>0.014 (-0.011, 0.036)  </td><td>0.546 (0.519, 0.55) </td><td>0.543 (0.516, 0.548)</td><td>-0.003 (-0.004, -0.001)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_517    </td><td>Gastrointestinal angiodysplasia                                                                         </td><td>0.68 (0.649, 0.712) </td><td>0.692 (0.663, 0.725)</td><td>0.014 (-0.01, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_537    </td><td>Abnormality of the peritoneum                                                                           </td><td>0.54 (0.521, 0.57)  </td><td>0.557 (0.533, 0.583)</td><td>0.014 (-0.006, 0.036)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_327    </td><td>Other degenerative diseases of nervous system                                                           </td><td>0.692 (0.667, 0.72) </td><td>0.707 (0.683, 0.729)</td><td>0.014 (-0.003, 0.036)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_711-1  </td><td>Derangement of meniscus                                                                                 </td><td>0.524 (0.51, 0.535) </td><td>0.538 (0.525, 0.548)</td><td>0.014 (-0.001, 0.028)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460    </td><td>Acute respiratory infection                                                                             </td><td>0.527 (0.522, 0.531)</td><td>0.54 (0.537, 0.544) </td><td>0.013 (0.01, 0.016)    </td><td>0.709 (0.686, 0.722)</td><td>0.716 (0.697, 0.726)</td><td>0.007 (0.001, 0.01)    </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-3  </td><td>Fungal infections                                                                                       </td><td>0.52 (0.516, 0.525) </td><td>0.532 (0.527, 0.538)</td><td>0.013 (0.009, 0.016)   </td><td>0.6 (0.562, 0.611)  </td><td>0.593 (0.556, 0.609)</td><td>-0.003 (-0.02, 0.005)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_722-1  </td><td>Plantar fascial fibromatosis [Plantar fasciitis]                                                        </td><td>0.536 (0.529, 0.544)</td><td>0.549 (0.541, 0.556)</td><td>0.013 (0.007, 0.018)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_425    </td><td>Cardiomegaly                                                                                            </td><td>0.679 (0.666, 0.694)</td><td>0.692 (0.682, 0.706)</td><td>0.013 (0.005, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479    </td><td>Pulmonary insufficiency and acute respiratory distress syndrome                                         </td><td>0.657 (0.646, 0.672)</td><td>0.67 (0.657, 0.685) </td><td>0.013 (0.005, 0.022)   </td><td>0.655 (0.623, 0.692)</td><td>0.705 (0.676, 0.75) </td><td>0.045 (0.032, 0.068)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-1  </td><td>Radiculopathy                                                                                           </td><td>0.573 (0.561, 0.587)</td><td>0.586 (0.573, 0.6)  </td><td>0.013 (0.004, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_558    </td><td>Abnormal findings on diagnostic imaging of the digestive tract                                          </td><td>0.588 (0.578, 0.601)</td><td>0.601 (0.586, 0.611)</td><td>0.013 (0.004, 0.02)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_491    </td><td>Pleurisy                                                                                                </td><td>0.623 (0.602, 0.643)</td><td>0.637 (0.616, 0.653)</td><td>0.013 (0.003, 0.025)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-5  </td><td>Exostosis                                                                                               </td><td>0.559 (0.543, 0.577)</td><td>0.574 (0.554, 0.587)</td><td>0.013 (0.003, 0.024)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-13 </td><td>Umbilical hernia                                                                                        </td><td>0.625 (0.614, 0.639)</td><td>0.637 (0.625, 0.652)</td><td>0.013 (0.003, 0.023)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_711    </td><td>Disorder of patella                                                                                     </td><td>0.523 (0.51, 0.536) </td><td>0.536 (0.525, 0.549)</td><td>0.013 (0.002, 0.029)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-3  </td><td>Allergy to narcotic agent                                                                               </td><td>0.657 (0.641, 0.68) </td><td>0.672 (0.654, 0.689)</td><td>0.013 (0.002, 0.024)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-3  </td><td>Dystonia                                                                                                </td><td>0.548 (0.529, 0.566)</td><td>0.561 (0.55, 0.579) </td><td>0.013 (0, 0.028)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_344-1  </td><td>Hydrocephalus                                                                                           </td><td>0.627 (0.587, 0.67) </td><td>0.638 (0.604, 0.692)</td><td>0.013 (-0.036, 0.054)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-7  </td><td>Restlessness and agitation*                                                                             </td><td>0.569 (0.536, 0.6)  </td><td>0.583 (0.554, 0.617)</td><td>0.013 (-0.019, 0.046)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_348-2  </td><td>Myelopathies                                                                                            </td><td>0.555 (0.537, 0.58) </td><td>0.57 (0.546, 0.594) </td><td>0.013 (-0.012, 0.038)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_015    </td><td>Clostridium                                                                                             </td><td>0.602 (0.574, 0.632)</td><td>0.615 (0.589, 0.649)</td><td>0.013 (-0.011, 0.041)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-11 </td><td>Acute pancreatitis                                                                                      </td><td>0.571 (0.547, 0.601)</td><td>0.585 (0.563, 0.607)</td><td>0.013 (-0.01, 0.038)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_149    </td><td>Benign neoplasm of the endocrine glands                                                                 </td><td>0.581 (0.558, 0.611)</td><td>0.597 (0.574, 0.619)</td><td>0.013 (-0.01, 0.032)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-1  </td><td>Pancreatitis                                                                                            </td><td>0.584 (0.558, 0.605)</td><td>0.595 (0.575, 0.617)</td><td>0.013 (-0.008, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_100    </td><td>Malignant neoplasm of the head and neck                                                                 </td><td>0.607 (0.578, 0.638)</td><td>0.622 (0.597, 0.651)</td><td>0.013 (-0.005, 0.037)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_084    </td><td>Parasites                                                                                               </td><td>0.58 (0.563, 0.605) </td><td>0.593 (0.568, 0.619)</td><td>0.013 (-0.005, 0.029)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488-1  </td><td>Dyspnea [Shortness of breath]                                                                           </td><td>0.599 (0.594, 0.605)</td><td>0.612 (0.606, 0.616)</td><td>0.012 (0.009, 0.016)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_801    </td><td>Cough                                                                                                   </td><td>0.527 (0.524, 0.531)</td><td>0.539 (0.535, 0.543)</td><td>0.012 (0.009, 0.015)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_389    </td><td>Other disorders of eye                                                                                  </td><td>0.561 (0.555, 0.569)</td><td>0.573 (0.566, 0.579)</td><td>0.012 (0.007, 0.016)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_807    </td><td>Malaise and fatigue                                                                                     </td><td>0.547 (0.543, 0.551)</td><td>0.559 (0.554, 0.565)</td><td>0.012 (0.007, 0.016)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325    </td><td>Symptoms and signs related to movement disorders                                                        </td><td>0.636 (0.627, 0.643)</td><td>0.648 (0.64, 0.656) </td><td>0.012 (0.006, 0.019)   </td><td>0.751 (0.735, 0.782)</td><td>0.748 (0.73, 0.778) </td><td>-0.004 (-0.005, -0.002)</td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-7  </td><td>Volume depletion                                                                                        </td><td>0.662 (0.648, 0.675)</td><td>0.674 (0.661, 0.684)</td><td>0.012 (0.003, 0.021)   </td><td>0.728 (0.707, 0.746)</td><td>0.728 (0.706, 0.744)</td><td>0 (-0.002, 0.001)      </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-11 </td><td>Hordeolum externum                                                                                      </td><td>0.519 (0.51, 0.533) </td><td>0.531 (0.519, 0.543)</td><td>0.012 (0.002, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_169-11 </td><td>Immune thrombocytopenic purpura [ITP]                                                                   </td><td>0.599 (0.561, 0.639)</td><td>0.614 (0.567, 0.653)</td><td>0.012 (-0.013, 0.042)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_353-1  </td><td>Hallucinations                                                                                          </td><td>0.615 (0.583, 0.654)</td><td>0.626 (0.601, 0.651)</td><td>0.012 (-0.012, 0.039)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_673    </td><td>Skin changes due to chronic exposure to nonionizing radiation                                           </td><td>0.598 (0.593, 0.602)</td><td>0.609 (0.604, 0.613)</td><td>0.011 (0.009, 0.013)   </td><td>0.586 (0.549, 0.611)</td><td>0.57 (0.533, 0.598) </td><td>-0.015 (-0.018, -0.009)</td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_707    </td><td>Other arthropathies                                                                                     </td><td>0.641 (0.636, 0.647)</td><td>0.652 (0.646, 0.659)</td><td>0.011 (0.008, 0.014)   </td><td>0.571 (0.556, 0.584)</td><td>0.582 (0.572, 0.596)</td><td>0.013 (0.005, 0.02)    </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256    </td><td>Disorders of fluid, electrolyte and acid-base balance                                                   </td><td>0.581 (0.575, 0.588)</td><td>0.592 (0.585, 0.599)</td><td>0.011 (0.007, 0.016)   </td><td>0.712 (0.701, 0.724)</td><td>0.715 (0.702, 0.726)</td><td>0.002 (0, 0.003)       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_681    </td><td>Localized swelling, mass and lump of skin and subcutaneous tissue                                       </td><td>0.556 (0.552, 0.561)</td><td>0.567 (0.563, 0.573)</td><td>0.011 (0.007, 0.015)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-2  </td><td>Cervicalgia                                                                                             </td><td>0.55 (0.545, 0.556) </td><td>0.561 (0.556, 0.566)</td><td>0.011 (0.006, 0.017)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_812    </td><td>Edema                                                                                                   </td><td>0.61 (0.603, 0.617) </td><td>0.621 (0.614, 0.631)</td><td>0.011 (0.006, 0.017)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-5  </td><td>Sciatica                                                                                                </td><td>0.546 (0.54, 0.553) </td><td>0.557 (0.55, 0.563) </td><td>0.011 (0.006, 0.016)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526    </td><td>Intestinal infection                                                                                    </td><td>0.568 (0.561, 0.575)</td><td>0.579 (0.572, 0.588)</td><td>0.011 (0.005, 0.016)   </td><td>0.65 (0.631, 0.658) </td><td>0.653 (0.629, 0.663)</td><td>0.003 (-0.002, 0.005)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_350-5  </td><td>Repeated falls*                                                                                         </td><td>0.717 (0.707, 0.726)</td><td>0.727 (0.72, 0.735) </td><td>0.011 (0.004, 0.016)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-1  </td><td>Hordeolum                                                                                               </td><td>0.519 (0.507, 0.533)</td><td>0.531 (0.52, 0.541) </td><td>0.011 (0.003, 0.022)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_524    </td><td>Functional intestinal disorder                                                                          </td><td>0.6 (0.589, 0.612)  </td><td>0.612 (0.599, 0.623)</td><td>0.011 (0.003, 0.02)    </td><td>0.628 (0.623, 0.648)</td><td>0.627 (0.623, 0.647)</td><td>-0.001 (-0.003, 0)     </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-1  </td><td>Cutaneous cyst                                                                                          </td><td>0.496 (0.489, 0.503)</td><td>0.506 (0.499, 0.514)</td><td>0.011 (0.002, 0.02)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139    </td><td>Benign sarcoma-related cancers                                                                          </td><td>0.5 (0.49, 0.508)   </td><td>0.511 (0.501, 0.521)</td><td>0.011 (0, 0.021)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-2  </td><td>Viral enteritis                                                                                         </td><td>0.57 (0.537, 0.602) </td><td>0.585 (0.552, 0.616)</td><td>0.011 (-0.016, 0.04)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-7  </td><td>Perforation of tympanic membrane                                                                        </td><td>0.532 (0.506, 0.555)</td><td>0.542 (0.517, 0.564)</td><td>0.011 (-0.015, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_495-1  </td><td>Solitary pulmonary nodule                                                                               </td><td>0.632 (0.594, 0.657)</td><td>0.642 (0.609, 0.674)</td><td>0.011 (-0.011, 0.041)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_095    </td><td>Sequela of infection                                                                                    </td><td>0.546 (0.522, 0.574)</td><td>0.558 (0.534, 0.592)</td><td>0.011 (-0.011, 0.032)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_484    </td><td>Pneumothorax and air leak                                                                               </td><td>0.611 (0.583, 0.641)</td><td>0.624 (0.591, 0.652)</td><td>0.011 (-0.01, 0.04)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_004    </td><td>Streptococcus                                                                                           </td><td>0.578 (0.557, 0.599)</td><td>0.59 (0.565, 0.609) </td><td>0.011 (-0.006, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554    </td><td>Diseases of the pancreas                                                                                </td><td>0.598 (0.578, 0.616)</td><td>0.606 (0.588, 0.626)</td><td>0.011 (-0.006, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-6  </td><td>Hemangioma and lymphangioma                                                                             </td><td>0.501 (0.485, 0.517)</td><td>0.513 (0.498, 0.534)</td><td>0.011 (-0.004, 0.034)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-22 </td><td>Hallux rigidus                                                                                          </td><td>0.573 (0.552, 0.592)</td><td>0.585 (0.561, 0.605)</td><td>0.011 (-0.003, 0.027)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-1  </td><td>Melanomas of skin                                                                                       </td><td>0.603 (0.588, 0.621)</td><td>0.615 (0.598, 0.633)</td><td>0.011 (-0.002, 0.021)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_584    </td><td>Renal failure                                                                                           </td><td>0.683 (0.663, 0.699)</td><td>0.692 (0.676, 0.712)</td><td>0.011 (-0.001, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103    </td><td>Malignant neoplasm of the skin                                                                          </td><td>0.655 (0.648, 0.664)</td><td>0.666 (0.658, 0.674)</td><td>0.01 (0.008, 0.013)    </td><td>0.625 (0.606, 0.633)</td><td>0.623 (0.604, 0.632)</td><td>-0.002 (-0.003, -0.001)</td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_673-1  </td><td>Actinic keratosis                                                                                       </td><td>0.599 (0.595, 0.603)</td><td>0.609 (0.605, 0.614)</td><td>0.01 (0.008, 0.012)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660    </td><td>Infection of the skin                                                                                   </td><td>0.524 (0.52, 0.528) </td><td>0.534 (0.53, 0.539) </td><td>0.01 (0.007, 0.013)    </td><td>0.676 (0.666, 0.692)</td><td>0.68 (0.673, 0.699) </td><td>0.007 (-0.001, 0.01)   </td></tr>\n",
       "\t<tr><td>Death         </td><td>OMOP_4306655   </td><td>All-Cause Death                                                                                         </td><td>0.707 (0.702, 0.714)</td><td>0.718 (0.712, 0.723)</td><td>0.01 (0.006, 0.014)    </td><td>0.733 (0.705, 0.784)</td><td>0.727 (0.701, 0.773)</td><td>-0.006 (-0.015, 0.008) </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424    </td><td>Heart failure                                                                                           </td><td>0.737 (0.731, 0.748)</td><td>0.747 (0.739, 0.756)</td><td>0.01 (0.005, 0.016)    </td><td>0.767 (0.757, 0.778)</td><td>0.768 (0.759, 0.78) </td><td>0.002 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424-1  </td><td>Left heart failure                                                                                      </td><td>0.73 (0.716, 0.743) </td><td>0.739 (0.726, 0.752)</td><td>0.01 (0.004, 0.015)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463    </td><td>Rhinitis and nasal congestion                                                                           </td><td>0.522 (0.517, 0.529)</td><td>0.532 (0.525, 0.538)</td><td>0.01 (0.004, 0.015)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_234    </td><td>Other nutritional deficiencies                                                                          </td><td>0.58 (0.57, 0.593)  </td><td>0.59 (0.58, 0.604)  </td><td>0.01 (0.002, 0.02)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_181    </td><td>Autoimmune disease                                                                                      </td><td>0.547 (0.536, 0.556)</td><td>0.557 (0.548, 0.568)</td><td>0.01 (0.001, 0.022)    </td><td>0.561 (0.549, 0.58) </td><td>0.561 (0.539, 0.573)</td><td>-0.002 (-0.014, 0.01)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_336-5  </td><td>Mononeuritis of lower limb                                                                              </td><td>0.563 (0.549, 0.578)</td><td>0.574 (0.56, 0.589) </td><td>0.01 (0.001, 0.02)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_509-3  </td><td>Hypertrophy of tongue papillae                                                                          </td><td>0.533 (0.497, 0.576)</td><td>0.543 (0.507, 0.576)</td><td>0.01 (-0.024, 0.039)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_366-4  </td><td>Vascular abnormalities of conjunctiva                                                                   </td><td>0.524 (0.495, 0.56) </td><td>0.533 (0.51, 0.567) </td><td>0.01 (-0.02, 0.042)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_162    </td><td>Aplastic anemia                                                                                         </td><td>0.657 (0.631, 0.689)</td><td>0.667 (0.636, 0.699)</td><td>0.01 (-0.018, 0.033)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-12 </td><td>Intestinal infection due to C. difficile                                                                </td><td>0.646 (0.619, 0.681)</td><td>0.657 (0.628, 0.692)</td><td>0.01 (-0.017, 0.038)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_452    </td><td>Hemorrhage, NOS                                                                                         </td><td>0.575 (0.546, 0.6)  </td><td>0.586 (0.554, 0.611)</td><td>0.01 (-0.014, 0.034)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840-1  </td><td>Food allergy                                                                                            </td><td>0.547 (0.523, 0.573)</td><td>0.556 (0.531, 0.584)</td><td>0.01 (-0.008, 0.028)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-1  </td><td>Esophageal ulcer                                                                                        </td><td>0.599 (0.577, 0.618)</td><td>0.609 (0.593, 0.632)</td><td>0.01 (-0.005, 0.026)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-11 </td><td>Sebaceous cyst [Epidermal cyst]                                                                         </td><td>0.486 (0.479, 0.496)</td><td>0.497 (0.489, 0.506)</td><td>0.01 (-0.003, 0.021)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_585-1  </td><td>Renal colic                                                                                             </td><td>0.608 (0.589, 0.629)</td><td>0.62 (0.598, 0.641) </td><td>0.01 (-0.002, 0.026)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-21 </td><td>Basal cell carcinoma                                                                                    </td><td>0.643 (0.634, 0.652)</td><td>0.652 (0.643, 0.661)</td><td>0.009 (0.006, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-2  </td><td>Keratinocyte carcinoma                                                                                  </td><td>0.652 (0.646, 0.659)</td><td>0.66 (0.654, 0.668) </td><td>0.009 (0.006, 0.011)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_605    </td><td>Male sexual dysfuction                                                                                  </td><td>0.558 (0.552, 0.564)</td><td>0.567 (0.56, 0.575) </td><td>0.009 (0.005, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_460-1  </td><td>Acute upper respiratory infection                                                                       </td><td>0.534 (0.529, 0.54) </td><td>0.543 (0.539, 0.548)</td><td>0.009 (0.005, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_809-3  </td><td>Pain in limb                                                                                            </td><td>0.524 (0.52, 0.529) </td><td>0.533 (0.529, 0.537)</td><td>0.009 (0.005, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_809    </td><td>Pain                                                                                                    </td><td>0.528 (0.525, 0.531)</td><td>0.537 (0.533, 0.541)</td><td>0.009 (0.005, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_605-1  </td><td>Male erectile dysfunction                                                                               </td><td>0.558 (0.551, 0.564)</td><td>0.567 (0.559, 0.573)</td><td>0.009 (0.004, 0.014)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-9  </td><td>Gastritis                                                                                               </td><td>0.565 (0.558, 0.571)</td><td>0.574 (0.568, 0.58) </td><td>0.009 (0.004, 0.014)   </td><td>0.571 (0.552, 0.583)</td><td>0.57 (0.55, 0.582)  </td><td>-0.001 (-0.001, -0.001)</td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-8  </td><td>Headache NOS                                                                                            </td><td>0.57 (0.564, 0.574) </td><td>0.578 (0.573, 0.584)</td><td>0.009 (0.004, 0.014)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_823-2  </td><td>Abnormal levels of other serum enzymes                                                                  </td><td>0.56 (0.552, 0.568) </td><td>0.569 (0.56, 0.578) </td><td>0.009 (0.004, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433    </td><td>Other cerebrovascular disease                                                                           </td><td>0.716 (0.705, 0.726)</td><td>0.725 (0.717, 0.734)</td><td>0.009 (0.003, 0.016)   </td><td>0.773 (0.759, 0.78) </td><td>0.77 (0.756, 0.779) </td><td>-0.002 (-0.006, 0)     </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_823    </td><td>Abnormal serum enzyme levels                                                                            </td><td>0.56 (0.55, 0.569)  </td><td>0.569 (0.56, 0.578) </td><td>0.009 (0.003, 0.014)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_716-3  </td><td>Spinal disc displacement (herniation)                                                                   </td><td>0.542 (0.531, 0.556)</td><td>0.552 (0.541, 0.563)</td><td>0.009 (0.002, 0.019)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-1  </td><td>Myalgia                                                                                                 </td><td>0.555 (0.547, 0.564)</td><td>0.563 (0.553, 0.571)</td><td>0.009 (0.001, 0.015)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_015-2  </td><td>Clostridium difficile                                                                                   </td><td>0.646 (0.622, 0.673)</td><td>0.656 (0.629, 0.684)</td><td>0.009 (-0.017, 0.033)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-1  </td><td>Hematemesis                                                                                             </td><td>0.596 (0.578, 0.619)</td><td>0.605 (0.578, 0.627)</td><td>0.009 (-0.017, 0.031)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-1  </td><td>Entropion and trichiasis of eyelid                                                                      </td><td>0.682 (0.651, 0.712)</td><td>0.691 (0.662, 0.72) </td><td>0.009 (-0.013, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_468-8  </td><td>Bronchopneumonia                                                                                        </td><td>0.686 (0.653, 0.731)</td><td>0.695 (0.663, 0.739)</td><td>0.009 (-0.012, 0.029)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_437    </td><td>Vascular insufficiency of intestine                                                                     </td><td>0.665 (0.634, 0.687)</td><td>0.673 (0.645, 0.707)</td><td>0.009 (-0.008, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168    </td><td>Coagulation defects, purpura and other hemorrhagic conditions                                           </td><td>0.595 (0.579, 0.612)</td><td>0.604 (0.589, 0.618)</td><td>0.009 (-0.004, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-2  </td><td>Chalazion                                                                                               </td><td>0.52 (0.503, 0.535) </td><td>0.531 (0.514, 0.541)</td><td>0.009 (-0.002, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705-1  </td><td>Rheumatoid arthritis                                                                                    </td><td>0.591 (0.576, 0.609)</td><td>0.601 (0.583, 0.617)</td><td>0.009 (-0.001, 0.023)  </td><td>0.596 (0.576, 0.613)</td><td>0.59 (0.577, 0.616) </td><td>0.002 (-0.012, 0.012)  </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-11 </td><td>Pure hypercholesterolemia                                                                               </td><td>0.614 (0.611, 0.618)</td><td>0.623 (0.619, 0.627)</td><td>0.008 (0.006, 0.011)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239-1  </td><td>Hypercholesterolemia                                                                                    </td><td>0.613 (0.609, 0.617)</td><td>0.621 (0.616, 0.626)</td><td>0.008 (0.006, 0.01)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-1  </td><td>Fungal infection of the skin                                                                            </td><td>0.541 (0.535, 0.548)</td><td>0.55 (0.544, 0.556) </td><td>0.008 (0.005, 0.012)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_830    </td><td>Proteinuria                                                                                             </td><td>0.584 (0.579, 0.59) </td><td>0.591 (0.587, 0.597)</td><td>0.008 (0.005, 0.012)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_239    </td><td>Hyperlipidemia                                                                                          </td><td>0.606 (0.602, 0.612)</td><td>0.615 (0.61, 0.62)  </td><td>0.008 (0.005, 0.011)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_070    </td><td>Candidiasis                                                                                             </td><td>0.586 (0.579, 0.594)</td><td>0.594 (0.586, 0.603)</td><td>0.008 (0.003, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522    </td><td>Gastrointestinal inflammation                                                                           </td><td>0.555 (0.549, 0.56) </td><td>0.563 (0.558, 0.568)</td><td>0.008 (0.003, 0.012)   </td><td>0.566 (0.56, 0.58)  </td><td>0.565 (0.559, 0.58) </td><td>-0.001 (-0.001, 0)     </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-4  </td><td>Spinal stenosis                                                                                         </td><td>0.645 (0.633, 0.657)</td><td>0.653 (0.641, 0.666)</td><td>0.008 (0.001, 0.015)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_473    </td><td>Other diseases of upper respiratory tract                                                               </td><td>0.537 (0.525, 0.551)</td><td>0.545 (0.532, 0.558)</td><td>0.008 (0, 0.014)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_469-1  </td><td>Acute bronchitis                                                                                        </td><td>0.564 (0.542, 0.584)</td><td>0.571 (0.545, 0.594)</td><td>0.008 (-0.016, 0.031)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_375-12 </td><td>Angle-Closure Glaucoma                                                                                  </td><td>0.675 (0.65, 0.698) </td><td>0.683 (0.659, 0.712)</td><td>0.008 (-0.008, 0.027)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713-4  </td><td>Stiffness of joint                                                                                      </td><td>0.529 (0.512, 0.545)</td><td>0.537 (0.511, 0.557)</td><td>0.008 (-0.008, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-2  </td><td>Arterial embolism and thrombosis                                                                        </td><td>0.689 (0.668, 0.709)</td><td>0.697 (0.679, 0.715)</td><td>0.008 (-0.008, 0.02)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726-2  </td><td>Pathologic fracture                                                                                     </td><td>0.724 (0.706, 0.745)</td><td>0.732 (0.714, 0.751)</td><td>0.008 (-0.005, 0.021)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424-2  </td><td>Systolic heart failure                                                                                  </td><td>0.721 (0.696, 0.743)</td><td>0.73 (0.702, 0.751) </td><td>0.008 (-0.003, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_526-1  </td><td>Bacterial enteritis                                                                                     </td><td>0.528 (0.518, 0.543)</td><td>0.538 (0.525, 0.55) </td><td>0.008 (-0.002, 0.022)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800-1  </td><td>Chest pain on breathing                                                                                 </td><td>0.54 (0.53, 0.557)  </td><td>0.55 (0.54, 0.563)  </td><td>0.008 (-0.002, 0.02)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513    </td><td>Peptic ulcer                                                                                            </td><td>0.594 (0.585, 0.603)</td><td>0.601 (0.595, 0.613)</td><td>0.008 (-0.002, 0.018)  </td><td>0.672 (0.637, 0.69) </td><td>0.677 (0.649, 0.7)  </td><td>0.009 (0.002, 0.015)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_443    </td><td>Other specified disorders of arteries and arterioles                                                    </td><td>0.687 (0.677, 0.702)</td><td>0.696 (0.682, 0.708)</td><td>0.008 (-0.001, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713-3  </td><td>Pain in joint                                                                                           </td><td>0.526 (0.523, 0.53) </td><td>0.533 (0.529, 0.536)</td><td>0.007 (0.004, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_713    </td><td>Symptoms related to joints                                                                              </td><td>0.526 (0.523, 0.53) </td><td>0.533 (0.53, 0.536) </td><td>0.007 (0.004, 0.009)   </td><td>0.63 (0.609, 0.662) </td><td>0.634 (0.613, 0.662)</td><td>0.004 (-0.004, 0.014)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_403    </td><td>Angina pectoris                                                                                         </td><td>0.672 (0.665, 0.682)</td><td>0.679 (0.671, 0.686)</td><td>0.007 (0.003, 0.011)   </td><td>0.662 (0.648, 0.669)</td><td>0.662 (0.649, 0.671)</td><td>0.001 (-0.002, 0.005)  </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089    </td><td>Infections                                                                                              </td><td>0.521 (0.517, 0.525)</td><td>0.528 (0.524, 0.531)</td><td>0.007 (0.003, 0.01)    </td><td>0.675 (0.664, 0.683)</td><td>0.68 (0.671, 0.693) </td><td>0.006 (0.004, 0.01)    </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703-1  </td><td>Hyperuricemia                                                                                           </td><td>0.701 (0.693, 0.708)</td><td>0.707 (0.7, 0.715)  </td><td>0.007 (0.003, 0.01)    </td><td>0.78 (0.758, 0.796) </td><td>0.782 (0.768, 0.8)  </td><td>0.004 (-0.001, 0.01)   </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_483    </td><td>Pleural effusion                                                                                        </td><td>0.682 (0.672, 0.691)</td><td>0.688 (0.679, 0.696)</td><td>0.007 (0.002, 0.014)   </td><td>0.647 (0.629, 0.659)</td><td>0.65 (0.635, 0.661) </td><td>0.004 (0.002, 0.011)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_092-2  </td><td>Sepsis                                                                                                  </td><td>0.663 (0.652, 0.672)</td><td>0.671 (0.66, 0.682) </td><td>0.007 (0.001, 0.013)   </td><td>0.683 (0.652, 0.698)</td><td>0.682 (0.654, 0.696)</td><td>0.001 (-0.002, 0.003)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-1  </td><td>Myocardial infarction [Heart attack]                                                                    </td><td>0.707 (0.699, 0.715)</td><td>0.715 (0.707, 0.723)</td><td>0.007 (0.001, 0.012)   </td><td>0.711 (0.694, 0.728)</td><td>0.714 (0.701, 0.731)</td><td>0.004 (0, 0.006)       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-1  </td><td>Synovitis and tenosynovitis                                                                             </td><td>0.539 (0.534, 0.547)</td><td>0.546 (0.54, 0.553) </td><td>0.007 (0.001, 0.012)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-11 </td><td>Cerebral infarction [Ischemic stroke]                                                                   </td><td>0.704 (0.692, 0.715)</td><td>0.711 (0.7, 0.721)  </td><td>0.007 (0, 0.014)       </td><td>0.723 (0.704, 0.727)</td><td>0.721 (0.702, 0.726)</td><td>0 (-0.003, 0.005)      </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_802    </td><td>Throat pain                                                                                             </td><td>0.549 (0.537, 0.559)</td><td>0.555 (0.544, 0.567)</td><td>0.007 (0, 0.013)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_439    </td><td>Hemorrhoids                                                                                             </td><td>0.504 (0.499, 0.509)</td><td>0.511 (0.506, 0.517)</td><td>0.007 (0, 0.012)       </td><td>0.47 (0.432, 0.496) </td><td>0.491 (0.455, 0.514)</td><td>0.018 (0.013, 0.028)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_424-3  </td><td>Diastolic heart failure                                                                                 </td><td>0.697 (0.667, 0.722)</td><td>0.703 (0.677, 0.73) </td><td>0.007 (-0.017, 0.026)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_554-2  </td><td>Cyst and pseudocyst of pancreas                                                                         </td><td>0.626 (0.591, 0.658)</td><td>0.634 (0.6, 0.663)  </td><td>0.007 (-0.016, 0.033)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_807-11 </td><td>Postviral fatigue syndrome*                                                                             </td><td>0.605 (0.574, 0.644)</td><td>0.611 (0.576, 0.646)</td><td>0.007 (-0.015, 0.023)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_411    </td><td>Other diseases of pericardium                                                                           </td><td>0.642 (0.619, 0.662)</td><td>0.65 (0.626, 0.67)  </td><td>0.007 (-0.013, 0.026)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-3  </td><td>Anorexia                                                                                                </td><td>0.604 (0.588, 0.623)</td><td>0.611 (0.593, 0.629)</td><td>0.007 (-0.006, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-5  </td><td>Disorders of calcium metabolism                                                                         </td><td>0.609 (0.595, 0.621)</td><td>0.615 (0.6, 0.632)  </td><td>0.007 (-0.005, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_397    </td><td>Other hearing abnormality                                                                               </td><td>0.502 (0.494, 0.511)</td><td>0.509 (0.5, 0.517)  </td><td>0.007 (-0.005, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_827    </td><td>Toxicology findings                                                                                     </td><td>0.622 (0.604, 0.647)</td><td>0.629 (0.613, 0.65) </td><td>0.007 (-0.003, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_426    </td><td>Other heart disorders in diseases NEC                                                                   </td><td>0.709 (0.697, 0.72) </td><td>0.715 (0.705, 0.729)</td><td>0.007 (-0.002, 0.015)  </td><td>0.676 (0.656, 0.685)</td><td>0.684 (0.658, 0.693)</td><td>0.007 (0, 0.011)       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-1  </td><td>Stroke                                                                                                  </td><td>0.695 (0.683, 0.706)</td><td>0.702 (0.692, 0.712)</td><td>0.007 (-0.001, 0.017)  </td><td>0.711 (0.701, 0.738)</td><td>0.711 (0.699, 0.74) </td><td>-0.001 (-0.003, 0.004) </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_092    </td><td>Bacteremia, Sepsis, and SIRS                                                                            </td><td>0.666 (0.655, 0.676)</td><td>0.673 (0.663, 0.683)</td><td>0.007 (-0.001, 0.014)  </td><td>0.678 (0.671, 0.692)</td><td>0.679 (0.673, 0.696)</td><td>0.002 (-0.001, 0.004)  </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286-2  </td><td>Major depressive disorder                                                                               </td><td>0.569 (0.562, 0.574)</td><td>0.574 (0.569, 0.581)</td><td>0.006 (0.002, 0.011)   </td><td>0.566 (0.548, 0.582)</td><td>0.569 (0.55, 0.588) </td><td>0.003 (-0.001, 0.007)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_722-4  </td><td>Palmar fascial fibromatosis [Dupuytren]                                                                 </td><td>0.645 (0.634, 0.658)</td><td>0.651 (0.641, 0.663)</td><td>0.006 (0.002, 0.011)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668    </td><td>Dermatitis [eczema]                                                                                     </td><td>0.537 (0.531, 0.542)</td><td>0.543 (0.538, 0.55) </td><td>0.006 (0.002, 0.01)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703-11 </td><td>Gout                                                                                                    </td><td>0.706 (0.698, 0.716)</td><td>0.712 (0.702, 0.722)</td><td>0.006 (0.002, 0.01)    </td><td>0.78 (0.753, 0.805) </td><td>0.78 (0.757, 0.804) </td><td>0 (-0.003, 0.008)      </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550    </td><td>Disorders of the gallbladder                                                                            </td><td>0.572 (0.566, 0.582)</td><td>0.579 (0.572, 0.587)</td><td>0.006 (0.001, 0.012)   </td><td>0.569 (0.536, 0.581)</td><td>0.565 (0.534, 0.577)</td><td>-0.003 (-0.006, -0.001)</td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-11 </td><td>Penicillin allergy                                                                                      </td><td>0.584 (0.577, 0.593)</td><td>0.59 (0.581, 0.597) </td><td>0.006 (0.001, 0.01)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_732    </td><td>Nonspecific abnormal findings on radiological and other examination of musculoskeletal system           </td><td>0.632 (0.62, 0.641) </td><td>0.638 (0.626, 0.647)</td><td>0.006 (0.001, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_840-2  </td><td>Allergy to insects                                                                                      </td><td>0.572 (0.56, 0.583) </td><td>0.579 (0.568, 0.59) </td><td>0.006 (0, 0.014)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391    </td><td>Disorders of the middle ear                                                                             </td><td>0.522 (0.516, 0.53) </td><td>0.528 (0.522, 0.535)</td><td>0.006 (0, 0.012)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-11 </td><td>Generalized epilepsy                                                                                    </td><td>0.536 (0.501, 0.578)</td><td>0.54 (0.498, 0.59)  </td><td>0.006 (-0.042, 0.055)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_383    </td><td>Irregular eye movements                                                                                 </td><td>0.541 (0.497, 0.591)</td><td>0.546 (0.501, 0.589)</td><td>0.006 (-0.031, 0.041)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-5  </td><td>Secondary malignancy of brain/spine                                                                     </td><td>0.625 (0.599, 0.651)</td><td>0.628 (0.608, 0.66) </td><td>0.006 (-0.022, 0.028)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-7  </td><td>Ulceration of the lower GI tract                                                                        </td><td>0.541 (0.516, 0.57) </td><td>0.548 (0.52, 0.581) </td><td>0.006 (-0.019, 0.038)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_174    </td><td>Diseases of spleen                                                                                      </td><td>0.586 (0.558, 0.62) </td><td>0.594 (0.567, 0.617)</td><td>0.006 (-0.018, 0.031)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-32 </td><td>Tricuspid value insufficiency*                                                                          </td><td>0.724 (0.695, 0.752)</td><td>0.73 (0.705, 0.758) </td><td>0.006 (-0.014, 0.029)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-12 </td><td>Hemorrhagic stroke                                                                                      </td><td>0.65 (0.626, 0.676) </td><td>0.658 (0.635, 0.675)</td><td>0.006 (-0.012, 0.026)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288-2  </td><td>Panic disorder [episodic paroxysmal anxiety]                                                            </td><td>0.567 (0.55, 0.586) </td><td>0.575 (0.557, 0.591)</td><td>0.006 (-0.009, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_420    </td><td>Cardiac arrest                                                                                          </td><td>0.728 (0.709, 0.748)</td><td>0.733 (0.713, 0.756)</td><td>0.006 (-0.009, 0.022)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-2  </td><td>Spermatocele                                                                                            </td><td>0.531 (0.505, 0.552)</td><td>0.538 (0.519, 0.562)</td><td>0.006 (-0.008, 0.027)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-52 </td><td>Osteophyte*                                                                                             </td><td>0.582 (0.565, 0.601)</td><td>0.588 (0.567, 0.607)</td><td>0.006 (-0.008, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-1  </td><td>Atopic dermatitis                                                                                       </td><td>0.519 (0.505, 0.528)</td><td>0.524 (0.511, 0.535)</td><td>0.006 (-0.007, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_508    </td><td>Diseases of lips                                                                                        </td><td>0.584 (0.569, 0.6)  </td><td>0.591 (0.575, 0.606)</td><td>0.006 (-0.006, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_800-11 </td><td>Pleurodynia*                                                                                            </td><td>0.546 (0.535, 0.559)</td><td>0.552 (0.54, 0.564) </td><td>0.006 (-0.006, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-3  </td><td>Contact dermatitis                                                                                      </td><td>0.539 (0.525, 0.549)</td><td>0.545 (0.529, 0.557)</td><td>0.006 (-0.003, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532    </td><td>Other disorders of the intestines                                                                       </td><td>0.553 (0.54, 0.566) </td><td>0.559 (0.543, 0.574)</td><td>0.006 (-0.002, 0.017)  </td><td>0.549 (0.526, 0.578)</td><td>0.544 (0.526, 0.575)</td><td>-0.003 (-0.005, -0.001)</td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471    </td><td>Other disorders of nose and nasal sinuses                                                               </td><td>0.507 (0.499, 0.513)</td><td>0.513 (0.507, 0.519)</td><td>0.006 (-0.002, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-8  </td><td>Hemorrhage of rectum and anus                                                                           </td><td>0.51 (0.502, 0.521) </td><td>0.516 (0.507, 0.525)</td><td>0.006 (-0.002, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_827-1  </td><td>Finding of alcohol in blood                                                                             </td><td>0.627 (0.609, 0.652)</td><td>0.635 (0.616, 0.657)</td><td>0.006 (-0.002, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-6  </td><td>Secondary malignancy of bone                                                                            </td><td>0.687 (0.677, 0.699)</td><td>0.694 (0.682, 0.706)</td><td>0.006 (-0.001, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550-1  </td><td>Gallstones [Cholelithiasis]                                                                             </td><td>0.579 (0.57, 0.587) </td><td>0.583 (0.577, 0.593)</td><td>0.006 (-0.001, 0.012)  </td><td>0.572 (0.545, 0.597)</td><td>0.573 (0.542, 0.596)</td><td>-0.002 (-0.005, 0.003) </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_678    </td><td>Other skin and connective tissue disorders                                                              </td><td>0.553 (0.549, 0.557)</td><td>0.558 (0.554, 0.563)</td><td>0.005 (0.003, 0.007)   </td><td>0.613 (0.587, 0.626)</td><td>0.607 (0.58, 0.618) </td><td>-0.006 (-0.008, -0.006)</td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286    </td><td>Mood [affective] disorders                                                                              </td><td>0.569 (0.562, 0.576)</td><td>0.574 (0.569, 0.582)</td><td>0.005 (0.002, 0.01)    </td><td>0.566 (0.549, 0.579)</td><td>0.57 (0.557, 0.586) </td><td>0.004 (-0.005, 0.01)   </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-12 </td><td>Dermatophytosis                                                                                         </td><td>0.55 (0.543, 0.558) </td><td>0.556 (0.549, 0.564)</td><td>0.005 (0.002, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-5  </td><td>Constipation                                                                                            </td><td>0.609 (0.604, 0.616)</td><td>0.614 (0.609, 0.621)</td><td>0.005 (0.002, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-4  </td><td>Benign neoplasm of colon, rectum, anus and anal canal                                                   </td><td>0.59 (0.585, 0.597) </td><td>0.596 (0.59, 0.602) </td><td>0.005 (0.002, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_527    </td><td>Abdominal pain                                                                                          </td><td>0.548 (0.544, 0.553)</td><td>0.553 (0.549, 0.558)</td><td>0.005 (0.002, 0.008)   </td><td>0.553 (0.543, 0.564)</td><td>0.55 (0.54, 0.561)  </td><td>-0.003 (-0.005, -0.003)</td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841    </td><td>Drug and medical agent allergy                                                                          </td><td>0.604 (0.6, 0.608)  </td><td>0.609 (0.604, 0.614)</td><td>0.005 (0.002, 0.008)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_350    </td><td>Other symptoms involving nervous system                                                                 </td><td>0.61 (0.602, 0.617) </td><td>0.615 (0.608, 0.622)</td><td>0.005 (0.001, 0.01)    </td><td>0.803 (0.79, 0.813) </td><td>0.803 (0.791, 0.813)</td><td>0 (0, 0.001)           </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_436    </td><td>Atherosclerosis [ASCVD]                                                                                 </td><td>0.704 (0.697, 0.711)</td><td>0.709 (0.701, 0.715)</td><td>0.005 (0.001, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367    </td><td>Inflammation of the eye                                                                                 </td><td>0.564 (0.558, 0.572)</td><td>0.569 (0.564, 0.576)</td><td>0.005 (0.001, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-3  </td><td>Carcinoma in situ of skin                                                                               </td><td>0.718 (0.701, 0.729)</td><td>0.724 (0.706, 0.734)</td><td>0.005 (0.001, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-2  </td><td>Abdominal distension and flatulence                                                                     </td><td>0.569 (0.561, 0.575)</td><td>0.573 (0.566, 0.582)</td><td>0.005 (0, 0.011)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230    </td><td>Malnutrition and underweight                                                                            </td><td>0.602 (0.593, 0.61) </td><td>0.607 (0.598, 0.614)</td><td>0.005 (0, 0.011)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-2  </td><td>Coronary atherosclerosis [Atherosclerotic heart disease]                                                </td><td>0.703 (0.696, 0.71) </td><td>0.707 (0.701, 0.714)</td><td>0.005 (0, 0.008)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_465    </td><td>Pharyngitis                                                                                             </td><td>0.561 (0.554, 0.566)</td><td>0.566 (0.558, 0.571)</td><td>0.005 (0, 0.008)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-3  </td><td>Benign neoplasms of the ovary                                                                           </td><td>0.492 (0.456, 0.524)</td><td>0.498 (0.464, 0.539)</td><td>0.005 (-0.031, 0.057)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_472    </td><td>Diseases of vocal cords and larynx, not elsewhere classified                                            </td><td>0.57 (0.543, 0.594) </td><td>0.573 (0.551, 0.608)</td><td>0.005 (-0.025, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_688-3  </td><td>Pyogenic granuloma of skin and subcutaneous tissue                                                      </td><td>0.51 (0.48, 0.543)  </td><td>0.519 (0.486, 0.546)</td><td>0.005 (-0.021, 0.041)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_613-7  </td><td>Other signs and symptoms in breast                                                                      </td><td>0.458 (0.434, 0.477)</td><td>0.463 (0.447, 0.482)</td><td>0.005 (-0.013, 0.03)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_477    </td><td>Inhalation lung injury                                                                                  </td><td>0.719 (0.677, 0.749)</td><td>0.723 (0.683, 0.769)</td><td>0.005 (-0.012, 0.03)   </td><td>0.747 (0.721, 0.779)</td><td>0.75 (0.723, 0.783) </td><td>0.002 (-0.004, 0.004)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330    </td><td>Epilepsy, recurrent seizures, convulsions                                                               </td><td>0.578 (0.561, 0.597)</td><td>0.583 (0.563, 0.602)</td><td>0.005 (-0.012, 0.019)  </td><td>0.601 (0.546, 0.64) </td><td>0.598 (0.549, 0.649)</td><td>0.002 (-0.007, 0.013)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_815    </td><td>Symptoms and signs concerning food and fluid intake                                                     </td><td>0.538 (0.522, 0.56) </td><td>0.542 (0.524, 0.566)</td><td>0.005 (-0.011, 0.021)  </td><td>0.602 (0.578, 0.654)</td><td>0.61 (0.585, 0.662) </td><td>0.008 (0, 0.012)       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_414    </td><td>Cardiomyopathy                                                                                          </td><td>0.658 (0.635, 0.679)</td><td>0.665 (0.644, 0.684)</td><td>0.005 (-0.005, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_718-3  </td><td>Mid back pain                                                                                           </td><td>0.574 (0.558, 0.591)</td><td>0.58 (0.567, 0.593) </td><td>0.005 (-0.005, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_170    </td><td>Decreased white blood cell count                                                                        </td><td>0.586 (0.574, 0.597)</td><td>0.591 (0.579, 0.605)</td><td>0.005 (-0.004, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-2  </td><td>Rotator cuff tear or rupture                                                                            </td><td>0.536 (0.528, 0.547)</td><td>0.541 (0.533, 0.551)</td><td>0.005 (-0.004, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_103-22 </td><td>Squamous cell carcinoma of the skin                                                                     </td><td>0.716 (0.695, 0.743)</td><td>0.721 (0.699, 0.744)</td><td>0.005 (-0.004, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-1  </td><td>Otitis media                                                                                            </td><td>0.527 (0.516, 0.536)</td><td>0.532 (0.522, 0.54) </td><td>0.005 (-0.002, 0.014)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-21 </td><td>Aortic stenosis                                                                                         </td><td>0.755 (0.741, 0.765)</td><td>0.758 (0.747, 0.772)</td><td>0.005 (-0.002, 0.012)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308    </td><td>Signs and symptoms involving emotional state                                                            </td><td>0.564 (0.557, 0.571)</td><td>0.569 (0.561, 0.576)</td><td>0.005 (-0.002, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_256-2  </td><td>Hyposmolality and/or hyponatremia                                                                       </td><td>0.534 (0.524, 0.546)</td><td>0.539 (0.531, 0.55) </td><td>0.005 (-0.001, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431    </td><td>Stroke and transient cerebral ischemic attacks                                                          </td><td>0.689 (0.679, 0.696)</td><td>0.693 (0.686, 0.701)</td><td>0.005 (-0.001, 0.01)   </td><td>0.707 (0.692, 0.737)</td><td>0.707 (0.693, 0.735)</td><td>-0.001 (-0.002, 0.001) </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_294    </td><td>Sexual dysfunction and disorders                                                                        </td><td>0.786 (0.782, 0.791)</td><td>0.791 (0.786, 0.795)</td><td>0.004 (0.003, 0.006)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679    </td><td>Skin symptoms                                                                                           </td><td>0.536 (0.532, 0.541)</td><td>0.541 (0.537, 0.545)</td><td>0.004 (0.002, 0.007)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404    </td><td>Ischemic heart disease                                                                                  </td><td>0.69 (0.683, 0.695) </td><td>0.694 (0.687, 0.699)</td><td>0.004 (0.001, 0.008)   </td><td>0.68 (0.664, 0.689) </td><td>0.68 (0.665, 0.692) </td><td>0.001 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703    </td><td>Chrystal arthropathies                                                                                  </td><td>0.698 (0.691, 0.704)</td><td>0.702 (0.695, 0.71) </td><td>0.004 (0.001, 0.008)   </td><td>0.73 (0.7, 0.748)   </td><td>0.73 (0.702, 0.748) </td><td>0 (-0.003, 0.003)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-41 </td><td>Benign neoplasm of the colon                                                                            </td><td>0.601 (0.595, 0.607)</td><td>0.606 (0.599, 0.612)</td><td>0.004 (0.001, 0.008)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363    </td><td>Disorders of lacrimal system                                                                            </td><td>0.634 (0.628, 0.64) </td><td>0.638 (0.632, 0.644)</td><td>0.004 (0.001, 0.007)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_819    </td><td>General symptoms and other findings                                                                     </td><td>0.582 (0.577, 0.586)</td><td>0.586 (0.581, 0.59) </td><td>0.004 (0.001, 0.007)   </td><td>0.708 (0.655, 0.732)</td><td>0.713 (0.66, 0.733) </td><td>0.006 (-0.004, 0.009)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_829    </td><td>Nonspecific findings on examination of blood                                                            </td><td>0.652 (0.646, 0.659)</td><td>0.656 (0.65, 0.664) </td><td>0.004 (0.001, 0.006)   </td><td>0.649 (0.634, 0.683)</td><td>0.648 (0.633, 0.682)</td><td>-0.001 (-0.002, 0)     </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_675    </td><td>Atrophic conditions of skin                                                                             </td><td>0.716 (0.704, 0.726)</td><td>0.72 (0.709, 0.73)  </td><td>0.004 (0, 0.008)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_675-1  </td><td>Circumscribed scleroderma                                                                               </td><td>0.716 (0.704, 0.727)</td><td>0.72 (0.708, 0.734) </td><td>0.004 (0, 0.008)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_465-1  </td><td>Acute Pharyngitis                                                                                       </td><td>0.561 (0.555, 0.567)</td><td>0.566 (0.558, 0.573)</td><td>0.004 (0, 0.008)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363-2  </td><td>Dry eye syndrome [Tear film insufficiency]                                                              </td><td>0.64 (0.634, 0.648) </td><td>0.644 (0.638, 0.653)</td><td>0.004 (0, 0.007)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-8  </td><td>Other psychoactive substance related disorders                                                          </td><td>0.598 (0.553, 0.638)</td><td>0.598 (0.565, 0.643)</td><td>0.004 (-0.029, 0.042)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-6  </td><td>Malignant neoplasm of the liver and intrahepatic bile ducts                                             </td><td>0.719 (0.685, 0.752)</td><td>0.725 (0.678, 0.76) </td><td>0.004 (-0.022, 0.028)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_406-1  </td><td>Pulmonary hypertension                                                                                  </td><td>0.745 (0.724, 0.761)</td><td>0.747 (0.725, 0.768)</td><td>0.004 (-0.013, 0.023)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-8  </td><td>Restless legs syndrome                                                                                  </td><td>0.592 (0.572, 0.613)</td><td>0.597 (0.58, 0.618) </td><td>0.004 (-0.01, 0.023)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-22 </td><td>Uninodular goiter [single thyroid nodule]                                                               </td><td>0.628 (0.603, 0.651)</td><td>0.631 (0.604, 0.651)</td><td>0.004 (-0.01, 0.012)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_550-4  </td><td>Cholesterolosis of gallbladder                                                                          </td><td>0.582 (0.545, 0.613)</td><td>0.586 (0.553, 0.615)</td><td>0.004 (-0.009, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_390-6  </td><td>Perichondritis and chondritis of pinna                                                                  </td><td>0.678 (0.651, 0.7)  </td><td>0.68 (0.656, 0.703) </td><td>0.004 (-0.008, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_349    </td><td>Disorder of nervous system                                                                              </td><td>0.603 (0.587, 0.616)</td><td>0.607 (0.59, 0.62)  </td><td>0.004 (-0.008, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_423    </td><td>Abnormal cardiac sounds                                                                                 </td><td>0.642 (0.626, 0.656)</td><td>0.645 (0.63, 0.661) </td><td>0.004 (-0.008, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_170-1  </td><td>Neutropenia                                                                                             </td><td>0.585 (0.573, 0.599)</td><td>0.589 (0.577, 0.603)</td><td>0.004 (-0.008, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_397-1  </td><td>Tinnitus                                                                                                </td><td>0.503 (0.493, 0.514)</td><td>0.507 (0.497, 0.515)</td><td>0.004 (-0.007, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557-2  </td><td>Blood in stool                                                                                          </td><td>0.621 (0.608, 0.64) </td><td>0.626 (0.611, 0.642)</td><td>0.004 (-0.007, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_169    </td><td>Platelet defects                                                                                        </td><td>0.666 (0.649, 0.68) </td><td>0.669 (0.654, 0.684)</td><td>0.004 (-0.006, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_674-2  </td><td>Hypepigmentation                                                                                        </td><td>0.587 (0.569, 0.609)</td><td>0.593 (0.573, 0.613)</td><td>0.004 (-0.006, 0.014)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_720    </td><td>Spontaneous rupture of synovium and tendon                                                              </td><td>0.605 (0.589, 0.63) </td><td>0.608 (0.593, 0.633)</td><td>0.004 (-0.006, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-2  </td><td>Intestinal obstruction                                                                                  </td><td>0.621 (0.606, 0.636)</td><td>0.625 (0.608, 0.643)</td><td>0.004 (-0.005, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-3  </td><td>Fecal incontinence                                                                                      </td><td>0.639 (0.626, 0.652)</td><td>0.642 (0.627, 0.657)</td><td>0.004 (-0.005, 0.014)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530    </td><td>Disease of anus and rectum                                                                              </td><td>0.527 (0.518, 0.54) </td><td>0.53 (0.52, 0.544)  </td><td>0.004 (-0.005, 0.013)  </td><td>0.544 (0.514, 0.573)</td><td>0.55 (0.527, 0.591) </td><td>0.012 (0, 0.019)       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_512    </td><td>Dysphagia                                                                                               </td><td>0.575 (0.567, 0.585)</td><td>0.578 (0.57, 0.59)  </td><td>0.004 (-0.004, 0.012)  </td><td>0.613 (0.606, 0.628)</td><td>0.611 (0.606, 0.628)</td><td>-0.001 (-0.004, 0.003) </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_398    </td><td>Other disorders of ear                                                                                  </td><td>0.575 (0.563, 0.588)</td><td>0.579 (0.567, 0.595)</td><td>0.004 (-0.004, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_419    </td><td>Presence of cardiac device                                                                              </td><td>0.738 (0.723, 0.755)</td><td>0.743 (0.727, 0.759)</td><td>0.004 (-0.003, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-5  </td><td>Venous insufficiency (chronic) (peripheral)                                                             </td><td>0.662 (0.648, 0.676)</td><td>0.666 (0.654, 0.68) </td><td>0.004 (-0.002, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_446    </td><td>Hypotension                                                                                             </td><td>0.663 (0.655, 0.671)</td><td>0.667 (0.66, 0.674) </td><td>0.004 (-0.001, 0.011)  </td><td>0.723 (0.71, 0.745) </td><td>0.724 (0.711, 0.746)</td><td>0.001 (-0.001, 0.003)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_557    </td><td>Gastrointestinal hemorrhage                                                                             </td><td>0.532 (0.525, 0.538)</td><td>0.536 (0.53, 0.544) </td><td>0.004 (-0.001, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-42 </td><td>Benign neoplasm of rectum and anus                                                                      </td><td>0.594 (0.586, 0.605)</td><td>0.599 (0.589, 0.611)</td><td>0.004 (-0.001, 0.009)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440    </td><td>Embolism and thrombosis                                                                                 </td><td>0.597 (0.588, 0.605)</td><td>0.601 (0.594, 0.608)</td><td>0.004 (-0.001, 0.008)  </td><td>0.476 (0.463, 0.499)</td><td>0.481 (0.466, 0.503)</td><td>0.004 (-0.01, 0.015)   </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288-3  </td><td>Generalized anxiety disorder                                                                            </td><td>0.593 (0.58, 0.609) </td><td>0.597 (0.585, 0.61) </td><td>0.004 (-0.001, 0.008)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528    </td><td>Nausea and vomiting                                                                                     </td><td>0.584 (0.577, 0.592)</td><td>0.588 (0.581, 0.594)</td><td>0.004 (-0.001, 0.007)  </td><td>0.628 (0.614, 0.642)</td><td>0.626 (0.611, 0.644)</td><td>-0.002 (-0.005, 0.004) </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708    </td><td>Osteoarthritis                                                                                          </td><td>0.612 (0.609, 0.616)</td><td>0.615 (0.612, 0.619)</td><td>0.003 (0.002, 0.004)   </td><td>0.588 (0.577, 0.608)</td><td>0.589 (0.575, 0.607)</td><td>0 (-0.003, 0.003)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136    </td><td>Benign neoplasm of the digestive organs                                                                 </td><td>0.589 (0.583, 0.593)</td><td>0.592 (0.586, 0.597)</td><td>0.003 (0.001, 0.006)   </td><td>0.584 (0.565, 0.596)</td><td>0.583 (0.563, 0.594)</td><td>-0.002 (-0.002, -0.001)</td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523    </td><td>Diverticular disease [Bowel diverticulosis]                                                             </td><td>0.622 (0.616, 0.627)</td><td>0.625 (0.62, 0.63)  </td><td>0.003 (0.001, 0.005)   </td><td>0.568 (0.558, 0.577)</td><td>0.564 (0.551, 0.577)</td><td>-0.003 (-0.007, 0)     </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726-1  </td><td>Osteoporosis                                                                                            </td><td>0.746 (0.74, 0.753) </td><td>0.748 (0.743, 0.755)</td><td>0.003 (0.001, 0.005)   </td><td>0.752 (0.731, 0.762)</td><td>0.756 (0.737, 0.769)</td><td>0.005 (0.002, 0.008)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-1  </td><td>Primary osteoarthritis                                                                                  </td><td>0.611 (0.603, 0.617)</td><td>0.614 (0.607, 0.62) </td><td>0.003 (0.001, 0.005)   </td><td>0.565 (0.541, 0.581)</td><td>0.576 (0.563, 0.596)</td><td>0.013 (0.007, 0.028)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528-1  </td><td>Nausea                                                                                                  </td><td>0.585 (0.576, 0.59) </td><td>0.588 (0.579, 0.594)</td><td>0.003 (0, 0.008)       </td><td>0.624 (0.604, 0.635)</td><td>0.621 (0.602, 0.631)</td><td>-0.003 (-0.007, 0)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_583    </td><td>Chronic kidney disease                                                                                  </td><td>0.684 (0.677, 0.692)</td><td>0.688 (0.681, 0.693)</td><td>0.003 (0, 0.007)       </td><td>0.742 (0.733, 0.758)</td><td>0.745 (0.734, 0.76) </td><td>0.002 (0, 0.004)       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288    </td><td>Anxiety disorders                                                                                       </td><td>0.59 (0.584, 0.596) </td><td>0.593 (0.587, 0.598)</td><td>0.003 (0, 0.006)       </td><td>0.593 (0.578, 0.606)</td><td>0.592 (0.575, 0.603)</td><td>-0.001 (-0.004, 0.002) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_354    </td><td>Dizziness and giddiness                                                                                 </td><td>0.571 (0.566, 0.576)</td><td>0.575 (0.569, 0.58) </td><td>0.003 (0, 0.006)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_007    </td><td>Hemophilus infection                                                                                    </td><td>0.611 (0.572, 0.669)</td><td>0.615 (0.584, 0.66) </td><td>0.003 (-0.025, 0.035)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_030    </td><td>Campylobacter                                                                                           </td><td>0.532 (0.516, 0.552)</td><td>0.535 (0.518, 0.555)</td><td>0.003 (-0.022, 0.019)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-1  </td><td>Occlusion and stenosis of cerebral arteries                                                             </td><td>0.716 (0.693, 0.746)</td><td>0.719 (0.695, 0.739)</td><td>0.003 (-0.02, 0.019)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_506-3  </td><td>Sialoadenitis                                                                                           </td><td>0.553 (0.53, 0.575) </td><td>0.555 (0.527, 0.582)</td><td>0.003 (-0.019, 0.023)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_406    </td><td>Chronic pulmonary heart disease                                                                         </td><td>0.741 (0.723, 0.758)</td><td>0.745 (0.726, 0.764)</td><td>0.003 (-0.012, 0.02)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_447    </td><td>Nonspecific low blood-pressure reading                                                                  </td><td>0.642 (0.623, 0.664)</td><td>0.646 (0.625, 0.668)</td><td>0.003 (-0.012, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-3  </td><td>Spondylolisthesis                                                                                       </td><td>0.663 (0.638, 0.679)</td><td>0.665 (0.644, 0.682)</td><td>0.003 (-0.012, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-2  </td><td>Secondary malignancy of respiratory organs                                                              </td><td>0.632 (0.618, 0.646)</td><td>0.634 (0.616, 0.65) </td><td>0.003 (-0.01, 0.014)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_597-1  </td><td>Urethral stricture                                                                                      </td><td>0.655 (0.631, 0.675)</td><td>0.657 (0.638, 0.678)</td><td>0.003 (-0.01, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_479-6  </td><td>Pulmonary collapse [Atelectasis]                                                                        </td><td>0.646 (0.631, 0.666)</td><td>0.649 (0.635, 0.664)</td><td>0.003 (-0.009, 0.012)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_169-1  </td><td>Thrombocytopenia                                                                                        </td><td>0.667 (0.652, 0.683)</td><td>0.67 (0.656, 0.692) </td><td>0.003 (-0.008, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_586    </td><td>Other disorders of the kidney and ureters                                                               </td><td>0.644 (0.632, 0.653)</td><td>0.645 (0.637, 0.658)</td><td>0.003 (-0.008, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_423-1  </td><td>Cardiac murmurs                                                                                         </td><td>0.641 (0.623, 0.655)</td><td>0.644 (0.628, 0.66) </td><td>0.003 (-0.007, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-12 </td><td>Pilar and trichodermal cyst                                                                             </td><td>0.502 (0.491, 0.511)</td><td>0.506 (0.496, 0.513)</td><td>0.003 (-0.004, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_446-2  </td><td>Orthostatic hypotension                                                                                 </td><td>0.69 (0.677, 0.703) </td><td>0.692 (0.679, 0.706)</td><td>0.003 (-0.004, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-13 </td><td>Phlebitis and thrombophlebitis                                                                          </td><td>0.583 (0.575, 0.593)</td><td>0.587 (0.575, 0.596)</td><td>0.003 (-0.003, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_507    </td><td>Lesions of mouth                                                                                        </td><td>0.565 (0.555, 0.576)</td><td>0.569 (0.556, 0.578)</td><td>0.003 (-0.003, 0.009)  </td><td>0.536 (0.514, 0.563)</td><td>0.564 (0.544, 0.589)</td><td>0.025 (-0.007, 0.061)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-1  </td><td>Postmenopausal bleeding                                                                                 </td><td>0.551 (0.542, 0.559)</td><td>0.553 (0.545, 0.562)</td><td>0.003 (-0.003, 0.008)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-7  </td><td>Generalized osteoarthritis                                                                              </td><td>0.65 (0.643, 0.659) </td><td>0.654 (0.646, 0.661)</td><td>0.003 (-0.003, 0.008)  </td><td>0.598 (0.565, 0.619)</td><td>0.593 (0.559, 0.608)</td><td>-0.006 (-0.012, -0.001)</td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-2  </td><td>Abnormal loss of weight and underweight                                                                 </td><td>0.608 (0.598, 0.617)</td><td>0.61 (0.602, 0.62)  </td><td>0.003 (-0.003, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-21 </td><td>Abnormal weight loss                                                                                    </td><td>0.612 (0.602, 0.621)</td><td>0.616 (0.606, 0.624)</td><td>0.003 (-0.002, 0.009)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329    </td><td>Symptoms and signs involving cognitive functions and awareness                                          </td><td>0.644 (0.637, 0.652)</td><td>0.648 (0.64, 0.654) </td><td>0.003 (-0.002, 0.007)  </td><td>0.774 (0.752, 0.777)</td><td>0.774 (0.754, 0.777)</td><td>0 (-0.001, 0.001)      </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_528-2  </td><td>Vomiting                                                                                                </td><td>0.585 (0.576, 0.591)</td><td>0.588 (0.579, 0.595)</td><td>0.003 (-0.001, 0.008)  </td><td>0.622 (0.607, 0.639)</td><td>0.62 (0.604, 0.636) </td><td>-0.004 (-0.005, 0.001) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_465-2  </td><td>Chronic Pharyngitis                                                                                     </td><td>0.564 (0.558, 0.571)</td><td>0.567 (0.56, 0.574) </td><td>0.003 (-0.001, 0.008)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-1  </td><td>Palpitations                                                                                            </td><td>0.577 (0.571, 0.584)</td><td>0.58 (0.574, 0.587) </td><td>0.003 (-0.001, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715    </td><td>Non-inflammatory spondylopathy                                                                          </td><td>0.622 (0.615, 0.629)</td><td>0.625 (0.618, 0.633)</td><td>0.003 (-0.001, 0.007)  </td><td>0.62 (0.593, 0.651) </td><td>0.627 (0.603, 0.655)</td><td>0.005 (0.002, 0.012)   </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_089-2  </td><td>Viral infections                                                                                        </td><td>0.528 (0.522, 0.532)</td><td>0.531 (0.525, 0.536)</td><td>0.003 (-0.001, 0.006)  </td><td>0.625 (0.616, 0.637)</td><td>0.634 (0.626, 0.644)</td><td>0.009 (-0.002, 0.015)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723    </td><td>Enthesopathy/Enthesitis/Tendinopathy                                                                    </td><td>0.535 (0.529, 0.538)</td><td>0.538 (0.533, 0.542)</td><td>0.003 (-0.001, 0.006)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_727    </td><td>Other disorders of bone                                                                                 </td><td>0.71 (0.706, 0.716) </td><td>0.712 (0.708, 0.718)</td><td>0.002 (0.001, 0.003)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-21 </td><td>Atrial fibrillation                                                                                     </td><td>0.731 (0.722, 0.737)</td><td>0.733 (0.725, 0.74) </td><td>0.002 (0, 0.006)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523-2  </td><td>Diverticula of colon                                                                                    </td><td>0.63 (0.625, 0.636) </td><td>0.632 (0.627, 0.638)</td><td>0.002 (0, 0.005)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331    </td><td>Headache                                                                                                </td><td>0.579 (0.571, 0.584)</td><td>0.581 (0.575, 0.585)</td><td>0.002 (0, 0.005)       </td><td>0.581 (0.55, 0.592) </td><td>0.588 (0.549, 0.599)</td><td>0.005 (-0.004, 0.01)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_726    </td><td>Osteoporosis and low bone density                                                                       </td><td>0.741 (0.734, 0.747)</td><td>0.743 (0.737, 0.748)</td><td>0.002 (0, 0.004)       </td><td>0.746 (0.733, 0.776)</td><td>0.75 (0.735, 0.776) </td><td>0.003 (0, 0.006)       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_835    </td><td>Cytology and pathology findings                                                                         </td><td>0.722 (0.713, 0.729)</td><td>0.723 (0.714, 0.73) </td><td>0.002 (0, 0.003)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_330-3  </td><td>Convulsions                                                                                             </td><td>0.567 (0.546, 0.589)</td><td>0.568 (0.546, 0.586)</td><td>0.002 (-0.023, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_667    </td><td>Erythematous conditions                                                                                 </td><td>0.555 (0.534, 0.57) </td><td>0.556 (0.54, 0.571) </td><td>0.002 (-0.017, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_703-2  </td><td>Chondrocalcinosis                                                                                       </td><td>0.678 (0.649, 0.707)</td><td>0.68 (0.645, 0.711) </td><td>0.002 (-0.013, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_700    </td><td>Diffuse diseases of connective tissue                                                                   </td><td>0.63 (0.613, 0.652) </td><td>0.635 (0.613, 0.652)</td><td>0.002 (-0.012, 0.02)   </td><td>0.631 (0.612, 0.664)</td><td>0.634 (0.605, 0.668)</td><td>0.001 (-0.008, 0.007)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_478    </td><td>Aspiration pneumonia                                                                                    </td><td>0.738 (0.719, 0.757)</td><td>0.74 (0.722, 0.758) </td><td>0.002 (-0.012, 0.018)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_734-9  </td><td>Jaw pain                                                                                                </td><td>0.589 (0.569, 0.61) </td><td>0.591 (0.57, 0.615) </td><td>0.002 (-0.012, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_481    </td><td>Interstitial pulmonary diseases                                                                         </td><td>0.729 (0.711, 0.744)</td><td>0.731 (0.715, 0.748)</td><td>0.002 (-0.011, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-14 </td><td>Primary osteoarthritis of the shoulder, upper arm                                                       </td><td>0.605 (0.589, 0.62) </td><td>0.605 (0.59, 0.625) </td><td>0.002 (-0.011, 0.012)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581    </td><td>Renal tubulo-interstitial diseases                                                                      </td><td>0.547 (0.533, 0.559)</td><td>0.549 (0.537, 0.562)</td><td>0.002 (-0.01, 0.015)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-13 </td><td>Blepharoconjunctivitis                                                                                  </td><td>0.637 (0.615, 0.673)</td><td>0.641 (0.617, 0.67) </td><td>0.002 (-0.01, 0.011)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-16 </td><td>Primary osteoarthritis ankle and foot                                                                   </td><td>0.578 (0.566, 0.592)</td><td>0.579 (0.564, 0.595)</td><td>0.002 (-0.01, 0.01)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_507-1  </td><td>Stomatitis                                                                                              </td><td>0.558 (0.545, 0.572)</td><td>0.558 (0.543, 0.573)</td><td>0.002 (-0.008, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514    </td><td>Gastrointestinal obstruction                                                                            </td><td>0.625 (0.613, 0.64) </td><td>0.626 (0.616, 0.642)</td><td>0.002 (-0.005, 0.01)   </td><td>0.565 (0.544, 0.598)</td><td>0.584 (0.551, 0.614)</td><td>0.02 (0.006, 0.036)    </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438    </td><td>Aneurysm or ectasia                                                                                     </td><td>0.718 (0.705, 0.73) </td><td>0.721 (0.708, 0.732)</td><td>0.002 (-0.005, 0.008)  </td><td>0.739 (0.732, 0.751)</td><td>0.74 (0.729, 0.753) </td><td>0.001 (-0.004, 0.005)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-13 </td><td>Primary osteoarthritis of the hand                                                                      </td><td>0.644 (0.633, 0.659)</td><td>0.646 (0.636, 0.66) </td><td>0.002 (-0.004, 0.009)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_404-11 </td><td>Acute myocardial infarction                                                                             </td><td>0.702 (0.693, 0.711)</td><td>0.704 (0.694, 0.713)</td><td>0.002 (-0.004, 0.008)  </td><td>0.708 (0.686, 0.73) </td><td>0.715 (0.693, 0.734)</td><td>0.005 (0.002, 0.008)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556-8  </td><td>Nonspecific abnormal findings in stool contents                                                         </td><td>0.56 (0.552, 0.568) </td><td>0.562 (0.554, 0.571)</td><td>0.002 (-0.003, 0.009)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_392    </td><td>Otalgia and effusion of ear                                                                             </td><td>0.56 (0.552, 0.568) </td><td>0.562 (0.555, 0.569)</td><td>0.002 (-0.003, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_556    </td><td>Other symptoms involving the digestive system and abdomen                                               </td><td>0.557 (0.551, 0.564)</td><td>0.559 (0.552, 0.566)</td><td>0.002 (-0.003, 0.006)  </td><td>0.543 (0.527, 0.552)</td><td>0.544 (0.529, 0.557)</td><td>0.001 (-0.009, 0.009)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_715-1  </td><td>Spondylosis                                                                                             </td><td>0.62 (0.611, 0.627) </td><td>0.622 (0.613, 0.629)</td><td>0.002 (-0.002, 0.006)  </td><td>0.588 (0.559, 0.618)</td><td>0.596 (0.57, 0.616) </td><td>0.005 (-0.009, 0.019)  </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-1  </td><td>Allergy to other anti-infective agents                                                                  </td><td>0.602 (0.595, 0.609)</td><td>0.604 (0.596, 0.611)</td><td>0.002 (-0.002, 0.006)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-2  </td><td>Atrial fibrillation and flutter                                                                         </td><td>0.731 (0.726, 0.736)</td><td>0.733 (0.728, 0.739)</td><td>0.002 (-0.001, 0.005)  </td><td>0.701 (0.692, 0.712)</td><td>0.704 (0.696, 0.713)</td><td>0.002 (0, 0.005)       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-1  </td><td>Conjunctivitis                                                                                          </td><td>0.57 (0.563, 0.578) </td><td>0.571 (0.564, 0.579)</td><td>0.002 (-0.001, 0.005)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_969    </td><td>Adverse effects of agents primarily affecting gastrointestinal system                                   </td><td>0.593 (0.587, 0.6)  </td><td>0.595 (0.589, 0.601)</td><td>0.002 (-0.001, 0.005)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-4  </td><td>Noninflammatory disorders of vagina                                                                     </td><td>0.597 (0.589, 0.605)</td><td>0.598 (0.589, 0.607)</td><td>0.001 (0, 0.003)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627    </td><td>Menopausal and postmenopausal disorders                                                                 </td><td>0.686 (0.681, 0.691)</td><td>0.687 (0.682, 0.692)</td><td>0.001 (0, 0.002)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396    </td><td>Hearing impairment                                                                                      </td><td>0.638 (0.633, 0.643)</td><td>0.638 (0.634, 0.643)</td><td>0.001 (0, 0.002)       </td><td>0.659 (0.648, 0.682)</td><td>0.658 (0.646, 0.681)</td><td>-0.001 (-0.004, 0.001) </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_390    </td><td>Disorders of external ear                                                                               </td><td>0.559 (0.556, 0.564)</td><td>0.561 (0.557, 0.565)</td><td>0.001 (0, 0.002)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_390-4  </td><td>Impacted cerumen                                                                                        </td><td>0.59 (0.585, 0.595) </td><td>0.591 (0.586, 0.596)</td><td>0.001 (0, 0.001)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-2  </td><td>Malignant neoplasm of the uterus                                                                        </td><td>0.556 (0.528, 0.578)</td><td>0.554 (0.529, 0.582)</td><td>0.001 (-0.026, 0.028)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_820    </td><td>Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity                             </td><td>0.656 (0.628, 0.702)</td><td>0.657 (0.619, 0.698)</td><td>0.001 (-0.025, 0.022)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_540    </td><td>Hepatitis                                                                                               </td><td>0.567 (0.531, 0.595)</td><td>0.569 (0.535, 0.599)</td><td>0.001 (-0.023, 0.022)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_176    </td><td>Other diseases of blood and blood-forming organs                                                        </td><td>0.569 (0.552, 0.59) </td><td>0.571 (0.548, 0.588)</td><td>0.001 (-0.02, 0.021)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_009    </td><td>Pseudomonas                                                                                             </td><td>0.658 (0.63, 0.688) </td><td>0.661 (0.632, 0.689)</td><td>0.001 (-0.018, 0.024)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-9  </td><td>Otorrhea                                                                                                </td><td>0.553 (0.529, 0.58) </td><td>0.553 (0.534, 0.58) </td><td>0.001 (-0.016, 0.023)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_676-2  </td><td>Scar conditions and fibrosis of skin                                                                    </td><td>0.539 (0.518, 0.561)</td><td>0.539 (0.519, 0.566)</td><td>0.001 (-0.014, 0.021)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_707-8  </td><td>Polyarthritis                                                                                           </td><td>0.603 (0.58, 0.629) </td><td>0.602 (0.578, 0.631)</td><td>0.001 (-0.014, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_135    </td><td>Benign neoplasm of the head and neck                                                                    </td><td>0.558 (0.542, 0.577)</td><td>0.559 (0.542, 0.573)</td><td>0.001 (-0.012, 0.014)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471-2  </td><td>Deviated nasal septum                                                                                   </td><td>0.583 (0.566, 0.605)</td><td>0.584 (0.567, 0.607)</td><td>0.001 (-0.012, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_546    </td><td>Other disorders of liver                                                                                </td><td>0.592 (0.576, 0.605)</td><td>0.592 (0.579, 0.607)</td><td>0.001 (-0.011, 0.015)  </td><td>0.525 (0.516, 0.536)</td><td>0.568 (0.539, 0.61) </td><td>0.044 (0.016, 0.084)   </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_734    </td><td>Diseases of the jaws                                                                                    </td><td>0.584 (0.565, 0.605)</td><td>0.585 (0.565, 0.604)</td><td>0.001 (-0.011, 0.013)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710    </td><td>Acquired deformities of limbs                                                                           </td><td>0.599 (0.583, 0.611)</td><td>0.6 (0.585, 0.613)  </td><td>0.001 (-0.01, 0.012)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-3  </td><td>Tricuspid valve disorders                                                                               </td><td>0.738 (0.722, 0.748)</td><td>0.738 (0.723, 0.748)</td><td>0.001 (-0.01, 0.01)    </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-61 </td><td>Migraine with aura                                                                                      </td><td>0.595 (0.576, 0.619)</td><td>0.598 (0.575, 0.62) </td><td>0.001 (-0.009, 0.017)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_714-3  </td><td>Scoliosis                                                                                               </td><td>0.693 (0.67, 0.712) </td><td>0.694 (0.676, 0.712)</td><td>0.001 (-0.009, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-1  </td><td>Venous thromboembolism                                                                                  </td><td>0.566 (0.554, 0.575)</td><td>0.566 (0.555, 0.574)</td><td>0.001 (-0.007, 0.006)  </td><td>0.423 (0.407, 0.436)</td><td>0.398 (0.383, 0.419)</td><td>-0.023 (-0.032, -0.015)</td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_848-2  </td><td>Nonspecific abnormal findings on radiological and other examination of other intrathoracic organs (echo)</td><td>0.697 (0.685, 0.709)</td><td>0.697 (0.685, 0.709)</td><td>0.001 (-0.006, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-2  </td><td>Goiter                                                                                                  </td><td>0.639 (0.625, 0.655)</td><td>0.641 (0.627, 0.655)</td><td>0.001 (-0.005, 0.008)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-11 </td><td>Abdominal aortic aneurysm                                                                               </td><td>0.822 (0.811, 0.834)</td><td>0.824 (0.81, 0.836) </td><td>0.001 (-0.005, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_431-2  </td><td>Transient cerebral ischemic attacks                                                                     </td><td>0.677 (0.666, 0.69) </td><td>0.678 (0.667, 0.69) </td><td>0.001 (-0.005, 0.006)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705    </td><td>Rheumatoid arthritis and other inflammatory polyarthropathies                                           </td><td>0.619 (0.608, 0.628)</td><td>0.62 (0.61, 0.629)  </td><td>0.001 (-0.004, 0.007)  </td><td>0.587 (0.564, 0.604)</td><td>0.581 (0.565, 0.598)</td><td>-0.005 (-0.009, 0.003) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-6  </td><td>Scrotal pain*                                                                                           </td><td>0.804 (0.795, 0.813)</td><td>0.805 (0.796, 0.813)</td><td>0.001 (-0.004, 0.006)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-5  </td><td>Bursitis                                                                                                </td><td>0.535 (0.529, 0.542)</td><td>0.536 (0.529, 0.543)</td><td>0.001 (-0.004, 0.005)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-1  </td><td>Memory loss                                                                                             </td><td>0.651 (0.643, 0.66) </td><td>0.652 (0.644, 0.663)</td><td>0.001 (-0.004, 0.005)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487    </td><td>Hemorrhage from respiratory passages                                                                    </td><td>0.587 (0.576, 0.597)</td><td>0.587 (0.576, 0.596)</td><td>0.001 (-0.004, 0.005)  </td><td>0.65 (0.618, 0.672) </td><td>0.646 (0.615, 0.674)</td><td>-0.001 (-0.005, 0.004) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_511    </td><td>Gastro-esophageal reflux disease                                                                        </td><td>0.561 (0.556, 0.566)</td><td>0.562 (0.556, 0.567)</td><td>0.001 (-0.003, 0.006)  </td><td>0.545 (0.53, 0.555) </td><td>0.539 (0.525, 0.55) </td><td>-0.006 (-0.009, -0.004)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_112    </td><td>Malignant neoplasm of other and ill-defined sites                                                       </td><td>0.662 (0.655, 0.667)</td><td>0.663 (0.657, 0.669)</td><td>0.001 (-0.001, 0.003)  </td><td>0.627 (0.618, 0.635)</td><td>0.625 (0.617, 0.634)</td><td>-0.001 (-0.003, 0)     </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-51 </td><td>Long term (current) use of hormonal contraceptives                                                      </td><td>0.922 (0.916, 0.935)</td><td>0.923 (0.917, 0.936)</td><td>0.001 (-0.001, 0.002)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-11 </td><td>Inguinal hernia                                                                                         </td><td>0.788 (0.783, 0.794)</td><td>0.788 (0.783, 0.794)</td><td>0 (0, 0.001)           </td><td>0.717 (0.701, 0.732)</td><td>0.714 (0.7, 0.73)   </td><td>-0.002 (-0.011, 0.001) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_593-3  </td><td>Recurrent and persistent hematuria*                                                                     </td><td>0.547 (0.512, 0.59) </td><td>0.547 (0.517, 0.575)</td><td>0 (-0.037, 0.035)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_174-2  </td><td>Splenomegaly                                                                                            </td><td>0.617 (0.566, 0.665)</td><td>0.618 (0.582, 0.646)</td><td>0 (-0.032, 0.035)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-15 </td><td>Incisional hernia                                                                                       </td><td>0.59 (0.565, 0.618) </td><td>0.59 (0.568, 0.614) </td><td>0 (-0.022, 0.022)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532-1  </td><td>Intestinal fistula                                                                                      </td><td>0.606 (0.579, 0.637)</td><td>0.606 (0.582, 0.63) </td><td>0 (-0.02, 0.015)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_342    </td><td>Plegia and unspecified paralysis                                                                        </td><td>0.56 (0.533, 0.58)  </td><td>0.559 (0.534, 0.582)</td><td>0 (-0.019, 0.022)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-21 </td><td>Carotid artery stenosis                                                                                 </td><td>0.734 (0.708, 0.758)</td><td>0.733 (0.712, 0.753)</td><td>0 (-0.018, 0.014)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-7  </td><td>Abnormal granulation tissue, NOS                                                                        </td><td>0.649 (0.626, 0.671)</td><td>0.649 (0.62, 0.673) </td><td>0 (-0.017, 0.018)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_433-2  </td><td>Occlusion and stenosis of precerebral arteries                                                          </td><td>0.738 (0.718, 0.76) </td><td>0.737 (0.715, 0.754)</td><td>0 (-0.015, 0.015)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-7  </td><td>Iodine-deficiency related thyroid disorders*                                                            </td><td>0.585 (0.569, 0.606)</td><td>0.586 (0.567, 0.602)</td><td>0 (-0.015, 0.014)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-12 </td><td>Rectocele                                                                                               </td><td>0.558 (0.538, 0.578)</td><td>0.558 (0.54, 0.573) </td><td>0 (-0.011, 0.01)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396-22 </td><td>Presbycusis                                                                                             </td><td>0.7 (0.684, 0.72)   </td><td>0.698 (0.683, 0.721)</td><td>0 (-0.01, 0.007)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-5  </td><td>Lipoma                                                                                                  </td><td>0.519 (0.51, 0.531) </td><td>0.52 (0.508, 0.532) </td><td>0 (-0.009, 0.01)       </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603    </td><td>Disorders and symptoms of testis                                                                        </td><td>0.526 (0.514, 0.539)</td><td>0.527 (0.511, 0.538)</td><td>0 (-0.009, 0.009)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_717    </td><td>Other and unspecified dorsopathies                                                                      </td><td>0.578 (0.563, 0.594)</td><td>0.578 (0.561, 0.592)</td><td>0 (-0.009, 0.009)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_670    </td><td>Seborrheic keratosis                                                                                    </td><td>0.622 (0.597, 0.64) </td><td>0.623 (0.599, 0.642)</td><td>0 (-0.009, 0.008)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-8  </td><td>Duodenitis                                                                                              </td><td>0.598 (0.584, 0.613)</td><td>0.598 (0.586, 0.609)</td><td>0 (-0.009, 0.008)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_377    </td><td>Hemorrhage of the eye                                                                                   </td><td>0.587 (0.575, 0.597)</td><td>0.587 (0.575, 0.597)</td><td>0 (-0.008, 0.007)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-12 </td><td>Primary osteoarthritis of knee, lower leg                                                               </td><td>0.618 (0.605, 0.628)</td><td>0.618 (0.605, 0.627)</td><td>0 (-0.008, 0.006)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-5  </td><td>Inflammatory disease of cervix, vagina, and vulva                                                       </td><td>0.562 (0.548, 0.577)</td><td>0.562 (0.55, 0.572) </td><td>0 (-0.007, 0.007)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_615    </td><td>Endometriosis                                                                                           </td><td>0.734 (0.71, 0.756) </td><td>0.733 (0.711, 0.754)</td><td>0 (-0.007, 0.005)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_494    </td><td>Voice disturbance                                                                                       </td><td>0.595 (0.584, 0.608)</td><td>0.595 (0.585, 0.605)</td><td>0 (-0.007, 0.005)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-211</td><td>Paroxysmal atrial fibrillation*                                                                         </td><td>0.683 (0.674, 0.695)</td><td>0.683 (0.674, 0.694)</td><td>0 (-0.007, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-55 </td><td>Candidiasis of vulva and vagina                                                                         </td><td>0.763 (0.756, 0.773)</td><td>0.764 (0.757, 0.772)</td><td>0 (-0.006, 0.008)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-1  </td><td>Tension headache                                                                                        </td><td>0.615 (0.603, 0.628)</td><td>0.615 (0.602, 0.629)</td><td>0 (-0.006, 0.007)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614    </td><td>Inflammatory diseases of female pelvic organs                                                           </td><td>0.564 (0.551, 0.573)</td><td>0.565 (0.553, 0.574)</td><td>0 (-0.005, 0.007)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-24 </td><td>Hammer toe                                                                                              </td><td>0.687 (0.671, 0.707)</td><td>0.687 (0.67, 0.705) </td><td>0 (-0.005, 0.006)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_146-2  </td><td>Benign neoplasm of the prostate                                                                         </td><td>0.647 (0.634, 0.66) </td><td>0.648 (0.634, 0.661)</td><td>0 (-0.005, 0.005)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-1  </td><td>Aortic aneurysm and ectasia                                                                             </td><td>0.788 (0.777, 0.797)</td><td>0.788 (0.778, 0.796)</td><td>0 (-0.005, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529-1  </td><td>Diarrhea                                                                                                </td><td>0.544 (0.538, 0.551)</td><td>0.545 (0.538, 0.55) </td><td>0 (-0.005, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-11 </td><td>Primary osteoarthritis of hip, pelvic region and thigh                                                  </td><td>0.657 (0.641, 0.674)</td><td>0.657 (0.642, 0.675)</td><td>0 (-0.004, 0.006)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_418    </td><td>Abnormal results of cardiovascular function studies                                                     </td><td>0.66 (0.651, 0.666) </td><td>0.659 (0.651, 0.668)</td><td>0 (-0.004, 0.005)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-2  </td><td>Dysuria                                                                                                 </td><td>0.611 (0.603, 0.621)</td><td>0.611 (0.605, 0.62) </td><td>0 (-0.004, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-21 </td><td>Leiomyoma of uterus                                                                                     </td><td>0.709 (0.697, 0.72) </td><td>0.71 (0.697, 0.72)  </td><td>0 (-0.004, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144    </td><td>Gynecological benign neoplasms                                                                          </td><td>0.649 (0.64, 0.661) </td><td>0.649 (0.638, 0.661)</td><td>0 (-0.004, 0.003)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_679-1  </td><td>Rash and other nonspecific skin eruption                                                                </td><td>0.533 (0.529, 0.538)</td><td>0.534 (0.53, 0.538) </td><td>0 (-0.003, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-52 </td><td>Hormone replacement therapy (postmenopausal)                                                            </td><td>0.749 (0.733, 0.764)</td><td>0.749 (0.734, 0.766)</td><td>0 (-0.003, 0.004)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-2  </td><td>Diaphragmatic hernia [Hiatal hernia]                                                                    </td><td>0.603 (0.597, 0.612)</td><td>0.603 (0.596, 0.612)</td><td>0 (-0.003, 0.003)      </td><td>0.593 (0.582, 0.607)</td><td>0.591 (0.579, 0.606)</td><td>-0.001 (-0.003, 0)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-14 </td><td>Irregular menstrual bleeding                                                                            </td><td>0.871 (0.863, 0.878)</td><td>0.87 (0.863, 0.879) </td><td>0 (-0.003, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721    </td><td>Synoviopathy and bursopathy                                                                             </td><td>0.535 (0.53, 0.54)  </td><td>0.535 (0.53, 0.54)  </td><td>0 (-0.003, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_529    </td><td>Symptoms involving digestive system                                                                     </td><td>0.562 (0.558, 0.566)</td><td>0.562 (0.559, 0.566)</td><td>0 (-0.002, 0.003)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416    </td><td>Cardiac arrhythmia and conduction disorders                                                             </td><td>0.697 (0.692, 0.702)</td><td>0.698 (0.692, 0.701)</td><td>0 (-0.002, 0.002)      </td><td>0.708 (0.697, 0.721)</td><td>0.71 (0.698, 0.723) </td><td>0.001 (-0.001, 0.004)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619    </td><td>Noninflammatory female genital disorders                                                                </td><td>0.581 (0.573, 0.588)</td><td>0.58 (0.574, 0.588) </td><td>0 (-0.002, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_146    </td><td>Benign neoplasm of the genitourinary system                                                             </td><td>0.834 (0.827, 0.841)</td><td>0.834 (0.828, 0.841)</td><td>0 (-0.002, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_142    </td><td>Lump or mass in breast or nonspecific abnormal breast exam                                              </td><td>0.761 (0.756, 0.765)</td><td>0.76 (0.756, 0.765) </td><td>0 (-0.001, 0)          </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-13 </td><td>Irregular menstrual cycle                                                                               </td><td>0.889 (0.883, 0.895)</td><td>0.889 (0.883, 0.896)</td><td>0 (-0.001, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-1  </td><td>Irregular menstrual cycle/bleeding                                                                      </td><td>0.877 (0.873, 0.885)</td><td>0.878 (0.874, 0.884)</td><td>0 (-0.001, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-4  </td><td>Menorrhagia/Excessive and frequent menstruation                                                         </td><td>0.878 (0.873, 0.883)</td><td>0.879 (0.873, 0.883)</td><td>0 (-0.001, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-4  </td><td>Lateral epicondylitis (Tennis elbow)                                                                    </td><td>0.638 (0.629, 0.645)</td><td>0.638 (0.629, 0.645)</td><td>0 (-0.001, 0.002)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_600    </td><td>Benign prostatic hyperplasia                                                                            </td><td>0.664 (0.659, 0.669)</td><td>0.664 (0.659, 0.669)</td><td>0 (-0.001, 0.001)      </td><td>0.613 (0.598, 0.629)</td><td>0.609 (0.594, 0.626)</td><td>-0.003 (-0.005, -0.002)</td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-41 </td><td>Nocturia                                                                                                </td><td>0.716 (0.704, 0.723)</td><td>0.715 (0.704, 0.723)</td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_627-2  </td><td>Symptomatic menopause                                                                                   </td><td>0.766 (0.761, 0.771)</td><td>0.767 (0.761, 0.772)</td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520    </td><td>Hernia                                                                                                  </td><td>0.624 (0.619, 0.629)</td><td>0.624 (0.619, 0.629)</td><td>0 (-0.001, 0.001)      </td><td>0.604 (0.587, 0.618)</td><td>0.602 (0.585, 0.618)</td><td>-0.002 (-0.003, 0.001) </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-1  </td><td>Hernia of the abdominal wall                                                                            </td><td>0.715 (0.71, 0.72)  </td><td>0.715 (0.71, 0.72)  </td><td>0 (-0.001, 0.001)      </td><td>0.674 (0.647, 0.69) </td><td>0.682 (0.666, 0.696)</td><td>0.008 (0.005, 0.02)    </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_290    </td><td>Reaction to severe stress, and adjustment disorders                                                     </td><td>0.642 (0.634, 0.65) </td><td>0.642 (0.634, 0.65) </td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-6  </td><td>Migraine                                                                                                </td><td>0.643 (0.635, 0.651)</td><td>0.643 (0.635, 0.65) </td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Rx            </td><td>phecode_977-5  </td><td>Long term (current) use of agents affecting hormones                                                    </td><td>0.896 (0.886, 0.901)</td><td>0.896 (0.886, 0.902)</td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_832    </td><td>Other abnormal findings in urine                                                                        </td><td>0.645 (0.641, 0.65) </td><td>0.645 (0.641, 0.649)</td><td>0 (-0.001, 0.001)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Stat          </td><td>phecode_979    </td><td>Transplated organ                                                                                       </td><td>0.547 (0.517, 0.585)</td><td>0.406 (0.368, 0.442)</td><td>-0.139 (-0.203, -0.096)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_701    </td><td>Osteomyelitis, periostitis, and other infections involving bone                                         </td><td>0.602 (0.56, 0.642) </td><td>0.47 (0.425, 0.514) </td><td>-0.128 (-0.192, -0.06) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-3  </td><td>Ileus                                                                                                   </td><td>0.69 (0.655, 0.718) </td><td>0.612 (0.576, 0.652)</td><td>-0.076 (-0.105, -0.042)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_701-1  </td><td>Osteomyelitis                                                                                           </td><td>0.574 (0.547, 0.616)</td><td>0.508 (0.464, 0.561)</td><td>-0.072 (-0.136, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_583-1  </td><td>End stage renal disease [CDK, stage 5]                                                                  </td><td>0.708 (0.674, 0.738)</td><td>0.659 (0.623, 0.697)</td><td>-0.048 (-0.09, -0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500    </td><td>Disorders of tooth develoment                                                                           </td><td>0.573 (0.54, 0.619) </td><td>0.527 (0.499, 0.57) </td><td>-0.046 (-0.063, -0.029)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500-4  </td><td>Disturbances in tooth eruption                                                                          </td><td>0.569 (0.532, 0.599)</td><td>0.525 (0.49, 0.565) </td><td>-0.042 (-0.064, -0.019)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122-22 </td><td>Diffuse large B-cell lymphoma*                                                                          </td><td>0.669 (0.637, 0.705)</td><td>0.632 (0.597, 0.671)</td><td>-0.037 (-0.059, -0.009)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-4  </td><td>Thyroiditis                                                                                             </td><td>0.607 (0.566, 0.642)</td><td>0.574 (0.523, 0.611)</td><td>-0.036 (-0.068, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-42 </td><td>Pulmonary valve insufficiency*                                                                          </td><td>0.69 (0.64, 0.734)  </td><td>0.655 (0.618, 0.696)</td><td>-0.036 (-0.059, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_323    </td><td>Systemic atrophies primarily affecting the central nervous system                                       </td><td>0.623 (0.593, 0.662)</td><td>0.591 (0.559, 0.627)</td><td>-0.036 (-0.055, -0.017)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-21 </td><td>Diffuse goiter                                                                                          </td><td>0.627 (0.591, 0.654)</td><td>0.591 (0.56, 0.62)  </td><td>-0.036 (-0.05, -0.018) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-31 </td><td>Graves' disease [Toxic diffuse goiter]                                                                  </td><td>0.634 (0.603, 0.661)</td><td>0.597 (0.56, 0.622) </td><td>-0.035 (-0.052, -0.016)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-5  </td><td>Allergy to serum and vaccine                                                                            </td><td>0.623 (0.583, 0.677)</td><td>0.587 (0.536, 0.638)</td><td>-0.034 (-0.066, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_500-41 </td><td>Impacted teeth*                                                                                         </td><td>0.593 (0.553, 0.632)</td><td>0.559 (0.516, 0.599)</td><td>-0.034 (-0.054, -0.009)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_331-3  </td><td>Headache syndromes, non migraine                                                                        </td><td>0.552 (0.506, 0.583)</td><td>0.519 (0.478, 0.557)</td><td>-0.033 (-0.07, -0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-33 </td><td>Stricture or kinking of ureter                                                                          </td><td>0.609 (0.574, 0.644)</td><td>0.579 (0.539, 0.61) </td><td>-0.033 (-0.058, -0.015)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_664-2  </td><td>Pityriasis                                                                                              </td><td>0.588 (0.556, 0.626)</td><td>0.556 (0.527, 0.594)</td><td>-0.033 (-0.05, -0.014) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-21 </td><td>Impaction of intestine                                                                                  </td><td>0.571 (0.531, 0.62) </td><td>0.542 (0.506, 0.591)</td><td>-0.032 (-0.067, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-4  </td><td>Pulmonary valve disorders                                                                               </td><td>0.693 (0.652, 0.729)</td><td>0.658 (0.618, 0.702)</td><td>-0.032 (-0.055, -0.004)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_381-1  </td><td>Paralytic strabismus [Neurogenic strabismus]                                                            </td><td>0.649 (0.617, 0.683)</td><td>0.62 (0.578, 0.648) </td><td>-0.031 (-0.056, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712-5  </td><td>Disorder of ligament                                                                                    </td><td>0.61 (0.565, 0.657) </td><td>0.582 (0.541, 0.62) </td><td>-0.029 (-0.06, -0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-31 </td><td>Genu valgum (acquired)                                                                                  </td><td>0.645 (0.599, 0.687)</td><td>0.616 (0.566, 0.668)</td><td>-0.029 (-0.048, -0.013)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_486-21 </td><td>Bronchospasm                                                                                            </td><td>0.543 (0.507, 0.576)</td><td>0.518 (0.478, 0.552)</td><td>-0.028 (-0.058, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-42 </td><td>Cognitive communication deficit                                                                         </td><td>0.549 (0.526, 0.58) </td><td>0.523 (0.501, 0.555)</td><td>-0.027 (-0.05, -0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_624-2  </td><td>Atrophy of female genital tract                                                                         </td><td>0.562 (0.535, 0.591)</td><td>0.532 (0.507, 0.567)</td><td>-0.027 (-0.049, -0.009)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_349-2  </td><td>Abnormal results of function studies of peripheral nervous system                                       </td><td>0.58 (0.556, 0.611) </td><td>0.555 (0.531, 0.586)</td><td>-0.027 (-0.045, -0.008)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_356-2  </td><td>Aphasia and dysphasia                                                                                   </td><td>0.692 (0.664, 0.723)</td><td>0.664 (0.636, 0.694)</td><td>-0.027 (-0.044, -0.011)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_124    </td><td>Myeloproliferative disorder                                                                             </td><td>0.674 (0.648, 0.696)</td><td>0.647 (0.618, 0.665)</td><td>-0.027 (-0.043, -0.009)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_124-5  </td><td>Essential thrombocythemia                                                                               </td><td>0.639 (0.584, 0.685)</td><td>0.61 (0.571, 0.65)  </td><td>-0.026 (-0.059, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-4  </td><td>Abnormal vestibular function study                                                                      </td><td>0.612 (0.565, 0.648)</td><td>0.584 (0.546, 0.621)</td><td>-0.026 (-0.048, -0.007)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-6  </td><td>Transient global amnesia                                                                                </td><td>0.622 (0.594, 0.655)</td><td>0.597 (0.561, 0.631)</td><td>-0.026 (-0.043, -0.011)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_355-1  </td><td>Coma                                                                                                    </td><td>0.577 (0.548, 0.608)</td><td>0.553 (0.517, 0.594)</td><td>-0.024 (-0.044, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-12 </td><td>Ventricular tachycardia                                                                                 </td><td>0.709 (0.685, 0.734)</td><td>0.683 (0.66, 0.714) </td><td>-0.024 (-0.037, -0.015)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_230-22 </td><td>Underweight                                                                                             </td><td>0.593 (0.563, 0.631)</td><td>0.572 (0.538, 0.606)</td><td>-0.023 (-0.049, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_532-4  </td><td>Volvulus                                                                                                </td><td>0.598 (0.557, 0.644)</td><td>0.572 (0.53, 0.622) </td><td>-0.023 (-0.044, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-3  </td><td>Disorder of phosphorus metabolism                                                                       </td><td>0.637 (0.611, 0.663)</td><td>0.619 (0.58, 0.653) </td><td>-0.022 (-0.057, 0.017) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_672    </td><td>Other acute skin changes due to ultraviolet radiation                                                   </td><td>0.59 (0.551, 0.627) </td><td>0.565 (0.533, 0.603)</td><td>-0.022 (-0.047, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_172    </td><td>Other disorders of white blood cells                                                                    </td><td>0.624 (0.598, 0.649)</td><td>0.602 (0.576, 0.634)</td><td>-0.022 (-0.043, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_438-12 </td><td>Thoracic aneurysm                                                                                       </td><td>0.675 (0.65, 0.702) </td><td>0.652 (0.625, 0.687)</td><td>-0.022 (-0.043, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Metab         </td><td>phecode_247-52 </td><td>Hypercalcemia                                                                                           </td><td>0.66 (0.636, 0.69)  </td><td>0.639 (0.606, 0.671)</td><td>-0.022 (-0.035, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_179-9  </td><td>Immunodeficiency NOS                                                                                    </td><td>0.543 (0.502, 0.579)</td><td>0.52 (0.477, 0.571) </td><td>-0.021 (-0.057, 0.025) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_475-5  </td><td>Exercise induced bronchospasm                                                                           </td><td>0.54 (0.5, 0.582)   </td><td>0.524 (0.484, 0.559)</td><td>-0.02 (-0.063, 0.032)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504-32 </td><td>Chronic periodontitis                                                                                   </td><td>0.548 (0.509, 0.581)</td><td>0.527 (0.492, 0.569)</td><td>-0.02 (-0.051, 0.007)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_398-1  </td><td>Abnormal auditory function study                                                                        </td><td>0.606 (0.581, 0.631)</td><td>0.585 (0.558, 0.616)</td><td>-0.02 (-0.033, -0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530-3  </td><td>Rectal prolapse                                                                                         </td><td>0.717 (0.694, 0.744)</td><td>0.697 (0.676, 0.728)</td><td>-0.02 (-0.031, -0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-4  </td><td>Calcium deposits in tendon and bursa                                                                    </td><td>0.543 (0.508, 0.586)</td><td>0.527 (0.491, 0.569)</td><td>-0.019 (-0.051, 0.026) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_621    </td><td>Endometrial hyperplasia                                                                                 </td><td>0.588 (0.548, 0.627)</td><td>0.568 (0.53, 0.615) </td><td>-0.019 (-0.051, 0.013) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552-2  </td><td>Obstruction of bile duct                                                                                </td><td>0.635 (0.607, 0.674)</td><td>0.617 (0.587, 0.653)</td><td>-0.019 (-0.048, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121-2  </td><td>Chronic leukemia                                                                                        </td><td>0.698 (0.673, 0.726)</td><td>0.679 (0.65, 0.709) </td><td>-0.019 (-0.043, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_123-1  </td><td>Multiple myeloma                                                                                        </td><td>0.672 (0.637, 0.715)</td><td>0.654 (0.613, 0.707)</td><td>-0.019 (-0.041, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121    </td><td>Leukemia                                                                                                </td><td>0.683 (0.659, 0.709)</td><td>0.664 (0.628, 0.691)</td><td>-0.019 (-0.039, -0.004)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_664-21 </td><td>Pityriasis rosea                                                                                        </td><td>0.608 (0.573, 0.647)</td><td>0.592 (0.553, 0.626)</td><td>-0.019 (-0.031, -0.007)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_171-1  </td><td>Lymphocytosis (symptomatic)                                                                             </td><td>0.607 (0.569, 0.648)</td><td>0.589 (0.546, 0.636)</td><td>-0.018 (-0.054, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-11 </td><td>Crohn's disease                                                                                         </td><td>0.537 (0.507, 0.58) </td><td>0.518 (0.491, 0.553)</td><td>-0.018 (-0.046, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510-5  </td><td>Dyskinesia of esophagus                                                                                 </td><td>0.612 (0.58, 0.645) </td><td>0.595 (0.554, 0.633)</td><td>-0.018 (-0.04, 0.002)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_123    </td><td>Multiple myeloma and malignant plasma cell neoplasms                                                    </td><td>0.683 (0.647, 0.722)</td><td>0.665 (0.631, 0.707)</td><td>-0.018 (-0.04, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-4  </td><td>Prickly heat and miliaria                                                                               </td><td>0.525 (0.491, 0.56) </td><td>0.509 (0.476, 0.544)</td><td>-0.018 (-0.038, 0.01)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_509-11 </td><td>Glossodynia                                                                                             </td><td>0.591 (0.561, 0.625)</td><td>0.573 (0.548, 0.606)</td><td>-0.018 (-0.037, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-21 </td><td>Corneal ulcer                                                                                           </td><td>0.601 (0.562, 0.655)</td><td>0.585 (0.54, 0.627) </td><td>-0.018 (-0.035, 0.011) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-1  </td><td>Myeloid                                                                                                 </td><td>0.689 (0.668, 0.709)</td><td>0.67 (0.649, 0.686) </td><td>-0.018 (-0.031, -0.008)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601-12 </td><td>Chronic prostatitis                                                                                     </td><td>0.616 (0.59, 0.657) </td><td>0.602 (0.575, 0.639)</td><td>-0.018 (-0.027, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-8  </td><td>Malignant neoplasm of the pancreas                                                                      </td><td>0.669 (0.643, 0.692)</td><td>0.653 (0.621, 0.675)</td><td>-0.017 (-0.039, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-4  </td><td>Other specified cognitive deficit                                                                       </td><td>0.515 (0.489, 0.542)</td><td>0.5 (0.481, 0.522)  </td><td>-0.016 (-0.042, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_466-4  </td><td>Hypertrophy of tonsils and adenoids                                                                     </td><td>0.611 (0.577, 0.657)</td><td>0.598 (0.558, 0.635)</td><td>-0.016 (-0.041, 0.017) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148-2  </td><td>Benign neoplasm of meninges (Meningioma)                                                                </td><td>0.655 (0.622, 0.686)</td><td>0.639 (0.606, 0.679)</td><td>-0.016 (-0.037, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_121-21 </td><td>Chronic lymphoid leukemia                                                                               </td><td>0.706 (0.673, 0.735)</td><td>0.689 (0.657, 0.718)</td><td>-0.016 (-0.035, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-71 </td><td>Sick sinus syndrome*                                                                                    </td><td>0.733 (0.7, 0.771)  </td><td>0.717 (0.678, 0.75) </td><td>-0.016 (-0.035, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-7  </td><td>Sinoatrial node dysfunction                                                                             </td><td>0.735 (0.695, 0.775)</td><td>0.718 (0.683, 0.766)</td><td>-0.016 (-0.035, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_168-4  </td><td>Abnormal coagulation profile                                                                            </td><td>0.729 (0.694, 0.763)</td><td>0.712 (0.679, 0.743)</td><td>-0.016 (-0.028, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-54 </td><td>Testicular limpoma                                                                                      </td><td>0.609 (0.571, 0.65) </td><td>0.593 (0.551, 0.635)</td><td>-0.016 (-0.027, -0.004)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_668-4  </td><td>Dermatitis due to substances taken internally                                                           </td><td>0.564 (0.531, 0.601)</td><td>0.554 (0.505, 0.584)</td><td>-0.015 (-0.058, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430-3  </td><td>Nontraumatic subdural hemorrhage                                                                        </td><td>0.664 (0.624, 0.71) </td><td>0.65 (0.613, 0.692) </td><td>-0.015 (-0.032, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_374-39 </td><td>Transient retinal arterial occlusion [Amaurosis fugax]                                                  </td><td>0.683 (0.651, 0.714)</td><td>0.666 (0.637, 0.696)</td><td>-0.015 (-0.031, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-13 </td><td>Benign neoplasms of the cervix                                                                          </td><td>0.624 (0.597, 0.648)</td><td>0.61 (0.582, 0.628) </td><td>-0.015 (-0.03, 0)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_509-1  </td><td>Glossitis                                                                                               </td><td>0.602 (0.581, 0.624)</td><td>0.585 (0.565, 0.61) </td><td>-0.015 (-0.03, -0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_613-1  </td><td>Inflammatory disease of breast                                                                          </td><td>0.582 (0.556, 0.616)</td><td>0.567 (0.537, 0.597)</td><td>-0.015 (-0.027, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_530-1  </td><td>Anal fissure                                                                                            </td><td>0.555 (0.536, 0.57) </td><td>0.54 (0.52, 0.554)  </td><td>-0.015 (-0.024, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120    </td><td>Hemo onc - by cell of origin                                                                            </td><td>0.667 (0.653, 0.679)</td><td>0.652 (0.637, 0.665)</td><td>-0.015 (-0.023, -0.006)</td><td>0.635 (0.61, 0.653) </td><td>0.633 (0.606, 0.652)</td><td>-0.002 (-0.004, 0)     </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_414-2  </td><td>Dilated cardiomyopathy*                                                                                 </td><td>0.662 (0.633, 0.703)</td><td>0.65 (0.61, 0.684)  </td><td>-0.014 (-0.046, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_604-1  </td><td>Redundant prepuce and phimosis                                                                          </td><td>0.487 (0.459, 0.53) </td><td>0.477 (0.441, 0.516)</td><td>-0.014 (-0.044, 0.014) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_171    </td><td>Increased white blood cell count                                                                        </td><td>0.595 (0.565, 0.627)</td><td>0.579 (0.545, 0.61) </td><td>-0.014 (-0.044, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-21 </td><td>Eustachian salpingitis                                                                                  </td><td>0.521 (0.501, 0.562)</td><td>0.511 (0.481, 0.541)</td><td>-0.014 (-0.037, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-2  </td><td>Malignant neoplasm of stomach                                                                           </td><td>0.688 (0.656, 0.729)</td><td>0.673 (0.65, 0.708) </td><td>-0.014 (-0.036, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622-2  </td><td>Mucous polyp of cervix                                                                                  </td><td>0.618 (0.598, 0.64) </td><td>0.605 (0.584, 0.625)</td><td>-0.014 (-0.03, 0)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-6  </td><td>Heart valve replaced                                                                                    </td><td>0.726 (0.706, 0.751)</td><td>0.711 (0.692, 0.732)</td><td>-0.014 (-0.027, -0.004)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-21 </td><td>Mature B-cell                                                                                           </td><td>0.68 (0.66, 0.703)  </td><td>0.665 (0.646, 0.687)</td><td>-0.014 (-0.026, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-13 </td><td>Postprocedural hypothyroidism                                                                           </td><td>0.659 (0.643, 0.681)</td><td>0.647 (0.626, 0.665)</td><td>-0.014 (-0.025, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-3  </td><td>Emotional lability                                                                                      </td><td>0.653 (0.618, 0.704)</td><td>0.642 (0.61, 0.682) </td><td>-0.013 (-0.036, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_685-1  </td><td>Dyshidrosis                                                                                             </td><td>0.537 (0.502, 0.563)</td><td>0.523 (0.492, 0.549)</td><td>-0.013 (-0.031, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122-2  </td><td>Non-Hodgkin lymphoma                                                                                    </td><td>0.667 (0.643, 0.691)</td><td>0.654 (0.629, 0.68) </td><td>-0.013 (-0.03, 0.004)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_704-5  </td><td>Giant cell arteritis                                                                                    </td><td>0.752 (0.725, 0.784)</td><td>0.741 (0.713, 0.775)</td><td>-0.013 (-0.029, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208-21 </td><td>Primary hyperparathyroidism                                                                             </td><td>0.678 (0.651, 0.7)  </td><td>0.663 (0.638, 0.684)</td><td>-0.013 (-0.029, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-1  </td><td>Meniere disease                                                                                         </td><td>0.612 (0.581, 0.634)</td><td>0.599 (0.569, 0.623)</td><td>-0.013 (-0.027, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_120-2  </td><td>Lymphoid                                                                                                </td><td>0.666 (0.649, 0.685)</td><td>0.653 (0.635, 0.672)</td><td>-0.013 (-0.026, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_728-1  </td><td>Chondromalacia                                                                                          </td><td>0.659 (0.629, 0.7)  </td><td>0.646 (0.616, 0.684)</td><td>-0.013 (-0.023, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_109    </td><td>Malignant neoplasm of the eye, brain and other parts of central nervous system                          </td><td>0.603 (0.573, 0.637)</td><td>0.592 (0.557, 0.627)</td><td>-0.012 (-0.044, 0.015) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_604-3  </td><td>Peyronie's disease                                                                                      </td><td>0.499 (0.468, 0.525)</td><td>0.489 (0.461, 0.515)</td><td>-0.012 (-0.043, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-22 </td><td>Vestibular neuronitis                                                                                   </td><td>0.549 (0.526, 0.574)</td><td>0.537 (0.509, 0.56) </td><td>-0.012 (-0.039, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-1  </td><td>Pelvic peritoneal adhesions, female (postoperative) (postinfection)                                     </td><td>0.575 (0.539, 0.61) </td><td>0.563 (0.53, 0.595) </td><td>-0.012 (-0.037, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_471-3  </td><td>Hypertrophy of nasal turbinates                                                                         </td><td>0.59 (0.55, 0.625)  </td><td>0.577 (0.532, 0.613)</td><td>-0.012 (-0.036, 0.013) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-1  </td><td>Malignant neoplasm of the esophagus                                                                     </td><td>0.735 (0.71, 0.759) </td><td>0.721 (0.697, 0.746)</td><td>-0.012 (-0.028, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_122    </td><td>Lymphoma                                                                                                </td><td>0.658 (0.631, 0.683)</td><td>0.646 (0.626, 0.668)</td><td>-0.012 (-0.026, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_700-2  </td><td>Sicca syndrome [Sjogren syndrome]                                                                       </td><td>0.731 (0.707, 0.758)</td><td>0.718 (0.689, 0.751)</td><td>-0.012 (-0.026, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_381    </td><td>Strabismus                                                                                              </td><td>0.631 (0.6, 0.655)  </td><td>0.617 (0.592, 0.64) </td><td>-0.012 (-0.025, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284-1  </td><td>Suicidal ideations                                                                                      </td><td>0.611 (0.596, 0.635)</td><td>0.599 (0.581, 0.622)</td><td>-0.012 (-0.024, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_704    </td><td>Systemic vasculitis                                                                                     </td><td>0.677 (0.653, 0.7)  </td><td>0.665 (0.643, 0.686)</td><td>-0.012 (-0.024, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_604    </td><td>Disorders of penis                                                                                      </td><td>0.51 (0.496, 0.526) </td><td>0.499 (0.483, 0.513)</td><td>-0.012 (-0.022, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601-1  </td><td>Prostatitis                                                                                             </td><td>0.576 (0.555, 0.592)</td><td>0.564 (0.544, 0.581)</td><td>-0.012 (-0.019, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-12 </td><td>Femoral hernia                                                                                          </td><td>0.585 (0.546, 0.627)</td><td>0.575 (0.535, 0.614)</td><td>-0.011 (-0.039, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_580-3  </td><td>Nephrotic syndrome                                                                                      </td><td>0.553 (0.523, 0.58) </td><td>0.543 (0.516, 0.577)</td><td>-0.011 (-0.036, 0.021) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-21 </td><td>Malignant neoplasm of endometrium                                                                       </td><td>0.566 (0.533, 0.592)</td><td>0.554 (0.529, 0.576)</td><td>-0.011 (-0.035, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_389-1  </td><td>Ocular pain                                                                                             </td><td>0.538 (0.518, 0.559)</td><td>0.528 (0.5, 0.548)  </td><td>-0.011 (-0.034, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_481-4  </td><td>Pulmonary fibrosis                                                                                      </td><td>0.726 (0.702, 0.748)</td><td>0.716 (0.681, 0.738)</td><td>-0.011 (-0.032, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-14 </td><td>Microscopic colitis*                                                                                    </td><td>0.64 (0.604, 0.665) </td><td>0.63 (0.591, 0.659) </td><td>-0.011 (-0.031, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_379-2  </td><td>Eye infection, viral                                                                                    </td><td>0.546 (0.517, 0.571)</td><td>0.533 (0.512, 0.558)</td><td>-0.011 (-0.031, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_702    </td><td>Infective and reactive arthropathies                                                                    </td><td>0.556 (0.526, 0.581)</td><td>0.543 (0.518, 0.576)</td><td>-0.011 (-0.029, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_624    </td><td>Symptoms involving female genital tract                                                                 </td><td>0.57 (0.553, 0.589) </td><td>0.558 (0.537, 0.581)</td><td>-0.011 (-0.029, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-1  </td><td>Benign neoplasms of external female genital organs and cervix                                           </td><td>0.612 (0.59, 0.635) </td><td>0.601 (0.58, 0.623) </td><td>-0.011 (-0.027, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_410-2  </td><td>Endocarditis                                                                                            </td><td>0.646 (0.627, 0.669)</td><td>0.635 (0.618, 0.665)</td><td>-0.011 (-0.024, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-3  </td><td>Secondary malignant neoplasm of digestive systems                                                       </td><td>0.633 (0.614, 0.654)</td><td>0.623 (0.605, 0.642)</td><td>-0.011 (-0.024, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-32 </td><td>Genu varum (acquired)                                                                                   </td><td>0.682 (0.646, 0.721)</td><td>0.672 (0.636, 0.715)</td><td>-0.011 (-0.022, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622-1  </td><td>Polyp of corpus uteri                                                                                   </td><td>0.536 (0.52, 0.557) </td><td>0.525 (0.508, 0.549)</td><td>-0.011 (-0.021, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-5  </td><td>Noninflammatory disorders of vulva and perineum                                                         </td><td>0.531 (0.519, 0.544)</td><td>0.52 (0.505, 0.537) </td><td>-0.011 (-0.018, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-43 </td><td>Right bundle branch block                                                                               </td><td>0.706 (0.69, 0.721) </td><td>0.695 (0.678, 0.711)</td><td>-0.011 (-0.016, -0.005)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_803    </td><td>Snoring*                                                                                                </td><td>0.631 (0.615, 0.648)</td><td>0.62 (0.605, 0.637) </td><td>-0.011 (-0.015, -0.007)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_352-3  </td><td>Parageusia*                                                                                             </td><td>0.537 (0.505, 0.569)</td><td>0.523 (0.495, 0.562)</td><td>-0.01 (-0.04, 0.013)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-12 </td><td>Mitral valve prolapse*                                                                                  </td><td>0.639 (0.605, 0.674)</td><td>0.628 (0.595, 0.667)</td><td>-0.01 (-0.039, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-1  </td><td>Irritability                                                                                            </td><td>0.575 (0.535, 0.615)</td><td>0.568 (0.532, 0.603)</td><td>-0.01 (-0.038, 0.015)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-9  </td><td>Visual distortions and subjective visual disturbances                                                   </td><td>0.626 (0.597, 0.664)</td><td>0.618 (0.583, 0.647)</td><td>-0.01 (-0.031, 0.016)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-41 </td><td>Flat foot [pes planus]                                                                                  </td><td>0.584 (0.559, 0.616)</td><td>0.572 (0.537, 0.608)</td><td>-0.01 (-0.03, 0.009)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_518    </td><td>Appendicitis                                                                                            </td><td>0.557 (0.532, 0.585)</td><td>0.549 (0.524, 0.579)</td><td>-0.01 (-0.029, 0.008)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_513-3  </td><td>Duodenal ulcer                                                                                          </td><td>0.62 (0.602, 0.641) </td><td>0.609 (0.592, 0.628)</td><td>-0.01 (-0.026, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_139-53 </td><td>Lipoma of other skin subcutaneous tissue                                                                </td><td>0.526 (0.508, 0.54) </td><td>0.517 (0.492, 0.537)</td><td>-0.01 (-0.025, 0.011)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325-23 </td><td>Unsteadiness on feet*                                                                                   </td><td>0.651 (0.625, 0.676)</td><td>0.641 (0.615, 0.666)</td><td>-0.01 (-0.024, 0)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180-3  </td><td>Paraproteinemias                                                                                        </td><td>0.687 (0.66, 0.714) </td><td>0.675 (0.654, 0.704)</td><td>-0.01 (-0.024, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-3  </td><td>Obstructive and reflux uropathy                                                                         </td><td>0.62 (0.604, 0.635) </td><td>0.61 (0.593, 0.625) </td><td>-0.01 (-0.021, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_386-2  </td><td>Diplopia                                                                                                </td><td>0.595 (0.576, 0.617)</td><td>0.587 (0.563, 0.608)</td><td>-0.01 (-0.019, 0.004)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601    </td><td>Inflammatory diseases of prostate                                                                       </td><td>0.575 (0.556, 0.593)</td><td>0.565 (0.542, 0.582)</td><td>-0.01 (-0.017, -0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_597-5  </td><td>Urethral caruncle                                                                                       </td><td>0.787 (0.766, 0.81) </td><td>0.778 (0.754, 0.801)</td><td>-0.01 (-0.015, -0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_209-1  </td><td>Pituitary hyperfunction                                                                                 </td><td>0.615 (0.555, 0.653)</td><td>0.605 (0.554, 0.649)</td><td>-0.009 (-0.047, 0.034) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_601-11 </td><td>Acute prostatitis                                                                                       </td><td>0.559 (0.532, 0.591)</td><td>0.553 (0.514, 0.588)</td><td>-0.009 (-0.046, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_814    </td><td>Jaundice (not of newborn)                                                                               </td><td>0.621 (0.591, 0.653)</td><td>0.613 (0.588, 0.636)</td><td>-0.009 (-0.031, 0.015) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-41 </td><td>Malignant neoplasm of kidney, except pelvis                                                             </td><td>0.663 (0.63, 0.699) </td><td>0.652 (0.624, 0.683)</td><td>-0.009 (-0.029, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_525    </td><td>Intestinal malabsorption                                                                                </td><td>0.534 (0.515, 0.553)</td><td>0.525 (0.504, 0.542)</td><td>-0.009 (-0.026, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_361-9  </td><td>Ectropion of eyelid                                                                                     </td><td>0.684 (0.64, 0.722) </td><td>0.676 (0.629, 0.714)</td><td>-0.009 (-0.023, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-1  </td><td>Trigeminal nerve disorders [CN5]                                                                        </td><td>0.6 (0.575, 0.618)  </td><td>0.59 (0.57, 0.611)  </td><td>-0.009 (-0.021, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_410    </td><td>Inflammation of the heart [Carditis]                                                                    </td><td>0.623 (0.605, 0.648)</td><td>0.615 (0.595, 0.638)</td><td>-0.009 (-0.021, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-22 </td><td>Aortic insufficiency                                                                                    </td><td>0.677 (0.662, 0.692)</td><td>0.668 (0.651, 0.684)</td><td>-0.009 (-0.021, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_522-1  </td><td>Inflammatory bowel disease                                                                              </td><td>0.546 (0.53, 0.574) </td><td>0.538 (0.522, 0.558)</td><td>-0.009 (-0.02, 0.007)  </td><td>0.43 (0.321, 0.494) </td><td>0.436 (0.33, 0.501) </td><td>0.005 (-0.012, 0.011)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-1  </td><td>Paroxysmal tachycardia                                                                                  </td><td>0.63 (0.617, 0.647) </td><td>0.621 (0.608, 0.637)</td><td>-0.009 (-0.019, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-9  </td><td>Dementia NOS                                                                                            </td><td>0.779 (0.761, 0.794)</td><td>0.768 (0.751, 0.783)</td><td>-0.009 (-0.018, -0.002)</td><td>0.814 (0.801, 0.826)</td><td>0.813 (0.799, 0.825)</td><td>-0.001 (-0.003, 0)     </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-1  </td><td>Parkinsonism                                                                                            </td><td>0.722 (0.71, 0.737) </td><td>0.713 (0.7, 0.729)  </td><td>-0.009 (-0.017, -0.004)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_105-1  </td><td>Malignant neoplasm of the breast, female                                                                </td><td>0.533 (0.518, 0.546)</td><td>0.525 (0.513, 0.537)</td><td>-0.009 (-0.017, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-15 </td><td>Scrotal varices [Varicocele]                                                                            </td><td>0.802 (0.788, 0.815)</td><td>0.794 (0.778, 0.807)</td><td>-0.009 (-0.016, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-4  </td><td>Nasal congestion*                                                                                       </td><td>0.536 (0.525, 0.546)</td><td>0.527 (0.518, 0.537)</td><td>-0.009 (-0.016, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-23 </td><td>Multinodular goiter                                                                                     </td><td>0.69 (0.671, 0.715) </td><td>0.682 (0.66, 0.705) </td><td>-0.009 (-0.016, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-2  </td><td>Overactive bladder                                                                                      </td><td>0.597 (0.585, 0.612)</td><td>0.587 (0.576, 0.602)</td><td>-0.009 (-0.014, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_488-8  </td><td>Mouth breathing*                                                                                        </td><td>0.598 (0.583, 0.615)</td><td>0.589 (0.574, 0.605)</td><td>-0.009 (-0.013, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-51 </td><td>Atrial premature depolarization [Supraventricular premature beats]                                      </td><td>0.629 (0.604, 0.66) </td><td>0.623 (0.597, 0.648)</td><td>-0.008 (-0.031, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523-1  </td><td>Diverticula of small intestine                                                                          </td><td>0.643 (0.608, 0.691)</td><td>0.632 (0.595, 0.673)</td><td>-0.008 (-0.031, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-4  </td><td>Malignant neoplasm of the kidney                                                                        </td><td>0.661 (0.634, 0.687)</td><td>0.653 (0.626, 0.678)</td><td>-0.008 (-0.027, 0.01)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_286-21 </td><td>Major depressive disorder, recurrent                                                                    </td><td>0.587 (0.561, 0.611)</td><td>0.577 (0.55, 0.606) </td><td>-0.008 (-0.024, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363-7  </td><td>Stenosis and insufficiency of lacrimal passages                                                         </td><td>0.622 (0.595, 0.649)</td><td>0.615 (0.588, 0.642)</td><td>-0.008 (-0.022, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_325-3  </td><td>Lack of coordination                                                                                    </td><td>0.603 (0.582, 0.619)</td><td>0.594 (0.575, 0.613)</td><td>-0.008 (-0.021, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-1  </td><td>Hydrocele                                                                                               </td><td>0.555 (0.53, 0.584) </td><td>0.547 (0.523, 0.573)</td><td>-0.008 (-0.021, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_581-31 </td><td>Hydronephrosis                                                                                          </td><td>0.606 (0.589, 0.629)</td><td>0.598 (0.578, 0.617)</td><td>-0.008 (-0.021, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-42 </td><td>Malignant neoplasm of the rectum                                                                        </td><td>0.682 (0.657, 0.705)</td><td>0.675 (0.65, 0.693) </td><td>-0.008 (-0.019, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-11 </td><td>Supraventricular tachycardia                                                                            </td><td>0.62 (0.602, 0.635) </td><td>0.613 (0.595, 0.63) </td><td>-0.008 (-0.018, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-4  </td><td>Tremor                                                                                                  </td><td>0.629 (0.616, 0.641)</td><td>0.621 (0.607, 0.634)</td><td>-0.008 (-0.016, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-11 </td><td>Parkinson's disease (Primary)                                                                           </td><td>0.724 (0.709, 0.74) </td><td>0.716 (0.698, 0.731)</td><td>-0.008 (-0.015, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396-21 </td><td>Sensorineural hearing loss, bilateral                                                                   </td><td>0.647 (0.629, 0.665)</td><td>0.64 (0.622, 0.656) </td><td>-0.008 (-0.012, -0.003)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-6  </td><td>Excessive crying of child, adolescent, or adult                                                         </td><td>0.674 (0.646, 0.71) </td><td>0.665 (0.634, 0.702)</td><td>-0.007 (-0.035, 0.015) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_580    </td><td>Glomerular diseases                                                                                     </td><td>0.628 (0.607, 0.652)</td><td>0.622 (0.599, 0.646)</td><td>-0.007 (-0.032, 0.02)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_391-12 </td><td>Chronic otitis media                                                                                    </td><td>0.496 (0.478, 0.52) </td><td>0.492 (0.47, 0.512) </td><td>-0.007 (-0.029, 0.021) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180-31 </td><td>Monoclonal gammopathy                                                                                   </td><td>0.689 (0.668, 0.713)</td><td>0.683 (0.657, 0.704)</td><td>-0.007 (-0.026, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106    </td><td>Gynecological malignant neoplasms                                                                       </td><td>0.551 (0.526, 0.57) </td><td>0.543 (0.519, 0.564)</td><td>-0.007 (-0.024, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-41 </td><td>Attention and concentration deficit                                                                     </td><td>0.677 (0.647, 0.714)</td><td>0.67 (0.642, 0.708) </td><td>-0.007 (-0.015, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_593-2  </td><td>Microscopic hematuria                                                                                   </td><td>0.598 (0.582, 0.611)</td><td>0.592 (0.576, 0.606)</td><td>-0.007 (-0.015, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_610    </td><td>Benign mammary dysplasias                                                                               </td><td>0.634 (0.608, 0.652)</td><td>0.628 (0.603, 0.645)</td><td>-0.007 (-0.015, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_400-2  </td><td>Chronic rheumatic heart diseases                                                                        </td><td>0.723 (0.713, 0.737)</td><td>0.717 (0.701, 0.73) </td><td>-0.007 (-0.014, 0)     </td><td>0.651 (0.634, 0.671)</td><td>0.657 (0.642, 0.677)</td><td>0.007 (-0.006, 0.01)   </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510-8  </td><td>Barrett's esophagus                                                                                     </td><td>0.641 (0.627, 0.657)</td><td>0.634 (0.617, 0.649)</td><td>-0.007 (-0.014, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_329-5  </td><td>Mild cognitive impairment, so stated                                                                    </td><td>0.764 (0.751, 0.782)</td><td>0.756 (0.743, 0.775)</td><td>-0.007 (-0.014, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_088    </td><td>Sexually transmitted disease                                                                            </td><td>0.645 (0.62, 0.674) </td><td>0.638 (0.612, 0.667)</td><td>-0.007 (-0.013, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_628    </td><td>Ovarian cyst                                                                                            </td><td>0.592 (0.577, 0.612)</td><td>0.585 (0.571, 0.605)</td><td>-0.007 (-0.012, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_683    </td><td>Nail disorders                                                                                          </td><td>0.533 (0.527, 0.541)</td><td>0.528 (0.521, 0.536)</td><td>-0.007 (-0.011, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_099    </td><td>Lab findings related to infections                                                                      </td><td>0.648 (0.638, 0.663)</td><td>0.64 (0.631, 0.656) </td><td>-0.007 (-0.01, -0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592-12 </td><td>Chronic cystitis                                                                                        </td><td>0.603 (0.565, 0.633)</td><td>0.595 (0.559, 0.628)</td><td>-0.006 (-0.034, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_367-2  </td><td>Keratitis                                                                                               </td><td>0.536 (0.503, 0.556)</td><td>0.53 (0.502, 0.552) </td><td>-0.006 (-0.029, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_180    </td><td>Other disorders involving the immune mechanism                                                          </td><td>0.608 (0.589, 0.63) </td><td>0.603 (0.586, 0.622)</td><td>-0.006 (-0.021, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-13 </td><td>Allergy to sulfonamides                                                                                 </td><td>0.718 (0.693, 0.743)</td><td>0.712 (0.684, 0.735)</td><td>-0.006 (-0.021, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_362    </td><td>Other disorders of the eyelids                                                                          </td><td>0.553 (0.538, 0.567)</td><td>0.545 (0.53, 0.564) </td><td>-0.006 (-0.019, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_514-1  </td><td>Esophageal obstruction (Stricture and stenosis of esophagus)                                            </td><td>0.633 (0.615, 0.648)</td><td>0.626 (0.61, 0.645) </td><td>-0.006 (-0.018, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_604-5  </td><td>Balanoposthitis                                                                                         </td><td>0.526 (0.503, 0.547)</td><td>0.519 (0.499, 0.542)</td><td>-0.006 (-0.018, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-4  </td><td>Secondary malignant neoplasm of liver                                                                   </td><td>0.661 (0.646, 0.673)</td><td>0.654 (0.638, 0.668)</td><td>-0.006 (-0.017, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-11 </td><td>Urinary hesitancy                                                                                       </td><td>0.75 (0.724, 0.781) </td><td>0.745 (0.721, 0.771)</td><td>-0.006 (-0.016, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_710-3  </td><td>Acquired deformities of the knee                                                                        </td><td>0.651 (0.624, 0.676)</td><td>0.646 (0.616, 0.667)</td><td>-0.006 (-0.016, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_353    </td><td>Symptoms and signs involving general sensations and perceptions                                         </td><td>0.577 (0.564, 0.595)</td><td>0.572 (0.559, 0.588)</td><td>-0.006 (-0.014, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-22 </td><td>Atrial flutter                                                                                          </td><td>0.739 (0.725, 0.753)</td><td>0.732 (0.718, 0.747)</td><td>-0.006 (-0.013, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_717-2  </td><td>Sacrococcygeal disorders                                                                                </td><td>0.621 (0.602, 0.639)</td><td>0.616 (0.594, 0.635)</td><td>-0.006 (-0.013, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_714    </td><td>Deforming dorsopathies                                                                                  </td><td>0.677 (0.659, 0.696)</td><td>0.672 (0.656, 0.692)</td><td>-0.006 (-0.013, 0.003) </td><td>0.583 (0.563, 0.601)</td><td>0.618 (0.591, 0.649)</td><td>0.034 (0.02, 0.06)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_622    </td><td>Polyp of female genital organs                                                                          </td><td>0.571 (0.558, 0.583)</td><td>0.565 (0.551, 0.578)</td><td>-0.006 (-0.013, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-5  </td><td>Tendinitis                                                                                              </td><td>0.523 (0.512, 0.534)</td><td>0.517 (0.506, 0.53) </td><td>-0.006 (-0.013, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_628-2  </td><td>Corpus luteum cyst or hematoma                                                                          </td><td>0.589 (0.573, 0.606)</td><td>0.583 (0.566, 0.599)</td><td>-0.006 (-0.013, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_288-4  </td><td>Phobic disorders                                                                                        </td><td>0.602 (0.581, 0.613)</td><td>0.596 (0.574, 0.609)</td><td>-0.006 (-0.012, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-31 </td><td>Urge incontinence                                                                                       </td><td>0.648 (0.636, 0.66) </td><td>0.642 (0.628, 0.654)</td><td>-0.006 (-0.012, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_487-1  </td><td>Epistaxis                                                                                               </td><td>0.592 (0.58, 0.605) </td><td>0.586 (0.575, 0.599)</td><td>-0.006 (-0.011, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_808    </td><td>Syncope and collapse                                                                                    </td><td>0.6 (0.592, 0.606)  </td><td>0.593 (0.587, 0.6)  </td><td>-0.006 (-0.01, -0.002) </td><td>0.666 (0.645, 0.686)</td><td>0.668 (0.645, 0.685)</td><td>0 (-0.001, 0.003)      </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_593-1  </td><td>Gross hematuria                                                                                         </td><td>0.69 (0.668, 0.711) </td><td>0.683 (0.663, 0.705)</td><td>-0.006 (-0.009, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552-1  </td><td>Cholangitis                                                                                             </td><td>0.605 (0.571, 0.641)</td><td>0.599 (0.56, 0.641) </td><td>-0.005 (-0.036, 0.026) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_624-1  </td><td>Dystrophy of female genital tract                                                                       </td><td>0.576 (0.551, 0.602)</td><td>0.57 (0.544, 0.597) </td><td>-0.005 (-0.034, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_109-3  </td><td>Malignant neoplasm of brain                                                                             </td><td>0.608 (0.57, 0.645) </td><td>0.604 (0.563, 0.643)</td><td>-0.005 (-0.032, 0.029) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_011    </td><td>Klebsiella                                                                                              </td><td>0.667 (0.625, 0.701)</td><td>0.662 (0.616, 0.695)</td><td>-0.005 (-0.031, 0.027) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_104    </td><td>Malignant sarcoma-related cancers                                                                       </td><td>0.552 (0.524, 0.582)</td><td>0.546 (0.519, 0.575)</td><td>-0.005 (-0.029, 0.028) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-15 </td><td>Primary osteoarthritis of the wrist, forearm                                                            </td><td>0.652 (0.614, 0.677)</td><td>0.646 (0.611, 0.673)</td><td>-0.005 (-0.025, 0.019) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_379    </td><td>Infection of the eye                                                                                    </td><td>0.546 (0.527, 0.567)</td><td>0.543 (0.519, 0.563)</td><td>-0.005 (-0.025, 0.018) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-53 </td><td>Cyst or abscess of Bartholin's gland                                                                    </td><td>0.627 (0.598, 0.668)</td><td>0.621 (0.592, 0.656)</td><td>-0.005 (-0.022, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-8  </td><td>Secondary osteoarthritis                                                                                </td><td>0.595 (0.58, 0.622) </td><td>0.592 (0.574, 0.613)</td><td>-0.005 (-0.02, 0.01)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_623    </td><td>Hypertrophy of female genital organs                                                                    </td><td>0.505 (0.493, 0.52) </td><td>0.501 (0.484, 0.515)</td><td>-0.005 (-0.019, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_284    </td><td>Suicide ideation and attempt or self harm                                                               </td><td>0.599 (0.585, 0.616)</td><td>0.594 (0.58, 0.613) </td><td>-0.005 (-0.018, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_597    </td><td>Other disorders of urethra and urinary tract                                                            </td><td>0.6 (0.581, 0.615)  </td><td>0.595 (0.578, 0.61) </td><td>-0.005 (-0.017, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-3  </td><td>Diverticulum of bladder                                                                                 </td><td>0.738 (0.709, 0.771)</td><td>0.734 (0.704, 0.767)</td><td>-0.005 (-0.013, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_400    </td><td>Rheumatic fever and chronic rheumatic heart diseases                                                    </td><td>0.723 (0.712, 0.733)</td><td>0.717 (0.707, 0.728)</td><td>-0.005 (-0.013, 0.003) </td><td>0.648 (0.632, 0.692)</td><td>0.653 (0.634, 0.692)</td><td>0.005 (-0.006, 0.01)   </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-11 </td><td>Mitral valve insufficiency                                                                              </td><td>0.696 (0.684, 0.713)</td><td>0.691 (0.679, 0.705)</td><td>-0.005 (-0.013, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_625-2  </td><td>Postcoital bleeding                                                                                     </td><td>0.754 (0.732, 0.774)</td><td>0.748 (0.727, 0.767)</td><td>-0.005 (-0.013, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682-4  </td><td>Acne                                                                                                    </td><td>0.635 (0.608, 0.658)</td><td>0.631 (0.604, 0.657)</td><td>-0.005 (-0.012, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324    </td><td>Extrapyramidal and movement disorders                                                                   </td><td>0.596 (0.586, 0.602)</td><td>0.59 (0.582, 0.599) </td><td>-0.005 (-0.011, 0)     </td><td>0.622 (0.611, 0.649)</td><td>0.621 (0.605, 0.645)</td><td>-0.004 (-0.009, 0.004) </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_467    </td><td>Laryngitis and tracheitis                                                                               </td><td>0.616 (0.606, 0.632)</td><td>0.611 (0.6, 0.629)  </td><td>-0.005 (-0.011, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-1  </td><td>Mitral valve disorders                                                                                  </td><td>0.706 (0.694, 0.717)</td><td>0.702 (0.689, 0.714)</td><td>-0.005 (-0.011, 0.002) </td><td>0.579 (0.558, 0.594)</td><td>0.565 (0.553, 0.589)</td><td>-0.007 (-0.021, 0.01)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_509    </td><td>Diseases of tongue                                                                                      </td><td>0.58 (0.568, 0.594) </td><td>0.575 (0.563, 0.59) </td><td>-0.005 (-0.011, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_056-1  </td><td>Plantar wart                                                                                            </td><td>0.542 (0.527, 0.555)</td><td>0.538 (0.522, 0.551)</td><td>-0.005 (-0.01, 0)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_136-2  </td><td>Benign neoplasm of stomach                                                                              </td><td>0.633 (0.623, 0.642)</td><td>0.627 (0.617, 0.64) </td><td>-0.005 (-0.01, 0)      </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-2  </td><td>Uterine/Uterovaginal prolapse                                                                           </td><td>0.587 (0.572, 0.6)  </td><td>0.582 (0.57, 0.595) </td><td>-0.005 (-0.01, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-41 </td><td>Malignant neoplasm of the colon                                                                         </td><td>0.687 (0.667, 0.702)</td><td>0.682 (0.664, 0.699)</td><td>-0.005 (-0.01, 0.001)  </td><td>0.601 (0.588, 0.626)</td><td>0.6 (0.581, 0.618)  </td><td>-0.006 (-0.011, 0.002) </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-8  </td><td>Dementia in conditions classified elsewhere                                                             </td><td>0.801 (0.79, 0.813) </td><td>0.796 (0.783, 0.808)</td><td>-0.005 (-0.01, -0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328    </td><td>Dementias and cerebral degeneration                                                                     </td><td>0.788 (0.776, 0.802)</td><td>0.783 (0.772, 0.796)</td><td>-0.005 (-0.01, -0.001) </td><td>0.805 (0.795, 0.812)</td><td>0.804 (0.794, 0.811)</td><td>-0.001 (-0.002, 0)     </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_467-1  </td><td>Acute laryngitis and tracheitis                                                                         </td><td>0.623 (0.612, 0.635)</td><td>0.619 (0.607, 0.631)</td><td>-0.005 (-0.01, -0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-3  </td><td>Urinary incontinence                                                                                    </td><td>0.618 (0.609, 0.624)</td><td>0.613 (0.604, 0.62) </td><td>-0.005 (-0.009, -0.002)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_395-1  </td><td>Labyrinthitis                                                                                           </td><td>0.576 (0.564, 0.587)</td><td>0.571 (0.561, 0.582)</td><td>-0.005 (-0.008, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_215    </td><td>Testicular dysfunction                                                                                  </td><td>0.515 (0.465, 0.567)</td><td>0.509 (0.458, 0.563)</td><td>-0.004 (-0.05, 0.04)   </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_362-5  </td><td>Cysts of eyelid                                                                                         </td><td>0.56 (0.526, 0.592) </td><td>0.553 (0.526, 0.59) </td><td>-0.004 (-0.038, 0.018) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208-2  </td><td>Hyperparathyroidism                                                                                     </td><td>0.654 (0.631, 0.676)</td><td>0.648 (0.621, 0.669)</td><td>-0.004 (-0.024, 0.013) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-2  </td><td>Disorders of uterus, NEC                                                                                </td><td>0.551 (0.531, 0.573)</td><td>0.546 (0.525, 0.572)</td><td>-0.004 (-0.019, 0.011) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-7  </td><td>Vascular dementia                                                                                       </td><td>0.8 (0.774, 0.823)  </td><td>0.795 (0.771, 0.819)</td><td>-0.004 (-0.018, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_208    </td><td>Disorders of parathyroid gland                                                                          </td><td>0.648 (0.627, 0.668)</td><td>0.645 (0.622, 0.665)</td><td>-0.004 (-0.017, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_520-14 </td><td>Ventral hernia                                                                                          </td><td>0.585 (0.562, 0.599)</td><td>0.58 (0.564, 0.594) </td><td>-0.004 (-0.016, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_610-1  </td><td>Cystic mastopathy                                                                                       </td><td>0.69 (0.664, 0.713) </td><td>0.685 (0.66, 0.71)  </td><td>-0.004 (-0.013, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_506-5  </td><td>Disturbances of salivary secretion                                                                      </td><td>0.629 (0.61, 0.645) </td><td>0.625 (0.607, 0.642)</td><td>-0.004 (-0.013, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_708-9  </td><td>Heberden's or Bouchard's nodes*                                                                         </td><td>0.634 (0.612, 0.655)</td><td>0.63 (0.606, 0.65)  </td><td>-0.004 (-0.013, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_683-1  </td><td>Ingrowing nail                                                                                          </td><td>0.534 (0.523, 0.548)</td><td>0.531 (0.517, 0.545)</td><td>-0.004 (-0.012, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-3  </td><td>Thyrotoxicosis [hyperthyroidism]                                                                        </td><td>0.613 (0.597, 0.63) </td><td>0.609 (0.59, 0.626) </td><td>-0.004 (-0.012, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_523-4  </td><td>Diverticulitis                                                                                          </td><td>0.612 (0.598, 0.627)</td><td>0.608 (0.596, 0.623)</td><td>-0.004 (-0.011, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108-5  </td><td>Malignant neoplasm of the bladder                                                                       </td><td>0.734 (0.718, 0.756)</td><td>0.73 (0.711, 0.753) </td><td>-0.004 (-0.011, 0.005) </td><td>0.716 (0.705, 0.731)</td><td>0.718 (0.706, 0.734)</td><td>0.001 (-0.003, 0.003)  </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-6  </td><td>Baker's cyst [popliteal cyst]                                                                           </td><td>0.584 (0.57, 0.598) </td><td>0.579 (0.562, 0.593)</td><td>-0.004 (-0.011, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-5  </td><td>Postnasal drip                                                                                          </td><td>0.579 (0.566, 0.591)</td><td>0.575 (0.561, 0.589)</td><td>-0.004 (-0.011, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-2  </td><td>Dysmenorrhea                                                                                            </td><td>0.894 (0.882, 0.908)</td><td>0.891 (0.879, 0.902)</td><td>-0.004 (-0.01, 0.004)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-41 </td><td>Atrioventricular block                                                                                  </td><td>0.75 (0.74, 0.763)  </td><td>0.747 (0.735, 0.76) </td><td>-0.004 (-0.01, 0.001)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_463-1  </td><td>Chronic rhinitis                                                                                        </td><td>0.549 (0.537, 0.561)</td><td>0.545 (0.534, 0.556)</td><td>-0.004 (-0.009, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_682    </td><td>Other follicular disorders                                                                              </td><td>0.512 (0.505, 0.519)</td><td>0.508 (0.502, 0.514)</td><td>-0.004 (-0.008, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-1  </td><td>Prolapse of vaginal walls                                                                               </td><td>0.581 (0.57, 0.593) </td><td>0.577 (0.567, 0.588)</td><td>-0.004 (-0.008, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-4  </td><td>Heart block                                                                                             </td><td>0.722 (0.715, 0.73) </td><td>0.718 (0.71, 0.726) </td><td>-0.004 (-0.007, 0)     </td><td>0.751 (0.731, 0.757)</td><td>0.75 (0.73, 0.756)  </td><td>-0.001 (-0.002, 0)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-6  </td><td>Urinary urgency                                                                                         </td><td>0.594 (0.582, 0.604)</td><td>0.591 (0.579, 0.603)</td><td>-0.004 (-0.007, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417-3  </td><td>Bradycardia*                                                                                            </td><td>0.658 (0.647, 0.67) </td><td>0.654 (0.644, 0.666)</td><td>-0.004 (-0.007, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_395    </td><td>Other diseases of inner ear                                                                             </td><td>0.572 (0.562, 0.583)</td><td>0.569 (0.56, 0.579) </td><td>-0.004 (-0.007, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_377-2  </td><td>Conjunctival hemorrhage                                                                                 </td><td>0.584 (0.573, 0.595)</td><td>0.581 (0.569, 0.592)</td><td>-0.004 (-0.006, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_504-3  </td><td>Periodontitis                                                                                           </td><td>0.54 (0.513, 0.57)  </td><td>0.539 (0.501, 0.574)</td><td>-0.003 (-0.036, 0.027) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_346    </td><td>Brain damage and brain death                                                                            </td><td>0.568 (0.532, 0.602)</td><td>0.565 (0.526, 0.6)  </td><td>-0.003 (-0.036, 0.025) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_106-3  </td><td>Malignant neoplasm of the ovary                                                                         </td><td>0.585 (0.558, 0.619)</td><td>0.582 (0.546, 0.609)</td><td>-0.003 (-0.034, 0.026) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_290-1  </td><td>Posttraumatic stress disorder                                                                           </td><td>0.657 (0.621, 0.709)</td><td>0.65 (0.62, 0.704)  </td><td>-0.003 (-0.034, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_342-4  </td><td>Monoplegia                                                                                              </td><td>0.561 (0.526, 0.596)</td><td>0.56 (0.53, 0.591)  </td><td>-0.003 (-0.03, 0.025)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430-2  </td><td>Nontraumatic intracerebral hemorrhage                                                                   </td><td>0.697 (0.678, 0.72) </td><td>0.695 (0.676, 0.719)</td><td>-0.003 (-0.029, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_724-3  </td><td>Nontraumatic hematoma of soft tissue                                                                    </td><td>0.569 (0.535, 0.597)</td><td>0.565 (0.528, 0.593)</td><td>-0.003 (-0.026, 0.015) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Blood         </td><td>phecode_177-4  </td><td>Lymphedema                                                                                              </td><td>0.656 (0.641, 0.673)</td><td>0.655 (0.639, 0.671)</td><td>-0.003 (-0.016, 0.013) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-11 </td><td>Deep vein thrombosis [DVT]                                                                              </td><td>0.603 (0.588, 0.62) </td><td>0.599 (0.581, 0.619)</td><td>-0.003 (-0.016, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_363-5  </td><td>Epiphora                                                                                                </td><td>0.592 (0.576, 0.607)</td><td>0.589 (0.574, 0.605)</td><td>-0.003 (-0.015, 0.01)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334    </td><td>Disorders of other cranial nerves                                                                       </td><td>0.55 (0.536, 0.568) </td><td>0.547 (0.533, 0.563)</td><td>-0.003 (-0.014, 0.014) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_712    </td><td>Other specific joint derangements                                                                       </td><td>0.539 (0.521, 0.552)</td><td>0.536 (0.519, 0.549)</td><td>-0.003 (-0.014, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_440-3  </td><td>Pulmonary embolism                                                                                      </td><td>0.63 (0.616, 0.642) </td><td>0.626 (0.614, 0.641)</td><td>-0.003 (-0.014, 0.005) </td><td>0.537 (0.499, 0.55) </td><td>0.544 (0.512, 0.565)</td><td>0.006 (-0.013, 0.031)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_586-2  </td><td>Cyst of kidney                                                                                          </td><td>0.652 (0.636, 0.671)</td><td>0.65 (0.634, 0.668) </td><td>-0.003 (-0.013, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_448-1  </td><td>Raynaud's syndrome                                                                                      </td><td>0.585 (0.568, 0.603)</td><td>0.582 (0.565, 0.603)</td><td>-0.003 (-0.013, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-3  </td><td>Medial epicondylitis (Golfer's elbow)                                                                   </td><td>0.562 (0.546, 0.578)</td><td>0.559 (0.545, 0.577)</td><td>-0.003 (-0.012, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_841-12 </td><td>Allergy to antibiotic agent (excluding penicillin)                                                      </td><td>0.661 (0.649, 0.672)</td><td>0.658 (0.647, 0.669)</td><td>-0.003 (-0.01, 0.003)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-5  </td><td>Premature depolarization [Premature beats]                                                              </td><td>0.626 (0.61, 0.638) </td><td>0.623 (0.606, 0.636)</td><td>-0.003 (-0.009, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592-11 </td><td>Acute cystitis                                                                                          </td><td>0.712 (0.698, 0.731)</td><td>0.71 (0.695, 0.729) </td><td>-0.003 (-0.009, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101    </td><td>Malignant neoplasm of the digestive organs                                                              </td><td>0.672 (0.663, 0.683)</td><td>0.669 (0.659, 0.68) </td><td>-0.003 (-0.009, 0.002) </td><td>0.623 (0.595, 0.63) </td><td>0.622 (0.594, 0.627)</td><td>-0.002 (-0.003, 0)     </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_101-4  </td><td>Malignant neoplasm of the colon and rectum                                                              </td><td>0.685 (0.673, 0.699)</td><td>0.682 (0.672, 0.696)</td><td>-0.003 (-0.008, 0.002) </td><td>0.596 (0.57, 0.627) </td><td>0.596 (0.57, 0.628) </td><td>0 (-0.001, 0.001)      </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_140    </td><td>Benign neoplasm of the breast                                                                           </td><td>0.797 (0.779, 0.812)</td><td>0.795 (0.779, 0.809)</td><td>-0.003 (-0.008, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413    </td><td>Heart valve disorders                                                                                   </td><td>0.712 (0.705, 0.72) </td><td>0.709 (0.702, 0.718)</td><td>-0.003 (-0.007, 0.002) </td><td>0.696 (0.667, 0.714)</td><td>0.696 (0.672, 0.719)</td><td>0.003 (-0.003, 0.008)  </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_328-1  </td><td>Alzheimer's disease                                                                                     </td><td>0.812 (0.798, 0.826)</td><td>0.809 (0.796, 0.822)</td><td>-0.003 (-0.007, 0.002) </td><td>0.756 (0.722, 0.801)</td><td>0.752 (0.716, 0.797)</td><td>-0.004 (-0.006, -0.002)</td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_832-6  </td><td>Pyuria*                                                                                                 </td><td>0.657 (0.642, 0.672)</td><td>0.655 (0.638, 0.67) </td><td>-0.003 (-0.007, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_613-5  </td><td>Mastodynia                                                                                              </td><td>0.554 (0.543, 0.564)</td><td>0.55 (0.54, 0.563)  </td><td>-0.003 (-0.007, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596    </td><td>Other disorders of bladder                                                                              </td><td>0.607 (0.599, 0.617)</td><td>0.604 (0.596, 0.613)</td><td>-0.003 (-0.007, 0.001) </td><td>0.685 (0.651, 0.695)</td><td>0.688 (0.657, 0.7)  </td><td>0.003 (0.002, 0.007)   </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_591    </td><td>Urinary tract infection                                                                                 </td><td>0.62 (0.615, 0.625) </td><td>0.618 (0.612, 0.622)</td><td>-0.003 (-0.006, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_602    </td><td>Other disorders of prostate                                                                             </td><td>0.636 (0.625, 0.646)</td><td>0.632 (0.623, 0.643)</td><td>-0.003 (-0.006, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_613    </td><td>Other nonmalignant breast conditions                                                                    </td><td>0.544 (0.537, 0.554)</td><td>0.542 (0.533, 0.552)</td><td>-0.003 (-0.006, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618    </td><td>Genital prolapse                                                                                        </td><td>0.577 (0.569, 0.587)</td><td>0.575 (0.566, 0.586)</td><td>-0.003 (-0.006, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360    </td><td>Inflammation of eyelids                                                                                 </td><td>0.564 (0.557, 0.571)</td><td>0.561 (0.554, 0.568)</td><td>-0.003 (-0.006, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_105    </td><td>Malignant neoplasm of the breast                                                                        </td><td>0.753 (0.747, 0.76) </td><td>0.75 (0.743, 0.756) </td><td>-0.003 (-0.006, -0.001)</td><td>0.706 (0.7, 0.718)  </td><td>0.705 (0.699, 0.726)</td><td>0.002 (-0.015, 0.02)   </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_360-4  </td><td>Blepharitis                                                                                             </td><td>0.595 (0.586, 0.606)</td><td>0.593 (0.584, 0.603)</td><td>-0.003 (-0.005, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-21 </td><td>Paroxysmal vertigo                                                                                      </td><td>0.618 (0.606, 0.629)</td><td>0.614 (0.603, 0.627)</td><td>-0.003 (-0.005, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592    </td><td>Cystitis and urethritis                                                                                 </td><td>0.685 (0.674, 0.693)</td><td>0.682 (0.672, 0.69) </td><td>-0.003 (-0.005, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_592-1  </td><td>Cystitis                                                                                                </td><td>0.694 (0.686, 0.703)</td><td>0.691 (0.683, 0.701)</td><td>-0.003 (-0.005, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_462-1  </td><td>Acute sinusitis                                                                                         </td><td>0.579 (0.57, 0.588) </td><td>0.576 (0.567, 0.586)</td><td>-0.003 (-0.004, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_308-5  </td><td>Nervousness                                                                                             </td><td>0.561 (0.531, 0.591)</td><td>0.553 (0.526, 0.591)</td><td>-0.002 (-0.035, 0.022) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430-1  </td><td>Nontraumatic subarachnoid hemorrhage                                                                    </td><td>0.61 (0.575, 0.644) </td><td>0.613 (0.57, 0.641) </td><td>-0.002 (-0.026, 0.034) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_817    </td><td>Motion sickness                                                                                         </td><td>0.651 (0.627, 0.687)</td><td>0.651 (0.619, 0.682)</td><td>-0.002 (-0.026, 0.02)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_603-5  </td><td>Orchitis and epididymitis                                                                               </td><td>0.518 (0.502, 0.539)</td><td>0.517 (0.498, 0.532)</td><td>-0.002 (-0.019, 0.014) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_356    </td><td>Speech disturbance                                                                                      </td><td>0.635 (0.617, 0.655)</td><td>0.633 (0.619, 0.651)</td><td>-0.002 (-0.018, 0.012) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_430    </td><td>Nontraumatic Intracranial hemorrhage                                                                    </td><td>0.656 (0.638, 0.68) </td><td>0.652 (0.634, 0.674)</td><td>-0.002 (-0.017, 0.01)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_324-41 </td><td>Essential tremor*                                                                                       </td><td>0.64 (0.619, 0.669) </td><td>0.639 (0.618, 0.66) </td><td>-0.002 (-0.015, 0.015) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_552    </td><td>Other diseases of biliary tract                                                                         </td><td>0.62 (0.596, 0.638) </td><td>0.616 (0.598, 0.642)</td><td>-0.002 (-0.015, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-52 </td><td>Ventricular premature depolarization*                                                                   </td><td>0.636 (0.621, 0.655)</td><td>0.633 (0.617, 0.654)</td><td>-0.002 (-0.01, 0.005)  </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_614-52 </td><td>Vaginitis and vulvovaginitis                                                                            </td><td>0.561 (0.548, 0.574)</td><td>0.56 (0.549, 0.573) </td><td>-0.002 (-0.009, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_625-1  </td><td>Dyspareunia                                                                                             </td><td>0.65 (0.632, 0.664) </td><td>0.649 (0.633, 0.666)</td><td>-0.002 (-0.009, 0.008) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-42 </td><td>Left bundle branch block                                                                                </td><td>0.722 (0.706, 0.735)</td><td>0.719 (0.706, 0.734)</td><td>-0.002 (-0.009, 0.007) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052-1  </td><td>Herpes simplex                                                                                          </td><td>0.598 (0.585, 0.613)</td><td>0.597 (0.583, 0.611)</td><td>-0.002 (-0.008, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_723-51 </td><td>Achilles tendinitis                                                                                     </td><td>0.539 (0.525, 0.549)</td><td>0.536 (0.523, 0.547)</td><td>-0.002 (-0.008, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-11 </td><td>Trigger finger                                                                                          </td><td>0.58 (0.569, 0.593) </td><td>0.578 (0.568, 0.59) </td><td>-0.002 (-0.008, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_728    </td><td>Chondropathies                                                                                          </td><td>0.608 (0.596, 0.623)</td><td>0.608 (0.592, 0.623)</td><td>-0.002 (-0.007, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116    </td><td>Secondary malignant neoplasm                                                                            </td><td>0.655 (0.646, 0.664)</td><td>0.653 (0.644, 0.663)</td><td>-0.002 (-0.007, 0.004) </td><td>0.587 (0.578, 0.609)</td><td>0.586 (0.577, 0.609)</td><td>-0.001 (-0.001, 0)     </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_619-3  </td><td>Noninflammatory disorders of cervix                                                                     </td><td>0.686 (0.664, 0.703)</td><td>0.684 (0.663, 0.702)</td><td>-0.002 (-0.007, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_721-2  </td><td>Ganglion cyst                                                                                           </td><td>0.547 (0.537, 0.557)</td><td>0.544 (0.534, 0.554)</td><td>-0.002 (-0.007, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_132    </td><td>Sequelae of cancer                                                                                      </td><td>0.734 (0.725, 0.745)</td><td>0.733 (0.722, 0.745)</td><td>-0.002 (-0.007, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-1  </td><td>Varicose veins                                                                                          </td><td>0.586 (0.578, 0.595)</td><td>0.584 (0.576, 0.593)</td><td>-0.002 (-0.007, 0.002) </td><td>0.542 (0.518, 0.582)</td><td>0.549 (0.523, 0.582)</td><td>0.003 (-0.005, 0.025)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_602-4  </td><td>Elevated prostate specific antigen [PSA]                                                                </td><td>0.63 (0.62, 0.64)   </td><td>0.628 (0.618, 0.638)</td><td>-0.002 (-0.007, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_418-1  </td><td>Abnormal electrocardiogram [ECG] [EKG]                                                                  </td><td>0.664 (0.655, 0.672)</td><td>0.661 (0.654, 0.672)</td><td>-0.002 (-0.006, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_618-11 </td><td>Cystocele                                                                                               </td><td>0.59 (0.58, 0.602)  </td><td>0.588 (0.576, 0.601)</td><td>-0.002 (-0.006, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_625    </td><td>Pain and other symptoms associated with female genital organs                                           </td><td>0.611 (0.6, 0.622)  </td><td>0.609 (0.597, 0.621)</td><td>-0.002 (-0.006, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_596-1  </td><td>Bladder neck obstruction                                                                                </td><td>0.801 (0.788, 0.818)</td><td>0.799 (0.787, 0.816)</td><td>-0.002 (-0.006, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_417    </td><td>Abnormalities of heart beat                                                                             </td><td>0.588 (0.584, 0.593)</td><td>0.586 (0.581, 0.59) </td><td>-0.002 (-0.005, 0)     </td><td>0.652 (0.631, 0.677)</td><td>0.649 (0.628, 0.675)</td><td>-0.004 (-0.005, -0.001)</td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394    </td><td>Disorders of vestibular function                                                                        </td><td>0.603 (0.593, 0.613)</td><td>0.602 (0.592, 0.612)</td><td>-0.002 (-0.005, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052    </td><td>Herpesvirus                                                                                             </td><td>0.561 (0.555, 0.566)</td><td>0.558 (0.553, 0.565)</td><td>-0.002 (-0.005, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444    </td><td>Venous insufficiency                                                                                    </td><td>0.591 (0.585, 0.6)  </td><td>0.589 (0.582, 0.597)</td><td>-0.002 (-0.005, 0.001) </td><td>0.525 (0.485, 0.555)</td><td>0.536 (0.5, 0.556)  </td><td>0.009 (-0.002, 0.025)  </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_444-11 </td><td>Varicose veins of lower extremities                                                                     </td><td>0.596 (0.588, 0.606)</td><td>0.594 (0.585, 0.603)</td><td>-0.002 (-0.005, 0.001) </td><td>0.54 (0.498, 0.562) </td><td>0.553 (0.53, 0.59)  </td><td>0.018 (0, 0.038)       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-1  </td><td>Hypothyroidism                                                                                          </td><td>0.635 (0.629, 0.643)</td><td>0.633 (0.626, 0.639)</td><td>-0.002 (-0.005, 0.001) </td><td>0.649 (0.641, 0.668)</td><td>0.651 (0.642, 0.668)</td><td>0.001 (-0.001, 0.005)  </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_462    </td><td>Sinusitis                                                                                               </td><td>0.558 (0.551, 0.565)</td><td>0.556 (0.549, 0.562)</td><td>-0.002 (-0.005, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200    </td><td>Disorders of thyroid gland                                                                              </td><td>0.632 (0.626, 0.638)</td><td>0.629 (0.624, 0.636)</td><td>-0.002 (-0.004, 0)     </td><td>0.641 (0.631, 0.662)</td><td>0.642 (0.635, 0.66) </td><td>0.003 (-0.003, 0.005)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_593    </td><td>Hematuria                                                                                               </td><td>0.588 (0.583, 0.592)</td><td>0.586 (0.582, 0.59) </td><td>-0.002 (-0.004, 0)     </td><td>0.637 (0.617, 0.652)</td><td>0.637 (0.615, 0.651)</td><td>-0.001 (-0.002, 0)     </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052-32 </td><td>Herpes zoster                                                                                           </td><td>0.578 (0.57, 0.585) </td><td>0.576 (0.568, 0.583)</td><td>-0.002 (-0.004, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594    </td><td>Abnormality of urination                                                                                </td><td>0.584 (0.579, 0.589)</td><td>0.583 (0.577, 0.588)</td><td>-0.002 (-0.004, 0.001) </td><td>0.713 (0.705, 0.72) </td><td>0.713 (0.706, 0.721)</td><td>0 (0, 0.002)           </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-1  </td><td>Retention of urine                                                                                      </td><td>0.735 (0.726, 0.744)</td><td>0.733 (0.724, 0.741)</td><td>-0.002 (-0.004, 0.001) </td><td>0.727 (0.719, 0.742)</td><td>0.727 (0.718, 0.742)</td><td>0 (-0.001, 0)          </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_394-2  </td><td>Vertigo                                                                                                 </td><td>0.607 (0.597, 0.618)</td><td>0.606 (0.594, 0.616)</td><td>-0.002 (-0.004, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_599    </td><td>Other symptoms/disorders or the urinary system                                                          </td><td>0.577 (0.571, 0.582)</td><td>0.574 (0.568, 0.58) </td><td>-0.002 (-0.004, -0.001)</td><td>0.697 (0.69, 0.71)  </td><td>0.696 (0.69, 0.71)  </td><td>0 (-0.001, 0)          </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-21 </td><td>Hallux valgus (Bunion)                                                                                  </td><td>0.667 (0.66, 0.675) </td><td>0.665 (0.658, 0.674)</td><td>-0.002 (-0.003, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Mental        </td><td>phecode_280-82 </td><td>Other psychoactive substance dependence                                                                 </td><td>0.59 (0.548, 0.629) </td><td>0.589 (0.545, 0.63) </td><td>-0.001 (-0.043, 0.049) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Eye           </td><td>phecode_379-21 </td><td>Infection of the eye, herpes                                                                            </td><td>0.584 (0.54, 0.61)  </td><td>0.581 (0.548, 0.611)</td><td>-0.001 (-0.022, 0.023) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_416-212</td><td>Persistent atrial fibrillation*                                                                         </td><td>0.717 (0.689, 0.742)</td><td>0.713 (0.689, 0.741)</td><td>-0.001 (-0.018, 0.014) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neuro         </td><td>phecode_334-11 </td><td>Trigeminal neuralgia                                                                                    </td><td>0.596 (0.574, 0.619)</td><td>0.592 (0.571, 0.617)</td><td>-0.001 (-0.014, 0.011) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Derm          </td><td>phecode_660-13 </td><td>Pityriasis versicolor                                                                                   </td><td>0.666 (0.635, 0.696)</td><td>0.666 (0.632, 0.692)</td><td>-0.001 (-0.013, 0.013) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_148    </td><td>Benign neoplasm of the eye, brain and other parts of central nervous system                             </td><td>0.602 (0.582, 0.626)</td><td>0.603 (0.583, 0.625)</td><td>-0.001 (-0.012, 0.016) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_116-1  </td><td>Secondary malignancy of lymph nodes                                                                     </td><td>0.617 (0.601, 0.63) </td><td>0.616 (0.599, 0.63) </td><td>-0.001 (-0.012, 0.008) </td><td>0.463 (0.431, 0.486)</td><td>0.45 (0.425, 0.48)  </td><td>-0.008 (-0.024, 0.001) </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_620    </td><td>Dysplasia of female genital organs                                                                      </td><td>0.72 (0.691, 0.746) </td><td>0.72 (0.692, 0.746) </td><td>-0.001 (-0.009, 0.009) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_728-3  </td><td>Costochondritis (Tietze's disease)                                                                      </td><td>0.611 (0.595, 0.626)</td><td>0.61 (0.595, 0.627) </td><td>-0.001 (-0.009, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_108    </td><td>Malignant neoplasm of the urinary tract                                                                 </td><td>0.71 (0.693, 0.724) </td><td>0.709 (0.692, 0.724)</td><td>-0.001 (-0.008, 0.007) </td><td>0.703 (0.672, 0.723)</td><td>0.705 (0.676, 0.73) </td><td>0.004 (-0.001, 0.007)  </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-32 </td><td>Stress incontinence                                                                                     </td><td>0.716 (0.705, 0.724)</td><td>0.714 (0.706, 0.723)</td><td>-0.001 (-0.008, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_506    </td><td>Diseases of salivary glands                                                                             </td><td>0.59 (0.577, 0.605) </td><td>0.59 (0.574, 0.606) </td><td>-0.001 (-0.008, 0.006) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_476    </td><td>Bronchiectasis                                                                                          </td><td>0.677 (0.667, 0.692)</td><td>0.676 (0.664, 0.692)</td><td>-0.001 (-0.008, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_413-2  </td><td>Aortic valve disorders                                                                                  </td><td>0.727 (0.716, 0.734)</td><td>0.726 (0.714, 0.734)</td><td>-0.001 (-0.008, 0.003) </td><td>0.722 (0.7, 0.746)  </td><td>0.723 (0.702, 0.749)</td><td>0.002 (-0.001, 0.004)  </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510-2  </td><td>Esophagitis                                                                                             </td><td>0.57 (0.563, 0.581) </td><td>0.569 (0.561, 0.58) </td><td>-0.001 (-0.007, 0.005) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_848    </td><td>Nonspecific abnormal findings of other body structures                                                  </td><td>0.617 (0.609, 0.624)</td><td>0.617 (0.609, 0.624)</td><td>-0.001 (-0.006, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_705-3  </td><td>Polymyalgia rheumatica                                                                                  </td><td>0.709 (0.692, 0.719)</td><td>0.708 (0.692, 0.717)</td><td>-0.001 (-0.006, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Cardio        </td><td>phecode_401-6  </td><td>Secondary hypertension                                                                                  </td><td>0.626 (0.609, 0.647)</td><td>0.625 (0.607, 0.646)</td><td>-0.001 (-0.005, 0.004) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>GI            </td><td>phecode_510    </td><td>Diseases of esophagus                                                                                   </td><td>0.575 (0.568, 0.581)</td><td>0.575 (0.568, 0.582)</td><td>-0.001 (-0.005, 0.004) </td><td>0.616 (0.603, 0.632)</td><td>0.615 (0.602, 0.629)</td><td>0 (-0.005, 0.001)      </td></tr>\n",
       "\t<tr><td>Hearing       </td><td>phecode_396-2  </td><td>Sensorineural hearing loss                                                                              </td><td>0.637 (0.626, 0.649)</td><td>0.635 (0.625, 0.646)</td><td>-0.001 (-0.005, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>ID            </td><td>phecode_052-3  </td><td>Varicella zoster virus                                                                                  </td><td>0.57 (0.563, 0.578) </td><td>0.569 (0.562, 0.575)</td><td>-0.001 (-0.004, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_144-2  </td><td>Benign neoplasms of the uterus                                                                          </td><td>0.662 (0.65, 0.672) </td><td>0.661 (0.649, 0.671)</td><td>-0.001 (-0.004, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Endo          </td><td>phecode_200-14 </td><td>Hypothyroidism, not specified as secondary                                                              </td><td>0.638 (0.631, 0.646)</td><td>0.637 (0.629, 0.645)</td><td>-0.001 (-0.004, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626-11 </td><td>Absent or infrequent menstruation                                                                       </td><td>0.847 (0.836, 0.857)</td><td>0.846 (0.835, 0.859)</td><td>-0.001 (-0.004, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709    </td><td>Acquired deformities of fingers and toes                                                                </td><td>0.636 (0.629, 0.645)</td><td>0.635 (0.627, 0.643)</td><td>-0.001 (-0.003, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_107    </td><td>Malignant neoplasm of male genitalia                                                                    </td><td>0.685 (0.675, 0.693)</td><td>0.684 (0.674, 0.692)</td><td>-0.001 (-0.003, 0)     </td><td>0.534 (0.496, 0.565)</td><td>0.525 (0.486, 0.553)</td><td>-0.009 (-0.014, -0.005)</td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_107-2  </td><td>Malignant neoplasm of the prostate                                                                      </td><td>0.689 (0.683, 0.697)</td><td>0.688 (0.681, 0.696)</td><td>-0.001 (-0.003, 0)     </td><td>0.523 (0.495, 0.544)</td><td>0.517 (0.485, 0.539)</td><td>-0.008 (-0.012, -0.005)</td></tr>\n",
       "\t<tr><td>Signs/Symptoms</td><td>phecode_807-1  </td><td>Chronic fatigue syndrome                                                                                </td><td>0.597 (0.59, 0.604) </td><td>0.596 (0.589, 0.604)</td><td>-0.001 (-0.003, 0.003) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_608    </td><td>Other disorders of male genital organs                                                                  </td><td>0.53 (0.524, 0.539) </td><td>0.529 (0.524, 0.538)</td><td>-0.001 (-0.003, 0.002) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_594-4  </td><td>Frequency of urination and polyuria                                                                     </td><td>0.587 (0.581, 0.594)</td><td>0.586 (0.58, 0.593) </td><td>-0.001 (-0.003, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Musc/Skel     </td><td>phecode_709-2  </td><td>Acquired deformities of toe                                                                             </td><td>0.649 (0.639, 0.657)</td><td>0.647 (0.638, 0.655)</td><td>-0.001 (-0.003, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_626    </td><td>Disorders of menstruation and other abnormal bleeding from female genital tract                         </td><td>0.792 (0.783, 0.801)</td><td>0.791 (0.782, 0.8)  </td><td>-0.001 (-0.002, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Genitourinary </td><td>phecode_608-1  </td><td>Abnormal findings in semen                                                                              </td><td>0.824 (0.819, 0.829)</td><td>0.823 (0.818, 0.828)</td><td>-0.001 (-0.002, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_466    </td><td>Tonsillitis and adenoiditis                                                                             </td><td>0.649 (0.636, 0.66) </td><td>0.648 (0.635, 0.659)</td><td>-0.001 (-0.002, 0)     </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_130    </td><td>Cancer (solid tumor, excluding BCC)                                                                     </td><td>0.644 (0.639, 0.649)</td><td>0.643 (0.638, 0.648)</td><td>-0.001 (-0.002, 0.001) </td><td>0.612 (0.598, 0.616)</td><td>0.612 (0.597, 0.615)</td><td>-0.001 (-0.001, 0)     </td></tr>\n",
       "\t<tr><td>Resp          </td><td>phecode_466-1  </td><td>Acute tonsillitis and adenoiditis                                                                       </td><td>0.663 (0.653, 0.675)</td><td>0.662 (0.652, 0.675)</td><td>-0.001 (-0.002, 0.001) </td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "\t<tr><td>Neoplasms     </td><td>phecode_142-1  </td><td>Lump or mass in breast                                                                                  </td><td>0.748 (0.74, 0.755) </td><td>0.747 (0.739, 0.753)</td><td>-0.001 (-0.002, -0.001)</td><td>                    </td><td>                    </td><td>                       </td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 1171 × 9\n",
       "\\begin{tabular}{lllllllll}\n",
       " phecode\\_category & endpoint & phecode\\_string & ukb\\_agesex & ukb\\_agesexretina & ukb\\_delta & epic\\_agesex & epic\\_agesexretina & epic\\_delta\\\\\n",
       " <chr> & <chr> & <chr> & <chr> & <chr> & <chr> & <glue> & <glue> & <glue>\\\\\n",
       "\\hline\n",
       "\t Blood          & phecode\\_165     & Hemoglobinopathies                                                                                       & 0.612 (0.575, 0.655) & 0.872 (0.85, 0.905)  & 0.259 (0.214, 0.312)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_387-2   & Myopia                                                                                                   & 0.585 (0.565, 0.603) & 0.818 (0.803, 0.833) & 0.232 (0.213, 0.26)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_688-1   & Sarcoidosis                                                                                              & 0.29 (0.255, 0.319)  & 0.5 (0.457, 0.543)   & 0.207 (0.161, 0.263)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_665-3   & Other psoriasis                                                                                          & 0.373 (0.328, 0.41)  & 0.547 (0.506, 0.579) & 0.175 (0.12, 0.23)      &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_373     & Noninflammatory disorders of choroid                                                                     & 0.582 (0.547, 0.613) & 0.753 (0.712, 0.783) & 0.173 (0.139, 0.203)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_665-2   & Psoriatic arthropathy                                                                                    & 0.37 (0.324, 0.405)  & 0.537 (0.5, 0.572)   & 0.169 (0.122, 0.214)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_005     & Mycobacteria                                                                                             & 0.485 (0.447, 0.532) & 0.651 (0.602, 0.695) & 0.169 (0.117, 0.225)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-3   & Benign neoplasm of other connective and soft tissue                                                      & 0.4 (0.352, 0.446)   & 0.551 (0.502, 0.592) & 0.149 (0.096, 0.188)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_377-5   & Vitreous hemorrhage                                                                                      & 0.546 (0.507, 0.577) & 0.684 (0.645, 0.732) & 0.143 (0.094, 0.184)    &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-71  & Long term (current) use of insulin                                                                       & 0.595 (0.576, 0.616) & 0.735 (0.715, 0.755) & 0.139 (0.12, 0.161)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709-11  & Mallet finger                                                                                            & 0.396 (0.369, 0.43)  & 0.535 (0.498, 0.56)  & 0.138 (0.081, 0.173)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_096     & Contact or exposure to infectious agent                                                                  & 0.429 (0.405, 0.451) & 0.563 (0.536, 0.593) & 0.135 (0.099, 0.165)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_008     & Helicobacter {[}H. pylori{]}                                                                                 & 0.442 (0.421, 0.471) & 0.574 (0.548, 0.602) & 0.132 (0.1, 0.168)      &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_370     & Disorders of iris and ciliary body                                                                       & 0.622 (0.595, 0.648) & 0.745 (0.725, 0.774) & 0.127 (0.1, 0.152)      &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_369-5   & Hereditary corneal dystrophies                                                                           & 0.64 (0.611, 0.675)  & 0.766 (0.735, 0.804) & 0.126 (0.092, 0.162)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529-6   & Halitosis*                                                                                               & 0.406 (0.355, 0.442) & 0.529 (0.493, 0.567) & 0.125 (0.086, 0.168)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_386-1   & Amblyopia                                                                                                & 0.599 (0.576, 0.622) & 0.712 (0.688, 0.738) & 0.114 (0.086, 0.136)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_337-8   & Polyneuropathy in diseases classified elsewhere                                                          & 0.645 (0.613, 0.681) & 0.756 (0.726, 0.8)   & 0.111 (0.065, 0.155)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-52  & Lipoma of intrathoracic organs                                                                           & 0.431 (0.383, 0.465) & 0.537 (0.495, 0.569) & 0.109 (0.061, 0.16)     &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_110     & Malignant neoplasm of the endocrine glands                                                               & 0.458 (0.417, 0.492) & 0.564 (0.513, 0.611) & 0.109 (0.047, 0.158)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-8   & Retinal edema                                                                                            & 0.652 (0.628, 0.682) & 0.758 (0.732, 0.785) & 0.107 (0.089, 0.126)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_387     & Disorders of refraction and accommodation                                                                & 0.656 (0.643, 0.666) & 0.761 (0.751, 0.772) & 0.106 (0.093, 0.119)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_059-1   & COVID-19*                                                                                                & 0.504 (0.468, 0.542) & 0.61 (0.57, 0.651)   & 0.106 (0.06, 0.17)      &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977     & Long term (current) drug therapy                                                                         & 0.489 (0.481, 0.494) & 0.593 (0.588, 0.599) & 0.105 (0.098, 0.112)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-11  & Serous retinal detachment                                                                                & 0.59 (0.568, 0.615)  & 0.696 (0.675, 0.723) & 0.105 (0.076, 0.131)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_676-1   & Hypertrophic scar {[}Keloid scar{]}                                                                          & 0.507 (0.478, 0.542) & 0.613 (0.576, 0.647) & 0.103 (0.065, 0.143)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_712-1   & Loose body in joint                                                                                      & 0.444 (0.412, 0.485) & 0.546 (0.511, 0.583) & 0.102 (0.058, 0.138)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-512 & Exuadative (wet) age-related macular degeneration                                                        & 0.751 (0.722, 0.78)  & 0.85 (0.826, 0.88)   & 0.101 (0.071, 0.127)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_387-1   & Hypermetropia                                                                                            & 0.707 (0.671, 0.741) & 0.803 (0.777, 0.828) & 0.097 (0.063, 0.125)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-21  & Pallor                                                                                                   & 0.462 (0.419, 0.508) & 0.558 (0.512, 0.606) & 0.097 (0.038, 0.143)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-6   & Episcleritis                                                                                             & 0.478 (0.446, 0.509) & 0.572 (0.543, 0.61)  & 0.096 (0.066, 0.13)     &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_205     & Hypoglycemia                                                                                             & 0.656 (0.639, 0.68)  & 0.75 (0.728, 0.769)  & 0.094 (0.07, 0.119)     &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-1   & Retinal detachments and breaks                                                                           & 0.582 (0.567, 0.599) & 0.676 (0.661, 0.688) & 0.093 (0.078, 0.111)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_385     & Abnormal results of function studies of eye                                                              & 0.587 (0.557, 0.622) & 0.678 (0.646, 0.708) & 0.093 (0.057, 0.115)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_504-1   & Gingivitis                                                                                               & 0.422 (0.389, 0.454) & 0.515 (0.478, 0.554) & 0.093 (0.055, 0.141)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_236-11  & Morbid obesity                                                                                           & 0.577 (0.553, 0.605) & 0.666 (0.646, 0.69)  & 0.088 (0.068, 0.111)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_059     & Coronavirus                                                                                              & 0.501 (0.465, 0.541) & 0.59 (0.536, 0.641)  & 0.088 (0.041, 0.135)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_352-1   & Anosmia*                                                                                                 & 0.455 (0.418, 0.488) & 0.544 (0.503, 0.574) & 0.088 (0.039, 0.135)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_202-4   & Other specified diabetes*                                                                                & 0.613 (0.607, 0.619) & 0.698 (0.693, 0.704) & 0.086 (0.08, 0.091)     &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-7   & Long term (current) use of insulin or oral hypoglycemic drugs                                            & 0.61 (0.601, 0.618)  & 0.696 (0.687, 0.703) & 0.086 (0.078, 0.094)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_280-12  & Alcohol dependence                                                                                       & 0.535 (0.518, 0.553) & 0.622 (0.605, 0.637) & 0.086 (0.066, 0.105)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-4   & Retinal disorders in diseases classified elsewhere                                                       & 0.629 (0.622, 0.64)  & 0.714 (0.705, 0.725) & 0.085 (0.074, 0.093)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724-51  & Calcaneal spur                                                                                           & 0.43 (0.389, 0.457)  & 0.517 (0.486, 0.551) & 0.084 (0.047, 0.138)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_168-2   & Hyper-coagulability                                                                                      & 0.446 (0.4, 0.487)   & 0.528 (0.485, 0.563) & 0.084 (0.034, 0.13)     &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-51  & Age-related macular degeneration                                                                         & 0.752 (0.738, 0.766) & 0.834 (0.819, 0.844) & 0.083 (0.071, 0.094)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-5   & Uveitis                                                                                                  & 0.526 (0.505, 0.551) & 0.61 (0.59, 0.636)   & 0.083 (0.059, 0.11)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_498     & Asphyxia and hypoxemia                                                                                   & 0.616 (0.576, 0.656) & 0.7 (0.666, 0.741)   & 0.083 (0.045, 0.114)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_097-1   & Methicillin resistant Staphylococcus aureus                                                              & 0.458 (0.421, 0.492) & 0.541 (0.502, 0.583) & 0.083 (0.033, 0.125)    &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-72  & Long term (current) use of oral hypoglycemic drugs                                                       & 0.614 (0.606, 0.623) & 0.695 (0.688, 0.704) & 0.082 (0.073, 0.089)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_202-1   & Type 1 diabetes                                                                                          & 0.615 (0.596, 0.638) & 0.698 (0.679, 0.719) & 0.082 (0.06, 0.11)      &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-52  & Iridocyclitis                                                                                            & 0.523 (0.504, 0.549) & 0.608 (0.59, 0.628)  & 0.082 (0.058, 0.105)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_366-1   & Pterygium of eye                                                                                         & 0.498 (0.458, 0.536) & 0.576 (0.543, 0.631) & 0.081 (0.035, 0.136)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-42  & Diabetic retinopathy                                                                                     & 0.63 (0.621, 0.637)  & 0.708 (0.697, 0.714) & 0.079 (0.071, 0.086)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-72  & Iron deficiency                                                                                          & 0.545 (0.536, 0.554) & 0.624 (0.617, 0.631) & 0.079 (0.069, 0.086)    & 0.62 (0.606, 0.644)  & 0.631 (0.617, 0.652) & 0.012 (0.007, 0.017)   \\\\\n",
       "\t GI             & phecode\\_501     & Dental caries                                                                                            & 0.482 (0.465, 0.498) & 0.56 (0.538, 0.579)  & 0.079 (0.053, 0.104)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_211     & Disorders of adrenal glands                                                                              & 0.553 (0.516, 0.592) & 0.634 (0.6, 0.673)   & 0.079 (0.042, 0.123)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_325-1   & Abnormal involuntary movements                                                                           & 0.382 (0.339, 0.427) & 0.459 (0.421, 0.503) & 0.079 (0.029, 0.133)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_160-1   & Iron deficiency anemia                                                                                   & 0.554 (0.545, 0.565) & 0.632 (0.621, 0.639) & 0.077 (0.066, 0.085)    & 0.607 (0.594, 0.62)  & 0.619 (0.6, 0.634)   & 0.011 (0.005, 0.016)   \\\\\n",
       "\t Blood          & phecode\\_164-1   & Microcytic anemia                                                                                        & 0.555 (0.544, 0.563) & 0.631 (0.62, 0.639)  & 0.076 (0.068, 0.084)    & 0.62 (0.598, 0.641)  & 0.632 (0.607, 0.647) & 0.009 (0.005, 0.016)   \\\\\n",
       "\t Eye            & phecode\\_369     & Noninflammatory disorders of the cornea                                                                  & 0.633 (0.617, 0.648) & 0.709 (0.685, 0.728) & 0.076 (0.061, 0.09)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_546-3   & Hepatomegaly                                                                                             & 0.538 (0.504, 0.585) & 0.616 (0.574, 0.67)  & 0.076 (0.023, 0.134)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709-1   & Acquired deformities of fingers                                                                          & 0.445 (0.424, 0.476) & 0.523 (0.499, 0.549) & 0.075 (0.043, 0.109)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_239-3   & Mixed hyperlipidemia                                                                                     & 0.48 (0.455, 0.51)   & 0.56 (0.528, 0.595)  & 0.075 (0.041, 0.123)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_236-1   & Obesity                                                                                                  & 0.511 (0.506, 0.516) & 0.585 (0.58, 0.589)  & 0.074 (0.067, 0.08)     &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_283-4   & Patient's noncompliance with medical treatment and regimen                                               & 0.497 (0.489, 0.505) & 0.572 (0.564, 0.579) & 0.074 (0.062, 0.087)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-4   & Demoralization and apathy                                                                                & 0.548 (0.521, 0.575) & 0.622 (0.594, 0.649) & 0.074 (0.038, 0.107)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_674-11  & Vitiligo                                                                                                 & 0.516 (0.476, 0.558) & 0.587 (0.539, 0.638) & 0.074 (0.011, 0.13)     &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_097     & Drug resistant microorganisms                                                                            & 0.479 (0.441, 0.514) & 0.55 (0.517, 0.587)  & 0.073 (0.039, 0.109)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_236     & Overweight and obesity                                                                                   & 0.512 (0.506, 0.517) & 0.584 (0.58, 0.59)   & 0.072 (0.066, 0.079)    & 0.462 (0.429, 0.496) & 0.503 (0.483, 0.535) & 0.048 (0.018, 0.063)   \\\\\n",
       "\t Metab          & phecode\\_247-7   & Disorders of iron metabolism                                                                             & 0.546 (0.538, 0.554) & 0.618 (0.61, 0.625)  & 0.072 (0.063, 0.078)    & 0.619 (0.6, 0.624)   & 0.626 (0.613, 0.641) & 0.012 (0.004, 0.019)   \\\\\n",
       "\t GI             & phecode\\_542     & Chronic liver disease and sequelae                                                                       & 0.517 (0.509, 0.528) & 0.589 (0.579, 0.598) & 0.072 (0.057, 0.084)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_829-2   & Abnormal level of blood mineral*                                                                         & 0.498 (0.481, 0.513) & 0.571 (0.552, 0.591) & 0.072 (0.055, 0.097)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_202-2   & Type 2 diabetes                                                                                          & 0.591 (0.585, 0.599) & 0.662 (0.657, 0.667) & 0.071 (0.063, 0.077)    & 0.604 (0.595, 0.621) & 0.637 (0.625, 0.643) & 0.029 (0.018, 0.041)   \\\\\n",
       "\t GI             & phecode\\_542-1   & Fibrosis and cirrhosis of liver                                                                          & 0.636 (0.603, 0.66)  & 0.705 (0.678, 0.737) & 0.071 (0.05, 0.1)       &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_333-4   & Circadian rhythm sleep disorder                                                                          & 0.438 (0.398, 0.481) & 0.508 (0.468, 0.55)  & 0.071 (0.022, 0.119)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_202     & Diabetes mellitus                                                                                        & 0.593 (0.586, 0.597) & 0.662 (0.657, 0.668) & 0.07 (0.063, 0.076)     & 0.608 (0.591, 0.627) & 0.635 (0.622, 0.654) & 0.028 (0.013, 0.04)    \\\\\n",
       "\t Signs/Symptoms & phecode\\_821     & Abnormality of red blood cells                                                                           & 0.515 (0.485, 0.542) & 0.587 (0.551, 0.611) & 0.07 (0.044, 0.099)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-51  & Hypocalcemia                                                                                             & 0.49 (0.449, 0.531)  & 0.564 (0.512, 0.597) & 0.07 (0.016, 0.113)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_232     & Vitamin deficiencies                                                                                     & 0.549 (0.543, 0.556) & 0.619 (0.613, 0.624) & 0.069 (0.062, 0.077)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_160     & Nutritional anemias                                                                                      & 0.564 (0.556, 0.575) & 0.633 (0.625, 0.641) & 0.069 (0.061, 0.076)    & 0.625 (0.61, 0.635)  & 0.634 (0.622, 0.65)  & 0.011 (0.008, 0.016)   \\\\\n",
       "\t Mental         & phecode\\_280-13  & Alcoholic liver disease                                                                                  & 0.635 (0.601, 0.66)  & 0.702 (0.669, 0.733) & 0.069 (0.041, 0.095)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-54  & Abscess or ulceration of vulva                                                                           & 0.418 (0.369, 0.452) & 0.484 (0.439, 0.535) & 0.069 (0.018, 0.118)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_542-4   & Portal hypertension                                                                                      & 0.646 (0.601, 0.681) & 0.713 (0.672, 0.749) & 0.068 (0.038, 0.098)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_674-1   & Hypopigmentation                                                                                         & 0.537 (0.498, 0.571) & 0.603 (0.562, 0.642) & 0.068 (0.021, 0.099)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_135-1   & Benign neoplasm of the oral cavity                                                                       & 0.503 (0.466, 0.541) & 0.57 (0.533, 0.606)  & 0.067 (0.015, 0.1)      &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_281-2   & Substance dependence                                                                                     & 0.538 (0.53, 0.545)  & 0.605 (0.596, 0.613) & 0.066 (0.058, 0.074)    & 0.541 (0.517, 0.563) & 0.634 (0.609, 0.664) & 0.095 (0.062, 0.134)   \\\\\n",
       "\t Eye            & phecode\\_374-511 & Nonexuadative (dry) age-related macular degeneration                                                     & 0.759 (0.736, 0.784) & 0.824 (0.806, 0.846) & 0.064 (0.045, 0.086)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_287     & Psychotic disorder                                                                                       & 0.531 (0.497, 0.559) & 0.592 (0.554, 0.631) & 0.064 (0.015, 0.1)      &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_540-1   & Chronic hepatitis                                                                                        & 0.535 (0.498, 0.585) & 0.598 (0.567, 0.634) & 0.063 (0.029, 0.102)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_371-3   & Nuclear cataract                                                                                         & 0.744 (0.736, 0.754) & 0.805 (0.799, 0.814) & 0.062 (0.054, 0.067)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_232-2   & Vitamin B group deficiency                                                                               & 0.568 (0.558, 0.581) & 0.63 (0.618, 0.643)  & 0.062 (0.048, 0.072)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_292     & Somatoform disorders                                                                                     & 0.487 (0.449, 0.526) & 0.546 (0.494, 0.598) & 0.062 (0.016, 0.096)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_371-31  & Age-related nuclear cataract                                                                             & 0.745 (0.735, 0.751) & 0.806 (0.799, 0.812) & 0.061 (0.055, 0.069)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_232-4   & Vitamin D deficiency                                                                                     & 0.571 (0.565, 0.578) & 0.631 (0.624, 0.64)  & 0.06 (0.052, 0.067)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_542-2   & Fatty liver disease (FLD)                                                                                & 0.525 (0.513, 0.535) & 0.585 (0.573, 0.596) & 0.06 (0.043, 0.072)     &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_380-2   & Disorders of optic disc                                                                                  & 0.551 (0.513, 0.581) & 0.611 (0.574, 0.645) & 0.06 (0.023, 0.091)     &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-5   & Macular degeneration                                                                                     & 0.715 (0.707, 0.725) & 0.775 (0.769, 0.784) & 0.059 (0.052, 0.066)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_343     & Disorders of autonomic nervous system                                                                    & 0.52 (0.495, 0.546)  & 0.579 (0.544, 0.616) & 0.059 (0.029, 0.093)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_369-1   & Corneal scars and opacities                                                                              & 0.631 (0.587, 0.674) & 0.692 (0.655, 0.736) & 0.058 (0.023, 0.107)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-2   & Pallor and flushing                                                                                      & 0.516 (0.491, 0.542) & 0.573 (0.551, 0.602) & 0.057 (0.036, 0.084)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_251-1   & Gilbert syndrome*                                                                                        & 0.551 (0.523, 0.59)  & 0.61 (0.575, 0.639)  & 0.056 (0.038, 0.071)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_360-5   & Noninfectious dermatoses of eyelid                                                                       & 0.595 (0.568, 0.622) & 0.652 (0.621, 0.677) & 0.056 (0.034, 0.079)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_237     & Abnormal weight gain                                                                                     & 0.504 (0.477, 0.523) & 0.559 (0.541, 0.583) & 0.056 (0.03, 0.081)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_705-5   & Rheumatism, unspecified                                                                                  & 0.457 (0.422, 0.49)  & 0.512 (0.473, 0.552) & 0.056 (0.005, 0.102)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374     & Disorders of the retina                                                                                  & 0.632 (0.624, 0.637) & 0.687 (0.68, 0.693)  & 0.055 (0.051, 0.06)     & 0.685 (0.67, 0.696)  & 0.741 (0.721, 0.763) & 0.059 (0.037, 0.069)   \\\\\n",
       "\t Neuro          & phecode\\_351-2   & Hypoesthesia of skin*                                                                                    & 0.701 (0.688, 0.717) & 0.755 (0.741, 0.768) & 0.055 (0.041, 0.067)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_098     & Carrier or suspected carrier of infectious diseases                                                      & 0.59 (0.56, 0.622)   & 0.645 (0.621, 0.681) & 0.055 (0.03, 0.082)     &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_281     & Substance abuse, dependence, and withdrawl                                                               & 0.546 (0.537, 0.551) & 0.6 (0.594, 0.607)   & 0.054 (0.049, 0.063)    & 0.549 (0.502, 0.569) & 0.63 (0.61, 0.647)   & 0.089 (0.064, 0.111)   \\\\\n",
       "\t Eye            & phecode\\_380     & Disorders of optic nerve and visual pathways                                                             & 0.582 (0.554, 0.603) & 0.637 (0.613, 0.658) & 0.054 (0.032, 0.081)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_086     & Pediculosis, acariasis and other infestations                                                            & 0.455 (0.432, 0.488) & 0.51 (0.48, 0.541)   & 0.054 (0.023, 0.087)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_812-2   & Angioneurotic edema                                                                                      & 0.473 (0.427, 0.5)   & 0.525 (0.485, 0.561) & 0.054 (0.021, 0.101)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_371     & Cataract                                                                                                 & 0.732 (0.728, 0.736) & 0.784 (0.781, 0.789) & 0.053 (0.049, 0.055)    & 0.711 (0.708, 0.72)  & 0.762 (0.755, 0.765) & 0.049 (0.042, 0.054)   \\\\\n",
       "\t Metab          & phecode\\_247     & Disorders of mineral metabolism and mineral deficiencies                                                 & 0.563 (0.556, 0.571) & 0.616 (0.608, 0.625) & 0.053 (0.046, 0.06)     & 0.621 (0.6, 0.636)   & 0.629 (0.608, 0.642) & 0.007 (0.005, 0.012)   \\\\\n",
       "\t Metab          & phecode\\_256-3   & Mixed disorder of acid-base balance                                                                      & 0.653 (0.635, 0.672) & 0.708 (0.691, 0.727) & 0.053 (0.036, 0.068)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_251     & Disorders of bilirubin excretion                                                                         & 0.553 (0.52, 0.584)  & 0.606 (0.569, 0.633) & 0.053 (0.033, 0.072)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_824     & Other abnormalities of plasma proteins*                                                                  & 0.513 (0.495, 0.527) & 0.566 (0.546, 0.585) & 0.053 (0.032, 0.077)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_175     & Polycythemias                                                                                            & 0.618 (0.585, 0.655) & 0.673 (0.639, 0.701) & 0.053 (0.023, 0.093)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_114     & Neuroendocrine tumors                                                                                    & 0.579 (0.551, 0.614) & 0.632 (0.589, 0.674) & 0.052 (0.016, 0.095)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_831     & Glycosuria                                                                                               & 0.595 (0.582, 0.605) & 0.646 (0.632, 0.656) & 0.051 (0.041, 0.062)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_684-11  & Alopecia Areata                                                                                          & 0.624 (0.601, 0.64)  & 0.676 (0.653, 0.693) & 0.051 (0.035, 0.069)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_809-1   & Acute pain                                                                                               & 0.494 (0.457, 0.527) & 0.545 (0.496, 0.586) & 0.051 (0.014, 0.092)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_504     & Periodontal diseases                                                                                     & 0.508 (0.487, 0.531) & 0.559 (0.539, 0.577) & 0.05 (0.023, 0.073)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_488-6   & Wheezing                                                                                                 & 0.519 (0.512, 0.531) & 0.569 (0.56, 0.581)  & 0.049 (0.039, 0.061)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-11  & Open angle glaucoma                                                                                      & 0.67 (0.655, 0.685)  & 0.719 (0.703, 0.734) & 0.049 (0.037, 0.062)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-12  & Ulcerative colitis                                                                                       & 0.482 (0.45, 0.512)  & 0.532 (0.499, 0.562) & 0.049 (0.012, 0.085)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_164     & Anemia                                                                                                   & 0.588 (0.58, 0.595)  & 0.635 (0.628, 0.643) & 0.048 (0.041, 0.053)    & 0.636 (0.622, 0.653) & 0.645 (0.631, 0.659) & 0.008 (0.005, 0.01)    \\\\\n",
       "\t Eye            & phecode\\_374-55  & Puckering of macula                                                                                      & 0.66 (0.637, 0.673)  & 0.706 (0.684, 0.721) & 0.048 (0.031, 0.066)    &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_973     & Adverse effect of other drug                                                                             & 0.645 (0.617, 0.675) & 0.698 (0.663, 0.726) & 0.048 (0.023, 0.08)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_537-1   & Peritonitis                                                                                              & 0.508 (0.486, 0.54)  & 0.557 (0.532, 0.577) & 0.048 (0.015, 0.073)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_596-5   & Neuromuscular dysfunction of bladder                                                                     & 0.564 (0.532, 0.611) & 0.618 (0.584, 0.654) & 0.048 (0.012, 0.089)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_805     & Fever of unknown origin                                                                                  & 0.527 (0.515, 0.539) & 0.574 (0.563, 0.584) & 0.047 (0.035, 0.059)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_170-19  & Neutropenia NOS                                                                                          & 0.555 (0.524, 0.582) & 0.599 (0.578, 0.631) & 0.047 (0.013, 0.068)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_282-1   & Current tobacco use and nicotine dependence                                                              & 0.568 (0.559, 0.576) & 0.614 (0.608, 0.622) & 0.046 (0.039, 0.055)    & 0.548 (0.52, 0.572)  & 0.633 (0.615, 0.661) & 0.088 (0.075, 0.103)   \\\\\n",
       "\t GI             & phecode\\_503     & Diseases of pulp and periapical tissues                                                                  & 0.509 (0.494, 0.525) & 0.557 (0.54, 0.569)  & 0.046 (0.033, 0.064)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_449     & Other disorders of the circulatory system                                                                & 0.633 (0.604, 0.668) & 0.679 (0.643, 0.723) & 0.046 (0.021, 0.075)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_164-6   & Anemia secondary to chronic diseases and conditions                                                      & 0.648 (0.618, 0.688) & 0.697 (0.662, 0.726) & 0.046 (0.013, 0.08)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_666-2   & Idiopathic urticaria                                                                                     & 0.557 (0.515, 0.604) & 0.603 (0.558, 0.643) & 0.046 (0.001, 0.088)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-1   & Hyperosmolality and/or hypernatremia                                                                     & 0.502 (0.475, 0.531) & 0.547 (0.523, 0.568) & 0.044 (0.021, 0.074)    &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_396-1   & Conductive hearing loss                                                                                  & 0.537 (0.501, 0.572) & 0.579 (0.548, 0.615) & 0.044 (0.011, 0.076)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_474-1   & Emphysema                                                                                                & 0.697 (0.677, 0.712) & 0.738 (0.719, 0.755) & 0.043 (0.026, 0.055)    & 0.689 (0.671, 0.741) & 0.714 (0.701, 0.754) & 0.027 (0.01, 0.04)     \\\\\n",
       "\t Neuro          & phecode\\_334-21  & Bell's palsy                                                                                             & 0.527 (0.501, 0.557) & 0.57 (0.544, 0.59)   & 0.043 (0.012, 0.069)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_826-3   & Raised antibody titer*                                                                                   & 0.517 (0.491, 0.555) & 0.562 (0.531, 0.588) & 0.042 (0.012, 0.068)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_387-3   & Astigmatism                                                                                              & 0.717 (0.702, 0.739) & 0.759 (0.741, 0.779) & 0.041 (0.028, 0.055)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-4   & Disorders of magnesium metabolism                                                                        & 0.67 (0.649, 0.691)  & 0.712 (0.69, 0.735)  & 0.041 (0.024, 0.058)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_719-3   & Separation of muscle (nontraumatic)                                                                      & 0.672 (0.643, 0.697) & 0.71 (0.684, 0.735)  & 0.041 (0.02, 0.057)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_540-3   & Viral hepatitits                                                                                         & 0.544 (0.506, 0.584) & 0.587 (0.535, 0.622) & 0.041 (0.011, 0.077)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_054     & Hepatovirus                                                                                              & 0.555 (0.507, 0.603) & 0.594 (0.559, 0.642) & 0.041 (0.011, 0.07)     &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_204-2   & Impaired glucose tolerance (oral)                                                                        & 0.581 (0.57, 0.59)   & 0.621 (0.613, 0.629) & 0.04 (0.031, 0.048)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721-12  & Radial styloid tenosynovitis {[}de Quervain{]}                                                               & 0.544 (0.524, 0.563) & 0.584 (0.566, 0.602) & 0.04 (0.026, 0.057)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-4   & Hyperkalemia {[}Hyperpotassemia{]}                                                                           & 0.667 (0.651, 0.687) & 0.708 (0.691, 0.724) & 0.04 (0.025, 0.052)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_706-1   & Sacroiliitis NEC                                                                                         & 0.559 (0.531, 0.597) & 0.598 (0.567, 0.633) & 0.04 (0.014, 0.07)      &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_712-6   & Instability of joint                                                                                     & 0.475 (0.437, 0.499) & 0.513 (0.481, 0.558) & 0.04 (0.014, 0.068)     &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_175-2   & Secondary polycythemia                                                                                   & 0.627 (0.587, 0.671) & 0.668 (0.627, 0.712) & 0.04 (-0.01, 0.081)     &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_840-8   & Allergies related to other diseases/symptoms                                                             & 0.508 (0.5, 0.517)   & 0.547 (0.54, 0.556)  & 0.039 (0.031, 0.047)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_627-3   & Postmenopausal atrophic vaginitis                                                                        & 0.513 (0.504, 0.522) & 0.552 (0.54, 0.56)   & 0.039 (0.027, 0.051)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-3   & Retinal vascular changes and occlusions                                                                  & 0.668 (0.656, 0.683) & 0.707 (0.693, 0.72)  & 0.039 (0.027, 0.048)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_443-1   & Stricture of artery {[}Arterial stenosis{]}                                                                  & 0.726 (0.697, 0.76)  & 0.764 (0.739, 0.795) & 0.039 (0.015, 0.057)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_334-2   & Facial nerve disorders and weakness                                                                      & 0.527 (0.5, 0.546)   & 0.565 (0.541, 0.591) & 0.039 (0.014, 0.066)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_299     & Mental disorder, not otherwise specified                                                                 & 0.532 (0.501, 0.559) & 0.568 (0.542, 0.596) & 0.039 (0.013, 0.058)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_286-1   & Bipolar disorder                                                                                         & 0.512 (0.458, 0.55)  & 0.554 (0.505, 0.585) & 0.039 (-0.001, 0.092)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_474     & Chronic obstructive pulmonary disease {[}COPD{]}                                                             & 0.666 (0.658, 0.674) & 0.704 (0.697, 0.711) & 0.038 (0.033, 0.046)    & 0.696 (0.661, 0.711) & 0.719 (0.694, 0.736) & 0.027 (0.017, 0.038)   \\\\\n",
       "\t Neuro          & phecode\\_333-1   & Sleep apnea                                                                                              & 0.598 (0.587, 0.611) & 0.637 (0.627, 0.649) & 0.038 (0.029, 0.05)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_662     & Rosacea                                                                                                  & 0.53 (0.52, 0.542)   & 0.567 (0.559, 0.576) & 0.038 (0.029, 0.045)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463-2   & Allergic rhinitis                                                                                        & 0.501 (0.493, 0.51)  & 0.539 (0.532, 0.548) & 0.038 (0.028, 0.048)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_686-2   & Non-pressure chronic ulcer                                                                               & 0.683 (0.667, 0.699) & 0.72 (0.707, 0.737)  & 0.038 (0.027, 0.052)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_388     & Blindness and low vision                                                                                 & 0.681 (0.666, 0.697) & 0.72 (0.705, 0.735)  & 0.038 (0.027, 0.048)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_469-2   & Chronic bronchitis                                                                                       & 0.651 (0.626, 0.676) & 0.689 (0.668, 0.712) & 0.038 (0.016, 0.064)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_526-11  & Intestinal e.coli                                                                                        & 0.504 (0.466, 0.538) & 0.543 (0.514, 0.58)  & 0.038 (0.008, 0.074)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_204     & Elevated blood glucose level                                                                             & 0.581 (0.575, 0.587) & 0.618 (0.612, 0.624) & 0.037 (0.031, 0.044)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_503-5   & Periapical abscess                                                                                       & 0.512 (0.497, 0.526) & 0.548 (0.533, 0.563) & 0.037 (0.022, 0.055)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_665     & Psoriasis                                                                                                & 0.512 (0.498, 0.528) & 0.549 (0.537, 0.562) & 0.037 (0.022, 0.054)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_542-3   & Hepatic failure                                                                                          & 0.654 (0.622, 0.692) & 0.694 (0.66, 0.724)  & 0.037 (0.008, 0.072)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-1   & Glaucoma                                                                                                 & 0.653 (0.643, 0.661) & 0.689 (0.678, 0.697) & 0.036 (0.028, 0.043)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_685-8   & Hyperhidrosis                                                                                            & 0.54 (0.528, 0.554)  & 0.577 (0.565, 0.59)  & 0.036 (0.025, 0.05)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_733-62  & Arthralgia of temporomandibular joint                                                                    & 0.594 (0.57, 0.623)  & 0.629 (0.604, 0.664) & 0.036 (0.016, 0.059)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-38  & Retinal vein occlusions                                                                                  & 0.67 (0.649, 0.691)  & 0.703 (0.688, 0.724) & 0.036 (0.016, 0.05)     &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581-11  & Acute pyelonephritis                                                                                     & 0.559 (0.533, 0.585) & 0.595 (0.568, 0.616) & 0.036 (0.012, 0.052)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_685-82  & Generalized hyperhidrosis                                                                                & 0.542 (0.527, 0.558) & 0.578 (0.565, 0.591) & 0.035 (0.022, 0.051)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-14  & Low-tension glaucoma (Normal-tension glaucoma)                                                           & 0.682 (0.657, 0.717) & 0.72 (0.683, 0.749)  & 0.035 (0.009, 0.061)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_356-1   & Dysarthria                                                                                               & 0.646 (0.604, 0.683) & 0.684 (0.646, 0.721) & 0.035 (0.007, 0.089)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_384     & Anomalies of pupillary function                                                                          & 0.558 (0.528, 0.598) & 0.592 (0.555, 0.647) & 0.035 (-0.013, 0.078)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_351     & Disturbances of skin sensation                                                                           & 0.535 (0.529, 0.54)  & 0.568 (0.563, 0.573) & 0.034 (0.027, 0.039)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463-21  & Seasonal allergic rhinitis                                                                               & 0.51 (0.499, 0.52)   & 0.545 (0.532, 0.555) & 0.034 (0.019, 0.048)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-113 & Primary open angle glaucoma                                                                              & 0.661 (0.636, 0.684) & 0.694 (0.666, 0.714) & 0.034 (0.016, 0.052)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_376-1   & Vitreous degeneration                                                                                    & 0.606 (0.598, 0.615) & 0.638 (0.631, 0.647) & 0.033 (0.022, 0.041)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_102-1   & Malignant neoplasm of the of bronchus and lung                                                           & 0.679 (0.665, 0.697) & 0.714 (0.697, 0.726) & 0.033 (0.021, 0.045)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_168-19  & Spontaneous ecchymoses                                                                                   & 0.533 (0.507, 0.558) & 0.566 (0.536, 0.591) & 0.033 (0.004, 0.064)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375     & Abnormal intraocular pressure                                                                            & 0.619 (0.61, 0.629)  & 0.651 (0.641, 0.66)  & 0.032 (0.026, 0.038)    & 0.633 (0.622, 0.638) & 0.696 (0.69, 0.701)  & 0.065 (0.057, 0.073)   \\\\\n",
       "\t Mental         & phecode\\_280-11  & Alcohol abuse                                                                                            & 0.616 (0.603, 0.631) & 0.648 (0.636, 0.66)  & 0.032 (0.023, 0.042)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_336-55  & Lesion of plantar nerve                                                                                  & 0.599 (0.581, 0.611) & 0.631 (0.613, 0.647) & 0.032 (0.021, 0.047)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_680-3   & Xerosis cutis*                                                                                           & 0.592 (0.578, 0.606) & 0.622 (0.609, 0.638) & 0.032 (0.019, 0.042)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_164-2   & Macrocytic anemia                                                                                        & 0.624 (0.599, 0.643) & 0.656 (0.632, 0.675) & 0.032 (0.017, 0.046)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-4   & Carbuncle and furuncle                                                                                   & 0.524 (0.511, 0.541) & 0.557 (0.543, 0.573) & 0.032 (0.014, 0.046)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_401-3   & Hypertensive chronic kidney disease                                                                      & 0.7 (0.67, 0.737)    & 0.732 (0.699, 0.768) & 0.032 (0.009, 0.059)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_386-4   & Visual field defects                                                                                     & 0.608 (0.585, 0.63)  & 0.639 (0.611, 0.662) & 0.032 (0.005, 0.054)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_486-2   & Other diseases of bronchus                                                                               & 0.506 (0.477, 0.538) & 0.54 (0.499, 0.57)   & 0.032 (-0.009, 0.078)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_351-3   & Paresthesia of skin*                                                                                     & 0.488 (0.477, 0.497) & 0.52 (0.51, 0.53)    & 0.031 (0.023, 0.042)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_664     & Papulosquamous disorders                                                                                 & 0.532 (0.512, 0.55)  & 0.564 (0.544, 0.577) & 0.031 (0.018, 0.049)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_680-1   & Corns and callosities                                                                                    & 0.557 (0.542, 0.57)  & 0.587 (0.575, 0.602) & 0.031 (0.018, 0.044)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_502     & Other diseases of teeth and supporting structures                                                        & 0.505 (0.491, 0.521) & 0.535 (0.52, 0.549)  & 0.031 (0.012, 0.05)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_730     & Other disorders and symptoms of the musculoskeletal system                                               & 0.519 (0.498, 0.538) & 0.55 (0.532, 0.567)  & 0.031 (0.008, 0.052)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_347     & Other disorders of the brain and CNS                                                                     & 0.574 (0.547, 0.593) & 0.603 (0.569, 0.631) & 0.031 (0.006, 0.052)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_702-3   & Enteropathic arthropathies                                                                               & 0.508 (0.466, 0.556) & 0.54 (0.502, 0.574)  & 0.031 (-0.006, 0.071)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_686     & Chronic ulcer of skin                                                                                    & 0.695 (0.685, 0.708) & 0.726 (0.716, 0.737) & 0.03 (0.024, 0.041)     & 0.771 (0.749, 0.787) & 0.781 (0.761, 0.797) & 0.01 (0.008, 0.012)    \\\\\n",
       "\t Neuro          & phecode\\_333     & Sleep disorders                                                                                          & 0.521 (0.514, 0.528) & 0.551 (0.545, 0.557) & 0.03 (0.023, 0.037)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_676     & Hypertrophic conditions of skin                                                                          & 0.482 (0.474, 0.491) & 0.514 (0.504, 0.523) & 0.03 (0.021, 0.043)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_471-5   & Nasal polyps                                                                                             & 0.546 (0.528, 0.565) & 0.577 (0.558, 0.596) & 0.03 (0.017, 0.049)     &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-12  & Allergic {[}atopic{]} conjunctivitis                                                                         & 0.567 (0.545, 0.586) & 0.598 (0.578, 0.617) & 0.03 (0.015, 0.048)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_244     & Disorders of lipoprotein metabolism and other lipidemias                                                 & 0.594 (0.577, 0.617) & 0.625 (0.602, 0.643) & 0.03 (0.01, 0.045)      & 0.588 (0.576, 0.6)   & 0.586 (0.573, 0.597) & -0.003 (-0.003, -0.002)\\\\\n",
       "\t Eye            & phecode\\_360-51  & Eczematous dermatitis of eyelid                                                                          & 0.619 (0.591, 0.645) & 0.647 (0.618, 0.673) & 0.03 (0.007, 0.053)     &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_336-2   & Lesion of median, ulnar, radial nerve                                                                    & 0.52 (0.501, 0.541)  & 0.55 (0.528, 0.572)  & 0.03 (0.007, 0.047)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_239-2   & Hyperglyceridemia                                                                                        & 0.541 (0.511, 0.564) & 0.567 (0.546, 0.598) & 0.03 (0.003, 0.061)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_525-3   & Disorders of intestinal carbohydrate absorption                                                          & 0.55 (0.5, 0.589)    & 0.581 (0.546, 0.622) & 0.03 (-0.004, 0.075)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_283     & Other behavioral problems                                                                                & 0.506 (0.502, 0.511) & 0.536 (0.532, 0.542) & 0.029 (0.024, 0.035)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_722     & Fasciopathy                                                                                              & 0.505 (0.499, 0.512) & 0.534 (0.529, 0.541) & 0.029 (0.023, 0.036)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_280     & Substance related disorders                                                                              & 0.573 (0.563, 0.582) & 0.602 (0.593, 0.611) & 0.029 (0.021, 0.037)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_448-9   & Peripheral vascular disease NOS {[}includes PAD{]}                                                           & 0.73 (0.717, 0.744)  & 0.759 (0.745, 0.773) & 0.029 (0.019, 0.04)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_232-29  & Folate deficiency {[}Vitamin B9{]}                                                                           & 0.72 (0.69, 0.745)   & 0.748 (0.712, 0.773) & 0.029 (0.011, 0.046)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-6   & Impingement syndrome of shoulder*                                                                        & 0.5 (0.489, 0.51)    & 0.528 (0.517, 0.537) & 0.029 (0.011, 0.04)     &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-41  & Long term (current) use of inhaled steroids*                                                             & 0.547 (0.523, 0.566) & 0.576 (0.554, 0.596) & 0.029 (0.01, 0.055)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-31  & Acidosis                                                                                                 & 0.647 (0.624, 0.673) & 0.678 (0.658, 0.697) & 0.029 (0.008, 0.05)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_232-27  & Vitamin B12 deficiency                                                                                   & 0.576 (0.552, 0.603) & 0.604 (0.58, 0.629)  & 0.029 (0.004, 0.053)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_666     & Urticaria                                                                                                & 0.55 (0.54, 0.56)    & 0.578 (0.569, 0.589) & 0.028 (0.019, 0.037)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_102     & Malignant neoplasm of the thoracic and respiratory organs                                                & 0.677 (0.657, 0.689) & 0.704 (0.689, 0.714) & 0.028 (0.013, 0.04)     &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-4   & Long term (current) use of steroids                                                                      & 0.545 (0.528, 0.563) & 0.575 (0.552, 0.594) & 0.028 (0.011, 0.052)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_369-4   & Corneal degenerations                                                                                    & 0.676 (0.651, 0.708) & 0.705 (0.682, 0.738) & 0.028 (0.009, 0.046)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581-1   & Pyelonephritis                                                                                           & 0.542 (0.518, 0.562) & 0.568 (0.539, 0.592) & 0.028 (0.005, 0.044)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_352     & Disturbances of sensation of smell and taste                                                             & 0.502 (0.484, 0.522) & 0.531 (0.508, 0.548) & 0.028 (0.004, 0.047)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_344     & Disorders of the circulation of the cerebrospinal fluid                                                  & 0.566 (0.533, 0.602) & 0.595 (0.564, 0.629) & 0.028 (0, 0.07)         &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_727-1   & Osteonecrosis                                                                                            & 0.525 (0.476, 0.568) & 0.549 (0.518, 0.595) & 0.028 (-0.03, 0.077)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_719-11  & Spasm of muscle                                                                                          & 0.472 (0.442, 0.512) & 0.501 (0.461, 0.532) & 0.028 (-0.024, 0.066)   &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_204-4   & Prediabetes*                                                                                             & 0.544 (0.509, 0.589) & 0.57 (0.535, 0.611)  & 0.028 (-0.014, 0.063)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_281-1   & Substance abuse                                                                                          & 0.622 (0.608, 0.633) & 0.648 (0.636, 0.658) & 0.027 (0.019, 0.036)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_337     & Polyneuropathies                                                                                         & 0.597 (0.583, 0.609) & 0.624 (0.608, 0.64)  & 0.027 (0.018, 0.037)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_475     & Asthma                                                                                                   & 0.52 (0.512, 0.53)   & 0.548 (0.537, 0.556) & 0.027 (0.018, 0.035)    & 0.501 (0.49, 0.525)  & 0.532 (0.518, 0.547) & 0.032 (0.02, 0.038)    \\\\\n",
       "\t Blood          & phecode\\_177-2   & Enlargement of lymph nodes {[}Lymphadenopathy{]}                                                             & 0.531 (0.52, 0.541)  & 0.558 (0.547, 0.569) & 0.027 (0.014, 0.038)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_160-2   & Megaloblastic anemia                                                                                     & 0.624 (0.605, 0.652) & 0.651 (0.631, 0.671) & 0.027 (0.013, 0.042)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_479-3   & Respiratory failure                                                                                      & 0.672 (0.653, 0.695) & 0.701 (0.679, 0.722) & 0.027 (0.012, 0.042)    & 0.66 (0.636, 0.7)    & 0.69 (0.663, 0.721)  & 0.026 (0.009, 0.046)   \\\\\n",
       "\t Resp           & phecode\\_468-2   & Bacterial pneumonia                                                                                      & 0.619 (0.599, 0.644) & 0.647 (0.624, 0.671) & 0.027 (0.011, 0.047)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_341     & Cerebral palsy and other paralytic syndromes                                                             & 0.65 (0.626, 0.674)  & 0.675 (0.655, 0.695) & 0.027 (0.011, 0.042)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_377-4   & Retinal hemorrhage                                                                                       & 0.641 (0.611, 0.675) & 0.668 (0.633, 0.702) & 0.027 (0.01, 0.046)     &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_411-2   & Pericardial effusion (noninflammatory)*                                                                  & 0.635 (0.608, 0.663) & 0.662 (0.635, 0.693) & 0.027 (0.004, 0.049)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_257     & Polydipsia                                                                                               & 0.512 (0.483, 0.545) & 0.537 (0.509, 0.57)  & 0.027 (0, 0.049)        &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_284-2   & Suicide and self-inflicted harm                                                                          & 0.566 (0.533, 0.597) & 0.594 (0.563, 0.63)  & 0.027 (-0.005, 0.066)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_486     & Other respiratory disorders                                                                              & 0.544 (0.54, 0.55)   & 0.571 (0.565, 0.576) & 0.026 (0.021, 0.03)     & 0.613 (0.595, 0.635) & 0.619 (0.6, 0.644)   & 0.006 (0.001, 0.014)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_800     & Chest pain                                                                                               & 0.513 (0.508, 0.519) & 0.539 (0.533, 0.543) & 0.026 (0.02, 0.031)     & 0.546 (0.512, 0.561) & 0.559 (0.532, 0.577) & 0.015 (0.006, 0.028)   \\\\\n",
       "\t Hearing        & phecode\\_390-1   & Otitis externa                                                                                           & 0.502 (0.496, 0.508) & 0.529 (0.523, 0.536) & 0.026 (0.019, 0.034)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_280-1   & Alcohol use disorders                                                                                    & 0.578 (0.568, 0.585) & 0.604 (0.595, 0.614) & 0.026 (0.018, 0.034)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_333-11  & Obstructive sleep apnea                                                                                  & 0.612 (0.593, 0.629) & 0.638 (0.622, 0.654) & 0.026 (0.015, 0.041)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_535     & Intestinal or peritoneal adhesions                                                                       & 0.554 (0.539, 0.569) & 0.579 (0.566, 0.601) & 0.026 (0.012, 0.041)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_487-3   & Hemoptysis                                                                                               & 0.585 (0.566, 0.602) & 0.611 (0.594, 0.627) & 0.026 (0.012, 0.041)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_686-1   & Pressure ulcer                                                                                           & 0.721 (0.705, 0.737) & 0.746 (0.733, 0.761) & 0.026 (0.011, 0.038)    & 0.787 (0.766, 0.814) & 0.792 (0.766, 0.822) & 0.004 (-0.003, 0.012)  \\\\\n",
       "\t Derm           & phecode\\_660-21  & Impetigo                                                                                                 & 0.513 (0.493, 0.534) & 0.537 (0.522, 0.563) & 0.026 (0.01, 0.04)      &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_840-9   & Anaphylactic reaction                                                                                    & 0.496 (0.455, 0.552) & 0.524 (0.476, 0.566) & 0.026 (-0.021, 0.073)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-6   & Prurigo                                                                                                  & 0.528 (0.497, 0.565) & 0.556 (0.523, 0.589) & 0.026 (-0.009, 0.061)   &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_248     & Disorders of plasma-protein metabolism, NEC                                                              & 0.601 (0.56, 0.653)  & 0.629 (0.573, 0.676) & 0.026 (-0.003, 0.056)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_284-29  & Intentional self-harm*                                                                                   & 0.566 (0.531, 0.599) & 0.595 (0.563, 0.632) & 0.026 (-0.003, 0.052)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_683-2   & Nail dystrophy*                                                                                          & 0.593 (0.56, 0.623)  & 0.618 (0.585, 0.651) & 0.026 (-0.002, 0.051)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_804     & Other symptoms and signs involving the circulatory and respiratory system                                & 0.533 (0.527, 0.54)  & 0.558 (0.553, 0.564) & 0.025 (0.02, 0.031)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_469     & Bronchitis                                                                                               & 0.543 (0.534, 0.553) & 0.568 (0.561, 0.578) & 0.025 (0.016, 0.034)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-2   & Bacterial infection of the skin                                                                          & 0.503 (0.486, 0.52)  & 0.53 (0.506, 0.545)  & 0.025 (0.012, 0.04)     &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_800-2   & Precordial pain                                                                                          & 0.536 (0.521, 0.551) & 0.561 (0.545, 0.576) & 0.025 (0.012, 0.037)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_832-5   & Acetonuria                                                                                               & 0.547 (0.529, 0.563) & 0.572 (0.556, 0.586) & 0.025 (0.011, 0.038)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-6   & Fluid overload                                                                                           & 0.721 (0.697, 0.74)  & 0.744 (0.725, 0.766) & 0.025 (0.008, 0.041)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_507-11  & Recurrent oral aphthae {[}Recurrent aphthous stomatitis{]}                                                   & 0.559 (0.53, 0.584)  & 0.583 (0.55, 0.61)   & 0.025 (0.001, 0.052)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_330-12  & Partial epilepsy                                                                                         & 0.587 (0.559, 0.62)  & 0.612 (0.573, 0.656) & 0.025 (-0.017, 0.057)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_525-1   & Celiac disease                                                                                           & 0.508 (0.482, 0.537) & 0.534 (0.506, 0.563) & 0.025 (-0.016, 0.055)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_336-52  & Meralgia paresthetica                                                                                    & 0.472 (0.441, 0.5)   & 0.496 (0.471, 0.524) & 0.025 (-0.01, 0.057)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_666-1   & Allergic urticaria                                                                                       & 0.599 (0.575, 0.627) & 0.621 (0.587, 0.654) & 0.025 (-0.007, 0.054)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_089-1   & Bacterial infections                                                                                     & 0.552 (0.546, 0.559) & 0.577 (0.57, 0.582)  & 0.024 (0.017, 0.029)    & 0.715 (0.694, 0.733) & 0.716 (0.695, 0.734) & 0.001 (0, 0.004)       \\\\\n",
       "\t Neuro          & phecode\\_336-1   & Carpal tunnel syndrome                                                                                   & 0.542 (0.534, 0.552) & 0.566 (0.555, 0.577) & 0.024 (0.013, 0.034)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_341-2   & Hemiplegia and hemiparesis                                                                               & 0.667 (0.65, 0.685)  & 0.692 (0.669, 0.712) & 0.024 (0.01, 0.041)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710-4   & Acquired deformities of the ankle and foot                                                               & 0.582 (0.563, 0.597) & 0.605 (0.586, 0.621) & 0.024 (0.009, 0.042)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_361-3   & Ptosis of eyelid                                                                                         & 0.627 (0.606, 0.648) & 0.652 (0.628, 0.673) & 0.024 (0.009, 0.041)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_168-1   & Hypo-coagulability                                                                                       & 0.592 (0.566, 0.617) & 0.614 (0.594, 0.64)  & 0.024 (0.008, 0.039)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_355-2   & Alteration of consciousness                                                                              & 0.621 (0.603, 0.646) & 0.647 (0.625, 0.668) & 0.024 (0.008, 0.039)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_351-1   & Anesthesia of skin*                                                                                      & 0.5 (0.487, 0.513)   & 0.524 (0.512, 0.537) & 0.024 (0.008, 0.038)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_239-12  & Familial hypercholesterolemia*                                                                           & 0.598 (0.571, 0.624) & 0.625 (0.594, 0.646) & 0.024 (0.006, 0.045)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_366     & Noninflammatory disorders of conjunctiva                                                                 & 0.536 (0.52, 0.554)  & 0.559 (0.539, 0.58)  & 0.024 (0.003, 0.044)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_588-2   & Abnormal results of function study of kidney                                                             & 0.687 (0.653, 0.712) & 0.71 (0.676, 0.739)  & 0.024 (0.002, 0.047)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_810     & Shock                                                                                                    & 0.722 (0.687, 0.754) & 0.745 (0.71, 0.781)  & 0.024 (-0.004, 0.048)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-2   & Eustachian tube disorders                                                                                & 0.53 (0.52, 0.538)   & 0.553 (0.543, 0.563) & 0.023 (0.016, 0.029)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_376-2   & Vitreous opacities                                                                                       & 0.612 (0.604, 0.618) & 0.634 (0.626, 0.643) & 0.023 (0.016, 0.028)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-5   & Lichen simplex chronicus                                                                                 & 0.566 (0.542, 0.596) & 0.591 (0.558, 0.617) & 0.023 (0.002, 0.049)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_366-42  & Conjunctival hyperemia                                                                                   & 0.516 (0.473, 0.552) & 0.538 (0.502, 0.576) & 0.023 (-0.008, 0.061)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_376     & Disorders of vitreous body                                                                               & 0.612 (0.604, 0.619) & 0.635 (0.627, 0.642) & 0.022 (0.017, 0.029)    &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_283-8   & Other problems related to lifestyle                                                                      & 0.513 (0.508, 0.518) & 0.535 (0.529, 0.538) & 0.022 (0.017, 0.027)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_733     & Dentofacial anomalies, including malocclusion                                                            & 0.587 (0.572, 0.605) & 0.607 (0.591, 0.624) & 0.022 (0.012, 0.032)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_376-21  & Crystalline deposits in vitreous body                                                                    & 0.592 (0.571, 0.608) & 0.614 (0.601, 0.629) & 0.022 (0.01, 0.035)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_733-6   & Temporomandibular joint disorders                                                                        & 0.587 (0.575, 0.599) & 0.609 (0.595, 0.621) & 0.022 (0.01, 0.031)     &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_335     & Nerve root and plexus disorders                                                                          & 0.543 (0.527, 0.558) & 0.565 (0.553, 0.578) & 0.022 (0.009, 0.035)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_135-5   & Benign neoplasm of the paranasal sinus and nasal cavity                                                  & 0.555 (0.535, 0.569) & 0.577 (0.559, 0.597) & 0.022 (0.008, 0.041)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_550-2   & Cholecystitis                                                                                            & 0.535 (0.52, 0.55)   & 0.559 (0.539, 0.577) & 0.022 (0.006, 0.045)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_061     & Influenza virus                                                                                          & 0.56 (0.538, 0.586)  & 0.582 (0.559, 0.611) & 0.022 (0.004, 0.041)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_588     & Disorders and findings from impaired renal function                                                      & 0.655 (0.624, 0.692) & 0.678 (0.647, 0.716) & 0.022 (0.002, 0.046)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_361-4   & Blepharochalasis                                                                                         & 0.623 (0.59, 0.653)  & 0.643 (0.603, 0.68)  & 0.022 (-0.01, 0.052)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_149-3   & Benign neoplasm of the parathyroid gland                                                                 & 0.64 (0.61, 0.671)   & 0.661 (0.633, 0.694) & 0.022 (-0.009, 0.047)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-6   & Cellulitis and abscess                                                                                   & 0.538 (0.533, 0.543) & 0.559 (0.554, 0.564) & 0.021 (0.016, 0.026)    & 0.668 (0.64, 0.684)  & 0.667 (0.642, 0.678) & 0 (-0.006, 0.004)      \\\\\n",
       "\t Genitourinary  & phecode\\_582     & Acute kidney failure                                                                                     & 0.705 (0.696, 0.711) & 0.725 (0.718, 0.731) & 0.021 (0.014, 0.028)    & 0.74 (0.727, 0.749)  & 0.748 (0.734, 0.752) & 0.007 (0.004, 0.009)   \\\\\n",
       "\t Endo           & phecode\\_200-9   & Abnormal thyroid function studies                                                                        & 0.593 (0.57, 0.616)  & 0.614 (0.587, 0.638) & 0.021 (0.005, 0.033)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_731     & Symptoms involving musculoskeletal systems                                                               & 0.496 (0.485, 0.507) & 0.516 (0.503, 0.526) & 0.021 (0.004, 0.032)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_530-2   & Anorectal abscess                                                                                        & 0.596 (0.566, 0.632) & 0.615 (0.58, 0.652)  & 0.021 (-0.007, 0.046)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-52  & Macular cyst, hole, or pseudohole                                                                        & 0.663 (0.643, 0.685) & 0.686 (0.663, 0.707) & 0.021 (-0.002, 0.045)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_462-2   & Chronic sinusitis                                                                                        & 0.54 (0.531, 0.547)  & 0.559 (0.551, 0.567) & 0.02 (0.015, 0.025)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_719-1   & Cramp and spasm                                                                                          & 0.577 (0.567, 0.588) & 0.598 (0.587, 0.608) & 0.02 (0.012, 0.028)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-1   & Adhesive capsulitis of shoulder                                                                          & 0.536 (0.527, 0.548) & 0.557 (0.546, 0.567) & 0.02 (0.011, 0.033)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_684-1   & Alopecia                                                                                                 & 0.687 (0.677, 0.697) & 0.708 (0.697, 0.717) & 0.02 (0.011, 0.029)     &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_333-2   & Insomnia                                                                                                 & 0.541 (0.531, 0.551) & 0.561 (0.551, 0.569) & 0.02 (0.01, 0.029)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_585     & Kidney stone disease                                                                                     & 0.592 (0.58, 0.604)  & 0.612 (0.598, 0.624) & 0.02 (0.01, 0.027)      & 0.59 (0.566, 0.617)  & 0.6 (0.578, 0.636)   & 0.01 (0.004, 0.019)    \\\\\n",
       "\t Resp           & phecode\\_495     & Abnormal findings on diagnostic imaging of lung                                                          & 0.645 (0.634, 0.658) & 0.666 (0.655, 0.678) & 0.02 (0.009, 0.031)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_513-2   & Gastric ulcer                                                                                            & 0.589 (0.572, 0.603) & 0.608 (0.591, 0.623) & 0.02 (0.003, 0.033)     &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_002-1   & Staphylococcus aureus                                                                                    & 0.581 (0.561, 0.606) & 0.601 (0.577, 0.621) & 0.02 (0.002, 0.041)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_468-1   & Viral pneumonia                                                                                          & 0.632 (0.596, 0.666) & 0.652 (0.617, 0.685) & 0.02 (-0.009, 0.055)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_330-1   & Epilepsy                                                                                                 & 0.563 (0.543, 0.584) & 0.584 (0.558, 0.606) & 0.02 (-0.009, 0.042)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_148-1   & Benign neoplasm of eye                                                                                   & 0.572 (0.539, 0.603) & 0.594 (0.565, 0.617) & 0.02 (-0.006, 0.046)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-61  & Hemangioma                                                                                               & 0.498 (0.48, 0.516)  & 0.516 (0.496, 0.537) & 0.02 (-0.006, 0.04)     &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_056     & Human papillomavirus                                                                                     & 0.492 (0.482, 0.5)   & 0.511 (0.501, 0.518) & 0.019 (0.007, 0.029)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-9   & Delirium                                                                                                 & 0.75 (0.732, 0.763)  & 0.769 (0.753, 0.783) & 0.019 (0.007, 0.029)    & 0.802 (0.783, 0.817) & 0.802 (0.784, 0.818) & 0 (-0.002, 0.004)      \\\\\n",
       "\t Derm           & phecode\\_664-1   & Lichen planus, nitidus, or striatus                                                                      & 0.579 (0.56, 0.596)  & 0.597 (0.58, 0.612)  & 0.019 (0.002, 0.031)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-11  & Candidiasis of skin and nails                                                                            & 0.543 (0.527, 0.559) & 0.563 (0.545, 0.575) & 0.019 (0.001, 0.04)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_719-7   & Muscle weakness (generalized)                                                                            & 0.55 (0.524, 0.575)  & 0.568 (0.545, 0.599) & 0.019 (-0.01, 0.048)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-34  & Torticollis                                                                                              & 0.53 (0.511, 0.546)  & 0.549 (0.528, 0.567) & 0.019 (-0.001, 0.038)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_719     & Disorders of muscle                                                                                      & 0.565 (0.554, 0.573) & 0.583 (0.575, 0.593) & 0.018 (0.011, 0.027)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_713-2   & Effusion of joint                                                                                        & 0.578 (0.57, 0.586)  & 0.596 (0.587, 0.604) & 0.018 (0.011, 0.026)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_402     & Elevated blood pressure reading without diagnosis of hypertension                                        & 0.536 (0.529, 0.543) & 0.554 (0.546, 0.561) & 0.018 (0.01, 0.025)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_545     & Nonspecific abnormal results of function study of liver                                                  & 0.544 (0.533, 0.553) & 0.561 (0.553, 0.572) & 0.018 (0.008, 0.029)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_706     & Other inflammatory spondylopathies                                                                       & 0.585 (0.565, 0.603) & 0.604 (0.586, 0.62)  & 0.018 (0.006, 0.032)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_349-13  & Abnormal findings on diagnostic imaging of skull and head                                                & 0.627 (0.607, 0.65)  & 0.647 (0.622, 0.672) & 0.018 (0.004, 0.039)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_417-2   & Tachycardia                                                                                              & 0.596 (0.583, 0.613) & 0.615 (0.602, 0.628) & 0.018 (0.004, 0.03)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-3   & Changes in skin texture                                                                                  & 0.581 (0.57, 0.596)  & 0.599 (0.585, 0.614) & 0.018 (0.003, 0.03)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_555     & Ascites                                                                                                  & 0.642 (0.622, 0.66)  & 0.66 (0.635, 0.679)  & 0.018 (0.002, 0.037)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_349-1   & Abnormal findings on diagnostic test of central nervous system                                           & 0.612 (0.594, 0.638) & 0.633 (0.609, 0.654) & 0.018 (0.001, 0.039)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_826     & Other abnormal immunological findings in serum                                                           & 0.521 (0.499, 0.55)  & 0.537 (0.507, 0.562) & 0.018 (-0.016, 0.045)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_718-4   & Low back pain                                                                                            & 0.517 (0.512, 0.522) & 0.534 (0.529, 0.538) & 0.017 (0.011, 0.022)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_003     & Escherichia coli                                                                                         & 0.599 (0.588, 0.611) & 0.617 (0.601, 0.63)  & 0.017 (0.008, 0.027)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_204-1   & Impaired fasting glucose                                                                                 & 0.608 (0.591, 0.618) & 0.625 (0.609, 0.641) & 0.017 (0.006, 0.028)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-6   & Ocular hypertension                                                                                      & 0.591 (0.577, 0.604) & 0.607 (0.594, 0.624) & 0.017 (0.003, 0.03)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_516     & Other diseases of stomach and duodenum                                                                   & 0.586 (0.566, 0.601) & 0.602 (0.589, 0.62)  & 0.017 (0.003, 0.029)    & 0.527 (0.51, 0.538)  & 0.524 (0.507, 0.535) & -0.003 (-0.005, -0.001)\\\\\n",
       "\t Neuro          & phecode\\_348     & Other diseases of spinal cord                                                                            & 0.563 (0.548, 0.582) & 0.58 (0.562, 0.603)  & 0.017 (0.002, 0.033)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_179     & Immunodeficiencies                                                                                       & 0.465 (0.437, 0.497) & 0.483 (0.455, 0.51)  & 0.017 (-0.019, 0.051)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_360-12  & Hordeolum internum                                                                                       & 0.544 (0.513, 0.57)  & 0.56 (0.525, 0.586)  & 0.017 (-0.015, 0.041)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_148-16  & Benign neoplasm of choroid                                                                               & 0.58 (0.557, 0.613)  & 0.596 (0.569, 0.626) & 0.017 (-0.011, 0.044)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_480     & Pulmonary edema                                                                                          & 0.709 (0.681, 0.737) & 0.726 (0.696, 0.759) & 0.017 (-0.002, 0.04)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_002     & Staphylococcus                                                                                           & 0.605 (0.583, 0.623) & 0.622 (0.601, 0.639) & 0.017 (-0.002, 0.036)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_401     & Hypertension                                                                                             & 0.626 (0.623, 0.63)  & 0.642 (0.638, 0.646) & 0.016 (0.014, 0.019)    & 0.639 (0.631, 0.647) & 0.648 (0.64, 0.656)  & 0.009 (0.006, 0.01)    \\\\\n",
       "\t Cardio         & phecode\\_401-1   & Essential hypertension                                                                                   & 0.626 (0.622, 0.63)  & 0.642 (0.638, 0.647) & 0.016 (0.014, 0.019)    & 0.641 (0.631, 0.648) & 0.648 (0.642, 0.653) & 0.009 (0.005, 0.011)   \\\\\n",
       "\t Resp           & phecode\\_488     & Abnormalities of breathing                                                                               & 0.57 (0.565, 0.575)  & 0.586 (0.581, 0.591) & 0.016 (0.013, 0.02)     & 0.596 (0.564, 0.629) & 0.627 (0.589, 0.649) & 0.019 (0.002, 0.041)   \\\\\n",
       "\t Resp           & phecode\\_460-2   & Acute lower respiratory infection                                                                        & 0.559 (0.555, 0.563) & 0.575 (0.572, 0.579) & 0.016 (0.013, 0.02)     & 0.717 (0.7, 0.736)   & 0.724 (0.704, 0.741) & 0.006 (0.004, 0.01)    \\\\\n",
       "\t Musc/Skel      & phecode\\_718     & Back pain                                                                                                & 0.518 (0.513, 0.522) & 0.534 (0.529, 0.537) & 0.016 (0.012, 0.02)     & 0.572 (0.556, 0.602) & 0.573 (0.557, 0.605) & 0.001 (-0.001, 0.003)  \\\\\n",
       "\t Eye            & phecode\\_386     & Visual disturbances                                                                                      & 0.588 (0.579, 0.595) & 0.605 (0.596, 0.613) & 0.016 (0.011, 0.024)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_138     & Benign neoplasm of the skin                                                                              & 0.528 (0.522, 0.535) & 0.544 (0.537, 0.55)  & 0.016 (0.01, 0.021)     & 0.475 (0.452, 0.5)   & 0.474 (0.448, 0.51)  & 0.004 (-0.011, 0.016)  \\\\\n",
       "\t Derm           & phecode\\_684     & Diseases of hair and hair follicles                                                                      & 0.695 (0.684, 0.704) & 0.711 (0.7, 0.721)   & 0.016 (0.009, 0.025)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_325-2   & Abnormality of gait and mobility                                                                         & 0.647 (0.639, 0.656) & 0.662 (0.655, 0.671) & 0.016 (0.009, 0.023)    & 0.778 (0.75, 0.795)  & 0.774 (0.747, 0.793) & -0.002 (-0.005, -0.001)\\\\\n",
       "\t Neuro          & phecode\\_336     & Mononeuropathies                                                                                         & 0.544 (0.537, 0.552) & 0.56 (0.554, 0.567)  & 0.016 (0.009, 0.022)    & 0.512 (0.494, 0.527) & 0.526 (0.506, 0.538) & 0.012 (-0.002, 0.02)   \\\\\n",
       "\t Resp           & phecode\\_486-5   & Abnormal sputum                                                                                          & 0.555 (0.547, 0.562) & 0.571 (0.563, 0.58)  & 0.016 (0.009, 0.022)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_496     & Abnormal results of pulmonary function studies                                                           & 0.58 (0.57, 0.591)   & 0.597 (0.587, 0.608) & 0.016 (0.008, 0.024)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_524-1   & Irritable bowel syndrome                                                                                 & 0.606 (0.595, 0.617) & 0.621 (0.611, 0.635) & 0.016 (0.007, 0.026)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-5   & Hypokalemia {[}Hypopotassemia{]}                                                                             & 0.638 (0.624, 0.655) & 0.655 (0.643, 0.668) & 0.016 (0.005, 0.029)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_464-1   & Acute nasopharyngitis                                                                                    & 0.534 (0.523, 0.543) & 0.55 (0.538, 0.563)  & 0.016 (0.005, 0.027)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_464     & Nasopharyngitis                                                                                          & 0.534 (0.521, 0.547) & 0.549 (0.539, 0.562) & 0.016 (0.003, 0.028)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_012     & Proteus                                                                                                  & 0.675 (0.627, 0.723) & 0.689 (0.64, 0.742)  & 0.016 (-0.034, 0.061)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-11  & Acute otitis media                                                                                       & 0.506 (0.474, 0.536) & 0.521 (0.491, 0.552) & 0.016 (-0.017, 0.053)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-22  & Flushing                                                                                                 & 0.562 (0.535, 0.592) & 0.578 (0.556, 0.602) & 0.016 (-0.004, 0.04)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_515     & Heartburn and epigastric pain                                                                            & 0.553 (0.545, 0.563) & 0.569 (0.562, 0.578) & 0.015 (0.01, 0.023)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_468     & Pneumonia                                                                                                & 0.665 (0.657, 0.671) & 0.68 (0.672, 0.687)  & 0.015 (0.01, 0.021)     & 0.73 (0.719, 0.748)  & 0.735 (0.722, 0.752) & 0.004 (0.001, 0.005)   \\\\\n",
       "\t Derm           & phecode\\_679-4   & Pruritus                                                                                                 & 0.554 (0.547, 0.562) & 0.57 (0.562, 0.576)  & 0.015 (0.01, 0.02)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_448     & Peripheral vascular disease                                                                              & 0.613 (0.601, 0.628) & 0.629 (0.616, 0.643) & 0.015 (0.009, 0.024)    & 0.715 (0.68, 0.735)  & 0.715 (0.686, 0.732) & 0.003 (-0.009, 0.012)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-4   & Allergy to analgesic agent                                                                               & 0.624 (0.612, 0.633) & 0.638 (0.626, 0.648) & 0.015 (0.009, 0.021)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_468-9   & Lobar pneumonia*                                                                                         & 0.675 (0.667, 0.683) & 0.689 (0.681, 0.699) & 0.015 (0.008, 0.022)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_361     & Disorders of eyelid function                                                                             & 0.64 (0.629, 0.655)  & 0.655 (0.642, 0.672) & 0.015 (0.004, 0.026)    & 0.641 (0.621, 0.671) & 0.639 (0.621, 0.673) & 0 (-0.007, 0.003)      \\\\\n",
       "\t Derm           & phecode\\_685     & Disorders of sweat glands                                                                                & 0.55 (0.536, 0.561)  & 0.565 (0.553, 0.578) & 0.015 (0.003, 0.028)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_355     & Coma and other alteration of consciousness                                                               & 0.61 (0.593, 0.631)  & 0.626 (0.61, 0.641)  & 0.015 (0.001, 0.029)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_716-2   & Degenerative disc disease                                                                                & 0.525 (0.508, 0.539) & 0.54 (0.524, 0.551)  & 0.015 (0, 0.03)         &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_688     & Granulomatous disorder of the skin                                                                       & 0.507 (0.478, 0.527) & 0.522 (0.501, 0.543) & 0.015 (-0.005, 0.034)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_138-1   & Nevus, non-neoplastic                                                                                    & 0.532 (0.508, 0.552) & 0.546 (0.527, 0.564) & 0.015 (-0.005, 0.034)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_556-3   & Abdominal or pelvic swelling, mass, or lump                                                              & 0.543 (0.53, 0.559)  & 0.559 (0.542, 0.572) & 0.015 (-0.001, 0.029)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724     & Other symptoms and disorders of the soft tissue                                                          & 0.55 (0.543, 0.555)  & 0.565 (0.56, 0.57)   & 0.014 (0.01, 0.019)     & 0.541 (0.523, 0.556) & 0.542 (0.523, 0.56)  & 0.004 (-0.01, 0.012)   \\\\\n",
       "\t Signs/Symptoms & phecode\\_840     & Allergy                                                                                                  & 0.541 (0.534, 0.545) & 0.554 (0.547, 0.56)  & 0.014 (0.009, 0.017)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_138-2   & Melanocytic nevi*                                                                                        & 0.544 (0.537, 0.553) & 0.559 (0.551, 0.567) & 0.014 (0.008, 0.019)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_177     & Abnormality of the lymph nodes                                                                           & 0.555 (0.547, 0.565) & 0.57 (0.56, 0.58)    & 0.014 (0.006, 0.024)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-2   & Seborrheic dermatitis                                                                                    & 0.541 (0.53, 0.551)  & 0.555 (0.544, 0.566) & 0.014 (0.006, 0.022)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_716     & Intervertebral disc disorder                                                                             & 0.535 (0.527, 0.544) & 0.548 (0.539, 0.556) & 0.014 (0.005, 0.02)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_680     & Epidermal thickening                                                                                     & 0.586 (0.576, 0.595) & 0.598 (0.589, 0.61)  & 0.014 (0.005, 0.019)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_674     & Disorders of pigmentation                                                                                & 0.545 (0.533, 0.556) & 0.558 (0.548, 0.57)  & 0.014 (0.003, 0.022)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_209     & Disorders of the pituitary gland and its hypothalamic control                                            & 0.609 (0.582, 0.648) & 0.621 (0.584, 0.657) & 0.014 (-0.022, 0.038)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_007-1   & Hemophilus influenzae                                                                                    & 0.595 (0.552, 0.627) & 0.611 (0.566, 0.659) & 0.014 (-0.012, 0.056)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_559     & Other disease of digestive system, NOS                                                                   & 0.523 (0.493, 0.548) & 0.537 (0.508, 0.561) & 0.014 (-0.011, 0.036)   & 0.546 (0.519, 0.55)  & 0.543 (0.516, 0.548) & -0.003 (-0.004, -0.001)\\\\\n",
       "\t GI             & phecode\\_517     & Gastrointestinal angiodysplasia                                                                          & 0.68 (0.649, 0.712)  & 0.692 (0.663, 0.725) & 0.014 (-0.01, 0.04)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_537     & Abnormality of the peritoneum                                                                            & 0.54 (0.521, 0.57)   & 0.557 (0.533, 0.583) & 0.014 (-0.006, 0.036)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_327     & Other degenerative diseases of nervous system                                                            & 0.692 (0.667, 0.72)  & 0.707 (0.683, 0.729) & 0.014 (-0.003, 0.036)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_711-1   & Derangement of meniscus                                                                                  & 0.524 (0.51, 0.535)  & 0.538 (0.525, 0.548) & 0.014 (-0.001, 0.028)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_460     & Acute respiratory infection                                                                              & 0.527 (0.522, 0.531) & 0.54 (0.537, 0.544)  & 0.013 (0.01, 0.016)     & 0.709 (0.686, 0.722) & 0.716 (0.697, 0.726) & 0.007 (0.001, 0.01)    \\\\\n",
       "\t ID             & phecode\\_089-3   & Fungal infections                                                                                        & 0.52 (0.516, 0.525)  & 0.532 (0.527, 0.538) & 0.013 (0.009, 0.016)    & 0.6 (0.562, 0.611)   & 0.593 (0.556, 0.609) & -0.003 (-0.02, 0.005)  \\\\\n",
       "\t Musc/Skel      & phecode\\_722-1   & Plantar fascial fibromatosis {[}Plantar fasciitis{]}                                                         & 0.536 (0.529, 0.544) & 0.549 (0.541, 0.556) & 0.013 (0.007, 0.018)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_425     & Cardiomegaly                                                                                             & 0.679 (0.666, 0.694) & 0.692 (0.682, 0.706) & 0.013 (0.005, 0.022)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_479     & Pulmonary insufficiency and acute respiratory distress syndrome                                          & 0.657 (0.646, 0.672) & 0.67 (0.657, 0.685)  & 0.013 (0.005, 0.022)    & 0.655 (0.623, 0.692) & 0.705 (0.676, 0.75)  & 0.045 (0.032, 0.068)   \\\\\n",
       "\t Musc/Skel      & phecode\\_718-1   & Radiculopathy                                                                                            & 0.573 (0.561, 0.587) & 0.586 (0.573, 0.6)   & 0.013 (0.004, 0.022)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_558     & Abnormal findings on diagnostic imaging of the digestive tract                                           & 0.588 (0.578, 0.601) & 0.601 (0.586, 0.611) & 0.013 (0.004, 0.02)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_491     & Pleurisy                                                                                                 & 0.623 (0.602, 0.643) & 0.637 (0.616, 0.653) & 0.013 (0.003, 0.025)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724-5   & Exostosis                                                                                                & 0.559 (0.543, 0.577) & 0.574 (0.554, 0.587) & 0.013 (0.003, 0.024)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-13  & Umbilical hernia                                                                                         & 0.625 (0.614, 0.639) & 0.637 (0.625, 0.652) & 0.013 (0.003, 0.023)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_711     & Disorder of patella                                                                                      & 0.523 (0.51, 0.536)  & 0.536 (0.525, 0.549) & 0.013 (0.002, 0.029)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-3   & Allergy to narcotic agent                                                                                & 0.657 (0.641, 0.68)  & 0.672 (0.654, 0.689) & 0.013 (0.002, 0.024)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-3   & Dystonia                                                                                                 & 0.548 (0.529, 0.566) & 0.561 (0.55, 0.579)  & 0.013 (0, 0.028)        &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_344-1   & Hydrocephalus                                                                                            & 0.627 (0.587, 0.67)  & 0.638 (0.604, 0.692) & 0.013 (-0.036, 0.054)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-7   & Restlessness and agitation*                                                                              & 0.569 (0.536, 0.6)   & 0.583 (0.554, 0.617) & 0.013 (-0.019, 0.046)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_348-2   & Myelopathies                                                                                             & 0.555 (0.537, 0.58)  & 0.57 (0.546, 0.594)  & 0.013 (-0.012, 0.038)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_015     & Clostridium                                                                                              & 0.602 (0.574, 0.632) & 0.615 (0.589, 0.649) & 0.013 (-0.011, 0.041)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_554-11  & Acute pancreatitis                                                                                       & 0.571 (0.547, 0.601) & 0.585 (0.563, 0.607) & 0.013 (-0.01, 0.038)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_149     & Benign neoplasm of the endocrine glands                                                                  & 0.581 (0.558, 0.611) & 0.597 (0.574, 0.619) & 0.013 (-0.01, 0.032)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_554-1   & Pancreatitis                                                                                             & 0.584 (0.558, 0.605) & 0.595 (0.575, 0.617) & 0.013 (-0.008, 0.03)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_100     & Malignant neoplasm of the head and neck                                                                  & 0.607 (0.578, 0.638) & 0.622 (0.597, 0.651) & 0.013 (-0.005, 0.037)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_084     & Parasites                                                                                                & 0.58 (0.563, 0.605)  & 0.593 (0.568, 0.619) & 0.013 (-0.005, 0.029)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_488-1   & Dyspnea {[}Shortness of breath{]}                                                                            & 0.599 (0.594, 0.605) & 0.612 (0.606, 0.616) & 0.012 (0.009, 0.016)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_801     & Cough                                                                                                    & 0.527 (0.524, 0.531) & 0.539 (0.535, 0.543) & 0.012 (0.009, 0.015)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_389     & Other disorders of eye                                                                                   & 0.561 (0.555, 0.569) & 0.573 (0.566, 0.579) & 0.012 (0.007, 0.016)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_807     & Malaise and fatigue                                                                                      & 0.547 (0.543, 0.551) & 0.559 (0.554, 0.565) & 0.012 (0.007, 0.016)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_325     & Symptoms and signs related to movement disorders                                                         & 0.636 (0.627, 0.643) & 0.648 (0.64, 0.656)  & 0.012 (0.006, 0.019)    & 0.751 (0.735, 0.782) & 0.748 (0.73, 0.778)  & -0.004 (-0.005, -0.002)\\\\\n",
       "\t Metab          & phecode\\_256-7   & Volume depletion                                                                                         & 0.662 (0.648, 0.675) & 0.674 (0.661, 0.684) & 0.012 (0.003, 0.021)    & 0.728 (0.707, 0.746) & 0.728 (0.706, 0.744) & 0 (-0.002, 0.001)      \\\\\n",
       "\t Eye            & phecode\\_360-11  & Hordeolum externum                                                                                       & 0.519 (0.51, 0.533)  & 0.531 (0.519, 0.543) & 0.012 (0.002, 0.022)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_169-11  & Immune thrombocytopenic purpura {[}ITP{]}                                                                    & 0.599 (0.561, 0.639) & 0.614 (0.567, 0.653) & 0.012 (-0.013, 0.042)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_353-1   & Hallucinations                                                                                           & 0.615 (0.583, 0.654) & 0.626 (0.601, 0.651) & 0.012 (-0.012, 0.039)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_673     & Skin changes due to chronic exposure to nonionizing radiation                                            & 0.598 (0.593, 0.602) & 0.609 (0.604, 0.613) & 0.011 (0.009, 0.013)    & 0.586 (0.549, 0.611) & 0.57 (0.533, 0.598)  & -0.015 (-0.018, -0.009)\\\\\n",
       "\t Musc/Skel      & phecode\\_707     & Other arthropathies                                                                                      & 0.641 (0.636, 0.647) & 0.652 (0.646, 0.659) & 0.011 (0.008, 0.014)    & 0.571 (0.556, 0.584) & 0.582 (0.572, 0.596) & 0.013 (0.005, 0.02)    \\\\\n",
       "\t Metab          & phecode\\_256     & Disorders of fluid, electrolyte and acid-base balance                                                    & 0.581 (0.575, 0.588) & 0.592 (0.585, 0.599) & 0.011 (0.007, 0.016)    & 0.712 (0.701, 0.724) & 0.715 (0.702, 0.726) & 0.002 (0, 0.003)       \\\\\n",
       "\t Derm           & phecode\\_681     & Localized swelling, mass and lump of skin and subcutaneous tissue                                        & 0.556 (0.552, 0.561) & 0.567 (0.563, 0.573) & 0.011 (0.007, 0.015)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_718-2   & Cervicalgia                                                                                              & 0.55 (0.545, 0.556)  & 0.561 (0.556, 0.566) & 0.011 (0.006, 0.017)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_812     & Edema                                                                                                    & 0.61 (0.603, 0.617)  & 0.621 (0.614, 0.631) & 0.011 (0.006, 0.017)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_718-5   & Sciatica                                                                                                 & 0.546 (0.54, 0.553)  & 0.557 (0.55, 0.563)  & 0.011 (0.006, 0.016)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_526     & Intestinal infection                                                                                     & 0.568 (0.561, 0.575) & 0.579 (0.572, 0.588) & 0.011 (0.005, 0.016)    & 0.65 (0.631, 0.658)  & 0.653 (0.629, 0.663) & 0.003 (-0.002, 0.005)  \\\\\n",
       "\t Neuro          & phecode\\_350-5   & Repeated falls*                                                                                          & 0.717 (0.707, 0.726) & 0.727 (0.72, 0.735)  & 0.011 (0.004, 0.016)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_360-1   & Hordeolum                                                                                                & 0.519 (0.507, 0.533) & 0.531 (0.52, 0.541)  & 0.011 (0.003, 0.022)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_524     & Functional intestinal disorder                                                                           & 0.6 (0.589, 0.612)   & 0.612 (0.599, 0.623) & 0.011 (0.003, 0.02)     & 0.628 (0.623, 0.648) & 0.627 (0.623, 0.647) & -0.001 (-0.003, 0)     \\\\\n",
       "\t Derm           & phecode\\_682-1   & Cutaneous cyst                                                                                           & 0.496 (0.489, 0.503) & 0.506 (0.499, 0.514) & 0.011 (0.002, 0.02)     &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139     & Benign sarcoma-related cancers                                                                           & 0.5 (0.49, 0.508)    & 0.511 (0.501, 0.521) & 0.011 (0, 0.021)        &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_526-2   & Viral enteritis                                                                                          & 0.57 (0.537, 0.602)  & 0.585 (0.552, 0.616) & 0.011 (-0.016, 0.04)    &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-7   & Perforation of tympanic membrane                                                                         & 0.532 (0.506, 0.555) & 0.542 (0.517, 0.564) & 0.011 (-0.015, 0.03)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_495-1   & Solitary pulmonary nodule                                                                                & 0.632 (0.594, 0.657) & 0.642 (0.609, 0.674) & 0.011 (-0.011, 0.041)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_095     & Sequela of infection                                                                                     & 0.546 (0.522, 0.574) & 0.558 (0.534, 0.592) & 0.011 (-0.011, 0.032)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_484     & Pneumothorax and air leak                                                                                & 0.611 (0.583, 0.641) & 0.624 (0.591, 0.652) & 0.011 (-0.01, 0.04)     &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_004     & Streptococcus                                                                                            & 0.578 (0.557, 0.599) & 0.59 (0.565, 0.609)  & 0.011 (-0.006, 0.03)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_554     & Diseases of the pancreas                                                                                 & 0.598 (0.578, 0.616) & 0.606 (0.588, 0.626) & 0.011 (-0.006, 0.024)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-6   & Hemangioma and lymphangioma                                                                              & 0.501 (0.485, 0.517) & 0.513 (0.498, 0.534) & 0.011 (-0.004, 0.034)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709-22  & Hallux rigidus                                                                                           & 0.573 (0.552, 0.592) & 0.585 (0.561, 0.605) & 0.011 (-0.003, 0.027)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103-1   & Melanomas of skin                                                                                        & 0.603 (0.588, 0.621) & 0.615 (0.598, 0.633) & 0.011 (-0.002, 0.021)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_584     & Renal failure                                                                                            & 0.683 (0.663, 0.699) & 0.692 (0.676, 0.712) & 0.011 (-0.001, 0.024)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103     & Malignant neoplasm of the skin                                                                           & 0.655 (0.648, 0.664) & 0.666 (0.658, 0.674) & 0.01 (0.008, 0.013)     & 0.625 (0.606, 0.633) & 0.623 (0.604, 0.632) & -0.002 (-0.003, -0.001)\\\\\n",
       "\t Derm           & phecode\\_673-1   & Actinic keratosis                                                                                        & 0.599 (0.595, 0.603) & 0.609 (0.605, 0.614) & 0.01 (0.008, 0.012)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660     & Infection of the skin                                                                                    & 0.524 (0.52, 0.528)  & 0.534 (0.53, 0.539)  & 0.01 (0.007, 0.013)     & 0.676 (0.666, 0.692) & 0.68 (0.673, 0.699)  & 0.007 (-0.001, 0.01)   \\\\\n",
       "\t Death          & OMOP\\_4306655    & All-Cause Death                                                                                          & 0.707 (0.702, 0.714) & 0.718 (0.712, 0.723) & 0.01 (0.006, 0.014)     & 0.733 (0.705, 0.784) & 0.727 (0.701, 0.773) & -0.006 (-0.015, 0.008) \\\\\n",
       "\t Cardio         & phecode\\_424     & Heart failure                                                                                            & 0.737 (0.731, 0.748) & 0.747 (0.739, 0.756) & 0.01 (0.005, 0.016)     & 0.767 (0.757, 0.778) & 0.768 (0.759, 0.78)  & 0.002 (0, 0.004)       \\\\\n",
       "\t Cardio         & phecode\\_424-1   & Left heart failure                                                                                       & 0.73 (0.716, 0.743)  & 0.739 (0.726, 0.752) & 0.01 (0.004, 0.015)     &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463     & Rhinitis and nasal congestion                                                                            & 0.522 (0.517, 0.529) & 0.532 (0.525, 0.538) & 0.01 (0.004, 0.015)     &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_234     & Other nutritional deficiencies                                                                           & 0.58 (0.57, 0.593)   & 0.59 (0.58, 0.604)   & 0.01 (0.002, 0.02)      &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_181     & Autoimmune disease                                                                                       & 0.547 (0.536, 0.556) & 0.557 (0.548, 0.568) & 0.01 (0.001, 0.022)     & 0.561 (0.549, 0.58)  & 0.561 (0.539, 0.573) & -0.002 (-0.014, 0.01)  \\\\\n",
       "\t Neuro          & phecode\\_336-5   & Mononeuritis of lower limb                                                                               & 0.563 (0.549, 0.578) & 0.574 (0.56, 0.589)  & 0.01 (0.001, 0.02)      &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_509-3   & Hypertrophy of tongue papillae                                                                           & 0.533 (0.497, 0.576) & 0.543 (0.507, 0.576) & 0.01 (-0.024, 0.039)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_366-4   & Vascular abnormalities of conjunctiva                                                                    & 0.524 (0.495, 0.56)  & 0.533 (0.51, 0.567)  & 0.01 (-0.02, 0.042)     &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_162     & Aplastic anemia                                                                                          & 0.657 (0.631, 0.689) & 0.667 (0.636, 0.699) & 0.01 (-0.018, 0.033)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_526-12  & Intestinal infection due to C. difficile                                                                 & 0.646 (0.619, 0.681) & 0.657 (0.628, 0.692) & 0.01 (-0.017, 0.038)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_452     & Hemorrhage, NOS                                                                                          & 0.575 (0.546, 0.6)   & 0.586 (0.554, 0.611) & 0.01 (-0.014, 0.034)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_840-1   & Food allergy                                                                                             & 0.547 (0.523, 0.573) & 0.556 (0.531, 0.584) & 0.01 (-0.008, 0.028)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_513-1   & Esophageal ulcer                                                                                         & 0.599 (0.577, 0.618) & 0.609 (0.593, 0.632) & 0.01 (-0.005, 0.026)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_682-11  & Sebaceous cyst {[}Epidermal cyst{]}                                                                          & 0.486 (0.479, 0.496) & 0.497 (0.489, 0.506) & 0.01 (-0.003, 0.021)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_585-1   & Renal colic                                                                                              & 0.608 (0.589, 0.629) & 0.62 (0.598, 0.641)  & 0.01 (-0.002, 0.026)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103-21  & Basal cell carcinoma                                                                                     & 0.643 (0.634, 0.652) & 0.652 (0.643, 0.661) & 0.009 (0.006, 0.013)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103-2   & Keratinocyte carcinoma                                                                                   & 0.652 (0.646, 0.659) & 0.66 (0.654, 0.668)  & 0.009 (0.006, 0.011)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_605     & Male sexual dysfuction                                                                                   & 0.558 (0.552, 0.564) & 0.567 (0.56, 0.575)  & 0.009 (0.005, 0.013)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_460-1   & Acute upper respiratory infection                                                                        & 0.534 (0.529, 0.54)  & 0.543 (0.539, 0.548) & 0.009 (0.005, 0.013)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_809-3   & Pain in limb                                                                                             & 0.524 (0.52, 0.529)  & 0.533 (0.529, 0.537) & 0.009 (0.005, 0.013)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_809     & Pain                                                                                                     & 0.528 (0.525, 0.531) & 0.537 (0.533, 0.541) & 0.009 (0.005, 0.013)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_605-1   & Male erectile dysfunction                                                                                & 0.558 (0.551, 0.564) & 0.567 (0.559, 0.573) & 0.009 (0.004, 0.014)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-9   & Gastritis                                                                                                & 0.565 (0.558, 0.571) & 0.574 (0.568, 0.58)  & 0.009 (0.004, 0.014)    & 0.571 (0.552, 0.583) & 0.57 (0.55, 0.582)   & -0.001 (-0.001, -0.001)\\\\\n",
       "\t Neuro          & phecode\\_331-8   & Headache NOS                                                                                             & 0.57 (0.564, 0.574)  & 0.578 (0.573, 0.584) & 0.009 (0.004, 0.014)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_823-2   & Abnormal levels of other serum enzymes                                                                   & 0.56 (0.552, 0.568)  & 0.569 (0.56, 0.578)  & 0.009 (0.004, 0.013)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_433     & Other cerebrovascular disease                                                                            & 0.716 (0.705, 0.726) & 0.725 (0.717, 0.734) & 0.009 (0.003, 0.016)    & 0.773 (0.759, 0.78)  & 0.77 (0.756, 0.779)  & -0.002 (-0.006, 0)     \\\\\n",
       "\t Signs/Symptoms & phecode\\_823     & Abnormal serum enzyme levels                                                                             & 0.56 (0.55, 0.569)   & 0.569 (0.56, 0.578)  & 0.009 (0.003, 0.014)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_716-3   & Spinal disc displacement (herniation)                                                                    & 0.542 (0.531, 0.556) & 0.552 (0.541, 0.563) & 0.009 (0.002, 0.019)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724-1   & Myalgia                                                                                                  & 0.555 (0.547, 0.564) & 0.563 (0.553, 0.571) & 0.009 (0.001, 0.015)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_015-2   & Clostridium difficile                                                                                    & 0.646 (0.622, 0.673) & 0.656 (0.629, 0.684) & 0.009 (-0.017, 0.033)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_557-1   & Hematemesis                                                                                              & 0.596 (0.578, 0.619) & 0.605 (0.578, 0.627) & 0.009 (-0.017, 0.031)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_361-1   & Entropion and trichiasis of eyelid                                                                       & 0.682 (0.651, 0.712) & 0.691 (0.662, 0.72)  & 0.009 (-0.013, 0.024)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_468-8   & Bronchopneumonia                                                                                         & 0.686 (0.653, 0.731) & 0.695 (0.663, 0.739) & 0.009 (-0.012, 0.029)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_437     & Vascular insufficiency of intestine                                                                      & 0.665 (0.634, 0.687) & 0.673 (0.645, 0.707) & 0.009 (-0.008, 0.03)    &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_168     & Coagulation defects, purpura and other hemorrhagic conditions                                            & 0.595 (0.579, 0.612) & 0.604 (0.589, 0.618) & 0.009 (-0.004, 0.018)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_360-2   & Chalazion                                                                                                & 0.52 (0.503, 0.535)  & 0.531 (0.514, 0.541) & 0.009 (-0.002, 0.018)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_705-1   & Rheumatoid arthritis                                                                                     & 0.591 (0.576, 0.609) & 0.601 (0.583, 0.617) & 0.009 (-0.001, 0.023)   & 0.596 (0.576, 0.613) & 0.59 (0.577, 0.616)  & 0.002 (-0.012, 0.012)  \\\\\n",
       "\t Metab          & phecode\\_239-11  & Pure hypercholesterolemia                                                                                & 0.614 (0.611, 0.618) & 0.623 (0.619, 0.627) & 0.008 (0.006, 0.011)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_239-1   & Hypercholesterolemia                                                                                     & 0.613 (0.609, 0.617) & 0.621 (0.616, 0.626) & 0.008 (0.006, 0.01)     &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-1   & Fungal infection of the skin                                                                             & 0.541 (0.535, 0.548) & 0.55 (0.544, 0.556)  & 0.008 (0.005, 0.012)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_830     & Proteinuria                                                                                              & 0.584 (0.579, 0.59)  & 0.591 (0.587, 0.597) & 0.008 (0.005, 0.012)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_239     & Hyperlipidemia                                                                                           & 0.606 (0.602, 0.612) & 0.615 (0.61, 0.62)   & 0.008 (0.005, 0.011)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_070     & Candidiasis                                                                                              & 0.586 (0.579, 0.594) & 0.594 (0.586, 0.603) & 0.008 (0.003, 0.013)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522     & Gastrointestinal inflammation                                                                            & 0.555 (0.549, 0.56)  & 0.563 (0.558, 0.568) & 0.008 (0.003, 0.012)    & 0.566 (0.56, 0.58)   & 0.565 (0.559, 0.58)  & -0.001 (-0.001, 0)     \\\\\n",
       "\t Musc/Skel      & phecode\\_715-4   & Spinal stenosis                                                                                          & 0.645 (0.633, 0.657) & 0.653 (0.641, 0.666) & 0.008 (0.001, 0.015)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_473     & Other diseases of upper respiratory tract                                                                & 0.537 (0.525, 0.551) & 0.545 (0.532, 0.558) & 0.008 (0, 0.014)        &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_469-1   & Acute bronchitis                                                                                         & 0.564 (0.542, 0.584) & 0.571 (0.545, 0.594) & 0.008 (-0.016, 0.031)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_375-12  & Angle-Closure Glaucoma                                                                                   & 0.675 (0.65, 0.698)  & 0.683 (0.659, 0.712) & 0.008 (-0.008, 0.027)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_713-4   & Stiffness of joint                                                                                       & 0.529 (0.512, 0.545) & 0.537 (0.511, 0.557) & 0.008 (-0.008, 0.024)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440-2   & Arterial embolism and thrombosis                                                                         & 0.689 (0.668, 0.709) & 0.697 (0.679, 0.715) & 0.008 (-0.008, 0.02)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_726-2   & Pathologic fracture                                                                                      & 0.724 (0.706, 0.745) & 0.732 (0.714, 0.751) & 0.008 (-0.005, 0.021)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_424-2   & Systolic heart failure                                                                                   & 0.721 (0.696, 0.743) & 0.73 (0.702, 0.751)  & 0.008 (-0.003, 0.019)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_526-1   & Bacterial enteritis                                                                                      & 0.528 (0.518, 0.543) & 0.538 (0.525, 0.55)  & 0.008 (-0.002, 0.022)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_800-1   & Chest pain on breathing                                                                                  & 0.54 (0.53, 0.557)   & 0.55 (0.54, 0.563)   & 0.008 (-0.002, 0.02)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_513     & Peptic ulcer                                                                                             & 0.594 (0.585, 0.603) & 0.601 (0.595, 0.613) & 0.008 (-0.002, 0.018)   & 0.672 (0.637, 0.69)  & 0.677 (0.649, 0.7)   & 0.009 (0.002, 0.015)   \\\\\n",
       "\t Cardio         & phecode\\_443     & Other specified disorders of arteries and arterioles                                                     & 0.687 (0.677, 0.702) & 0.696 (0.682, 0.708) & 0.008 (-0.001, 0.017)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_713-3   & Pain in joint                                                                                            & 0.526 (0.523, 0.53)  & 0.533 (0.529, 0.536) & 0.007 (0.004, 0.009)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_713     & Symptoms related to joints                                                                               & 0.526 (0.523, 0.53)  & 0.533 (0.53, 0.536)  & 0.007 (0.004, 0.009)    & 0.63 (0.609, 0.662)  & 0.634 (0.613, 0.662) & 0.004 (-0.004, 0.014)  \\\\\n",
       "\t Cardio         & phecode\\_403     & Angina pectoris                                                                                          & 0.672 (0.665, 0.682) & 0.679 (0.671, 0.686) & 0.007 (0.003, 0.011)    & 0.662 (0.648, 0.669) & 0.662 (0.649, 0.671) & 0.001 (-0.002, 0.005)  \\\\\n",
       "\t ID             & phecode\\_089     & Infections                                                                                               & 0.521 (0.517, 0.525) & 0.528 (0.524, 0.531) & 0.007 (0.003, 0.01)     & 0.675 (0.664, 0.683) & 0.68 (0.671, 0.693)  & 0.006 (0.004, 0.01)    \\\\\n",
       "\t Musc/Skel      & phecode\\_703-1   & Hyperuricemia                                                                                            & 0.701 (0.693, 0.708) & 0.707 (0.7, 0.715)   & 0.007 (0.003, 0.01)     & 0.78 (0.758, 0.796)  & 0.782 (0.768, 0.8)   & 0.004 (-0.001, 0.01)   \\\\\n",
       "\t Resp           & phecode\\_483     & Pleural effusion                                                                                         & 0.682 (0.672, 0.691) & 0.688 (0.679, 0.696) & 0.007 (0.002, 0.014)    & 0.647 (0.629, 0.659) & 0.65 (0.635, 0.661)  & 0.004 (0.002, 0.011)   \\\\\n",
       "\t ID             & phecode\\_092-2   & Sepsis                                                                                                   & 0.663 (0.652, 0.672) & 0.671 (0.66, 0.682)  & 0.007 (0.001, 0.013)    & 0.683 (0.652, 0.698) & 0.682 (0.654, 0.696) & 0.001 (-0.002, 0.003)  \\\\\n",
       "\t Cardio         & phecode\\_404-1   & Myocardial infarction {[}Heart attack{]}                                                                     & 0.707 (0.699, 0.715) & 0.715 (0.707, 0.723) & 0.007 (0.001, 0.012)    & 0.711 (0.694, 0.728) & 0.714 (0.701, 0.731) & 0.004 (0, 0.006)       \\\\\n",
       "\t Musc/Skel      & phecode\\_721-1   & Synovitis and tenosynovitis                                                                              & 0.539 (0.534, 0.547) & 0.546 (0.54, 0.553)  & 0.007 (0.001, 0.012)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_431-11  & Cerebral infarction {[}Ischemic stroke{]}                                                                    & 0.704 (0.692, 0.715) & 0.711 (0.7, 0.721)   & 0.007 (0, 0.014)        & 0.723 (0.704, 0.727) & 0.721 (0.702, 0.726) & 0 (-0.003, 0.005)      \\\\\n",
       "\t Signs/Symptoms & phecode\\_802     & Throat pain                                                                                              & 0.549 (0.537, 0.559) & 0.555 (0.544, 0.567) & 0.007 (0, 0.013)        &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_439     & Hemorrhoids                                                                                              & 0.504 (0.499, 0.509) & 0.511 (0.506, 0.517) & 0.007 (0, 0.012)        & 0.47 (0.432, 0.496)  & 0.491 (0.455, 0.514) & 0.018 (0.013, 0.028)   \\\\\n",
       "\t Cardio         & phecode\\_424-3   & Diastolic heart failure                                                                                  & 0.697 (0.667, 0.722) & 0.703 (0.677, 0.73)  & 0.007 (-0.017, 0.026)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_554-2   & Cyst and pseudocyst of pancreas                                                                          & 0.626 (0.591, 0.658) & 0.634 (0.6, 0.663)   & 0.007 (-0.016, 0.033)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_807-11  & Postviral fatigue syndrome*                                                                              & 0.605 (0.574, 0.644) & 0.611 (0.576, 0.646) & 0.007 (-0.015, 0.023)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_411     & Other diseases of pericardium                                                                            & 0.642 (0.619, 0.662) & 0.65 (0.626, 0.67)   & 0.007 (-0.013, 0.026)   &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_230-3   & Anorexia                                                                                                 & 0.604 (0.588, 0.623) & 0.611 (0.593, 0.629) & 0.007 (-0.006, 0.019)   &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-5   & Disorders of calcium metabolism                                                                          & 0.609 (0.595, 0.621) & 0.615 (0.6, 0.632)   & 0.007 (-0.005, 0.019)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_397     & Other hearing abnormality                                                                                & 0.502 (0.494, 0.511) & 0.509 (0.5, 0.517)   & 0.007 (-0.005, 0.017)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_827     & Toxicology findings                                                                                      & 0.622 (0.604, 0.647) & 0.629 (0.613, 0.65)  & 0.007 (-0.003, 0.015)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_426     & Other heart disorders in diseases NEC                                                                    & 0.709 (0.697, 0.72)  & 0.715 (0.705, 0.729) & 0.007 (-0.002, 0.015)   & 0.676 (0.656, 0.685) & 0.684 (0.658, 0.693) & 0.007 (0, 0.011)       \\\\\n",
       "\t Cardio         & phecode\\_431-1   & Stroke                                                                                                   & 0.695 (0.683, 0.706) & 0.702 (0.692, 0.712) & 0.007 (-0.001, 0.017)   & 0.711 (0.701, 0.738) & 0.711 (0.699, 0.74)  & -0.001 (-0.003, 0.004) \\\\\n",
       "\t ID             & phecode\\_092     & Bacteremia, Sepsis, and SIRS                                                                             & 0.666 (0.655, 0.676) & 0.673 (0.663, 0.683) & 0.007 (-0.001, 0.014)   & 0.678 (0.671, 0.692) & 0.679 (0.673, 0.696) & 0.002 (-0.001, 0.004)  \\\\\n",
       "\t Mental         & phecode\\_286-2   & Major depressive disorder                                                                                & 0.569 (0.562, 0.574) & 0.574 (0.569, 0.581) & 0.006 (0.002, 0.011)    & 0.566 (0.548, 0.582) & 0.569 (0.55, 0.588)  & 0.003 (-0.001, 0.007)  \\\\\n",
       "\t Musc/Skel      & phecode\\_722-4   & Palmar fascial fibromatosis {[}Dupuytren{]}                                                                  & 0.645 (0.634, 0.658) & 0.651 (0.641, 0.663) & 0.006 (0.002, 0.011)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668     & Dermatitis {[}eczema{]}                                                                                      & 0.537 (0.531, 0.542) & 0.543 (0.538, 0.55)  & 0.006 (0.002, 0.01)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_703-11  & Gout                                                                                                     & 0.706 (0.698, 0.716) & 0.712 (0.702, 0.722) & 0.006 (0.002, 0.01)     & 0.78 (0.753, 0.805)  & 0.78 (0.757, 0.804)  & 0 (-0.003, 0.008)      \\\\\n",
       "\t GI             & phecode\\_550     & Disorders of the gallbladder                                                                             & 0.572 (0.566, 0.582) & 0.579 (0.572, 0.587) & 0.006 (0.001, 0.012)    & 0.569 (0.536, 0.581) & 0.565 (0.534, 0.577) & -0.003 (-0.006, -0.001)\\\\\n",
       "\t Signs/Symptoms & phecode\\_841-11  & Penicillin allergy                                                                                       & 0.584 (0.577, 0.593) & 0.59 (0.581, 0.597)  & 0.006 (0.001, 0.01)     &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_732     & Nonspecific abnormal findings on radiological and other examination of musculoskeletal system            & 0.632 (0.62, 0.641)  & 0.638 (0.626, 0.647) & 0.006 (0.001, 0.009)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_840-2   & Allergy to insects                                                                                       & 0.572 (0.56, 0.583)  & 0.579 (0.568, 0.59)  & 0.006 (0, 0.014)        &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391     & Disorders of the middle ear                                                                              & 0.522 (0.516, 0.53)  & 0.528 (0.522, 0.535) & 0.006 (0, 0.012)        &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_330-11  & Generalized epilepsy                                                                                     & 0.536 (0.501, 0.578) & 0.54 (0.498, 0.59)   & 0.006 (-0.042, 0.055)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_383     & Irregular eye movements                                                                                  & 0.541 (0.497, 0.591) & 0.546 (0.501, 0.589) & 0.006 (-0.031, 0.041)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-5   & Secondary malignancy of brain/spine                                                                      & 0.625 (0.599, 0.651) & 0.628 (0.608, 0.66)  & 0.006 (-0.022, 0.028)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-7   & Ulceration of the lower GI tract                                                                         & 0.541 (0.516, 0.57)  & 0.548 (0.52, 0.581)  & 0.006 (-0.019, 0.038)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_174     & Diseases of spleen                                                                                       & 0.586 (0.558, 0.62)  & 0.594 (0.567, 0.617) & 0.006 (-0.018, 0.031)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-32  & Tricuspid value insufficiency*                                                                           & 0.724 (0.695, 0.752) & 0.73 (0.705, 0.758)  & 0.006 (-0.014, 0.029)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_431-12  & Hemorrhagic stroke                                                                                       & 0.65 (0.626, 0.676)  & 0.658 (0.635, 0.675) & 0.006 (-0.012, 0.026)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_288-2   & Panic disorder {[}episodic paroxysmal anxiety{]}                                                             & 0.567 (0.55, 0.586)  & 0.575 (0.557, 0.591) & 0.006 (-0.009, 0.024)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_420     & Cardiac arrest                                                                                           & 0.728 (0.709, 0.748) & 0.733 (0.713, 0.756) & 0.006 (-0.009, 0.022)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_603-2   & Spermatocele                                                                                             & 0.531 (0.505, 0.552) & 0.538 (0.519, 0.562) & 0.006 (-0.008, 0.027)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724-52  & Osteophyte*                                                                                              & 0.582 (0.565, 0.601) & 0.588 (0.567, 0.607) & 0.006 (-0.008, 0.015)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-1   & Atopic dermatitis                                                                                        & 0.519 (0.505, 0.528) & 0.524 (0.511, 0.535) & 0.006 (-0.007, 0.018)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_508     & Diseases of lips                                                                                         & 0.584 (0.569, 0.6)   & 0.591 (0.575, 0.606) & 0.006 (-0.006, 0.019)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_800-11  & Pleurodynia*                                                                                             & 0.546 (0.535, 0.559) & 0.552 (0.54, 0.564)  & 0.006 (-0.006, 0.017)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-3   & Contact dermatitis                                                                                       & 0.539 (0.525, 0.549) & 0.545 (0.529, 0.557) & 0.006 (-0.003, 0.013)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_532     & Other disorders of the intestines                                                                        & 0.553 (0.54, 0.566)  & 0.559 (0.543, 0.574) & 0.006 (-0.002, 0.017)   & 0.549 (0.526, 0.578) & 0.544 (0.526, 0.575) & -0.003 (-0.005, -0.001)\\\\\n",
       "\t Resp           & phecode\\_471     & Other disorders of nose and nasal sinuses                                                                & 0.507 (0.499, 0.513) & 0.513 (0.507, 0.519) & 0.006 (-0.002, 0.016)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_557-8   & Hemorrhage of rectum and anus                                                                            & 0.51 (0.502, 0.521)  & 0.516 (0.507, 0.525) & 0.006 (-0.002, 0.015)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_827-1   & Finding of alcohol in blood                                                                              & 0.627 (0.609, 0.652) & 0.635 (0.616, 0.657) & 0.006 (-0.002, 0.015)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-6   & Secondary malignancy of bone                                                                             & 0.687 (0.677, 0.699) & 0.694 (0.682, 0.706) & 0.006 (-0.001, 0.016)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_550-1   & Gallstones {[}Cholelithiasis{]}                                                                              & 0.579 (0.57, 0.587)  & 0.583 (0.577, 0.593) & 0.006 (-0.001, 0.012)   & 0.572 (0.545, 0.597) & 0.573 (0.542, 0.596) & -0.002 (-0.005, 0.003) \\\\\n",
       "\t Derm           & phecode\\_678     & Other skin and connective tissue disorders                                                               & 0.553 (0.549, 0.557) & 0.558 (0.554, 0.563) & 0.005 (0.003, 0.007)    & 0.613 (0.587, 0.626) & 0.607 (0.58, 0.618)  & -0.006 (-0.008, -0.006)\\\\\n",
       "\t Mental         & phecode\\_286     & Mood {[}affective{]} disorders                                                                               & 0.569 (0.562, 0.576) & 0.574 (0.569, 0.582) & 0.005 (0.002, 0.01)     & 0.566 (0.549, 0.579) & 0.57 (0.557, 0.586)  & 0.004 (-0.005, 0.01)   \\\\\n",
       "\t Derm           & phecode\\_660-12  & Dermatophytosis                                                                                          & 0.55 (0.543, 0.558)  & 0.556 (0.549, 0.564) & 0.005 (0.002, 0.009)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529-5   & Constipation                                                                                             & 0.609 (0.604, 0.616) & 0.614 (0.609, 0.621) & 0.005 (0.002, 0.009)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_136-4   & Benign neoplasm of colon, rectum, anus and anal canal                                                    & 0.59 (0.585, 0.597)  & 0.596 (0.59, 0.602)  & 0.005 (0.002, 0.009)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_527     & Abdominal pain                                                                                           & 0.548 (0.544, 0.553) & 0.553 (0.549, 0.558) & 0.005 (0.002, 0.008)    & 0.553 (0.543, 0.564) & 0.55 (0.54, 0.561)   & -0.003 (-0.005, -0.003)\\\\\n",
       "\t Signs/Symptoms & phecode\\_841     & Drug and medical agent allergy                                                                           & 0.604 (0.6, 0.608)   & 0.609 (0.604, 0.614) & 0.005 (0.002, 0.008)    &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_350     & Other symptoms involving nervous system                                                                  & 0.61 (0.602, 0.617)  & 0.615 (0.608, 0.622) & 0.005 (0.001, 0.01)     & 0.803 (0.79, 0.813)  & 0.803 (0.791, 0.813) & 0 (0, 0.001)           \\\\\n",
       "\t Cardio         & phecode\\_436     & Atherosclerosis {[}ASCVD{]}                                                                                  & 0.704 (0.697, 0.711) & 0.709 (0.701, 0.715) & 0.005 (0.001, 0.009)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367     & Inflammation of the eye                                                                                  & 0.564 (0.558, 0.572) & 0.569 (0.564, 0.576) & 0.005 (0.001, 0.009)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103-3   & Carcinoma in situ of skin                                                                                & 0.718 (0.701, 0.729) & 0.724 (0.706, 0.734) & 0.005 (0.001, 0.009)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529-2   & Abdominal distension and flatulence                                                                      & 0.569 (0.561, 0.575) & 0.573 (0.566, 0.582) & 0.005 (0, 0.011)        &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_230     & Malnutrition and underweight                                                                             & 0.602 (0.593, 0.61)  & 0.607 (0.598, 0.614) & 0.005 (0, 0.011)        &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_404-2   & Coronary atherosclerosis {[}Atherosclerotic heart disease{]}                                                 & 0.703 (0.696, 0.71)  & 0.707 (0.701, 0.714) & 0.005 (0, 0.008)        &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_465     & Pharyngitis                                                                                              & 0.561 (0.554, 0.566) & 0.566 (0.558, 0.571) & 0.005 (0, 0.008)        &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144-3   & Benign neoplasms of the ovary                                                                            & 0.492 (0.456, 0.524) & 0.498 (0.464, 0.539) & 0.005 (-0.031, 0.057)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_472     & Diseases of vocal cords and larynx, not elsewhere classified                                             & 0.57 (0.543, 0.594)  & 0.573 (0.551, 0.608) & 0.005 (-0.025, 0.03)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_688-3   & Pyogenic granuloma of skin and subcutaneous tissue                                                       & 0.51 (0.48, 0.543)   & 0.519 (0.486, 0.546) & 0.005 (-0.021, 0.041)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_613-7   & Other signs and symptoms in breast                                                                       & 0.458 (0.434, 0.477) & 0.463 (0.447, 0.482) & 0.005 (-0.013, 0.03)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_477     & Inhalation lung injury                                                                                   & 0.719 (0.677, 0.749) & 0.723 (0.683, 0.769) & 0.005 (-0.012, 0.03)    & 0.747 (0.721, 0.779) & 0.75 (0.723, 0.783)  & 0.002 (-0.004, 0.004)  \\\\\n",
       "\t Neuro          & phecode\\_330     & Epilepsy, recurrent seizures, convulsions                                                                & 0.578 (0.561, 0.597) & 0.583 (0.563, 0.602) & 0.005 (-0.012, 0.019)   & 0.601 (0.546, 0.64)  & 0.598 (0.549, 0.649) & 0.002 (-0.007, 0.013)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_815     & Symptoms and signs concerning food and fluid intake                                                      & 0.538 (0.522, 0.56)  & 0.542 (0.524, 0.566) & 0.005 (-0.011, 0.021)   & 0.602 (0.578, 0.654) & 0.61 (0.585, 0.662)  & 0.008 (0, 0.012)       \\\\\n",
       "\t Cardio         & phecode\\_414     & Cardiomyopathy                                                                                           & 0.658 (0.635, 0.679) & 0.665 (0.644, 0.684) & 0.005 (-0.005, 0.019)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_718-3   & Mid back pain                                                                                            & 0.574 (0.558, 0.591) & 0.58 (0.567, 0.593)  & 0.005 (-0.005, 0.016)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_170     & Decreased white blood cell count                                                                         & 0.586 (0.574, 0.597) & 0.591 (0.579, 0.605) & 0.005 (-0.004, 0.019)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-2   & Rotator cuff tear or rupture                                                                             & 0.536 (0.528, 0.547) & 0.541 (0.533, 0.551) & 0.005 (-0.004, 0.013)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_103-22  & Squamous cell carcinoma of the skin                                                                      & 0.716 (0.695, 0.743) & 0.721 (0.699, 0.744) & 0.005 (-0.004, 0.011)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-1   & Otitis media                                                                                             & 0.527 (0.516, 0.536) & 0.532 (0.522, 0.54)  & 0.005 (-0.002, 0.014)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-21  & Aortic stenosis                                                                                          & 0.755 (0.741, 0.765) & 0.758 (0.747, 0.772) & 0.005 (-0.002, 0.012)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308     & Signs and symptoms involving emotional state                                                             & 0.564 (0.557, 0.571) & 0.569 (0.561, 0.576) & 0.005 (-0.002, 0.01)    &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_256-2   & Hyposmolality and/or hyponatremia                                                                        & 0.534 (0.524, 0.546) & 0.539 (0.531, 0.55)  & 0.005 (-0.001, 0.013)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_431     & Stroke and transient cerebral ischemic attacks                                                           & 0.689 (0.679, 0.696) & 0.693 (0.686, 0.701) & 0.005 (-0.001, 0.01)    & 0.707 (0.692, 0.737) & 0.707 (0.693, 0.735) & -0.001 (-0.002, 0.001) \\\\\n",
       "\t Mental         & phecode\\_294     & Sexual dysfunction and disorders                                                                         & 0.786 (0.782, 0.791) & 0.791 (0.786, 0.795) & 0.004 (0.003, 0.006)    &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679     & Skin symptoms                                                                                            & 0.536 (0.532, 0.541) & 0.541 (0.537, 0.545) & 0.004 (0.002, 0.007)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_404     & Ischemic heart disease                                                                                   & 0.69 (0.683, 0.695)  & 0.694 (0.687, 0.699) & 0.004 (0.001, 0.008)    & 0.68 (0.664, 0.689)  & 0.68 (0.665, 0.692)  & 0.001 (0, 0.004)       \\\\\n",
       "\t Musc/Skel      & phecode\\_703     & Chrystal arthropathies                                                                                   & 0.698 (0.691, 0.704) & 0.702 (0.695, 0.71)  & 0.004 (0.001, 0.008)    & 0.73 (0.7, 0.748)    & 0.73 (0.702, 0.748)  & 0 (-0.003, 0.003)      \\\\\n",
       "\t Neoplasms      & phecode\\_136-41  & Benign neoplasm of the colon                                                                             & 0.601 (0.595, 0.607) & 0.606 (0.599, 0.612) & 0.004 (0.001, 0.008)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_363     & Disorders of lacrimal system                                                                             & 0.634 (0.628, 0.64)  & 0.638 (0.632, 0.644) & 0.004 (0.001, 0.007)    &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_819     & General symptoms and other findings                                                                      & 0.582 (0.577, 0.586) & 0.586 (0.581, 0.59)  & 0.004 (0.001, 0.007)    & 0.708 (0.655, 0.732) & 0.713 (0.66, 0.733)  & 0.006 (-0.004, 0.009)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_829     & Nonspecific findings on examination of blood                                                             & 0.652 (0.646, 0.659) & 0.656 (0.65, 0.664)  & 0.004 (0.001, 0.006)    & 0.649 (0.634, 0.683) & 0.648 (0.633, 0.682) & -0.001 (-0.002, 0)     \\\\\n",
       "\t Derm           & phecode\\_675     & Atrophic conditions of skin                                                                              & 0.716 (0.704, 0.726) & 0.72 (0.709, 0.73)   & 0.004 (0, 0.008)        &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_675-1   & Circumscribed scleroderma                                                                                & 0.716 (0.704, 0.727) & 0.72 (0.708, 0.734)  & 0.004 (0, 0.008)        &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_465-1   & Acute Pharyngitis                                                                                        & 0.561 (0.555, 0.567) & 0.566 (0.558, 0.573) & 0.004 (0, 0.008)        &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_363-2   & Dry eye syndrome {[}Tear film insufficiency{]}                                                               & 0.64 (0.634, 0.648)  & 0.644 (0.638, 0.653) & 0.004 (0, 0.007)        &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_280-8   & Other psychoactive substance related disorders                                                           & 0.598 (0.553, 0.638) & 0.598 (0.565, 0.643) & 0.004 (-0.029, 0.042)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-6   & Malignant neoplasm of the liver and intrahepatic bile ducts                                              & 0.719 (0.685, 0.752) & 0.725 (0.678, 0.76)  & 0.004 (-0.022, 0.028)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_406-1   & Pulmonary hypertension                                                                                   & 0.745 (0.724, 0.761) & 0.747 (0.725, 0.768) & 0.004 (-0.013, 0.023)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-8   & Restless legs syndrome                                                                                   & 0.592 (0.572, 0.613) & 0.597 (0.58, 0.618)  & 0.004 (-0.01, 0.023)    &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-22  & Uninodular goiter {[}single thyroid nodule{]}                                                                & 0.628 (0.603, 0.651) & 0.631 (0.604, 0.651) & 0.004 (-0.01, 0.012)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_550-4   & Cholesterolosis of gallbladder                                                                           & 0.582 (0.545, 0.613) & 0.586 (0.553, 0.615) & 0.004 (-0.009, 0.018)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_390-6   & Perichondritis and chondritis of pinna                                                                   & 0.678 (0.651, 0.7)   & 0.68 (0.656, 0.703)  & 0.004 (-0.008, 0.016)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_349     & Disorder of nervous system                                                                               & 0.603 (0.587, 0.616) & 0.607 (0.59, 0.62)   & 0.004 (-0.008, 0.016)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_423     & Abnormal cardiac sounds                                                                                  & 0.642 (0.626, 0.656) & 0.645 (0.63, 0.661)  & 0.004 (-0.008, 0.015)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_170-1   & Neutropenia                                                                                              & 0.585 (0.573, 0.599) & 0.589 (0.577, 0.603) & 0.004 (-0.008, 0.013)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_397-1   & Tinnitus                                                                                                 & 0.503 (0.493, 0.514) & 0.507 (0.497, 0.515) & 0.004 (-0.007, 0.016)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_557-2   & Blood in stool                                                                                           & 0.621 (0.608, 0.64)  & 0.626 (0.611, 0.642) & 0.004 (-0.007, 0.015)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_169     & Platelet defects                                                                                         & 0.666 (0.649, 0.68)  & 0.669 (0.654, 0.684) & 0.004 (-0.006, 0.016)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_674-2   & Hypepigmentation                                                                                         & 0.587 (0.569, 0.609) & 0.593 (0.573, 0.613) & 0.004 (-0.006, 0.014)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_720     & Spontaneous rupture of synovium and tendon                                                               & 0.605 (0.589, 0.63)  & 0.608 (0.593, 0.633) & 0.004 (-0.006, 0.011)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_514-2   & Intestinal obstruction                                                                                   & 0.621 (0.606, 0.636) & 0.625 (0.608, 0.643) & 0.004 (-0.005, 0.015)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529-3   & Fecal incontinence                                                                                       & 0.639 (0.626, 0.652) & 0.642 (0.627, 0.657) & 0.004 (-0.005, 0.014)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_530     & Disease of anus and rectum                                                                               & 0.527 (0.518, 0.54)  & 0.53 (0.52, 0.544)   & 0.004 (-0.005, 0.013)   & 0.544 (0.514, 0.573) & 0.55 (0.527, 0.591)  & 0.012 (0, 0.019)       \\\\\n",
       "\t GI             & phecode\\_512     & Dysphagia                                                                                                & 0.575 (0.567, 0.585) & 0.578 (0.57, 0.59)   & 0.004 (-0.004, 0.012)   & 0.613 (0.606, 0.628) & 0.611 (0.606, 0.628) & -0.001 (-0.004, 0.003) \\\\\n",
       "\t Hearing        & phecode\\_398     & Other disorders of ear                                                                                   & 0.575 (0.563, 0.588) & 0.579 (0.567, 0.595) & 0.004 (-0.004, 0.011)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_419     & Presence of cardiac device                                                                               & 0.738 (0.723, 0.755) & 0.743 (0.727, 0.759) & 0.004 (-0.003, 0.011)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_444-5   & Venous insufficiency (chronic) (peripheral)                                                              & 0.662 (0.648, 0.676) & 0.666 (0.654, 0.68)  & 0.004 (-0.002, 0.011)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_446     & Hypotension                                                                                              & 0.663 (0.655, 0.671) & 0.667 (0.66, 0.674)  & 0.004 (-0.001, 0.011)   & 0.723 (0.71, 0.745)  & 0.724 (0.711, 0.746) & 0.001 (-0.001, 0.003)  \\\\\n",
       "\t GI             & phecode\\_557     & Gastrointestinal hemorrhage                                                                              & 0.532 (0.525, 0.538) & 0.536 (0.53, 0.544)  & 0.004 (-0.001, 0.01)    &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_136-42  & Benign neoplasm of rectum and anus                                                                       & 0.594 (0.586, 0.605) & 0.599 (0.589, 0.611) & 0.004 (-0.001, 0.009)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440     & Embolism and thrombosis                                                                                  & 0.597 (0.588, 0.605) & 0.601 (0.594, 0.608) & 0.004 (-0.001, 0.008)   & 0.476 (0.463, 0.499) & 0.481 (0.466, 0.503) & 0.004 (-0.01, 0.015)   \\\\\n",
       "\t Mental         & phecode\\_288-3   & Generalized anxiety disorder                                                                             & 0.593 (0.58, 0.609)  & 0.597 (0.585, 0.61)  & 0.004 (-0.001, 0.008)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_528     & Nausea and vomiting                                                                                      & 0.584 (0.577, 0.592) & 0.588 (0.581, 0.594) & 0.004 (-0.001, 0.007)   & 0.628 (0.614, 0.642) & 0.626 (0.611, 0.644) & -0.002 (-0.005, 0.004) \\\\\n",
       "\t Musc/Skel      & phecode\\_708     & Osteoarthritis                                                                                           & 0.612 (0.609, 0.616) & 0.615 (0.612, 0.619) & 0.003 (0.002, 0.004)    & 0.588 (0.577, 0.608) & 0.589 (0.575, 0.607) & 0 (-0.003, 0.003)      \\\\\n",
       "\t Neoplasms      & phecode\\_136     & Benign neoplasm of the digestive organs                                                                  & 0.589 (0.583, 0.593) & 0.592 (0.586, 0.597) & 0.003 (0.001, 0.006)    & 0.584 (0.565, 0.596) & 0.583 (0.563, 0.594) & -0.002 (-0.002, -0.001)\\\\\n",
       "\t GI             & phecode\\_523     & Diverticular disease {[}Bowel diverticulosis{]}                                                              & 0.622 (0.616, 0.627) & 0.625 (0.62, 0.63)   & 0.003 (0.001, 0.005)    & 0.568 (0.558, 0.577) & 0.564 (0.551, 0.577) & -0.003 (-0.007, 0)     \\\\\n",
       "\t Musc/Skel      & phecode\\_726-1   & Osteoporosis                                                                                             & 0.746 (0.74, 0.753)  & 0.748 (0.743, 0.755) & 0.003 (0.001, 0.005)    & 0.752 (0.731, 0.762) & 0.756 (0.737, 0.769) & 0.005 (0.002, 0.008)   \\\\\n",
       "\t Musc/Skel      & phecode\\_708-1   & Primary osteoarthritis                                                                                   & 0.611 (0.603, 0.617) & 0.614 (0.607, 0.62)  & 0.003 (0.001, 0.005)    & 0.565 (0.541, 0.581) & 0.576 (0.563, 0.596) & 0.013 (0.007, 0.028)   \\\\\n",
       "\t GI             & phecode\\_528-1   & Nausea                                                                                                   & 0.585 (0.576, 0.59)  & 0.588 (0.579, 0.594) & 0.003 (0, 0.008)        & 0.624 (0.604, 0.635) & 0.621 (0.602, 0.631) & -0.003 (-0.007, 0)     \\\\\n",
       "\t Genitourinary  & phecode\\_583     & Chronic kidney disease                                                                                   & 0.684 (0.677, 0.692) & 0.688 (0.681, 0.693) & 0.003 (0, 0.007)        & 0.742 (0.733, 0.758) & 0.745 (0.734, 0.76)  & 0.002 (0, 0.004)       \\\\\n",
       "\t Mental         & phecode\\_288     & Anxiety disorders                                                                                        & 0.59 (0.584, 0.596)  & 0.593 (0.587, 0.598) & 0.003 (0, 0.006)        & 0.593 (0.578, 0.606) & 0.592 (0.575, 0.603) & -0.001 (-0.004, 0.002) \\\\\n",
       "\t Neuro          & phecode\\_354     & Dizziness and giddiness                                                                                  & 0.571 (0.566, 0.576) & 0.575 (0.569, 0.58)  & 0.003 (0, 0.006)        &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_007     & Hemophilus infection                                                                                     & 0.611 (0.572, 0.669) & 0.615 (0.584, 0.66)  & 0.003 (-0.025, 0.035)   &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_030     & Campylobacter                                                                                            & 0.532 (0.516, 0.552) & 0.535 (0.518, 0.555) & 0.003 (-0.022, 0.019)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_433-1   & Occlusion and stenosis of cerebral arteries                                                              & 0.716 (0.693, 0.746) & 0.719 (0.695, 0.739) & 0.003 (-0.02, 0.019)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_506-3   & Sialoadenitis                                                                                            & 0.553 (0.53, 0.575)  & 0.555 (0.527, 0.582) & 0.003 (-0.019, 0.023)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_406     & Chronic pulmonary heart disease                                                                          & 0.741 (0.723, 0.758) & 0.745 (0.726, 0.764) & 0.003 (-0.012, 0.02)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_447     & Nonspecific low blood-pressure reading                                                                   & 0.642 (0.623, 0.664) & 0.646 (0.625, 0.668) & 0.003 (-0.012, 0.016)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_715-3   & Spondylolisthesis                                                                                        & 0.663 (0.638, 0.679) & 0.665 (0.644, 0.682) & 0.003 (-0.012, 0.015)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-2   & Secondary malignancy of respiratory organs                                                               & 0.632 (0.618, 0.646) & 0.634 (0.616, 0.65)  & 0.003 (-0.01, 0.014)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_597-1   & Urethral stricture                                                                                       & 0.655 (0.631, 0.675) & 0.657 (0.638, 0.678) & 0.003 (-0.01, 0.013)    &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_479-6   & Pulmonary collapse {[}Atelectasis{]}                                                                         & 0.646 (0.631, 0.666) & 0.649 (0.635, 0.664) & 0.003 (-0.009, 0.012)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_169-1   & Thrombocytopenia                                                                                         & 0.667 (0.652, 0.683) & 0.67 (0.656, 0.692)  & 0.003 (-0.008, 0.016)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_586     & Other disorders of the kidney and ureters                                                                & 0.644 (0.632, 0.653) & 0.645 (0.637, 0.658) & 0.003 (-0.008, 0.01)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_423-1   & Cardiac murmurs                                                                                          & 0.641 (0.623, 0.655) & 0.644 (0.628, 0.66)  & 0.003 (-0.007, 0.015)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_682-12  & Pilar and trichodermal cyst                                                                              & 0.502 (0.491, 0.511) & 0.506 (0.496, 0.513) & 0.003 (-0.004, 0.013)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_446-2   & Orthostatic hypotension                                                                                  & 0.69 (0.677, 0.703)  & 0.692 (0.679, 0.706) & 0.003 (-0.004, 0.01)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440-13  & Phlebitis and thrombophlebitis                                                                           & 0.583 (0.575, 0.593) & 0.587 (0.575, 0.596) & 0.003 (-0.003, 0.01)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_507     & Lesions of mouth                                                                                         & 0.565 (0.555, 0.576) & 0.569 (0.556, 0.578) & 0.003 (-0.003, 0.009)   & 0.536 (0.514, 0.563) & 0.564 (0.544, 0.589) & 0.025 (-0.007, 0.061)  \\\\\n",
       "\t Genitourinary  & phecode\\_627-1   & Postmenopausal bleeding                                                                                  & 0.551 (0.542, 0.559) & 0.553 (0.545, 0.562) & 0.003 (-0.003, 0.008)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-7   & Generalized osteoarthritis                                                                               & 0.65 (0.643, 0.659)  & 0.654 (0.646, 0.661) & 0.003 (-0.003, 0.008)   & 0.598 (0.565, 0.619) & 0.593 (0.559, 0.608) & -0.006 (-0.012, -0.001)\\\\\n",
       "\t Metab          & phecode\\_230-2   & Abnormal loss of weight and underweight                                                                  & 0.608 (0.598, 0.617) & 0.61 (0.602, 0.62)   & 0.003 (-0.003, 0.007)   &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_230-21  & Abnormal weight loss                                                                                     & 0.612 (0.602, 0.621) & 0.616 (0.606, 0.624) & 0.003 (-0.002, 0.009)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329     & Symptoms and signs involving cognitive functions and awareness                                           & 0.644 (0.637, 0.652) & 0.648 (0.64, 0.654)  & 0.003 (-0.002, 0.007)   & 0.774 (0.752, 0.777) & 0.774 (0.754, 0.777) & 0 (-0.001, 0.001)      \\\\\n",
       "\t GI             & phecode\\_528-2   & Vomiting                                                                                                 & 0.585 (0.576, 0.591) & 0.588 (0.579, 0.595) & 0.003 (-0.001, 0.008)   & 0.622 (0.607, 0.639) & 0.62 (0.604, 0.636)  & -0.004 (-0.005, 0.001) \\\\\n",
       "\t Resp           & phecode\\_465-2   & Chronic Pharyngitis                                                                                      & 0.564 (0.558, 0.571) & 0.567 (0.56, 0.574)  & 0.003 (-0.001, 0.008)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_417-1   & Palpitations                                                                                             & 0.577 (0.571, 0.584) & 0.58 (0.574, 0.587)  & 0.003 (-0.001, 0.007)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_715     & Non-inflammatory spondylopathy                                                                           & 0.622 (0.615, 0.629) & 0.625 (0.618, 0.633) & 0.003 (-0.001, 0.007)   & 0.62 (0.593, 0.651)  & 0.627 (0.603, 0.655) & 0.005 (0.002, 0.012)   \\\\\n",
       "\t ID             & phecode\\_089-2   & Viral infections                                                                                         & 0.528 (0.522, 0.532) & 0.531 (0.525, 0.536) & 0.003 (-0.001, 0.006)   & 0.625 (0.616, 0.637) & 0.634 (0.626, 0.644) & 0.009 (-0.002, 0.015)  \\\\\n",
       "\t Musc/Skel      & phecode\\_723     & Enthesopathy/Enthesitis/Tendinopathy                                                                     & 0.535 (0.529, 0.538) & 0.538 (0.533, 0.542) & 0.003 (-0.001, 0.006)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_727     & Other disorders of bone                                                                                  & 0.71 (0.706, 0.716)  & 0.712 (0.708, 0.718) & 0.002 (0.001, 0.003)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-21  & Atrial fibrillation                                                                                      & 0.731 (0.722, 0.737) & 0.733 (0.725, 0.74)  & 0.002 (0, 0.006)        &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_523-2   & Diverticula of colon                                                                                     & 0.63 (0.625, 0.636)  & 0.632 (0.627, 0.638) & 0.002 (0, 0.005)        &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_331     & Headache                                                                                                 & 0.579 (0.571, 0.584) & 0.581 (0.575, 0.585) & 0.002 (0, 0.005)        & 0.581 (0.55, 0.592)  & 0.588 (0.549, 0.599) & 0.005 (-0.004, 0.01)   \\\\\n",
       "\t Musc/Skel      & phecode\\_726     & Osteoporosis and low bone density                                                                        & 0.741 (0.734, 0.747) & 0.743 (0.737, 0.748) & 0.002 (0, 0.004)        & 0.746 (0.733, 0.776) & 0.75 (0.735, 0.776)  & 0.003 (0, 0.006)       \\\\\n",
       "\t Signs/Symptoms & phecode\\_835     & Cytology and pathology findings                                                                          & 0.722 (0.713, 0.729) & 0.723 (0.714, 0.73)  & 0.002 (0, 0.003)        &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_330-3   & Convulsions                                                                                              & 0.567 (0.546, 0.589) & 0.568 (0.546, 0.586) & 0.002 (-0.023, 0.018)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_667     & Erythematous conditions                                                                                  & 0.555 (0.534, 0.57)  & 0.556 (0.54, 0.571)  & 0.002 (-0.017, 0.024)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_703-2   & Chondrocalcinosis                                                                                        & 0.678 (0.649, 0.707) & 0.68 (0.645, 0.711)  & 0.002 (-0.013, 0.015)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_700     & Diffuse diseases of connective tissue                                                                    & 0.63 (0.613, 0.652)  & 0.635 (0.613, 0.652) & 0.002 (-0.012, 0.02)    & 0.631 (0.612, 0.664) & 0.634 (0.605, 0.668) & 0.001 (-0.008, 0.007)  \\\\\n",
       "\t Resp           & phecode\\_478     & Aspiration pneumonia                                                                                     & 0.738 (0.719, 0.757) & 0.74 (0.722, 0.758)  & 0.002 (-0.012, 0.018)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_734-9   & Jaw pain                                                                                                 & 0.589 (0.569, 0.61)  & 0.591 (0.57, 0.615)  & 0.002 (-0.012, 0.017)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_481     & Interstitial pulmonary diseases                                                                          & 0.729 (0.711, 0.744) & 0.731 (0.715, 0.748) & 0.002 (-0.011, 0.017)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-14  & Primary osteoarthritis of the shoulder, upper arm                                                        & 0.605 (0.589, 0.62)  & 0.605 (0.59, 0.625)  & 0.002 (-0.011, 0.012)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581     & Renal tubulo-interstitial diseases                                                                       & 0.547 (0.533, 0.559) & 0.549 (0.537, 0.562) & 0.002 (-0.01, 0.015)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-13  & Blepharoconjunctivitis                                                                                   & 0.637 (0.615, 0.673) & 0.641 (0.617, 0.67)  & 0.002 (-0.01, 0.011)    &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-16  & Primary osteoarthritis ankle and foot                                                                    & 0.578 (0.566, 0.592) & 0.579 (0.564, 0.595) & 0.002 (-0.01, 0.01)     &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_507-1   & Stomatitis                                                                                               & 0.558 (0.545, 0.572) & 0.558 (0.543, 0.573) & 0.002 (-0.008, 0.011)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_514     & Gastrointestinal obstruction                                                                             & 0.625 (0.613, 0.64)  & 0.626 (0.616, 0.642) & 0.002 (-0.005, 0.01)    & 0.565 (0.544, 0.598) & 0.584 (0.551, 0.614) & 0.02 (0.006, 0.036)    \\\\\n",
       "\t Cardio         & phecode\\_438     & Aneurysm or ectasia                                                                                      & 0.718 (0.705, 0.73)  & 0.721 (0.708, 0.732) & 0.002 (-0.005, 0.008)   & 0.739 (0.732, 0.751) & 0.74 (0.729, 0.753)  & 0.001 (-0.004, 0.005)  \\\\\n",
       "\t Musc/Skel      & phecode\\_708-13  & Primary osteoarthritis of the hand                                                                       & 0.644 (0.633, 0.659) & 0.646 (0.636, 0.66)  & 0.002 (-0.004, 0.009)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_404-11  & Acute myocardial infarction                                                                              & 0.702 (0.693, 0.711) & 0.704 (0.694, 0.713) & 0.002 (-0.004, 0.008)   & 0.708 (0.686, 0.73)  & 0.715 (0.693, 0.734) & 0.005 (0.002, 0.008)   \\\\\n",
       "\t GI             & phecode\\_556-8   & Nonspecific abnormal findings in stool contents                                                          & 0.56 (0.552, 0.568)  & 0.562 (0.554, 0.571) & 0.002 (-0.003, 0.009)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_392     & Otalgia and effusion of ear                                                                              & 0.56 (0.552, 0.568)  & 0.562 (0.555, 0.569) & 0.002 (-0.003, 0.007)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_556     & Other symptoms involving the digestive system and abdomen                                                & 0.557 (0.551, 0.564) & 0.559 (0.552, 0.566) & 0.002 (-0.003, 0.006)   & 0.543 (0.527, 0.552) & 0.544 (0.529, 0.557) & 0.001 (-0.009, 0.009)  \\\\\n",
       "\t Musc/Skel      & phecode\\_715-1   & Spondylosis                                                                                              & 0.62 (0.611, 0.627)  & 0.622 (0.613, 0.629) & 0.002 (-0.002, 0.006)   & 0.588 (0.559, 0.618) & 0.596 (0.57, 0.616)  & 0.005 (-0.009, 0.019)  \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-1   & Allergy to other anti-infective agents                                                                   & 0.602 (0.595, 0.609) & 0.604 (0.596, 0.611) & 0.002 (-0.002, 0.006)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-2   & Atrial fibrillation and flutter                                                                          & 0.731 (0.726, 0.736) & 0.733 (0.728, 0.739) & 0.002 (-0.001, 0.005)   & 0.701 (0.692, 0.712) & 0.704 (0.696, 0.713) & 0.002 (0, 0.005)       \\\\\n",
       "\t Eye            & phecode\\_367-1   & Conjunctivitis                                                                                           & 0.57 (0.563, 0.578)  & 0.571 (0.564, 0.579) & 0.002 (-0.001, 0.005)   &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_969     & Adverse effects of agents primarily affecting gastrointestinal system                                    & 0.593 (0.587, 0.6)   & 0.595 (0.589, 0.601) & 0.002 (-0.001, 0.005)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_619-4   & Noninflammatory disorders of vagina                                                                      & 0.597 (0.589, 0.605) & 0.598 (0.589, 0.607) & 0.001 (0, 0.003)        &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_627     & Menopausal and postmenopausal disorders                                                                  & 0.686 (0.681, 0.691) & 0.687 (0.682, 0.692) & 0.001 (0, 0.002)        &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_396     & Hearing impairment                                                                                       & 0.638 (0.633, 0.643) & 0.638 (0.634, 0.643) & 0.001 (0, 0.002)        & 0.659 (0.648, 0.682) & 0.658 (0.646, 0.681) & -0.001 (-0.004, 0.001) \\\\\n",
       "\t Hearing        & phecode\\_390     & Disorders of external ear                                                                                & 0.559 (0.556, 0.564) & 0.561 (0.557, 0.565) & 0.001 (0, 0.002)        &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_390-4   & Impacted cerumen                                                                                         & 0.59 (0.585, 0.595)  & 0.591 (0.586, 0.596) & 0.001 (0, 0.001)        &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_106-2   & Malignant neoplasm of the uterus                                                                         & 0.556 (0.528, 0.578) & 0.554 (0.529, 0.582) & 0.001 (-0.026, 0.028)   &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_820     & Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity                              & 0.656 (0.628, 0.702) & 0.657 (0.619, 0.698) & 0.001 (-0.025, 0.022)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_540     & Hepatitis                                                                                                & 0.567 (0.531, 0.595) & 0.569 (0.535, 0.599) & 0.001 (-0.023, 0.022)   &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_176     & Other diseases of blood and blood-forming organs                                                         & 0.569 (0.552, 0.59)  & 0.571 (0.548, 0.588) & 0.001 (-0.02, 0.021)    &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_009     & Pseudomonas                                                                                              & 0.658 (0.63, 0.688)  & 0.661 (0.632, 0.689) & 0.001 (-0.018, 0.024)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-9   & Otorrhea                                                                                                 & 0.553 (0.529, 0.58)  & 0.553 (0.534, 0.58)  & 0.001 (-0.016, 0.023)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_676-2   & Scar conditions and fibrosis of skin                                                                     & 0.539 (0.518, 0.561) & 0.539 (0.519, 0.566) & 0.001 (-0.014, 0.021)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_707-8   & Polyarthritis                                                                                            & 0.603 (0.58, 0.629)  & 0.602 (0.578, 0.631) & 0.001 (-0.014, 0.015)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_135     & Benign neoplasm of the head and neck                                                                     & 0.558 (0.542, 0.577) & 0.559 (0.542, 0.573) & 0.001 (-0.012, 0.014)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_471-2   & Deviated nasal septum                                                                                    & 0.583 (0.566, 0.605) & 0.584 (0.567, 0.607) & 0.001 (-0.012, 0.013)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_546     & Other disorders of liver                                                                                 & 0.592 (0.576, 0.605) & 0.592 (0.579, 0.607) & 0.001 (-0.011, 0.015)   & 0.525 (0.516, 0.536) & 0.568 (0.539, 0.61)  & 0.044 (0.016, 0.084)   \\\\\n",
       "\t Musc/Skel      & phecode\\_734     & Diseases of the jaws                                                                                     & 0.584 (0.565, 0.605) & 0.585 (0.565, 0.604) & 0.001 (-0.011, 0.013)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710     & Acquired deformities of limbs                                                                            & 0.599 (0.583, 0.611) & 0.6 (0.585, 0.613)   & 0.001 (-0.01, 0.012)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-3   & Tricuspid valve disorders                                                                                & 0.738 (0.722, 0.748) & 0.738 (0.723, 0.748) & 0.001 (-0.01, 0.01)     &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_331-61  & Migraine with aura                                                                                       & 0.595 (0.576, 0.619) & 0.598 (0.575, 0.62)  & 0.001 (-0.009, 0.017)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_714-3   & Scoliosis                                                                                                & 0.693 (0.67, 0.712)  & 0.694 (0.676, 0.712) & 0.001 (-0.009, 0.01)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440-1   & Venous thromboembolism                                                                                   & 0.566 (0.554, 0.575) & 0.566 (0.555, 0.574) & 0.001 (-0.007, 0.006)   & 0.423 (0.407, 0.436) & 0.398 (0.383, 0.419) & -0.023 (-0.032, -0.015)\\\\\n",
       "\t Signs/Symptoms & phecode\\_848-2   & Nonspecific abnormal findings on radiological and other examination of other intrathoracic organs (echo) & 0.697 (0.685, 0.709) & 0.697 (0.685, 0.709) & 0.001 (-0.006, 0.007)   &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-2   & Goiter                                                                                                   & 0.639 (0.625, 0.655) & 0.641 (0.627, 0.655) & 0.001 (-0.005, 0.008)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_438-11  & Abdominal aortic aneurysm                                                                                & 0.822 (0.811, 0.834) & 0.824 (0.81, 0.836)  & 0.001 (-0.005, 0.007)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_431-2   & Transient cerebral ischemic attacks                                                                      & 0.677 (0.666, 0.69)  & 0.678 (0.667, 0.69)  & 0.001 (-0.005, 0.006)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_705     & Rheumatoid arthritis and other inflammatory polyarthropathies                                            & 0.619 (0.608, 0.628) & 0.62 (0.61, 0.629)   & 0.001 (-0.004, 0.007)   & 0.587 (0.564, 0.604) & 0.581 (0.565, 0.598) & -0.005 (-0.009, 0.003) \\\\\n",
       "\t Genitourinary  & phecode\\_603-6   & Scrotal pain*                                                                                            & 0.804 (0.795, 0.813) & 0.805 (0.796, 0.813) & 0.001 (-0.004, 0.006)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721-5   & Bursitis                                                                                                 & 0.535 (0.529, 0.542) & 0.536 (0.529, 0.543) & 0.001 (-0.004, 0.005)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-1   & Memory loss                                                                                              & 0.651 (0.643, 0.66)  & 0.652 (0.644, 0.663) & 0.001 (-0.004, 0.005)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_487     & Hemorrhage from respiratory passages                                                                     & 0.587 (0.576, 0.597) & 0.587 (0.576, 0.596) & 0.001 (-0.004, 0.005)   & 0.65 (0.618, 0.672)  & 0.646 (0.615, 0.674) & -0.001 (-0.005, 0.004) \\\\\n",
       "\t GI             & phecode\\_511     & Gastro-esophageal reflux disease                                                                         & 0.561 (0.556, 0.566) & 0.562 (0.556, 0.567) & 0.001 (-0.003, 0.006)   & 0.545 (0.53, 0.555)  & 0.539 (0.525, 0.55)  & -0.006 (-0.009, -0.004)\\\\\n",
       "\t Neoplasms      & phecode\\_112     & Malignant neoplasm of other and ill-defined sites                                                        & 0.662 (0.655, 0.667) & 0.663 (0.657, 0.669) & 0.001 (-0.001, 0.003)   & 0.627 (0.618, 0.635) & 0.625 (0.617, 0.634) & -0.001 (-0.003, 0)     \\\\\n",
       "\t Rx             & phecode\\_977-51  & Long term (current) use of hormonal contraceptives                                                       & 0.922 (0.916, 0.935) & 0.923 (0.917, 0.936) & 0.001 (-0.001, 0.002)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-11  & Inguinal hernia                                                                                          & 0.788 (0.783, 0.794) & 0.788 (0.783, 0.794) & 0 (0, 0.001)            & 0.717 (0.701, 0.732) & 0.714 (0.7, 0.73)    & -0.002 (-0.011, 0.001) \\\\\n",
       "\t Genitourinary  & phecode\\_593-3   & Recurrent and persistent hematuria*                                                                      & 0.547 (0.512, 0.59)  & 0.547 (0.517, 0.575) & 0 (-0.037, 0.035)       &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_174-2   & Splenomegaly                                                                                             & 0.617 (0.566, 0.665) & 0.618 (0.582, 0.646) & 0 (-0.032, 0.035)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-15  & Incisional hernia                                                                                        & 0.59 (0.565, 0.618)  & 0.59 (0.568, 0.614)  & 0 (-0.022, 0.022)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_532-1   & Intestinal fistula                                                                                       & 0.606 (0.579, 0.637) & 0.606 (0.582, 0.63)  & 0 (-0.02, 0.015)        &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_342     & Plegia and unspecified paralysis                                                                         & 0.56 (0.533, 0.58)   & 0.559 (0.534, 0.582) & 0 (-0.019, 0.022)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_433-21  & Carotid artery stenosis                                                                                  & 0.734 (0.708, 0.758) & 0.733 (0.712, 0.753) & 0 (-0.018, 0.014)       &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-7   & Abnormal granulation tissue, NOS                                                                         & 0.649 (0.626, 0.671) & 0.649 (0.62, 0.673)  & 0 (-0.017, 0.018)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_433-2   & Occlusion and stenosis of precerebral arteries                                                           & 0.738 (0.718, 0.76)  & 0.737 (0.715, 0.754) & 0 (-0.015, 0.015)       &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-7   & Iodine-deficiency related thyroid disorders*                                                             & 0.585 (0.569, 0.606) & 0.586 (0.567, 0.602) & 0 (-0.015, 0.014)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_618-12  & Rectocele                                                                                                & 0.558 (0.538, 0.578) & 0.558 (0.54, 0.573)  & 0 (-0.011, 0.01)        &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_396-22  & Presbycusis                                                                                              & 0.7 (0.684, 0.72)    & 0.698 (0.683, 0.721) & 0 (-0.01, 0.007)        &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-5   & Lipoma                                                                                                   & 0.519 (0.51, 0.531)  & 0.52 (0.508, 0.532)  & 0 (-0.009, 0.01)        &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_603     & Disorders and symptoms of testis                                                                         & 0.526 (0.514, 0.539) & 0.527 (0.511, 0.538) & 0 (-0.009, 0.009)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_717     & Other and unspecified dorsopathies                                                                       & 0.578 (0.563, 0.594) & 0.578 (0.561, 0.592) & 0 (-0.009, 0.009)       &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_670     & Seborrheic keratosis                                                                                     & 0.622 (0.597, 0.64)  & 0.623 (0.599, 0.642) & 0 (-0.009, 0.008)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-8   & Duodenitis                                                                                               & 0.598 (0.584, 0.613) & 0.598 (0.586, 0.609) & 0 (-0.009, 0.008)       &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_377     & Hemorrhage of the eye                                                                                    & 0.587 (0.575, 0.597) & 0.587 (0.575, 0.597) & 0 (-0.008, 0.007)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-12  & Primary osteoarthritis of knee, lower leg                                                                & 0.618 (0.605, 0.628) & 0.618 (0.605, 0.627) & 0 (-0.008, 0.006)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-5   & Inflammatory disease of cervix, vagina, and vulva                                                        & 0.562 (0.548, 0.577) & 0.562 (0.55, 0.572)  & 0 (-0.007, 0.007)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_615     & Endometriosis                                                                                            & 0.734 (0.71, 0.756)  & 0.733 (0.711, 0.754) & 0 (-0.007, 0.005)       &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_494     & Voice disturbance                                                                                        & 0.595 (0.584, 0.608) & 0.595 (0.585, 0.605) & 0 (-0.007, 0.005)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-211 & Paroxysmal atrial fibrillation*                                                                          & 0.683 (0.674, 0.695) & 0.683 (0.674, 0.694) & 0 (-0.007, 0.004)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-55  & Candidiasis of vulva and vagina                                                                          & 0.763 (0.756, 0.773) & 0.764 (0.757, 0.772) & 0 (-0.006, 0.008)       &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_331-1   & Tension headache                                                                                         & 0.615 (0.603, 0.628) & 0.615 (0.602, 0.629) & 0 (-0.006, 0.007)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614     & Inflammatory diseases of female pelvic organs                                                            & 0.564 (0.551, 0.573) & 0.565 (0.553, 0.574) & 0 (-0.005, 0.007)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709-24  & Hammer toe                                                                                               & 0.687 (0.671, 0.707) & 0.687 (0.67, 0.705)  & 0 (-0.005, 0.006)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_146-2   & Benign neoplasm of the prostate                                                                          & 0.647 (0.634, 0.66)  & 0.648 (0.634, 0.661) & 0 (-0.005, 0.005)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_438-1   & Aortic aneurysm and ectasia                                                                              & 0.788 (0.777, 0.797) & 0.788 (0.778, 0.796) & 0 (-0.005, 0.004)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529-1   & Diarrhea                                                                                                 & 0.544 (0.538, 0.551) & 0.545 (0.538, 0.55)  & 0 (-0.005, 0.004)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-11  & Primary osteoarthritis of hip, pelvic region and thigh                                                   & 0.657 (0.641, 0.674) & 0.657 (0.642, 0.675) & 0 (-0.004, 0.006)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_418     & Abnormal results of cardiovascular function studies                                                      & 0.66 (0.651, 0.666)  & 0.659 (0.651, 0.668) & 0 (-0.004, 0.005)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594-2   & Dysuria                                                                                                  & 0.611 (0.603, 0.621) & 0.611 (0.605, 0.62)  & 0 (-0.004, 0.004)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144-21  & Leiomyoma of uterus                                                                                      & 0.709 (0.697, 0.72)  & 0.71 (0.697, 0.72)   & 0 (-0.004, 0.004)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144     & Gynecological benign neoplasms                                                                           & 0.649 (0.64, 0.661)  & 0.649 (0.638, 0.661) & 0 (-0.004, 0.003)       &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_679-1   & Rash and other nonspecific skin eruption                                                                 & 0.533 (0.529, 0.538) & 0.534 (0.53, 0.538)  & 0 (-0.003, 0.004)       &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-52  & Hormone replacement therapy (postmenopausal)                                                             & 0.749 (0.733, 0.764) & 0.749 (0.734, 0.766) & 0 (-0.003, 0.004)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-2   & Diaphragmatic hernia {[}Hiatal hernia{]}                                                                     & 0.603 (0.597, 0.612) & 0.603 (0.596, 0.612) & 0 (-0.003, 0.003)       & 0.593 (0.582, 0.607) & 0.591 (0.579, 0.606) & -0.001 (-0.003, 0)     \\\\\n",
       "\t Genitourinary  & phecode\\_626-14  & Irregular menstrual bleeding                                                                             & 0.871 (0.863, 0.878) & 0.87 (0.863, 0.879)  & 0 (-0.003, 0.002)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721     & Synoviopathy and bursopathy                                                                              & 0.535 (0.53, 0.54)   & 0.535 (0.53, 0.54)   & 0 (-0.003, 0.002)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_529     & Symptoms involving digestive system                                                                      & 0.562 (0.558, 0.566) & 0.562 (0.559, 0.566) & 0 (-0.002, 0.003)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416     & Cardiac arrhythmia and conduction disorders                                                              & 0.697 (0.692, 0.702) & 0.698 (0.692, 0.701) & 0 (-0.002, 0.002)       & 0.708 (0.697, 0.721) & 0.71 (0.698, 0.723)  & 0.001 (-0.001, 0.004)  \\\\\n",
       "\t Genitourinary  & phecode\\_619     & Noninflammatory female genital disorders                                                                 & 0.581 (0.573, 0.588) & 0.58 (0.574, 0.588)  & 0 (-0.002, 0.002)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_146     & Benign neoplasm of the genitourinary system                                                              & 0.834 (0.827, 0.841) & 0.834 (0.828, 0.841) & 0 (-0.002, 0.002)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_142     & Lump or mass in breast or nonspecific abnormal breast exam                                               & 0.761 (0.756, 0.765) & 0.76 (0.756, 0.765)  & 0 (-0.001, 0)           &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_626-13  & Irregular menstrual cycle                                                                                & 0.889 (0.883, 0.895) & 0.889 (0.883, 0.896) & 0 (-0.001, 0.002)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_626-1   & Irregular menstrual cycle/bleeding                                                                       & 0.877 (0.873, 0.885) & 0.878 (0.874, 0.884) & 0 (-0.001, 0.002)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_627-4   & Menorrhagia/Excessive and frequent menstruation                                                          & 0.878 (0.873, 0.883) & 0.879 (0.873, 0.883) & 0 (-0.001, 0.002)       &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-4   & Lateral epicondylitis (Tennis elbow)                                                                     & 0.638 (0.629, 0.645) & 0.638 (0.629, 0.645) & 0 (-0.001, 0.002)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_600     & Benign prostatic hyperplasia                                                                             & 0.664 (0.659, 0.669) & 0.664 (0.659, 0.669) & 0 (-0.001, 0.001)       & 0.613 (0.598, 0.629) & 0.609 (0.594, 0.626) & -0.003 (-0.005, -0.002)\\\\\n",
       "\t Genitourinary  & phecode\\_594-41  & Nocturia                                                                                                 & 0.716 (0.704, 0.723) & 0.715 (0.704, 0.723) & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_627-2   & Symptomatic menopause                                                                                    & 0.766 (0.761, 0.771) & 0.767 (0.761, 0.772) & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520     & Hernia                                                                                                   & 0.624 (0.619, 0.629) & 0.624 (0.619, 0.629) & 0 (-0.001, 0.001)       & 0.604 (0.587, 0.618) & 0.602 (0.585, 0.618) & -0.002 (-0.003, 0.001) \\\\\n",
       "\t GI             & phecode\\_520-1   & Hernia of the abdominal wall                                                                             & 0.715 (0.71, 0.72)   & 0.715 (0.71, 0.72)   & 0 (-0.001, 0.001)       & 0.674 (0.647, 0.69)  & 0.682 (0.666, 0.696) & 0.008 (0.005, 0.02)    \\\\\n",
       "\t Mental         & phecode\\_290     & Reaction to severe stress, and adjustment disorders                                                      & 0.642 (0.634, 0.65)  & 0.642 (0.634, 0.65)  & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_331-6   & Migraine                                                                                                 & 0.643 (0.635, 0.651) & 0.643 (0.635, 0.65)  & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t Rx             & phecode\\_977-5   & Long term (current) use of agents affecting hormones                                                     & 0.896 (0.886, 0.901) & 0.896 (0.886, 0.902) & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_832     & Other abnormal findings in urine                                                                         & 0.645 (0.641, 0.65)  & 0.645 (0.641, 0.649) & 0 (-0.001, 0.001)       &                      &                      &                        \\\\\n",
       "\t Stat           & phecode\\_979     & Transplated organ                                                                                        & 0.547 (0.517, 0.585) & 0.406 (0.368, 0.442) & -0.139 (-0.203, -0.096) &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_701     & Osteomyelitis, periostitis, and other infections involving bone                                          & 0.602 (0.56, 0.642)  & 0.47 (0.425, 0.514)  & -0.128 (-0.192, -0.06)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_514-3   & Ileus                                                                                                    & 0.69 (0.655, 0.718)  & 0.612 (0.576, 0.652) & -0.076 (-0.105, -0.042) &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_701-1   & Osteomyelitis                                                                                            & 0.574 (0.547, 0.616) & 0.508 (0.464, 0.561) & -0.072 (-0.136, 0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_583-1   & End stage renal disease {[}CDK, stage 5{]}                                                                   & 0.708 (0.674, 0.738) & 0.659 (0.623, 0.697) & -0.048 (-0.09, -0.002)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_500     & Disorders of tooth develoment                                                                            & 0.573 (0.54, 0.619)  & 0.527 (0.499, 0.57)  & -0.046 (-0.063, -0.029) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_500-4   & Disturbances in tooth eruption                                                                           & 0.569 (0.532, 0.599) & 0.525 (0.49, 0.565)  & -0.042 (-0.064, -0.019) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_122-22  & Diffuse large B-cell lymphoma*                                                                           & 0.669 (0.637, 0.705) & 0.632 (0.597, 0.671) & -0.037 (-0.059, -0.009) &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-4   & Thyroiditis                                                                                              & 0.607 (0.566, 0.642) & 0.574 (0.523, 0.611) & -0.036 (-0.068, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-42  & Pulmonary valve insufficiency*                                                                           & 0.69 (0.64, 0.734)   & 0.655 (0.618, 0.696) & -0.036 (-0.059, -0.001) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_323     & Systemic atrophies primarily affecting the central nervous system                                        & 0.623 (0.593, 0.662) & 0.591 (0.559, 0.627) & -0.036 (-0.055, -0.017) &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-21  & Diffuse goiter                                                                                           & 0.627 (0.591, 0.654) & 0.591 (0.56, 0.62)   & -0.036 (-0.05, -0.018)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-31  & Graves' disease {[}Toxic diffuse goiter{]}                                                                   & 0.634 (0.603, 0.661) & 0.597 (0.56, 0.622)  & -0.035 (-0.052, -0.016) &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-5   & Allergy to serum and vaccine                                                                             & 0.623 (0.583, 0.677) & 0.587 (0.536, 0.638) & -0.034 (-0.066, -0.005) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_500-41  & Impacted teeth*                                                                                          & 0.593 (0.553, 0.632) & 0.559 (0.516, 0.599) & -0.034 (-0.054, -0.009) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_331-3   & Headache syndromes, non migraine                                                                         & 0.552 (0.506, 0.583) & 0.519 (0.478, 0.557) & -0.033 (-0.07, -0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581-33  & Stricture or kinking of ureter                                                                           & 0.609 (0.574, 0.644) & 0.579 (0.539, 0.61)  & -0.033 (-0.058, -0.015) &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_664-2   & Pityriasis                                                                                               & 0.588 (0.556, 0.626) & 0.556 (0.527, 0.594) & -0.033 (-0.05, -0.014)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_514-21  & Impaction of intestine                                                                                   & 0.571 (0.531, 0.62)  & 0.542 (0.506, 0.591) & -0.032 (-0.067, 0.008)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-4   & Pulmonary valve disorders                                                                                & 0.693 (0.652, 0.729) & 0.658 (0.618, 0.702) & -0.032 (-0.055, -0.004) &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_381-1   & Paralytic strabismus {[}Neurogenic strabismus{]}                                                             & 0.649 (0.617, 0.683) & 0.62 (0.578, 0.648)  & -0.031 (-0.056, -0.003) &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_712-5   & Disorder of ligament                                                                                     & 0.61 (0.565, 0.657)  & 0.582 (0.541, 0.62)  & -0.029 (-0.06, -0.006)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710-31  & Genu valgum (acquired)                                                                                   & 0.645 (0.599, 0.687) & 0.616 (0.566, 0.668) & -0.029 (-0.048, -0.013) &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_486-21  & Bronchospasm                                                                                             & 0.543 (0.507, 0.576) & 0.518 (0.478, 0.552) & -0.028 (-0.058, 0.009)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-42  & Cognitive communication deficit                                                                          & 0.549 (0.526, 0.58)  & 0.523 (0.501, 0.555) & -0.027 (-0.05, -0.006)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_624-2   & Atrophy of female genital tract                                                                          & 0.562 (0.535, 0.591) & 0.532 (0.507, 0.567) & -0.027 (-0.049, -0.009) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_349-2   & Abnormal results of function studies of peripheral nervous system                                        & 0.58 (0.556, 0.611)  & 0.555 (0.531, 0.586) & -0.027 (-0.045, -0.008) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_356-2   & Aphasia and dysphasia                                                                                    & 0.692 (0.664, 0.723) & 0.664 (0.636, 0.694) & -0.027 (-0.044, -0.011) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_124     & Myeloproliferative disorder                                                                              & 0.674 (0.648, 0.696) & 0.647 (0.618, 0.665) & -0.027 (-0.043, -0.009) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_124-5   & Essential thrombocythemia                                                                                & 0.639 (0.584, 0.685) & 0.61 (0.571, 0.65)   & -0.026 (-0.059, 0.008)  &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_394-4   & Abnormal vestibular function study                                                                       & 0.612 (0.565, 0.648) & 0.584 (0.546, 0.621) & -0.026 (-0.048, -0.007) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-6   & Transient global amnesia                                                                                 & 0.622 (0.594, 0.655) & 0.597 (0.561, 0.631) & -0.026 (-0.043, -0.011) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_355-1   & Coma                                                                                                     & 0.577 (0.548, 0.608) & 0.553 (0.517, 0.594) & -0.024 (-0.044, -0.003) &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-12  & Ventricular tachycardia                                                                                  & 0.709 (0.685, 0.734) & 0.683 (0.66, 0.714)  & -0.024 (-0.037, -0.015) &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_230-22  & Underweight                                                                                              & 0.593 (0.563, 0.631) & 0.572 (0.538, 0.606) & -0.023 (-0.049, 0.003)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_532-4   & Volvulus                                                                                                 & 0.598 (0.557, 0.644) & 0.572 (0.53, 0.622)  & -0.023 (-0.044, -0.003) &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-3   & Disorder of phosphorus metabolism                                                                        & 0.637 (0.611, 0.663) & 0.619 (0.58, 0.653)  & -0.022 (-0.057, 0.017)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_672     & Other acute skin changes due to ultraviolet radiation                                                    & 0.59 (0.551, 0.627)  & 0.565 (0.533, 0.603) & -0.022 (-0.047, 0.001)  &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_172     & Other disorders of white blood cells                                                                     & 0.624 (0.598, 0.649) & 0.602 (0.576, 0.634) & -0.022 (-0.043, 0)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_438-12  & Thoracic aneurysm                                                                                        & 0.675 (0.65, 0.702)  & 0.652 (0.625, 0.687) & -0.022 (-0.043, -0.001) &                      &                      &                        \\\\\n",
       "\t Metab          & phecode\\_247-52  & Hypercalcemia                                                                                            & 0.66 (0.636, 0.69)   & 0.639 (0.606, 0.671) & -0.022 (-0.035, -0.005) &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_179-9   & Immunodeficiency NOS                                                                                     & 0.543 (0.502, 0.579) & 0.52 (0.477, 0.571)  & -0.021 (-0.057, 0.025)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_475-5   & Exercise induced bronchospasm                                                                            & 0.54 (0.5, 0.582)    & 0.524 (0.484, 0.559) & -0.02 (-0.063, 0.032)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_504-32  & Chronic periodontitis                                                                                    & 0.548 (0.509, 0.581) & 0.527 (0.492, 0.569) & -0.02 (-0.051, 0.007)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_398-1   & Abnormal auditory function study                                                                         & 0.606 (0.581, 0.631) & 0.585 (0.558, 0.616) & -0.02 (-0.033, -0.005)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_530-3   & Rectal prolapse                                                                                          & 0.717 (0.694, 0.744) & 0.697 (0.676, 0.728) & -0.02 (-0.031, -0.009)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721-4   & Calcium deposits in tendon and bursa                                                                     & 0.543 (0.508, 0.586) & 0.527 (0.491, 0.569) & -0.019 (-0.051, 0.026)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_621     & Endometrial hyperplasia                                                                                  & 0.588 (0.548, 0.627) & 0.568 (0.53, 0.615)  & -0.019 (-0.051, 0.013)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_552-2   & Obstruction of bile duct                                                                                 & 0.635 (0.607, 0.674) & 0.617 (0.587, 0.653) & -0.019 (-0.048, 0.009)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_121-2   & Chronic leukemia                                                                                         & 0.698 (0.673, 0.726) & 0.679 (0.65, 0.709)  & -0.019 (-0.043, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_123-1   & Multiple myeloma                                                                                         & 0.672 (0.637, 0.715) & 0.654 (0.613, 0.707) & -0.019 (-0.041, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_121     & Leukemia                                                                                                 & 0.683 (0.659, 0.709) & 0.664 (0.628, 0.691) & -0.019 (-0.039, -0.004) &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_664-21  & Pityriasis rosea                                                                                         & 0.608 (0.573, 0.647) & 0.592 (0.553, 0.626) & -0.019 (-0.031, -0.007) &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_171-1   & Lymphocytosis (symptomatic)                                                                              & 0.607 (0.569, 0.648) & 0.589 (0.546, 0.636) & -0.018 (-0.054, 0.019)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-11  & Crohn's disease                                                                                          & 0.537 (0.507, 0.58)  & 0.518 (0.491, 0.553) & -0.018 (-0.046, 0.008)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_510-5   & Dyskinesia of esophagus                                                                                  & 0.612 (0.58, 0.645)  & 0.595 (0.554, 0.633) & -0.018 (-0.04, 0.002)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_123     & Multiple myeloma and malignant plasma cell neoplasms                                                     & 0.683 (0.647, 0.722) & 0.665 (0.631, 0.707) & -0.018 (-0.04, 0.001)   &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_685-4   & Prickly heat and miliaria                                                                                & 0.525 (0.491, 0.56)  & 0.509 (0.476, 0.544) & -0.018 (-0.038, 0.01)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_509-11  & Glossodynia                                                                                              & 0.591 (0.561, 0.625) & 0.573 (0.548, 0.606) & -0.018 (-0.037, 0.002)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-21  & Corneal ulcer                                                                                            & 0.601 (0.562, 0.655) & 0.585 (0.54, 0.627)  & -0.018 (-0.035, 0.011)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_120-1   & Myeloid                                                                                                  & 0.689 (0.668, 0.709) & 0.67 (0.649, 0.686)  & -0.018 (-0.031, -0.008) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_601-12  & Chronic prostatitis                                                                                      & 0.616 (0.59, 0.657)  & 0.602 (0.575, 0.639) & -0.018 (-0.027, -0.001) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-8   & Malignant neoplasm of the pancreas                                                                       & 0.669 (0.643, 0.692) & 0.653 (0.621, 0.675) & -0.017 (-0.039, 0.006)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-4   & Other specified cognitive deficit                                                                        & 0.515 (0.489, 0.542) & 0.5 (0.481, 0.522)   & -0.016 (-0.042, 0.016)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_466-4   & Hypertrophy of tonsils and adenoids                                                                      & 0.611 (0.577, 0.657) & 0.598 (0.558, 0.635) & -0.016 (-0.041, 0.017)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_148-2   & Benign neoplasm of meninges (Meningioma)                                                                 & 0.655 (0.622, 0.686) & 0.639 (0.606, 0.679) & -0.016 (-0.037, 0.008)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_121-21  & Chronic lymphoid leukemia                                                                                & 0.706 (0.673, 0.735) & 0.689 (0.657, 0.718) & -0.016 (-0.035, 0.003)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-71  & Sick sinus syndrome*                                                                                     & 0.733 (0.7, 0.771)   & 0.717 (0.678, 0.75)  & -0.016 (-0.035, -0.002) &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-7   & Sinoatrial node dysfunction                                                                              & 0.735 (0.695, 0.775) & 0.718 (0.683, 0.766) & -0.016 (-0.035, -0.001) &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_168-4   & Abnormal coagulation profile                                                                             & 0.729 (0.694, 0.763) & 0.712 (0.679, 0.743) & -0.016 (-0.028, -0.002) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-54  & Testicular limpoma                                                                                       & 0.609 (0.571, 0.65)  & 0.593 (0.551, 0.635) & -0.016 (-0.027, -0.004) &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_668-4   & Dermatitis due to substances taken internally                                                            & 0.564 (0.531, 0.601) & 0.554 (0.505, 0.584) & -0.015 (-0.058, 0.019)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_430-3   & Nontraumatic subdural hemorrhage                                                                         & 0.664 (0.624, 0.71)  & 0.65 (0.613, 0.692)  & -0.015 (-0.032, 0.004)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_374-39  & Transient retinal arterial occlusion {[}Amaurosis fugax{]}                                                   & 0.683 (0.651, 0.714) & 0.666 (0.637, 0.696) & -0.015 (-0.031, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144-13  & Benign neoplasms of the cervix                                                                           & 0.624 (0.597, 0.648) & 0.61 (0.582, 0.628)  & -0.015 (-0.03, 0)       &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_509-1   & Glossitis                                                                                                & 0.602 (0.581, 0.624) & 0.585 (0.565, 0.61)  & -0.015 (-0.03, -0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_613-1   & Inflammatory disease of breast                                                                           & 0.582 (0.556, 0.616) & 0.567 (0.537, 0.597) & -0.015 (-0.027, -0.005) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_530-1   & Anal fissure                                                                                             & 0.555 (0.536, 0.57)  & 0.54 (0.52, 0.554)   & -0.015 (-0.024, -0.005) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_120     & Hemo onc - by cell of origin                                                                             & 0.667 (0.653, 0.679) & 0.652 (0.637, 0.665) & -0.015 (-0.023, -0.006) & 0.635 (0.61, 0.653)  & 0.633 (0.606, 0.652) & -0.002 (-0.004, 0)     \\\\\n",
       "\t Cardio         & phecode\\_414-2   & Dilated cardiomyopathy*                                                                                  & 0.662 (0.633, 0.703) & 0.65 (0.61, 0.684)   & -0.014 (-0.046, 0.007)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_604-1   & Redundant prepuce and phimosis                                                                           & 0.487 (0.459, 0.53)  & 0.477 (0.441, 0.516) & -0.014 (-0.044, 0.014)  &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_171     & Increased white blood cell count                                                                         & 0.595 (0.565, 0.627) & 0.579 (0.545, 0.61)  & -0.014 (-0.044, 0.006)  &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-21  & Eustachian salpingitis                                                                                   & 0.521 (0.501, 0.562) & 0.511 (0.481, 0.541) & -0.014 (-0.037, 0.009)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-2   & Malignant neoplasm of stomach                                                                            & 0.688 (0.656, 0.729) & 0.673 (0.65, 0.708)  & -0.014 (-0.036, 0.006)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_622-2   & Mucous polyp of cervix                                                                                   & 0.618 (0.598, 0.64)  & 0.605 (0.584, 0.625) & -0.014 (-0.03, 0)       &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-6   & Heart valve replaced                                                                                     & 0.726 (0.706, 0.751) & 0.711 (0.692, 0.732) & -0.014 (-0.027, -0.004) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_120-21  & Mature B-cell                                                                                            & 0.68 (0.66, 0.703)   & 0.665 (0.646, 0.687) & -0.014 (-0.026, -0.002) &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-13  & Postprocedural hypothyroidism                                                                            & 0.659 (0.643, 0.681) & 0.647 (0.626, 0.665) & -0.014 (-0.025, -0.002) &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-3   & Emotional lability                                                                                       & 0.653 (0.618, 0.704) & 0.642 (0.61, 0.682)  & -0.013 (-0.036, 0.007)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_685-1   & Dyshidrosis                                                                                              & 0.537 (0.502, 0.563) & 0.523 (0.492, 0.549) & -0.013 (-0.031, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_122-2   & Non-Hodgkin lymphoma                                                                                     & 0.667 (0.643, 0.691) & 0.654 (0.629, 0.68)  & -0.013 (-0.03, 0.004)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_704-5   & Giant cell arteritis                                                                                     & 0.752 (0.725, 0.784) & 0.741 (0.713, 0.775) & -0.013 (-0.029, 0.003)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_208-21  & Primary hyperparathyroidism                                                                              & 0.678 (0.651, 0.7)   & 0.663 (0.638, 0.684) & -0.013 (-0.029, 0.002)  &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_394-1   & Meniere disease                                                                                          & 0.612 (0.581, 0.634) & 0.599 (0.569, 0.623) & -0.013 (-0.027, 0.001)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_120-2   & Lymphoid                                                                                                 & 0.666 (0.649, 0.685) & 0.653 (0.635, 0.672) & -0.013 (-0.026, -0.001) &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_728-1   & Chondromalacia                                                                                           & 0.659 (0.629, 0.7)   & 0.646 (0.616, 0.684) & -0.013 (-0.023, -0.005) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_109     & Malignant neoplasm of the eye, brain and other parts of central nervous system                           & 0.603 (0.573, 0.637) & 0.592 (0.557, 0.627) & -0.012 (-0.044, 0.015)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_604-3   & Peyronie's disease                                                                                       & 0.499 (0.468, 0.525) & 0.489 (0.461, 0.515) & -0.012 (-0.043, 0.023)  &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_394-22  & Vestibular neuronitis                                                                                    & 0.549 (0.526, 0.574) & 0.537 (0.509, 0.56)  & -0.012 (-0.039, 0.007)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-1   & Pelvic peritoneal adhesions, female (postoperative) (postinfection)                                      & 0.575 (0.539, 0.61)  & 0.563 (0.53, 0.595)  & -0.012 (-0.037, 0.009)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_471-3   & Hypertrophy of nasal turbinates                                                                          & 0.59 (0.55, 0.625)   & 0.577 (0.532, 0.613) & -0.012 (-0.036, 0.013)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-1   & Malignant neoplasm of the esophagus                                                                      & 0.735 (0.71, 0.759)  & 0.721 (0.697, 0.746) & -0.012 (-0.028, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_122     & Lymphoma                                                                                                 & 0.658 (0.631, 0.683) & 0.646 (0.626, 0.668) & -0.012 (-0.026, 0.005)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_700-2   & Sicca syndrome {[}Sjogren syndrome{]}                                                                        & 0.731 (0.707, 0.758) & 0.718 (0.689, 0.751) & -0.012 (-0.026, 0.003)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_381     & Strabismus                                                                                               & 0.631 (0.6, 0.655)   & 0.617 (0.592, 0.64)  & -0.012 (-0.025, 0.006)  &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_284-1   & Suicidal ideations                                                                                       & 0.611 (0.596, 0.635) & 0.599 (0.581, 0.622) & -0.012 (-0.024, 0)      &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_704     & Systemic vasculitis                                                                                      & 0.677 (0.653, 0.7)   & 0.665 (0.643, 0.686) & -0.012 (-0.024, 0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_604     & Disorders of penis                                                                                       & 0.51 (0.496, 0.526)  & 0.499 (0.483, 0.513) & -0.012 (-0.022, -0.001) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_601-1   & Prostatitis                                                                                              & 0.576 (0.555, 0.592) & 0.564 (0.544, 0.581) & -0.012 (-0.019, -0.005) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-12  & Femoral hernia                                                                                           & 0.585 (0.546, 0.627) & 0.575 (0.535, 0.614) & -0.011 (-0.039, 0.023)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_580-3   & Nephrotic syndrome                                                                                       & 0.553 (0.523, 0.58)  & 0.543 (0.516, 0.577) & -0.011 (-0.036, 0.021)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_106-21  & Malignant neoplasm of endometrium                                                                        & 0.566 (0.533, 0.592) & 0.554 (0.529, 0.576) & -0.011 (-0.035, 0.007)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_389-1   & Ocular pain                                                                                              & 0.538 (0.518, 0.559) & 0.528 (0.5, 0.548)   & -0.011 (-0.034, 0.009)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_481-4   & Pulmonary fibrosis                                                                                       & 0.726 (0.702, 0.748) & 0.716 (0.681, 0.738) & -0.011 (-0.032, 0.009)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-14  & Microscopic colitis*                                                                                     & 0.64 (0.604, 0.665)  & 0.63 (0.591, 0.659)  & -0.011 (-0.031, 0.016)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_379-2   & Eye infection, viral                                                                                     & 0.546 (0.517, 0.571) & 0.533 (0.512, 0.558) & -0.011 (-0.031, 0.009)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_702     & Infective and reactive arthropathies                                                                     & 0.556 (0.526, 0.581) & 0.543 (0.518, 0.576) & -0.011 (-0.029, 0.007)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_624     & Symptoms involving female genital tract                                                                  & 0.57 (0.553, 0.589)  & 0.558 (0.537, 0.581) & -0.011 (-0.029, 0.002)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144-1   & Benign neoplasms of external female genital organs and cervix                                            & 0.612 (0.59, 0.635)  & 0.601 (0.58, 0.623)  & -0.011 (-0.027, 0)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_410-2   & Endocarditis                                                                                             & 0.646 (0.627, 0.669) & 0.635 (0.618, 0.665) & -0.011 (-0.024, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-3   & Secondary malignant neoplasm of digestive systems                                                        & 0.633 (0.614, 0.654) & 0.623 (0.605, 0.642) & -0.011 (-0.024, 0.003)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710-32  & Genu varum (acquired)                                                                                    & 0.682 (0.646, 0.721) & 0.672 (0.636, 0.715) & -0.011 (-0.022, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_622-1   & Polyp of corpus uteri                                                                                    & 0.536 (0.52, 0.557)  & 0.525 (0.508, 0.549) & -0.011 (-0.021, 0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_619-5   & Noninflammatory disorders of vulva and perineum                                                          & 0.531 (0.519, 0.544) & 0.52 (0.505, 0.537)  & -0.011 (-0.018, -0.001) &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-43  & Right bundle branch block                                                                                & 0.706 (0.69, 0.721)  & 0.695 (0.678, 0.711) & -0.011 (-0.016, -0.005) &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_803     & Snoring*                                                                                                 & 0.631 (0.615, 0.648) & 0.62 (0.605, 0.637)  & -0.011 (-0.015, -0.007) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_352-3   & Parageusia*                                                                                              & 0.537 (0.505, 0.569) & 0.523 (0.495, 0.562) & -0.01 (-0.04, 0.013)    &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-12  & Mitral valve prolapse*                                                                                   & 0.639 (0.605, 0.674) & 0.628 (0.595, 0.667) & -0.01 (-0.039, 0.011)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-1   & Irritability                                                                                             & 0.575 (0.535, 0.615) & 0.568 (0.532, 0.603) & -0.01 (-0.038, 0.015)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_386-9   & Visual distortions and subjective visual disturbances                                                    & 0.626 (0.597, 0.664) & 0.618 (0.583, 0.647) & -0.01 (-0.031, 0.016)   &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710-41  & Flat foot {[}pes planus{]}                                                                                   & 0.584 (0.559, 0.616) & 0.572 (0.537, 0.608) & -0.01 (-0.03, 0.009)    &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_518     & Appendicitis                                                                                             & 0.557 (0.532, 0.585) & 0.549 (0.524, 0.579) & -0.01 (-0.029, 0.008)   &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_513-3   & Duodenal ulcer                                                                                           & 0.62 (0.602, 0.641)  & 0.609 (0.592, 0.628) & -0.01 (-0.026, 0.001)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_139-53  & Lipoma of other skin subcutaneous tissue                                                                 & 0.526 (0.508, 0.54)  & 0.517 (0.492, 0.537) & -0.01 (-0.025, 0.011)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_325-23  & Unsteadiness on feet*                                                                                    & 0.651 (0.625, 0.676) & 0.641 (0.615, 0.666) & -0.01 (-0.024, 0)       &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_180-3   & Paraproteinemias                                                                                         & 0.687 (0.66, 0.714)  & 0.675 (0.654, 0.704) & -0.01 (-0.024, 0.001)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581-3   & Obstructive and reflux uropathy                                                                          & 0.62 (0.604, 0.635)  & 0.61 (0.593, 0.625)  & -0.01 (-0.021, 0.001)   &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_386-2   & Diplopia                                                                                                 & 0.595 (0.576, 0.617) & 0.587 (0.563, 0.608) & -0.01 (-0.019, 0.004)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_601     & Inflammatory diseases of prostate                                                                        & 0.575 (0.556, 0.593) & 0.565 (0.542, 0.582) & -0.01 (-0.017, -0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_597-5   & Urethral caruncle                                                                                        & 0.787 (0.766, 0.81)  & 0.778 (0.754, 0.801) & -0.01 (-0.015, -0.004)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_209-1   & Pituitary hyperfunction                                                                                  & 0.615 (0.555, 0.653) & 0.605 (0.554, 0.649) & -0.009 (-0.047, 0.034)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_601-11  & Acute prostatitis                                                                                        & 0.559 (0.532, 0.591) & 0.553 (0.514, 0.588) & -0.009 (-0.046, 0.019)  &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_814     & Jaundice (not of newborn)                                                                                & 0.621 (0.591, 0.653) & 0.613 (0.588, 0.636) & -0.009 (-0.031, 0.015)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_108-41  & Malignant neoplasm of kidney, except pelvis                                                              & 0.663 (0.63, 0.699)  & 0.652 (0.624, 0.683) & -0.009 (-0.029, 0.008)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_525     & Intestinal malabsorption                                                                                 & 0.534 (0.515, 0.553) & 0.525 (0.504, 0.542) & -0.009 (-0.026, 0.008)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_361-9   & Ectropion of eyelid                                                                                      & 0.684 (0.64, 0.722)  & 0.676 (0.629, 0.714) & -0.009 (-0.023, 0.008)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_334-1   & Trigeminal nerve disorders {[}CN5{]}                                                                         & 0.6 (0.575, 0.618)   & 0.59 (0.57, 0.611)   & -0.009 (-0.021, 0.005)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_410     & Inflammation of the heart {[}Carditis{]}                                                                     & 0.623 (0.605, 0.648) & 0.615 (0.595, 0.638) & -0.009 (-0.021, 0.002)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-22  & Aortic insufficiency                                                                                     & 0.677 (0.662, 0.692) & 0.668 (0.651, 0.684) & -0.009 (-0.021, 0.002)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_522-1   & Inflammatory bowel disease                                                                               & 0.546 (0.53, 0.574)  & 0.538 (0.522, 0.558) & -0.009 (-0.02, 0.007)   & 0.43 (0.321, 0.494)  & 0.436 (0.33, 0.501)  & 0.005 (-0.012, 0.011)  \\\\\n",
       "\t Cardio         & phecode\\_416-1   & Paroxysmal tachycardia                                                                                   & 0.63 (0.617, 0.647)  & 0.621 (0.608, 0.637) & -0.009 (-0.019, -0.001) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_328-9   & Dementia NOS                                                                                             & 0.779 (0.761, 0.794) & 0.768 (0.751, 0.783) & -0.009 (-0.018, -0.002) & 0.814 (0.801, 0.826) & 0.813 (0.799, 0.825) & -0.001 (-0.003, 0)     \\\\\n",
       "\t Neuro          & phecode\\_324-1   & Parkinsonism                                                                                             & 0.722 (0.71, 0.737)  & 0.713 (0.7, 0.729)   & -0.009 (-0.017, -0.004) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_105-1   & Malignant neoplasm of the breast, female                                                                 & 0.533 (0.518, 0.546) & 0.525 (0.513, 0.537) & -0.009 (-0.017, -0.001) &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_444-15  & Scrotal varices {[}Varicocele{]}                                                                             & 0.802 (0.788, 0.815) & 0.794 (0.778, 0.807) & -0.009 (-0.016, 0)      &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463-4   & Nasal congestion*                                                                                        & 0.536 (0.525, 0.546) & 0.527 (0.518, 0.537) & -0.009 (-0.016, 0.002)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-23  & Multinodular goiter                                                                                      & 0.69 (0.671, 0.715)  & 0.682 (0.66, 0.705)  & -0.009 (-0.016, -0.003) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_596-2   & Overactive bladder                                                                                       & 0.597 (0.585, 0.612) & 0.587 (0.576, 0.602) & -0.009 (-0.014, -0.003) &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_488-8   & Mouth breathing*                                                                                         & 0.598 (0.583, 0.615) & 0.589 (0.574, 0.605) & -0.009 (-0.013, -0.002) &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-51  & Atrial premature depolarization {[}Supraventricular premature beats{]}                                       & 0.629 (0.604, 0.66)  & 0.623 (0.597, 0.648) & -0.008 (-0.031, 0.023)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_523-1   & Diverticula of small intestine                                                                           & 0.643 (0.608, 0.691) & 0.632 (0.595, 0.673) & -0.008 (-0.031, 0.023)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_108-4   & Malignant neoplasm of the kidney                                                                         & 0.661 (0.634, 0.687) & 0.653 (0.626, 0.678) & -0.008 (-0.027, 0.01)   &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_286-21  & Major depressive disorder, recurrent                                                                     & 0.587 (0.561, 0.611) & 0.577 (0.55, 0.606)  & -0.008 (-0.024, 0.008)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_363-7   & Stenosis and insufficiency of lacrimal passages                                                          & 0.622 (0.595, 0.649) & 0.615 (0.588, 0.642) & -0.008 (-0.022, 0.007)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_325-3   & Lack of coordination                                                                                     & 0.603 (0.582, 0.619) & 0.594 (0.575, 0.613) & -0.008 (-0.021, 0.007)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_603-1   & Hydrocele                                                                                                & 0.555 (0.53, 0.584)  & 0.547 (0.523, 0.573) & -0.008 (-0.021, 0.005)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_581-31  & Hydronephrosis                                                                                           & 0.606 (0.589, 0.629) & 0.598 (0.578, 0.617) & -0.008 (-0.021, 0.004)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-42  & Malignant neoplasm of the rectum                                                                         & 0.682 (0.657, 0.705) & 0.675 (0.65, 0.693)  & -0.008 (-0.019, 0.003)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-11  & Supraventricular tachycardia                                                                             & 0.62 (0.602, 0.635)  & 0.613 (0.595, 0.63)  & -0.008 (-0.018, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-4   & Tremor                                                                                                   & 0.629 (0.616, 0.641) & 0.621 (0.607, 0.634) & -0.008 (-0.016, -0.001) &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-11  & Parkinson's disease (Primary)                                                                            & 0.724 (0.709, 0.74)  & 0.716 (0.698, 0.731) & -0.008 (-0.015, -0.002) &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_396-21  & Sensorineural hearing loss, bilateral                                                                    & 0.647 (0.629, 0.665) & 0.64 (0.622, 0.656)  & -0.008 (-0.012, -0.003) &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-6   & Excessive crying of child, adolescent, or adult                                                          & 0.674 (0.646, 0.71)  & 0.665 (0.634, 0.702) & -0.007 (-0.035, 0.015)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_580     & Glomerular diseases                                                                                      & 0.628 (0.607, 0.652) & 0.622 (0.599, 0.646) & -0.007 (-0.032, 0.02)   &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_391-12  & Chronic otitis media                                                                                     & 0.496 (0.478, 0.52)  & 0.492 (0.47, 0.512)  & -0.007 (-0.029, 0.021)  &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_180-31  & Monoclonal gammopathy                                                                                    & 0.689 (0.668, 0.713) & 0.683 (0.657, 0.704) & -0.007 (-0.026, 0.009)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_106     & Gynecological malignant neoplasms                                                                        & 0.551 (0.526, 0.57)  & 0.543 (0.519, 0.564) & -0.007 (-0.024, 0.009)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-41  & Attention and concentration deficit                                                                      & 0.677 (0.647, 0.714) & 0.67 (0.642, 0.708)  & -0.007 (-0.015, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_593-2   & Microscopic hematuria                                                                                    & 0.598 (0.582, 0.611) & 0.592 (0.576, 0.606) & -0.007 (-0.015, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_610     & Benign mammary dysplasias                                                                                & 0.634 (0.608, 0.652) & 0.628 (0.603, 0.645) & -0.007 (-0.015, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_400-2   & Chronic rheumatic heart diseases                                                                         & 0.723 (0.713, 0.737) & 0.717 (0.701, 0.73)  & -0.007 (-0.014, 0)      & 0.651 (0.634, 0.671) & 0.657 (0.642, 0.677) & 0.007 (-0.006, 0.01)   \\\\\n",
       "\t GI             & phecode\\_510-8   & Barrett's esophagus                                                                                      & 0.641 (0.627, 0.657) & 0.634 (0.617, 0.649) & -0.007 (-0.014, 0)      &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_329-5   & Mild cognitive impairment, so stated                                                                     & 0.764 (0.751, 0.782) & 0.756 (0.743, 0.775) & -0.007 (-0.014, -0.001) &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_088     & Sexually transmitted disease                                                                             & 0.645 (0.62, 0.674)  & 0.638 (0.612, 0.667) & -0.007 (-0.013, -0.001) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_628     & Ovarian cyst                                                                                             & 0.592 (0.577, 0.612) & 0.585 (0.571, 0.605) & -0.007 (-0.012, -0.001) &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_683     & Nail disorders                                                                                           & 0.533 (0.527, 0.541) & 0.528 (0.521, 0.536) & -0.007 (-0.011, -0.001) &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_099     & Lab findings related to infections                                                                       & 0.648 (0.638, 0.663) & 0.64 (0.631, 0.656)  & -0.007 (-0.01, -0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_592-12  & Chronic cystitis                                                                                         & 0.603 (0.565, 0.633) & 0.595 (0.559, 0.628) & -0.006 (-0.034, 0.019)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_367-2   & Keratitis                                                                                                & 0.536 (0.503, 0.556) & 0.53 (0.502, 0.552)  & -0.006 (-0.029, 0.016)  &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_180     & Other disorders involving the immune mechanism                                                           & 0.608 (0.589, 0.63)  & 0.603 (0.586, 0.622) & -0.006 (-0.021, 0.008)  &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-13  & Allergy to sulfonamides                                                                                  & 0.718 (0.693, 0.743) & 0.712 (0.684, 0.735) & -0.006 (-0.021, 0.007)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_362     & Other disorders of the eyelids                                                                           & 0.553 (0.538, 0.567) & 0.545 (0.53, 0.564)  & -0.006 (-0.019, 0.004)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_514-1   & Esophageal obstruction (Stricture and stenosis of esophagus)                                             & 0.633 (0.615, 0.648) & 0.626 (0.61, 0.645)  & -0.006 (-0.018, 0.007)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_604-5   & Balanoposthitis                                                                                          & 0.526 (0.503, 0.547) & 0.519 (0.499, 0.542) & -0.006 (-0.018, 0.006)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-4   & Secondary malignant neoplasm of liver                                                                    & 0.661 (0.646, 0.673) & 0.654 (0.638, 0.668) & -0.006 (-0.017, 0.005)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594-11  & Urinary hesitancy                                                                                        & 0.75 (0.724, 0.781)  & 0.745 (0.721, 0.771) & -0.006 (-0.016, 0.008)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_710-3   & Acquired deformities of the knee                                                                         & 0.651 (0.624, 0.676) & 0.646 (0.616, 0.667) & -0.006 (-0.016, 0.006)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_353     & Symptoms and signs involving general sensations and perceptions                                          & 0.577 (0.564, 0.595) & 0.572 (0.559, 0.588) & -0.006 (-0.014, 0)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-22  & Atrial flutter                                                                                           & 0.739 (0.725, 0.753) & 0.732 (0.718, 0.747) & -0.006 (-0.013, 0)      &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_717-2   & Sacrococcygeal disorders                                                                                 & 0.621 (0.602, 0.639) & 0.616 (0.594, 0.635) & -0.006 (-0.013, 0.004)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_714     & Deforming dorsopathies                                                                                   & 0.677 (0.659, 0.696) & 0.672 (0.656, 0.692) & -0.006 (-0.013, 0.003)  & 0.583 (0.563, 0.601) & 0.618 (0.591, 0.649) & 0.034 (0.02, 0.06)     \\\\\n",
       "\t Genitourinary  & phecode\\_622     & Polyp of female genital organs                                                                           & 0.571 (0.558, 0.583) & 0.565 (0.551, 0.578) & -0.006 (-0.013, 0.002)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-5   & Tendinitis                                                                                               & 0.523 (0.512, 0.534) & 0.517 (0.506, 0.53)  & -0.006 (-0.013, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_628-2   & Corpus luteum cyst or hematoma                                                                           & 0.589 (0.573, 0.606) & 0.583 (0.566, 0.599) & -0.006 (-0.013, -0.001) &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_288-4   & Phobic disorders                                                                                         & 0.602 (0.581, 0.613) & 0.596 (0.574, 0.609) & -0.006 (-0.012, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594-31  & Urge incontinence                                                                                        & 0.648 (0.636, 0.66)  & 0.642 (0.628, 0.654) & -0.006 (-0.012, -0.001) &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_487-1   & Epistaxis                                                                                                & 0.592 (0.58, 0.605)  & 0.586 (0.575, 0.599) & -0.006 (-0.011, 0)      &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_808     & Syncope and collapse                                                                                     & 0.6 (0.592, 0.606)   & 0.593 (0.587, 0.6)   & -0.006 (-0.01, -0.002)  & 0.666 (0.645, 0.686) & 0.668 (0.645, 0.685) & 0 (-0.001, 0.003)      \\\\\n",
       "\t Genitourinary  & phecode\\_593-1   & Gross hematuria                                                                                          & 0.69 (0.668, 0.711)  & 0.683 (0.663, 0.705) & -0.006 (-0.009, -0.002) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_552-1   & Cholangitis                                                                                              & 0.605 (0.571, 0.641) & 0.599 (0.56, 0.641)  & -0.005 (-0.036, 0.026)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_624-1   & Dystrophy of female genital tract                                                                        & 0.576 (0.551, 0.602) & 0.57 (0.544, 0.597)  & -0.005 (-0.034, 0.019)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_109-3   & Malignant neoplasm of brain                                                                              & 0.608 (0.57, 0.645)  & 0.604 (0.563, 0.643) & -0.005 (-0.032, 0.029)  &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_011     & Klebsiella                                                                                               & 0.667 (0.625, 0.701) & 0.662 (0.616, 0.695) & -0.005 (-0.031, 0.027)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_104     & Malignant sarcoma-related cancers                                                                        & 0.552 (0.524, 0.582) & 0.546 (0.519, 0.575) & -0.005 (-0.029, 0.028)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-15  & Primary osteoarthritis of the wrist, forearm                                                             & 0.652 (0.614, 0.677) & 0.646 (0.611, 0.673) & -0.005 (-0.025, 0.019)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_379     & Infection of the eye                                                                                     & 0.546 (0.527, 0.567) & 0.543 (0.519, 0.563) & -0.005 (-0.025, 0.018)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-53  & Cyst or abscess of Bartholin's gland                                                                     & 0.627 (0.598, 0.668) & 0.621 (0.592, 0.656) & -0.005 (-0.022, 0.016)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-8   & Secondary osteoarthritis                                                                                 & 0.595 (0.58, 0.622)  & 0.592 (0.574, 0.613) & -0.005 (-0.02, 0.01)    &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_623     & Hypertrophy of female genital organs                                                                     & 0.505 (0.493, 0.52)  & 0.501 (0.484, 0.515) & -0.005 (-0.019, 0.007)  &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_284     & Suicide ideation and attempt or self harm                                                                & 0.599 (0.585, 0.616) & 0.594 (0.58, 0.613)  & -0.005 (-0.018, 0.009)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_597     & Other disorders of urethra and urinary tract                                                             & 0.6 (0.581, 0.615)   & 0.595 (0.578, 0.61)  & -0.005 (-0.017, 0.005)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_596-3   & Diverticulum of bladder                                                                                  & 0.738 (0.709, 0.771) & 0.734 (0.704, 0.767) & -0.005 (-0.013, 0.005)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_400     & Rheumatic fever and chronic rheumatic heart diseases                                                     & 0.723 (0.712, 0.733) & 0.717 (0.707, 0.728) & -0.005 (-0.013, 0.003)  & 0.648 (0.632, 0.692) & 0.653 (0.634, 0.692) & 0.005 (-0.006, 0.01)   \\\\\n",
       "\t Cardio         & phecode\\_413-11  & Mitral valve insufficiency                                                                               & 0.696 (0.684, 0.713) & 0.691 (0.679, 0.705) & -0.005 (-0.013, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_625-2   & Postcoital bleeding                                                                                      & 0.754 (0.732, 0.774) & 0.748 (0.727, 0.767) & -0.005 (-0.013, 0.001)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_682-4   & Acne                                                                                                     & 0.635 (0.608, 0.658) & 0.631 (0.604, 0.657) & -0.005 (-0.012, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324     & Extrapyramidal and movement disorders                                                                    & 0.596 (0.586, 0.602) & 0.59 (0.582, 0.599)  & -0.005 (-0.011, 0)      & 0.622 (0.611, 0.649) & 0.621 (0.605, 0.645) & -0.004 (-0.009, 0.004) \\\\\n",
       "\t Resp           & phecode\\_467     & Laryngitis and tracheitis                                                                                & 0.616 (0.606, 0.632) & 0.611 (0.6, 0.629)   & -0.005 (-0.011, 0)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-1   & Mitral valve disorders                                                                                   & 0.706 (0.694, 0.717) & 0.702 (0.689, 0.714) & -0.005 (-0.011, 0.002)  & 0.579 (0.558, 0.594) & 0.565 (0.553, 0.589) & -0.007 (-0.021, 0.01)  \\\\\n",
       "\t GI             & phecode\\_509     & Diseases of tongue                                                                                       & 0.58 (0.568, 0.594)  & 0.575 (0.563, 0.59)  & -0.005 (-0.011, 0.001)  &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_056-1   & Plantar wart                                                                                             & 0.542 (0.527, 0.555) & 0.538 (0.522, 0.551) & -0.005 (-0.01, 0)       &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_136-2   & Benign neoplasm of stomach                                                                               & 0.633 (0.623, 0.642) & 0.627 (0.617, 0.64)  & -0.005 (-0.01, 0)       &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_618-2   & Uterine/Uterovaginal prolapse                                                                            & 0.587 (0.572, 0.6)   & 0.582 (0.57, 0.595)  & -0.005 (-0.01, 0.001)   &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101-41  & Malignant neoplasm of the colon                                                                          & 0.687 (0.667, 0.702) & 0.682 (0.664, 0.699) & -0.005 (-0.01, 0.001)   & 0.601 (0.588, 0.626) & 0.6 (0.581, 0.618)   & -0.006 (-0.011, 0.002) \\\\\n",
       "\t Neuro          & phecode\\_328-8   & Dementia in conditions classified elsewhere                                                              & 0.801 (0.79, 0.813)  & 0.796 (0.783, 0.808) & -0.005 (-0.01, -0.002)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_328     & Dementias and cerebral degeneration                                                                      & 0.788 (0.776, 0.802) & 0.783 (0.772, 0.796) & -0.005 (-0.01, -0.001)  & 0.805 (0.795, 0.812) & 0.804 (0.794, 0.811) & -0.001 (-0.002, 0)     \\\\\n",
       "\t Resp           & phecode\\_467-1   & Acute laryngitis and tracheitis                                                                          & 0.623 (0.612, 0.635) & 0.619 (0.607, 0.631) & -0.005 (-0.01, -0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594-3   & Urinary incontinence                                                                                     & 0.618 (0.609, 0.624) & 0.613 (0.604, 0.62)  & -0.005 (-0.009, -0.002) &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_395-1   & Labyrinthitis                                                                                            & 0.576 (0.564, 0.587) & 0.571 (0.561, 0.582) & -0.005 (-0.008, 0)      &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_215     & Testicular dysfunction                                                                                   & 0.515 (0.465, 0.567) & 0.509 (0.458, 0.563) & -0.004 (-0.05, 0.04)    &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_362-5   & Cysts of eyelid                                                                                          & 0.56 (0.526, 0.592)  & 0.553 (0.526, 0.59)  & -0.004 (-0.038, 0.018)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_208-2   & Hyperparathyroidism                                                                                      & 0.654 (0.631, 0.676) & 0.648 (0.621, 0.669) & -0.004 (-0.024, 0.013)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_619-2   & Disorders of uterus, NEC                                                                                 & 0.551 (0.531, 0.573) & 0.546 (0.525, 0.572) & -0.004 (-0.019, 0.011)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_328-7   & Vascular dementia                                                                                        & 0.8 (0.774, 0.823)   & 0.795 (0.771, 0.819) & -0.004 (-0.018, 0.009)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_208     & Disorders of parathyroid gland                                                                           & 0.648 (0.627, 0.668) & 0.645 (0.622, 0.665) & -0.004 (-0.017, 0.008)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_520-14  & Ventral hernia                                                                                           & 0.585 (0.562, 0.599) & 0.58 (0.564, 0.594)  & -0.004 (-0.016, 0.009)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_610-1   & Cystic mastopathy                                                                                        & 0.69 (0.664, 0.713)  & 0.685 (0.66, 0.71)   & -0.004 (-0.013, 0.006)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_506-5   & Disturbances of salivary secretion                                                                       & 0.629 (0.61, 0.645)  & 0.625 (0.607, 0.642) & -0.004 (-0.013, 0.006)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_708-9   & Heberden's or Bouchard's nodes*                                                                          & 0.634 (0.612, 0.655) & 0.63 (0.606, 0.65)   & -0.004 (-0.013, 0.003)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_683-1   & Ingrowing nail                                                                                           & 0.534 (0.523, 0.548) & 0.531 (0.517, 0.545) & -0.004 (-0.012, 0.009)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-3   & Thyrotoxicosis {[}hyperthyroidism{]}                                                                         & 0.613 (0.597, 0.63)  & 0.609 (0.59, 0.626)  & -0.004 (-0.012, 0.002)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_523-4   & Diverticulitis                                                                                           & 0.612 (0.598, 0.627) & 0.608 (0.596, 0.623) & -0.004 (-0.011, 0.007)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_108-5   & Malignant neoplasm of the bladder                                                                        & 0.734 (0.718, 0.756) & 0.73 (0.711, 0.753)  & -0.004 (-0.011, 0.005)  & 0.716 (0.705, 0.731) & 0.718 (0.706, 0.734) & 0.001 (-0.003, 0.003)  \\\\\n",
       "\t Musc/Skel      & phecode\\_721-6   & Baker's cyst {[}popliteal cyst{]}                                                                            & 0.584 (0.57, 0.598)  & 0.579 (0.562, 0.593) & -0.004 (-0.011, 0.003)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463-5   & Postnasal drip                                                                                           & 0.579 (0.566, 0.591) & 0.575 (0.561, 0.589) & -0.004 (-0.011, 0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_626-2   & Dysmenorrhea                                                                                             & 0.894 (0.882, 0.908) & 0.891 (0.879, 0.902) & -0.004 (-0.01, 0.004)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-41  & Atrioventricular block                                                                                   & 0.75 (0.74, 0.763)   & 0.747 (0.735, 0.76)  & -0.004 (-0.01, 0.001)   &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_463-1   & Chronic rhinitis                                                                                         & 0.549 (0.537, 0.561) & 0.545 (0.534, 0.556) & -0.004 (-0.009, 0.003)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_682     & Other follicular disorders                                                                               & 0.512 (0.505, 0.519) & 0.508 (0.502, 0.514) & -0.004 (-0.008, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_618-1   & Prolapse of vaginal walls                                                                                & 0.581 (0.57, 0.593)  & 0.577 (0.567, 0.588) & -0.004 (-0.008, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-4   & Heart block                                                                                              & 0.722 (0.715, 0.73)  & 0.718 (0.71, 0.726)  & -0.004 (-0.007, 0)      & 0.751 (0.731, 0.757) & 0.75 (0.73, 0.756)   & -0.001 (-0.002, 0)     \\\\\n",
       "\t Genitourinary  & phecode\\_594-6   & Urinary urgency                                                                                          & 0.594 (0.582, 0.604) & 0.591 (0.579, 0.603) & -0.004 (-0.007, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_417-3   & Bradycardia*                                                                                             & 0.658 (0.647, 0.67)  & 0.654 (0.644, 0.666) & -0.004 (-0.007, -0.001) &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_395     & Other diseases of inner ear                                                                              & 0.572 (0.562, 0.583) & 0.569 (0.56, 0.579)  & -0.004 (-0.007, -0.001) &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_377-2   & Conjunctival hemorrhage                                                                                  & 0.584 (0.573, 0.595) & 0.581 (0.569, 0.592) & -0.004 (-0.006, -0.001) &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_504-3   & Periodontitis                                                                                            & 0.54 (0.513, 0.57)   & 0.539 (0.501, 0.574) & -0.003 (-0.036, 0.027)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_346     & Brain damage and brain death                                                                             & 0.568 (0.532, 0.602) & 0.565 (0.526, 0.6)   & -0.003 (-0.036, 0.025)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_106-3   & Malignant neoplasm of the ovary                                                                          & 0.585 (0.558, 0.619) & 0.582 (0.546, 0.609) & -0.003 (-0.034, 0.026)  &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_290-1   & Posttraumatic stress disorder                                                                            & 0.657 (0.621, 0.709) & 0.65 (0.62, 0.704)   & -0.003 (-0.034, 0.023)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_342-4   & Monoplegia                                                                                               & 0.561 (0.526, 0.596) & 0.56 (0.53, 0.591)   & -0.003 (-0.03, 0.025)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_430-2   & Nontraumatic intracerebral hemorrhage                                                                    & 0.697 (0.678, 0.72)  & 0.695 (0.676, 0.719) & -0.003 (-0.029, 0.016)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_724-3   & Nontraumatic hematoma of soft tissue                                                                     & 0.569 (0.535, 0.597) & 0.565 (0.528, 0.593) & -0.003 (-0.026, 0.015)  &                      &                      &                        \\\\\n",
       "\t Blood          & phecode\\_177-4   & Lymphedema                                                                                               & 0.656 (0.641, 0.673) & 0.655 (0.639, 0.671) & -0.003 (-0.016, 0.013)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440-11  & Deep vein thrombosis {[}DVT{]}                                                                               & 0.603 (0.588, 0.62)  & 0.599 (0.581, 0.619) & -0.003 (-0.016, 0.008)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_363-5   & Epiphora                                                                                                 & 0.592 (0.576, 0.607) & 0.589 (0.574, 0.605) & -0.003 (-0.015, 0.01)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_334     & Disorders of other cranial nerves                                                                        & 0.55 (0.536, 0.568)  & 0.547 (0.533, 0.563) & -0.003 (-0.014, 0.014)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_712     & Other specific joint derangements                                                                        & 0.539 (0.521, 0.552) & 0.536 (0.519, 0.549) & -0.003 (-0.014, 0.007)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_440-3   & Pulmonary embolism                                                                                       & 0.63 (0.616, 0.642)  & 0.626 (0.614, 0.641) & -0.003 (-0.014, 0.005)  & 0.537 (0.499, 0.55)  & 0.544 (0.512, 0.565) & 0.006 (-0.013, 0.031)  \\\\\n",
       "\t Genitourinary  & phecode\\_586-2   & Cyst of kidney                                                                                           & 0.652 (0.636, 0.671) & 0.65 (0.634, 0.668)  & -0.003 (-0.013, 0.009)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_448-1   & Raynaud's syndrome                                                                                       & 0.585 (0.568, 0.603) & 0.582 (0.565, 0.603) & -0.003 (-0.013, 0.005)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-3   & Medial epicondylitis (Golfer's elbow)                                                                    & 0.562 (0.546, 0.578) & 0.559 (0.545, 0.577) & -0.003 (-0.012, 0.008)  &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_841-12  & Allergy to antibiotic agent (excluding penicillin)                                                       & 0.661 (0.649, 0.672) & 0.658 (0.647, 0.669) & -0.003 (-0.01, 0.003)   &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-5   & Premature depolarization {[}Premature beats{]}                                                               & 0.626 (0.61, 0.638)  & 0.623 (0.606, 0.636) & -0.003 (-0.009, 0.006)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_592-11  & Acute cystitis                                                                                           & 0.712 (0.698, 0.731) & 0.71 (0.695, 0.729)  & -0.003 (-0.009, 0.006)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_101     & Malignant neoplasm of the digestive organs                                                               & 0.672 (0.663, 0.683) & 0.669 (0.659, 0.68)  & -0.003 (-0.009, 0.002)  & 0.623 (0.595, 0.63)  & 0.622 (0.594, 0.627) & -0.002 (-0.003, 0)     \\\\\n",
       "\t Neoplasms      & phecode\\_101-4   & Malignant neoplasm of the colon and rectum                                                               & 0.685 (0.673, 0.699) & 0.682 (0.672, 0.696) & -0.003 (-0.008, 0.002)  & 0.596 (0.57, 0.627)  & 0.596 (0.57, 0.628)  & 0 (-0.001, 0.001)      \\\\\n",
       "\t Neoplasms      & phecode\\_140     & Benign neoplasm of the breast                                                                            & 0.797 (0.779, 0.812) & 0.795 (0.779, 0.809) & -0.003 (-0.008, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413     & Heart valve disorders                                                                                    & 0.712 (0.705, 0.72)  & 0.709 (0.702, 0.718) & -0.003 (-0.007, 0.002)  & 0.696 (0.667, 0.714) & 0.696 (0.672, 0.719) & 0.003 (-0.003, 0.008)  \\\\\n",
       "\t Neuro          & phecode\\_328-1   & Alzheimer's disease                                                                                      & 0.812 (0.798, 0.826) & 0.809 (0.796, 0.822) & -0.003 (-0.007, 0.002)  & 0.756 (0.722, 0.801) & 0.752 (0.716, 0.797) & -0.004 (-0.006, -0.002)\\\\\n",
       "\t Signs/Symptoms & phecode\\_832-6   & Pyuria*                                                                                                  & 0.657 (0.642, 0.672) & 0.655 (0.638, 0.67)  & -0.003 (-0.007, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_613-5   & Mastodynia                                                                                               & 0.554 (0.543, 0.564) & 0.55 (0.54, 0.563)   & -0.003 (-0.007, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_596     & Other disorders of bladder                                                                               & 0.607 (0.599, 0.617) & 0.604 (0.596, 0.613) & -0.003 (-0.007, 0.001)  & 0.685 (0.651, 0.695) & 0.688 (0.657, 0.7)   & 0.003 (0.002, 0.007)   \\\\\n",
       "\t Genitourinary  & phecode\\_591     & Urinary tract infection                                                                                  & 0.62 (0.615, 0.625)  & 0.618 (0.612, 0.622) & -0.003 (-0.006, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_602     & Other disorders of prostate                                                                              & 0.636 (0.625, 0.646) & 0.632 (0.623, 0.643) & -0.003 (-0.006, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_613     & Other nonmalignant breast conditions                                                                     & 0.544 (0.537, 0.554) & 0.542 (0.533, 0.552) & -0.003 (-0.006, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_618     & Genital prolapse                                                                                         & 0.577 (0.569, 0.587) & 0.575 (0.566, 0.586) & -0.003 (-0.006, 0.001)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_360     & Inflammation of eyelids                                                                                  & 0.564 (0.557, 0.571) & 0.561 (0.554, 0.568) & -0.003 (-0.006, -0.001) &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_105     & Malignant neoplasm of the breast                                                                         & 0.753 (0.747, 0.76)  & 0.75 (0.743, 0.756)  & -0.003 (-0.006, -0.001) & 0.706 (0.7, 0.718)   & 0.705 (0.699, 0.726) & 0.002 (-0.015, 0.02)   \\\\\n",
       "\t Eye            & phecode\\_360-4   & Blepharitis                                                                                              & 0.595 (0.586, 0.606) & 0.593 (0.584, 0.603) & -0.003 (-0.005, 0)      &                      &                      &                        \\\\\n",
       "\t Hearing        & phecode\\_394-21  & Paroxysmal vertigo                                                                                       & 0.618 (0.606, 0.629) & 0.614 (0.603, 0.627) & -0.003 (-0.005, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_592     & Cystitis and urethritis                                                                                  & 0.685 (0.674, 0.693) & 0.682 (0.672, 0.69)  & -0.003 (-0.005, -0.001) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_592-1   & Cystitis                                                                                                 & 0.694 (0.686, 0.703) & 0.691 (0.683, 0.701) & -0.003 (-0.005, -0.001) &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_462-1   & Acute sinusitis                                                                                          & 0.579 (0.57, 0.588)  & 0.576 (0.567, 0.586) & -0.003 (-0.004, -0.001) &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_308-5   & Nervousness                                                                                              & 0.561 (0.531, 0.591) & 0.553 (0.526, 0.591) & -0.002 (-0.035, 0.022)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_430-1   & Nontraumatic subarachnoid hemorrhage                                                                     & 0.61 (0.575, 0.644)  & 0.613 (0.57, 0.641)  & -0.002 (-0.026, 0.034)  &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_817     & Motion sickness                                                                                          & 0.651 (0.627, 0.687) & 0.651 (0.619, 0.682) & -0.002 (-0.026, 0.02)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_603-5   & Orchitis and epididymitis                                                                                & 0.518 (0.502, 0.539) & 0.517 (0.498, 0.532) & -0.002 (-0.019, 0.014)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_356     & Speech disturbance                                                                                       & 0.635 (0.617, 0.655) & 0.633 (0.619, 0.651) & -0.002 (-0.018, 0.012)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_430     & Nontraumatic Intracranial hemorrhage                                                                     & 0.656 (0.638, 0.68)  & 0.652 (0.634, 0.674) & -0.002 (-0.017, 0.01)   &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_324-41  & Essential tremor*                                                                                        & 0.64 (0.619, 0.669)  & 0.639 (0.618, 0.66)  & -0.002 (-0.015, 0.015)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_552     & Other diseases of biliary tract                                                                          & 0.62 (0.596, 0.638)  & 0.616 (0.598, 0.642) & -0.002 (-0.015, 0.009)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-52  & Ventricular premature depolarization*                                                                    & 0.636 (0.621, 0.655) & 0.633 (0.617, 0.654) & -0.002 (-0.01, 0.005)   &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_614-52  & Vaginitis and vulvovaginitis                                                                             & 0.561 (0.548, 0.574) & 0.56 (0.549, 0.573)  & -0.002 (-0.009, 0.008)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_625-1   & Dyspareunia                                                                                              & 0.65 (0.632, 0.664)  & 0.649 (0.633, 0.666) & -0.002 (-0.009, 0.008)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-42  & Left bundle branch block                                                                                 & 0.722 (0.706, 0.735) & 0.719 (0.706, 0.734) & -0.002 (-0.009, 0.007)  &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_052-1   & Herpes simplex                                                                                           & 0.598 (0.585, 0.613) & 0.597 (0.583, 0.611) & -0.002 (-0.008, 0.004)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_723-51  & Achilles tendinitis                                                                                      & 0.539 (0.525, 0.549) & 0.536 (0.523, 0.547) & -0.002 (-0.008, 0.004)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721-11  & Trigger finger                                                                                           & 0.58 (0.569, 0.593)  & 0.578 (0.568, 0.59)  & -0.002 (-0.008, 0.004)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_728     & Chondropathies                                                                                           & 0.608 (0.596, 0.623) & 0.608 (0.592, 0.623) & -0.002 (-0.007, 0.005)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116     & Secondary malignant neoplasm                                                                             & 0.655 (0.646, 0.664) & 0.653 (0.644, 0.663) & -0.002 (-0.007, 0.004)  & 0.587 (0.578, 0.609) & 0.586 (0.577, 0.609) & -0.001 (-0.001, 0)     \\\\\n",
       "\t Genitourinary  & phecode\\_619-3   & Noninflammatory disorders of cervix                                                                      & 0.686 (0.664, 0.703) & 0.684 (0.663, 0.702) & -0.002 (-0.007, 0.003)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_721-2   & Ganglion cyst                                                                                            & 0.547 (0.537, 0.557) & 0.544 (0.534, 0.554) & -0.002 (-0.007, 0.003)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_132     & Sequelae of cancer                                                                                       & 0.734 (0.725, 0.745) & 0.733 (0.722, 0.745) & -0.002 (-0.007, 0.003)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_444-1   & Varicose veins                                                                                           & 0.586 (0.578, 0.595) & 0.584 (0.576, 0.593) & -0.002 (-0.007, 0.002)  & 0.542 (0.518, 0.582) & 0.549 (0.523, 0.582) & 0.003 (-0.005, 0.025)  \\\\\n",
       "\t Genitourinary  & phecode\\_602-4   & Elevated prostate specific antigen {[}PSA{]}                                                                 & 0.63 (0.62, 0.64)    & 0.628 (0.618, 0.638) & -0.002 (-0.007, 0.001)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_418-1   & Abnormal electrocardiogram {[}ECG{]} {[}EKG{]}                                                                   & 0.664 (0.655, 0.672) & 0.661 (0.654, 0.672) & -0.002 (-0.006, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_618-11  & Cystocele                                                                                                & 0.59 (0.58, 0.602)   & 0.588 (0.576, 0.601) & -0.002 (-0.006, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_625     & Pain and other symptoms associated with female genital organs                                            & 0.611 (0.6, 0.622)   & 0.609 (0.597, 0.621) & -0.002 (-0.006, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_596-1   & Bladder neck obstruction                                                                                 & 0.801 (0.788, 0.818) & 0.799 (0.787, 0.816) & -0.002 (-0.006, 0.002)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_417     & Abnormalities of heart beat                                                                              & 0.588 (0.584, 0.593) & 0.586 (0.581, 0.59)  & -0.002 (-0.005, 0)      & 0.652 (0.631, 0.677) & 0.649 (0.628, 0.675) & -0.004 (-0.005, -0.001)\\\\\n",
       "\t Hearing        & phecode\\_394     & Disorders of vestibular function                                                                         & 0.603 (0.593, 0.613) & 0.602 (0.592, 0.612) & -0.002 (-0.005, 0)      &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_052     & Herpesvirus                                                                                              & 0.561 (0.555, 0.566) & 0.558 (0.553, 0.565) & -0.002 (-0.005, 0)      &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_444     & Venous insufficiency                                                                                     & 0.591 (0.585, 0.6)   & 0.589 (0.582, 0.597) & -0.002 (-0.005, 0.001)  & 0.525 (0.485, 0.555) & 0.536 (0.5, 0.556)   & 0.009 (-0.002, 0.025)  \\\\\n",
       "\t Cardio         & phecode\\_444-11  & Varicose veins of lower extremities                                                                      & 0.596 (0.588, 0.606) & 0.594 (0.585, 0.603) & -0.002 (-0.005, 0.001)  & 0.54 (0.498, 0.562)  & 0.553 (0.53, 0.59)   & 0.018 (0, 0.038)       \\\\\n",
       "\t Endo           & phecode\\_200-1   & Hypothyroidism                                                                                           & 0.635 (0.629, 0.643) & 0.633 (0.626, 0.639) & -0.002 (-0.005, 0.001)  & 0.649 (0.641, 0.668) & 0.651 (0.642, 0.668) & 0.001 (-0.001, 0.005)  \\\\\n",
       "\t Resp           & phecode\\_462     & Sinusitis                                                                                                & 0.558 (0.551, 0.565) & 0.556 (0.549, 0.562) & -0.002 (-0.005, 0.001)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200     & Disorders of thyroid gland                                                                               & 0.632 (0.626, 0.638) & 0.629 (0.624, 0.636) & -0.002 (-0.004, 0)      & 0.641 (0.631, 0.662) & 0.642 (0.635, 0.66)  & 0.003 (-0.003, 0.005)  \\\\\n",
       "\t Genitourinary  & phecode\\_593     & Hematuria                                                                                                & 0.588 (0.583, 0.592) & 0.586 (0.582, 0.59)  & -0.002 (-0.004, 0)      & 0.637 (0.617, 0.652) & 0.637 (0.615, 0.651) & -0.001 (-0.002, 0)     \\\\\n",
       "\t ID             & phecode\\_052-32  & Herpes zoster                                                                                            & 0.578 (0.57, 0.585)  & 0.576 (0.568, 0.583) & -0.002 (-0.004, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594     & Abnormality of urination                                                                                 & 0.584 (0.579, 0.589) & 0.583 (0.577, 0.588) & -0.002 (-0.004, 0.001)  & 0.713 (0.705, 0.72)  & 0.713 (0.706, 0.721) & 0 (0, 0.002)           \\\\\n",
       "\t Genitourinary  & phecode\\_594-1   & Retention of urine                                                                                       & 0.735 (0.726, 0.744) & 0.733 (0.724, 0.741) & -0.002 (-0.004, 0.001)  & 0.727 (0.719, 0.742) & 0.727 (0.718, 0.742) & 0 (-0.001, 0)          \\\\\n",
       "\t Hearing        & phecode\\_394-2   & Vertigo                                                                                                  & 0.607 (0.597, 0.618) & 0.606 (0.594, 0.616) & -0.002 (-0.004, 0.001)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_599     & Other symptoms/disorders or the urinary system                                                           & 0.577 (0.571, 0.582) & 0.574 (0.568, 0.58)  & -0.002 (-0.004, -0.001) & 0.697 (0.69, 0.71)   & 0.696 (0.69, 0.71)   & 0 (-0.001, 0)          \\\\\n",
       "\t Musc/Skel      & phecode\\_709-21  & Hallux valgus (Bunion)                                                                                   & 0.667 (0.66, 0.675)  & 0.665 (0.658, 0.674) & -0.002 (-0.003, 0)      &                      &                      &                        \\\\\n",
       "\t Mental         & phecode\\_280-82  & Other psychoactive substance dependence                                                                  & 0.59 (0.548, 0.629)  & 0.589 (0.545, 0.63)  & -0.001 (-0.043, 0.049)  &                      &                      &                        \\\\\n",
       "\t Eye            & phecode\\_379-21  & Infection of the eye, herpes                                                                             & 0.584 (0.54, 0.61)   & 0.581 (0.548, 0.611) & -0.001 (-0.022, 0.023)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_416-212 & Persistent atrial fibrillation*                                                                          & 0.717 (0.689, 0.742) & 0.713 (0.689, 0.741) & -0.001 (-0.018, 0.014)  &                      &                      &                        \\\\\n",
       "\t Neuro          & phecode\\_334-11  & Trigeminal neuralgia                                                                                     & 0.596 (0.574, 0.619) & 0.592 (0.571, 0.617) & -0.001 (-0.014, 0.011)  &                      &                      &                        \\\\\n",
       "\t Derm           & phecode\\_660-13  & Pityriasis versicolor                                                                                    & 0.666 (0.635, 0.696) & 0.666 (0.632, 0.692) & -0.001 (-0.013, 0.013)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_148     & Benign neoplasm of the eye, brain and other parts of central nervous system                              & 0.602 (0.582, 0.626) & 0.603 (0.583, 0.625) & -0.001 (-0.012, 0.016)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_116-1   & Secondary malignancy of lymph nodes                                                                      & 0.617 (0.601, 0.63)  & 0.616 (0.599, 0.63)  & -0.001 (-0.012, 0.008)  & 0.463 (0.431, 0.486) & 0.45 (0.425, 0.48)   & -0.008 (-0.024, 0.001) \\\\\n",
       "\t Genitourinary  & phecode\\_620     & Dysplasia of female genital organs                                                                       & 0.72 (0.691, 0.746)  & 0.72 (0.692, 0.746)  & -0.001 (-0.009, 0.009)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_728-3   & Costochondritis (Tietze's disease)                                                                       & 0.611 (0.595, 0.626) & 0.61 (0.595, 0.627)  & -0.001 (-0.009, 0.006)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_108     & Malignant neoplasm of the urinary tract                                                                  & 0.71 (0.693, 0.724)  & 0.709 (0.692, 0.724) & -0.001 (-0.008, 0.007)  & 0.703 (0.672, 0.723) & 0.705 (0.676, 0.73)  & 0.004 (-0.001, 0.007)  \\\\\n",
       "\t Genitourinary  & phecode\\_594-32  & Stress incontinence                                                                                      & 0.716 (0.705, 0.724) & 0.714 (0.706, 0.723) & -0.001 (-0.008, 0.006)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_506     & Diseases of salivary glands                                                                              & 0.59 (0.577, 0.605)  & 0.59 (0.574, 0.606)  & -0.001 (-0.008, 0.006)  &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_476     & Bronchiectasis                                                                                           & 0.677 (0.667, 0.692) & 0.676 (0.664, 0.692) & -0.001 (-0.008, 0.005)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_413-2   & Aortic valve disorders                                                                                   & 0.727 (0.716, 0.734) & 0.726 (0.714, 0.734) & -0.001 (-0.008, 0.003)  & 0.722 (0.7, 0.746)   & 0.723 (0.702, 0.749) & 0.002 (-0.001, 0.004)  \\\\\n",
       "\t GI             & phecode\\_510-2   & Esophagitis                                                                                              & 0.57 (0.563, 0.581)  & 0.569 (0.561, 0.58)  & -0.001 (-0.007, 0.005)  &                      &                      &                        \\\\\n",
       "\t Signs/Symptoms & phecode\\_848     & Nonspecific abnormal findings of other body structures                                                   & 0.617 (0.609, 0.624) & 0.617 (0.609, 0.624) & -0.001 (-0.006, 0.004)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_705-3   & Polymyalgia rheumatica                                                                                   & 0.709 (0.692, 0.719) & 0.708 (0.692, 0.717) & -0.001 (-0.006, 0.003)  &                      &                      &                        \\\\\n",
       "\t Cardio         & phecode\\_401-6   & Secondary hypertension                                                                                   & 0.626 (0.609, 0.647) & 0.625 (0.607, 0.646) & -0.001 (-0.005, 0.004)  &                      &                      &                        \\\\\n",
       "\t GI             & phecode\\_510     & Diseases of esophagus                                                                                    & 0.575 (0.568, 0.581) & 0.575 (0.568, 0.582) & -0.001 (-0.005, 0.004)  & 0.616 (0.603, 0.632) & 0.615 (0.602, 0.629) & 0 (-0.005, 0.001)      \\\\\n",
       "\t Hearing        & phecode\\_396-2   & Sensorineural hearing loss                                                                               & 0.637 (0.626, 0.649) & 0.635 (0.625, 0.646) & -0.001 (-0.005, 0.002)  &                      &                      &                        \\\\\n",
       "\t ID             & phecode\\_052-3   & Varicella zoster virus                                                                                   & 0.57 (0.563, 0.578)  & 0.569 (0.562, 0.575) & -0.001 (-0.004, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_144-2   & Benign neoplasms of the uterus                                                                           & 0.662 (0.65, 0.672)  & 0.661 (0.649, 0.671) & -0.001 (-0.004, 0.003)  &                      &                      &                        \\\\\n",
       "\t Endo           & phecode\\_200-14  & Hypothyroidism, not specified as secondary                                                               & 0.638 (0.631, 0.646) & 0.637 (0.629, 0.645) & -0.001 (-0.004, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_626-11  & Absent or infrequent menstruation                                                                        & 0.847 (0.836, 0.857) & 0.846 (0.835, 0.859) & -0.001 (-0.004, 0.002)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709     & Acquired deformities of fingers and toes                                                                 & 0.636 (0.629, 0.645) & 0.635 (0.627, 0.643) & -0.001 (-0.003, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_107     & Malignant neoplasm of male genitalia                                                                     & 0.685 (0.675, 0.693) & 0.684 (0.674, 0.692) & -0.001 (-0.003, 0)      & 0.534 (0.496, 0.565) & 0.525 (0.486, 0.553) & -0.009 (-0.014, -0.005)\\\\\n",
       "\t Neoplasms      & phecode\\_107-2   & Malignant neoplasm of the prostate                                                                       & 0.689 (0.683, 0.697) & 0.688 (0.681, 0.696) & -0.001 (-0.003, 0)      & 0.523 (0.495, 0.544) & 0.517 (0.485, 0.539) & -0.008 (-0.012, -0.005)\\\\\n",
       "\t Signs/Symptoms & phecode\\_807-1   & Chronic fatigue syndrome                                                                                 & 0.597 (0.59, 0.604)  & 0.596 (0.589, 0.604) & -0.001 (-0.003, 0.003)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_608     & Other disorders of male genital organs                                                                   & 0.53 (0.524, 0.539)  & 0.529 (0.524, 0.538) & -0.001 (-0.003, 0.002)  &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_594-4   & Frequency of urination and polyuria                                                                      & 0.587 (0.581, 0.594) & 0.586 (0.58, 0.593)  & -0.001 (-0.003, 0.001)  &                      &                      &                        \\\\\n",
       "\t Musc/Skel      & phecode\\_709-2   & Acquired deformities of toe                                                                              & 0.649 (0.639, 0.657) & 0.647 (0.638, 0.655) & -0.001 (-0.003, -0.001) &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_626     & Disorders of menstruation and other abnormal bleeding from female genital tract                          & 0.792 (0.783, 0.801) & 0.791 (0.782, 0.8)   & -0.001 (-0.002, 0)      &                      &                      &                        \\\\\n",
       "\t Genitourinary  & phecode\\_608-1   & Abnormal findings in semen                                                                               & 0.824 (0.819, 0.829) & 0.823 (0.818, 0.828) & -0.001 (-0.002, 0)      &                      &                      &                        \\\\\n",
       "\t Resp           & phecode\\_466     & Tonsillitis and adenoiditis                                                                              & 0.649 (0.636, 0.66)  & 0.648 (0.635, 0.659) & -0.001 (-0.002, 0)      &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_130     & Cancer (solid tumor, excluding BCC)                                                                      & 0.644 (0.639, 0.649) & 0.643 (0.638, 0.648) & -0.001 (-0.002, 0.001)  & 0.612 (0.598, 0.616) & 0.612 (0.597, 0.615) & -0.001 (-0.001, 0)     \\\\\n",
       "\t Resp           & phecode\\_466-1   & Acute tonsillitis and adenoiditis                                                                        & 0.663 (0.653, 0.675) & 0.662 (0.652, 0.675) & -0.001 (-0.002, 0.001)  &                      &                      &                        \\\\\n",
       "\t Neoplasms      & phecode\\_142-1   & Lump or mass in breast                                                                                   & 0.748 (0.74, 0.755)  & 0.747 (0.739, 0.753) & -0.001 (-0.002, -0.001) &                      &                      &                        \\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 1171 × 9\n",
       "\n",
       "| phecode_category &lt;chr&gt; | endpoint &lt;chr&gt; | phecode_string &lt;chr&gt; | ukb_agesex &lt;chr&gt; | ukb_agesexretina &lt;chr&gt; | ukb_delta &lt;chr&gt; | epic_agesex &lt;glue&gt; | epic_agesexretina &lt;glue&gt; | epic_delta &lt;glue&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|\n",
       "| Blood          | phecode_165     | Hemoglobinopathies                                                                                       | 0.612 (0.575, 0.655) | 0.872 (0.85, 0.905)  | 0.259 (0.214, 0.312)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_387-2   | Myopia                                                                                                   | 0.585 (0.565, 0.603) | 0.818 (0.803, 0.833) | 0.232 (0.213, 0.26)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_688-1   | Sarcoidosis                                                                                              | 0.29 (0.255, 0.319)  | 0.5 (0.457, 0.543)   | 0.207 (0.161, 0.263)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_665-3   | Other psoriasis                                                                                          | 0.373 (0.328, 0.41)  | 0.547 (0.506, 0.579) | 0.175 (0.12, 0.23)      | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_373     | Noninflammatory disorders of choroid                                                                     | 0.582 (0.547, 0.613) | 0.753 (0.712, 0.783) | 0.173 (0.139, 0.203)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_665-2   | Psoriatic arthropathy                                                                                    | 0.37 (0.324, 0.405)  | 0.537 (0.5, 0.572)   | 0.169 (0.122, 0.214)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_005     | Mycobacteria                                                                                             | 0.485 (0.447, 0.532) | 0.651 (0.602, 0.695) | 0.169 (0.117, 0.225)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-3   | Benign neoplasm of other connective and soft tissue                                                      | 0.4 (0.352, 0.446)   | 0.551 (0.502, 0.592) | 0.149 (0.096, 0.188)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_377-5   | Vitreous hemorrhage                                                                                      | 0.546 (0.507, 0.577) | 0.684 (0.645, 0.732) | 0.143 (0.094, 0.184)    | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-71  | Long term (current) use of insulin                                                                       | 0.595 (0.576, 0.616) | 0.735 (0.715, 0.755) | 0.139 (0.12, 0.161)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709-11  | Mallet finger                                                                                            | 0.396 (0.369, 0.43)  | 0.535 (0.498, 0.56)  | 0.138 (0.081, 0.173)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_096     | Contact or exposure to infectious agent                                                                  | 0.429 (0.405, 0.451) | 0.563 (0.536, 0.593) | 0.135 (0.099, 0.165)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_008     | Helicobacter [H. pylori]                                                                                 | 0.442 (0.421, 0.471) | 0.574 (0.548, 0.602) | 0.132 (0.1, 0.168)      | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_370     | Disorders of iris and ciliary body                                                                       | 0.622 (0.595, 0.648) | 0.745 (0.725, 0.774) | 0.127 (0.1, 0.152)      | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_369-5   | Hereditary corneal dystrophies                                                                           | 0.64 (0.611, 0.675)  | 0.766 (0.735, 0.804) | 0.126 (0.092, 0.162)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529-6   | Halitosis*                                                                                               | 0.406 (0.355, 0.442) | 0.529 (0.493, 0.567) | 0.125 (0.086, 0.168)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_386-1   | Amblyopia                                                                                                | 0.599 (0.576, 0.622) | 0.712 (0.688, 0.738) | 0.114 (0.086, 0.136)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_337-8   | Polyneuropathy in diseases classified elsewhere                                                          | 0.645 (0.613, 0.681) | 0.756 (0.726, 0.8)   | 0.111 (0.065, 0.155)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-52  | Lipoma of intrathoracic organs                                                                           | 0.431 (0.383, 0.465) | 0.537 (0.495, 0.569) | 0.109 (0.061, 0.16)     | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_110     | Malignant neoplasm of the endocrine glands                                                               | 0.458 (0.417, 0.492) | 0.564 (0.513, 0.611) | 0.109 (0.047, 0.158)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-8   | Retinal edema                                                                                            | 0.652 (0.628, 0.682) | 0.758 (0.732, 0.785) | 0.107 (0.089, 0.126)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_387     | Disorders of refraction and accommodation                                                                | 0.656 (0.643, 0.666) | 0.761 (0.751, 0.772) | 0.106 (0.093, 0.119)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_059-1   | COVID-19*                                                                                                | 0.504 (0.468, 0.542) | 0.61 (0.57, 0.651)   | 0.106 (0.06, 0.17)      | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977     | Long term (current) drug therapy                                                                         | 0.489 (0.481, 0.494) | 0.593 (0.588, 0.599) | 0.105 (0.098, 0.112)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-11  | Serous retinal detachment                                                                                | 0.59 (0.568, 0.615)  | 0.696 (0.675, 0.723) | 0.105 (0.076, 0.131)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_676-1   | Hypertrophic scar [Keloid scar]                                                                          | 0.507 (0.478, 0.542) | 0.613 (0.576, 0.647) | 0.103 (0.065, 0.143)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_712-1   | Loose body in joint                                                                                      | 0.444 (0.412, 0.485) | 0.546 (0.511, 0.583) | 0.102 (0.058, 0.138)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-512 | Exuadative (wet) age-related macular degeneration                                                        | 0.751 (0.722, 0.78)  | 0.85 (0.826, 0.88)   | 0.101 (0.071, 0.127)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_387-1   | Hypermetropia                                                                                            | 0.707 (0.671, 0.741) | 0.803 (0.777, 0.828) | 0.097 (0.063, 0.125)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-21  | Pallor                                                                                                   | 0.462 (0.419, 0.508) | 0.558 (0.512, 0.606) | 0.097 (0.038, 0.143)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-6   | Episcleritis                                                                                             | 0.478 (0.446, 0.509) | 0.572 (0.543, 0.61)  | 0.096 (0.066, 0.13)     | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_205     | Hypoglycemia                                                                                             | 0.656 (0.639, 0.68)  | 0.75 (0.728, 0.769)  | 0.094 (0.07, 0.119)     | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-1   | Retinal detachments and breaks                                                                           | 0.582 (0.567, 0.599) | 0.676 (0.661, 0.688) | 0.093 (0.078, 0.111)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_385     | Abnormal results of function studies of eye                                                              | 0.587 (0.557, 0.622) | 0.678 (0.646, 0.708) | 0.093 (0.057, 0.115)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_504-1   | Gingivitis                                                                                               | 0.422 (0.389, 0.454) | 0.515 (0.478, 0.554) | 0.093 (0.055, 0.141)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_236-11  | Morbid obesity                                                                                           | 0.577 (0.553, 0.605) | 0.666 (0.646, 0.69)  | 0.088 (0.068, 0.111)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_059     | Coronavirus                                                                                              | 0.501 (0.465, 0.541) | 0.59 (0.536, 0.641)  | 0.088 (0.041, 0.135)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_352-1   | Anosmia*                                                                                                 | 0.455 (0.418, 0.488) | 0.544 (0.503, 0.574) | 0.088 (0.039, 0.135)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_202-4   | Other specified diabetes*                                                                                | 0.613 (0.607, 0.619) | 0.698 (0.693, 0.704) | 0.086 (0.08, 0.091)     | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-7   | Long term (current) use of insulin or oral hypoglycemic drugs                                            | 0.61 (0.601, 0.618)  | 0.696 (0.687, 0.703) | 0.086 (0.078, 0.094)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_280-12  | Alcohol dependence                                                                                       | 0.535 (0.518, 0.553) | 0.622 (0.605, 0.637) | 0.086 (0.066, 0.105)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-4   | Retinal disorders in diseases classified elsewhere                                                       | 0.629 (0.622, 0.64)  | 0.714 (0.705, 0.725) | 0.085 (0.074, 0.093)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724-51  | Calcaneal spur                                                                                           | 0.43 (0.389, 0.457)  | 0.517 (0.486, 0.551) | 0.084 (0.047, 0.138)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_168-2   | Hyper-coagulability                                                                                      | 0.446 (0.4, 0.487)   | 0.528 (0.485, 0.563) | 0.084 (0.034, 0.13)     | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-51  | Age-related macular degeneration                                                                         | 0.752 (0.738, 0.766) | 0.834 (0.819, 0.844) | 0.083 (0.071, 0.094)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-5   | Uveitis                                                                                                  | 0.526 (0.505, 0.551) | 0.61 (0.59, 0.636)   | 0.083 (0.059, 0.11)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_498     | Asphyxia and hypoxemia                                                                                   | 0.616 (0.576, 0.656) | 0.7 (0.666, 0.741)   | 0.083 (0.045, 0.114)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_097-1   | Methicillin resistant Staphylococcus aureus                                                              | 0.458 (0.421, 0.492) | 0.541 (0.502, 0.583) | 0.083 (0.033, 0.125)    | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-72  | Long term (current) use of oral hypoglycemic drugs                                                       | 0.614 (0.606, 0.623) | 0.695 (0.688, 0.704) | 0.082 (0.073, 0.089)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_202-1   | Type 1 diabetes                                                                                          | 0.615 (0.596, 0.638) | 0.698 (0.679, 0.719) | 0.082 (0.06, 0.11)      | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-52  | Iridocyclitis                                                                                            | 0.523 (0.504, 0.549) | 0.608 (0.59, 0.628)  | 0.082 (0.058, 0.105)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_366-1   | Pterygium of eye                                                                                         | 0.498 (0.458, 0.536) | 0.576 (0.543, 0.631) | 0.081 (0.035, 0.136)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-42  | Diabetic retinopathy                                                                                     | 0.63 (0.621, 0.637)  | 0.708 (0.697, 0.714) | 0.079 (0.071, 0.086)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-72  | Iron deficiency                                                                                          | 0.545 (0.536, 0.554) | 0.624 (0.617, 0.631) | 0.079 (0.069, 0.086)    | 0.62 (0.606, 0.644)  | 0.631 (0.617, 0.652) | 0.012 (0.007, 0.017)    |\n",
       "| GI             | phecode_501     | Dental caries                                                                                            | 0.482 (0.465, 0.498) | 0.56 (0.538, 0.579)  | 0.079 (0.053, 0.104)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_211     | Disorders of adrenal glands                                                                              | 0.553 (0.516, 0.592) | 0.634 (0.6, 0.673)   | 0.079 (0.042, 0.123)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_325-1   | Abnormal involuntary movements                                                                           | 0.382 (0.339, 0.427) | 0.459 (0.421, 0.503) | 0.079 (0.029, 0.133)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_160-1   | Iron deficiency anemia                                                                                   | 0.554 (0.545, 0.565) | 0.632 (0.621, 0.639) | 0.077 (0.066, 0.085)    | 0.607 (0.594, 0.62)  | 0.619 (0.6, 0.634)   | 0.011 (0.005, 0.016)    |\n",
       "| Blood          | phecode_164-1   | Microcytic anemia                                                                                        | 0.555 (0.544, 0.563) | 0.631 (0.62, 0.639)  | 0.076 (0.068, 0.084)    | 0.62 (0.598, 0.641)  | 0.632 (0.607, 0.647) | 0.009 (0.005, 0.016)    |\n",
       "| Eye            | phecode_369     | Noninflammatory disorders of the cornea                                                                  | 0.633 (0.617, 0.648) | 0.709 (0.685, 0.728) | 0.076 (0.061, 0.09)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_546-3   | Hepatomegaly                                                                                             | 0.538 (0.504, 0.585) | 0.616 (0.574, 0.67)  | 0.076 (0.023, 0.134)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709-1   | Acquired deformities of fingers                                                                          | 0.445 (0.424, 0.476) | 0.523 (0.499, 0.549) | 0.075 (0.043, 0.109)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_239-3   | Mixed hyperlipidemia                                                                                     | 0.48 (0.455, 0.51)   | 0.56 (0.528, 0.595)  | 0.075 (0.041, 0.123)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_236-1   | Obesity                                                                                                  | 0.511 (0.506, 0.516) | 0.585 (0.58, 0.589)  | 0.074 (0.067, 0.08)     | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_283-4   | Patient's noncompliance with medical treatment and regimen                                               | 0.497 (0.489, 0.505) | 0.572 (0.564, 0.579) | 0.074 (0.062, 0.087)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-4   | Demoralization and apathy                                                                                | 0.548 (0.521, 0.575) | 0.622 (0.594, 0.649) | 0.074 (0.038, 0.107)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_674-11  | Vitiligo                                                                                                 | 0.516 (0.476, 0.558) | 0.587 (0.539, 0.638) | 0.074 (0.011, 0.13)     | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_097     | Drug resistant microorganisms                                                                            | 0.479 (0.441, 0.514) | 0.55 (0.517, 0.587)  | 0.073 (0.039, 0.109)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_236     | Overweight and obesity                                                                                   | 0.512 (0.506, 0.517) | 0.584 (0.58, 0.59)   | 0.072 (0.066, 0.079)    | 0.462 (0.429, 0.496) | 0.503 (0.483, 0.535) | 0.048 (0.018, 0.063)    |\n",
       "| Metab          | phecode_247-7   | Disorders of iron metabolism                                                                             | 0.546 (0.538, 0.554) | 0.618 (0.61, 0.625)  | 0.072 (0.063, 0.078)    | 0.619 (0.6, 0.624)   | 0.626 (0.613, 0.641) | 0.012 (0.004, 0.019)    |\n",
       "| GI             | phecode_542     | Chronic liver disease and sequelae                                                                       | 0.517 (0.509, 0.528) | 0.589 (0.579, 0.598) | 0.072 (0.057, 0.084)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_829-2   | Abnormal level of blood mineral*                                                                         | 0.498 (0.481, 0.513) | 0.571 (0.552, 0.591) | 0.072 (0.055, 0.097)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_202-2   | Type 2 diabetes                                                                                          | 0.591 (0.585, 0.599) | 0.662 (0.657, 0.667) | 0.071 (0.063, 0.077)    | 0.604 (0.595, 0.621) | 0.637 (0.625, 0.643) | 0.029 (0.018, 0.041)    |\n",
       "| GI             | phecode_542-1   | Fibrosis and cirrhosis of liver                                                                          | 0.636 (0.603, 0.66)  | 0.705 (0.678, 0.737) | 0.071 (0.05, 0.1)       | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_333-4   | Circadian rhythm sleep disorder                                                                          | 0.438 (0.398, 0.481) | 0.508 (0.468, 0.55)  | 0.071 (0.022, 0.119)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_202     | Diabetes mellitus                                                                                        | 0.593 (0.586, 0.597) | 0.662 (0.657, 0.668) | 0.07 (0.063, 0.076)     | 0.608 (0.591, 0.627) | 0.635 (0.622, 0.654) | 0.028 (0.013, 0.04)     |\n",
       "| Signs/Symptoms | phecode_821     | Abnormality of red blood cells                                                                           | 0.515 (0.485, 0.542) | 0.587 (0.551, 0.611) | 0.07 (0.044, 0.099)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-51  | Hypocalcemia                                                                                             | 0.49 (0.449, 0.531)  | 0.564 (0.512, 0.597) | 0.07 (0.016, 0.113)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_232     | Vitamin deficiencies                                                                                     | 0.549 (0.543, 0.556) | 0.619 (0.613, 0.624) | 0.069 (0.062, 0.077)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_160     | Nutritional anemias                                                                                      | 0.564 (0.556, 0.575) | 0.633 (0.625, 0.641) | 0.069 (0.061, 0.076)    | 0.625 (0.61, 0.635)  | 0.634 (0.622, 0.65)  | 0.011 (0.008, 0.016)    |\n",
       "| Mental         | phecode_280-13  | Alcoholic liver disease                                                                                  | 0.635 (0.601, 0.66)  | 0.702 (0.669, 0.733) | 0.069 (0.041, 0.095)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-54  | Abscess or ulceration of vulva                                                                           | 0.418 (0.369, 0.452) | 0.484 (0.439, 0.535) | 0.069 (0.018, 0.118)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_542-4   | Portal hypertension                                                                                      | 0.646 (0.601, 0.681) | 0.713 (0.672, 0.749) | 0.068 (0.038, 0.098)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_674-1   | Hypopigmentation                                                                                         | 0.537 (0.498, 0.571) | 0.603 (0.562, 0.642) | 0.068 (0.021, 0.099)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_135-1   | Benign neoplasm of the oral cavity                                                                       | 0.503 (0.466, 0.541) | 0.57 (0.533, 0.606)  | 0.067 (0.015, 0.1)      | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_281-2   | Substance dependence                                                                                     | 0.538 (0.53, 0.545)  | 0.605 (0.596, 0.613) | 0.066 (0.058, 0.074)    | 0.541 (0.517, 0.563) | 0.634 (0.609, 0.664) | 0.095 (0.062, 0.134)    |\n",
       "| Eye            | phecode_374-511 | Nonexuadative (dry) age-related macular degeneration                                                     | 0.759 (0.736, 0.784) | 0.824 (0.806, 0.846) | 0.064 (0.045, 0.086)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_287     | Psychotic disorder                                                                                       | 0.531 (0.497, 0.559) | 0.592 (0.554, 0.631) | 0.064 (0.015, 0.1)      | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_540-1   | Chronic hepatitis                                                                                        | 0.535 (0.498, 0.585) | 0.598 (0.567, 0.634) | 0.063 (0.029, 0.102)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_371-3   | Nuclear cataract                                                                                         | 0.744 (0.736, 0.754) | 0.805 (0.799, 0.814) | 0.062 (0.054, 0.067)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_232-2   | Vitamin B group deficiency                                                                               | 0.568 (0.558, 0.581) | 0.63 (0.618, 0.643)  | 0.062 (0.048, 0.072)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_292     | Somatoform disorders                                                                                     | 0.487 (0.449, 0.526) | 0.546 (0.494, 0.598) | 0.062 (0.016, 0.096)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_371-31  | Age-related nuclear cataract                                                                             | 0.745 (0.735, 0.751) | 0.806 (0.799, 0.812) | 0.061 (0.055, 0.069)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_232-4   | Vitamin D deficiency                                                                                     | 0.571 (0.565, 0.578) | 0.631 (0.624, 0.64)  | 0.06 (0.052, 0.067)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_542-2   | Fatty liver disease (FLD)                                                                                | 0.525 (0.513, 0.535) | 0.585 (0.573, 0.596) | 0.06 (0.043, 0.072)     | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_380-2   | Disorders of optic disc                                                                                  | 0.551 (0.513, 0.581) | 0.611 (0.574, 0.645) | 0.06 (0.023, 0.091)     | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-5   | Macular degeneration                                                                                     | 0.715 (0.707, 0.725) | 0.775 (0.769, 0.784) | 0.059 (0.052, 0.066)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_343     | Disorders of autonomic nervous system                                                                    | 0.52 (0.495, 0.546)  | 0.579 (0.544, 0.616) | 0.059 (0.029, 0.093)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_369-1   | Corneal scars and opacities                                                                              | 0.631 (0.587, 0.674) | 0.692 (0.655, 0.736) | 0.058 (0.023, 0.107)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-2   | Pallor and flushing                                                                                      | 0.516 (0.491, 0.542) | 0.573 (0.551, 0.602) | 0.057 (0.036, 0.084)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_251-1   | Gilbert syndrome*                                                                                        | 0.551 (0.523, 0.59)  | 0.61 (0.575, 0.639)  | 0.056 (0.038, 0.071)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_360-5   | Noninfectious dermatoses of eyelid                                                                       | 0.595 (0.568, 0.622) | 0.652 (0.621, 0.677) | 0.056 (0.034, 0.079)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_237     | Abnormal weight gain                                                                                     | 0.504 (0.477, 0.523) | 0.559 (0.541, 0.583) | 0.056 (0.03, 0.081)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_705-5   | Rheumatism, unspecified                                                                                  | 0.457 (0.422, 0.49)  | 0.512 (0.473, 0.552) | 0.056 (0.005, 0.102)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374     | Disorders of the retina                                                                                  | 0.632 (0.624, 0.637) | 0.687 (0.68, 0.693)  | 0.055 (0.051, 0.06)     | 0.685 (0.67, 0.696)  | 0.741 (0.721, 0.763) | 0.059 (0.037, 0.069)    |\n",
       "| Neuro          | phecode_351-2   | Hypoesthesia of skin*                                                                                    | 0.701 (0.688, 0.717) | 0.755 (0.741, 0.768) | 0.055 (0.041, 0.067)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_098     | Carrier or suspected carrier of infectious diseases                                                      | 0.59 (0.56, 0.622)   | 0.645 (0.621, 0.681) | 0.055 (0.03, 0.082)     | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_281     | Substance abuse, dependence, and withdrawl                                                               | 0.546 (0.537, 0.551) | 0.6 (0.594, 0.607)   | 0.054 (0.049, 0.063)    | 0.549 (0.502, 0.569) | 0.63 (0.61, 0.647)   | 0.089 (0.064, 0.111)    |\n",
       "| Eye            | phecode_380     | Disorders of optic nerve and visual pathways                                                             | 0.582 (0.554, 0.603) | 0.637 (0.613, 0.658) | 0.054 (0.032, 0.081)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_086     | Pediculosis, acariasis and other infestations                                                            | 0.455 (0.432, 0.488) | 0.51 (0.48, 0.541)   | 0.054 (0.023, 0.087)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_812-2   | Angioneurotic edema                                                                                      | 0.473 (0.427, 0.5)   | 0.525 (0.485, 0.561) | 0.054 (0.021, 0.101)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_371     | Cataract                                                                                                 | 0.732 (0.728, 0.736) | 0.784 (0.781, 0.789) | 0.053 (0.049, 0.055)    | 0.711 (0.708, 0.72)  | 0.762 (0.755, 0.765) | 0.049 (0.042, 0.054)    |\n",
       "| Metab          | phecode_247     | Disorders of mineral metabolism and mineral deficiencies                                                 | 0.563 (0.556, 0.571) | 0.616 (0.608, 0.625) | 0.053 (0.046, 0.06)     | 0.621 (0.6, 0.636)   | 0.629 (0.608, 0.642) | 0.007 (0.005, 0.012)    |\n",
       "| Metab          | phecode_256-3   | Mixed disorder of acid-base balance                                                                      | 0.653 (0.635, 0.672) | 0.708 (0.691, 0.727) | 0.053 (0.036, 0.068)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_251     | Disorders of bilirubin excretion                                                                         | 0.553 (0.52, 0.584)  | 0.606 (0.569, 0.633) | 0.053 (0.033, 0.072)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_824     | Other abnormalities of plasma proteins*                                                                  | 0.513 (0.495, 0.527) | 0.566 (0.546, 0.585) | 0.053 (0.032, 0.077)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_175     | Polycythemias                                                                                            | 0.618 (0.585, 0.655) | 0.673 (0.639, 0.701) | 0.053 (0.023, 0.093)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_114     | Neuroendocrine tumors                                                                                    | 0.579 (0.551, 0.614) | 0.632 (0.589, 0.674) | 0.052 (0.016, 0.095)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_831     | Glycosuria                                                                                               | 0.595 (0.582, 0.605) | 0.646 (0.632, 0.656) | 0.051 (0.041, 0.062)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_684-11  | Alopecia Areata                                                                                          | 0.624 (0.601, 0.64)  | 0.676 (0.653, 0.693) | 0.051 (0.035, 0.069)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_809-1   | Acute pain                                                                                               | 0.494 (0.457, 0.527) | 0.545 (0.496, 0.586) | 0.051 (0.014, 0.092)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_504     | Periodontal diseases                                                                                     | 0.508 (0.487, 0.531) | 0.559 (0.539, 0.577) | 0.05 (0.023, 0.073)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_488-6   | Wheezing                                                                                                 | 0.519 (0.512, 0.531) | 0.569 (0.56, 0.581)  | 0.049 (0.039, 0.061)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-11  | Open angle glaucoma                                                                                      | 0.67 (0.655, 0.685)  | 0.719 (0.703, 0.734) | 0.049 (0.037, 0.062)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-12  | Ulcerative colitis                                                                                       | 0.482 (0.45, 0.512)  | 0.532 (0.499, 0.562) | 0.049 (0.012, 0.085)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_164     | Anemia                                                                                                   | 0.588 (0.58, 0.595)  | 0.635 (0.628, 0.643) | 0.048 (0.041, 0.053)    | 0.636 (0.622, 0.653) | 0.645 (0.631, 0.659) | 0.008 (0.005, 0.01)     |\n",
       "| Eye            | phecode_374-55  | Puckering of macula                                                                                      | 0.66 (0.637, 0.673)  | 0.706 (0.684, 0.721) | 0.048 (0.031, 0.066)    | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_973     | Adverse effect of other drug                                                                             | 0.645 (0.617, 0.675) | 0.698 (0.663, 0.726) | 0.048 (0.023, 0.08)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_537-1   | Peritonitis                                                                                              | 0.508 (0.486, 0.54)  | 0.557 (0.532, 0.577) | 0.048 (0.015, 0.073)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_596-5   | Neuromuscular dysfunction of bladder                                                                     | 0.564 (0.532, 0.611) | 0.618 (0.584, 0.654) | 0.048 (0.012, 0.089)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_805     | Fever of unknown origin                                                                                  | 0.527 (0.515, 0.539) | 0.574 (0.563, 0.584) | 0.047 (0.035, 0.059)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_170-19  | Neutropenia NOS                                                                                          | 0.555 (0.524, 0.582) | 0.599 (0.578, 0.631) | 0.047 (0.013, 0.068)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_282-1   | Current tobacco use and nicotine dependence                                                              | 0.568 (0.559, 0.576) | 0.614 (0.608, 0.622) | 0.046 (0.039, 0.055)    | 0.548 (0.52, 0.572)  | 0.633 (0.615, 0.661) | 0.088 (0.075, 0.103)    |\n",
       "| GI             | phecode_503     | Diseases of pulp and periapical tissues                                                                  | 0.509 (0.494, 0.525) | 0.557 (0.54, 0.569)  | 0.046 (0.033, 0.064)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_449     | Other disorders of the circulatory system                                                                | 0.633 (0.604, 0.668) | 0.679 (0.643, 0.723) | 0.046 (0.021, 0.075)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_164-6   | Anemia secondary to chronic diseases and conditions                                                      | 0.648 (0.618, 0.688) | 0.697 (0.662, 0.726) | 0.046 (0.013, 0.08)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_666-2   | Idiopathic urticaria                                                                                     | 0.557 (0.515, 0.604) | 0.603 (0.558, 0.643) | 0.046 (0.001, 0.088)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-1   | Hyperosmolality and/or hypernatremia                                                                     | 0.502 (0.475, 0.531) | 0.547 (0.523, 0.568) | 0.044 (0.021, 0.074)    | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_396-1   | Conductive hearing loss                                                                                  | 0.537 (0.501, 0.572) | 0.579 (0.548, 0.615) | 0.044 (0.011, 0.076)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_474-1   | Emphysema                                                                                                | 0.697 (0.677, 0.712) | 0.738 (0.719, 0.755) | 0.043 (0.026, 0.055)    | 0.689 (0.671, 0.741) | 0.714 (0.701, 0.754) | 0.027 (0.01, 0.04)      |\n",
       "| Neuro          | phecode_334-21  | Bell's palsy                                                                                             | 0.527 (0.501, 0.557) | 0.57 (0.544, 0.59)   | 0.043 (0.012, 0.069)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_826-3   | Raised antibody titer*                                                                                   | 0.517 (0.491, 0.555) | 0.562 (0.531, 0.588) | 0.042 (0.012, 0.068)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_387-3   | Astigmatism                                                                                              | 0.717 (0.702, 0.739) | 0.759 (0.741, 0.779) | 0.041 (0.028, 0.055)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-4   | Disorders of magnesium metabolism                                                                        | 0.67 (0.649, 0.691)  | 0.712 (0.69, 0.735)  | 0.041 (0.024, 0.058)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_719-3   | Separation of muscle (nontraumatic)                                                                      | 0.672 (0.643, 0.697) | 0.71 (0.684, 0.735)  | 0.041 (0.02, 0.057)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_540-3   | Viral hepatitits                                                                                         | 0.544 (0.506, 0.584) | 0.587 (0.535, 0.622) | 0.041 (0.011, 0.077)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_054     | Hepatovirus                                                                                              | 0.555 (0.507, 0.603) | 0.594 (0.559, 0.642) | 0.041 (0.011, 0.07)     | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_204-2   | Impaired glucose tolerance (oral)                                                                        | 0.581 (0.57, 0.59)   | 0.621 (0.613, 0.629) | 0.04 (0.031, 0.048)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721-12  | Radial styloid tenosynovitis [de Quervain]                                                               | 0.544 (0.524, 0.563) | 0.584 (0.566, 0.602) | 0.04 (0.026, 0.057)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-4   | Hyperkalemia [Hyperpotassemia]                                                                           | 0.667 (0.651, 0.687) | 0.708 (0.691, 0.724) | 0.04 (0.025, 0.052)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_706-1   | Sacroiliitis NEC                                                                                         | 0.559 (0.531, 0.597) | 0.598 (0.567, 0.633) | 0.04 (0.014, 0.07)      | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_712-6   | Instability of joint                                                                                     | 0.475 (0.437, 0.499) | 0.513 (0.481, 0.558) | 0.04 (0.014, 0.068)     | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_175-2   | Secondary polycythemia                                                                                   | 0.627 (0.587, 0.671) | 0.668 (0.627, 0.712) | 0.04 (-0.01, 0.081)     | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_840-8   | Allergies related to other diseases/symptoms                                                             | 0.508 (0.5, 0.517)   | 0.547 (0.54, 0.556)  | 0.039 (0.031, 0.047)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_627-3   | Postmenopausal atrophic vaginitis                                                                        | 0.513 (0.504, 0.522) | 0.552 (0.54, 0.56)   | 0.039 (0.027, 0.051)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-3   | Retinal vascular changes and occlusions                                                                  | 0.668 (0.656, 0.683) | 0.707 (0.693, 0.72)  | 0.039 (0.027, 0.048)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_443-1   | Stricture of artery [Arterial stenosis]                                                                  | 0.726 (0.697, 0.76)  | 0.764 (0.739, 0.795) | 0.039 (0.015, 0.057)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_334-2   | Facial nerve disorders and weakness                                                                      | 0.527 (0.5, 0.546)   | 0.565 (0.541, 0.591) | 0.039 (0.014, 0.066)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_299     | Mental disorder, not otherwise specified                                                                 | 0.532 (0.501, 0.559) | 0.568 (0.542, 0.596) | 0.039 (0.013, 0.058)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_286-1   | Bipolar disorder                                                                                         | 0.512 (0.458, 0.55)  | 0.554 (0.505, 0.585) | 0.039 (-0.001, 0.092)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_474     | Chronic obstructive pulmonary disease [COPD]                                                             | 0.666 (0.658, 0.674) | 0.704 (0.697, 0.711) | 0.038 (0.033, 0.046)    | 0.696 (0.661, 0.711) | 0.719 (0.694, 0.736) | 0.027 (0.017, 0.038)    |\n",
       "| Neuro          | phecode_333-1   | Sleep apnea                                                                                              | 0.598 (0.587, 0.611) | 0.637 (0.627, 0.649) | 0.038 (0.029, 0.05)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_662     | Rosacea                                                                                                  | 0.53 (0.52, 0.542)   | 0.567 (0.559, 0.576) | 0.038 (0.029, 0.045)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463-2   | Allergic rhinitis                                                                                        | 0.501 (0.493, 0.51)  | 0.539 (0.532, 0.548) | 0.038 (0.028, 0.048)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_686-2   | Non-pressure chronic ulcer                                                                               | 0.683 (0.667, 0.699) | 0.72 (0.707, 0.737)  | 0.038 (0.027, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_388     | Blindness and low vision                                                                                 | 0.681 (0.666, 0.697) | 0.72 (0.705, 0.735)  | 0.038 (0.027, 0.048)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_469-2   | Chronic bronchitis                                                                                       | 0.651 (0.626, 0.676) | 0.689 (0.668, 0.712) | 0.038 (0.016, 0.064)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_526-11  | Intestinal e.coli                                                                                        | 0.504 (0.466, 0.538) | 0.543 (0.514, 0.58)  | 0.038 (0.008, 0.074)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_204     | Elevated blood glucose level                                                                             | 0.581 (0.575, 0.587) | 0.618 (0.612, 0.624) | 0.037 (0.031, 0.044)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_503-5   | Periapical abscess                                                                                       | 0.512 (0.497, 0.526) | 0.548 (0.533, 0.563) | 0.037 (0.022, 0.055)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_665     | Psoriasis                                                                                                | 0.512 (0.498, 0.528) | 0.549 (0.537, 0.562) | 0.037 (0.022, 0.054)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_542-3   | Hepatic failure                                                                                          | 0.654 (0.622, 0.692) | 0.694 (0.66, 0.724)  | 0.037 (0.008, 0.072)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-1   | Glaucoma                                                                                                 | 0.653 (0.643, 0.661) | 0.689 (0.678, 0.697) | 0.036 (0.028, 0.043)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_685-8   | Hyperhidrosis                                                                                            | 0.54 (0.528, 0.554)  | 0.577 (0.565, 0.59)  | 0.036 (0.025, 0.05)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_733-62  | Arthralgia of temporomandibular joint                                                                    | 0.594 (0.57, 0.623)  | 0.629 (0.604, 0.664) | 0.036 (0.016, 0.059)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-38  | Retinal vein occlusions                                                                                  | 0.67 (0.649, 0.691)  | 0.703 (0.688, 0.724) | 0.036 (0.016, 0.05)     | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581-11  | Acute pyelonephritis                                                                                     | 0.559 (0.533, 0.585) | 0.595 (0.568, 0.616) | 0.036 (0.012, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_685-82  | Generalized hyperhidrosis                                                                                | 0.542 (0.527, 0.558) | 0.578 (0.565, 0.591) | 0.035 (0.022, 0.051)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-14  | Low-tension glaucoma (Normal-tension glaucoma)                                                           | 0.682 (0.657, 0.717) | 0.72 (0.683, 0.749)  | 0.035 (0.009, 0.061)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_356-1   | Dysarthria                                                                                               | 0.646 (0.604, 0.683) | 0.684 (0.646, 0.721) | 0.035 (0.007, 0.089)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_384     | Anomalies of pupillary function                                                                          | 0.558 (0.528, 0.598) | 0.592 (0.555, 0.647) | 0.035 (-0.013, 0.078)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_351     | Disturbances of skin sensation                                                                           | 0.535 (0.529, 0.54)  | 0.568 (0.563, 0.573) | 0.034 (0.027, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463-21  | Seasonal allergic rhinitis                                                                               | 0.51 (0.499, 0.52)   | 0.545 (0.532, 0.555) | 0.034 (0.019, 0.048)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-113 | Primary open angle glaucoma                                                                              | 0.661 (0.636, 0.684) | 0.694 (0.666, 0.714) | 0.034 (0.016, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_376-1   | Vitreous degeneration                                                                                    | 0.606 (0.598, 0.615) | 0.638 (0.631, 0.647) | 0.033 (0.022, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_102-1   | Malignant neoplasm of the of bronchus and lung                                                           | 0.679 (0.665, 0.697) | 0.714 (0.697, 0.726) | 0.033 (0.021, 0.045)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_168-19  | Spontaneous ecchymoses                                                                                   | 0.533 (0.507, 0.558) | 0.566 (0.536, 0.591) | 0.033 (0.004, 0.064)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375     | Abnormal intraocular pressure                                                                            | 0.619 (0.61, 0.629)  | 0.651 (0.641, 0.66)  | 0.032 (0.026, 0.038)    | 0.633 (0.622, 0.638) | 0.696 (0.69, 0.701)  | 0.065 (0.057, 0.073)    |\n",
       "| Mental         | phecode_280-11  | Alcohol abuse                                                                                            | 0.616 (0.603, 0.631) | 0.648 (0.636, 0.66)  | 0.032 (0.023, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_336-55  | Lesion of plantar nerve                                                                                  | 0.599 (0.581, 0.611) | 0.631 (0.613, 0.647) | 0.032 (0.021, 0.047)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_680-3   | Xerosis cutis*                                                                                           | 0.592 (0.578, 0.606) | 0.622 (0.609, 0.638) | 0.032 (0.019, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_164-2   | Macrocytic anemia                                                                                        | 0.624 (0.599, 0.643) | 0.656 (0.632, 0.675) | 0.032 (0.017, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-4   | Carbuncle and furuncle                                                                                   | 0.524 (0.511, 0.541) | 0.557 (0.543, 0.573) | 0.032 (0.014, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_401-3   | Hypertensive chronic kidney disease                                                                      | 0.7 (0.67, 0.737)    | 0.732 (0.699, 0.768) | 0.032 (0.009, 0.059)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_386-4   | Visual field defects                                                                                     | 0.608 (0.585, 0.63)  | 0.639 (0.611, 0.662) | 0.032 (0.005, 0.054)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_486-2   | Other diseases of bronchus                                                                               | 0.506 (0.477, 0.538) | 0.54 (0.499, 0.57)   | 0.032 (-0.009, 0.078)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_351-3   | Paresthesia of skin*                                                                                     | 0.488 (0.477, 0.497) | 0.52 (0.51, 0.53)    | 0.031 (0.023, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_664     | Papulosquamous disorders                                                                                 | 0.532 (0.512, 0.55)  | 0.564 (0.544, 0.577) | 0.031 (0.018, 0.049)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_680-1   | Corns and callosities                                                                                    | 0.557 (0.542, 0.57)  | 0.587 (0.575, 0.602) | 0.031 (0.018, 0.044)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_502     | Other diseases of teeth and supporting structures                                                        | 0.505 (0.491, 0.521) | 0.535 (0.52, 0.549)  | 0.031 (0.012, 0.05)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_730     | Other disorders and symptoms of the musculoskeletal system                                               | 0.519 (0.498, 0.538) | 0.55 (0.532, 0.567)  | 0.031 (0.008, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_347     | Other disorders of the brain and CNS                                                                     | 0.574 (0.547, 0.593) | 0.603 (0.569, 0.631) | 0.031 (0.006, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_702-3   | Enteropathic arthropathies                                                                               | 0.508 (0.466, 0.556) | 0.54 (0.502, 0.574)  | 0.031 (-0.006, 0.071)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_686     | Chronic ulcer of skin                                                                                    | 0.695 (0.685, 0.708) | 0.726 (0.716, 0.737) | 0.03 (0.024, 0.041)     | 0.771 (0.749, 0.787) | 0.781 (0.761, 0.797) | 0.01 (0.008, 0.012)     |\n",
       "| Neuro          | phecode_333     | Sleep disorders                                                                                          | 0.521 (0.514, 0.528) | 0.551 (0.545, 0.557) | 0.03 (0.023, 0.037)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_676     | Hypertrophic conditions of skin                                                                          | 0.482 (0.474, 0.491) | 0.514 (0.504, 0.523) | 0.03 (0.021, 0.043)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_471-5   | Nasal polyps                                                                                             | 0.546 (0.528, 0.565) | 0.577 (0.558, 0.596) | 0.03 (0.017, 0.049)     | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-12  | Allergic [atopic] conjunctivitis                                                                         | 0.567 (0.545, 0.586) | 0.598 (0.578, 0.617) | 0.03 (0.015, 0.048)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_244     | Disorders of lipoprotein metabolism and other lipidemias                                                 | 0.594 (0.577, 0.617) | 0.625 (0.602, 0.643) | 0.03 (0.01, 0.045)      | 0.588 (0.576, 0.6)   | 0.586 (0.573, 0.597) | -0.003 (-0.003, -0.002) |\n",
       "| Eye            | phecode_360-51  | Eczematous dermatitis of eyelid                                                                          | 0.619 (0.591, 0.645) | 0.647 (0.618, 0.673) | 0.03 (0.007, 0.053)     | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_336-2   | Lesion of median, ulnar, radial nerve                                                                    | 0.52 (0.501, 0.541)  | 0.55 (0.528, 0.572)  | 0.03 (0.007, 0.047)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_239-2   | Hyperglyceridemia                                                                                        | 0.541 (0.511, 0.564) | 0.567 (0.546, 0.598) | 0.03 (0.003, 0.061)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_525-3   | Disorders of intestinal carbohydrate absorption                                                          | 0.55 (0.5, 0.589)    | 0.581 (0.546, 0.622) | 0.03 (-0.004, 0.075)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_283     | Other behavioral problems                                                                                | 0.506 (0.502, 0.511) | 0.536 (0.532, 0.542) | 0.029 (0.024, 0.035)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_722     | Fasciopathy                                                                                              | 0.505 (0.499, 0.512) | 0.534 (0.529, 0.541) | 0.029 (0.023, 0.036)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_280     | Substance related disorders                                                                              | 0.573 (0.563, 0.582) | 0.602 (0.593, 0.611) | 0.029 (0.021, 0.037)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_448-9   | Peripheral vascular disease NOS [includes PAD]                                                           | 0.73 (0.717, 0.744)  | 0.759 (0.745, 0.773) | 0.029 (0.019, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_232-29  | Folate deficiency [Vitamin B9]                                                                           | 0.72 (0.69, 0.745)   | 0.748 (0.712, 0.773) | 0.029 (0.011, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-6   | Impingement syndrome of shoulder*                                                                        | 0.5 (0.489, 0.51)    | 0.528 (0.517, 0.537) | 0.029 (0.011, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-41  | Long term (current) use of inhaled steroids*                                                             | 0.547 (0.523, 0.566) | 0.576 (0.554, 0.596) | 0.029 (0.01, 0.055)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-31  | Acidosis                                                                                                 | 0.647 (0.624, 0.673) | 0.678 (0.658, 0.697) | 0.029 (0.008, 0.05)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_232-27  | Vitamin B12 deficiency                                                                                   | 0.576 (0.552, 0.603) | 0.604 (0.58, 0.629)  | 0.029 (0.004, 0.053)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_666     | Urticaria                                                                                                | 0.55 (0.54, 0.56)    | 0.578 (0.569, 0.589) | 0.028 (0.019, 0.037)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_102     | Malignant neoplasm of the thoracic and respiratory organs                                                | 0.677 (0.657, 0.689) | 0.704 (0.689, 0.714) | 0.028 (0.013, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-4   | Long term (current) use of steroids                                                                      | 0.545 (0.528, 0.563) | 0.575 (0.552, 0.594) | 0.028 (0.011, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_369-4   | Corneal degenerations                                                                                    | 0.676 (0.651, 0.708) | 0.705 (0.682, 0.738) | 0.028 (0.009, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581-1   | Pyelonephritis                                                                                           | 0.542 (0.518, 0.562) | 0.568 (0.539, 0.592) | 0.028 (0.005, 0.044)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_352     | Disturbances of sensation of smell and taste                                                             | 0.502 (0.484, 0.522) | 0.531 (0.508, 0.548) | 0.028 (0.004, 0.047)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_344     | Disorders of the circulation of the cerebrospinal fluid                                                  | 0.566 (0.533, 0.602) | 0.595 (0.564, 0.629) | 0.028 (0, 0.07)         | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_727-1   | Osteonecrosis                                                                                            | 0.525 (0.476, 0.568) | 0.549 (0.518, 0.595) | 0.028 (-0.03, 0.077)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_719-11  | Spasm of muscle                                                                                          | 0.472 (0.442, 0.512) | 0.501 (0.461, 0.532) | 0.028 (-0.024, 0.066)   | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_204-4   | Prediabetes*                                                                                             | 0.544 (0.509, 0.589) | 0.57 (0.535, 0.611)  | 0.028 (-0.014, 0.063)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_281-1   | Substance abuse                                                                                          | 0.622 (0.608, 0.633) | 0.648 (0.636, 0.658) | 0.027 (0.019, 0.036)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_337     | Polyneuropathies                                                                                         | 0.597 (0.583, 0.609) | 0.624 (0.608, 0.64)  | 0.027 (0.018, 0.037)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_475     | Asthma                                                                                                   | 0.52 (0.512, 0.53)   | 0.548 (0.537, 0.556) | 0.027 (0.018, 0.035)    | 0.501 (0.49, 0.525)  | 0.532 (0.518, 0.547) | 0.032 (0.02, 0.038)     |\n",
       "| Blood          | phecode_177-2   | Enlargement of lymph nodes [Lymphadenopathy]                                                             | 0.531 (0.52, 0.541)  | 0.558 (0.547, 0.569) | 0.027 (0.014, 0.038)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_160-2   | Megaloblastic anemia                                                                                     | 0.624 (0.605, 0.652) | 0.651 (0.631, 0.671) | 0.027 (0.013, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_479-3   | Respiratory failure                                                                                      | 0.672 (0.653, 0.695) | 0.701 (0.679, 0.722) | 0.027 (0.012, 0.042)    | 0.66 (0.636, 0.7)    | 0.69 (0.663, 0.721)  | 0.026 (0.009, 0.046)    |\n",
       "| Resp           | phecode_468-2   | Bacterial pneumonia                                                                                      | 0.619 (0.599, 0.644) | 0.647 (0.624, 0.671) | 0.027 (0.011, 0.047)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_341     | Cerebral palsy and other paralytic syndromes                                                             | 0.65 (0.626, 0.674)  | 0.675 (0.655, 0.695) | 0.027 (0.011, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_377-4   | Retinal hemorrhage                                                                                       | 0.641 (0.611, 0.675) | 0.668 (0.633, 0.702) | 0.027 (0.01, 0.046)     | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_411-2   | Pericardial effusion (noninflammatory)*                                                                  | 0.635 (0.608, 0.663) | 0.662 (0.635, 0.693) | 0.027 (0.004, 0.049)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_257     | Polydipsia                                                                                               | 0.512 (0.483, 0.545) | 0.537 (0.509, 0.57)  | 0.027 (0, 0.049)        | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_284-2   | Suicide and self-inflicted harm                                                                          | 0.566 (0.533, 0.597) | 0.594 (0.563, 0.63)  | 0.027 (-0.005, 0.066)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_486     | Other respiratory disorders                                                                              | 0.544 (0.54, 0.55)   | 0.571 (0.565, 0.576) | 0.026 (0.021, 0.03)     | 0.613 (0.595, 0.635) | 0.619 (0.6, 0.644)   | 0.006 (0.001, 0.014)    |\n",
       "| Signs/Symptoms | phecode_800     | Chest pain                                                                                               | 0.513 (0.508, 0.519) | 0.539 (0.533, 0.543) | 0.026 (0.02, 0.031)     | 0.546 (0.512, 0.561) | 0.559 (0.532, 0.577) | 0.015 (0.006, 0.028)    |\n",
       "| Hearing        | phecode_390-1   | Otitis externa                                                                                           | 0.502 (0.496, 0.508) | 0.529 (0.523, 0.536) | 0.026 (0.019, 0.034)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_280-1   | Alcohol use disorders                                                                                    | 0.578 (0.568, 0.585) | 0.604 (0.595, 0.614) | 0.026 (0.018, 0.034)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_333-11  | Obstructive sleep apnea                                                                                  | 0.612 (0.593, 0.629) | 0.638 (0.622, 0.654) | 0.026 (0.015, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_535     | Intestinal or peritoneal adhesions                                                                       | 0.554 (0.539, 0.569) | 0.579 (0.566, 0.601) | 0.026 (0.012, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_487-3   | Hemoptysis                                                                                               | 0.585 (0.566, 0.602) | 0.611 (0.594, 0.627) | 0.026 (0.012, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_686-1   | Pressure ulcer                                                                                           | 0.721 (0.705, 0.737) | 0.746 (0.733, 0.761) | 0.026 (0.011, 0.038)    | 0.787 (0.766, 0.814) | 0.792 (0.766, 0.822) | 0.004 (-0.003, 0.012)   |\n",
       "| Derm           | phecode_660-21  | Impetigo                                                                                                 | 0.513 (0.493, 0.534) | 0.537 (0.522, 0.563) | 0.026 (0.01, 0.04)      | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_840-9   | Anaphylactic reaction                                                                                    | 0.496 (0.455, 0.552) | 0.524 (0.476, 0.566) | 0.026 (-0.021, 0.073)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-6   | Prurigo                                                                                                  | 0.528 (0.497, 0.565) | 0.556 (0.523, 0.589) | 0.026 (-0.009, 0.061)   | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_248     | Disorders of plasma-protein metabolism, NEC                                                              | 0.601 (0.56, 0.653)  | 0.629 (0.573, 0.676) | 0.026 (-0.003, 0.056)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_284-29  | Intentional self-harm*                                                                                   | 0.566 (0.531, 0.599) | 0.595 (0.563, 0.632) | 0.026 (-0.003, 0.052)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_683-2   | Nail dystrophy*                                                                                          | 0.593 (0.56, 0.623)  | 0.618 (0.585, 0.651) | 0.026 (-0.002, 0.051)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_804     | Other symptoms and signs involving the circulatory and respiratory system                                | 0.533 (0.527, 0.54)  | 0.558 (0.553, 0.564) | 0.025 (0.02, 0.031)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_469     | Bronchitis                                                                                               | 0.543 (0.534, 0.553) | 0.568 (0.561, 0.578) | 0.025 (0.016, 0.034)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-2   | Bacterial infection of the skin                                                                          | 0.503 (0.486, 0.52)  | 0.53 (0.506, 0.545)  | 0.025 (0.012, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_800-2   | Precordial pain                                                                                          | 0.536 (0.521, 0.551) | 0.561 (0.545, 0.576) | 0.025 (0.012, 0.037)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_832-5   | Acetonuria                                                                                               | 0.547 (0.529, 0.563) | 0.572 (0.556, 0.586) | 0.025 (0.011, 0.038)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-6   | Fluid overload                                                                                           | 0.721 (0.697, 0.74)  | 0.744 (0.725, 0.766) | 0.025 (0.008, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_507-11  | Recurrent oral aphthae [Recurrent aphthous stomatitis]                                                   | 0.559 (0.53, 0.584)  | 0.583 (0.55, 0.61)   | 0.025 (0.001, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_330-12  | Partial epilepsy                                                                                         | 0.587 (0.559, 0.62)  | 0.612 (0.573, 0.656) | 0.025 (-0.017, 0.057)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_525-1   | Celiac disease                                                                                           | 0.508 (0.482, 0.537) | 0.534 (0.506, 0.563) | 0.025 (-0.016, 0.055)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_336-52  | Meralgia paresthetica                                                                                    | 0.472 (0.441, 0.5)   | 0.496 (0.471, 0.524) | 0.025 (-0.01, 0.057)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_666-1   | Allergic urticaria                                                                                       | 0.599 (0.575, 0.627) | 0.621 (0.587, 0.654) | 0.025 (-0.007, 0.054)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_089-1   | Bacterial infections                                                                                     | 0.552 (0.546, 0.559) | 0.577 (0.57, 0.582)  | 0.024 (0.017, 0.029)    | 0.715 (0.694, 0.733) | 0.716 (0.695, 0.734) | 0.001 (0, 0.004)        |\n",
       "| Neuro          | phecode_336-1   | Carpal tunnel syndrome                                                                                   | 0.542 (0.534, 0.552) | 0.566 (0.555, 0.577) | 0.024 (0.013, 0.034)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_341-2   | Hemiplegia and hemiparesis                                                                               | 0.667 (0.65, 0.685)  | 0.692 (0.669, 0.712) | 0.024 (0.01, 0.041)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710-4   | Acquired deformities of the ankle and foot                                                               | 0.582 (0.563, 0.597) | 0.605 (0.586, 0.621) | 0.024 (0.009, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_361-3   | Ptosis of eyelid                                                                                         | 0.627 (0.606, 0.648) | 0.652 (0.628, 0.673) | 0.024 (0.009, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_168-1   | Hypo-coagulability                                                                                       | 0.592 (0.566, 0.617) | 0.614 (0.594, 0.64)  | 0.024 (0.008, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_355-2   | Alteration of consciousness                                                                              | 0.621 (0.603, 0.646) | 0.647 (0.625, 0.668) | 0.024 (0.008, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_351-1   | Anesthesia of skin*                                                                                      | 0.5 (0.487, 0.513)   | 0.524 (0.512, 0.537) | 0.024 (0.008, 0.038)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_239-12  | Familial hypercholesterolemia*                                                                           | 0.598 (0.571, 0.624) | 0.625 (0.594, 0.646) | 0.024 (0.006, 0.045)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_366     | Noninflammatory disorders of conjunctiva                                                                 | 0.536 (0.52, 0.554)  | 0.559 (0.539, 0.58)  | 0.024 (0.003, 0.044)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_588-2   | Abnormal results of function study of kidney                                                             | 0.687 (0.653, 0.712) | 0.71 (0.676, 0.739)  | 0.024 (0.002, 0.047)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_810     | Shock                                                                                                    | 0.722 (0.687, 0.754) | 0.745 (0.71, 0.781)  | 0.024 (-0.004, 0.048)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-2   | Eustachian tube disorders                                                                                | 0.53 (0.52, 0.538)   | 0.553 (0.543, 0.563) | 0.023 (0.016, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_376-2   | Vitreous opacities                                                                                       | 0.612 (0.604, 0.618) | 0.634 (0.626, 0.643) | 0.023 (0.016, 0.028)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-5   | Lichen simplex chronicus                                                                                 | 0.566 (0.542, 0.596) | 0.591 (0.558, 0.617) | 0.023 (0.002, 0.049)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_366-42  | Conjunctival hyperemia                                                                                   | 0.516 (0.473, 0.552) | 0.538 (0.502, 0.576) | 0.023 (-0.008, 0.061)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_376     | Disorders of vitreous body                                                                               | 0.612 (0.604, 0.619) | 0.635 (0.627, 0.642) | 0.022 (0.017, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_283-8   | Other problems related to lifestyle                                                                      | 0.513 (0.508, 0.518) | 0.535 (0.529, 0.538) | 0.022 (0.017, 0.027)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_733     | Dentofacial anomalies, including malocclusion                                                            | 0.587 (0.572, 0.605) | 0.607 (0.591, 0.624) | 0.022 (0.012, 0.032)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_376-21  | Crystalline deposits in vitreous body                                                                    | 0.592 (0.571, 0.608) | 0.614 (0.601, 0.629) | 0.022 (0.01, 0.035)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_733-6   | Temporomandibular joint disorders                                                                        | 0.587 (0.575, 0.599) | 0.609 (0.595, 0.621) | 0.022 (0.01, 0.031)     | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_335     | Nerve root and plexus disorders                                                                          | 0.543 (0.527, 0.558) | 0.565 (0.553, 0.578) | 0.022 (0.009, 0.035)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_135-5   | Benign neoplasm of the paranasal sinus and nasal cavity                                                  | 0.555 (0.535, 0.569) | 0.577 (0.559, 0.597) | 0.022 (0.008, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_550-2   | Cholecystitis                                                                                            | 0.535 (0.52, 0.55)   | 0.559 (0.539, 0.577) | 0.022 (0.006, 0.045)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_061     | Influenza virus                                                                                          | 0.56 (0.538, 0.586)  | 0.582 (0.559, 0.611) | 0.022 (0.004, 0.041)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_588     | Disorders and findings from impaired renal function                                                      | 0.655 (0.624, 0.692) | 0.678 (0.647, 0.716) | 0.022 (0.002, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_361-4   | Blepharochalasis                                                                                         | 0.623 (0.59, 0.653)  | 0.643 (0.603, 0.68)  | 0.022 (-0.01, 0.052)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_149-3   | Benign neoplasm of the parathyroid gland                                                                 | 0.64 (0.61, 0.671)   | 0.661 (0.633, 0.694) | 0.022 (-0.009, 0.047)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-6   | Cellulitis and abscess                                                                                   | 0.538 (0.533, 0.543) | 0.559 (0.554, 0.564) | 0.021 (0.016, 0.026)    | 0.668 (0.64, 0.684)  | 0.667 (0.642, 0.678) | 0 (-0.006, 0.004)       |\n",
       "| Genitourinary  | phecode_582     | Acute kidney failure                                                                                     | 0.705 (0.696, 0.711) | 0.725 (0.718, 0.731) | 0.021 (0.014, 0.028)    | 0.74 (0.727, 0.749)  | 0.748 (0.734, 0.752) | 0.007 (0.004, 0.009)    |\n",
       "| Endo           | phecode_200-9   | Abnormal thyroid function studies                                                                        | 0.593 (0.57, 0.616)  | 0.614 (0.587, 0.638) | 0.021 (0.005, 0.033)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_731     | Symptoms involving musculoskeletal systems                                                               | 0.496 (0.485, 0.507) | 0.516 (0.503, 0.526) | 0.021 (0.004, 0.032)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_530-2   | Anorectal abscess                                                                                        | 0.596 (0.566, 0.632) | 0.615 (0.58, 0.652)  | 0.021 (-0.007, 0.046)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-52  | Macular cyst, hole, or pseudohole                                                                        | 0.663 (0.643, 0.685) | 0.686 (0.663, 0.707) | 0.021 (-0.002, 0.045)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_462-2   | Chronic sinusitis                                                                                        | 0.54 (0.531, 0.547)  | 0.559 (0.551, 0.567) | 0.02 (0.015, 0.025)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_719-1   | Cramp and spasm                                                                                          | 0.577 (0.567, 0.588) | 0.598 (0.587, 0.608) | 0.02 (0.012, 0.028)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-1   | Adhesive capsulitis of shoulder                                                                          | 0.536 (0.527, 0.548) | 0.557 (0.546, 0.567) | 0.02 (0.011, 0.033)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_684-1   | Alopecia                                                                                                 | 0.687 (0.677, 0.697) | 0.708 (0.697, 0.717) | 0.02 (0.011, 0.029)     | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_333-2   | Insomnia                                                                                                 | 0.541 (0.531, 0.551) | 0.561 (0.551, 0.569) | 0.02 (0.01, 0.029)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_585     | Kidney stone disease                                                                                     | 0.592 (0.58, 0.604)  | 0.612 (0.598, 0.624) | 0.02 (0.01, 0.027)      | 0.59 (0.566, 0.617)  | 0.6 (0.578, 0.636)   | 0.01 (0.004, 0.019)     |\n",
       "| Resp           | phecode_495     | Abnormal findings on diagnostic imaging of lung                                                          | 0.645 (0.634, 0.658) | 0.666 (0.655, 0.678) | 0.02 (0.009, 0.031)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_513-2   | Gastric ulcer                                                                                            | 0.589 (0.572, 0.603) | 0.608 (0.591, 0.623) | 0.02 (0.003, 0.033)     | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_002-1   | Staphylococcus aureus                                                                                    | 0.581 (0.561, 0.606) | 0.601 (0.577, 0.621) | 0.02 (0.002, 0.041)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_468-1   | Viral pneumonia                                                                                          | 0.632 (0.596, 0.666) | 0.652 (0.617, 0.685) | 0.02 (-0.009, 0.055)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_330-1   | Epilepsy                                                                                                 | 0.563 (0.543, 0.584) | 0.584 (0.558, 0.606) | 0.02 (-0.009, 0.042)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_148-1   | Benign neoplasm of eye                                                                                   | 0.572 (0.539, 0.603) | 0.594 (0.565, 0.617) | 0.02 (-0.006, 0.046)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-61  | Hemangioma                                                                                               | 0.498 (0.48, 0.516)  | 0.516 (0.496, 0.537) | 0.02 (-0.006, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_056     | Human papillomavirus                                                                                     | 0.492 (0.482, 0.5)   | 0.511 (0.501, 0.518) | 0.019 (0.007, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-9   | Delirium                                                                                                 | 0.75 (0.732, 0.763)  | 0.769 (0.753, 0.783) | 0.019 (0.007, 0.029)    | 0.802 (0.783, 0.817) | 0.802 (0.784, 0.818) | 0 (-0.002, 0.004)       |\n",
       "| Derm           | phecode_664-1   | Lichen planus, nitidus, or striatus                                                                      | 0.579 (0.56, 0.596)  | 0.597 (0.58, 0.612)  | 0.019 (0.002, 0.031)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-11  | Candidiasis of skin and nails                                                                            | 0.543 (0.527, 0.559) | 0.563 (0.545, 0.575) | 0.019 (0.001, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_719-7   | Muscle weakness (generalized)                                                                            | 0.55 (0.524, 0.575)  | 0.568 (0.545, 0.599) | 0.019 (-0.01, 0.048)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-34  | Torticollis                                                                                              | 0.53 (0.511, 0.546)  | 0.549 (0.528, 0.567) | 0.019 (-0.001, 0.038)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_719     | Disorders of muscle                                                                                      | 0.565 (0.554, 0.573) | 0.583 (0.575, 0.593) | 0.018 (0.011, 0.027)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_713-2   | Effusion of joint                                                                                        | 0.578 (0.57, 0.586)  | 0.596 (0.587, 0.604) | 0.018 (0.011, 0.026)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_402     | Elevated blood pressure reading without diagnosis of hypertension                                        | 0.536 (0.529, 0.543) | 0.554 (0.546, 0.561) | 0.018 (0.01, 0.025)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_545     | Nonspecific abnormal results of function study of liver                                                  | 0.544 (0.533, 0.553) | 0.561 (0.553, 0.572) | 0.018 (0.008, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_706     | Other inflammatory spondylopathies                                                                       | 0.585 (0.565, 0.603) | 0.604 (0.586, 0.62)  | 0.018 (0.006, 0.032)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_349-13  | Abnormal findings on diagnostic imaging of skull and head                                                | 0.627 (0.607, 0.65)  | 0.647 (0.622, 0.672) | 0.018 (0.004, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_417-2   | Tachycardia                                                                                              | 0.596 (0.583, 0.613) | 0.615 (0.602, 0.628) | 0.018 (0.004, 0.03)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-3   | Changes in skin texture                                                                                  | 0.581 (0.57, 0.596)  | 0.599 (0.585, 0.614) | 0.018 (0.003, 0.03)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_555     | Ascites                                                                                                  | 0.642 (0.622, 0.66)  | 0.66 (0.635, 0.679)  | 0.018 (0.002, 0.037)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_349-1   | Abnormal findings on diagnostic test of central nervous system                                           | 0.612 (0.594, 0.638) | 0.633 (0.609, 0.654) | 0.018 (0.001, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_826     | Other abnormal immunological findings in serum                                                           | 0.521 (0.499, 0.55)  | 0.537 (0.507, 0.562) | 0.018 (-0.016, 0.045)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_718-4   | Low back pain                                                                                            | 0.517 (0.512, 0.522) | 0.534 (0.529, 0.538) | 0.017 (0.011, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_003     | Escherichia coli                                                                                         | 0.599 (0.588, 0.611) | 0.617 (0.601, 0.63)  | 0.017 (0.008, 0.027)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_204-1   | Impaired fasting glucose                                                                                 | 0.608 (0.591, 0.618) | 0.625 (0.609, 0.641) | 0.017 (0.006, 0.028)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-6   | Ocular hypertension                                                                                      | 0.591 (0.577, 0.604) | 0.607 (0.594, 0.624) | 0.017 (0.003, 0.03)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_516     | Other diseases of stomach and duodenum                                                                   | 0.586 (0.566, 0.601) | 0.602 (0.589, 0.62)  | 0.017 (0.003, 0.029)    | 0.527 (0.51, 0.538)  | 0.524 (0.507, 0.535) | -0.003 (-0.005, -0.001) |\n",
       "| Neuro          | phecode_348     | Other diseases of spinal cord                                                                            | 0.563 (0.548, 0.582) | 0.58 (0.562, 0.603)  | 0.017 (0.002, 0.033)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_179     | Immunodeficiencies                                                                                       | 0.465 (0.437, 0.497) | 0.483 (0.455, 0.51)  | 0.017 (-0.019, 0.051)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_360-12  | Hordeolum internum                                                                                       | 0.544 (0.513, 0.57)  | 0.56 (0.525, 0.586)  | 0.017 (-0.015, 0.041)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_148-16  | Benign neoplasm of choroid                                                                               | 0.58 (0.557, 0.613)  | 0.596 (0.569, 0.626) | 0.017 (-0.011, 0.044)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_480     | Pulmonary edema                                                                                          | 0.709 (0.681, 0.737) | 0.726 (0.696, 0.759) | 0.017 (-0.002, 0.04)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_002     | Staphylococcus                                                                                           | 0.605 (0.583, 0.623) | 0.622 (0.601, 0.639) | 0.017 (-0.002, 0.036)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_401     | Hypertension                                                                                             | 0.626 (0.623, 0.63)  | 0.642 (0.638, 0.646) | 0.016 (0.014, 0.019)    | 0.639 (0.631, 0.647) | 0.648 (0.64, 0.656)  | 0.009 (0.006, 0.01)     |\n",
       "| Cardio         | phecode_401-1   | Essential hypertension                                                                                   | 0.626 (0.622, 0.63)  | 0.642 (0.638, 0.647) | 0.016 (0.014, 0.019)    | 0.641 (0.631, 0.648) | 0.648 (0.642, 0.653) | 0.009 (0.005, 0.011)    |\n",
       "| Resp           | phecode_488     | Abnormalities of breathing                                                                               | 0.57 (0.565, 0.575)  | 0.586 (0.581, 0.591) | 0.016 (0.013, 0.02)     | 0.596 (0.564, 0.629) | 0.627 (0.589, 0.649) | 0.019 (0.002, 0.041)    |\n",
       "| Resp           | phecode_460-2   | Acute lower respiratory infection                                                                        | 0.559 (0.555, 0.563) | 0.575 (0.572, 0.579) | 0.016 (0.013, 0.02)     | 0.717 (0.7, 0.736)   | 0.724 (0.704, 0.741) | 0.006 (0.004, 0.01)     |\n",
       "| Musc/Skel      | phecode_718     | Back pain                                                                                                | 0.518 (0.513, 0.522) | 0.534 (0.529, 0.537) | 0.016 (0.012, 0.02)     | 0.572 (0.556, 0.602) | 0.573 (0.557, 0.605) | 0.001 (-0.001, 0.003)   |\n",
       "| Eye            | phecode_386     | Visual disturbances                                                                                      | 0.588 (0.579, 0.595) | 0.605 (0.596, 0.613) | 0.016 (0.011, 0.024)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_138     | Benign neoplasm of the skin                                                                              | 0.528 (0.522, 0.535) | 0.544 (0.537, 0.55)  | 0.016 (0.01, 0.021)     | 0.475 (0.452, 0.5)   | 0.474 (0.448, 0.51)  | 0.004 (-0.011, 0.016)   |\n",
       "| Derm           | phecode_684     | Diseases of hair and hair follicles                                                                      | 0.695 (0.684, 0.704) | 0.711 (0.7, 0.721)   | 0.016 (0.009, 0.025)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_325-2   | Abnormality of gait and mobility                                                                         | 0.647 (0.639, 0.656) | 0.662 (0.655, 0.671) | 0.016 (0.009, 0.023)    | 0.778 (0.75, 0.795)  | 0.774 (0.747, 0.793) | -0.002 (-0.005, -0.001) |\n",
       "| Neuro          | phecode_336     | Mononeuropathies                                                                                         | 0.544 (0.537, 0.552) | 0.56 (0.554, 0.567)  | 0.016 (0.009, 0.022)    | 0.512 (0.494, 0.527) | 0.526 (0.506, 0.538) | 0.012 (-0.002, 0.02)    |\n",
       "| Resp           | phecode_486-5   | Abnormal sputum                                                                                          | 0.555 (0.547, 0.562) | 0.571 (0.563, 0.58)  | 0.016 (0.009, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_496     | Abnormal results of pulmonary function studies                                                           | 0.58 (0.57, 0.591)   | 0.597 (0.587, 0.608) | 0.016 (0.008, 0.024)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_524-1   | Irritable bowel syndrome                                                                                 | 0.606 (0.595, 0.617) | 0.621 (0.611, 0.635) | 0.016 (0.007, 0.026)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-5   | Hypokalemia [Hypopotassemia]                                                                             | 0.638 (0.624, 0.655) | 0.655 (0.643, 0.668) | 0.016 (0.005, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_464-1   | Acute nasopharyngitis                                                                                    | 0.534 (0.523, 0.543) | 0.55 (0.538, 0.563)  | 0.016 (0.005, 0.027)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_464     | Nasopharyngitis                                                                                          | 0.534 (0.521, 0.547) | 0.549 (0.539, 0.562) | 0.016 (0.003, 0.028)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_012     | Proteus                                                                                                  | 0.675 (0.627, 0.723) | 0.689 (0.64, 0.742)  | 0.016 (-0.034, 0.061)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-11  | Acute otitis media                                                                                       | 0.506 (0.474, 0.536) | 0.521 (0.491, 0.552) | 0.016 (-0.017, 0.053)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-22  | Flushing                                                                                                 | 0.562 (0.535, 0.592) | 0.578 (0.556, 0.602) | 0.016 (-0.004, 0.04)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_515     | Heartburn and epigastric pain                                                                            | 0.553 (0.545, 0.563) | 0.569 (0.562, 0.578) | 0.015 (0.01, 0.023)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_468     | Pneumonia                                                                                                | 0.665 (0.657, 0.671) | 0.68 (0.672, 0.687)  | 0.015 (0.01, 0.021)     | 0.73 (0.719, 0.748)  | 0.735 (0.722, 0.752) | 0.004 (0.001, 0.005)    |\n",
       "| Derm           | phecode_679-4   | Pruritus                                                                                                 | 0.554 (0.547, 0.562) | 0.57 (0.562, 0.576)  | 0.015 (0.01, 0.02)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_448     | Peripheral vascular disease                                                                              | 0.613 (0.601, 0.628) | 0.629 (0.616, 0.643) | 0.015 (0.009, 0.024)    | 0.715 (0.68, 0.735)  | 0.715 (0.686, 0.732) | 0.003 (-0.009, 0.012)   |\n",
       "| Signs/Symptoms | phecode_841-4   | Allergy to analgesic agent                                                                               | 0.624 (0.612, 0.633) | 0.638 (0.626, 0.648) | 0.015 (0.009, 0.021)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_468-9   | Lobar pneumonia*                                                                                         | 0.675 (0.667, 0.683) | 0.689 (0.681, 0.699) | 0.015 (0.008, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_361     | Disorders of eyelid function                                                                             | 0.64 (0.629, 0.655)  | 0.655 (0.642, 0.672) | 0.015 (0.004, 0.026)    | 0.641 (0.621, 0.671) | 0.639 (0.621, 0.673) | 0 (-0.007, 0.003)       |\n",
       "| Derm           | phecode_685     | Disorders of sweat glands                                                                                | 0.55 (0.536, 0.561)  | 0.565 (0.553, 0.578) | 0.015 (0.003, 0.028)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_355     | Coma and other alteration of consciousness                                                               | 0.61 (0.593, 0.631)  | 0.626 (0.61, 0.641)  | 0.015 (0.001, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_716-2   | Degenerative disc disease                                                                                | 0.525 (0.508, 0.539) | 0.54 (0.524, 0.551)  | 0.015 (0, 0.03)         | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_688     | Granulomatous disorder of the skin                                                                       | 0.507 (0.478, 0.527) | 0.522 (0.501, 0.543) | 0.015 (-0.005, 0.034)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_138-1   | Nevus, non-neoplastic                                                                                    | 0.532 (0.508, 0.552) | 0.546 (0.527, 0.564) | 0.015 (-0.005, 0.034)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_556-3   | Abdominal or pelvic swelling, mass, or lump                                                              | 0.543 (0.53, 0.559)  | 0.559 (0.542, 0.572) | 0.015 (-0.001, 0.029)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724     | Other symptoms and disorders of the soft tissue                                                          | 0.55 (0.543, 0.555)  | 0.565 (0.56, 0.57)   | 0.014 (0.01, 0.019)     | 0.541 (0.523, 0.556) | 0.542 (0.523, 0.56)  | 0.004 (-0.01, 0.012)    |\n",
       "| Signs/Symptoms | phecode_840     | Allergy                                                                                                  | 0.541 (0.534, 0.545) | 0.554 (0.547, 0.56)  | 0.014 (0.009, 0.017)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_138-2   | Melanocytic nevi*                                                                                        | 0.544 (0.537, 0.553) | 0.559 (0.551, 0.567) | 0.014 (0.008, 0.019)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_177     | Abnormality of the lymph nodes                                                                           | 0.555 (0.547, 0.565) | 0.57 (0.56, 0.58)    | 0.014 (0.006, 0.024)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-2   | Seborrheic dermatitis                                                                                    | 0.541 (0.53, 0.551)  | 0.555 (0.544, 0.566) | 0.014 (0.006, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_716     | Intervertebral disc disorder                                                                             | 0.535 (0.527, 0.544) | 0.548 (0.539, 0.556) | 0.014 (0.005, 0.02)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_680     | Epidermal thickening                                                                                     | 0.586 (0.576, 0.595) | 0.598 (0.589, 0.61)  | 0.014 (0.005, 0.019)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_674     | Disorders of pigmentation                                                                                | 0.545 (0.533, 0.556) | 0.558 (0.548, 0.57)  | 0.014 (0.003, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_209     | Disorders of the pituitary gland and its hypothalamic control                                            | 0.609 (0.582, 0.648) | 0.621 (0.584, 0.657) | 0.014 (-0.022, 0.038)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_007-1   | Hemophilus influenzae                                                                                    | 0.595 (0.552, 0.627) | 0.611 (0.566, 0.659) | 0.014 (-0.012, 0.056)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_559     | Other disease of digestive system, NOS                                                                   | 0.523 (0.493, 0.548) | 0.537 (0.508, 0.561) | 0.014 (-0.011, 0.036)   | 0.546 (0.519, 0.55)  | 0.543 (0.516, 0.548) | -0.003 (-0.004, -0.001) |\n",
       "| GI             | phecode_517     | Gastrointestinal angiodysplasia                                                                          | 0.68 (0.649, 0.712)  | 0.692 (0.663, 0.725) | 0.014 (-0.01, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_537     | Abnormality of the peritoneum                                                                            | 0.54 (0.521, 0.57)   | 0.557 (0.533, 0.583) | 0.014 (-0.006, 0.036)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_327     | Other degenerative diseases of nervous system                                                            | 0.692 (0.667, 0.72)  | 0.707 (0.683, 0.729) | 0.014 (-0.003, 0.036)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_711-1   | Derangement of meniscus                                                                                  | 0.524 (0.51, 0.535)  | 0.538 (0.525, 0.548) | 0.014 (-0.001, 0.028)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_460     | Acute respiratory infection                                                                              | 0.527 (0.522, 0.531) | 0.54 (0.537, 0.544)  | 0.013 (0.01, 0.016)     | 0.709 (0.686, 0.722) | 0.716 (0.697, 0.726) | 0.007 (0.001, 0.01)     |\n",
       "| ID             | phecode_089-3   | Fungal infections                                                                                        | 0.52 (0.516, 0.525)  | 0.532 (0.527, 0.538) | 0.013 (0.009, 0.016)    | 0.6 (0.562, 0.611)   | 0.593 (0.556, 0.609) | -0.003 (-0.02, 0.005)   |\n",
       "| Musc/Skel      | phecode_722-1   | Plantar fascial fibromatosis [Plantar fasciitis]                                                         | 0.536 (0.529, 0.544) | 0.549 (0.541, 0.556) | 0.013 (0.007, 0.018)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_425     | Cardiomegaly                                                                                             | 0.679 (0.666, 0.694) | 0.692 (0.682, 0.706) | 0.013 (0.005, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_479     | Pulmonary insufficiency and acute respiratory distress syndrome                                          | 0.657 (0.646, 0.672) | 0.67 (0.657, 0.685)  | 0.013 (0.005, 0.022)    | 0.655 (0.623, 0.692) | 0.705 (0.676, 0.75)  | 0.045 (0.032, 0.068)    |\n",
       "| Musc/Skel      | phecode_718-1   | Radiculopathy                                                                                            | 0.573 (0.561, 0.587) | 0.586 (0.573, 0.6)   | 0.013 (0.004, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_558     | Abnormal findings on diagnostic imaging of the digestive tract                                           | 0.588 (0.578, 0.601) | 0.601 (0.586, 0.611) | 0.013 (0.004, 0.02)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_491     | Pleurisy                                                                                                 | 0.623 (0.602, 0.643) | 0.637 (0.616, 0.653) | 0.013 (0.003, 0.025)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724-5   | Exostosis                                                                                                | 0.559 (0.543, 0.577) | 0.574 (0.554, 0.587) | 0.013 (0.003, 0.024)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-13  | Umbilical hernia                                                                                         | 0.625 (0.614, 0.639) | 0.637 (0.625, 0.652) | 0.013 (0.003, 0.023)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_711     | Disorder of patella                                                                                      | 0.523 (0.51, 0.536)  | 0.536 (0.525, 0.549) | 0.013 (0.002, 0.029)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_841-3   | Allergy to narcotic agent                                                                                | 0.657 (0.641, 0.68)  | 0.672 (0.654, 0.689) | 0.013 (0.002, 0.024)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-3   | Dystonia                                                                                                 | 0.548 (0.529, 0.566) | 0.561 (0.55, 0.579)  | 0.013 (0, 0.028)        | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_344-1   | Hydrocephalus                                                                                            | 0.627 (0.587, 0.67)  | 0.638 (0.604, 0.692) | 0.013 (-0.036, 0.054)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-7   | Restlessness and agitation*                                                                              | 0.569 (0.536, 0.6)   | 0.583 (0.554, 0.617) | 0.013 (-0.019, 0.046)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_348-2   | Myelopathies                                                                                             | 0.555 (0.537, 0.58)  | 0.57 (0.546, 0.594)  | 0.013 (-0.012, 0.038)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_015     | Clostridium                                                                                              | 0.602 (0.574, 0.632) | 0.615 (0.589, 0.649) | 0.013 (-0.011, 0.041)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_554-11  | Acute pancreatitis                                                                                       | 0.571 (0.547, 0.601) | 0.585 (0.563, 0.607) | 0.013 (-0.01, 0.038)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_149     | Benign neoplasm of the endocrine glands                                                                  | 0.581 (0.558, 0.611) | 0.597 (0.574, 0.619) | 0.013 (-0.01, 0.032)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_554-1   | Pancreatitis                                                                                             | 0.584 (0.558, 0.605) | 0.595 (0.575, 0.617) | 0.013 (-0.008, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_100     | Malignant neoplasm of the head and neck                                                                  | 0.607 (0.578, 0.638) | 0.622 (0.597, 0.651) | 0.013 (-0.005, 0.037)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_084     | Parasites                                                                                                | 0.58 (0.563, 0.605)  | 0.593 (0.568, 0.619) | 0.013 (-0.005, 0.029)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_488-1   | Dyspnea [Shortness of breath]                                                                            | 0.599 (0.594, 0.605) | 0.612 (0.606, 0.616) | 0.012 (0.009, 0.016)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_801     | Cough                                                                                                    | 0.527 (0.524, 0.531) | 0.539 (0.535, 0.543) | 0.012 (0.009, 0.015)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_389     | Other disorders of eye                                                                                   | 0.561 (0.555, 0.569) | 0.573 (0.566, 0.579) | 0.012 (0.007, 0.016)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_807     | Malaise and fatigue                                                                                      | 0.547 (0.543, 0.551) | 0.559 (0.554, 0.565) | 0.012 (0.007, 0.016)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_325     | Symptoms and signs related to movement disorders                                                         | 0.636 (0.627, 0.643) | 0.648 (0.64, 0.656)  | 0.012 (0.006, 0.019)    | 0.751 (0.735, 0.782) | 0.748 (0.73, 0.778)  | -0.004 (-0.005, -0.002) |\n",
       "| Metab          | phecode_256-7   | Volume depletion                                                                                         | 0.662 (0.648, 0.675) | 0.674 (0.661, 0.684) | 0.012 (0.003, 0.021)    | 0.728 (0.707, 0.746) | 0.728 (0.706, 0.744) | 0 (-0.002, 0.001)       |\n",
       "| Eye            | phecode_360-11  | Hordeolum externum                                                                                       | 0.519 (0.51, 0.533)  | 0.531 (0.519, 0.543) | 0.012 (0.002, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_169-11  | Immune thrombocytopenic purpura [ITP]                                                                    | 0.599 (0.561, 0.639) | 0.614 (0.567, 0.653) | 0.012 (-0.013, 0.042)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_353-1   | Hallucinations                                                                                           | 0.615 (0.583, 0.654) | 0.626 (0.601, 0.651) | 0.012 (-0.012, 0.039)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_673     | Skin changes due to chronic exposure to nonionizing radiation                                            | 0.598 (0.593, 0.602) | 0.609 (0.604, 0.613) | 0.011 (0.009, 0.013)    | 0.586 (0.549, 0.611) | 0.57 (0.533, 0.598)  | -0.015 (-0.018, -0.009) |\n",
       "| Musc/Skel      | phecode_707     | Other arthropathies                                                                                      | 0.641 (0.636, 0.647) | 0.652 (0.646, 0.659) | 0.011 (0.008, 0.014)    | 0.571 (0.556, 0.584) | 0.582 (0.572, 0.596) | 0.013 (0.005, 0.02)     |\n",
       "| Metab          | phecode_256     | Disorders of fluid, electrolyte and acid-base balance                                                    | 0.581 (0.575, 0.588) | 0.592 (0.585, 0.599) | 0.011 (0.007, 0.016)    | 0.712 (0.701, 0.724) | 0.715 (0.702, 0.726) | 0.002 (0, 0.003)        |\n",
       "| Derm           | phecode_681     | Localized swelling, mass and lump of skin and subcutaneous tissue                                        | 0.556 (0.552, 0.561) | 0.567 (0.563, 0.573) | 0.011 (0.007, 0.015)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_718-2   | Cervicalgia                                                                                              | 0.55 (0.545, 0.556)  | 0.561 (0.556, 0.566) | 0.011 (0.006, 0.017)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_812     | Edema                                                                                                    | 0.61 (0.603, 0.617)  | 0.621 (0.614, 0.631) | 0.011 (0.006, 0.017)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_718-5   | Sciatica                                                                                                 | 0.546 (0.54, 0.553)  | 0.557 (0.55, 0.563)  | 0.011 (0.006, 0.016)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_526     | Intestinal infection                                                                                     | 0.568 (0.561, 0.575) | 0.579 (0.572, 0.588) | 0.011 (0.005, 0.016)    | 0.65 (0.631, 0.658)  | 0.653 (0.629, 0.663) | 0.003 (-0.002, 0.005)   |\n",
       "| Neuro          | phecode_350-5   | Repeated falls*                                                                                          | 0.717 (0.707, 0.726) | 0.727 (0.72, 0.735)  | 0.011 (0.004, 0.016)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_360-1   | Hordeolum                                                                                                | 0.519 (0.507, 0.533) | 0.531 (0.52, 0.541)  | 0.011 (0.003, 0.022)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_524     | Functional intestinal disorder                                                                           | 0.6 (0.589, 0.612)   | 0.612 (0.599, 0.623) | 0.011 (0.003, 0.02)     | 0.628 (0.623, 0.648) | 0.627 (0.623, 0.647) | -0.001 (-0.003, 0)      |\n",
       "| Derm           | phecode_682-1   | Cutaneous cyst                                                                                           | 0.496 (0.489, 0.503) | 0.506 (0.499, 0.514) | 0.011 (0.002, 0.02)     | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139     | Benign sarcoma-related cancers                                                                           | 0.5 (0.49, 0.508)    | 0.511 (0.501, 0.521) | 0.011 (0, 0.021)        | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_526-2   | Viral enteritis                                                                                          | 0.57 (0.537, 0.602)  | 0.585 (0.552, 0.616) | 0.011 (-0.016, 0.04)    | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-7   | Perforation of tympanic membrane                                                                         | 0.532 (0.506, 0.555) | 0.542 (0.517, 0.564) | 0.011 (-0.015, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_495-1   | Solitary pulmonary nodule                                                                                | 0.632 (0.594, 0.657) | 0.642 (0.609, 0.674) | 0.011 (-0.011, 0.041)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_095     | Sequela of infection                                                                                     | 0.546 (0.522, 0.574) | 0.558 (0.534, 0.592) | 0.011 (-0.011, 0.032)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_484     | Pneumothorax and air leak                                                                                | 0.611 (0.583, 0.641) | 0.624 (0.591, 0.652) | 0.011 (-0.01, 0.04)     | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_004     | Streptococcus                                                                                            | 0.578 (0.557, 0.599) | 0.59 (0.565, 0.609)  | 0.011 (-0.006, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_554     | Diseases of the pancreas                                                                                 | 0.598 (0.578, 0.616) | 0.606 (0.588, 0.626) | 0.011 (-0.006, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-6   | Hemangioma and lymphangioma                                                                              | 0.501 (0.485, 0.517) | 0.513 (0.498, 0.534) | 0.011 (-0.004, 0.034)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709-22  | Hallux rigidus                                                                                           | 0.573 (0.552, 0.592) | 0.585 (0.561, 0.605) | 0.011 (-0.003, 0.027)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103-1   | Melanomas of skin                                                                                        | 0.603 (0.588, 0.621) | 0.615 (0.598, 0.633) | 0.011 (-0.002, 0.021)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_584     | Renal failure                                                                                            | 0.683 (0.663, 0.699) | 0.692 (0.676, 0.712) | 0.011 (-0.001, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103     | Malignant neoplasm of the skin                                                                           | 0.655 (0.648, 0.664) | 0.666 (0.658, 0.674) | 0.01 (0.008, 0.013)     | 0.625 (0.606, 0.633) | 0.623 (0.604, 0.632) | -0.002 (-0.003, -0.001) |\n",
       "| Derm           | phecode_673-1   | Actinic keratosis                                                                                        | 0.599 (0.595, 0.603) | 0.609 (0.605, 0.614) | 0.01 (0.008, 0.012)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660     | Infection of the skin                                                                                    | 0.524 (0.52, 0.528)  | 0.534 (0.53, 0.539)  | 0.01 (0.007, 0.013)     | 0.676 (0.666, 0.692) | 0.68 (0.673, 0.699)  | 0.007 (-0.001, 0.01)    |\n",
       "| Death          | OMOP_4306655    | All-Cause Death                                                                                          | 0.707 (0.702, 0.714) | 0.718 (0.712, 0.723) | 0.01 (0.006, 0.014)     | 0.733 (0.705, 0.784) | 0.727 (0.701, 0.773) | -0.006 (-0.015, 0.008)  |\n",
       "| Cardio         | phecode_424     | Heart failure                                                                                            | 0.737 (0.731, 0.748) | 0.747 (0.739, 0.756) | 0.01 (0.005, 0.016)     | 0.767 (0.757, 0.778) | 0.768 (0.759, 0.78)  | 0.002 (0, 0.004)        |\n",
       "| Cardio         | phecode_424-1   | Left heart failure                                                                                       | 0.73 (0.716, 0.743)  | 0.739 (0.726, 0.752) | 0.01 (0.004, 0.015)     | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463     | Rhinitis and nasal congestion                                                                            | 0.522 (0.517, 0.529) | 0.532 (0.525, 0.538) | 0.01 (0.004, 0.015)     | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_234     | Other nutritional deficiencies                                                                           | 0.58 (0.57, 0.593)   | 0.59 (0.58, 0.604)   | 0.01 (0.002, 0.02)      | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_181     | Autoimmune disease                                                                                       | 0.547 (0.536, 0.556) | 0.557 (0.548, 0.568) | 0.01 (0.001, 0.022)     | 0.561 (0.549, 0.58)  | 0.561 (0.539, 0.573) | -0.002 (-0.014, 0.01)   |\n",
       "| Neuro          | phecode_336-5   | Mononeuritis of lower limb                                                                               | 0.563 (0.549, 0.578) | 0.574 (0.56, 0.589)  | 0.01 (0.001, 0.02)      | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_509-3   | Hypertrophy of tongue papillae                                                                           | 0.533 (0.497, 0.576) | 0.543 (0.507, 0.576) | 0.01 (-0.024, 0.039)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_366-4   | Vascular abnormalities of conjunctiva                                                                    | 0.524 (0.495, 0.56)  | 0.533 (0.51, 0.567)  | 0.01 (-0.02, 0.042)     | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_162     | Aplastic anemia                                                                                          | 0.657 (0.631, 0.689) | 0.667 (0.636, 0.699) | 0.01 (-0.018, 0.033)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_526-12  | Intestinal infection due to C. difficile                                                                 | 0.646 (0.619, 0.681) | 0.657 (0.628, 0.692) | 0.01 (-0.017, 0.038)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_452     | Hemorrhage, NOS                                                                                          | 0.575 (0.546, 0.6)   | 0.586 (0.554, 0.611) | 0.01 (-0.014, 0.034)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_840-1   | Food allergy                                                                                             | 0.547 (0.523, 0.573) | 0.556 (0.531, 0.584) | 0.01 (-0.008, 0.028)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_513-1   | Esophageal ulcer                                                                                         | 0.599 (0.577, 0.618) | 0.609 (0.593, 0.632) | 0.01 (-0.005, 0.026)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_682-11  | Sebaceous cyst [Epidermal cyst]                                                                          | 0.486 (0.479, 0.496) | 0.497 (0.489, 0.506) | 0.01 (-0.003, 0.021)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_585-1   | Renal colic                                                                                              | 0.608 (0.589, 0.629) | 0.62 (0.598, 0.641)  | 0.01 (-0.002, 0.026)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103-21  | Basal cell carcinoma                                                                                     | 0.643 (0.634, 0.652) | 0.652 (0.643, 0.661) | 0.009 (0.006, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103-2   | Keratinocyte carcinoma                                                                                   | 0.652 (0.646, 0.659) | 0.66 (0.654, 0.668)  | 0.009 (0.006, 0.011)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_605     | Male sexual dysfuction                                                                                   | 0.558 (0.552, 0.564) | 0.567 (0.56, 0.575)  | 0.009 (0.005, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_460-1   | Acute upper respiratory infection                                                                        | 0.534 (0.529, 0.54)  | 0.543 (0.539, 0.548) | 0.009 (0.005, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_809-3   | Pain in limb                                                                                             | 0.524 (0.52, 0.529)  | 0.533 (0.529, 0.537) | 0.009 (0.005, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_809     | Pain                                                                                                     | 0.528 (0.525, 0.531) | 0.537 (0.533, 0.541) | 0.009 (0.005, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_605-1   | Male erectile dysfunction                                                                                | 0.558 (0.551, 0.564) | 0.567 (0.559, 0.573) | 0.009 (0.004, 0.014)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-9   | Gastritis                                                                                                | 0.565 (0.558, 0.571) | 0.574 (0.568, 0.58)  | 0.009 (0.004, 0.014)    | 0.571 (0.552, 0.583) | 0.57 (0.55, 0.582)   | -0.001 (-0.001, -0.001) |\n",
       "| Neuro          | phecode_331-8   | Headache NOS                                                                                             | 0.57 (0.564, 0.574)  | 0.578 (0.573, 0.584) | 0.009 (0.004, 0.014)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_823-2   | Abnormal levels of other serum enzymes                                                                   | 0.56 (0.552, 0.568)  | 0.569 (0.56, 0.578)  | 0.009 (0.004, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_433     | Other cerebrovascular disease                                                                            | 0.716 (0.705, 0.726) | 0.725 (0.717, 0.734) | 0.009 (0.003, 0.016)    | 0.773 (0.759, 0.78)  | 0.77 (0.756, 0.779)  | -0.002 (-0.006, 0)      |\n",
       "| Signs/Symptoms | phecode_823     | Abnormal serum enzyme levels                                                                             | 0.56 (0.55, 0.569)   | 0.569 (0.56, 0.578)  | 0.009 (0.003, 0.014)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_716-3   | Spinal disc displacement (herniation)                                                                    | 0.542 (0.531, 0.556) | 0.552 (0.541, 0.563) | 0.009 (0.002, 0.019)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724-1   | Myalgia                                                                                                  | 0.555 (0.547, 0.564) | 0.563 (0.553, 0.571) | 0.009 (0.001, 0.015)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_015-2   | Clostridium difficile                                                                                    | 0.646 (0.622, 0.673) | 0.656 (0.629, 0.684) | 0.009 (-0.017, 0.033)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_557-1   | Hematemesis                                                                                              | 0.596 (0.578, 0.619) | 0.605 (0.578, 0.627) | 0.009 (-0.017, 0.031)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_361-1   | Entropion and trichiasis of eyelid                                                                       | 0.682 (0.651, 0.712) | 0.691 (0.662, 0.72)  | 0.009 (-0.013, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_468-8   | Bronchopneumonia                                                                                         | 0.686 (0.653, 0.731) | 0.695 (0.663, 0.739) | 0.009 (-0.012, 0.029)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_437     | Vascular insufficiency of intestine                                                                      | 0.665 (0.634, 0.687) | 0.673 (0.645, 0.707) | 0.009 (-0.008, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_168     | Coagulation defects, purpura and other hemorrhagic conditions                                            | 0.595 (0.579, 0.612) | 0.604 (0.589, 0.618) | 0.009 (-0.004, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_360-2   | Chalazion                                                                                                | 0.52 (0.503, 0.535)  | 0.531 (0.514, 0.541) | 0.009 (-0.002, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_705-1   | Rheumatoid arthritis                                                                                     | 0.591 (0.576, 0.609) | 0.601 (0.583, 0.617) | 0.009 (-0.001, 0.023)   | 0.596 (0.576, 0.613) | 0.59 (0.577, 0.616)  | 0.002 (-0.012, 0.012)   |\n",
       "| Metab          | phecode_239-11  | Pure hypercholesterolemia                                                                                | 0.614 (0.611, 0.618) | 0.623 (0.619, 0.627) | 0.008 (0.006, 0.011)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_239-1   | Hypercholesterolemia                                                                                     | 0.613 (0.609, 0.617) | 0.621 (0.616, 0.626) | 0.008 (0.006, 0.01)     | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-1   | Fungal infection of the skin                                                                             | 0.541 (0.535, 0.548) | 0.55 (0.544, 0.556)  | 0.008 (0.005, 0.012)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_830     | Proteinuria                                                                                              | 0.584 (0.579, 0.59)  | 0.591 (0.587, 0.597) | 0.008 (0.005, 0.012)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_239     | Hyperlipidemia                                                                                           | 0.606 (0.602, 0.612) | 0.615 (0.61, 0.62)   | 0.008 (0.005, 0.011)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_070     | Candidiasis                                                                                              | 0.586 (0.579, 0.594) | 0.594 (0.586, 0.603) | 0.008 (0.003, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522     | Gastrointestinal inflammation                                                                            | 0.555 (0.549, 0.56)  | 0.563 (0.558, 0.568) | 0.008 (0.003, 0.012)    | 0.566 (0.56, 0.58)   | 0.565 (0.559, 0.58)  | -0.001 (-0.001, 0)      |\n",
       "| Musc/Skel      | phecode_715-4   | Spinal stenosis                                                                                          | 0.645 (0.633, 0.657) | 0.653 (0.641, 0.666) | 0.008 (0.001, 0.015)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_473     | Other diseases of upper respiratory tract                                                                | 0.537 (0.525, 0.551) | 0.545 (0.532, 0.558) | 0.008 (0, 0.014)        | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_469-1   | Acute bronchitis                                                                                         | 0.564 (0.542, 0.584) | 0.571 (0.545, 0.594) | 0.008 (-0.016, 0.031)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_375-12  | Angle-Closure Glaucoma                                                                                   | 0.675 (0.65, 0.698)  | 0.683 (0.659, 0.712) | 0.008 (-0.008, 0.027)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_713-4   | Stiffness of joint                                                                                       | 0.529 (0.512, 0.545) | 0.537 (0.511, 0.557) | 0.008 (-0.008, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440-2   | Arterial embolism and thrombosis                                                                         | 0.689 (0.668, 0.709) | 0.697 (0.679, 0.715) | 0.008 (-0.008, 0.02)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_726-2   | Pathologic fracture                                                                                      | 0.724 (0.706, 0.745) | 0.732 (0.714, 0.751) | 0.008 (-0.005, 0.021)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_424-2   | Systolic heart failure                                                                                   | 0.721 (0.696, 0.743) | 0.73 (0.702, 0.751)  | 0.008 (-0.003, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_526-1   | Bacterial enteritis                                                                                      | 0.528 (0.518, 0.543) | 0.538 (0.525, 0.55)  | 0.008 (-0.002, 0.022)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_800-1   | Chest pain on breathing                                                                                  | 0.54 (0.53, 0.557)   | 0.55 (0.54, 0.563)   | 0.008 (-0.002, 0.02)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_513     | Peptic ulcer                                                                                             | 0.594 (0.585, 0.603) | 0.601 (0.595, 0.613) | 0.008 (-0.002, 0.018)   | 0.672 (0.637, 0.69)  | 0.677 (0.649, 0.7)   | 0.009 (0.002, 0.015)    |\n",
       "| Cardio         | phecode_443     | Other specified disorders of arteries and arterioles                                                     | 0.687 (0.677, 0.702) | 0.696 (0.682, 0.708) | 0.008 (-0.001, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_713-3   | Pain in joint                                                                                            | 0.526 (0.523, 0.53)  | 0.533 (0.529, 0.536) | 0.007 (0.004, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_713     | Symptoms related to joints                                                                               | 0.526 (0.523, 0.53)  | 0.533 (0.53, 0.536)  | 0.007 (0.004, 0.009)    | 0.63 (0.609, 0.662)  | 0.634 (0.613, 0.662) | 0.004 (-0.004, 0.014)   |\n",
       "| Cardio         | phecode_403     | Angina pectoris                                                                                          | 0.672 (0.665, 0.682) | 0.679 (0.671, 0.686) | 0.007 (0.003, 0.011)    | 0.662 (0.648, 0.669) | 0.662 (0.649, 0.671) | 0.001 (-0.002, 0.005)   |\n",
       "| ID             | phecode_089     | Infections                                                                                               | 0.521 (0.517, 0.525) | 0.528 (0.524, 0.531) | 0.007 (0.003, 0.01)     | 0.675 (0.664, 0.683) | 0.68 (0.671, 0.693)  | 0.006 (0.004, 0.01)     |\n",
       "| Musc/Skel      | phecode_703-1   | Hyperuricemia                                                                                            | 0.701 (0.693, 0.708) | 0.707 (0.7, 0.715)   | 0.007 (0.003, 0.01)     | 0.78 (0.758, 0.796)  | 0.782 (0.768, 0.8)   | 0.004 (-0.001, 0.01)    |\n",
       "| Resp           | phecode_483     | Pleural effusion                                                                                         | 0.682 (0.672, 0.691) | 0.688 (0.679, 0.696) | 0.007 (0.002, 0.014)    | 0.647 (0.629, 0.659) | 0.65 (0.635, 0.661)  | 0.004 (0.002, 0.011)    |\n",
       "| ID             | phecode_092-2   | Sepsis                                                                                                   | 0.663 (0.652, 0.672) | 0.671 (0.66, 0.682)  | 0.007 (0.001, 0.013)    | 0.683 (0.652, 0.698) | 0.682 (0.654, 0.696) | 0.001 (-0.002, 0.003)   |\n",
       "| Cardio         | phecode_404-1   | Myocardial infarction [Heart attack]                                                                     | 0.707 (0.699, 0.715) | 0.715 (0.707, 0.723) | 0.007 (0.001, 0.012)    | 0.711 (0.694, 0.728) | 0.714 (0.701, 0.731) | 0.004 (0, 0.006)        |\n",
       "| Musc/Skel      | phecode_721-1   | Synovitis and tenosynovitis                                                                              | 0.539 (0.534, 0.547) | 0.546 (0.54, 0.553)  | 0.007 (0.001, 0.012)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_431-11  | Cerebral infarction [Ischemic stroke]                                                                    | 0.704 (0.692, 0.715) | 0.711 (0.7, 0.721)   | 0.007 (0, 0.014)        | 0.723 (0.704, 0.727) | 0.721 (0.702, 0.726) | 0 (-0.003, 0.005)       |\n",
       "| Signs/Symptoms | phecode_802     | Throat pain                                                                                              | 0.549 (0.537, 0.559) | 0.555 (0.544, 0.567) | 0.007 (0, 0.013)        | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_439     | Hemorrhoids                                                                                              | 0.504 (0.499, 0.509) | 0.511 (0.506, 0.517) | 0.007 (0, 0.012)        | 0.47 (0.432, 0.496)  | 0.491 (0.455, 0.514) | 0.018 (0.013, 0.028)    |\n",
       "| Cardio         | phecode_424-3   | Diastolic heart failure                                                                                  | 0.697 (0.667, 0.722) | 0.703 (0.677, 0.73)  | 0.007 (-0.017, 0.026)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_554-2   | Cyst and pseudocyst of pancreas                                                                          | 0.626 (0.591, 0.658) | 0.634 (0.6, 0.663)   | 0.007 (-0.016, 0.033)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_807-11  | Postviral fatigue syndrome*                                                                              | 0.605 (0.574, 0.644) | 0.611 (0.576, 0.646) | 0.007 (-0.015, 0.023)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_411     | Other diseases of pericardium                                                                            | 0.642 (0.619, 0.662) | 0.65 (0.626, 0.67)   | 0.007 (-0.013, 0.026)   | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_230-3   | Anorexia                                                                                                 | 0.604 (0.588, 0.623) | 0.611 (0.593, 0.629) | 0.007 (-0.006, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-5   | Disorders of calcium metabolism                                                                          | 0.609 (0.595, 0.621) | 0.615 (0.6, 0.632)   | 0.007 (-0.005, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_397     | Other hearing abnormality                                                                                | 0.502 (0.494, 0.511) | 0.509 (0.5, 0.517)   | 0.007 (-0.005, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_827     | Toxicology findings                                                                                      | 0.622 (0.604, 0.647) | 0.629 (0.613, 0.65)  | 0.007 (-0.003, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_426     | Other heart disorders in diseases NEC                                                                    | 0.709 (0.697, 0.72)  | 0.715 (0.705, 0.729) | 0.007 (-0.002, 0.015)   | 0.676 (0.656, 0.685) | 0.684 (0.658, 0.693) | 0.007 (0, 0.011)        |\n",
       "| Cardio         | phecode_431-1   | Stroke                                                                                                   | 0.695 (0.683, 0.706) | 0.702 (0.692, 0.712) | 0.007 (-0.001, 0.017)   | 0.711 (0.701, 0.738) | 0.711 (0.699, 0.74)  | -0.001 (-0.003, 0.004)  |\n",
       "| ID             | phecode_092     | Bacteremia, Sepsis, and SIRS                                                                             | 0.666 (0.655, 0.676) | 0.673 (0.663, 0.683) | 0.007 (-0.001, 0.014)   | 0.678 (0.671, 0.692) | 0.679 (0.673, 0.696) | 0.002 (-0.001, 0.004)   |\n",
       "| Mental         | phecode_286-2   | Major depressive disorder                                                                                | 0.569 (0.562, 0.574) | 0.574 (0.569, 0.581) | 0.006 (0.002, 0.011)    | 0.566 (0.548, 0.582) | 0.569 (0.55, 0.588)  | 0.003 (-0.001, 0.007)   |\n",
       "| Musc/Skel      | phecode_722-4   | Palmar fascial fibromatosis [Dupuytren]                                                                  | 0.645 (0.634, 0.658) | 0.651 (0.641, 0.663) | 0.006 (0.002, 0.011)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668     | Dermatitis [eczema]                                                                                      | 0.537 (0.531, 0.542) | 0.543 (0.538, 0.55)  | 0.006 (0.002, 0.01)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_703-11  | Gout                                                                                                     | 0.706 (0.698, 0.716) | 0.712 (0.702, 0.722) | 0.006 (0.002, 0.01)     | 0.78 (0.753, 0.805)  | 0.78 (0.757, 0.804)  | 0 (-0.003, 0.008)       |\n",
       "| GI             | phecode_550     | Disorders of the gallbladder                                                                             | 0.572 (0.566, 0.582) | 0.579 (0.572, 0.587) | 0.006 (0.001, 0.012)    | 0.569 (0.536, 0.581) | 0.565 (0.534, 0.577) | -0.003 (-0.006, -0.001) |\n",
       "| Signs/Symptoms | phecode_841-11  | Penicillin allergy                                                                                       | 0.584 (0.577, 0.593) | 0.59 (0.581, 0.597)  | 0.006 (0.001, 0.01)     | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_732     | Nonspecific abnormal findings on radiological and other examination of musculoskeletal system            | 0.632 (0.62, 0.641)  | 0.638 (0.626, 0.647) | 0.006 (0.001, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_840-2   | Allergy to insects                                                                                       | 0.572 (0.56, 0.583)  | 0.579 (0.568, 0.59)  | 0.006 (0, 0.014)        | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391     | Disorders of the middle ear                                                                              | 0.522 (0.516, 0.53)  | 0.528 (0.522, 0.535) | 0.006 (0, 0.012)        | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_330-11  | Generalized epilepsy                                                                                     | 0.536 (0.501, 0.578) | 0.54 (0.498, 0.59)   | 0.006 (-0.042, 0.055)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_383     | Irregular eye movements                                                                                  | 0.541 (0.497, 0.591) | 0.546 (0.501, 0.589) | 0.006 (-0.031, 0.041)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-5   | Secondary malignancy of brain/spine                                                                      | 0.625 (0.599, 0.651) | 0.628 (0.608, 0.66)  | 0.006 (-0.022, 0.028)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-7   | Ulceration of the lower GI tract                                                                         | 0.541 (0.516, 0.57)  | 0.548 (0.52, 0.581)  | 0.006 (-0.019, 0.038)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_174     | Diseases of spleen                                                                                       | 0.586 (0.558, 0.62)  | 0.594 (0.567, 0.617) | 0.006 (-0.018, 0.031)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-32  | Tricuspid value insufficiency*                                                                           | 0.724 (0.695, 0.752) | 0.73 (0.705, 0.758)  | 0.006 (-0.014, 0.029)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_431-12  | Hemorrhagic stroke                                                                                       | 0.65 (0.626, 0.676)  | 0.658 (0.635, 0.675) | 0.006 (-0.012, 0.026)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_288-2   | Panic disorder [episodic paroxysmal anxiety]                                                             | 0.567 (0.55, 0.586)  | 0.575 (0.557, 0.591) | 0.006 (-0.009, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_420     | Cardiac arrest                                                                                           | 0.728 (0.709, 0.748) | 0.733 (0.713, 0.756) | 0.006 (-0.009, 0.022)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_603-2   | Spermatocele                                                                                             | 0.531 (0.505, 0.552) | 0.538 (0.519, 0.562) | 0.006 (-0.008, 0.027)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724-52  | Osteophyte*                                                                                              | 0.582 (0.565, 0.601) | 0.588 (0.567, 0.607) | 0.006 (-0.008, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-1   | Atopic dermatitis                                                                                        | 0.519 (0.505, 0.528) | 0.524 (0.511, 0.535) | 0.006 (-0.007, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_508     | Diseases of lips                                                                                         | 0.584 (0.569, 0.6)   | 0.591 (0.575, 0.606) | 0.006 (-0.006, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_800-11  | Pleurodynia*                                                                                             | 0.546 (0.535, 0.559) | 0.552 (0.54, 0.564)  | 0.006 (-0.006, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-3   | Contact dermatitis                                                                                       | 0.539 (0.525, 0.549) | 0.545 (0.529, 0.557) | 0.006 (-0.003, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_532     | Other disorders of the intestines                                                                        | 0.553 (0.54, 0.566)  | 0.559 (0.543, 0.574) | 0.006 (-0.002, 0.017)   | 0.549 (0.526, 0.578) | 0.544 (0.526, 0.575) | -0.003 (-0.005, -0.001) |\n",
       "| Resp           | phecode_471     | Other disorders of nose and nasal sinuses                                                                | 0.507 (0.499, 0.513) | 0.513 (0.507, 0.519) | 0.006 (-0.002, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_557-8   | Hemorrhage of rectum and anus                                                                            | 0.51 (0.502, 0.521)  | 0.516 (0.507, 0.525) | 0.006 (-0.002, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_827-1   | Finding of alcohol in blood                                                                              | 0.627 (0.609, 0.652) | 0.635 (0.616, 0.657) | 0.006 (-0.002, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-6   | Secondary malignancy of bone                                                                             | 0.687 (0.677, 0.699) | 0.694 (0.682, 0.706) | 0.006 (-0.001, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_550-1   | Gallstones [Cholelithiasis]                                                                              | 0.579 (0.57, 0.587)  | 0.583 (0.577, 0.593) | 0.006 (-0.001, 0.012)   | 0.572 (0.545, 0.597) | 0.573 (0.542, 0.596) | -0.002 (-0.005, 0.003)  |\n",
       "| Derm           | phecode_678     | Other skin and connective tissue disorders                                                               | 0.553 (0.549, 0.557) | 0.558 (0.554, 0.563) | 0.005 (0.003, 0.007)    | 0.613 (0.587, 0.626) | 0.607 (0.58, 0.618)  | -0.006 (-0.008, -0.006) |\n",
       "| Mental         | phecode_286     | Mood [affective] disorders                                                                               | 0.569 (0.562, 0.576) | 0.574 (0.569, 0.582) | 0.005 (0.002, 0.01)     | 0.566 (0.549, 0.579) | 0.57 (0.557, 0.586)  | 0.004 (-0.005, 0.01)    |\n",
       "| Derm           | phecode_660-12  | Dermatophytosis                                                                                          | 0.55 (0.543, 0.558)  | 0.556 (0.549, 0.564) | 0.005 (0.002, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529-5   | Constipation                                                                                             | 0.609 (0.604, 0.616) | 0.614 (0.609, 0.621) | 0.005 (0.002, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_136-4   | Benign neoplasm of colon, rectum, anus and anal canal                                                    | 0.59 (0.585, 0.597)  | 0.596 (0.59, 0.602)  | 0.005 (0.002, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_527     | Abdominal pain                                                                                           | 0.548 (0.544, 0.553) | 0.553 (0.549, 0.558) | 0.005 (0.002, 0.008)    | 0.553 (0.543, 0.564) | 0.55 (0.54, 0.561)   | -0.003 (-0.005, -0.003) |\n",
       "| Signs/Symptoms | phecode_841     | Drug and medical agent allergy                                                                           | 0.604 (0.6, 0.608)   | 0.609 (0.604, 0.614) | 0.005 (0.002, 0.008)    | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_350     | Other symptoms involving nervous system                                                                  | 0.61 (0.602, 0.617)  | 0.615 (0.608, 0.622) | 0.005 (0.001, 0.01)     | 0.803 (0.79, 0.813)  | 0.803 (0.791, 0.813) | 0 (0, 0.001)            |\n",
       "| Cardio         | phecode_436     | Atherosclerosis [ASCVD]                                                                                  | 0.704 (0.697, 0.711) | 0.709 (0.701, 0.715) | 0.005 (0.001, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367     | Inflammation of the eye                                                                                  | 0.564 (0.558, 0.572) | 0.569 (0.564, 0.576) | 0.005 (0.001, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103-3   | Carcinoma in situ of skin                                                                                | 0.718 (0.701, 0.729) | 0.724 (0.706, 0.734) | 0.005 (0.001, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529-2   | Abdominal distension and flatulence                                                                      | 0.569 (0.561, 0.575) | 0.573 (0.566, 0.582) | 0.005 (0, 0.011)        | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_230     | Malnutrition and underweight                                                                             | 0.602 (0.593, 0.61)  | 0.607 (0.598, 0.614) | 0.005 (0, 0.011)        | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_404-2   | Coronary atherosclerosis [Atherosclerotic heart disease]                                                 | 0.703 (0.696, 0.71)  | 0.707 (0.701, 0.714) | 0.005 (0, 0.008)        | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_465     | Pharyngitis                                                                                              | 0.561 (0.554, 0.566) | 0.566 (0.558, 0.571) | 0.005 (0, 0.008)        | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144-3   | Benign neoplasms of the ovary                                                                            | 0.492 (0.456, 0.524) | 0.498 (0.464, 0.539) | 0.005 (-0.031, 0.057)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_472     | Diseases of vocal cords and larynx, not elsewhere classified                                             | 0.57 (0.543, 0.594)  | 0.573 (0.551, 0.608) | 0.005 (-0.025, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_688-3   | Pyogenic granuloma of skin and subcutaneous tissue                                                       | 0.51 (0.48, 0.543)   | 0.519 (0.486, 0.546) | 0.005 (-0.021, 0.041)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_613-7   | Other signs and symptoms in breast                                                                       | 0.458 (0.434, 0.477) | 0.463 (0.447, 0.482) | 0.005 (-0.013, 0.03)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_477     | Inhalation lung injury                                                                                   | 0.719 (0.677, 0.749) | 0.723 (0.683, 0.769) | 0.005 (-0.012, 0.03)    | 0.747 (0.721, 0.779) | 0.75 (0.723, 0.783)  | 0.002 (-0.004, 0.004)   |\n",
       "| Neuro          | phecode_330     | Epilepsy, recurrent seizures, convulsions                                                                | 0.578 (0.561, 0.597) | 0.583 (0.563, 0.602) | 0.005 (-0.012, 0.019)   | 0.601 (0.546, 0.64)  | 0.598 (0.549, 0.649) | 0.002 (-0.007, 0.013)   |\n",
       "| Signs/Symptoms | phecode_815     | Symptoms and signs concerning food and fluid intake                                                      | 0.538 (0.522, 0.56)  | 0.542 (0.524, 0.566) | 0.005 (-0.011, 0.021)   | 0.602 (0.578, 0.654) | 0.61 (0.585, 0.662)  | 0.008 (0, 0.012)        |\n",
       "| Cardio         | phecode_414     | Cardiomyopathy                                                                                           | 0.658 (0.635, 0.679) | 0.665 (0.644, 0.684) | 0.005 (-0.005, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_718-3   | Mid back pain                                                                                            | 0.574 (0.558, 0.591) | 0.58 (0.567, 0.593)  | 0.005 (-0.005, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_170     | Decreased white blood cell count                                                                         | 0.586 (0.574, 0.597) | 0.591 (0.579, 0.605) | 0.005 (-0.004, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-2   | Rotator cuff tear or rupture                                                                             | 0.536 (0.528, 0.547) | 0.541 (0.533, 0.551) | 0.005 (-0.004, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_103-22  | Squamous cell carcinoma of the skin                                                                      | 0.716 (0.695, 0.743) | 0.721 (0.699, 0.744) | 0.005 (-0.004, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-1   | Otitis media                                                                                             | 0.527 (0.516, 0.536) | 0.532 (0.522, 0.54)  | 0.005 (-0.002, 0.014)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-21  | Aortic stenosis                                                                                          | 0.755 (0.741, 0.765) | 0.758 (0.747, 0.772) | 0.005 (-0.002, 0.012)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308     | Signs and symptoms involving emotional state                                                             | 0.564 (0.557, 0.571) | 0.569 (0.561, 0.576) | 0.005 (-0.002, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_256-2   | Hyposmolality and/or hyponatremia                                                                        | 0.534 (0.524, 0.546) | 0.539 (0.531, 0.55)  | 0.005 (-0.001, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_431     | Stroke and transient cerebral ischemic attacks                                                           | 0.689 (0.679, 0.696) | 0.693 (0.686, 0.701) | 0.005 (-0.001, 0.01)    | 0.707 (0.692, 0.737) | 0.707 (0.693, 0.735) | -0.001 (-0.002, 0.001)  |\n",
       "| Mental         | phecode_294     | Sexual dysfunction and disorders                                                                         | 0.786 (0.782, 0.791) | 0.791 (0.786, 0.795) | 0.004 (0.003, 0.006)    | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679     | Skin symptoms                                                                                            | 0.536 (0.532, 0.541) | 0.541 (0.537, 0.545) | 0.004 (0.002, 0.007)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_404     | Ischemic heart disease                                                                                   | 0.69 (0.683, 0.695)  | 0.694 (0.687, 0.699) | 0.004 (0.001, 0.008)    | 0.68 (0.664, 0.689)  | 0.68 (0.665, 0.692)  | 0.001 (0, 0.004)        |\n",
       "| Musc/Skel      | phecode_703     | Chrystal arthropathies                                                                                   | 0.698 (0.691, 0.704) | 0.702 (0.695, 0.71)  | 0.004 (0.001, 0.008)    | 0.73 (0.7, 0.748)    | 0.73 (0.702, 0.748)  | 0 (-0.003, 0.003)       |\n",
       "| Neoplasms      | phecode_136-41  | Benign neoplasm of the colon                                                                             | 0.601 (0.595, 0.607) | 0.606 (0.599, 0.612) | 0.004 (0.001, 0.008)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_363     | Disorders of lacrimal system                                                                             | 0.634 (0.628, 0.64)  | 0.638 (0.632, 0.644) | 0.004 (0.001, 0.007)    | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_819     | General symptoms and other findings                                                                      | 0.582 (0.577, 0.586) | 0.586 (0.581, 0.59)  | 0.004 (0.001, 0.007)    | 0.708 (0.655, 0.732) | 0.713 (0.66, 0.733)  | 0.006 (-0.004, 0.009)   |\n",
       "| Signs/Symptoms | phecode_829     | Nonspecific findings on examination of blood                                                             | 0.652 (0.646, 0.659) | 0.656 (0.65, 0.664)  | 0.004 (0.001, 0.006)    | 0.649 (0.634, 0.683) | 0.648 (0.633, 0.682) | -0.001 (-0.002, 0)      |\n",
       "| Derm           | phecode_675     | Atrophic conditions of skin                                                                              | 0.716 (0.704, 0.726) | 0.72 (0.709, 0.73)   | 0.004 (0, 0.008)        | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_675-1   | Circumscribed scleroderma                                                                                | 0.716 (0.704, 0.727) | 0.72 (0.708, 0.734)  | 0.004 (0, 0.008)        | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_465-1   | Acute Pharyngitis                                                                                        | 0.561 (0.555, 0.567) | 0.566 (0.558, 0.573) | 0.004 (0, 0.008)        | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_363-2   | Dry eye syndrome [Tear film insufficiency]                                                               | 0.64 (0.634, 0.648)  | 0.644 (0.638, 0.653) | 0.004 (0, 0.007)        | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_280-8   | Other psychoactive substance related disorders                                                           | 0.598 (0.553, 0.638) | 0.598 (0.565, 0.643) | 0.004 (-0.029, 0.042)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-6   | Malignant neoplasm of the liver and intrahepatic bile ducts                                              | 0.719 (0.685, 0.752) | 0.725 (0.678, 0.76)  | 0.004 (-0.022, 0.028)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_406-1   | Pulmonary hypertension                                                                                   | 0.745 (0.724, 0.761) | 0.747 (0.725, 0.768) | 0.004 (-0.013, 0.023)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-8   | Restless legs syndrome                                                                                   | 0.592 (0.572, 0.613) | 0.597 (0.58, 0.618)  | 0.004 (-0.01, 0.023)    | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-22  | Uninodular goiter [single thyroid nodule]                                                                | 0.628 (0.603, 0.651) | 0.631 (0.604, 0.651) | 0.004 (-0.01, 0.012)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_550-4   | Cholesterolosis of gallbladder                                                                           | 0.582 (0.545, 0.613) | 0.586 (0.553, 0.615) | 0.004 (-0.009, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_390-6   | Perichondritis and chondritis of pinna                                                                   | 0.678 (0.651, 0.7)   | 0.68 (0.656, 0.703)  | 0.004 (-0.008, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_349     | Disorder of nervous system                                                                               | 0.603 (0.587, 0.616) | 0.607 (0.59, 0.62)   | 0.004 (-0.008, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_423     | Abnormal cardiac sounds                                                                                  | 0.642 (0.626, 0.656) | 0.645 (0.63, 0.661)  | 0.004 (-0.008, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_170-1   | Neutropenia                                                                                              | 0.585 (0.573, 0.599) | 0.589 (0.577, 0.603) | 0.004 (-0.008, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_397-1   | Tinnitus                                                                                                 | 0.503 (0.493, 0.514) | 0.507 (0.497, 0.515) | 0.004 (-0.007, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_557-2   | Blood in stool                                                                                           | 0.621 (0.608, 0.64)  | 0.626 (0.611, 0.642) | 0.004 (-0.007, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_169     | Platelet defects                                                                                         | 0.666 (0.649, 0.68)  | 0.669 (0.654, 0.684) | 0.004 (-0.006, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_674-2   | Hypepigmentation                                                                                         | 0.587 (0.569, 0.609) | 0.593 (0.573, 0.613) | 0.004 (-0.006, 0.014)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_720     | Spontaneous rupture of synovium and tendon                                                               | 0.605 (0.589, 0.63)  | 0.608 (0.593, 0.633) | 0.004 (-0.006, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_514-2   | Intestinal obstruction                                                                                   | 0.621 (0.606, 0.636) | 0.625 (0.608, 0.643) | 0.004 (-0.005, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529-3   | Fecal incontinence                                                                                       | 0.639 (0.626, 0.652) | 0.642 (0.627, 0.657) | 0.004 (-0.005, 0.014)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_530     | Disease of anus and rectum                                                                               | 0.527 (0.518, 0.54)  | 0.53 (0.52, 0.544)   | 0.004 (-0.005, 0.013)   | 0.544 (0.514, 0.573) | 0.55 (0.527, 0.591)  | 0.012 (0, 0.019)        |\n",
       "| GI             | phecode_512     | Dysphagia                                                                                                | 0.575 (0.567, 0.585) | 0.578 (0.57, 0.59)   | 0.004 (-0.004, 0.012)   | 0.613 (0.606, 0.628) | 0.611 (0.606, 0.628) | -0.001 (-0.004, 0.003)  |\n",
       "| Hearing        | phecode_398     | Other disorders of ear                                                                                   | 0.575 (0.563, 0.588) | 0.579 (0.567, 0.595) | 0.004 (-0.004, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_419     | Presence of cardiac device                                                                               | 0.738 (0.723, 0.755) | 0.743 (0.727, 0.759) | 0.004 (-0.003, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_444-5   | Venous insufficiency (chronic) (peripheral)                                                              | 0.662 (0.648, 0.676) | 0.666 (0.654, 0.68)  | 0.004 (-0.002, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_446     | Hypotension                                                                                              | 0.663 (0.655, 0.671) | 0.667 (0.66, 0.674)  | 0.004 (-0.001, 0.011)   | 0.723 (0.71, 0.745)  | 0.724 (0.711, 0.746) | 0.001 (-0.001, 0.003)   |\n",
       "| GI             | phecode_557     | Gastrointestinal hemorrhage                                                                              | 0.532 (0.525, 0.538) | 0.536 (0.53, 0.544)  | 0.004 (-0.001, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_136-42  | Benign neoplasm of rectum and anus                                                                       | 0.594 (0.586, 0.605) | 0.599 (0.589, 0.611) | 0.004 (-0.001, 0.009)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440     | Embolism and thrombosis                                                                                  | 0.597 (0.588, 0.605) | 0.601 (0.594, 0.608) | 0.004 (-0.001, 0.008)   | 0.476 (0.463, 0.499) | 0.481 (0.466, 0.503) | 0.004 (-0.01, 0.015)    |\n",
       "| Mental         | phecode_288-3   | Generalized anxiety disorder                                                                             | 0.593 (0.58, 0.609)  | 0.597 (0.585, 0.61)  | 0.004 (-0.001, 0.008)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_528     | Nausea and vomiting                                                                                      | 0.584 (0.577, 0.592) | 0.588 (0.581, 0.594) | 0.004 (-0.001, 0.007)   | 0.628 (0.614, 0.642) | 0.626 (0.611, 0.644) | -0.002 (-0.005, 0.004)  |\n",
       "| Musc/Skel      | phecode_708     | Osteoarthritis                                                                                           | 0.612 (0.609, 0.616) | 0.615 (0.612, 0.619) | 0.003 (0.002, 0.004)    | 0.588 (0.577, 0.608) | 0.589 (0.575, 0.607) | 0 (-0.003, 0.003)       |\n",
       "| Neoplasms      | phecode_136     | Benign neoplasm of the digestive organs                                                                  | 0.589 (0.583, 0.593) | 0.592 (0.586, 0.597) | 0.003 (0.001, 0.006)    | 0.584 (0.565, 0.596) | 0.583 (0.563, 0.594) | -0.002 (-0.002, -0.001) |\n",
       "| GI             | phecode_523     | Diverticular disease [Bowel diverticulosis]                                                              | 0.622 (0.616, 0.627) | 0.625 (0.62, 0.63)   | 0.003 (0.001, 0.005)    | 0.568 (0.558, 0.577) | 0.564 (0.551, 0.577) | -0.003 (-0.007, 0)      |\n",
       "| Musc/Skel      | phecode_726-1   | Osteoporosis                                                                                             | 0.746 (0.74, 0.753)  | 0.748 (0.743, 0.755) | 0.003 (0.001, 0.005)    | 0.752 (0.731, 0.762) | 0.756 (0.737, 0.769) | 0.005 (0.002, 0.008)    |\n",
       "| Musc/Skel      | phecode_708-1   | Primary osteoarthritis                                                                                   | 0.611 (0.603, 0.617) | 0.614 (0.607, 0.62)  | 0.003 (0.001, 0.005)    | 0.565 (0.541, 0.581) | 0.576 (0.563, 0.596) | 0.013 (0.007, 0.028)    |\n",
       "| GI             | phecode_528-1   | Nausea                                                                                                   | 0.585 (0.576, 0.59)  | 0.588 (0.579, 0.594) | 0.003 (0, 0.008)        | 0.624 (0.604, 0.635) | 0.621 (0.602, 0.631) | -0.003 (-0.007, 0)      |\n",
       "| Genitourinary  | phecode_583     | Chronic kidney disease                                                                                   | 0.684 (0.677, 0.692) | 0.688 (0.681, 0.693) | 0.003 (0, 0.007)        | 0.742 (0.733, 0.758) | 0.745 (0.734, 0.76)  | 0.002 (0, 0.004)        |\n",
       "| Mental         | phecode_288     | Anxiety disorders                                                                                        | 0.59 (0.584, 0.596)  | 0.593 (0.587, 0.598) | 0.003 (0, 0.006)        | 0.593 (0.578, 0.606) | 0.592 (0.575, 0.603) | -0.001 (-0.004, 0.002)  |\n",
       "| Neuro          | phecode_354     | Dizziness and giddiness                                                                                  | 0.571 (0.566, 0.576) | 0.575 (0.569, 0.58)  | 0.003 (0, 0.006)        | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_007     | Hemophilus infection                                                                                     | 0.611 (0.572, 0.669) | 0.615 (0.584, 0.66)  | 0.003 (-0.025, 0.035)   | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_030     | Campylobacter                                                                                            | 0.532 (0.516, 0.552) | 0.535 (0.518, 0.555) | 0.003 (-0.022, 0.019)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_433-1   | Occlusion and stenosis of cerebral arteries                                                              | 0.716 (0.693, 0.746) | 0.719 (0.695, 0.739) | 0.003 (-0.02, 0.019)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_506-3   | Sialoadenitis                                                                                            | 0.553 (0.53, 0.575)  | 0.555 (0.527, 0.582) | 0.003 (-0.019, 0.023)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_406     | Chronic pulmonary heart disease                                                                          | 0.741 (0.723, 0.758) | 0.745 (0.726, 0.764) | 0.003 (-0.012, 0.02)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_447     | Nonspecific low blood-pressure reading                                                                   | 0.642 (0.623, 0.664) | 0.646 (0.625, 0.668) | 0.003 (-0.012, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_715-3   | Spondylolisthesis                                                                                        | 0.663 (0.638, 0.679) | 0.665 (0.644, 0.682) | 0.003 (-0.012, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-2   | Secondary malignancy of respiratory organs                                                               | 0.632 (0.618, 0.646) | 0.634 (0.616, 0.65)  | 0.003 (-0.01, 0.014)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_597-1   | Urethral stricture                                                                                       | 0.655 (0.631, 0.675) | 0.657 (0.638, 0.678) | 0.003 (-0.01, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_479-6   | Pulmonary collapse [Atelectasis]                                                                         | 0.646 (0.631, 0.666) | 0.649 (0.635, 0.664) | 0.003 (-0.009, 0.012)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_169-1   | Thrombocytopenia                                                                                         | 0.667 (0.652, 0.683) | 0.67 (0.656, 0.692)  | 0.003 (-0.008, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_586     | Other disorders of the kidney and ureters                                                                | 0.644 (0.632, 0.653) | 0.645 (0.637, 0.658) | 0.003 (-0.008, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_423-1   | Cardiac murmurs                                                                                          | 0.641 (0.623, 0.655) | 0.644 (0.628, 0.66)  | 0.003 (-0.007, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_682-12  | Pilar and trichodermal cyst                                                                              | 0.502 (0.491, 0.511) | 0.506 (0.496, 0.513) | 0.003 (-0.004, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_446-2   | Orthostatic hypotension                                                                                  | 0.69 (0.677, 0.703)  | 0.692 (0.679, 0.706) | 0.003 (-0.004, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440-13  | Phlebitis and thrombophlebitis                                                                           | 0.583 (0.575, 0.593) | 0.587 (0.575, 0.596) | 0.003 (-0.003, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_507     | Lesions of mouth                                                                                         | 0.565 (0.555, 0.576) | 0.569 (0.556, 0.578) | 0.003 (-0.003, 0.009)   | 0.536 (0.514, 0.563) | 0.564 (0.544, 0.589) | 0.025 (-0.007, 0.061)   |\n",
       "| Genitourinary  | phecode_627-1   | Postmenopausal bleeding                                                                                  | 0.551 (0.542, 0.559) | 0.553 (0.545, 0.562) | 0.003 (-0.003, 0.008)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-7   | Generalized osteoarthritis                                                                               | 0.65 (0.643, 0.659)  | 0.654 (0.646, 0.661) | 0.003 (-0.003, 0.008)   | 0.598 (0.565, 0.619) | 0.593 (0.559, 0.608) | -0.006 (-0.012, -0.001) |\n",
       "| Metab          | phecode_230-2   | Abnormal loss of weight and underweight                                                                  | 0.608 (0.598, 0.617) | 0.61 (0.602, 0.62)   | 0.003 (-0.003, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_230-21  | Abnormal weight loss                                                                                     | 0.612 (0.602, 0.621) | 0.616 (0.606, 0.624) | 0.003 (-0.002, 0.009)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329     | Symptoms and signs involving cognitive functions and awareness                                           | 0.644 (0.637, 0.652) | 0.648 (0.64, 0.654)  | 0.003 (-0.002, 0.007)   | 0.774 (0.752, 0.777) | 0.774 (0.754, 0.777) | 0 (-0.001, 0.001)       |\n",
       "| GI             | phecode_528-2   | Vomiting                                                                                                 | 0.585 (0.576, 0.591) | 0.588 (0.579, 0.595) | 0.003 (-0.001, 0.008)   | 0.622 (0.607, 0.639) | 0.62 (0.604, 0.636)  | -0.004 (-0.005, 0.001)  |\n",
       "| Resp           | phecode_465-2   | Chronic Pharyngitis                                                                                      | 0.564 (0.558, 0.571) | 0.567 (0.56, 0.574)  | 0.003 (-0.001, 0.008)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_417-1   | Palpitations                                                                                             | 0.577 (0.571, 0.584) | 0.58 (0.574, 0.587)  | 0.003 (-0.001, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_715     | Non-inflammatory spondylopathy                                                                           | 0.622 (0.615, 0.629) | 0.625 (0.618, 0.633) | 0.003 (-0.001, 0.007)   | 0.62 (0.593, 0.651)  | 0.627 (0.603, 0.655) | 0.005 (0.002, 0.012)    |\n",
       "| ID             | phecode_089-2   | Viral infections                                                                                         | 0.528 (0.522, 0.532) | 0.531 (0.525, 0.536) | 0.003 (-0.001, 0.006)   | 0.625 (0.616, 0.637) | 0.634 (0.626, 0.644) | 0.009 (-0.002, 0.015)   |\n",
       "| Musc/Skel      | phecode_723     | Enthesopathy/Enthesitis/Tendinopathy                                                                     | 0.535 (0.529, 0.538) | 0.538 (0.533, 0.542) | 0.003 (-0.001, 0.006)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_727     | Other disorders of bone                                                                                  | 0.71 (0.706, 0.716)  | 0.712 (0.708, 0.718) | 0.002 (0.001, 0.003)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-21  | Atrial fibrillation                                                                                      | 0.731 (0.722, 0.737) | 0.733 (0.725, 0.74)  | 0.002 (0, 0.006)        | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_523-2   | Diverticula of colon                                                                                     | 0.63 (0.625, 0.636)  | 0.632 (0.627, 0.638) | 0.002 (0, 0.005)        | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_331     | Headache                                                                                                 | 0.579 (0.571, 0.584) | 0.581 (0.575, 0.585) | 0.002 (0, 0.005)        | 0.581 (0.55, 0.592)  | 0.588 (0.549, 0.599) | 0.005 (-0.004, 0.01)    |\n",
       "| Musc/Skel      | phecode_726     | Osteoporosis and low bone density                                                                        | 0.741 (0.734, 0.747) | 0.743 (0.737, 0.748) | 0.002 (0, 0.004)        | 0.746 (0.733, 0.776) | 0.75 (0.735, 0.776)  | 0.003 (0, 0.006)        |\n",
       "| Signs/Symptoms | phecode_835     | Cytology and pathology findings                                                                          | 0.722 (0.713, 0.729) | 0.723 (0.714, 0.73)  | 0.002 (0, 0.003)        | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_330-3   | Convulsions                                                                                              | 0.567 (0.546, 0.589) | 0.568 (0.546, 0.586) | 0.002 (-0.023, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_667     | Erythematous conditions                                                                                  | 0.555 (0.534, 0.57)  | 0.556 (0.54, 0.571)  | 0.002 (-0.017, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_703-2   | Chondrocalcinosis                                                                                        | 0.678 (0.649, 0.707) | 0.68 (0.645, 0.711)  | 0.002 (-0.013, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_700     | Diffuse diseases of connective tissue                                                                    | 0.63 (0.613, 0.652)  | 0.635 (0.613, 0.652) | 0.002 (-0.012, 0.02)    | 0.631 (0.612, 0.664) | 0.634 (0.605, 0.668) | 0.001 (-0.008, 0.007)   |\n",
       "| Resp           | phecode_478     | Aspiration pneumonia                                                                                     | 0.738 (0.719, 0.757) | 0.74 (0.722, 0.758)  | 0.002 (-0.012, 0.018)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_734-9   | Jaw pain                                                                                                 | 0.589 (0.569, 0.61)  | 0.591 (0.57, 0.615)  | 0.002 (-0.012, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_481     | Interstitial pulmonary diseases                                                                          | 0.729 (0.711, 0.744) | 0.731 (0.715, 0.748) | 0.002 (-0.011, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-14  | Primary osteoarthritis of the shoulder, upper arm                                                        | 0.605 (0.589, 0.62)  | 0.605 (0.59, 0.625)  | 0.002 (-0.011, 0.012)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581     | Renal tubulo-interstitial diseases                                                                       | 0.547 (0.533, 0.559) | 0.549 (0.537, 0.562) | 0.002 (-0.01, 0.015)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-13  | Blepharoconjunctivitis                                                                                   | 0.637 (0.615, 0.673) | 0.641 (0.617, 0.67)  | 0.002 (-0.01, 0.011)    | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-16  | Primary osteoarthritis ankle and foot                                                                    | 0.578 (0.566, 0.592) | 0.579 (0.564, 0.595) | 0.002 (-0.01, 0.01)     | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_507-1   | Stomatitis                                                                                               | 0.558 (0.545, 0.572) | 0.558 (0.543, 0.573) | 0.002 (-0.008, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_514     | Gastrointestinal obstruction                                                                             | 0.625 (0.613, 0.64)  | 0.626 (0.616, 0.642) | 0.002 (-0.005, 0.01)    | 0.565 (0.544, 0.598) | 0.584 (0.551, 0.614) | 0.02 (0.006, 0.036)     |\n",
       "| Cardio         | phecode_438     | Aneurysm or ectasia                                                                                      | 0.718 (0.705, 0.73)  | 0.721 (0.708, 0.732) | 0.002 (-0.005, 0.008)   | 0.739 (0.732, 0.751) | 0.74 (0.729, 0.753)  | 0.001 (-0.004, 0.005)   |\n",
       "| Musc/Skel      | phecode_708-13  | Primary osteoarthritis of the hand                                                                       | 0.644 (0.633, 0.659) | 0.646 (0.636, 0.66)  | 0.002 (-0.004, 0.009)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_404-11  | Acute myocardial infarction                                                                              | 0.702 (0.693, 0.711) | 0.704 (0.694, 0.713) | 0.002 (-0.004, 0.008)   | 0.708 (0.686, 0.73)  | 0.715 (0.693, 0.734) | 0.005 (0.002, 0.008)    |\n",
       "| GI             | phecode_556-8   | Nonspecific abnormal findings in stool contents                                                          | 0.56 (0.552, 0.568)  | 0.562 (0.554, 0.571) | 0.002 (-0.003, 0.009)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_392     | Otalgia and effusion of ear                                                                              | 0.56 (0.552, 0.568)  | 0.562 (0.555, 0.569) | 0.002 (-0.003, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_556     | Other symptoms involving the digestive system and abdomen                                                | 0.557 (0.551, 0.564) | 0.559 (0.552, 0.566) | 0.002 (-0.003, 0.006)   | 0.543 (0.527, 0.552) | 0.544 (0.529, 0.557) | 0.001 (-0.009, 0.009)   |\n",
       "| Musc/Skel      | phecode_715-1   | Spondylosis                                                                                              | 0.62 (0.611, 0.627)  | 0.622 (0.613, 0.629) | 0.002 (-0.002, 0.006)   | 0.588 (0.559, 0.618) | 0.596 (0.57, 0.616)  | 0.005 (-0.009, 0.019)   |\n",
       "| Signs/Symptoms | phecode_841-1   | Allergy to other anti-infective agents                                                                   | 0.602 (0.595, 0.609) | 0.604 (0.596, 0.611) | 0.002 (-0.002, 0.006)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-2   | Atrial fibrillation and flutter                                                                          | 0.731 (0.726, 0.736) | 0.733 (0.728, 0.739) | 0.002 (-0.001, 0.005)   | 0.701 (0.692, 0.712) | 0.704 (0.696, 0.713) | 0.002 (0, 0.005)        |\n",
       "| Eye            | phecode_367-1   | Conjunctivitis                                                                                           | 0.57 (0.563, 0.578)  | 0.571 (0.564, 0.579) | 0.002 (-0.001, 0.005)   | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_969     | Adverse effects of agents primarily affecting gastrointestinal system                                    | 0.593 (0.587, 0.6)   | 0.595 (0.589, 0.601) | 0.002 (-0.001, 0.005)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_619-4   | Noninflammatory disorders of vagina                                                                      | 0.597 (0.589, 0.605) | 0.598 (0.589, 0.607) | 0.001 (0, 0.003)        | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_627     | Menopausal and postmenopausal disorders                                                                  | 0.686 (0.681, 0.691) | 0.687 (0.682, 0.692) | 0.001 (0, 0.002)        | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_396     | Hearing impairment                                                                                       | 0.638 (0.633, 0.643) | 0.638 (0.634, 0.643) | 0.001 (0, 0.002)        | 0.659 (0.648, 0.682) | 0.658 (0.646, 0.681) | -0.001 (-0.004, 0.001)  |\n",
       "| Hearing        | phecode_390     | Disorders of external ear                                                                                | 0.559 (0.556, 0.564) | 0.561 (0.557, 0.565) | 0.001 (0, 0.002)        | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_390-4   | Impacted cerumen                                                                                         | 0.59 (0.585, 0.595)  | 0.591 (0.586, 0.596) | 0.001 (0, 0.001)        | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_106-2   | Malignant neoplasm of the uterus                                                                         | 0.556 (0.528, 0.578) | 0.554 (0.529, 0.582) | 0.001 (-0.026, 0.028)   | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_820     | Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity                              | 0.656 (0.628, 0.702) | 0.657 (0.619, 0.698) | 0.001 (-0.025, 0.022)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_540     | Hepatitis                                                                                                | 0.567 (0.531, 0.595) | 0.569 (0.535, 0.599) | 0.001 (-0.023, 0.022)   | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_176     | Other diseases of blood and blood-forming organs                                                         | 0.569 (0.552, 0.59)  | 0.571 (0.548, 0.588) | 0.001 (-0.02, 0.021)    | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_009     | Pseudomonas                                                                                              | 0.658 (0.63, 0.688)  | 0.661 (0.632, 0.689) | 0.001 (-0.018, 0.024)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-9   | Otorrhea                                                                                                 | 0.553 (0.529, 0.58)  | 0.553 (0.534, 0.58)  | 0.001 (-0.016, 0.023)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_676-2   | Scar conditions and fibrosis of skin                                                                     | 0.539 (0.518, 0.561) | 0.539 (0.519, 0.566) | 0.001 (-0.014, 0.021)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_707-8   | Polyarthritis                                                                                            | 0.603 (0.58, 0.629)  | 0.602 (0.578, 0.631) | 0.001 (-0.014, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_135     | Benign neoplasm of the head and neck                                                                     | 0.558 (0.542, 0.577) | 0.559 (0.542, 0.573) | 0.001 (-0.012, 0.014)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_471-2   | Deviated nasal septum                                                                                    | 0.583 (0.566, 0.605) | 0.584 (0.567, 0.607) | 0.001 (-0.012, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_546     | Other disorders of liver                                                                                 | 0.592 (0.576, 0.605) | 0.592 (0.579, 0.607) | 0.001 (-0.011, 0.015)   | 0.525 (0.516, 0.536) | 0.568 (0.539, 0.61)  | 0.044 (0.016, 0.084)    |\n",
       "| Musc/Skel      | phecode_734     | Diseases of the jaws                                                                                     | 0.584 (0.565, 0.605) | 0.585 (0.565, 0.604) | 0.001 (-0.011, 0.013)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710     | Acquired deformities of limbs                                                                            | 0.599 (0.583, 0.611) | 0.6 (0.585, 0.613)   | 0.001 (-0.01, 0.012)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-3   | Tricuspid valve disorders                                                                                | 0.738 (0.722, 0.748) | 0.738 (0.723, 0.748) | 0.001 (-0.01, 0.01)     | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_331-61  | Migraine with aura                                                                                       | 0.595 (0.576, 0.619) | 0.598 (0.575, 0.62)  | 0.001 (-0.009, 0.017)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_714-3   | Scoliosis                                                                                                | 0.693 (0.67, 0.712)  | 0.694 (0.676, 0.712) | 0.001 (-0.009, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440-1   | Venous thromboembolism                                                                                   | 0.566 (0.554, 0.575) | 0.566 (0.555, 0.574) | 0.001 (-0.007, 0.006)   | 0.423 (0.407, 0.436) | 0.398 (0.383, 0.419) | -0.023 (-0.032, -0.015) |\n",
       "| Signs/Symptoms | phecode_848-2   | Nonspecific abnormal findings on radiological and other examination of other intrathoracic organs (echo) | 0.697 (0.685, 0.709) | 0.697 (0.685, 0.709) | 0.001 (-0.006, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-2   | Goiter                                                                                                   | 0.639 (0.625, 0.655) | 0.641 (0.627, 0.655) | 0.001 (-0.005, 0.008)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_438-11  | Abdominal aortic aneurysm                                                                                | 0.822 (0.811, 0.834) | 0.824 (0.81, 0.836)  | 0.001 (-0.005, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_431-2   | Transient cerebral ischemic attacks                                                                      | 0.677 (0.666, 0.69)  | 0.678 (0.667, 0.69)  | 0.001 (-0.005, 0.006)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_705     | Rheumatoid arthritis and other inflammatory polyarthropathies                                            | 0.619 (0.608, 0.628) | 0.62 (0.61, 0.629)   | 0.001 (-0.004, 0.007)   | 0.587 (0.564, 0.604) | 0.581 (0.565, 0.598) | -0.005 (-0.009, 0.003)  |\n",
       "| Genitourinary  | phecode_603-6   | Scrotal pain*                                                                                            | 0.804 (0.795, 0.813) | 0.805 (0.796, 0.813) | 0.001 (-0.004, 0.006)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721-5   | Bursitis                                                                                                 | 0.535 (0.529, 0.542) | 0.536 (0.529, 0.543) | 0.001 (-0.004, 0.005)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-1   | Memory loss                                                                                              | 0.651 (0.643, 0.66)  | 0.652 (0.644, 0.663) | 0.001 (-0.004, 0.005)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_487     | Hemorrhage from respiratory passages                                                                     | 0.587 (0.576, 0.597) | 0.587 (0.576, 0.596) | 0.001 (-0.004, 0.005)   | 0.65 (0.618, 0.672)  | 0.646 (0.615, 0.674) | -0.001 (-0.005, 0.004)  |\n",
       "| GI             | phecode_511     | Gastro-esophageal reflux disease                                                                         | 0.561 (0.556, 0.566) | 0.562 (0.556, 0.567) | 0.001 (-0.003, 0.006)   | 0.545 (0.53, 0.555)  | 0.539 (0.525, 0.55)  | -0.006 (-0.009, -0.004) |\n",
       "| Neoplasms      | phecode_112     | Malignant neoplasm of other and ill-defined sites                                                        | 0.662 (0.655, 0.667) | 0.663 (0.657, 0.669) | 0.001 (-0.001, 0.003)   | 0.627 (0.618, 0.635) | 0.625 (0.617, 0.634) | -0.001 (-0.003, 0)      |\n",
       "| Rx             | phecode_977-51  | Long term (current) use of hormonal contraceptives                                                       | 0.922 (0.916, 0.935) | 0.923 (0.917, 0.936) | 0.001 (-0.001, 0.002)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-11  | Inguinal hernia                                                                                          | 0.788 (0.783, 0.794) | 0.788 (0.783, 0.794) | 0 (0, 0.001)            | 0.717 (0.701, 0.732) | 0.714 (0.7, 0.73)    | -0.002 (-0.011, 0.001)  |\n",
       "| Genitourinary  | phecode_593-3   | Recurrent and persistent hematuria*                                                                      | 0.547 (0.512, 0.59)  | 0.547 (0.517, 0.575) | 0 (-0.037, 0.035)       | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_174-2   | Splenomegaly                                                                                             | 0.617 (0.566, 0.665) | 0.618 (0.582, 0.646) | 0 (-0.032, 0.035)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-15  | Incisional hernia                                                                                        | 0.59 (0.565, 0.618)  | 0.59 (0.568, 0.614)  | 0 (-0.022, 0.022)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_532-1   | Intestinal fistula                                                                                       | 0.606 (0.579, 0.637) | 0.606 (0.582, 0.63)  | 0 (-0.02, 0.015)        | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_342     | Plegia and unspecified paralysis                                                                         | 0.56 (0.533, 0.58)   | 0.559 (0.534, 0.582) | 0 (-0.019, 0.022)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_433-21  | Carotid artery stenosis                                                                                  | 0.734 (0.708, 0.758) | 0.733 (0.712, 0.753) | 0 (-0.018, 0.014)       | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-7   | Abnormal granulation tissue, NOS                                                                         | 0.649 (0.626, 0.671) | 0.649 (0.62, 0.673)  | 0 (-0.017, 0.018)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_433-2   | Occlusion and stenosis of precerebral arteries                                                           | 0.738 (0.718, 0.76)  | 0.737 (0.715, 0.754) | 0 (-0.015, 0.015)       | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-7   | Iodine-deficiency related thyroid disorders*                                                             | 0.585 (0.569, 0.606) | 0.586 (0.567, 0.602) | 0 (-0.015, 0.014)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_618-12  | Rectocele                                                                                                | 0.558 (0.538, 0.578) | 0.558 (0.54, 0.573)  | 0 (-0.011, 0.01)        | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_396-22  | Presbycusis                                                                                              | 0.7 (0.684, 0.72)    | 0.698 (0.683, 0.721) | 0 (-0.01, 0.007)        | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-5   | Lipoma                                                                                                   | 0.519 (0.51, 0.531)  | 0.52 (0.508, 0.532)  | 0 (-0.009, 0.01)        | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_603     | Disorders and symptoms of testis                                                                         | 0.526 (0.514, 0.539) | 0.527 (0.511, 0.538) | 0 (-0.009, 0.009)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_717     | Other and unspecified dorsopathies                                                                       | 0.578 (0.563, 0.594) | 0.578 (0.561, 0.592) | 0 (-0.009, 0.009)       | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_670     | Seborrheic keratosis                                                                                     | 0.622 (0.597, 0.64)  | 0.623 (0.599, 0.642) | 0 (-0.009, 0.008)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-8   | Duodenitis                                                                                               | 0.598 (0.584, 0.613) | 0.598 (0.586, 0.609) | 0 (-0.009, 0.008)       | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_377     | Hemorrhage of the eye                                                                                    | 0.587 (0.575, 0.597) | 0.587 (0.575, 0.597) | 0 (-0.008, 0.007)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-12  | Primary osteoarthritis of knee, lower leg                                                                | 0.618 (0.605, 0.628) | 0.618 (0.605, 0.627) | 0 (-0.008, 0.006)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-5   | Inflammatory disease of cervix, vagina, and vulva                                                        | 0.562 (0.548, 0.577) | 0.562 (0.55, 0.572)  | 0 (-0.007, 0.007)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_615     | Endometriosis                                                                                            | 0.734 (0.71, 0.756)  | 0.733 (0.711, 0.754) | 0 (-0.007, 0.005)       | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_494     | Voice disturbance                                                                                        | 0.595 (0.584, 0.608) | 0.595 (0.585, 0.605) | 0 (-0.007, 0.005)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-211 | Paroxysmal atrial fibrillation*                                                                          | 0.683 (0.674, 0.695) | 0.683 (0.674, 0.694) | 0 (-0.007, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-55  | Candidiasis of vulva and vagina                                                                          | 0.763 (0.756, 0.773) | 0.764 (0.757, 0.772) | 0 (-0.006, 0.008)       | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_331-1   | Tension headache                                                                                         | 0.615 (0.603, 0.628) | 0.615 (0.602, 0.629) | 0 (-0.006, 0.007)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614     | Inflammatory diseases of female pelvic organs                                                            | 0.564 (0.551, 0.573) | 0.565 (0.553, 0.574) | 0 (-0.005, 0.007)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709-24  | Hammer toe                                                                                               | 0.687 (0.671, 0.707) | 0.687 (0.67, 0.705)  | 0 (-0.005, 0.006)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_146-2   | Benign neoplasm of the prostate                                                                          | 0.647 (0.634, 0.66)  | 0.648 (0.634, 0.661) | 0 (-0.005, 0.005)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_438-1   | Aortic aneurysm and ectasia                                                                              | 0.788 (0.777, 0.797) | 0.788 (0.778, 0.796) | 0 (-0.005, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529-1   | Diarrhea                                                                                                 | 0.544 (0.538, 0.551) | 0.545 (0.538, 0.55)  | 0 (-0.005, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-11  | Primary osteoarthritis of hip, pelvic region and thigh                                                   | 0.657 (0.641, 0.674) | 0.657 (0.642, 0.675) | 0 (-0.004, 0.006)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_418     | Abnormal results of cardiovascular function studies                                                      | 0.66 (0.651, 0.666)  | 0.659 (0.651, 0.668) | 0 (-0.004, 0.005)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594-2   | Dysuria                                                                                                  | 0.611 (0.603, 0.621) | 0.611 (0.605, 0.62)  | 0 (-0.004, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144-21  | Leiomyoma of uterus                                                                                      | 0.709 (0.697, 0.72)  | 0.71 (0.697, 0.72)   | 0 (-0.004, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144     | Gynecological benign neoplasms                                                                           | 0.649 (0.64, 0.661)  | 0.649 (0.638, 0.661) | 0 (-0.004, 0.003)       | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_679-1   | Rash and other nonspecific skin eruption                                                                 | 0.533 (0.529, 0.538) | 0.534 (0.53, 0.538)  | 0 (-0.003, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-52  | Hormone replacement therapy (postmenopausal)                                                             | 0.749 (0.733, 0.764) | 0.749 (0.734, 0.766) | 0 (-0.003, 0.004)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-2   | Diaphragmatic hernia [Hiatal hernia]                                                                     | 0.603 (0.597, 0.612) | 0.603 (0.596, 0.612) | 0 (-0.003, 0.003)       | 0.593 (0.582, 0.607) | 0.591 (0.579, 0.606) | -0.001 (-0.003, 0)      |\n",
       "| Genitourinary  | phecode_626-14  | Irregular menstrual bleeding                                                                             | 0.871 (0.863, 0.878) | 0.87 (0.863, 0.879)  | 0 (-0.003, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721     | Synoviopathy and bursopathy                                                                              | 0.535 (0.53, 0.54)   | 0.535 (0.53, 0.54)   | 0 (-0.003, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_529     | Symptoms involving digestive system                                                                      | 0.562 (0.558, 0.566) | 0.562 (0.559, 0.566) | 0 (-0.002, 0.003)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416     | Cardiac arrhythmia and conduction disorders                                                              | 0.697 (0.692, 0.702) | 0.698 (0.692, 0.701) | 0 (-0.002, 0.002)       | 0.708 (0.697, 0.721) | 0.71 (0.698, 0.723)  | 0.001 (-0.001, 0.004)   |\n",
       "| Genitourinary  | phecode_619     | Noninflammatory female genital disorders                                                                 | 0.581 (0.573, 0.588) | 0.58 (0.574, 0.588)  | 0 (-0.002, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_146     | Benign neoplasm of the genitourinary system                                                              | 0.834 (0.827, 0.841) | 0.834 (0.828, 0.841) | 0 (-0.002, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_142     | Lump or mass in breast or nonspecific abnormal breast exam                                               | 0.761 (0.756, 0.765) | 0.76 (0.756, 0.765)  | 0 (-0.001, 0)           | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_626-13  | Irregular menstrual cycle                                                                                | 0.889 (0.883, 0.895) | 0.889 (0.883, 0.896) | 0 (-0.001, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_626-1   | Irregular menstrual cycle/bleeding                                                                       | 0.877 (0.873, 0.885) | 0.878 (0.874, 0.884) | 0 (-0.001, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_627-4   | Menorrhagia/Excessive and frequent menstruation                                                          | 0.878 (0.873, 0.883) | 0.879 (0.873, 0.883) | 0 (-0.001, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-4   | Lateral epicondylitis (Tennis elbow)                                                                     | 0.638 (0.629, 0.645) | 0.638 (0.629, 0.645) | 0 (-0.001, 0.002)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_600     | Benign prostatic hyperplasia                                                                             | 0.664 (0.659, 0.669) | 0.664 (0.659, 0.669) | 0 (-0.001, 0.001)       | 0.613 (0.598, 0.629) | 0.609 (0.594, 0.626) | -0.003 (-0.005, -0.002) |\n",
       "| Genitourinary  | phecode_594-41  | Nocturia                                                                                                 | 0.716 (0.704, 0.723) | 0.715 (0.704, 0.723) | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_627-2   | Symptomatic menopause                                                                                    | 0.766 (0.761, 0.771) | 0.767 (0.761, 0.772) | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520     | Hernia                                                                                                   | 0.624 (0.619, 0.629) | 0.624 (0.619, 0.629) | 0 (-0.001, 0.001)       | 0.604 (0.587, 0.618) | 0.602 (0.585, 0.618) | -0.002 (-0.003, 0.001)  |\n",
       "| GI             | phecode_520-1   | Hernia of the abdominal wall                                                                             | 0.715 (0.71, 0.72)   | 0.715 (0.71, 0.72)   | 0 (-0.001, 0.001)       | 0.674 (0.647, 0.69)  | 0.682 (0.666, 0.696) | 0.008 (0.005, 0.02)     |\n",
       "| Mental         | phecode_290     | Reaction to severe stress, and adjustment disorders                                                      | 0.642 (0.634, 0.65)  | 0.642 (0.634, 0.65)  | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_331-6   | Migraine                                                                                                 | 0.643 (0.635, 0.651) | 0.643 (0.635, 0.65)  | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| Rx             | phecode_977-5   | Long term (current) use of agents affecting hormones                                                     | 0.896 (0.886, 0.901) | 0.896 (0.886, 0.902) | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_832     | Other abnormal findings in urine                                                                         | 0.645 (0.641, 0.65)  | 0.645 (0.641, 0.649) | 0 (-0.001, 0.001)       | <!----> | <!----> | <!----> |\n",
       "| Stat           | phecode_979     | Transplated organ                                                                                        | 0.547 (0.517, 0.585) | 0.406 (0.368, 0.442) | -0.139 (-0.203, -0.096) | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_701     | Osteomyelitis, periostitis, and other infections involving bone                                          | 0.602 (0.56, 0.642)  | 0.47 (0.425, 0.514)  | -0.128 (-0.192, -0.06)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_514-3   | Ileus                                                                                                    | 0.69 (0.655, 0.718)  | 0.612 (0.576, 0.652) | -0.076 (-0.105, -0.042) | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_701-1   | Osteomyelitis                                                                                            | 0.574 (0.547, 0.616) | 0.508 (0.464, 0.561) | -0.072 (-0.136, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_583-1   | End stage renal disease [CDK, stage 5]                                                                   | 0.708 (0.674, 0.738) | 0.659 (0.623, 0.697) | -0.048 (-0.09, -0.002)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_500     | Disorders of tooth develoment                                                                            | 0.573 (0.54, 0.619)  | 0.527 (0.499, 0.57)  | -0.046 (-0.063, -0.029) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_500-4   | Disturbances in tooth eruption                                                                           | 0.569 (0.532, 0.599) | 0.525 (0.49, 0.565)  | -0.042 (-0.064, -0.019) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_122-22  | Diffuse large B-cell lymphoma*                                                                           | 0.669 (0.637, 0.705) | 0.632 (0.597, 0.671) | -0.037 (-0.059, -0.009) | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-4   | Thyroiditis                                                                                              | 0.607 (0.566, 0.642) | 0.574 (0.523, 0.611) | -0.036 (-0.068, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-42  | Pulmonary valve insufficiency*                                                                           | 0.69 (0.64, 0.734)   | 0.655 (0.618, 0.696) | -0.036 (-0.059, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_323     | Systemic atrophies primarily affecting the central nervous system                                        | 0.623 (0.593, 0.662) | 0.591 (0.559, 0.627) | -0.036 (-0.055, -0.017) | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-21  | Diffuse goiter                                                                                           | 0.627 (0.591, 0.654) | 0.591 (0.56, 0.62)   | -0.036 (-0.05, -0.018)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-31  | Graves' disease [Toxic diffuse goiter]                                                                   | 0.634 (0.603, 0.661) | 0.597 (0.56, 0.622)  | -0.035 (-0.052, -0.016) | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_841-5   | Allergy to serum and vaccine                                                                             | 0.623 (0.583, 0.677) | 0.587 (0.536, 0.638) | -0.034 (-0.066, -0.005) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_500-41  | Impacted teeth*                                                                                          | 0.593 (0.553, 0.632) | 0.559 (0.516, 0.599) | -0.034 (-0.054, -0.009) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_331-3   | Headache syndromes, non migraine                                                                         | 0.552 (0.506, 0.583) | 0.519 (0.478, 0.557) | -0.033 (-0.07, -0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581-33  | Stricture or kinking of ureter                                                                           | 0.609 (0.574, 0.644) | 0.579 (0.539, 0.61)  | -0.033 (-0.058, -0.015) | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_664-2   | Pityriasis                                                                                               | 0.588 (0.556, 0.626) | 0.556 (0.527, 0.594) | -0.033 (-0.05, -0.014)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_514-21  | Impaction of intestine                                                                                   | 0.571 (0.531, 0.62)  | 0.542 (0.506, 0.591) | -0.032 (-0.067, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-4   | Pulmonary valve disorders                                                                                | 0.693 (0.652, 0.729) | 0.658 (0.618, 0.702) | -0.032 (-0.055, -0.004) | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_381-1   | Paralytic strabismus [Neurogenic strabismus]                                                             | 0.649 (0.617, 0.683) | 0.62 (0.578, 0.648)  | -0.031 (-0.056, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_712-5   | Disorder of ligament                                                                                     | 0.61 (0.565, 0.657)  | 0.582 (0.541, 0.62)  | -0.029 (-0.06, -0.006)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710-31  | Genu valgum (acquired)                                                                                   | 0.645 (0.599, 0.687) | 0.616 (0.566, 0.668) | -0.029 (-0.048, -0.013) | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_486-21  | Bronchospasm                                                                                             | 0.543 (0.507, 0.576) | 0.518 (0.478, 0.552) | -0.028 (-0.058, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-42  | Cognitive communication deficit                                                                          | 0.549 (0.526, 0.58)  | 0.523 (0.501, 0.555) | -0.027 (-0.05, -0.006)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_624-2   | Atrophy of female genital tract                                                                          | 0.562 (0.535, 0.591) | 0.532 (0.507, 0.567) | -0.027 (-0.049, -0.009) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_349-2   | Abnormal results of function studies of peripheral nervous system                                        | 0.58 (0.556, 0.611)  | 0.555 (0.531, 0.586) | -0.027 (-0.045, -0.008) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_356-2   | Aphasia and dysphasia                                                                                    | 0.692 (0.664, 0.723) | 0.664 (0.636, 0.694) | -0.027 (-0.044, -0.011) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_124     | Myeloproliferative disorder                                                                              | 0.674 (0.648, 0.696) | 0.647 (0.618, 0.665) | -0.027 (-0.043, -0.009) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_124-5   | Essential thrombocythemia                                                                                | 0.639 (0.584, 0.685) | 0.61 (0.571, 0.65)   | -0.026 (-0.059, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_394-4   | Abnormal vestibular function study                                                                       | 0.612 (0.565, 0.648) | 0.584 (0.546, 0.621) | -0.026 (-0.048, -0.007) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-6   | Transient global amnesia                                                                                 | 0.622 (0.594, 0.655) | 0.597 (0.561, 0.631) | -0.026 (-0.043, -0.011) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_355-1   | Coma                                                                                                     | 0.577 (0.548, 0.608) | 0.553 (0.517, 0.594) | -0.024 (-0.044, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-12  | Ventricular tachycardia                                                                                  | 0.709 (0.685, 0.734) | 0.683 (0.66, 0.714)  | -0.024 (-0.037, -0.015) | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_230-22  | Underweight                                                                                              | 0.593 (0.563, 0.631) | 0.572 (0.538, 0.606) | -0.023 (-0.049, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_532-4   | Volvulus                                                                                                 | 0.598 (0.557, 0.644) | 0.572 (0.53, 0.622)  | -0.023 (-0.044, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-3   | Disorder of phosphorus metabolism                                                                        | 0.637 (0.611, 0.663) | 0.619 (0.58, 0.653)  | -0.022 (-0.057, 0.017)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_672     | Other acute skin changes due to ultraviolet radiation                                                    | 0.59 (0.551, 0.627)  | 0.565 (0.533, 0.603) | -0.022 (-0.047, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_172     | Other disorders of white blood cells                                                                     | 0.624 (0.598, 0.649) | 0.602 (0.576, 0.634) | -0.022 (-0.043, 0)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_438-12  | Thoracic aneurysm                                                                                        | 0.675 (0.65, 0.702)  | 0.652 (0.625, 0.687) | -0.022 (-0.043, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Metab          | phecode_247-52  | Hypercalcemia                                                                                            | 0.66 (0.636, 0.69)   | 0.639 (0.606, 0.671) | -0.022 (-0.035, -0.005) | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_179-9   | Immunodeficiency NOS                                                                                     | 0.543 (0.502, 0.579) | 0.52 (0.477, 0.571)  | -0.021 (-0.057, 0.025)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_475-5   | Exercise induced bronchospasm                                                                            | 0.54 (0.5, 0.582)    | 0.524 (0.484, 0.559) | -0.02 (-0.063, 0.032)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_504-32  | Chronic periodontitis                                                                                    | 0.548 (0.509, 0.581) | 0.527 (0.492, 0.569) | -0.02 (-0.051, 0.007)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_398-1   | Abnormal auditory function study                                                                         | 0.606 (0.581, 0.631) | 0.585 (0.558, 0.616) | -0.02 (-0.033, -0.005)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_530-3   | Rectal prolapse                                                                                          | 0.717 (0.694, 0.744) | 0.697 (0.676, 0.728) | -0.02 (-0.031, -0.009)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721-4   | Calcium deposits in tendon and bursa                                                                     | 0.543 (0.508, 0.586) | 0.527 (0.491, 0.569) | -0.019 (-0.051, 0.026)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_621     | Endometrial hyperplasia                                                                                  | 0.588 (0.548, 0.627) | 0.568 (0.53, 0.615)  | -0.019 (-0.051, 0.013)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_552-2   | Obstruction of bile duct                                                                                 | 0.635 (0.607, 0.674) | 0.617 (0.587, 0.653) | -0.019 (-0.048, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_121-2   | Chronic leukemia                                                                                         | 0.698 (0.673, 0.726) | 0.679 (0.65, 0.709)  | -0.019 (-0.043, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_123-1   | Multiple myeloma                                                                                         | 0.672 (0.637, 0.715) | 0.654 (0.613, 0.707) | -0.019 (-0.041, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_121     | Leukemia                                                                                                 | 0.683 (0.659, 0.709) | 0.664 (0.628, 0.691) | -0.019 (-0.039, -0.004) | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_664-21  | Pityriasis rosea                                                                                         | 0.608 (0.573, 0.647) | 0.592 (0.553, 0.626) | -0.019 (-0.031, -0.007) | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_171-1   | Lymphocytosis (symptomatic)                                                                              | 0.607 (0.569, 0.648) | 0.589 (0.546, 0.636) | -0.018 (-0.054, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-11  | Crohn's disease                                                                                          | 0.537 (0.507, 0.58)  | 0.518 (0.491, 0.553) | -0.018 (-0.046, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_510-5   | Dyskinesia of esophagus                                                                                  | 0.612 (0.58, 0.645)  | 0.595 (0.554, 0.633) | -0.018 (-0.04, 0.002)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_123     | Multiple myeloma and malignant plasma cell neoplasms                                                     | 0.683 (0.647, 0.722) | 0.665 (0.631, 0.707) | -0.018 (-0.04, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_685-4   | Prickly heat and miliaria                                                                                | 0.525 (0.491, 0.56)  | 0.509 (0.476, 0.544) | -0.018 (-0.038, 0.01)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_509-11  | Glossodynia                                                                                              | 0.591 (0.561, 0.625) | 0.573 (0.548, 0.606) | -0.018 (-0.037, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-21  | Corneal ulcer                                                                                            | 0.601 (0.562, 0.655) | 0.585 (0.54, 0.627)  | -0.018 (-0.035, 0.011)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_120-1   | Myeloid                                                                                                  | 0.689 (0.668, 0.709) | 0.67 (0.649, 0.686)  | -0.018 (-0.031, -0.008) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_601-12  | Chronic prostatitis                                                                                      | 0.616 (0.59, 0.657)  | 0.602 (0.575, 0.639) | -0.018 (-0.027, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-8   | Malignant neoplasm of the pancreas                                                                       | 0.669 (0.643, 0.692) | 0.653 (0.621, 0.675) | -0.017 (-0.039, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-4   | Other specified cognitive deficit                                                                        | 0.515 (0.489, 0.542) | 0.5 (0.481, 0.522)   | -0.016 (-0.042, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_466-4   | Hypertrophy of tonsils and adenoids                                                                      | 0.611 (0.577, 0.657) | 0.598 (0.558, 0.635) | -0.016 (-0.041, 0.017)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_148-2   | Benign neoplasm of meninges (Meningioma)                                                                 | 0.655 (0.622, 0.686) | 0.639 (0.606, 0.679) | -0.016 (-0.037, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_121-21  | Chronic lymphoid leukemia                                                                                | 0.706 (0.673, 0.735) | 0.689 (0.657, 0.718) | -0.016 (-0.035, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-71  | Sick sinus syndrome*                                                                                     | 0.733 (0.7, 0.771)   | 0.717 (0.678, 0.75)  | -0.016 (-0.035, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-7   | Sinoatrial node dysfunction                                                                              | 0.735 (0.695, 0.775) | 0.718 (0.683, 0.766) | -0.016 (-0.035, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_168-4   | Abnormal coagulation profile                                                                             | 0.729 (0.694, 0.763) | 0.712 (0.679, 0.743) | -0.016 (-0.028, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-54  | Testicular limpoma                                                                                       | 0.609 (0.571, 0.65)  | 0.593 (0.551, 0.635) | -0.016 (-0.027, -0.004) | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_668-4   | Dermatitis due to substances taken internally                                                            | 0.564 (0.531, 0.601) | 0.554 (0.505, 0.584) | -0.015 (-0.058, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_430-3   | Nontraumatic subdural hemorrhage                                                                         | 0.664 (0.624, 0.71)  | 0.65 (0.613, 0.692)  | -0.015 (-0.032, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_374-39  | Transient retinal arterial occlusion [Amaurosis fugax]                                                   | 0.683 (0.651, 0.714) | 0.666 (0.637, 0.696) | -0.015 (-0.031, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144-13  | Benign neoplasms of the cervix                                                                           | 0.624 (0.597, 0.648) | 0.61 (0.582, 0.628)  | -0.015 (-0.03, 0)       | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_509-1   | Glossitis                                                                                                | 0.602 (0.581, 0.624) | 0.585 (0.565, 0.61)  | -0.015 (-0.03, -0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_613-1   | Inflammatory disease of breast                                                                           | 0.582 (0.556, 0.616) | 0.567 (0.537, 0.597) | -0.015 (-0.027, -0.005) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_530-1   | Anal fissure                                                                                             | 0.555 (0.536, 0.57)  | 0.54 (0.52, 0.554)   | -0.015 (-0.024, -0.005) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_120     | Hemo onc - by cell of origin                                                                             | 0.667 (0.653, 0.679) | 0.652 (0.637, 0.665) | -0.015 (-0.023, -0.006) | 0.635 (0.61, 0.653)  | 0.633 (0.606, 0.652) | -0.002 (-0.004, 0)      |\n",
       "| Cardio         | phecode_414-2   | Dilated cardiomyopathy*                                                                                  | 0.662 (0.633, 0.703) | 0.65 (0.61, 0.684)   | -0.014 (-0.046, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_604-1   | Redundant prepuce and phimosis                                                                           | 0.487 (0.459, 0.53)  | 0.477 (0.441, 0.516) | -0.014 (-0.044, 0.014)  | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_171     | Increased white blood cell count                                                                         | 0.595 (0.565, 0.627) | 0.579 (0.545, 0.61)  | -0.014 (-0.044, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-21  | Eustachian salpingitis                                                                                   | 0.521 (0.501, 0.562) | 0.511 (0.481, 0.541) | -0.014 (-0.037, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-2   | Malignant neoplasm of stomach                                                                            | 0.688 (0.656, 0.729) | 0.673 (0.65, 0.708)  | -0.014 (-0.036, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_622-2   | Mucous polyp of cervix                                                                                   | 0.618 (0.598, 0.64)  | 0.605 (0.584, 0.625) | -0.014 (-0.03, 0)       | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-6   | Heart valve replaced                                                                                     | 0.726 (0.706, 0.751) | 0.711 (0.692, 0.732) | -0.014 (-0.027, -0.004) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_120-21  | Mature B-cell                                                                                            | 0.68 (0.66, 0.703)   | 0.665 (0.646, 0.687) | -0.014 (-0.026, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-13  | Postprocedural hypothyroidism                                                                            | 0.659 (0.643, 0.681) | 0.647 (0.626, 0.665) | -0.014 (-0.025, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-3   | Emotional lability                                                                                       | 0.653 (0.618, 0.704) | 0.642 (0.61, 0.682)  | -0.013 (-0.036, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_685-1   | Dyshidrosis                                                                                              | 0.537 (0.502, 0.563) | 0.523 (0.492, 0.549) | -0.013 (-0.031, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_122-2   | Non-Hodgkin lymphoma                                                                                     | 0.667 (0.643, 0.691) | 0.654 (0.629, 0.68)  | -0.013 (-0.03, 0.004)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_704-5   | Giant cell arteritis                                                                                     | 0.752 (0.725, 0.784) | 0.741 (0.713, 0.775) | -0.013 (-0.029, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_208-21  | Primary hyperparathyroidism                                                                              | 0.678 (0.651, 0.7)   | 0.663 (0.638, 0.684) | -0.013 (-0.029, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_394-1   | Meniere disease                                                                                          | 0.612 (0.581, 0.634) | 0.599 (0.569, 0.623) | -0.013 (-0.027, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_120-2   | Lymphoid                                                                                                 | 0.666 (0.649, 0.685) | 0.653 (0.635, 0.672) | -0.013 (-0.026, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_728-1   | Chondromalacia                                                                                           | 0.659 (0.629, 0.7)   | 0.646 (0.616, 0.684) | -0.013 (-0.023, -0.005) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_109     | Malignant neoplasm of the eye, brain and other parts of central nervous system                           | 0.603 (0.573, 0.637) | 0.592 (0.557, 0.627) | -0.012 (-0.044, 0.015)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_604-3   | Peyronie's disease                                                                                       | 0.499 (0.468, 0.525) | 0.489 (0.461, 0.515) | -0.012 (-0.043, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_394-22  | Vestibular neuronitis                                                                                    | 0.549 (0.526, 0.574) | 0.537 (0.509, 0.56)  | -0.012 (-0.039, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-1   | Pelvic peritoneal adhesions, female (postoperative) (postinfection)                                      | 0.575 (0.539, 0.61)  | 0.563 (0.53, 0.595)  | -0.012 (-0.037, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_471-3   | Hypertrophy of nasal turbinates                                                                          | 0.59 (0.55, 0.625)   | 0.577 (0.532, 0.613) | -0.012 (-0.036, 0.013)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-1   | Malignant neoplasm of the esophagus                                                                      | 0.735 (0.71, 0.759)  | 0.721 (0.697, 0.746) | -0.012 (-0.028, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_122     | Lymphoma                                                                                                 | 0.658 (0.631, 0.683) | 0.646 (0.626, 0.668) | -0.012 (-0.026, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_700-2   | Sicca syndrome [Sjogren syndrome]                                                                        | 0.731 (0.707, 0.758) | 0.718 (0.689, 0.751) | -0.012 (-0.026, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_381     | Strabismus                                                                                               | 0.631 (0.6, 0.655)   | 0.617 (0.592, 0.64)  | -0.012 (-0.025, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_284-1   | Suicidal ideations                                                                                       | 0.611 (0.596, 0.635) | 0.599 (0.581, 0.622) | -0.012 (-0.024, 0)      | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_704     | Systemic vasculitis                                                                                      | 0.677 (0.653, 0.7)   | 0.665 (0.643, 0.686) | -0.012 (-0.024, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_604     | Disorders of penis                                                                                       | 0.51 (0.496, 0.526)  | 0.499 (0.483, 0.513) | -0.012 (-0.022, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_601-1   | Prostatitis                                                                                              | 0.576 (0.555, 0.592) | 0.564 (0.544, 0.581) | -0.012 (-0.019, -0.005) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-12  | Femoral hernia                                                                                           | 0.585 (0.546, 0.627) | 0.575 (0.535, 0.614) | -0.011 (-0.039, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_580-3   | Nephrotic syndrome                                                                                       | 0.553 (0.523, 0.58)  | 0.543 (0.516, 0.577) | -0.011 (-0.036, 0.021)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_106-21  | Malignant neoplasm of endometrium                                                                        | 0.566 (0.533, 0.592) | 0.554 (0.529, 0.576) | -0.011 (-0.035, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_389-1   | Ocular pain                                                                                              | 0.538 (0.518, 0.559) | 0.528 (0.5, 0.548)   | -0.011 (-0.034, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_481-4   | Pulmonary fibrosis                                                                                       | 0.726 (0.702, 0.748) | 0.716 (0.681, 0.738) | -0.011 (-0.032, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-14  | Microscopic colitis*                                                                                     | 0.64 (0.604, 0.665)  | 0.63 (0.591, 0.659)  | -0.011 (-0.031, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_379-2   | Eye infection, viral                                                                                     | 0.546 (0.517, 0.571) | 0.533 (0.512, 0.558) | -0.011 (-0.031, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_702     | Infective and reactive arthropathies                                                                     | 0.556 (0.526, 0.581) | 0.543 (0.518, 0.576) | -0.011 (-0.029, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_624     | Symptoms involving female genital tract                                                                  | 0.57 (0.553, 0.589)  | 0.558 (0.537, 0.581) | -0.011 (-0.029, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144-1   | Benign neoplasms of external female genital organs and cervix                                            | 0.612 (0.59, 0.635)  | 0.601 (0.58, 0.623)  | -0.011 (-0.027, 0)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_410-2   | Endocarditis                                                                                             | 0.646 (0.627, 0.669) | 0.635 (0.618, 0.665) | -0.011 (-0.024, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-3   | Secondary malignant neoplasm of digestive systems                                                        | 0.633 (0.614, 0.654) | 0.623 (0.605, 0.642) | -0.011 (-0.024, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710-32  | Genu varum (acquired)                                                                                    | 0.682 (0.646, 0.721) | 0.672 (0.636, 0.715) | -0.011 (-0.022, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_622-1   | Polyp of corpus uteri                                                                                    | 0.536 (0.52, 0.557)  | 0.525 (0.508, 0.549) | -0.011 (-0.021, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_619-5   | Noninflammatory disorders of vulva and perineum                                                          | 0.531 (0.519, 0.544) | 0.52 (0.505, 0.537)  | -0.011 (-0.018, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-43  | Right bundle branch block                                                                                | 0.706 (0.69, 0.721)  | 0.695 (0.678, 0.711) | -0.011 (-0.016, -0.005) | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_803     | Snoring*                                                                                                 | 0.631 (0.615, 0.648) | 0.62 (0.605, 0.637)  | -0.011 (-0.015, -0.007) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_352-3   | Parageusia*                                                                                              | 0.537 (0.505, 0.569) | 0.523 (0.495, 0.562) | -0.01 (-0.04, 0.013)    | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-12  | Mitral valve prolapse*                                                                                   | 0.639 (0.605, 0.674) | 0.628 (0.595, 0.667) | -0.01 (-0.039, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-1   | Irritability                                                                                             | 0.575 (0.535, 0.615) | 0.568 (0.532, 0.603) | -0.01 (-0.038, 0.015)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_386-9   | Visual distortions and subjective visual disturbances                                                    | 0.626 (0.597, 0.664) | 0.618 (0.583, 0.647) | -0.01 (-0.031, 0.016)   | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710-41  | Flat foot [pes planus]                                                                                   | 0.584 (0.559, 0.616) | 0.572 (0.537, 0.608) | -0.01 (-0.03, 0.009)    | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_518     | Appendicitis                                                                                             | 0.557 (0.532, 0.585) | 0.549 (0.524, 0.579) | -0.01 (-0.029, 0.008)   | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_513-3   | Duodenal ulcer                                                                                           | 0.62 (0.602, 0.641)  | 0.609 (0.592, 0.628) | -0.01 (-0.026, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_139-53  | Lipoma of other skin subcutaneous tissue                                                                 | 0.526 (0.508, 0.54)  | 0.517 (0.492, 0.537) | -0.01 (-0.025, 0.011)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_325-23  | Unsteadiness on feet*                                                                                    | 0.651 (0.625, 0.676) | 0.641 (0.615, 0.666) | -0.01 (-0.024, 0)       | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_180-3   | Paraproteinemias                                                                                         | 0.687 (0.66, 0.714)  | 0.675 (0.654, 0.704) | -0.01 (-0.024, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581-3   | Obstructive and reflux uropathy                                                                          | 0.62 (0.604, 0.635)  | 0.61 (0.593, 0.625)  | -0.01 (-0.021, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_386-2   | Diplopia                                                                                                 | 0.595 (0.576, 0.617) | 0.587 (0.563, 0.608) | -0.01 (-0.019, 0.004)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_601     | Inflammatory diseases of prostate                                                                        | 0.575 (0.556, 0.593) | 0.565 (0.542, 0.582) | -0.01 (-0.017, -0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_597-5   | Urethral caruncle                                                                                        | 0.787 (0.766, 0.81)  | 0.778 (0.754, 0.801) | -0.01 (-0.015, -0.004)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_209-1   | Pituitary hyperfunction                                                                                  | 0.615 (0.555, 0.653) | 0.605 (0.554, 0.649) | -0.009 (-0.047, 0.034)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_601-11  | Acute prostatitis                                                                                        | 0.559 (0.532, 0.591) | 0.553 (0.514, 0.588) | -0.009 (-0.046, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_814     | Jaundice (not of newborn)                                                                                | 0.621 (0.591, 0.653) | 0.613 (0.588, 0.636) | -0.009 (-0.031, 0.015)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_108-41  | Malignant neoplasm of kidney, except pelvis                                                              | 0.663 (0.63, 0.699)  | 0.652 (0.624, 0.683) | -0.009 (-0.029, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_525     | Intestinal malabsorption                                                                                 | 0.534 (0.515, 0.553) | 0.525 (0.504, 0.542) | -0.009 (-0.026, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_361-9   | Ectropion of eyelid                                                                                      | 0.684 (0.64, 0.722)  | 0.676 (0.629, 0.714) | -0.009 (-0.023, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_334-1   | Trigeminal nerve disorders [CN5]                                                                         | 0.6 (0.575, 0.618)   | 0.59 (0.57, 0.611)   | -0.009 (-0.021, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_410     | Inflammation of the heart [Carditis]                                                                     | 0.623 (0.605, 0.648) | 0.615 (0.595, 0.638) | -0.009 (-0.021, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-22  | Aortic insufficiency                                                                                     | 0.677 (0.662, 0.692) | 0.668 (0.651, 0.684) | -0.009 (-0.021, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_522-1   | Inflammatory bowel disease                                                                               | 0.546 (0.53, 0.574)  | 0.538 (0.522, 0.558) | -0.009 (-0.02, 0.007)   | 0.43 (0.321, 0.494)  | 0.436 (0.33, 0.501)  | 0.005 (-0.012, 0.011)   |\n",
       "| Cardio         | phecode_416-1   | Paroxysmal tachycardia                                                                                   | 0.63 (0.617, 0.647)  | 0.621 (0.608, 0.637) | -0.009 (-0.019, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_328-9   | Dementia NOS                                                                                             | 0.779 (0.761, 0.794) | 0.768 (0.751, 0.783) | -0.009 (-0.018, -0.002) | 0.814 (0.801, 0.826) | 0.813 (0.799, 0.825) | -0.001 (-0.003, 0)      |\n",
       "| Neuro          | phecode_324-1   | Parkinsonism                                                                                             | 0.722 (0.71, 0.737)  | 0.713 (0.7, 0.729)   | -0.009 (-0.017, -0.004) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_105-1   | Malignant neoplasm of the breast, female                                                                 | 0.533 (0.518, 0.546) | 0.525 (0.513, 0.537) | -0.009 (-0.017, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_444-15  | Scrotal varices [Varicocele]                                                                             | 0.802 (0.788, 0.815) | 0.794 (0.778, 0.807) | -0.009 (-0.016, 0)      | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463-4   | Nasal congestion*                                                                                        | 0.536 (0.525, 0.546) | 0.527 (0.518, 0.537) | -0.009 (-0.016, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-23  | Multinodular goiter                                                                                      | 0.69 (0.671, 0.715)  | 0.682 (0.66, 0.705)  | -0.009 (-0.016, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_596-2   | Overactive bladder                                                                                       | 0.597 (0.585, 0.612) | 0.587 (0.576, 0.602) | -0.009 (-0.014, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_488-8   | Mouth breathing*                                                                                         | 0.598 (0.583, 0.615) | 0.589 (0.574, 0.605) | -0.009 (-0.013, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-51  | Atrial premature depolarization [Supraventricular premature beats]                                       | 0.629 (0.604, 0.66)  | 0.623 (0.597, 0.648) | -0.008 (-0.031, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_523-1   | Diverticula of small intestine                                                                           | 0.643 (0.608, 0.691) | 0.632 (0.595, 0.673) | -0.008 (-0.031, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_108-4   | Malignant neoplasm of the kidney                                                                         | 0.661 (0.634, 0.687) | 0.653 (0.626, 0.678) | -0.008 (-0.027, 0.01)   | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_286-21  | Major depressive disorder, recurrent                                                                     | 0.587 (0.561, 0.611) | 0.577 (0.55, 0.606)  | -0.008 (-0.024, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_363-7   | Stenosis and insufficiency of lacrimal passages                                                          | 0.622 (0.595, 0.649) | 0.615 (0.588, 0.642) | -0.008 (-0.022, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_325-3   | Lack of coordination                                                                                     | 0.603 (0.582, 0.619) | 0.594 (0.575, 0.613) | -0.008 (-0.021, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_603-1   | Hydrocele                                                                                                | 0.555 (0.53, 0.584)  | 0.547 (0.523, 0.573) | -0.008 (-0.021, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_581-31  | Hydronephrosis                                                                                           | 0.606 (0.589, 0.629) | 0.598 (0.578, 0.617) | -0.008 (-0.021, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-42  | Malignant neoplasm of the rectum                                                                         | 0.682 (0.657, 0.705) | 0.675 (0.65, 0.693)  | -0.008 (-0.019, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-11  | Supraventricular tachycardia                                                                             | 0.62 (0.602, 0.635)  | 0.613 (0.595, 0.63)  | -0.008 (-0.018, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-4   | Tremor                                                                                                   | 0.629 (0.616, 0.641) | 0.621 (0.607, 0.634) | -0.008 (-0.016, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-11  | Parkinson's disease (Primary)                                                                            | 0.724 (0.709, 0.74)  | 0.716 (0.698, 0.731) | -0.008 (-0.015, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_396-21  | Sensorineural hearing loss, bilateral                                                                    | 0.647 (0.629, 0.665) | 0.64 (0.622, 0.656)  | -0.008 (-0.012, -0.003) | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-6   | Excessive crying of child, adolescent, or adult                                                          | 0.674 (0.646, 0.71)  | 0.665 (0.634, 0.702) | -0.007 (-0.035, 0.015)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_580     | Glomerular diseases                                                                                      | 0.628 (0.607, 0.652) | 0.622 (0.599, 0.646) | -0.007 (-0.032, 0.02)   | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_391-12  | Chronic otitis media                                                                                     | 0.496 (0.478, 0.52)  | 0.492 (0.47, 0.512)  | -0.007 (-0.029, 0.021)  | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_180-31  | Monoclonal gammopathy                                                                                    | 0.689 (0.668, 0.713) | 0.683 (0.657, 0.704) | -0.007 (-0.026, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_106     | Gynecological malignant neoplasms                                                                        | 0.551 (0.526, 0.57)  | 0.543 (0.519, 0.564) | -0.007 (-0.024, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-41  | Attention and concentration deficit                                                                      | 0.677 (0.647, 0.714) | 0.67 (0.642, 0.708)  | -0.007 (-0.015, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_593-2   | Microscopic hematuria                                                                                    | 0.598 (0.582, 0.611) | 0.592 (0.576, 0.606) | -0.007 (-0.015, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_610     | Benign mammary dysplasias                                                                                | 0.634 (0.608, 0.652) | 0.628 (0.603, 0.645) | -0.007 (-0.015, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_400-2   | Chronic rheumatic heart diseases                                                                         | 0.723 (0.713, 0.737) | 0.717 (0.701, 0.73)  | -0.007 (-0.014, 0)      | 0.651 (0.634, 0.671) | 0.657 (0.642, 0.677) | 0.007 (-0.006, 0.01)    |\n",
       "| GI             | phecode_510-8   | Barrett's esophagus                                                                                      | 0.641 (0.627, 0.657) | 0.634 (0.617, 0.649) | -0.007 (-0.014, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_329-5   | Mild cognitive impairment, so stated                                                                     | 0.764 (0.751, 0.782) | 0.756 (0.743, 0.775) | -0.007 (-0.014, -0.001) | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_088     | Sexually transmitted disease                                                                             | 0.645 (0.62, 0.674)  | 0.638 (0.612, 0.667) | -0.007 (-0.013, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_628     | Ovarian cyst                                                                                             | 0.592 (0.577, 0.612) | 0.585 (0.571, 0.605) | -0.007 (-0.012, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_683     | Nail disorders                                                                                           | 0.533 (0.527, 0.541) | 0.528 (0.521, 0.536) | -0.007 (-0.011, -0.001) | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_099     | Lab findings related to infections                                                                       | 0.648 (0.638, 0.663) | 0.64 (0.631, 0.656)  | -0.007 (-0.01, -0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_592-12  | Chronic cystitis                                                                                         | 0.603 (0.565, 0.633) | 0.595 (0.559, 0.628) | -0.006 (-0.034, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_367-2   | Keratitis                                                                                                | 0.536 (0.503, 0.556) | 0.53 (0.502, 0.552)  | -0.006 (-0.029, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_180     | Other disorders involving the immune mechanism                                                           | 0.608 (0.589, 0.63)  | 0.603 (0.586, 0.622) | -0.006 (-0.021, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_841-13  | Allergy to sulfonamides                                                                                  | 0.718 (0.693, 0.743) | 0.712 (0.684, 0.735) | -0.006 (-0.021, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_362     | Other disorders of the eyelids                                                                           | 0.553 (0.538, 0.567) | 0.545 (0.53, 0.564)  | -0.006 (-0.019, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_514-1   | Esophageal obstruction (Stricture and stenosis of esophagus)                                             | 0.633 (0.615, 0.648) | 0.626 (0.61, 0.645)  | -0.006 (-0.018, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_604-5   | Balanoposthitis                                                                                          | 0.526 (0.503, 0.547) | 0.519 (0.499, 0.542) | -0.006 (-0.018, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-4   | Secondary malignant neoplasm of liver                                                                    | 0.661 (0.646, 0.673) | 0.654 (0.638, 0.668) | -0.006 (-0.017, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594-11  | Urinary hesitancy                                                                                        | 0.75 (0.724, 0.781)  | 0.745 (0.721, 0.771) | -0.006 (-0.016, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_710-3   | Acquired deformities of the knee                                                                         | 0.651 (0.624, 0.676) | 0.646 (0.616, 0.667) | -0.006 (-0.016, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_353     | Symptoms and signs involving general sensations and perceptions                                          | 0.577 (0.564, 0.595) | 0.572 (0.559, 0.588) | -0.006 (-0.014, 0)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-22  | Atrial flutter                                                                                           | 0.739 (0.725, 0.753) | 0.732 (0.718, 0.747) | -0.006 (-0.013, 0)      | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_717-2   | Sacrococcygeal disorders                                                                                 | 0.621 (0.602, 0.639) | 0.616 (0.594, 0.635) | -0.006 (-0.013, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_714     | Deforming dorsopathies                                                                                   | 0.677 (0.659, 0.696) | 0.672 (0.656, 0.692) | -0.006 (-0.013, 0.003)  | 0.583 (0.563, 0.601) | 0.618 (0.591, 0.649) | 0.034 (0.02, 0.06)      |\n",
       "| Genitourinary  | phecode_622     | Polyp of female genital organs                                                                           | 0.571 (0.558, 0.583) | 0.565 (0.551, 0.578) | -0.006 (-0.013, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-5   | Tendinitis                                                                                               | 0.523 (0.512, 0.534) | 0.517 (0.506, 0.53)  | -0.006 (-0.013, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_628-2   | Corpus luteum cyst or hematoma                                                                           | 0.589 (0.573, 0.606) | 0.583 (0.566, 0.599) | -0.006 (-0.013, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_288-4   | Phobic disorders                                                                                         | 0.602 (0.581, 0.613) | 0.596 (0.574, 0.609) | -0.006 (-0.012, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594-31  | Urge incontinence                                                                                        | 0.648 (0.636, 0.66)  | 0.642 (0.628, 0.654) | -0.006 (-0.012, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_487-1   | Epistaxis                                                                                                | 0.592 (0.58, 0.605)  | 0.586 (0.575, 0.599) | -0.006 (-0.011, 0)      | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_808     | Syncope and collapse                                                                                     | 0.6 (0.592, 0.606)   | 0.593 (0.587, 0.6)   | -0.006 (-0.01, -0.002)  | 0.666 (0.645, 0.686) | 0.668 (0.645, 0.685) | 0 (-0.001, 0.003)       |\n",
       "| Genitourinary  | phecode_593-1   | Gross hematuria                                                                                          | 0.69 (0.668, 0.711)  | 0.683 (0.663, 0.705) | -0.006 (-0.009, -0.002) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_552-1   | Cholangitis                                                                                              | 0.605 (0.571, 0.641) | 0.599 (0.56, 0.641)  | -0.005 (-0.036, 0.026)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_624-1   | Dystrophy of female genital tract                                                                        | 0.576 (0.551, 0.602) | 0.57 (0.544, 0.597)  | -0.005 (-0.034, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_109-3   | Malignant neoplasm of brain                                                                              | 0.608 (0.57, 0.645)  | 0.604 (0.563, 0.643) | -0.005 (-0.032, 0.029)  | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_011     | Klebsiella                                                                                               | 0.667 (0.625, 0.701) | 0.662 (0.616, 0.695) | -0.005 (-0.031, 0.027)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_104     | Malignant sarcoma-related cancers                                                                        | 0.552 (0.524, 0.582) | 0.546 (0.519, 0.575) | -0.005 (-0.029, 0.028)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-15  | Primary osteoarthritis of the wrist, forearm                                                             | 0.652 (0.614, 0.677) | 0.646 (0.611, 0.673) | -0.005 (-0.025, 0.019)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_379     | Infection of the eye                                                                                     | 0.546 (0.527, 0.567) | 0.543 (0.519, 0.563) | -0.005 (-0.025, 0.018)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-53  | Cyst or abscess of Bartholin's gland                                                                     | 0.627 (0.598, 0.668) | 0.621 (0.592, 0.656) | -0.005 (-0.022, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-8   | Secondary osteoarthritis                                                                                 | 0.595 (0.58, 0.622)  | 0.592 (0.574, 0.613) | -0.005 (-0.02, 0.01)    | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_623     | Hypertrophy of female genital organs                                                                     | 0.505 (0.493, 0.52)  | 0.501 (0.484, 0.515) | -0.005 (-0.019, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_284     | Suicide ideation and attempt or self harm                                                                | 0.599 (0.585, 0.616) | 0.594 (0.58, 0.613)  | -0.005 (-0.018, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_597     | Other disorders of urethra and urinary tract                                                             | 0.6 (0.581, 0.615)   | 0.595 (0.578, 0.61)  | -0.005 (-0.017, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_596-3   | Diverticulum of bladder                                                                                  | 0.738 (0.709, 0.771) | 0.734 (0.704, 0.767) | -0.005 (-0.013, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_400     | Rheumatic fever and chronic rheumatic heart diseases                                                     | 0.723 (0.712, 0.733) | 0.717 (0.707, 0.728) | -0.005 (-0.013, 0.003)  | 0.648 (0.632, 0.692) | 0.653 (0.634, 0.692) | 0.005 (-0.006, 0.01)    |\n",
       "| Cardio         | phecode_413-11  | Mitral valve insufficiency                                                                               | 0.696 (0.684, 0.713) | 0.691 (0.679, 0.705) | -0.005 (-0.013, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_625-2   | Postcoital bleeding                                                                                      | 0.754 (0.732, 0.774) | 0.748 (0.727, 0.767) | -0.005 (-0.013, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_682-4   | Acne                                                                                                     | 0.635 (0.608, 0.658) | 0.631 (0.604, 0.657) | -0.005 (-0.012, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324     | Extrapyramidal and movement disorders                                                                    | 0.596 (0.586, 0.602) | 0.59 (0.582, 0.599)  | -0.005 (-0.011, 0)      | 0.622 (0.611, 0.649) | 0.621 (0.605, 0.645) | -0.004 (-0.009, 0.004)  |\n",
       "| Resp           | phecode_467     | Laryngitis and tracheitis                                                                                | 0.616 (0.606, 0.632) | 0.611 (0.6, 0.629)   | -0.005 (-0.011, 0)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-1   | Mitral valve disorders                                                                                   | 0.706 (0.694, 0.717) | 0.702 (0.689, 0.714) | -0.005 (-0.011, 0.002)  | 0.579 (0.558, 0.594) | 0.565 (0.553, 0.589) | -0.007 (-0.021, 0.01)   |\n",
       "| GI             | phecode_509     | Diseases of tongue                                                                                       | 0.58 (0.568, 0.594)  | 0.575 (0.563, 0.59)  | -0.005 (-0.011, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_056-1   | Plantar wart                                                                                             | 0.542 (0.527, 0.555) | 0.538 (0.522, 0.551) | -0.005 (-0.01, 0)       | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_136-2   | Benign neoplasm of stomach                                                                               | 0.633 (0.623, 0.642) | 0.627 (0.617, 0.64)  | -0.005 (-0.01, 0)       | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_618-2   | Uterine/Uterovaginal prolapse                                                                            | 0.587 (0.572, 0.6)   | 0.582 (0.57, 0.595)  | -0.005 (-0.01, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101-41  | Malignant neoplasm of the colon                                                                          | 0.687 (0.667, 0.702) | 0.682 (0.664, 0.699) | -0.005 (-0.01, 0.001)   | 0.601 (0.588, 0.626) | 0.6 (0.581, 0.618)   | -0.006 (-0.011, 0.002)  |\n",
       "| Neuro          | phecode_328-8   | Dementia in conditions classified elsewhere                                                              | 0.801 (0.79, 0.813)  | 0.796 (0.783, 0.808) | -0.005 (-0.01, -0.002)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_328     | Dementias and cerebral degeneration                                                                      | 0.788 (0.776, 0.802) | 0.783 (0.772, 0.796) | -0.005 (-0.01, -0.001)  | 0.805 (0.795, 0.812) | 0.804 (0.794, 0.811) | -0.001 (-0.002, 0)      |\n",
       "| Resp           | phecode_467-1   | Acute laryngitis and tracheitis                                                                          | 0.623 (0.612, 0.635) | 0.619 (0.607, 0.631) | -0.005 (-0.01, -0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594-3   | Urinary incontinence                                                                                     | 0.618 (0.609, 0.624) | 0.613 (0.604, 0.62)  | -0.005 (-0.009, -0.002) | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_395-1   | Labyrinthitis                                                                                            | 0.576 (0.564, 0.587) | 0.571 (0.561, 0.582) | -0.005 (-0.008, 0)      | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_215     | Testicular dysfunction                                                                                   | 0.515 (0.465, 0.567) | 0.509 (0.458, 0.563) | -0.004 (-0.05, 0.04)    | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_362-5   | Cysts of eyelid                                                                                          | 0.56 (0.526, 0.592)  | 0.553 (0.526, 0.59)  | -0.004 (-0.038, 0.018)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_208-2   | Hyperparathyroidism                                                                                      | 0.654 (0.631, 0.676) | 0.648 (0.621, 0.669) | -0.004 (-0.024, 0.013)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_619-2   | Disorders of uterus, NEC                                                                                 | 0.551 (0.531, 0.573) | 0.546 (0.525, 0.572) | -0.004 (-0.019, 0.011)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_328-7   | Vascular dementia                                                                                        | 0.8 (0.774, 0.823)   | 0.795 (0.771, 0.819) | -0.004 (-0.018, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_208     | Disorders of parathyroid gland                                                                           | 0.648 (0.627, 0.668) | 0.645 (0.622, 0.665) | -0.004 (-0.017, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_520-14  | Ventral hernia                                                                                           | 0.585 (0.562, 0.599) | 0.58 (0.564, 0.594)  | -0.004 (-0.016, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_610-1   | Cystic mastopathy                                                                                        | 0.69 (0.664, 0.713)  | 0.685 (0.66, 0.71)   | -0.004 (-0.013, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_506-5   | Disturbances of salivary secretion                                                                       | 0.629 (0.61, 0.645)  | 0.625 (0.607, 0.642) | -0.004 (-0.013, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_708-9   | Heberden's or Bouchard's nodes*                                                                          | 0.634 (0.612, 0.655) | 0.63 (0.606, 0.65)   | -0.004 (-0.013, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_683-1   | Ingrowing nail                                                                                           | 0.534 (0.523, 0.548) | 0.531 (0.517, 0.545) | -0.004 (-0.012, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-3   | Thyrotoxicosis [hyperthyroidism]                                                                         | 0.613 (0.597, 0.63)  | 0.609 (0.59, 0.626)  | -0.004 (-0.012, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_523-4   | Diverticulitis                                                                                           | 0.612 (0.598, 0.627) | 0.608 (0.596, 0.623) | -0.004 (-0.011, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_108-5   | Malignant neoplasm of the bladder                                                                        | 0.734 (0.718, 0.756) | 0.73 (0.711, 0.753)  | -0.004 (-0.011, 0.005)  | 0.716 (0.705, 0.731) | 0.718 (0.706, 0.734) | 0.001 (-0.003, 0.003)   |\n",
       "| Musc/Skel      | phecode_721-6   | Baker's cyst [popliteal cyst]                                                                            | 0.584 (0.57, 0.598)  | 0.579 (0.562, 0.593) | -0.004 (-0.011, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463-5   | Postnasal drip                                                                                           | 0.579 (0.566, 0.591) | 0.575 (0.561, 0.589) | -0.004 (-0.011, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_626-2   | Dysmenorrhea                                                                                             | 0.894 (0.882, 0.908) | 0.891 (0.879, 0.902) | -0.004 (-0.01, 0.004)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-41  | Atrioventricular block                                                                                   | 0.75 (0.74, 0.763)   | 0.747 (0.735, 0.76)  | -0.004 (-0.01, 0.001)   | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_463-1   | Chronic rhinitis                                                                                         | 0.549 (0.537, 0.561) | 0.545 (0.534, 0.556) | -0.004 (-0.009, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_682     | Other follicular disorders                                                                               | 0.512 (0.505, 0.519) | 0.508 (0.502, 0.514) | -0.004 (-0.008, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_618-1   | Prolapse of vaginal walls                                                                                | 0.581 (0.57, 0.593)  | 0.577 (0.567, 0.588) | -0.004 (-0.008, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-4   | Heart block                                                                                              | 0.722 (0.715, 0.73)  | 0.718 (0.71, 0.726)  | -0.004 (-0.007, 0)      | 0.751 (0.731, 0.757) | 0.75 (0.73, 0.756)   | -0.001 (-0.002, 0)      |\n",
       "| Genitourinary  | phecode_594-6   | Urinary urgency                                                                                          | 0.594 (0.582, 0.604) | 0.591 (0.579, 0.603) | -0.004 (-0.007, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_417-3   | Bradycardia*                                                                                             | 0.658 (0.647, 0.67)  | 0.654 (0.644, 0.666) | -0.004 (-0.007, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_395     | Other diseases of inner ear                                                                              | 0.572 (0.562, 0.583) | 0.569 (0.56, 0.579)  | -0.004 (-0.007, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_377-2   | Conjunctival hemorrhage                                                                                  | 0.584 (0.573, 0.595) | 0.581 (0.569, 0.592) | -0.004 (-0.006, -0.001) | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_504-3   | Periodontitis                                                                                            | 0.54 (0.513, 0.57)   | 0.539 (0.501, 0.574) | -0.003 (-0.036, 0.027)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_346     | Brain damage and brain death                                                                             | 0.568 (0.532, 0.602) | 0.565 (0.526, 0.6)   | -0.003 (-0.036, 0.025)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_106-3   | Malignant neoplasm of the ovary                                                                          | 0.585 (0.558, 0.619) | 0.582 (0.546, 0.609) | -0.003 (-0.034, 0.026)  | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_290-1   | Posttraumatic stress disorder                                                                            | 0.657 (0.621, 0.709) | 0.65 (0.62, 0.704)   | -0.003 (-0.034, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_342-4   | Monoplegia                                                                                               | 0.561 (0.526, 0.596) | 0.56 (0.53, 0.591)   | -0.003 (-0.03, 0.025)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_430-2   | Nontraumatic intracerebral hemorrhage                                                                    | 0.697 (0.678, 0.72)  | 0.695 (0.676, 0.719) | -0.003 (-0.029, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_724-3   | Nontraumatic hematoma of soft tissue                                                                     | 0.569 (0.535, 0.597) | 0.565 (0.528, 0.593) | -0.003 (-0.026, 0.015)  | <!----> | <!----> | <!----> |\n",
       "| Blood          | phecode_177-4   | Lymphedema                                                                                               | 0.656 (0.641, 0.673) | 0.655 (0.639, 0.671) | -0.003 (-0.016, 0.013)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440-11  | Deep vein thrombosis [DVT]                                                                               | 0.603 (0.588, 0.62)  | 0.599 (0.581, 0.619) | -0.003 (-0.016, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_363-5   | Epiphora                                                                                                 | 0.592 (0.576, 0.607) | 0.589 (0.574, 0.605) | -0.003 (-0.015, 0.01)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_334     | Disorders of other cranial nerves                                                                        | 0.55 (0.536, 0.568)  | 0.547 (0.533, 0.563) | -0.003 (-0.014, 0.014)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_712     | Other specific joint derangements                                                                        | 0.539 (0.521, 0.552) | 0.536 (0.519, 0.549) | -0.003 (-0.014, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_440-3   | Pulmonary embolism                                                                                       | 0.63 (0.616, 0.642)  | 0.626 (0.614, 0.641) | -0.003 (-0.014, 0.005)  | 0.537 (0.499, 0.55)  | 0.544 (0.512, 0.565) | 0.006 (-0.013, 0.031)   |\n",
       "| Genitourinary  | phecode_586-2   | Cyst of kidney                                                                                           | 0.652 (0.636, 0.671) | 0.65 (0.634, 0.668)  | -0.003 (-0.013, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_448-1   | Raynaud's syndrome                                                                                       | 0.585 (0.568, 0.603) | 0.582 (0.565, 0.603) | -0.003 (-0.013, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-3   | Medial epicondylitis (Golfer's elbow)                                                                    | 0.562 (0.546, 0.578) | 0.559 (0.545, 0.577) | -0.003 (-0.012, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_841-12  | Allergy to antibiotic agent (excluding penicillin)                                                       | 0.661 (0.649, 0.672) | 0.658 (0.647, 0.669) | -0.003 (-0.01, 0.003)   | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-5   | Premature depolarization [Premature beats]                                                               | 0.626 (0.61, 0.638)  | 0.623 (0.606, 0.636) | -0.003 (-0.009, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_592-11  | Acute cystitis                                                                                           | 0.712 (0.698, 0.731) | 0.71 (0.695, 0.729)  | -0.003 (-0.009, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_101     | Malignant neoplasm of the digestive organs                                                               | 0.672 (0.663, 0.683) | 0.669 (0.659, 0.68)  | -0.003 (-0.009, 0.002)  | 0.623 (0.595, 0.63)  | 0.622 (0.594, 0.627) | -0.002 (-0.003, 0)      |\n",
       "| Neoplasms      | phecode_101-4   | Malignant neoplasm of the colon and rectum                                                               | 0.685 (0.673, 0.699) | 0.682 (0.672, 0.696) | -0.003 (-0.008, 0.002)  | 0.596 (0.57, 0.627)  | 0.596 (0.57, 0.628)  | 0 (-0.001, 0.001)       |\n",
       "| Neoplasms      | phecode_140     | Benign neoplasm of the breast                                                                            | 0.797 (0.779, 0.812) | 0.795 (0.779, 0.809) | -0.003 (-0.008, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413     | Heart valve disorders                                                                                    | 0.712 (0.705, 0.72)  | 0.709 (0.702, 0.718) | -0.003 (-0.007, 0.002)  | 0.696 (0.667, 0.714) | 0.696 (0.672, 0.719) | 0.003 (-0.003, 0.008)   |\n",
       "| Neuro          | phecode_328-1   | Alzheimer's disease                                                                                      | 0.812 (0.798, 0.826) | 0.809 (0.796, 0.822) | -0.003 (-0.007, 0.002)  | 0.756 (0.722, 0.801) | 0.752 (0.716, 0.797) | -0.004 (-0.006, -0.002) |\n",
       "| Signs/Symptoms | phecode_832-6   | Pyuria*                                                                                                  | 0.657 (0.642, 0.672) | 0.655 (0.638, 0.67)  | -0.003 (-0.007, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_613-5   | Mastodynia                                                                                               | 0.554 (0.543, 0.564) | 0.55 (0.54, 0.563)   | -0.003 (-0.007, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_596     | Other disorders of bladder                                                                               | 0.607 (0.599, 0.617) | 0.604 (0.596, 0.613) | -0.003 (-0.007, 0.001)  | 0.685 (0.651, 0.695) | 0.688 (0.657, 0.7)   | 0.003 (0.002, 0.007)    |\n",
       "| Genitourinary  | phecode_591     | Urinary tract infection                                                                                  | 0.62 (0.615, 0.625)  | 0.618 (0.612, 0.622) | -0.003 (-0.006, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_602     | Other disorders of prostate                                                                              | 0.636 (0.625, 0.646) | 0.632 (0.623, 0.643) | -0.003 (-0.006, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_613     | Other nonmalignant breast conditions                                                                     | 0.544 (0.537, 0.554) | 0.542 (0.533, 0.552) | -0.003 (-0.006, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_618     | Genital prolapse                                                                                         | 0.577 (0.569, 0.587) | 0.575 (0.566, 0.586) | -0.003 (-0.006, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_360     | Inflammation of eyelids                                                                                  | 0.564 (0.557, 0.571) | 0.561 (0.554, 0.568) | -0.003 (-0.006, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_105     | Malignant neoplasm of the breast                                                                         | 0.753 (0.747, 0.76)  | 0.75 (0.743, 0.756)  | -0.003 (-0.006, -0.001) | 0.706 (0.7, 0.718)   | 0.705 (0.699, 0.726) | 0.002 (-0.015, 0.02)    |\n",
       "| Eye            | phecode_360-4   | Blepharitis                                                                                              | 0.595 (0.586, 0.606) | 0.593 (0.584, 0.603) | -0.003 (-0.005, 0)      | <!----> | <!----> | <!----> |\n",
       "| Hearing        | phecode_394-21  | Paroxysmal vertigo                                                                                       | 0.618 (0.606, 0.629) | 0.614 (0.603, 0.627) | -0.003 (-0.005, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_592     | Cystitis and urethritis                                                                                  | 0.685 (0.674, 0.693) | 0.682 (0.672, 0.69)  | -0.003 (-0.005, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_592-1   | Cystitis                                                                                                 | 0.694 (0.686, 0.703) | 0.691 (0.683, 0.701) | -0.003 (-0.005, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_462-1   | Acute sinusitis                                                                                          | 0.579 (0.57, 0.588)  | 0.576 (0.567, 0.586) | -0.003 (-0.004, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_308-5   | Nervousness                                                                                              | 0.561 (0.531, 0.591) | 0.553 (0.526, 0.591) | -0.002 (-0.035, 0.022)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_430-1   | Nontraumatic subarachnoid hemorrhage                                                                     | 0.61 (0.575, 0.644)  | 0.613 (0.57, 0.641)  | -0.002 (-0.026, 0.034)  | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_817     | Motion sickness                                                                                          | 0.651 (0.627, 0.687) | 0.651 (0.619, 0.682) | -0.002 (-0.026, 0.02)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_603-5   | Orchitis and epididymitis                                                                                | 0.518 (0.502, 0.539) | 0.517 (0.498, 0.532) | -0.002 (-0.019, 0.014)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_356     | Speech disturbance                                                                                       | 0.635 (0.617, 0.655) | 0.633 (0.619, 0.651) | -0.002 (-0.018, 0.012)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_430     | Nontraumatic Intracranial hemorrhage                                                                     | 0.656 (0.638, 0.68)  | 0.652 (0.634, 0.674) | -0.002 (-0.017, 0.01)   | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_324-41  | Essential tremor*                                                                                        | 0.64 (0.619, 0.669)  | 0.639 (0.618, 0.66)  | -0.002 (-0.015, 0.015)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_552     | Other diseases of biliary tract                                                                          | 0.62 (0.596, 0.638)  | 0.616 (0.598, 0.642) | -0.002 (-0.015, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-52  | Ventricular premature depolarization*                                                                    | 0.636 (0.621, 0.655) | 0.633 (0.617, 0.654) | -0.002 (-0.01, 0.005)   | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_614-52  | Vaginitis and vulvovaginitis                                                                             | 0.561 (0.548, 0.574) | 0.56 (0.549, 0.573)  | -0.002 (-0.009, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_625-1   | Dyspareunia                                                                                              | 0.65 (0.632, 0.664)  | 0.649 (0.633, 0.666) | -0.002 (-0.009, 0.008)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-42  | Left bundle branch block                                                                                 | 0.722 (0.706, 0.735) | 0.719 (0.706, 0.734) | -0.002 (-0.009, 0.007)  | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_052-1   | Herpes simplex                                                                                           | 0.598 (0.585, 0.613) | 0.597 (0.583, 0.611) | -0.002 (-0.008, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_723-51  | Achilles tendinitis                                                                                      | 0.539 (0.525, 0.549) | 0.536 (0.523, 0.547) | -0.002 (-0.008, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721-11  | Trigger finger                                                                                           | 0.58 (0.569, 0.593)  | 0.578 (0.568, 0.59)  | -0.002 (-0.008, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_728     | Chondropathies                                                                                           | 0.608 (0.596, 0.623) | 0.608 (0.592, 0.623) | -0.002 (-0.007, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116     | Secondary malignant neoplasm                                                                             | 0.655 (0.646, 0.664) | 0.653 (0.644, 0.663) | -0.002 (-0.007, 0.004)  | 0.587 (0.578, 0.609) | 0.586 (0.577, 0.609) | -0.001 (-0.001, 0)      |\n",
       "| Genitourinary  | phecode_619-3   | Noninflammatory disorders of cervix                                                                      | 0.686 (0.664, 0.703) | 0.684 (0.663, 0.702) | -0.002 (-0.007, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_721-2   | Ganglion cyst                                                                                            | 0.547 (0.537, 0.557) | 0.544 (0.534, 0.554) | -0.002 (-0.007, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_132     | Sequelae of cancer                                                                                       | 0.734 (0.725, 0.745) | 0.733 (0.722, 0.745) | -0.002 (-0.007, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_444-1   | Varicose veins                                                                                           | 0.586 (0.578, 0.595) | 0.584 (0.576, 0.593) | -0.002 (-0.007, 0.002)  | 0.542 (0.518, 0.582) | 0.549 (0.523, 0.582) | 0.003 (-0.005, 0.025)   |\n",
       "| Genitourinary  | phecode_602-4   | Elevated prostate specific antigen [PSA]                                                                 | 0.63 (0.62, 0.64)    | 0.628 (0.618, 0.638) | -0.002 (-0.007, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_418-1   | Abnormal electrocardiogram [ECG] [EKG]                                                                   | 0.664 (0.655, 0.672) | 0.661 (0.654, 0.672) | -0.002 (-0.006, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_618-11  | Cystocele                                                                                                | 0.59 (0.58, 0.602)   | 0.588 (0.576, 0.601) | -0.002 (-0.006, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_625     | Pain and other symptoms associated with female genital organs                                            | 0.611 (0.6, 0.622)   | 0.609 (0.597, 0.621) | -0.002 (-0.006, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_596-1   | Bladder neck obstruction                                                                                 | 0.801 (0.788, 0.818) | 0.799 (0.787, 0.816) | -0.002 (-0.006, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_417     | Abnormalities of heart beat                                                                              | 0.588 (0.584, 0.593) | 0.586 (0.581, 0.59)  | -0.002 (-0.005, 0)      | 0.652 (0.631, 0.677) | 0.649 (0.628, 0.675) | -0.004 (-0.005, -0.001) |\n",
       "| Hearing        | phecode_394     | Disorders of vestibular function                                                                         | 0.603 (0.593, 0.613) | 0.602 (0.592, 0.612) | -0.002 (-0.005, 0)      | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_052     | Herpesvirus                                                                                              | 0.561 (0.555, 0.566) | 0.558 (0.553, 0.565) | -0.002 (-0.005, 0)      | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_444     | Venous insufficiency                                                                                     | 0.591 (0.585, 0.6)   | 0.589 (0.582, 0.597) | -0.002 (-0.005, 0.001)  | 0.525 (0.485, 0.555) | 0.536 (0.5, 0.556)   | 0.009 (-0.002, 0.025)   |\n",
       "| Cardio         | phecode_444-11  | Varicose veins of lower extremities                                                                      | 0.596 (0.588, 0.606) | 0.594 (0.585, 0.603) | -0.002 (-0.005, 0.001)  | 0.54 (0.498, 0.562)  | 0.553 (0.53, 0.59)   | 0.018 (0, 0.038)        |\n",
       "| Endo           | phecode_200-1   | Hypothyroidism                                                                                           | 0.635 (0.629, 0.643) | 0.633 (0.626, 0.639) | -0.002 (-0.005, 0.001)  | 0.649 (0.641, 0.668) | 0.651 (0.642, 0.668) | 0.001 (-0.001, 0.005)   |\n",
       "| Resp           | phecode_462     | Sinusitis                                                                                                | 0.558 (0.551, 0.565) | 0.556 (0.549, 0.562) | -0.002 (-0.005, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200     | Disorders of thyroid gland                                                                               | 0.632 (0.626, 0.638) | 0.629 (0.624, 0.636) | -0.002 (-0.004, 0)      | 0.641 (0.631, 0.662) | 0.642 (0.635, 0.66)  | 0.003 (-0.003, 0.005)   |\n",
       "| Genitourinary  | phecode_593     | Hematuria                                                                                                | 0.588 (0.583, 0.592) | 0.586 (0.582, 0.59)  | -0.002 (-0.004, 0)      | 0.637 (0.617, 0.652) | 0.637 (0.615, 0.651) | -0.001 (-0.002, 0)      |\n",
       "| ID             | phecode_052-32  | Herpes zoster                                                                                            | 0.578 (0.57, 0.585)  | 0.576 (0.568, 0.583) | -0.002 (-0.004, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594     | Abnormality of urination                                                                                 | 0.584 (0.579, 0.589) | 0.583 (0.577, 0.588) | -0.002 (-0.004, 0.001)  | 0.713 (0.705, 0.72)  | 0.713 (0.706, 0.721) | 0 (0, 0.002)            |\n",
       "| Genitourinary  | phecode_594-1   | Retention of urine                                                                                       | 0.735 (0.726, 0.744) | 0.733 (0.724, 0.741) | -0.002 (-0.004, 0.001)  | 0.727 (0.719, 0.742) | 0.727 (0.718, 0.742) | 0 (-0.001, 0)           |\n",
       "| Hearing        | phecode_394-2   | Vertigo                                                                                                  | 0.607 (0.597, 0.618) | 0.606 (0.594, 0.616) | -0.002 (-0.004, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_599     | Other symptoms/disorders or the urinary system                                                           | 0.577 (0.571, 0.582) | 0.574 (0.568, 0.58)  | -0.002 (-0.004, -0.001) | 0.697 (0.69, 0.71)   | 0.696 (0.69, 0.71)   | 0 (-0.001, 0)           |\n",
       "| Musc/Skel      | phecode_709-21  | Hallux valgus (Bunion)                                                                                   | 0.667 (0.66, 0.675)  | 0.665 (0.658, 0.674) | -0.002 (-0.003, 0)      | <!----> | <!----> | <!----> |\n",
       "| Mental         | phecode_280-82  | Other psychoactive substance dependence                                                                  | 0.59 (0.548, 0.629)  | 0.589 (0.545, 0.63)  | -0.001 (-0.043, 0.049)  | <!----> | <!----> | <!----> |\n",
       "| Eye            | phecode_379-21  | Infection of the eye, herpes                                                                             | 0.584 (0.54, 0.61)   | 0.581 (0.548, 0.611) | -0.001 (-0.022, 0.023)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_416-212 | Persistent atrial fibrillation*                                                                          | 0.717 (0.689, 0.742) | 0.713 (0.689, 0.741) | -0.001 (-0.018, 0.014)  | <!----> | <!----> | <!----> |\n",
       "| Neuro          | phecode_334-11  | Trigeminal neuralgia                                                                                     | 0.596 (0.574, 0.619) | 0.592 (0.571, 0.617) | -0.001 (-0.014, 0.011)  | <!----> | <!----> | <!----> |\n",
       "| Derm           | phecode_660-13  | Pityriasis versicolor                                                                                    | 0.666 (0.635, 0.696) | 0.666 (0.632, 0.692) | -0.001 (-0.013, 0.013)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_148     | Benign neoplasm of the eye, brain and other parts of central nervous system                              | 0.602 (0.582, 0.626) | 0.603 (0.583, 0.625) | -0.001 (-0.012, 0.016)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_116-1   | Secondary malignancy of lymph nodes                                                                      | 0.617 (0.601, 0.63)  | 0.616 (0.599, 0.63)  | -0.001 (-0.012, 0.008)  | 0.463 (0.431, 0.486) | 0.45 (0.425, 0.48)   | -0.008 (-0.024, 0.001)  |\n",
       "| Genitourinary  | phecode_620     | Dysplasia of female genital organs                                                                       | 0.72 (0.691, 0.746)  | 0.72 (0.692, 0.746)  | -0.001 (-0.009, 0.009)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_728-3   | Costochondritis (Tietze's disease)                                                                       | 0.611 (0.595, 0.626) | 0.61 (0.595, 0.627)  | -0.001 (-0.009, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_108     | Malignant neoplasm of the urinary tract                                                                  | 0.71 (0.693, 0.724)  | 0.709 (0.692, 0.724) | -0.001 (-0.008, 0.007)  | 0.703 (0.672, 0.723) | 0.705 (0.676, 0.73)  | 0.004 (-0.001, 0.007)   |\n",
       "| Genitourinary  | phecode_594-32  | Stress incontinence                                                                                      | 0.716 (0.705, 0.724) | 0.714 (0.706, 0.723) | -0.001 (-0.008, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_506     | Diseases of salivary glands                                                                              | 0.59 (0.577, 0.605)  | 0.59 (0.574, 0.606)  | -0.001 (-0.008, 0.006)  | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_476     | Bronchiectasis                                                                                           | 0.677 (0.667, 0.692) | 0.676 (0.664, 0.692) | -0.001 (-0.008, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_413-2   | Aortic valve disorders                                                                                   | 0.727 (0.716, 0.734) | 0.726 (0.714, 0.734) | -0.001 (-0.008, 0.003)  | 0.722 (0.7, 0.746)   | 0.723 (0.702, 0.749) | 0.002 (-0.001, 0.004)   |\n",
       "| GI             | phecode_510-2   | Esophagitis                                                                                              | 0.57 (0.563, 0.581)  | 0.569 (0.561, 0.58)  | -0.001 (-0.007, 0.005)  | <!----> | <!----> | <!----> |\n",
       "| Signs/Symptoms | phecode_848     | Nonspecific abnormal findings of other body structures                                                   | 0.617 (0.609, 0.624) | 0.617 (0.609, 0.624) | -0.001 (-0.006, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_705-3   | Polymyalgia rheumatica                                                                                   | 0.709 (0.692, 0.719) | 0.708 (0.692, 0.717) | -0.001 (-0.006, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Cardio         | phecode_401-6   | Secondary hypertension                                                                                   | 0.626 (0.609, 0.647) | 0.625 (0.607, 0.646) | -0.001 (-0.005, 0.004)  | <!----> | <!----> | <!----> |\n",
       "| GI             | phecode_510     | Diseases of esophagus                                                                                    | 0.575 (0.568, 0.581) | 0.575 (0.568, 0.582) | -0.001 (-0.005, 0.004)  | 0.616 (0.603, 0.632) | 0.615 (0.602, 0.629) | 0 (-0.005, 0.001)       |\n",
       "| Hearing        | phecode_396-2   | Sensorineural hearing loss                                                                               | 0.637 (0.626, 0.649) | 0.635 (0.625, 0.646) | -0.001 (-0.005, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| ID             | phecode_052-3   | Varicella zoster virus                                                                                   | 0.57 (0.563, 0.578)  | 0.569 (0.562, 0.575) | -0.001 (-0.004, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_144-2   | Benign neoplasms of the uterus                                                                           | 0.662 (0.65, 0.672)  | 0.661 (0.649, 0.671) | -0.001 (-0.004, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Endo           | phecode_200-14  | Hypothyroidism, not specified as secondary                                                               | 0.638 (0.631, 0.646) | 0.637 (0.629, 0.645) | -0.001 (-0.004, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_626-11  | Absent or infrequent menstruation                                                                        | 0.847 (0.836, 0.857) | 0.846 (0.835, 0.859) | -0.001 (-0.004, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709     | Acquired deformities of fingers and toes                                                                 | 0.636 (0.629, 0.645) | 0.635 (0.627, 0.643) | -0.001 (-0.003, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_107     | Malignant neoplasm of male genitalia                                                                     | 0.685 (0.675, 0.693) | 0.684 (0.674, 0.692) | -0.001 (-0.003, 0)      | 0.534 (0.496, 0.565) | 0.525 (0.486, 0.553) | -0.009 (-0.014, -0.005) |\n",
       "| Neoplasms      | phecode_107-2   | Malignant neoplasm of the prostate                                                                       | 0.689 (0.683, 0.697) | 0.688 (0.681, 0.696) | -0.001 (-0.003, 0)      | 0.523 (0.495, 0.544) | 0.517 (0.485, 0.539) | -0.008 (-0.012, -0.005) |\n",
       "| Signs/Symptoms | phecode_807-1   | Chronic fatigue syndrome                                                                                 | 0.597 (0.59, 0.604)  | 0.596 (0.589, 0.604) | -0.001 (-0.003, 0.003)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_608     | Other disorders of male genital organs                                                                   | 0.53 (0.524, 0.539)  | 0.529 (0.524, 0.538) | -0.001 (-0.003, 0.002)  | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_594-4   | Frequency of urination and polyuria                                                                      | 0.587 (0.581, 0.594) | 0.586 (0.58, 0.593)  | -0.001 (-0.003, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Musc/Skel      | phecode_709-2   | Acquired deformities of toe                                                                              | 0.649 (0.639, 0.657) | 0.647 (0.638, 0.655) | -0.001 (-0.003, -0.001) | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_626     | Disorders of menstruation and other abnormal bleeding from female genital tract                          | 0.792 (0.783, 0.801) | 0.791 (0.782, 0.8)   | -0.001 (-0.002, 0)      | <!----> | <!----> | <!----> |\n",
       "| Genitourinary  | phecode_608-1   | Abnormal findings in semen                                                                               | 0.824 (0.819, 0.829) | 0.823 (0.818, 0.828) | -0.001 (-0.002, 0)      | <!----> | <!----> | <!----> |\n",
       "| Resp           | phecode_466     | Tonsillitis and adenoiditis                                                                              | 0.649 (0.636, 0.66)  | 0.648 (0.635, 0.659) | -0.001 (-0.002, 0)      | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_130     | Cancer (solid tumor, excluding BCC)                                                                      | 0.644 (0.639, 0.649) | 0.643 (0.638, 0.648) | -0.001 (-0.002, 0.001)  | 0.612 (0.598, 0.616) | 0.612 (0.597, 0.615) | -0.001 (-0.001, 0)      |\n",
       "| Resp           | phecode_466-1   | Acute tonsillitis and adenoiditis                                                                        | 0.663 (0.653, 0.675) | 0.662 (0.652, 0.675) | -0.001 (-0.002, 0.001)  | <!----> | <!----> | <!----> |\n",
       "| Neoplasms      | phecode_142-1   | Lump or mass in breast                                                                                   | 0.748 (0.74, 0.755)  | 0.747 (0.739, 0.753) | -0.001 (-0.002, -0.001) | <!----> | <!----> | <!----> |\n",
       "\n"
      ],
      "text/plain": [
       "     phecode_category endpoint       \n",
       "1    Blood            phecode_165    \n",
       "2    Eye              phecode_387-2  \n",
       "3    Derm             phecode_688-1  \n",
       "4    Derm             phecode_665-3  \n",
       "5    Eye              phecode_373    \n",
       "6    Derm             phecode_665-2  \n",
       "7    ID               phecode_005    \n",
       "8    Neoplasms        phecode_139-3  \n",
       "9    Eye              phecode_377-5  \n",
       "10   Rx               phecode_977-71 \n",
       "11   Musc/Skel        phecode_709-11 \n",
       "12   ID               phecode_096    \n",
       "13   ID               phecode_008    \n",
       "14   Eye              phecode_370    \n",
       "15   Eye              phecode_369-5  \n",
       "16   GI               phecode_529-6  \n",
       "17   Eye              phecode_386-1  \n",
       "18   Neuro            phecode_337-8  \n",
       "19   Neoplasms        phecode_139-52 \n",
       "20   Neoplasms        phecode_110    \n",
       "21   Eye              phecode_374-8  \n",
       "22   Eye              phecode_387    \n",
       "23   ID               phecode_059-1  \n",
       "24   Rx               phecode_977    \n",
       "25   Eye              phecode_374-11 \n",
       "26   Derm             phecode_676-1  \n",
       "27   Musc/Skel        phecode_712-1  \n",
       "28   Eye              phecode_374-512\n",
       "29   Eye              phecode_387-1  \n",
       "30   Derm             phecode_679-21 \n",
       "31   Eye              phecode_367-6  \n",
       "32   Endo             phecode_205    \n",
       "33   Eye              phecode_374-1  \n",
       "34   Eye              phecode_385    \n",
       "35   GI               phecode_504-1  \n",
       "36   Metab            phecode_236-11 \n",
       "37   ID               phecode_059    \n",
       "38   Neuro            phecode_352-1  \n",
       "39   Endo             phecode_202-4  \n",
       "40   Rx               phecode_977-7  \n",
       "41   Mental           phecode_280-12 \n",
       "42   Eye              phecode_374-4  \n",
       "43   Musc/Skel        phecode_724-51 \n",
       "44   Blood            phecode_168-2  \n",
       "45   Eye              phecode_374-51 \n",
       "46   Eye              phecode_367-5  \n",
       "47   Resp             phecode_498    \n",
       "48   ID               phecode_097-1  \n",
       "49   Rx               phecode_977-72 \n",
       "50   Endo             phecode_202-1  \n",
       "51   Eye              phecode_367-52 \n",
       "52   Eye              phecode_366-1  \n",
       "53   Eye              phecode_374-42 \n",
       "54   Metab            phecode_247-72 \n",
       "55   GI               phecode_501    \n",
       "56   Endo             phecode_211    \n",
       "57   Neuro            phecode_325-1  \n",
       "58   Blood            phecode_160-1  \n",
       "59   Blood            phecode_164-1  \n",
       "60   Eye              phecode_369    \n",
       "61   GI               phecode_546-3  \n",
       "62   Musc/Skel        phecode_709-1  \n",
       "63   Metab            phecode_239-3  \n",
       "64   Metab            phecode_236-1  \n",
       "65   Mental           phecode_283-4  \n",
       "66   Mental           phecode_308-4  \n",
       "67   Derm             phecode_674-11 \n",
       "68   ID               phecode_097    \n",
       "69   Metab            phecode_236    \n",
       "70   Metab            phecode_247-7  \n",
       "71   GI               phecode_542    \n",
       "72   Signs/Symptoms   phecode_829-2  \n",
       "73   Endo             phecode_202-2  \n",
       "74   GI               phecode_542-1  \n",
       "75   Neuro            phecode_333-4  \n",
       "76   Endo             phecode_202    \n",
       "77   Signs/Symptoms   phecode_821    \n",
       "78   Metab            phecode_247-51 \n",
       "79   Metab            phecode_232    \n",
       "80   Blood            phecode_160    \n",
       "81   Mental           phecode_280-13 \n",
       "82   Genitourinary    phecode_614-54 \n",
       "83   GI               phecode_542-4  \n",
       "84   Derm             phecode_674-1  \n",
       "85   Neoplasms        phecode_135-1  \n",
       "86   Mental           phecode_281-2  \n",
       "87   Eye              phecode_374-511\n",
       "88   Mental           phecode_287    \n",
       "89   GI               phecode_540-1  \n",
       "90   Eye              phecode_371-3  \n",
       "91   Metab            phecode_232-2  \n",
       "92   Mental           phecode_292    \n",
       "93   Eye              phecode_371-31 \n",
       "94   Metab            phecode_232-4  \n",
       "95   GI               phecode_542-2  \n",
       "96   Eye              phecode_380-2  \n",
       "97   Eye              phecode_374-5  \n",
       "98   Neuro            phecode_343    \n",
       "99   Eye              phecode_369-1  \n",
       "100  Derm             phecode_679-2  \n",
       "101  Metab            phecode_251-1  \n",
       "102  Eye              phecode_360-5  \n",
       "103  Metab            phecode_237    \n",
       "104  Musc/Skel        phecode_705-5  \n",
       "105  Eye              phecode_374    \n",
       "106  Neuro            phecode_351-2  \n",
       "107  ID               phecode_098    \n",
       "108  Mental           phecode_281    \n",
       "109  Eye              phecode_380    \n",
       "110  ID               phecode_086    \n",
       "111  Signs/Symptoms   phecode_812-2  \n",
       "112  Eye              phecode_371    \n",
       "113  Metab            phecode_247    \n",
       "114  Metab            phecode_256-3  \n",
       "115  Metab            phecode_251    \n",
       "116  Signs/Symptoms   phecode_824    \n",
       "117  Blood            phecode_175    \n",
       "118  Neoplasms        phecode_114    \n",
       "119  Signs/Symptoms   phecode_831    \n",
       "120  Derm             phecode_684-11 \n",
       "121  Signs/Symptoms   phecode_809-1  \n",
       "122  GI               phecode_504    \n",
       "123  Resp             phecode_488-6  \n",
       "124  Eye              phecode_375-11 \n",
       "125  GI               phecode_522-12 \n",
       "126  Blood            phecode_164    \n",
       "127  Eye              phecode_374-55 \n",
       "128  Rx               phecode_973    \n",
       "129  GI               phecode_537-1  \n",
       "130  Genitourinary    phecode_596-5  \n",
       "131  Signs/Symptoms   phecode_805    \n",
       "132  Blood            phecode_170-19 \n",
       "133  Mental           phecode_282-1  \n",
       "134  GI               phecode_503    \n",
       "135  Cardio           phecode_449    \n",
       "136  Blood            phecode_164-6  \n",
       "137  Derm             phecode_666-2  \n",
       "138  Metab            phecode_256-1  \n",
       "139  Hearing          phecode_396-1  \n",
       "140  Resp             phecode_474-1  \n",
       "141  Neuro            phecode_334-21 \n",
       "142  Signs/Symptoms   phecode_826-3  \n",
       "143  Eye              phecode_387-3  \n",
       "144  Metab            phecode_247-4  \n",
       "145  Musc/Skel        phecode_719-3  \n",
       "146  GI               phecode_540-3  \n",
       "147  ID               phecode_054    \n",
       "148  Endo             phecode_204-2  \n",
       "149  Musc/Skel        phecode_721-12 \n",
       "150  Metab            phecode_256-4  \n",
       "151  Musc/Skel        phecode_706-1  \n",
       "152  Musc/Skel        phecode_712-6  \n",
       "153  Blood            phecode_175-2  \n",
       "154  Signs/Symptoms   phecode_840-8  \n",
       "155  Genitourinary    phecode_627-3  \n",
       "156  Eye              phecode_374-3  \n",
       "157  Cardio           phecode_443-1  \n",
       "158  Neuro            phecode_334-2  \n",
       "159  Mental           phecode_299    \n",
       "160  Mental           phecode_286-1  \n",
       "161  Resp             phecode_474    \n",
       "162  Neuro            phecode_333-1  \n",
       "163  Derm             phecode_662    \n",
       "164  Resp             phecode_463-2  \n",
       "165  Derm             phecode_686-2  \n",
       "166  Eye              phecode_388    \n",
       "167  Resp             phecode_469-2  \n",
       "168  GI               phecode_526-11 \n",
       "169  Endo             phecode_204    \n",
       "170  GI               phecode_503-5  \n",
       "171  Derm             phecode_665    \n",
       "172  GI               phecode_542-3  \n",
       "173  Eye              phecode_375-1  \n",
       "174  Derm             phecode_685-8  \n",
       "175  Musc/Skel        phecode_733-62 \n",
       "176  Eye              phecode_374-38 \n",
       "177  Genitourinary    phecode_581-11 \n",
       "178  Derm             phecode_685-82 \n",
       "179  Eye              phecode_375-14 \n",
       "180  Neuro            phecode_356-1  \n",
       "181  Eye              phecode_384    \n",
       "182  Neuro            phecode_351    \n",
       "183  Resp             phecode_463-21 \n",
       "184  Eye              phecode_375-113\n",
       "185  Eye              phecode_376-1  \n",
       "186  Neoplasms        phecode_102-1  \n",
       "187  Blood            phecode_168-19 \n",
       "188  Eye              phecode_375    \n",
       "189  Mental           phecode_280-11 \n",
       "190  Neuro            phecode_336-55 \n",
       "191  Derm             phecode_680-3  \n",
       "192  Blood            phecode_164-2  \n",
       "193  Derm             phecode_660-4  \n",
       "194  Cardio           phecode_401-3  \n",
       "195  Eye              phecode_386-4  \n",
       "196  Resp             phecode_486-2  \n",
       "197  Neuro            phecode_351-3  \n",
       "198  Derm             phecode_664    \n",
       "199  Derm             phecode_680-1  \n",
       "200  GI               phecode_502    \n",
       "201  Musc/Skel        phecode_730    \n",
       "202  Neuro            phecode_347    \n",
       "203  Musc/Skel        phecode_702-3  \n",
       "204  Derm             phecode_686    \n",
       "205  Neuro            phecode_333    \n",
       "206  Derm             phecode_676    \n",
       "207  Resp             phecode_471-5  \n",
       "208  Eye              phecode_367-12 \n",
       "209  Metab            phecode_244    \n",
       "210  Eye              phecode_360-51 \n",
       "211  Neuro            phecode_336-2  \n",
       "212  Metab            phecode_239-2  \n",
       "213  GI               phecode_525-3  \n",
       "214  Mental           phecode_283    \n",
       "215  Musc/Skel        phecode_722    \n",
       "216  Mental           phecode_280    \n",
       "217  Cardio           phecode_448-9  \n",
       "218  Metab            phecode_232-29 \n",
       "219  Musc/Skel        phecode_723-6  \n",
       "220  Rx               phecode_977-41 \n",
       "221  Metab            phecode_256-31 \n",
       "222  Metab            phecode_232-27 \n",
       "223  Derm             phecode_666    \n",
       "224  Neoplasms        phecode_102    \n",
       "225  Rx               phecode_977-4  \n",
       "226  Eye              phecode_369-4  \n",
       "227  Genitourinary    phecode_581-1  \n",
       "228  Neuro            phecode_352    \n",
       "229  Neuro            phecode_344    \n",
       "230  Musc/Skel        phecode_727-1  \n",
       "231  Musc/Skel        phecode_719-11 \n",
       "232  Endo             phecode_204-4  \n",
       "233  Mental           phecode_281-1  \n",
       "234  Neuro            phecode_337    \n",
       "235  Resp             phecode_475    \n",
       "236  Blood            phecode_177-2  \n",
       "237  Blood            phecode_160-2  \n",
       "238  Resp             phecode_479-3  \n",
       "239  Resp             phecode_468-2  \n",
       "240  Neuro            phecode_341    \n",
       "241  Eye              phecode_377-4  \n",
       "242  Cardio           phecode_411-2  \n",
       "243  Metab            phecode_257    \n",
       "244  Mental           phecode_284-2  \n",
       "245  Resp             phecode_486    \n",
       "246  Signs/Symptoms   phecode_800    \n",
       "247  Hearing          phecode_390-1  \n",
       "248  Mental           phecode_280-1  \n",
       "249  Neuro            phecode_333-11 \n",
       "250  GI               phecode_535    \n",
       "251  Resp             phecode_487-3  \n",
       "252  Derm             phecode_686-1  \n",
       "253  Derm             phecode_660-21 \n",
       "254  Signs/Symptoms   phecode_840-9  \n",
       "255  Derm             phecode_668-6  \n",
       "256  Metab            phecode_248    \n",
       "257  Mental           phecode_284-29 \n",
       "258  Derm             phecode_683-2  \n",
       "259  Signs/Symptoms   phecode_804    \n",
       "260  Resp             phecode_469    \n",
       "261  Derm             phecode_660-2  \n",
       "262  Signs/Symptoms   phecode_800-2  \n",
       "263  Signs/Symptoms   phecode_832-5  \n",
       "264  Metab            phecode_256-6  \n",
       "265  GI               phecode_507-11 \n",
       "266  Neuro            phecode_330-12 \n",
       "267  GI               phecode_525-1  \n",
       "268  Neuro            phecode_336-52 \n",
       "269  Derm             phecode_666-1  \n",
       "270  ID               phecode_089-1  \n",
       "271  Neuro            phecode_336-1  \n",
       "272  Neuro            phecode_341-2  \n",
       "273  Musc/Skel        phecode_710-4  \n",
       "274  Eye              phecode_361-3  \n",
       "275  Blood            phecode_168-1  \n",
       "276  Neuro            phecode_355-2  \n",
       "277  Neuro            phecode_351-1  \n",
       "278  Metab            phecode_239-12 \n",
       "279  Eye              phecode_366    \n",
       "280  Genitourinary    phecode_588-2  \n",
       "281  Signs/Symptoms   phecode_810    \n",
       "282  Hearing          phecode_391-2  \n",
       "283  Eye              phecode_376-2  \n",
       "284  Derm             phecode_668-5  \n",
       "285  Eye              phecode_366-42 \n",
       "286  Eye              phecode_376    \n",
       "287  Mental           phecode_283-8  \n",
       "288  Musc/Skel        phecode_733    \n",
       "289  Eye              phecode_376-21 \n",
       "290  Musc/Skel        phecode_733-6  \n",
       "291  Neuro            phecode_335    \n",
       "292  Neoplasms        phecode_135-5  \n",
       "293  GI               phecode_550-2  \n",
       "294  ID               phecode_061    \n",
       "295  Genitourinary    phecode_588    \n",
       "296  Eye              phecode_361-4  \n",
       "297  Neoplasms        phecode_149-3  \n",
       "298  Derm             phecode_660-6  \n",
       "299  Genitourinary    phecode_582    \n",
       "300  Endo             phecode_200-9  \n",
       "301  Musc/Skel        phecode_731    \n",
       "302  GI               phecode_530-2  \n",
       "303  Eye              phecode_374-52 \n",
       "304  Resp             phecode_462-2  \n",
       "305  Musc/Skel        phecode_719-1  \n",
       "306  Musc/Skel        phecode_723-1  \n",
       "307  Derm             phecode_684-1  \n",
       "308  Neuro            phecode_333-2  \n",
       "309  Genitourinary    phecode_585    \n",
       "310  Resp             phecode_495    \n",
       "311  GI               phecode_513-2  \n",
       "312  ID               phecode_002-1  \n",
       "313  Resp             phecode_468-1  \n",
       "314  Neuro            phecode_330-1  \n",
       "315  Neoplasms        phecode_148-1  \n",
       "316  Neoplasms        phecode_139-61 \n",
       "317  ID               phecode_056    \n",
       "318  Neuro            phecode_329-9  \n",
       "319  Derm             phecode_664-1  \n",
       "320  Derm             phecode_660-11 \n",
       "321  Musc/Skel        phecode_719-7  \n",
       "322  Neuro            phecode_324-34 \n",
       "323  Musc/Skel        phecode_719    \n",
       "324  Musc/Skel        phecode_713-2  \n",
       "325  Cardio           phecode_402    \n",
       "326  GI               phecode_545    \n",
       "327  Musc/Skel        phecode_706    \n",
       "328  Neuro            phecode_349-13 \n",
       "329  Cardio           phecode_417-2  \n",
       "330  Derm             phecode_679-3  \n",
       "331  GI               phecode_555    \n",
       "332  Neuro            phecode_349-1  \n",
       "333  Signs/Symptoms   phecode_826    \n",
       "334  Musc/Skel        phecode_718-4  \n",
       "335  ID               phecode_003    \n",
       "336  Endo             phecode_204-1  \n",
       "337  Eye              phecode_375-6  \n",
       "338  GI               phecode_516    \n",
       "339  Neuro            phecode_348    \n",
       "340  Blood            phecode_179    \n",
       "341  Eye              phecode_360-12 \n",
       "342  Neoplasms        phecode_148-16 \n",
       "343  Resp             phecode_480    \n",
       "344  ID               phecode_002    \n",
       "345  Cardio           phecode_401    \n",
       "346  Cardio           phecode_401-1  \n",
       "347  Resp             phecode_488    \n",
       "348  Resp             phecode_460-2  \n",
       "349  Musc/Skel        phecode_718    \n",
       "350  Eye              phecode_386    \n",
       "351  Neoplasms        phecode_138    \n",
       "352  Derm             phecode_684    \n",
       "353  Neuro            phecode_325-2  \n",
       "354  Neuro            phecode_336    \n",
       "355  Resp             phecode_486-5  \n",
       "356  Resp             phecode_496    \n",
       "357  GI               phecode_524-1  \n",
       "358  Metab            phecode_256-5  \n",
       "359  Resp             phecode_464-1  \n",
       "360  Resp             phecode_464    \n",
       "361  ID               phecode_012    \n",
       "362  Hearing          phecode_391-11 \n",
       "363  Derm             phecode_679-22 \n",
       "364  GI               phecode_515    \n",
       "365  Resp             phecode_468    \n",
       "366  Derm             phecode_679-4  \n",
       "367  Cardio           phecode_448    \n",
       "368  Signs/Symptoms   phecode_841-4  \n",
       "369  Resp             phecode_468-9  \n",
       "370  Eye              phecode_361    \n",
       "371  Derm             phecode_685    \n",
       "372  Neuro            phecode_355    \n",
       "373  Musc/Skel        phecode_716-2  \n",
       "374  Derm             phecode_688    \n",
       "375  Neoplasms        phecode_138-1  \n",
       "376  GI               phecode_556-3  \n",
       "377  Musc/Skel        phecode_724    \n",
       "378  Signs/Symptoms   phecode_840    \n",
       "379  Neoplasms        phecode_138-2  \n",
       "380  Blood            phecode_177    \n",
       "381  Derm             phecode_668-2  \n",
       "382  Musc/Skel        phecode_716    \n",
       "383  Derm             phecode_680    \n",
       "384  Derm             phecode_674    \n",
       "385  Endo             phecode_209    \n",
       "386  ID               phecode_007-1  \n",
       "387  GI               phecode_559    \n",
       "388  GI               phecode_517    \n",
       "389  GI               phecode_537    \n",
       "390  Neuro            phecode_327    \n",
       "391  Musc/Skel        phecode_711-1  \n",
       "392  Resp             phecode_460    \n",
       "393  ID               phecode_089-3  \n",
       "394  Musc/Skel        phecode_722-1  \n",
       "395  Cardio           phecode_425    \n",
       "396  Resp             phecode_479    \n",
       "397  Musc/Skel        phecode_718-1  \n",
       "398  GI               phecode_558    \n",
       "399  Resp             phecode_491    \n",
       "400  Musc/Skel        phecode_724-5  \n",
       "401  GI               phecode_520-13 \n",
       "402  Musc/Skel        phecode_711    \n",
       "403  Signs/Symptoms   phecode_841-3  \n",
       "404  Neuro            phecode_324-3  \n",
       "405  Neuro            phecode_344-1  \n",
       "406  Mental           phecode_308-7  \n",
       "407  Neuro            phecode_348-2  \n",
       "408  ID               phecode_015    \n",
       "409  GI               phecode_554-11 \n",
       "410  Neoplasms        phecode_149    \n",
       "411  GI               phecode_554-1  \n",
       "412  Neoplasms        phecode_100    \n",
       "413  ID               phecode_084    \n",
       "414  Resp             phecode_488-1  \n",
       "415  Signs/Symptoms   phecode_801    \n",
       "416  Eye              phecode_389    \n",
       "417  Signs/Symptoms   phecode_807    \n",
       "418  Neuro            phecode_325    \n",
       "419  Metab            phecode_256-7  \n",
       "420  Eye              phecode_360-11 \n",
       "421  Blood            phecode_169-11 \n",
       "422  Neuro            phecode_353-1  \n",
       "423  Derm             phecode_673    \n",
       "424  Musc/Skel        phecode_707    \n",
       "425  Metab            phecode_256    \n",
       "426  Derm             phecode_681    \n",
       "427  Musc/Skel        phecode_718-2  \n",
       "428  Signs/Symptoms   phecode_812    \n",
       "429  Musc/Skel        phecode_718-5  \n",
       "430  GI               phecode_526    \n",
       "431  Neuro            phecode_350-5  \n",
       "432  Eye              phecode_360-1  \n",
       "433  GI               phecode_524    \n",
       "434  Derm             phecode_682-1  \n",
       "435  Neoplasms        phecode_139    \n",
       "436  GI               phecode_526-2  \n",
       "437  Hearing          phecode_391-7  \n",
       "438  Resp             phecode_495-1  \n",
       "439  ID               phecode_095    \n",
       "440  Resp             phecode_484    \n",
       "441  ID               phecode_004    \n",
       "442  GI               phecode_554    \n",
       "443  Neoplasms        phecode_139-6  \n",
       "444  Musc/Skel        phecode_709-22 \n",
       "445  Neoplasms        phecode_103-1  \n",
       "446  Genitourinary    phecode_584    \n",
       "447  Neoplasms        phecode_103    \n",
       "448  Derm             phecode_673-1  \n",
       "449  Derm             phecode_660    \n",
       "450  Death            OMOP_4306655   \n",
       "451  Cardio           phecode_424    \n",
       "452  Cardio           phecode_424-1  \n",
       "453  Resp             phecode_463    \n",
       "454  Metab            phecode_234    \n",
       "455  Blood            phecode_181    \n",
       "456  Neuro            phecode_336-5  \n",
       "457  GI               phecode_509-3  \n",
       "458  Eye              phecode_366-4  \n",
       "459  Blood            phecode_162    \n",
       "460  GI               phecode_526-12 \n",
       "461  Cardio           phecode_452    \n",
       "462  Signs/Symptoms   phecode_840-1  \n",
       "463  GI               phecode_513-1  \n",
       "464  Derm             phecode_682-11 \n",
       "465  Genitourinary    phecode_585-1  \n",
       "466  Neoplasms        phecode_103-21 \n",
       "467  Neoplasms        phecode_103-2  \n",
       "468  Genitourinary    phecode_605    \n",
       "469  Resp             phecode_460-1  \n",
       "470  Signs/Symptoms   phecode_809-3  \n",
       "471  Signs/Symptoms   phecode_809    \n",
       "472  Genitourinary    phecode_605-1  \n",
       "473  GI               phecode_522-9  \n",
       "474  Neuro            phecode_331-8  \n",
       "475  Signs/Symptoms   phecode_823-2  \n",
       "476  Cardio           phecode_433    \n",
       "477  Signs/Symptoms   phecode_823    \n",
       "478  Musc/Skel        phecode_716-3  \n",
       "479  Musc/Skel        phecode_724-1  \n",
       "480  ID               phecode_015-2  \n",
       "481  GI               phecode_557-1  \n",
       "482  Eye              phecode_361-1  \n",
       "483  Resp             phecode_468-8  \n",
       "484  Cardio           phecode_437    \n",
       "485  Blood            phecode_168    \n",
       "486  Eye              phecode_360-2  \n",
       "487  Musc/Skel        phecode_705-1  \n",
       "488  Metab            phecode_239-11 \n",
       "489  Metab            phecode_239-1  \n",
       "490  Derm             phecode_660-1  \n",
       "491  Signs/Symptoms   phecode_830    \n",
       "492  Metab            phecode_239    \n",
       "493  ID               phecode_070    \n",
       "494  GI               phecode_522    \n",
       "495  Musc/Skel        phecode_715-4  \n",
       "496  Resp             phecode_473    \n",
       "497  Resp             phecode_469-1  \n",
       "498  Eye              phecode_375-12 \n",
       "499  Musc/Skel        phecode_713-4  \n",
       "500  Cardio           phecode_440-2  \n",
       "501  Musc/Skel        phecode_726-2  \n",
       "502  Cardio           phecode_424-2  \n",
       "503  GI               phecode_526-1  \n",
       "504  Signs/Symptoms   phecode_800-1  \n",
       "505  GI               phecode_513    \n",
       "506  Cardio           phecode_443    \n",
       "507  Musc/Skel        phecode_713-3  \n",
       "508  Musc/Skel        phecode_713    \n",
       "509  Cardio           phecode_403    \n",
       "510  ID               phecode_089    \n",
       "511  Musc/Skel        phecode_703-1  \n",
       "512  Resp             phecode_483    \n",
       "513  ID               phecode_092-2  \n",
       "514  Cardio           phecode_404-1  \n",
       "515  Musc/Skel        phecode_721-1  \n",
       "516  Cardio           phecode_431-11 \n",
       "517  Signs/Symptoms   phecode_802    \n",
       "518  Cardio           phecode_439    \n",
       "519  Cardio           phecode_424-3  \n",
       "520  GI               phecode_554-2  \n",
       "521  Signs/Symptoms   phecode_807-11 \n",
       "522  Cardio           phecode_411    \n",
       "523  Metab            phecode_230-3  \n",
       "524  Metab            phecode_247-5  \n",
       "525  Hearing          phecode_397    \n",
       "526  Signs/Symptoms   phecode_827    \n",
       "527  Cardio           phecode_426    \n",
       "528  Cardio           phecode_431-1  \n",
       "529  ID               phecode_092    \n",
       "530  Mental           phecode_286-2  \n",
       "531  Musc/Skel        phecode_722-4  \n",
       "532  Derm             phecode_668    \n",
       "533  Musc/Skel        phecode_703-11 \n",
       "534  GI               phecode_550    \n",
       "535  Signs/Symptoms   phecode_841-11 \n",
       "536  Musc/Skel        phecode_732    \n",
       "537  Signs/Symptoms   phecode_840-2  \n",
       "538  Hearing          phecode_391    \n",
       "539  Neuro            phecode_330-11 \n",
       "540  Eye              phecode_383    \n",
       "541  Neoplasms        phecode_116-5  \n",
       "542  GI               phecode_522-7  \n",
       "543  Blood            phecode_174    \n",
       "544  Cardio           phecode_413-32 \n",
       "545  Cardio           phecode_431-12 \n",
       "546  Mental           phecode_288-2  \n",
       "547  Cardio           phecode_420    \n",
       "548  Genitourinary    phecode_603-2  \n",
       "549  Musc/Skel        phecode_724-52 \n",
       "550  Derm             phecode_668-1  \n",
       "551  GI               phecode_508    \n",
       "552  Signs/Symptoms   phecode_800-11 \n",
       "553  Derm             phecode_668-3  \n",
       "554  GI               phecode_532    \n",
       "555  Resp             phecode_471    \n",
       "556  GI               phecode_557-8  \n",
       "557  Signs/Symptoms   phecode_827-1  \n",
       "558  Neoplasms        phecode_116-6  \n",
       "559  GI               phecode_550-1  \n",
       "560  Derm             phecode_678    \n",
       "561  Mental           phecode_286    \n",
       "562  Derm             phecode_660-12 \n",
       "563  GI               phecode_529-5  \n",
       "564  Neoplasms        phecode_136-4  \n",
       "565  GI               phecode_527    \n",
       "566  Signs/Symptoms   phecode_841    \n",
       "567  Neuro            phecode_350    \n",
       "568  Cardio           phecode_436    \n",
       "569  Eye              phecode_367    \n",
       "570  Neoplasms        phecode_103-3  \n",
       "571  GI               phecode_529-2  \n",
       "572  Metab            phecode_230    \n",
       "573  Cardio           phecode_404-2  \n",
       "574  Resp             phecode_465    \n",
       "575  Neoplasms        phecode_144-3  \n",
       "576  Resp             phecode_472    \n",
       "577  Derm             phecode_688-3  \n",
       "578  Genitourinary    phecode_613-7  \n",
       "579  Resp             phecode_477    \n",
       "580  Neuro            phecode_330    \n",
       "581  Signs/Symptoms   phecode_815    \n",
       "582  Cardio           phecode_414    \n",
       "583  Musc/Skel        phecode_718-3  \n",
       "584  Blood            phecode_170    \n",
       "585  Musc/Skel        phecode_723-2  \n",
       "586  Neoplasms        phecode_103-22 \n",
       "587  Hearing          phecode_391-1  \n",
       "588  Cardio           phecode_413-21 \n",
       "589  Mental           phecode_308    \n",
       "590  Metab            phecode_256-2  \n",
       "591  Cardio           phecode_431    \n",
       "592  Mental           phecode_294    \n",
       "593  Derm             phecode_679    \n",
       "594  Cardio           phecode_404    \n",
       "595  Musc/Skel        phecode_703    \n",
       "596  Neoplasms        phecode_136-41 \n",
       "597  Eye              phecode_363    \n",
       "598  Signs/Symptoms   phecode_819    \n",
       "599  Signs/Symptoms   phecode_829    \n",
       "600  Derm             phecode_675    \n",
       "601  Derm             phecode_675-1  \n",
       "602  Resp             phecode_465-1  \n",
       "603  Eye              phecode_363-2  \n",
       "604  Mental           phecode_280-8  \n",
       "605  Neoplasms        phecode_101-6  \n",
       "606  Cardio           phecode_406-1  \n",
       "607  Neuro            phecode_324-8  \n",
       "608  Endo             phecode_200-22 \n",
       "609  GI               phecode_550-4  \n",
       "610  Hearing          phecode_390-6  \n",
       "611  Neuro            phecode_349    \n",
       "612  Cardio           phecode_423    \n",
       "613  Blood            phecode_170-1  \n",
       "614  Hearing          phecode_397-1  \n",
       "615  GI               phecode_557-2  \n",
       "616  Blood            phecode_169    \n",
       "617  Derm             phecode_674-2  \n",
       "618  Musc/Skel        phecode_720    \n",
       "619  GI               phecode_514-2  \n",
       "620  GI               phecode_529-3  \n",
       "621  GI               phecode_530    \n",
       "622  GI               phecode_512    \n",
       "623  Hearing          phecode_398    \n",
       "624  Cardio           phecode_419    \n",
       "625  Cardio           phecode_444-5  \n",
       "626  Cardio           phecode_446    \n",
       "627  GI               phecode_557    \n",
       "628  Neoplasms        phecode_136-42 \n",
       "629  Cardio           phecode_440    \n",
       "630  Mental           phecode_288-3  \n",
       "631  GI               phecode_528    \n",
       "632  Musc/Skel        phecode_708    \n",
       "633  Neoplasms        phecode_136    \n",
       "634  GI               phecode_523    \n",
       "635  Musc/Skel        phecode_726-1  \n",
       "636  Musc/Skel        phecode_708-1  \n",
       "637  GI               phecode_528-1  \n",
       "638  Genitourinary    phecode_583    \n",
       "639  Mental           phecode_288    \n",
       "640  Neuro            phecode_354    \n",
       "641  ID               phecode_007    \n",
       "642  ID               phecode_030    \n",
       "643  Cardio           phecode_433-1  \n",
       "644  GI               phecode_506-3  \n",
       "645  Cardio           phecode_406    \n",
       "646  Cardio           phecode_447    \n",
       "647  Musc/Skel        phecode_715-3  \n",
       "648  Neoplasms        phecode_116-2  \n",
       "649  Genitourinary    phecode_597-1  \n",
       "650  Resp             phecode_479-6  \n",
       "651  Blood            phecode_169-1  \n",
       "652  Genitourinary    phecode_586    \n",
       "653  Cardio           phecode_423-1  \n",
       "654  Derm             phecode_682-12 \n",
       "655  Cardio           phecode_446-2  \n",
       "656  Cardio           phecode_440-13 \n",
       "657  GI               phecode_507    \n",
       "658  Genitourinary    phecode_627-1  \n",
       "659  Musc/Skel        phecode_708-7  \n",
       "660  Metab            phecode_230-2  \n",
       "661  Metab            phecode_230-21 \n",
       "662  Neuro            phecode_329    \n",
       "663  GI               phecode_528-2  \n",
       "664  Resp             phecode_465-2  \n",
       "665  Cardio           phecode_417-1  \n",
       "666  Musc/Skel        phecode_715    \n",
       "667  ID               phecode_089-2  \n",
       "668  Musc/Skel        phecode_723    \n",
       "669  Musc/Skel        phecode_727    \n",
       "670  Cardio           phecode_416-21 \n",
       "671  GI               phecode_523-2  \n",
       "672  Neuro            phecode_331    \n",
       "673  Musc/Skel        phecode_726    \n",
       "674  Signs/Symptoms   phecode_835    \n",
       "675  Neuro            phecode_330-3  \n",
       "676  Derm             phecode_667    \n",
       "677  Musc/Skel        phecode_703-2  \n",
       "678  Musc/Skel        phecode_700    \n",
       "679  Resp             phecode_478    \n",
       "680  Musc/Skel        phecode_734-9  \n",
       "681  Resp             phecode_481    \n",
       "682  Musc/Skel        phecode_708-14 \n",
       "683  Genitourinary    phecode_581    \n",
       "684  Eye              phecode_367-13 \n",
       "685  Musc/Skel        phecode_708-16 \n",
       "686  GI               phecode_507-1  \n",
       "687  GI               phecode_514    \n",
       "688  Cardio           phecode_438    \n",
       "689  Musc/Skel        phecode_708-13 \n",
       "690  Cardio           phecode_404-11 \n",
       "691  GI               phecode_556-8  \n",
       "692  Hearing          phecode_392    \n",
       "693  GI               phecode_556    \n",
       "694  Musc/Skel        phecode_715-1  \n",
       "695  Signs/Symptoms   phecode_841-1  \n",
       "696  Cardio           phecode_416-2  \n",
       "697  Eye              phecode_367-1  \n",
       "698  Rx               phecode_969    \n",
       "699  Genitourinary    phecode_619-4  \n",
       "700  Genitourinary    phecode_627    \n",
       "701  Hearing          phecode_396    \n",
       "702  Hearing          phecode_390    \n",
       "703  Hearing          phecode_390-4  \n",
       "704  Neoplasms        phecode_106-2  \n",
       "705  Signs/Symptoms   phecode_820    \n",
       "706  GI               phecode_540    \n",
       "707  Blood            phecode_176    \n",
       "708  ID               phecode_009    \n",
       "709  Hearing          phecode_391-9  \n",
       "710  Derm             phecode_676-2  \n",
       "711  Musc/Skel        phecode_707-8  \n",
       "712  Neoplasms        phecode_135    \n",
       "713  Resp             phecode_471-2  \n",
       "714  GI               phecode_546    \n",
       "715  Musc/Skel        phecode_734    \n",
       "716  Musc/Skel        phecode_710    \n",
       "717  Cardio           phecode_413-3  \n",
       "718  Neuro            phecode_331-61 \n",
       "719  Musc/Skel        phecode_714-3  \n",
       "720  Cardio           phecode_440-1  \n",
       "721  Signs/Symptoms   phecode_848-2  \n",
       "722  Endo             phecode_200-2  \n",
       "723  Cardio           phecode_438-11 \n",
       "724  Cardio           phecode_431-2  \n",
       "725  Musc/Skel        phecode_705    \n",
       "726  Genitourinary    phecode_603-6  \n",
       "727  Musc/Skel        phecode_721-5  \n",
       "728  Neuro            phecode_329-1  \n",
       "729  Resp             phecode_487    \n",
       "730  GI               phecode_511    \n",
       "731  Neoplasms        phecode_112    \n",
       "732  Rx               phecode_977-51 \n",
       "733  GI               phecode_520-11 \n",
       "734  Genitourinary    phecode_593-3  \n",
       "735  Blood            phecode_174-2  \n",
       "736  GI               phecode_520-15 \n",
       "737  GI               phecode_532-1  \n",
       "738  Neuro            phecode_342    \n",
       "739  Cardio           phecode_433-21 \n",
       "740  Derm             phecode_679-7  \n",
       "741  Cardio           phecode_433-2  \n",
       "742  Endo             phecode_200-7  \n",
       "743  Genitourinary    phecode_618-12 \n",
       "744  Hearing          phecode_396-22 \n",
       "745  Neoplasms        phecode_139-5  \n",
       "746  Genitourinary    phecode_603    \n",
       "747  Musc/Skel        phecode_717    \n",
       "748  Derm             phecode_670    \n",
       "749  GI               phecode_522-8  \n",
       "750  Eye              phecode_377    \n",
       "751  Musc/Skel        phecode_708-12 \n",
       "752  Genitourinary    phecode_614-5  \n",
       "753  Genitourinary    phecode_615    \n",
       "754  Resp             phecode_494    \n",
       "755  Cardio           phecode_416-211\n",
       "756  Genitourinary    phecode_614-55 \n",
       "757  Neuro            phecode_331-1  \n",
       "758  Genitourinary    phecode_614    \n",
       "759  Musc/Skel        phecode_709-24 \n",
       "760  Neoplasms        phecode_146-2  \n",
       "761  Cardio           phecode_438-1  \n",
       "762  GI               phecode_529-1  \n",
       "763  Musc/Skel        phecode_708-11 \n",
       "764  Cardio           phecode_418    \n",
       "765  Genitourinary    phecode_594-2  \n",
       "766  Neoplasms        phecode_144-21 \n",
       "767  Neoplasms        phecode_144    \n",
       "768  Derm             phecode_679-1  \n",
       "769  Rx               phecode_977-52 \n",
       "770  GI               phecode_520-2  \n",
       "771  Genitourinary    phecode_626-14 \n",
       "772  Musc/Skel        phecode_721    \n",
       "773  GI               phecode_529    \n",
       "774  Cardio           phecode_416    \n",
       "775  Genitourinary    phecode_619    \n",
       "776  Neoplasms        phecode_146    \n",
       "777  Neoplasms        phecode_142    \n",
       "778  Genitourinary    phecode_626-13 \n",
       "779  Genitourinary    phecode_626-1  \n",
       "780  Genitourinary    phecode_627-4  \n",
       "781  Musc/Skel        phecode_723-4  \n",
       "782  Genitourinary    phecode_600    \n",
       "783  Genitourinary    phecode_594-41 \n",
       "784  Genitourinary    phecode_627-2  \n",
       "785  GI               phecode_520    \n",
       "786  GI               phecode_520-1  \n",
       "787  Mental           phecode_290    \n",
       "788  Neuro            phecode_331-6  \n",
       "789  Rx               phecode_977-5  \n",
       "790  Signs/Symptoms   phecode_832    \n",
       "791  Stat             phecode_979    \n",
       "792  Musc/Skel        phecode_701    \n",
       "793  GI               phecode_514-3  \n",
       "794  Musc/Skel        phecode_701-1  \n",
       "795  Genitourinary    phecode_583-1  \n",
       "796  GI               phecode_500    \n",
       "797  GI               phecode_500-4  \n",
       "798  Neoplasms        phecode_122-22 \n",
       "799  Endo             phecode_200-4  \n",
       "800  Cardio           phecode_413-42 \n",
       "801  Neuro            phecode_323    \n",
       "802  Endo             phecode_200-21 \n",
       "803  Endo             phecode_200-31 \n",
       "804  Signs/Symptoms   phecode_841-5  \n",
       "805  GI               phecode_500-41 \n",
       "806  Neuro            phecode_331-3  \n",
       "807  Genitourinary    phecode_581-33 \n",
       "808  Derm             phecode_664-2  \n",
       "809  GI               phecode_514-21 \n",
       "810  Cardio           phecode_413-4  \n",
       "811  Eye              phecode_381-1  \n",
       "812  Musc/Skel        phecode_712-5  \n",
       "813  Musc/Skel        phecode_710-31 \n",
       "814  Resp             phecode_486-21 \n",
       "815  Neuro            phecode_329-42 \n",
       "816  Genitourinary    phecode_624-2  \n",
       "817  Neuro            phecode_349-2  \n",
       "818  Neuro            phecode_356-2  \n",
       "819  Neoplasms        phecode_124    \n",
       "820  Neoplasms        phecode_124-5  \n",
       "821  Hearing          phecode_394-4  \n",
       "822  Neuro            phecode_329-6  \n",
       "823  Neuro            phecode_355-1  \n",
       "824  Cardio           phecode_416-12 \n",
       "825  Metab            phecode_230-22 \n",
       "826  GI               phecode_532-4  \n",
       "827  Metab            phecode_247-3  \n",
       "828  Derm             phecode_672    \n",
       "829  Blood            phecode_172    \n",
       "830  Cardio           phecode_438-12 \n",
       "831  Metab            phecode_247-52 \n",
       "832  Blood            phecode_179-9  \n",
       "833  Resp             phecode_475-5  \n",
       "834  GI               phecode_504-32 \n",
       "835  Hearing          phecode_398-1  \n",
       "836  GI               phecode_530-3  \n",
       "837  Musc/Skel        phecode_721-4  \n",
       "838  Genitourinary    phecode_621    \n",
       "839  GI               phecode_552-2  \n",
       "840  Neoplasms        phecode_121-2  \n",
       "841  Neoplasms        phecode_123-1  \n",
       "842  Neoplasms        phecode_121    \n",
       "843  Derm             phecode_664-21 \n",
       "844  Blood            phecode_171-1  \n",
       "845  GI               phecode_522-11 \n",
       "846  GI               phecode_510-5  \n",
       "847  Neoplasms        phecode_123    \n",
       "848  Derm             phecode_685-4  \n",
       "849  GI               phecode_509-11 \n",
       "850  Eye              phecode_367-21 \n",
       "851  Neoplasms        phecode_120-1  \n",
       "852  Genitourinary    phecode_601-12 \n",
       "853  Neoplasms        phecode_101-8  \n",
       "854  Neuro            phecode_329-4  \n",
       "855  Resp             phecode_466-4  \n",
       "856  Neoplasms        phecode_148-2  \n",
       "857  Neoplasms        phecode_121-21 \n",
       "858  Cardio           phecode_416-71 \n",
       "859  Cardio           phecode_416-7  \n",
       "860  Blood            phecode_168-4  \n",
       "861  Neoplasms        phecode_139-54 \n",
       "862  Derm             phecode_668-4  \n",
       "863  Cardio           phecode_430-3  \n",
       "864  Eye              phecode_374-39 \n",
       "865  Neoplasms        phecode_144-13 \n",
       "866  GI               phecode_509-1  \n",
       "867  Genitourinary    phecode_613-1  \n",
       "868  GI               phecode_530-1  \n",
       "869  Neoplasms        phecode_120    \n",
       "870  Cardio           phecode_414-2  \n",
       "871  Genitourinary    phecode_604-1  \n",
       "872  Blood            phecode_171    \n",
       "873  Hearing          phecode_391-21 \n",
       "874  Neoplasms        phecode_101-2  \n",
       "875  Genitourinary    phecode_622-2  \n",
       "876  Cardio           phecode_413-6  \n",
       "877  Neoplasms        phecode_120-21 \n",
       "878  Endo             phecode_200-13 \n",
       "879  Mental           phecode_308-3  \n",
       "880  Derm             phecode_685-1  \n",
       "881  Neoplasms        phecode_122-2  \n",
       "882  Musc/Skel        phecode_704-5  \n",
       "883  Endo             phecode_208-21 \n",
       "884  Hearing          phecode_394-1  \n",
       "885  Neoplasms        phecode_120-2  \n",
       "886  Musc/Skel        phecode_728-1  \n",
       "887  Neoplasms        phecode_109    \n",
       "888  Genitourinary    phecode_604-3  \n",
       "889  Hearing          phecode_394-22 \n",
       "890  Genitourinary    phecode_614-1  \n",
       "891  Resp             phecode_471-3  \n",
       "892  Neoplasms        phecode_101-1  \n",
       "893  Neoplasms        phecode_122    \n",
       "894  Musc/Skel        phecode_700-2  \n",
       "895  Eye              phecode_381    \n",
       "896  Mental           phecode_284-1  \n",
       "897  Musc/Skel        phecode_704    \n",
       "898  Genitourinary    phecode_604    \n",
       "899  Genitourinary    phecode_601-1  \n",
       "900  GI               phecode_520-12 \n",
       "901  Genitourinary    phecode_580-3  \n",
       "902  Neoplasms        phecode_106-21 \n",
       "903  Eye              phecode_389-1  \n",
       "904  Resp             phecode_481-4  \n",
       "905  GI               phecode_522-14 \n",
       "906  Eye              phecode_379-2  \n",
       "907  Musc/Skel        phecode_702    \n",
       "908  Genitourinary    phecode_624    \n",
       "909  Neoplasms        phecode_144-1  \n",
       "910  Cardio           phecode_410-2  \n",
       "911  Neoplasms        phecode_116-3  \n",
       "912  Musc/Skel        phecode_710-32 \n",
       "913  Genitourinary    phecode_622-1  \n",
       "914  Genitourinary    phecode_619-5  \n",
       "915  Cardio           phecode_416-43 \n",
       "916  Signs/Symptoms   phecode_803    \n",
       "917  Neuro            phecode_352-3  \n",
       "918  Cardio           phecode_413-12 \n",
       "919  Mental           phecode_308-1  \n",
       "920  Eye              phecode_386-9  \n",
       "921  Musc/Skel        phecode_710-41 \n",
       "922  GI               phecode_518    \n",
       "923  GI               phecode_513-3  \n",
       "924  Neoplasms        phecode_139-53 \n",
       "925  Neuro            phecode_325-23 \n",
       "926  Blood            phecode_180-3  \n",
       "927  Genitourinary    phecode_581-3  \n",
       "928  Eye              phecode_386-2  \n",
       "929  Genitourinary    phecode_601    \n",
       "930  Genitourinary    phecode_597-5  \n",
       "931  Endo             phecode_209-1  \n",
       "932  Genitourinary    phecode_601-11 \n",
       "933  Signs/Symptoms   phecode_814    \n",
       "934  Neoplasms        phecode_108-41 \n",
       "935  GI               phecode_525    \n",
       "936  Eye              phecode_361-9  \n",
       "937  Neuro            phecode_334-1  \n",
       "938  Cardio           phecode_410    \n",
       "939  Cardio           phecode_413-22 \n",
       "940  GI               phecode_522-1  \n",
       "941  Cardio           phecode_416-1  \n",
       "942  Neuro            phecode_328-9  \n",
       "943  Neuro            phecode_324-1  \n",
       "944  Neoplasms        phecode_105-1  \n",
       "945  Cardio           phecode_444-15 \n",
       "946  Resp             phecode_463-4  \n",
       "947  Endo             phecode_200-23 \n",
       "948  Genitourinary    phecode_596-2  \n",
       "949  Resp             phecode_488-8  \n",
       "950  Cardio           phecode_416-51 \n",
       "951  GI               phecode_523-1  \n",
       "952  Neoplasms        phecode_108-4  \n",
       "953  Mental           phecode_286-21 \n",
       "954  Eye              phecode_363-7  \n",
       "955  Neuro            phecode_325-3  \n",
       "956  Genitourinary    phecode_603-1  \n",
       "957  Genitourinary    phecode_581-31 \n",
       "958  Neoplasms        phecode_101-42 \n",
       "959  Cardio           phecode_416-11 \n",
       "960  Neuro            phecode_324-4  \n",
       "961  Neuro            phecode_324-11 \n",
       "962  Hearing          phecode_396-21 \n",
       "963  Mental           phecode_308-6  \n",
       "964  Genitourinary    phecode_580    \n",
       "965  Hearing          phecode_391-12 \n",
       "966  Blood            phecode_180-31 \n",
       "967  Neoplasms        phecode_106    \n",
       "968  Neuro            phecode_329-41 \n",
       "969  Genitourinary    phecode_593-2  \n",
       "970  Genitourinary    phecode_610    \n",
       "971  Cardio           phecode_400-2  \n",
       "972  GI               phecode_510-8  \n",
       "973  Neuro            phecode_329-5  \n",
       "974  ID               phecode_088    \n",
       "975  Genitourinary    phecode_628    \n",
       "976  Derm             phecode_683    \n",
       "977  ID               phecode_099    \n",
       "978  Genitourinary    phecode_592-12 \n",
       "979  Eye              phecode_367-2  \n",
       "980  Blood            phecode_180    \n",
       "981  Signs/Symptoms   phecode_841-13 \n",
       "982  Eye              phecode_362    \n",
       "983  GI               phecode_514-1  \n",
       "984  Genitourinary    phecode_604-5  \n",
       "985  Neoplasms        phecode_116-4  \n",
       "986  Genitourinary    phecode_594-11 \n",
       "987  Musc/Skel        phecode_710-3  \n",
       "988  Neuro            phecode_353    \n",
       "989  Cardio           phecode_416-22 \n",
       "990  Musc/Skel        phecode_717-2  \n",
       "991  Musc/Skel        phecode_714    \n",
       "992  Genitourinary    phecode_622    \n",
       "993  Musc/Skel        phecode_723-5  \n",
       "994  Genitourinary    phecode_628-2  \n",
       "995  Mental           phecode_288-4  \n",
       "996  Genitourinary    phecode_594-31 \n",
       "997  Resp             phecode_487-1  \n",
       "998  Signs/Symptoms   phecode_808    \n",
       "999  Genitourinary    phecode_593-1  \n",
       "1000 GI               phecode_552-1  \n",
       "1001 Genitourinary    phecode_624-1  \n",
       "1002 Neoplasms        phecode_109-3  \n",
       "1003 ID               phecode_011    \n",
       "1004 Neoplasms        phecode_104    \n",
       "1005 Musc/Skel        phecode_708-15 \n",
       "1006 Eye              phecode_379    \n",
       "1007 Genitourinary    phecode_614-53 \n",
       "1008 Musc/Skel        phecode_708-8  \n",
       "1009 Genitourinary    phecode_623    \n",
       "1010 Mental           phecode_284    \n",
       "1011 Genitourinary    phecode_597    \n",
       "1012 Genitourinary    phecode_596-3  \n",
       "1013 Cardio           phecode_400    \n",
       "1014 Cardio           phecode_413-11 \n",
       "1015 Genitourinary    phecode_625-2  \n",
       "1016 Derm             phecode_682-4  \n",
       "1017 Neuro            phecode_324    \n",
       "1018 Resp             phecode_467    \n",
       "1019 Cardio           phecode_413-1  \n",
       "1020 GI               phecode_509    \n",
       "1021 ID               phecode_056-1  \n",
       "1022 Neoplasms        phecode_136-2  \n",
       "1023 Genitourinary    phecode_618-2  \n",
       "1024 Neoplasms        phecode_101-41 \n",
       "1025 Neuro            phecode_328-8  \n",
       "1026 Neuro            phecode_328    \n",
       "1027 Resp             phecode_467-1  \n",
       "1028 Genitourinary    phecode_594-3  \n",
       "1029 Hearing          phecode_395-1  \n",
       "1030 Endo             phecode_215    \n",
       "1031 Eye              phecode_362-5  \n",
       "1032 Endo             phecode_208-2  \n",
       "1033 Genitourinary    phecode_619-2  \n",
       "1034 Neuro            phecode_328-7  \n",
       "1035 Endo             phecode_208    \n",
       "1036 GI               phecode_520-14 \n",
       "1037 Genitourinary    phecode_610-1  \n",
       "1038 GI               phecode_506-5  \n",
       "1039 Musc/Skel        phecode_708-9  \n",
       "1040 Derm             phecode_683-1  \n",
       "1041 Endo             phecode_200-3  \n",
       "1042 GI               phecode_523-4  \n",
       "1043 Neoplasms        phecode_108-5  \n",
       "1044 Musc/Skel        phecode_721-6  \n",
       "1045 Resp             phecode_463-5  \n",
       "1046 Genitourinary    phecode_626-2  \n",
       "1047 Cardio           phecode_416-41 \n",
       "1048 Resp             phecode_463-1  \n",
       "1049 Derm             phecode_682    \n",
       "1050 Genitourinary    phecode_618-1  \n",
       "1051 Cardio           phecode_416-4  \n",
       "1052 Genitourinary    phecode_594-6  \n",
       "1053 Cardio           phecode_417-3  \n",
       "1054 Hearing          phecode_395    \n",
       "1055 Eye              phecode_377-2  \n",
       "1056 GI               phecode_504-3  \n",
       "1057 Neuro            phecode_346    \n",
       "1058 Neoplasms        phecode_106-3  \n",
       "1059 Mental           phecode_290-1  \n",
       "1060 Neuro            phecode_342-4  \n",
       "1061 Cardio           phecode_430-2  \n",
       "1062 Musc/Skel        phecode_724-3  \n",
       "1063 Blood            phecode_177-4  \n",
       "1064 Cardio           phecode_440-11 \n",
       "1065 Eye              phecode_363-5  \n",
       "1066 Neuro            phecode_334    \n",
       "1067 Musc/Skel        phecode_712    \n",
       "1068 Cardio           phecode_440-3  \n",
       "1069 Genitourinary    phecode_586-2  \n",
       "1070 Cardio           phecode_448-1  \n",
       "1071 Musc/Skel        phecode_723-3  \n",
       "1072 Signs/Symptoms   phecode_841-12 \n",
       "1073 Cardio           phecode_416-5  \n",
       "1074 Genitourinary    phecode_592-11 \n",
       "1075 Neoplasms        phecode_101    \n",
       "1076 Neoplasms        phecode_101-4  \n",
       "1077 Neoplasms        phecode_140    \n",
       "1078 Cardio           phecode_413    \n",
       "1079 Neuro            phecode_328-1  \n",
       "1080 Signs/Symptoms   phecode_832-6  \n",
       "1081 Genitourinary    phecode_613-5  \n",
       "1082 Genitourinary    phecode_596    \n",
       "1083 Genitourinary    phecode_591    \n",
       "1084 Genitourinary    phecode_602    \n",
       "1085 Genitourinary    phecode_613    \n",
       "1086 Genitourinary    phecode_618    \n",
       "1087 Eye              phecode_360    \n",
       "1088 Neoplasms        phecode_105    \n",
       "1089 Eye              phecode_360-4  \n",
       "1090 Hearing          phecode_394-21 \n",
       "1091 Genitourinary    phecode_592    \n",
       "1092 Genitourinary    phecode_592-1  \n",
       "1093 Resp             phecode_462-1  \n",
       "1094 Mental           phecode_308-5  \n",
       "1095 Cardio           phecode_430-1  \n",
       "1096 Signs/Symptoms   phecode_817    \n",
       "1097 Genitourinary    phecode_603-5  \n",
       "1098 Neuro            phecode_356    \n",
       "1099 Cardio           phecode_430    \n",
       "1100 Neuro            phecode_324-41 \n",
       "1101 GI               phecode_552    \n",
       "1102 Cardio           phecode_416-52 \n",
       "1103 Genitourinary    phecode_614-52 \n",
       "1104 Genitourinary    phecode_625-1  \n",
       "1105 Cardio           phecode_416-42 \n",
       "1106 ID               phecode_052-1  \n",
       "1107 Musc/Skel        phecode_723-51 \n",
       "1108 Musc/Skel        phecode_721-11 \n",
       "1109 Musc/Skel        phecode_728    \n",
       "1110 Neoplasms        phecode_116    \n",
       "1111 Genitourinary    phecode_619-3  \n",
       "1112 Musc/Skel        phecode_721-2  \n",
       "1113 Neoplasms        phecode_132    \n",
       "1114 Cardio           phecode_444-1  \n",
       "1115 Genitourinary    phecode_602-4  \n",
       "1116 Cardio           phecode_418-1  \n",
       "1117 Genitourinary    phecode_618-11 \n",
       "1118 Genitourinary    phecode_625    \n",
       "1119 Genitourinary    phecode_596-1  \n",
       "1120 Cardio           phecode_417    \n",
       "1121 Hearing          phecode_394    \n",
       "1122 ID               phecode_052    \n",
       "1123 Cardio           phecode_444    \n",
       "1124 Cardio           phecode_444-11 \n",
       "1125 Endo             phecode_200-1  \n",
       "1126 Resp             phecode_462    \n",
       "1127 Endo             phecode_200    \n",
       "1128 Genitourinary    phecode_593    \n",
       "1129 ID               phecode_052-32 \n",
       "1130 Genitourinary    phecode_594    \n",
       "1131 Genitourinary    phecode_594-1  \n",
       "1132 Hearing          phecode_394-2  \n",
       "1133 Genitourinary    phecode_599    \n",
       "1134 Musc/Skel        phecode_709-21 \n",
       "1135 Mental           phecode_280-82 \n",
       "1136 Eye              phecode_379-21 \n",
       "1137 Cardio           phecode_416-212\n",
       "1138 Neuro            phecode_334-11 \n",
       "1139 Derm             phecode_660-13 \n",
       "1140 Neoplasms        phecode_148    \n",
       "1141 Neoplasms        phecode_116-1  \n",
       "1142 Genitourinary    phecode_620    \n",
       "1143 Musc/Skel        phecode_728-3  \n",
       "1144 Neoplasms        phecode_108    \n",
       "1145 Genitourinary    phecode_594-32 \n",
       "1146 GI               phecode_506    \n",
       "1147 Resp             phecode_476    \n",
       "1148 Cardio           phecode_413-2  \n",
       "1149 GI               phecode_510-2  \n",
       "1150 Signs/Symptoms   phecode_848    \n",
       "1151 Musc/Skel        phecode_705-3  \n",
       "1152 Cardio           phecode_401-6  \n",
       "1153 GI               phecode_510    \n",
       "1154 Hearing          phecode_396-2  \n",
       "1155 ID               phecode_052-3  \n",
       "1156 Neoplasms        phecode_144-2  \n",
       "1157 Endo             phecode_200-14 \n",
       "1158 Genitourinary    phecode_626-11 \n",
       "1159 Musc/Skel        phecode_709    \n",
       "1160 Neoplasms        phecode_107    \n",
       "1161 Neoplasms        phecode_107-2  \n",
       "1162 Signs/Symptoms   phecode_807-1  \n",
       "1163 Genitourinary    phecode_608    \n",
       "1164 Genitourinary    phecode_594-4  \n",
       "1165 Musc/Skel        phecode_709-2  \n",
       "1166 Genitourinary    phecode_626    \n",
       "1167 Genitourinary    phecode_608-1  \n",
       "1168 Resp             phecode_466    \n",
       "1169 Neoplasms        phecode_130    \n",
       "1170 Resp             phecode_466-1  \n",
       "1171 Neoplasms        phecode_142-1  \n",
       "     phecode_string                                                                                          \n",
       "1    Hemoglobinopathies                                                                                      \n",
       "2    Myopia                                                                                                  \n",
       "3    Sarcoidosis                                                                                             \n",
       "4    Other psoriasis                                                                                         \n",
       "5    Noninflammatory disorders of choroid                                                                    \n",
       "6    Psoriatic arthropathy                                                                                   \n",
       "7    Mycobacteria                                                                                            \n",
       "8    Benign neoplasm of other connective and soft tissue                                                     \n",
       "9    Vitreous hemorrhage                                                                                     \n",
       "10   Long term (current) use of insulin                                                                      \n",
       "11   Mallet finger                                                                                           \n",
       "12   Contact or exposure to infectious agent                                                                 \n",
       "13   Helicobacter [H. pylori]                                                                                \n",
       "14   Disorders of iris and ciliary body                                                                      \n",
       "15   Hereditary corneal dystrophies                                                                          \n",
       "16   Halitosis*                                                                                              \n",
       "17   Amblyopia                                                                                               \n",
       "18   Polyneuropathy in diseases classified elsewhere                                                         \n",
       "19   Lipoma of intrathoracic organs                                                                          \n",
       "20   Malignant neoplasm of the endocrine glands                                                              \n",
       "21   Retinal edema                                                                                           \n",
       "22   Disorders of refraction and accommodation                                                               \n",
       "23   COVID-19*                                                                                               \n",
       "24   Long term (current) drug therapy                                                                        \n",
       "25   Serous retinal detachment                                                                               \n",
       "26   Hypertrophic scar [Keloid scar]                                                                         \n",
       "27   Loose body in joint                                                                                     \n",
       "28   Exuadative (wet) age-related macular degeneration                                                       \n",
       "29   Hypermetropia                                                                                           \n",
       "30   Pallor                                                                                                  \n",
       "31   Episcleritis                                                                                            \n",
       "32   Hypoglycemia                                                                                            \n",
       "33   Retinal detachments and breaks                                                                          \n",
       "34   Abnormal results of function studies of eye                                                             \n",
       "35   Gingivitis                                                                                              \n",
       "36   Morbid obesity                                                                                          \n",
       "37   Coronavirus                                                                                             \n",
       "38   Anosmia*                                                                                                \n",
       "39   Other specified diabetes*                                                                               \n",
       "40   Long term (current) use of insulin or oral hypoglycemic drugs                                           \n",
       "41   Alcohol dependence                                                                                      \n",
       "42   Retinal disorders in diseases classified elsewhere                                                      \n",
       "43   Calcaneal spur                                                                                          \n",
       "44   Hyper-coagulability                                                                                     \n",
       "45   Age-related macular degeneration                                                                        \n",
       "46   Uveitis                                                                                                 \n",
       "47   Asphyxia and hypoxemia                                                                                  \n",
       "48   Methicillin resistant Staphylococcus aureus                                                             \n",
       "49   Long term (current) use of oral hypoglycemic drugs                                                      \n",
       "50   Type 1 diabetes                                                                                         \n",
       "51   Iridocyclitis                                                                                           \n",
       "52   Pterygium of eye                                                                                        \n",
       "53   Diabetic retinopathy                                                                                    \n",
       "54   Iron deficiency                                                                                         \n",
       "55   Dental caries                                                                                           \n",
       "56   Disorders of adrenal glands                                                                             \n",
       "57   Abnormal involuntary movements                                                                          \n",
       "58   Iron deficiency anemia                                                                                  \n",
       "59   Microcytic anemia                                                                                       \n",
       "60   Noninflammatory disorders of the cornea                                                                 \n",
       "61   Hepatomegaly                                                                                            \n",
       "62   Acquired deformities of fingers                                                                         \n",
       "63   Mixed hyperlipidemia                                                                                    \n",
       "64   Obesity                                                                                                 \n",
       "65   Patient's noncompliance with medical treatment and regimen                                              \n",
       "66   Demoralization and apathy                                                                               \n",
       "67   Vitiligo                                                                                                \n",
       "68   Drug resistant microorganisms                                                                           \n",
       "69   Overweight and obesity                                                                                  \n",
       "70   Disorders of iron metabolism                                                                            \n",
       "71   Chronic liver disease and sequelae                                                                      \n",
       "72   Abnormal level of blood mineral*                                                                        \n",
       "73   Type 2 diabetes                                                                                         \n",
       "74   Fibrosis and cirrhosis of liver                                                                         \n",
       "75   Circadian rhythm sleep disorder                                                                         \n",
       "76   Diabetes mellitus                                                                                       \n",
       "77   Abnormality of red blood cells                                                                          \n",
       "78   Hypocalcemia                                                                                            \n",
       "79   Vitamin deficiencies                                                                                    \n",
       "80   Nutritional anemias                                                                                     \n",
       "81   Alcoholic liver disease                                                                                 \n",
       "82   Abscess or ulceration of vulva                                                                          \n",
       "83   Portal hypertension                                                                                     \n",
       "84   Hypopigmentation                                                                                        \n",
       "85   Benign neoplasm of the oral cavity                                                                      \n",
       "86   Substance dependence                                                                                    \n",
       "87   Nonexuadative (dry) age-related macular degeneration                                                    \n",
       "88   Psychotic disorder                                                                                      \n",
       "89   Chronic hepatitis                                                                                       \n",
       "90   Nuclear cataract                                                                                        \n",
       "91   Vitamin B group deficiency                                                                              \n",
       "92   Somatoform disorders                                                                                    \n",
       "93   Age-related nuclear cataract                                                                            \n",
       "94   Vitamin D deficiency                                                                                    \n",
       "95   Fatty liver disease (FLD)                                                                               \n",
       "96   Disorders of optic disc                                                                                 \n",
       "97   Macular degeneration                                                                                    \n",
       "98   Disorders of autonomic nervous system                                                                   \n",
       "99   Corneal scars and opacities                                                                             \n",
       "100  Pallor and flushing                                                                                     \n",
       "101  Gilbert syndrome*                                                                                       \n",
       "102  Noninfectious dermatoses of eyelid                                                                      \n",
       "103  Abnormal weight gain                                                                                    \n",
       "104  Rheumatism, unspecified                                                                                 \n",
       "105  Disorders of the retina                                                                                 \n",
       "106  Hypoesthesia of skin*                                                                                   \n",
       "107  Carrier or suspected carrier of infectious diseases                                                     \n",
       "108  Substance abuse, dependence, and withdrawl                                                              \n",
       "109  Disorders of optic nerve and visual pathways                                                            \n",
       "110  Pediculosis, acariasis and other infestations                                                           \n",
       "111  Angioneurotic edema                                                                                     \n",
       "112  Cataract                                                                                                \n",
       "113  Disorders of mineral metabolism and mineral deficiencies                                                \n",
       "114  Mixed disorder of acid-base balance                                                                     \n",
       "115  Disorders of bilirubin excretion                                                                        \n",
       "116  Other abnormalities of plasma proteins*                                                                 \n",
       "117  Polycythemias                                                                                           \n",
       "118  Neuroendocrine tumors                                                                                   \n",
       "119  Glycosuria                                                                                              \n",
       "120  Alopecia Areata                                                                                         \n",
       "121  Acute pain                                                                                              \n",
       "122  Periodontal diseases                                                                                    \n",
       "123  Wheezing                                                                                                \n",
       "124  Open angle glaucoma                                                                                     \n",
       "125  Ulcerative colitis                                                                                      \n",
       "126  Anemia                                                                                                  \n",
       "127  Puckering of macula                                                                                     \n",
       "128  Adverse effect of other drug                                                                            \n",
       "129  Peritonitis                                                                                             \n",
       "130  Neuromuscular dysfunction of bladder                                                                    \n",
       "131  Fever of unknown origin                                                                                 \n",
       "132  Neutropenia NOS                                                                                         \n",
       "133  Current tobacco use and nicotine dependence                                                             \n",
       "134  Diseases of pulp and periapical tissues                                                                 \n",
       "135  Other disorders of the circulatory system                                                               \n",
       "136  Anemia secondary to chronic diseases and conditions                                                     \n",
       "137  Idiopathic urticaria                                                                                    \n",
       "138  Hyperosmolality and/or hypernatremia                                                                    \n",
       "139  Conductive hearing loss                                                                                 \n",
       "140  Emphysema                                                                                               \n",
       "141  Bell's palsy                                                                                            \n",
       "142  Raised antibody titer*                                                                                  \n",
       "143  Astigmatism                                                                                             \n",
       "144  Disorders of magnesium metabolism                                                                       \n",
       "145  Separation of muscle (nontraumatic)                                                                     \n",
       "146  Viral hepatitits                                                                                        \n",
       "147  Hepatovirus                                                                                             \n",
       "148  Impaired glucose tolerance (oral)                                                                       \n",
       "149  Radial styloid tenosynovitis [de Quervain]                                                              \n",
       "150  Hyperkalemia [Hyperpotassemia]                                                                          \n",
       "151  Sacroiliitis NEC                                                                                        \n",
       "152  Instability of joint                                                                                    \n",
       "153  Secondary polycythemia                                                                                  \n",
       "154  Allergies related to other diseases/symptoms                                                            \n",
       "155  Postmenopausal atrophic vaginitis                                                                       \n",
       "156  Retinal vascular changes and occlusions                                                                 \n",
       "157  Stricture of artery [Arterial stenosis]                                                                 \n",
       "158  Facial nerve disorders and weakness                                                                     \n",
       "159  Mental disorder, not otherwise specified                                                                \n",
       "160  Bipolar disorder                                                                                        \n",
       "161  Chronic obstructive pulmonary disease [COPD]                                                            \n",
       "162  Sleep apnea                                                                                             \n",
       "163  Rosacea                                                                                                 \n",
       "164  Allergic rhinitis                                                                                       \n",
       "165  Non-pressure chronic ulcer                                                                              \n",
       "166  Blindness and low vision                                                                                \n",
       "167  Chronic bronchitis                                                                                      \n",
       "168  Intestinal e.coli                                                                                       \n",
       "169  Elevated blood glucose level                                                                            \n",
       "170  Periapical abscess                                                                                      \n",
       "171  Psoriasis                                                                                               \n",
       "172  Hepatic failure                                                                                         \n",
       "173  Glaucoma                                                                                                \n",
       "174  Hyperhidrosis                                                                                           \n",
       "175  Arthralgia of temporomandibular joint                                                                   \n",
       "176  Retinal vein occlusions                                                                                 \n",
       "177  Acute pyelonephritis                                                                                    \n",
       "178  Generalized hyperhidrosis                                                                               \n",
       "179  Low-tension glaucoma (Normal-tension glaucoma)                                                          \n",
       "180  Dysarthria                                                                                              \n",
       "181  Anomalies of pupillary function                                                                         \n",
       "182  Disturbances of skin sensation                                                                          \n",
       "183  Seasonal allergic rhinitis                                                                              \n",
       "184  Primary open angle glaucoma                                                                             \n",
       "185  Vitreous degeneration                                                                                   \n",
       "186  Malignant neoplasm of the of bronchus and lung                                                          \n",
       "187  Spontaneous ecchymoses                                                                                  \n",
       "188  Abnormal intraocular pressure                                                                           \n",
       "189  Alcohol abuse                                                                                           \n",
       "190  Lesion of plantar nerve                                                                                 \n",
       "191  Xerosis cutis*                                                                                          \n",
       "192  Macrocytic anemia                                                                                       \n",
       "193  Carbuncle and furuncle                                                                                  \n",
       "194  Hypertensive chronic kidney disease                                                                     \n",
       "195  Visual field defects                                                                                    \n",
       "196  Other diseases of bronchus                                                                              \n",
       "197  Paresthesia of skin*                                                                                    \n",
       "198  Papulosquamous disorders                                                                                \n",
       "199  Corns and callosities                                                                                   \n",
       "200  Other diseases of teeth and supporting structures                                                       \n",
       "201  Other disorders and symptoms of the musculoskeletal system                                              \n",
       "202  Other disorders of the brain and CNS                                                                    \n",
       "203  Enteropathic arthropathies                                                                              \n",
       "204  Chronic ulcer of skin                                                                                   \n",
       "205  Sleep disorders                                                                                         \n",
       "206  Hypertrophic conditions of skin                                                                         \n",
       "207  Nasal polyps                                                                                            \n",
       "208  Allergic [atopic] conjunctivitis                                                                        \n",
       "209  Disorders of lipoprotein metabolism and other lipidemias                                                \n",
       "210  Eczematous dermatitis of eyelid                                                                         \n",
       "211  Lesion of median, ulnar, radial nerve                                                                   \n",
       "212  Hyperglyceridemia                                                                                       \n",
       "213  Disorders of intestinal carbohydrate absorption                                                         \n",
       "214  Other behavioral problems                                                                               \n",
       "215  Fasciopathy                                                                                             \n",
       "216  Substance related disorders                                                                             \n",
       "217  Peripheral vascular disease NOS [includes PAD]                                                          \n",
       "218  Folate deficiency [Vitamin B9]                                                                          \n",
       "219  Impingement syndrome of shoulder*                                                                       \n",
       "220  Long term (current) use of inhaled steroids*                                                            \n",
       "221  Acidosis                                                                                                \n",
       "222  Vitamin B12 deficiency                                                                                  \n",
       "223  Urticaria                                                                                               \n",
       "224  Malignant neoplasm of the thoracic and respiratory organs                                               \n",
       "225  Long term (current) use of steroids                                                                     \n",
       "226  Corneal degenerations                                                                                   \n",
       "227  Pyelonephritis                                                                                          \n",
       "228  Disturbances of sensation of smell and taste                                                            \n",
       "229  Disorders of the circulation of the cerebrospinal fluid                                                 \n",
       "230  Osteonecrosis                                                                                           \n",
       "231  Spasm of muscle                                                                                         \n",
       "232  Prediabetes*                                                                                            \n",
       "233  Substance abuse                                                                                         \n",
       "234  Polyneuropathies                                                                                        \n",
       "235  Asthma                                                                                                  \n",
       "236  Enlargement of lymph nodes [Lymphadenopathy]                                                            \n",
       "237  Megaloblastic anemia                                                                                    \n",
       "238  Respiratory failure                                                                                     \n",
       "239  Bacterial pneumonia                                                                                     \n",
       "240  Cerebral palsy and other paralytic syndromes                                                            \n",
       "241  Retinal hemorrhage                                                                                      \n",
       "242  Pericardial effusion (noninflammatory)*                                                                 \n",
       "243  Polydipsia                                                                                              \n",
       "244  Suicide and self-inflicted harm                                                                         \n",
       "245  Other respiratory disorders                                                                             \n",
       "246  Chest pain                                                                                              \n",
       "247  Otitis externa                                                                                          \n",
       "248  Alcohol use disorders                                                                                   \n",
       "249  Obstructive sleep apnea                                                                                 \n",
       "250  Intestinal or peritoneal adhesions                                                                      \n",
       "251  Hemoptysis                                                                                              \n",
       "252  Pressure ulcer                                                                                          \n",
       "253  Impetigo                                                                                                \n",
       "254  Anaphylactic reaction                                                                                   \n",
       "255  Prurigo                                                                                                 \n",
       "256  Disorders of plasma-protein metabolism, NEC                                                             \n",
       "257  Intentional self-harm*                                                                                  \n",
       "258  Nail dystrophy*                                                                                         \n",
       "259  Other symptoms and signs involving the circulatory and respiratory system                               \n",
       "260  Bronchitis                                                                                              \n",
       "261  Bacterial infection of the skin                                                                         \n",
       "262  Precordial pain                                                                                         \n",
       "263  Acetonuria                                                                                              \n",
       "264  Fluid overload                                                                                          \n",
       "265  Recurrent oral aphthae [Recurrent aphthous stomatitis]                                                  \n",
       "266  Partial epilepsy                                                                                        \n",
       "267  Celiac disease                                                                                          \n",
       "268  Meralgia paresthetica                                                                                   \n",
       "269  Allergic urticaria                                                                                      \n",
       "270  Bacterial infections                                                                                    \n",
       "271  Carpal tunnel syndrome                                                                                  \n",
       "272  Hemiplegia and hemiparesis                                                                              \n",
       "273  Acquired deformities of the ankle and foot                                                              \n",
       "274  Ptosis of eyelid                                                                                        \n",
       "275  Hypo-coagulability                                                                                      \n",
       "276  Alteration of consciousness                                                                             \n",
       "277  Anesthesia of skin*                                                                                     \n",
       "278  Familial hypercholesterolemia*                                                                          \n",
       "279  Noninflammatory disorders of conjunctiva                                                                \n",
       "280  Abnormal results of function study of kidney                                                            \n",
       "281  Shock                                                                                                   \n",
       "282  Eustachian tube disorders                                                                               \n",
       "283  Vitreous opacities                                                                                      \n",
       "284  Lichen simplex chronicus                                                                                \n",
       "285  Conjunctival hyperemia                                                                                  \n",
       "286  Disorders of vitreous body                                                                              \n",
       "287  Other problems related to lifestyle                                                                     \n",
       "288  Dentofacial anomalies, including malocclusion                                                           \n",
       "289  Crystalline deposits in vitreous body                                                                   \n",
       "290  Temporomandibular joint disorders                                                                       \n",
       "291  Nerve root and plexus disorders                                                                         \n",
       "292  Benign neoplasm of the paranasal sinus and nasal cavity                                                 \n",
       "293  Cholecystitis                                                                                           \n",
       "294  Influenza virus                                                                                         \n",
       "295  Disorders and findings from impaired renal function                                                     \n",
       "296  Blepharochalasis                                                                                        \n",
       "297  Benign neoplasm of the parathyroid gland                                                                \n",
       "298  Cellulitis and abscess                                                                                  \n",
       "299  Acute kidney failure                                                                                    \n",
       "300  Abnormal thyroid function studies                                                                       \n",
       "301  Symptoms involving musculoskeletal systems                                                              \n",
       "302  Anorectal abscess                                                                                       \n",
       "303  Macular cyst, hole, or pseudohole                                                                       \n",
       "304  Chronic sinusitis                                                                                       \n",
       "305  Cramp and spasm                                                                                         \n",
       "306  Adhesive capsulitis of shoulder                                                                         \n",
       "307  Alopecia                                                                                                \n",
       "308  Insomnia                                                                                                \n",
       "309  Kidney stone disease                                                                                    \n",
       "310  Abnormal findings on diagnostic imaging of lung                                                         \n",
       "311  Gastric ulcer                                                                                           \n",
       "312  Staphylococcus aureus                                                                                   \n",
       "313  Viral pneumonia                                                                                         \n",
       "314  Epilepsy                                                                                                \n",
       "315  Benign neoplasm of eye                                                                                  \n",
       "316  Hemangioma                                                                                              \n",
       "317  Human papillomavirus                                                                                    \n",
       "318  Delirium                                                                                                \n",
       "319  Lichen planus, nitidus, or striatus                                                                     \n",
       "320  Candidiasis of skin and nails                                                                           \n",
       "321  Muscle weakness (generalized)                                                                           \n",
       "322  Torticollis                                                                                             \n",
       "323  Disorders of muscle                                                                                     \n",
       "324  Effusion of joint                                                                                       \n",
       "325  Elevated blood pressure reading without diagnosis of hypertension                                       \n",
       "326  Nonspecific abnormal results of function study of liver                                                 \n",
       "327  Other inflammatory spondylopathies                                                                      \n",
       "328  Abnormal findings on diagnostic imaging of skull and head                                               \n",
       "329  Tachycardia                                                                                             \n",
       "330  Changes in skin texture                                                                                 \n",
       "331  Ascites                                                                                                 \n",
       "332  Abnormal findings on diagnostic test of central nervous system                                          \n",
       "333  Other abnormal immunological findings in serum                                                          \n",
       "334  Low back pain                                                                                           \n",
       "335  Escherichia coli                                                                                        \n",
       "336  Impaired fasting glucose                                                                                \n",
       "337  Ocular hypertension                                                                                     \n",
       "338  Other diseases of stomach and duodenum                                                                  \n",
       "339  Other diseases of spinal cord                                                                           \n",
       "340  Immunodeficiencies                                                                                      \n",
       "341  Hordeolum internum                                                                                      \n",
       "342  Benign neoplasm of choroid                                                                              \n",
       "343  Pulmonary edema                                                                                         \n",
       "344  Staphylococcus                                                                                          \n",
       "345  Hypertension                                                                                            \n",
       "346  Essential hypertension                                                                                  \n",
       "347  Abnormalities of breathing                                                                              \n",
       "348  Acute lower respiratory infection                                                                       \n",
       "349  Back pain                                                                                               \n",
       "350  Visual disturbances                                                                                     \n",
       "351  Benign neoplasm of the skin                                                                             \n",
       "352  Diseases of hair and hair follicles                                                                     \n",
       "353  Abnormality of gait and mobility                                                                        \n",
       "354  Mononeuropathies                                                                                        \n",
       "355  Abnormal sputum                                                                                         \n",
       "356  Abnormal results of pulmonary function studies                                                          \n",
       "357  Irritable bowel syndrome                                                                                \n",
       "358  Hypokalemia [Hypopotassemia]                                                                            \n",
       "359  Acute nasopharyngitis                                                                                   \n",
       "360  Nasopharyngitis                                                                                         \n",
       "361  Proteus                                                                                                 \n",
       "362  Acute otitis media                                                                                      \n",
       "363  Flushing                                                                                                \n",
       "364  Heartburn and epigastric pain                                                                           \n",
       "365  Pneumonia                                                                                               \n",
       "366  Pruritus                                                                                                \n",
       "367  Peripheral vascular disease                                                                             \n",
       "368  Allergy to analgesic agent                                                                              \n",
       "369  Lobar pneumonia*                                                                                        \n",
       "370  Disorders of eyelid function                                                                            \n",
       "371  Disorders of sweat glands                                                                               \n",
       "372  Coma and other alteration of consciousness                                                              \n",
       "373  Degenerative disc disease                                                                               \n",
       "374  Granulomatous disorder of the skin                                                                      \n",
       "375  Nevus, non-neoplastic                                                                                   \n",
       "376  Abdominal or pelvic swelling, mass, or lump                                                             \n",
       "377  Other symptoms and disorders of the soft tissue                                                         \n",
       "378  Allergy                                                                                                 \n",
       "379  Melanocytic nevi*                                                                                       \n",
       "380  Abnormality of the lymph nodes                                                                          \n",
       "381  Seborrheic dermatitis                                                                                   \n",
       "382  Intervertebral disc disorder                                                                            \n",
       "383  Epidermal thickening                                                                                    \n",
       "384  Disorders of pigmentation                                                                               \n",
       "385  Disorders of the pituitary gland and its hypothalamic control                                           \n",
       "386  Hemophilus influenzae                                                                                   \n",
       "387  Other disease of digestive system, NOS                                                                  \n",
       "388  Gastrointestinal angiodysplasia                                                                         \n",
       "389  Abnormality of the peritoneum                                                                           \n",
       "390  Other degenerative diseases of nervous system                                                           \n",
       "391  Derangement of meniscus                                                                                 \n",
       "392  Acute respiratory infection                                                                             \n",
       "393  Fungal infections                                                                                       \n",
       "394  Plantar fascial fibromatosis [Plantar fasciitis]                                                        \n",
       "395  Cardiomegaly                                                                                            \n",
       "396  Pulmonary insufficiency and acute respiratory distress syndrome                                         \n",
       "397  Radiculopathy                                                                                           \n",
       "398  Abnormal findings on diagnostic imaging of the digestive tract                                          \n",
       "399  Pleurisy                                                                                                \n",
       "400  Exostosis                                                                                               \n",
       "401  Umbilical hernia                                                                                        \n",
       "402  Disorder of patella                                                                                     \n",
       "403  Allergy to narcotic agent                                                                               \n",
       "404  Dystonia                                                                                                \n",
       "405  Hydrocephalus                                                                                           \n",
       "406  Restlessness and agitation*                                                                             \n",
       "407  Myelopathies                                                                                            \n",
       "408  Clostridium                                                                                             \n",
       "409  Acute pancreatitis                                                                                      \n",
       "410  Benign neoplasm of the endocrine glands                                                                 \n",
       "411  Pancreatitis                                                                                            \n",
       "412  Malignant neoplasm of the head and neck                                                                 \n",
       "413  Parasites                                                                                               \n",
       "414  Dyspnea [Shortness of breath]                                                                           \n",
       "415  Cough                                                                                                   \n",
       "416  Other disorders of eye                                                                                  \n",
       "417  Malaise and fatigue                                                                                     \n",
       "418  Symptoms and signs related to movement disorders                                                        \n",
       "419  Volume depletion                                                                                        \n",
       "420  Hordeolum externum                                                                                      \n",
       "421  Immune thrombocytopenic purpura [ITP]                                                                   \n",
       "422  Hallucinations                                                                                          \n",
       "423  Skin changes due to chronic exposure to nonionizing radiation                                           \n",
       "424  Other arthropathies                                                                                     \n",
       "425  Disorders of fluid, electrolyte and acid-base balance                                                   \n",
       "426  Localized swelling, mass and lump of skin and subcutaneous tissue                                       \n",
       "427  Cervicalgia                                                                                             \n",
       "428  Edema                                                                                                   \n",
       "429  Sciatica                                                                                                \n",
       "430  Intestinal infection                                                                                    \n",
       "431  Repeated falls*                                                                                         \n",
       "432  Hordeolum                                                                                               \n",
       "433  Functional intestinal disorder                                                                          \n",
       "434  Cutaneous cyst                                                                                          \n",
       "435  Benign sarcoma-related cancers                                                                          \n",
       "436  Viral enteritis                                                                                         \n",
       "437  Perforation of tympanic membrane                                                                        \n",
       "438  Solitary pulmonary nodule                                                                               \n",
       "439  Sequela of infection                                                                                    \n",
       "440  Pneumothorax and air leak                                                                               \n",
       "441  Streptococcus                                                                                           \n",
       "442  Diseases of the pancreas                                                                                \n",
       "443  Hemangioma and lymphangioma                                                                             \n",
       "444  Hallux rigidus                                                                                          \n",
       "445  Melanomas of skin                                                                                       \n",
       "446  Renal failure                                                                                           \n",
       "447  Malignant neoplasm of the skin                                                                          \n",
       "448  Actinic keratosis                                                                                       \n",
       "449  Infection of the skin                                                                                   \n",
       "450  All-Cause Death                                                                                         \n",
       "451  Heart failure                                                                                           \n",
       "452  Left heart failure                                                                                      \n",
       "453  Rhinitis and nasal congestion                                                                           \n",
       "454  Other nutritional deficiencies                                                                          \n",
       "455  Autoimmune disease                                                                                      \n",
       "456  Mononeuritis of lower limb                                                                              \n",
       "457  Hypertrophy of tongue papillae                                                                          \n",
       "458  Vascular abnormalities of conjunctiva                                                                   \n",
       "459  Aplastic anemia                                                                                         \n",
       "460  Intestinal infection due to C. difficile                                                                \n",
       "461  Hemorrhage, NOS                                                                                         \n",
       "462  Food allergy                                                                                            \n",
       "463  Esophageal ulcer                                                                                        \n",
       "464  Sebaceous cyst [Epidermal cyst]                                                                         \n",
       "465  Renal colic                                                                                             \n",
       "466  Basal cell carcinoma                                                                                    \n",
       "467  Keratinocyte carcinoma                                                                                  \n",
       "468  Male sexual dysfuction                                                                                  \n",
       "469  Acute upper respiratory infection                                                                       \n",
       "470  Pain in limb                                                                                            \n",
       "471  Pain                                                                                                    \n",
       "472  Male erectile dysfunction                                                                               \n",
       "473  Gastritis                                                                                               \n",
       "474  Headache NOS                                                                                            \n",
       "475  Abnormal levels of other serum enzymes                                                                  \n",
       "476  Other cerebrovascular disease                                                                           \n",
       "477  Abnormal serum enzyme levels                                                                            \n",
       "478  Spinal disc displacement (herniation)                                                                   \n",
       "479  Myalgia                                                                                                 \n",
       "480  Clostridium difficile                                                                                   \n",
       "481  Hematemesis                                                                                             \n",
       "482  Entropion and trichiasis of eyelid                                                                      \n",
       "483  Bronchopneumonia                                                                                        \n",
       "484  Vascular insufficiency of intestine                                                                     \n",
       "485  Coagulation defects, purpura and other hemorrhagic conditions                                           \n",
       "486  Chalazion                                                                                               \n",
       "487  Rheumatoid arthritis                                                                                    \n",
       "488  Pure hypercholesterolemia                                                                               \n",
       "489  Hypercholesterolemia                                                                                    \n",
       "490  Fungal infection of the skin                                                                            \n",
       "491  Proteinuria                                                                                             \n",
       "492  Hyperlipidemia                                                                                          \n",
       "493  Candidiasis                                                                                             \n",
       "494  Gastrointestinal inflammation                                                                           \n",
       "495  Spinal stenosis                                                                                         \n",
       "496  Other diseases of upper respiratory tract                                                               \n",
       "497  Acute bronchitis                                                                                        \n",
       "498  Angle-Closure Glaucoma                                                                                  \n",
       "499  Stiffness of joint                                                                                      \n",
       "500  Arterial embolism and thrombosis                                                                        \n",
       "501  Pathologic fracture                                                                                     \n",
       "502  Systolic heart failure                                                                                  \n",
       "503  Bacterial enteritis                                                                                     \n",
       "504  Chest pain on breathing                                                                                 \n",
       "505  Peptic ulcer                                                                                            \n",
       "506  Other specified disorders of arteries and arterioles                                                    \n",
       "507  Pain in joint                                                                                           \n",
       "508  Symptoms related to joints                                                                              \n",
       "509  Angina pectoris                                                                                         \n",
       "510  Infections                                                                                              \n",
       "511  Hyperuricemia                                                                                           \n",
       "512  Pleural effusion                                                                                        \n",
       "513  Sepsis                                                                                                  \n",
       "514  Myocardial infarction [Heart attack]                                                                    \n",
       "515  Synovitis and tenosynovitis                                                                             \n",
       "516  Cerebral infarction [Ischemic stroke]                                                                   \n",
       "517  Throat pain                                                                                             \n",
       "518  Hemorrhoids                                                                                             \n",
       "519  Diastolic heart failure                                                                                 \n",
       "520  Cyst and pseudocyst of pancreas                                                                         \n",
       "521  Postviral fatigue syndrome*                                                                             \n",
       "522  Other diseases of pericardium                                                                           \n",
       "523  Anorexia                                                                                                \n",
       "524  Disorders of calcium metabolism                                                                         \n",
       "525  Other hearing abnormality                                                                               \n",
       "526  Toxicology findings                                                                                     \n",
       "527  Other heart disorders in diseases NEC                                                                   \n",
       "528  Stroke                                                                                                  \n",
       "529  Bacteremia, Sepsis, and SIRS                                                                            \n",
       "530  Major depressive disorder                                                                               \n",
       "531  Palmar fascial fibromatosis [Dupuytren]                                                                 \n",
       "532  Dermatitis [eczema]                                                                                     \n",
       "533  Gout                                                                                                    \n",
       "534  Disorders of the gallbladder                                                                            \n",
       "535  Penicillin allergy                                                                                      \n",
       "536  Nonspecific abnormal findings on radiological and other examination of musculoskeletal system           \n",
       "537  Allergy to insects                                                                                      \n",
       "538  Disorders of the middle ear                                                                             \n",
       "539  Generalized epilepsy                                                                                    \n",
       "540  Irregular eye movements                                                                                 \n",
       "541  Secondary malignancy of brain/spine                                                                     \n",
       "542  Ulceration of the lower GI tract                                                                        \n",
       "543  Diseases of spleen                                                                                      \n",
       "544  Tricuspid value insufficiency*                                                                          \n",
       "545  Hemorrhagic stroke                                                                                      \n",
       "546  Panic disorder [episodic paroxysmal anxiety]                                                            \n",
       "547  Cardiac arrest                                                                                          \n",
       "548  Spermatocele                                                                                            \n",
       "549  Osteophyte*                                                                                             \n",
       "550  Atopic dermatitis                                                                                       \n",
       "551  Diseases of lips                                                                                        \n",
       "552  Pleurodynia*                                                                                            \n",
       "553  Contact dermatitis                                                                                      \n",
       "554  Other disorders of the intestines                                                                       \n",
       "555  Other disorders of nose and nasal sinuses                                                               \n",
       "556  Hemorrhage of rectum and anus                                                                           \n",
       "557  Finding of alcohol in blood                                                                             \n",
       "558  Secondary malignancy of bone                                                                            \n",
       "559  Gallstones [Cholelithiasis]                                                                             \n",
       "560  Other skin and connective tissue disorders                                                              \n",
       "561  Mood [affective] disorders                                                                              \n",
       "562  Dermatophytosis                                                                                         \n",
       "563  Constipation                                                                                            \n",
       "564  Benign neoplasm of colon, rectum, anus and anal canal                                                   \n",
       "565  Abdominal pain                                                                                          \n",
       "566  Drug and medical agent allergy                                                                          \n",
       "567  Other symptoms involving nervous system                                                                 \n",
       "568  Atherosclerosis [ASCVD]                                                                                 \n",
       "569  Inflammation of the eye                                                                                 \n",
       "570  Carcinoma in situ of skin                                                                               \n",
       "571  Abdominal distension and flatulence                                                                     \n",
       "572  Malnutrition and underweight                                                                            \n",
       "573  Coronary atherosclerosis [Atherosclerotic heart disease]                                                \n",
       "574  Pharyngitis                                                                                             \n",
       "575  Benign neoplasms of the ovary                                                                           \n",
       "576  Diseases of vocal cords and larynx, not elsewhere classified                                            \n",
       "577  Pyogenic granuloma of skin and subcutaneous tissue                                                      \n",
       "578  Other signs and symptoms in breast                                                                      \n",
       "579  Inhalation lung injury                                                                                  \n",
       "580  Epilepsy, recurrent seizures, convulsions                                                               \n",
       "581  Symptoms and signs concerning food and fluid intake                                                     \n",
       "582  Cardiomyopathy                                                                                          \n",
       "583  Mid back pain                                                                                           \n",
       "584  Decreased white blood cell count                                                                        \n",
       "585  Rotator cuff tear or rupture                                                                            \n",
       "586  Squamous cell carcinoma of the skin                                                                     \n",
       "587  Otitis media                                                                                            \n",
       "588  Aortic stenosis                                                                                         \n",
       "589  Signs and symptoms involving emotional state                                                            \n",
       "590  Hyposmolality and/or hyponatremia                                                                       \n",
       "591  Stroke and transient cerebral ischemic attacks                                                          \n",
       "592  Sexual dysfunction and disorders                                                                        \n",
       "593  Skin symptoms                                                                                           \n",
       "594  Ischemic heart disease                                                                                  \n",
       "595  Chrystal arthropathies                                                                                  \n",
       "596  Benign neoplasm of the colon                                                                            \n",
       "597  Disorders of lacrimal system                                                                            \n",
       "598  General symptoms and other findings                                                                     \n",
       "599  Nonspecific findings on examination of blood                                                            \n",
       "600  Atrophic conditions of skin                                                                             \n",
       "601  Circumscribed scleroderma                                                                               \n",
       "602  Acute Pharyngitis                                                                                       \n",
       "603  Dry eye syndrome [Tear film insufficiency]                                                              \n",
       "604  Other psychoactive substance related disorders                                                          \n",
       "605  Malignant neoplasm of the liver and intrahepatic bile ducts                                             \n",
       "606  Pulmonary hypertension                                                                                  \n",
       "607  Restless legs syndrome                                                                                  \n",
       "608  Uninodular goiter [single thyroid nodule]                                                               \n",
       "609  Cholesterolosis of gallbladder                                                                          \n",
       "610  Perichondritis and chondritis of pinna                                                                  \n",
       "611  Disorder of nervous system                                                                              \n",
       "612  Abnormal cardiac sounds                                                                                 \n",
       "613  Neutropenia                                                                                             \n",
       "614  Tinnitus                                                                                                \n",
       "615  Blood in stool                                                                                          \n",
       "616  Platelet defects                                                                                        \n",
       "617  Hypepigmentation                                                                                        \n",
       "618  Spontaneous rupture of synovium and tendon                                                              \n",
       "619  Intestinal obstruction                                                                                  \n",
       "620  Fecal incontinence                                                                                      \n",
       "621  Disease of anus and rectum                                                                              \n",
       "622  Dysphagia                                                                                               \n",
       "623  Other disorders of ear                                                                                  \n",
       "624  Presence of cardiac device                                                                              \n",
       "625  Venous insufficiency (chronic) (peripheral)                                                             \n",
       "626  Hypotension                                                                                             \n",
       "627  Gastrointestinal hemorrhage                                                                             \n",
       "628  Benign neoplasm of rectum and anus                                                                      \n",
       "629  Embolism and thrombosis                                                                                 \n",
       "630  Generalized anxiety disorder                                                                            \n",
       "631  Nausea and vomiting                                                                                     \n",
       "632  Osteoarthritis                                                                                          \n",
       "633  Benign neoplasm of the digestive organs                                                                 \n",
       "634  Diverticular disease [Bowel diverticulosis]                                                             \n",
       "635  Osteoporosis                                                                                            \n",
       "636  Primary osteoarthritis                                                                                  \n",
       "637  Nausea                                                                                                  \n",
       "638  Chronic kidney disease                                                                                  \n",
       "639  Anxiety disorders                                                                                       \n",
       "640  Dizziness and giddiness                                                                                 \n",
       "641  Hemophilus infection                                                                                    \n",
       "642  Campylobacter                                                                                           \n",
       "643  Occlusion and stenosis of cerebral arteries                                                             \n",
       "644  Sialoadenitis                                                                                           \n",
       "645  Chronic pulmonary heart disease                                                                         \n",
       "646  Nonspecific low blood-pressure reading                                                                  \n",
       "647  Spondylolisthesis                                                                                       \n",
       "648  Secondary malignancy of respiratory organs                                                              \n",
       "649  Urethral stricture                                                                                      \n",
       "650  Pulmonary collapse [Atelectasis]                                                                        \n",
       "651  Thrombocytopenia                                                                                        \n",
       "652  Other disorders of the kidney and ureters                                                               \n",
       "653  Cardiac murmurs                                                                                         \n",
       "654  Pilar and trichodermal cyst                                                                             \n",
       "655  Orthostatic hypotension                                                                                 \n",
       "656  Phlebitis and thrombophlebitis                                                                          \n",
       "657  Lesions of mouth                                                                                        \n",
       "658  Postmenopausal bleeding                                                                                 \n",
       "659  Generalized osteoarthritis                                                                              \n",
       "660  Abnormal loss of weight and underweight                                                                 \n",
       "661  Abnormal weight loss                                                                                    \n",
       "662  Symptoms and signs involving cognitive functions and awareness                                          \n",
       "663  Vomiting                                                                                                \n",
       "664  Chronic Pharyngitis                                                                                     \n",
       "665  Palpitations                                                                                            \n",
       "666  Non-inflammatory spondylopathy                                                                          \n",
       "667  Viral infections                                                                                        \n",
       "668  Enthesopathy/Enthesitis/Tendinopathy                                                                    \n",
       "669  Other disorders of bone                                                                                 \n",
       "670  Atrial fibrillation                                                                                     \n",
       "671  Diverticula of colon                                                                                    \n",
       "672  Headache                                                                                                \n",
       "673  Osteoporosis and low bone density                                                                       \n",
       "674  Cytology and pathology findings                                                                         \n",
       "675  Convulsions                                                                                             \n",
       "676  Erythematous conditions                                                                                 \n",
       "677  Chondrocalcinosis                                                                                       \n",
       "678  Diffuse diseases of connective tissue                                                                   \n",
       "679  Aspiration pneumonia                                                                                    \n",
       "680  Jaw pain                                                                                                \n",
       "681  Interstitial pulmonary diseases                                                                         \n",
       "682  Primary osteoarthritis of the shoulder, upper arm                                                       \n",
       "683  Renal tubulo-interstitial diseases                                                                      \n",
       "684  Blepharoconjunctivitis                                                                                  \n",
       "685  Primary osteoarthritis ankle and foot                                                                   \n",
       "686  Stomatitis                                                                                              \n",
       "687  Gastrointestinal obstruction                                                                            \n",
       "688  Aneurysm or ectasia                                                                                     \n",
       "689  Primary osteoarthritis of the hand                                                                      \n",
       "690  Acute myocardial infarction                                                                             \n",
       "691  Nonspecific abnormal findings in stool contents                                                         \n",
       "692  Otalgia and effusion of ear                                                                             \n",
       "693  Other symptoms involving the digestive system and abdomen                                               \n",
       "694  Spondylosis                                                                                             \n",
       "695  Allergy to other anti-infective agents                                                                  \n",
       "696  Atrial fibrillation and flutter                                                                         \n",
       "697  Conjunctivitis                                                                                          \n",
       "698  Adverse effects of agents primarily affecting gastrointestinal system                                   \n",
       "699  Noninflammatory disorders of vagina                                                                     \n",
       "700  Menopausal and postmenopausal disorders                                                                 \n",
       "701  Hearing impairment                                                                                      \n",
       "702  Disorders of external ear                                                                               \n",
       "703  Impacted cerumen                                                                                        \n",
       "704  Malignant neoplasm of the uterus                                                                        \n",
       "705  Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity                             \n",
       "706  Hepatitis                                                                                               \n",
       "707  Other diseases of blood and blood-forming organs                                                        \n",
       "708  Pseudomonas                                                                                             \n",
       "709  Otorrhea                                                                                                \n",
       "710  Scar conditions and fibrosis of skin                                                                    \n",
       "711  Polyarthritis                                                                                           \n",
       "712  Benign neoplasm of the head and neck                                                                    \n",
       "713  Deviated nasal septum                                                                                   \n",
       "714  Other disorders of liver                                                                                \n",
       "715  Diseases of the jaws                                                                                    \n",
       "716  Acquired deformities of limbs                                                                           \n",
       "717  Tricuspid valve disorders                                                                               \n",
       "718  Migraine with aura                                                                                      \n",
       "719  Scoliosis                                                                                               \n",
       "720  Venous thromboembolism                                                                                  \n",
       "721  Nonspecific abnormal findings on radiological and other examination of other intrathoracic organs (echo)\n",
       "722  Goiter                                                                                                  \n",
       "723  Abdominal aortic aneurysm                                                                               \n",
       "724  Transient cerebral ischemic attacks                                                                     \n",
       "725  Rheumatoid arthritis and other inflammatory polyarthropathies                                           \n",
       "726  Scrotal pain*                                                                                           \n",
       "727  Bursitis                                                                                                \n",
       "728  Memory loss                                                                                             \n",
       "729  Hemorrhage from respiratory passages                                                                    \n",
       "730  Gastro-esophageal reflux disease                                                                        \n",
       "731  Malignant neoplasm of other and ill-defined sites                                                       \n",
       "732  Long term (current) use of hormonal contraceptives                                                      \n",
       "733  Inguinal hernia                                                                                         \n",
       "734  Recurrent and persistent hematuria*                                                                     \n",
       "735  Splenomegaly                                                                                            \n",
       "736  Incisional hernia                                                                                       \n",
       "737  Intestinal fistula                                                                                      \n",
       "738  Plegia and unspecified paralysis                                                                        \n",
       "739  Carotid artery stenosis                                                                                 \n",
       "740  Abnormal granulation tissue, NOS                                                                        \n",
       "741  Occlusion and stenosis of precerebral arteries                                                          \n",
       "742  Iodine-deficiency related thyroid disorders*                                                            \n",
       "743  Rectocele                                                                                               \n",
       "744  Presbycusis                                                                                             \n",
       "745  Lipoma                                                                                                  \n",
       "746  Disorders and symptoms of testis                                                                        \n",
       "747  Other and unspecified dorsopathies                                                                      \n",
       "748  Seborrheic keratosis                                                                                    \n",
       "749  Duodenitis                                                                                              \n",
       "750  Hemorrhage of the eye                                                                                   \n",
       "751  Primary osteoarthritis of knee, lower leg                                                               \n",
       "752  Inflammatory disease of cervix, vagina, and vulva                                                       \n",
       "753  Endometriosis                                                                                           \n",
       "754  Voice disturbance                                                                                       \n",
       "755  Paroxysmal atrial fibrillation*                                                                         \n",
       "756  Candidiasis of vulva and vagina                                                                         \n",
       "757  Tension headache                                                                                        \n",
       "758  Inflammatory diseases of female pelvic organs                                                           \n",
       "759  Hammer toe                                                                                              \n",
       "760  Benign neoplasm of the prostate                                                                         \n",
       "761  Aortic aneurysm and ectasia                                                                             \n",
       "762  Diarrhea                                                                                                \n",
       "763  Primary osteoarthritis of hip, pelvic region and thigh                                                  \n",
       "764  Abnormal results of cardiovascular function studies                                                     \n",
       "765  Dysuria                                                                                                 \n",
       "766  Leiomyoma of uterus                                                                                     \n",
       "767  Gynecological benign neoplasms                                                                          \n",
       "768  Rash and other nonspecific skin eruption                                                                \n",
       "769  Hormone replacement therapy (postmenopausal)                                                            \n",
       "770  Diaphragmatic hernia [Hiatal hernia]                                                                    \n",
       "771  Irregular menstrual bleeding                                                                            \n",
       "772  Synoviopathy and bursopathy                                                                             \n",
       "773  Symptoms involving digestive system                                                                     \n",
       "774  Cardiac arrhythmia and conduction disorders                                                             \n",
       "775  Noninflammatory female genital disorders                                                                \n",
       "776  Benign neoplasm of the genitourinary system                                                             \n",
       "777  Lump or mass in breast or nonspecific abnormal breast exam                                              \n",
       "778  Irregular menstrual cycle                                                                               \n",
       "779  Irregular menstrual cycle/bleeding                                                                      \n",
       "780  Menorrhagia/Excessive and frequent menstruation                                                         \n",
       "781  Lateral epicondylitis (Tennis elbow)                                                                    \n",
       "782  Benign prostatic hyperplasia                                                                            \n",
       "783  Nocturia                                                                                                \n",
       "784  Symptomatic menopause                                                                                   \n",
       "785  Hernia                                                                                                  \n",
       "786  Hernia of the abdominal wall                                                                            \n",
       "787  Reaction to severe stress, and adjustment disorders                                                     \n",
       "788  Migraine                                                                                                \n",
       "789  Long term (current) use of agents affecting hormones                                                    \n",
       "790  Other abnormal findings in urine                                                                        \n",
       "791  Transplated organ                                                                                       \n",
       "792  Osteomyelitis, periostitis, and other infections involving bone                                         \n",
       "793  Ileus                                                                                                   \n",
       "794  Osteomyelitis                                                                                           \n",
       "795  End stage renal disease [CDK, stage 5]                                                                  \n",
       "796  Disorders of tooth develoment                                                                           \n",
       "797  Disturbances in tooth eruption                                                                          \n",
       "798  Diffuse large B-cell lymphoma*                                                                          \n",
       "799  Thyroiditis                                                                                             \n",
       "800  Pulmonary valve insufficiency*                                                                          \n",
       "801  Systemic atrophies primarily affecting the central nervous system                                       \n",
       "802  Diffuse goiter                                                                                          \n",
       "803  Graves' disease [Toxic diffuse goiter]                                                                  \n",
       "804  Allergy to serum and vaccine                                                                            \n",
       "805  Impacted teeth*                                                                                         \n",
       "806  Headache syndromes, non migraine                                                                        \n",
       "807  Stricture or kinking of ureter                                                                          \n",
       "808  Pityriasis                                                                                              \n",
       "809  Impaction of intestine                                                                                  \n",
       "810  Pulmonary valve disorders                                                                               \n",
       "811  Paralytic strabismus [Neurogenic strabismus]                                                            \n",
       "812  Disorder of ligament                                                                                    \n",
       "813  Genu valgum (acquired)                                                                                  \n",
       "814  Bronchospasm                                                                                            \n",
       "815  Cognitive communication deficit                                                                         \n",
       "816  Atrophy of female genital tract                                                                         \n",
       "817  Abnormal results of function studies of peripheral nervous system                                       \n",
       "818  Aphasia and dysphasia                                                                                   \n",
       "819  Myeloproliferative disorder                                                                             \n",
       "820  Essential thrombocythemia                                                                               \n",
       "821  Abnormal vestibular function study                                                                      \n",
       "822  Transient global amnesia                                                                                \n",
       "823  Coma                                                                                                    \n",
       "824  Ventricular tachycardia                                                                                 \n",
       "825  Underweight                                                                                             \n",
       "826  Volvulus                                                                                                \n",
       "827  Disorder of phosphorus metabolism                                                                       \n",
       "828  Other acute skin changes due to ultraviolet radiation                                                   \n",
       "829  Other disorders of white blood cells                                                                    \n",
       "830  Thoracic aneurysm                                                                                       \n",
       "831  Hypercalcemia                                                                                           \n",
       "832  Immunodeficiency NOS                                                                                    \n",
       "833  Exercise induced bronchospasm                                                                           \n",
       "834  Chronic periodontitis                                                                                   \n",
       "835  Abnormal auditory function study                                                                        \n",
       "836  Rectal prolapse                                                                                         \n",
       "837  Calcium deposits in tendon and bursa                                                                    \n",
       "838  Endometrial hyperplasia                                                                                 \n",
       "839  Obstruction of bile duct                                                                                \n",
       "840  Chronic leukemia                                                                                        \n",
       "841  Multiple myeloma                                                                                        \n",
       "842  Leukemia                                                                                                \n",
       "843  Pityriasis rosea                                                                                        \n",
       "844  Lymphocytosis (symptomatic)                                                                             \n",
       "845  Crohn's disease                                                                                         \n",
       "846  Dyskinesia of esophagus                                                                                 \n",
       "847  Multiple myeloma and malignant plasma cell neoplasms                                                    \n",
       "848  Prickly heat and miliaria                                                                               \n",
       "849  Glossodynia                                                                                             \n",
       "850  Corneal ulcer                                                                                           \n",
       "851  Myeloid                                                                                                 \n",
       "852  Chronic prostatitis                                                                                     \n",
       "853  Malignant neoplasm of the pancreas                                                                      \n",
       "854  Other specified cognitive deficit                                                                       \n",
       "855  Hypertrophy of tonsils and adenoids                                                                     \n",
       "856  Benign neoplasm of meninges (Meningioma)                                                                \n",
       "857  Chronic lymphoid leukemia                                                                               \n",
       "858  Sick sinus syndrome*                                                                                    \n",
       "859  Sinoatrial node dysfunction                                                                             \n",
       "860  Abnormal coagulation profile                                                                            \n",
       "861  Testicular limpoma                                                                                      \n",
       "862  Dermatitis due to substances taken internally                                                           \n",
       "863  Nontraumatic subdural hemorrhage                                                                        \n",
       "864  Transient retinal arterial occlusion [Amaurosis fugax]                                                  \n",
       "865  Benign neoplasms of the cervix                                                                          \n",
       "866  Glossitis                                                                                               \n",
       "867  Inflammatory disease of breast                                                                          \n",
       "868  Anal fissure                                                                                            \n",
       "869  Hemo onc - by cell of origin                                                                            \n",
       "870  Dilated cardiomyopathy*                                                                                 \n",
       "871  Redundant prepuce and phimosis                                                                          \n",
       "872  Increased white blood cell count                                                                        \n",
       "873  Eustachian salpingitis                                                                                  \n",
       "874  Malignant neoplasm of stomach                                                                           \n",
       "875  Mucous polyp of cervix                                                                                  \n",
       "876  Heart valve replaced                                                                                    \n",
       "877  Mature B-cell                                                                                           \n",
       "878  Postprocedural hypothyroidism                                                                           \n",
       "879  Emotional lability                                                                                      \n",
       "880  Dyshidrosis                                                                                             \n",
       "881  Non-Hodgkin lymphoma                                                                                    \n",
       "882  Giant cell arteritis                                                                                    \n",
       "883  Primary hyperparathyroidism                                                                             \n",
       "884  Meniere disease                                                                                         \n",
       "885  Lymphoid                                                                                                \n",
       "886  Chondromalacia                                                                                          \n",
       "887  Malignant neoplasm of the eye, brain and other parts of central nervous system                          \n",
       "888  Peyronie's disease                                                                                      \n",
       "889  Vestibular neuronitis                                                                                   \n",
       "890  Pelvic peritoneal adhesions, female (postoperative) (postinfection)                                     \n",
       "891  Hypertrophy of nasal turbinates                                                                         \n",
       "892  Malignant neoplasm of the esophagus                                                                     \n",
       "893  Lymphoma                                                                                                \n",
       "894  Sicca syndrome [Sjogren syndrome]                                                                       \n",
       "895  Strabismus                                                                                              \n",
       "896  Suicidal ideations                                                                                      \n",
       "897  Systemic vasculitis                                                                                     \n",
       "898  Disorders of penis                                                                                      \n",
       "899  Prostatitis                                                                                             \n",
       "900  Femoral hernia                                                                                          \n",
       "901  Nephrotic syndrome                                                                                      \n",
       "902  Malignant neoplasm of endometrium                                                                       \n",
       "903  Ocular pain                                                                                             \n",
       "904  Pulmonary fibrosis                                                                                      \n",
       "905  Microscopic colitis*                                                                                    \n",
       "906  Eye infection, viral                                                                                    \n",
       "907  Infective and reactive arthropathies                                                                    \n",
       "908  Symptoms involving female genital tract                                                                 \n",
       "909  Benign neoplasms of external female genital organs and cervix                                           \n",
       "910  Endocarditis                                                                                            \n",
       "911  Secondary malignant neoplasm of digestive systems                                                       \n",
       "912  Genu varum (acquired)                                                                                   \n",
       "913  Polyp of corpus uteri                                                                                   \n",
       "914  Noninflammatory disorders of vulva and perineum                                                         \n",
       "915  Right bundle branch block                                                                               \n",
       "916  Snoring*                                                                                                \n",
       "917  Parageusia*                                                                                             \n",
       "918  Mitral valve prolapse*                                                                                  \n",
       "919  Irritability                                                                                            \n",
       "920  Visual distortions and subjective visual disturbances                                                   \n",
       "921  Flat foot [pes planus]                                                                                  \n",
       "922  Appendicitis                                                                                            \n",
       "923  Duodenal ulcer                                                                                          \n",
       "924  Lipoma of other skin subcutaneous tissue                                                                \n",
       "925  Unsteadiness on feet*                                                                                   \n",
       "926  Paraproteinemias                                                                                        \n",
       "927  Obstructive and reflux uropathy                                                                         \n",
       "928  Diplopia                                                                                                \n",
       "929  Inflammatory diseases of prostate                                                                       \n",
       "930  Urethral caruncle                                                                                       \n",
       "931  Pituitary hyperfunction                                                                                 \n",
       "932  Acute prostatitis                                                                                       \n",
       "933  Jaundice (not of newborn)                                                                               \n",
       "934  Malignant neoplasm of kidney, except pelvis                                                             \n",
       "935  Intestinal malabsorption                                                                                \n",
       "936  Ectropion of eyelid                                                                                     \n",
       "937  Trigeminal nerve disorders [CN5]                                                                        \n",
       "938  Inflammation of the heart [Carditis]                                                                    \n",
       "939  Aortic insufficiency                                                                                    \n",
       "940  Inflammatory bowel disease                                                                              \n",
       "941  Paroxysmal tachycardia                                                                                  \n",
       "942  Dementia NOS                                                                                            \n",
       "943  Parkinsonism                                                                                            \n",
       "944  Malignant neoplasm of the breast, female                                                                \n",
       "945  Scrotal varices [Varicocele]                                                                            \n",
       "946  Nasal congestion*                                                                                       \n",
       "947  Multinodular goiter                                                                                     \n",
       "948  Overactive bladder                                                                                      \n",
       "949  Mouth breathing*                                                                                        \n",
       "950  Atrial premature depolarization [Supraventricular premature beats]                                      \n",
       "951  Diverticula of small intestine                                                                          \n",
       "952  Malignant neoplasm of the kidney                                                                        \n",
       "953  Major depressive disorder, recurrent                                                                    \n",
       "954  Stenosis and insufficiency of lacrimal passages                                                         \n",
       "955  Lack of coordination                                                                                    \n",
       "956  Hydrocele                                                                                               \n",
       "957  Hydronephrosis                                                                                          \n",
       "958  Malignant neoplasm of the rectum                                                                        \n",
       "959  Supraventricular tachycardia                                                                            \n",
       "960  Tremor                                                                                                  \n",
       "961  Parkinson's disease (Primary)                                                                           \n",
       "962  Sensorineural hearing loss, bilateral                                                                   \n",
       "963  Excessive crying of child, adolescent, or adult                                                         \n",
       "964  Glomerular diseases                                                                                     \n",
       "965  Chronic otitis media                                                                                    \n",
       "966  Monoclonal gammopathy                                                                                   \n",
       "967  Gynecological malignant neoplasms                                                                       \n",
       "968  Attention and concentration deficit                                                                     \n",
       "969  Microscopic hematuria                                                                                   \n",
       "970  Benign mammary dysplasias                                                                               \n",
       "971  Chronic rheumatic heart diseases                                                                        \n",
       "972  Barrett's esophagus                                                                                     \n",
       "973  Mild cognitive impairment, so stated                                                                    \n",
       "974  Sexually transmitted disease                                                                            \n",
       "975  Ovarian cyst                                                                                            \n",
       "976  Nail disorders                                                                                          \n",
       "977  Lab findings related to infections                                                                      \n",
       "978  Chronic cystitis                                                                                        \n",
       "979  Keratitis                                                                                               \n",
       "980  Other disorders involving the immune mechanism                                                          \n",
       "981  Allergy to sulfonamides                                                                                 \n",
       "982  Other disorders of the eyelids                                                                          \n",
       "983  Esophageal obstruction (Stricture and stenosis of esophagus)                                            \n",
       "984  Balanoposthitis                                                                                         \n",
       "985  Secondary malignant neoplasm of liver                                                                   \n",
       "986  Urinary hesitancy                                                                                       \n",
       "987  Acquired deformities of the knee                                                                        \n",
       "988  Symptoms and signs involving general sensations and perceptions                                         \n",
       "989  Atrial flutter                                                                                          \n",
       "990  Sacrococcygeal disorders                                                                                \n",
       "991  Deforming dorsopathies                                                                                  \n",
       "992  Polyp of female genital organs                                                                          \n",
       "993  Tendinitis                                                                                              \n",
       "994  Corpus luteum cyst or hematoma                                                                          \n",
       "995  Phobic disorders                                                                                        \n",
       "996  Urge incontinence                                                                                       \n",
       "997  Epistaxis                                                                                               \n",
       "998  Syncope and collapse                                                                                    \n",
       "999  Gross hematuria                                                                                         \n",
       "1000 Cholangitis                                                                                             \n",
       "1001 Dystrophy of female genital tract                                                                       \n",
       "1002 Malignant neoplasm of brain                                                                             \n",
       "1003 Klebsiella                                                                                              \n",
       "1004 Malignant sarcoma-related cancers                                                                       \n",
       "1005 Primary osteoarthritis of the wrist, forearm                                                            \n",
       "1006 Infection of the eye                                                                                    \n",
       "1007 Cyst or abscess of Bartholin's gland                                                                    \n",
       "1008 Secondary osteoarthritis                                                                                \n",
       "1009 Hypertrophy of female genital organs                                                                    \n",
       "1010 Suicide ideation and attempt or self harm                                                               \n",
       "1011 Other disorders of urethra and urinary tract                                                            \n",
       "1012 Diverticulum of bladder                                                                                 \n",
       "1013 Rheumatic fever and chronic rheumatic heart diseases                                                    \n",
       "1014 Mitral valve insufficiency                                                                              \n",
       "1015 Postcoital bleeding                                                                                     \n",
       "1016 Acne                                                                                                    \n",
       "1017 Extrapyramidal and movement disorders                                                                   \n",
       "1018 Laryngitis and tracheitis                                                                               \n",
       "1019 Mitral valve disorders                                                                                  \n",
       "1020 Diseases of tongue                                                                                      \n",
       "1021 Plantar wart                                                                                            \n",
       "1022 Benign neoplasm of stomach                                                                              \n",
       "1023 Uterine/Uterovaginal prolapse                                                                           \n",
       "1024 Malignant neoplasm of the colon                                                                         \n",
       "1025 Dementia in conditions classified elsewhere                                                             \n",
       "1026 Dementias and cerebral degeneration                                                                     \n",
       "1027 Acute laryngitis and tracheitis                                                                         \n",
       "1028 Urinary incontinence                                                                                    \n",
       "1029 Labyrinthitis                                                                                           \n",
       "1030 Testicular dysfunction                                                                                  \n",
       "1031 Cysts of eyelid                                                                                         \n",
       "1032 Hyperparathyroidism                                                                                     \n",
       "1033 Disorders of uterus, NEC                                                                                \n",
       "1034 Vascular dementia                                                                                       \n",
       "1035 Disorders of parathyroid gland                                                                          \n",
       "1036 Ventral hernia                                                                                          \n",
       "1037 Cystic mastopathy                                                                                       \n",
       "1038 Disturbances of salivary secretion                                                                      \n",
       "1039 Heberden's or Bouchard's nodes*                                                                         \n",
       "1040 Ingrowing nail                                                                                          \n",
       "1041 Thyrotoxicosis [hyperthyroidism]                                                                        \n",
       "1042 Diverticulitis                                                                                          \n",
       "1043 Malignant neoplasm of the bladder                                                                       \n",
       "1044 Baker's cyst [popliteal cyst]                                                                           \n",
       "1045 Postnasal drip                                                                                          \n",
       "1046 Dysmenorrhea                                                                                            \n",
       "1047 Atrioventricular block                                                                                  \n",
       "1048 Chronic rhinitis                                                                                        \n",
       "1049 Other follicular disorders                                                                              \n",
       "1050 Prolapse of vaginal walls                                                                               \n",
       "1051 Heart block                                                                                             \n",
       "1052 Urinary urgency                                                                                         \n",
       "1053 Bradycardia*                                                                                            \n",
       "1054 Other diseases of inner ear                                                                             \n",
       "1055 Conjunctival hemorrhage                                                                                 \n",
       "1056 Periodontitis                                                                                           \n",
       "1057 Brain damage and brain death                                                                            \n",
       "1058 Malignant neoplasm of the ovary                                                                         \n",
       "1059 Posttraumatic stress disorder                                                                           \n",
       "1060 Monoplegia                                                                                              \n",
       "1061 Nontraumatic intracerebral hemorrhage                                                                   \n",
       "1062 Nontraumatic hematoma of soft tissue                                                                    \n",
       "1063 Lymphedema                                                                                              \n",
       "1064 Deep vein thrombosis [DVT]                                                                              \n",
       "1065 Epiphora                                                                                                \n",
       "1066 Disorders of other cranial nerves                                                                       \n",
       "1067 Other specific joint derangements                                                                       \n",
       "1068 Pulmonary embolism                                                                                      \n",
       "1069 Cyst of kidney                                                                                          \n",
       "1070 Raynaud's syndrome                                                                                      \n",
       "1071 Medial epicondylitis (Golfer's elbow)                                                                   \n",
       "1072 Allergy to antibiotic agent (excluding penicillin)                                                      \n",
       "1073 Premature depolarization [Premature beats]                                                              \n",
       "1074 Acute cystitis                                                                                          \n",
       "1075 Malignant neoplasm of the digestive organs                                                              \n",
       "1076 Malignant neoplasm of the colon and rectum                                                              \n",
       "1077 Benign neoplasm of the breast                                                                           \n",
       "1078 Heart valve disorders                                                                                   \n",
       "1079 Alzheimer's disease                                                                                     \n",
       "1080 Pyuria*                                                                                                 \n",
       "1081 Mastodynia                                                                                              \n",
       "1082 Other disorders of bladder                                                                              \n",
       "1083 Urinary tract infection                                                                                 \n",
       "1084 Other disorders of prostate                                                                             \n",
       "1085 Other nonmalignant breast conditions                                                                    \n",
       "1086 Genital prolapse                                                                                        \n",
       "1087 Inflammation of eyelids                                                                                 \n",
       "1088 Malignant neoplasm of the breast                                                                        \n",
       "1089 Blepharitis                                                                                             \n",
       "1090 Paroxysmal vertigo                                                                                      \n",
       "1091 Cystitis and urethritis                                                                                 \n",
       "1092 Cystitis                                                                                                \n",
       "1093 Acute sinusitis                                                                                         \n",
       "1094 Nervousness                                                                                             \n",
       "1095 Nontraumatic subarachnoid hemorrhage                                                                    \n",
       "1096 Motion sickness                                                                                         \n",
       "1097 Orchitis and epididymitis                                                                               \n",
       "1098 Speech disturbance                                                                                      \n",
       "1099 Nontraumatic Intracranial hemorrhage                                                                    \n",
       "1100 Essential tremor*                                                                                       \n",
       "1101 Other diseases of biliary tract                                                                         \n",
       "1102 Ventricular premature depolarization*                                                                   \n",
       "1103 Vaginitis and vulvovaginitis                                                                            \n",
       "1104 Dyspareunia                                                                                             \n",
       "1105 Left bundle branch block                                                                                \n",
       "1106 Herpes simplex                                                                                          \n",
       "1107 Achilles tendinitis                                                                                     \n",
       "1108 Trigger finger                                                                                          \n",
       "1109 Chondropathies                                                                                          \n",
       "1110 Secondary malignant neoplasm                                                                            \n",
       "1111 Noninflammatory disorders of cervix                                                                     \n",
       "1112 Ganglion cyst                                                                                           \n",
       "1113 Sequelae of cancer                                                                                      \n",
       "1114 Varicose veins                                                                                          \n",
       "1115 Elevated prostate specific antigen [PSA]                                                                \n",
       "1116 Abnormal electrocardiogram [ECG] [EKG]                                                                  \n",
       "1117 Cystocele                                                                                               \n",
       "1118 Pain and other symptoms associated with female genital organs                                           \n",
       "1119 Bladder neck obstruction                                                                                \n",
       "1120 Abnormalities of heart beat                                                                             \n",
       "1121 Disorders of vestibular function                                                                        \n",
       "1122 Herpesvirus                                                                                             \n",
       "1123 Venous insufficiency                                                                                    \n",
       "1124 Varicose veins of lower extremities                                                                     \n",
       "1125 Hypothyroidism                                                                                          \n",
       "1126 Sinusitis                                                                                               \n",
       "1127 Disorders of thyroid gland                                                                              \n",
       "1128 Hematuria                                                                                               \n",
       "1129 Herpes zoster                                                                                           \n",
       "1130 Abnormality of urination                                                                                \n",
       "1131 Retention of urine                                                                                      \n",
       "1132 Vertigo                                                                                                 \n",
       "1133 Other symptoms/disorders or the urinary system                                                          \n",
       "1134 Hallux valgus (Bunion)                                                                                  \n",
       "1135 Other psychoactive substance dependence                                                                 \n",
       "1136 Infection of the eye, herpes                                                                            \n",
       "1137 Persistent atrial fibrillation*                                                                         \n",
       "1138 Trigeminal neuralgia                                                                                    \n",
       "1139 Pityriasis versicolor                                                                                   \n",
       "1140 Benign neoplasm of the eye, brain and other parts of central nervous system                             \n",
       "1141 Secondary malignancy of lymph nodes                                                                     \n",
       "1142 Dysplasia of female genital organs                                                                      \n",
       "1143 Costochondritis (Tietze's disease)                                                                      \n",
       "1144 Malignant neoplasm of the urinary tract                                                                 \n",
       "1145 Stress incontinence                                                                                     \n",
       "1146 Diseases of salivary glands                                                                             \n",
       "1147 Bronchiectasis                                                                                          \n",
       "1148 Aortic valve disorders                                                                                  \n",
       "1149 Esophagitis                                                                                             \n",
       "1150 Nonspecific abnormal findings of other body structures                                                  \n",
       "1151 Polymyalgia rheumatica                                                                                  \n",
       "1152 Secondary hypertension                                                                                  \n",
       "1153 Diseases of esophagus                                                                                   \n",
       "1154 Sensorineural hearing loss                                                                              \n",
       "1155 Varicella zoster virus                                                                                  \n",
       "1156 Benign neoplasms of the uterus                                                                          \n",
       "1157 Hypothyroidism, not specified as secondary                                                              \n",
       "1158 Absent or infrequent menstruation                                                                       \n",
       "1159 Acquired deformities of fingers and toes                                                                \n",
       "1160 Malignant neoplasm of male genitalia                                                                    \n",
       "1161 Malignant neoplasm of the prostate                                                                      \n",
       "1162 Chronic fatigue syndrome                                                                                \n",
       "1163 Other disorders of male genital organs                                                                  \n",
       "1164 Frequency of urination and polyuria                                                                     \n",
       "1165 Acquired deformities of toe                                                                             \n",
       "1166 Disorders of menstruation and other abnormal bleeding from female genital tract                         \n",
       "1167 Abnormal findings in semen                                                                              \n",
       "1168 Tonsillitis and adenoiditis                                                                             \n",
       "1169 Cancer (solid tumor, excluding BCC)                                                                     \n",
       "1170 Acute tonsillitis and adenoiditis                                                                       \n",
       "1171 Lump or mass in breast                                                                                  \n",
       "     ukb_agesex           ukb_agesexretina     ukb_delta              \n",
       "1    0.612 (0.575, 0.655) 0.872 (0.85, 0.905)  0.259 (0.214, 0.312)   \n",
       "2    0.585 (0.565, 0.603) 0.818 (0.803, 0.833) 0.232 (0.213, 0.26)    \n",
       "3    0.29 (0.255, 0.319)  0.5 (0.457, 0.543)   0.207 (0.161, 0.263)   \n",
       "4    0.373 (0.328, 0.41)  0.547 (0.506, 0.579) 0.175 (0.12, 0.23)     \n",
       "5    0.582 (0.547, 0.613) 0.753 (0.712, 0.783) 0.173 (0.139, 0.203)   \n",
       "6    0.37 (0.324, 0.405)  0.537 (0.5, 0.572)   0.169 (0.122, 0.214)   \n",
       "7    0.485 (0.447, 0.532) 0.651 (0.602, 0.695) 0.169 (0.117, 0.225)   \n",
       "8    0.4 (0.352, 0.446)   0.551 (0.502, 0.592) 0.149 (0.096, 0.188)   \n",
       "9    0.546 (0.507, 0.577) 0.684 (0.645, 0.732) 0.143 (0.094, 0.184)   \n",
       "10   0.595 (0.576, 0.616) 0.735 (0.715, 0.755) 0.139 (0.12, 0.161)    \n",
       "11   0.396 (0.369, 0.43)  0.535 (0.498, 0.56)  0.138 (0.081, 0.173)   \n",
       "12   0.429 (0.405, 0.451) 0.563 (0.536, 0.593) 0.135 (0.099, 0.165)   \n",
       "13   0.442 (0.421, 0.471) 0.574 (0.548, 0.602) 0.132 (0.1, 0.168)     \n",
       "14   0.622 (0.595, 0.648) 0.745 (0.725, 0.774) 0.127 (0.1, 0.152)     \n",
       "15   0.64 (0.611, 0.675)  0.766 (0.735, 0.804) 0.126 (0.092, 0.162)   \n",
       "16   0.406 (0.355, 0.442) 0.529 (0.493, 0.567) 0.125 (0.086, 0.168)   \n",
       "17   0.599 (0.576, 0.622) 0.712 (0.688, 0.738) 0.114 (0.086, 0.136)   \n",
       "18   0.645 (0.613, 0.681) 0.756 (0.726, 0.8)   0.111 (0.065, 0.155)   \n",
       "19   0.431 (0.383, 0.465) 0.537 (0.495, 0.569) 0.109 (0.061, 0.16)    \n",
       "20   0.458 (0.417, 0.492) 0.564 (0.513, 0.611) 0.109 (0.047, 0.158)   \n",
       "21   0.652 (0.628, 0.682) 0.758 (0.732, 0.785) 0.107 (0.089, 0.126)   \n",
       "22   0.656 (0.643, 0.666) 0.761 (0.751, 0.772) 0.106 (0.093, 0.119)   \n",
       "23   0.504 (0.468, 0.542) 0.61 (0.57, 0.651)   0.106 (0.06, 0.17)     \n",
       "24   0.489 (0.481, 0.494) 0.593 (0.588, 0.599) 0.105 (0.098, 0.112)   \n",
       "25   0.59 (0.568, 0.615)  0.696 (0.675, 0.723) 0.105 (0.076, 0.131)   \n",
       "26   0.507 (0.478, 0.542) 0.613 (0.576, 0.647) 0.103 (0.065, 0.143)   \n",
       "27   0.444 (0.412, 0.485) 0.546 (0.511, 0.583) 0.102 (0.058, 0.138)   \n",
       "28   0.751 (0.722, 0.78)  0.85 (0.826, 0.88)   0.101 (0.071, 0.127)   \n",
       "29   0.707 (0.671, 0.741) 0.803 (0.777, 0.828) 0.097 (0.063, 0.125)   \n",
       "30   0.462 (0.419, 0.508) 0.558 (0.512, 0.606) 0.097 (0.038, 0.143)   \n",
       "31   0.478 (0.446, 0.509) 0.572 (0.543, 0.61)  0.096 (0.066, 0.13)    \n",
       "32   0.656 (0.639, 0.68)  0.75 (0.728, 0.769)  0.094 (0.07, 0.119)    \n",
       "33   0.582 (0.567, 0.599) 0.676 (0.661, 0.688) 0.093 (0.078, 0.111)   \n",
       "34   0.587 (0.557, 0.622) 0.678 (0.646, 0.708) 0.093 (0.057, 0.115)   \n",
       "35   0.422 (0.389, 0.454) 0.515 (0.478, 0.554) 0.093 (0.055, 0.141)   \n",
       "36   0.577 (0.553, 0.605) 0.666 (0.646, 0.69)  0.088 (0.068, 0.111)   \n",
       "37   0.501 (0.465, 0.541) 0.59 (0.536, 0.641)  0.088 (0.041, 0.135)   \n",
       "38   0.455 (0.418, 0.488) 0.544 (0.503, 0.574) 0.088 (0.039, 0.135)   \n",
       "39   0.613 (0.607, 0.619) 0.698 (0.693, 0.704) 0.086 (0.08, 0.091)    \n",
       "40   0.61 (0.601, 0.618)  0.696 (0.687, 0.703) 0.086 (0.078, 0.094)   \n",
       "41   0.535 (0.518, 0.553) 0.622 (0.605, 0.637) 0.086 (0.066, 0.105)   \n",
       "42   0.629 (0.622, 0.64)  0.714 (0.705, 0.725) 0.085 (0.074, 0.093)   \n",
       "43   0.43 (0.389, 0.457)  0.517 (0.486, 0.551) 0.084 (0.047, 0.138)   \n",
       "44   0.446 (0.4, 0.487)   0.528 (0.485, 0.563) 0.084 (0.034, 0.13)    \n",
       "45   0.752 (0.738, 0.766) 0.834 (0.819, 0.844) 0.083 (0.071, 0.094)   \n",
       "46   0.526 (0.505, 0.551) 0.61 (0.59, 0.636)   0.083 (0.059, 0.11)    \n",
       "47   0.616 (0.576, 0.656) 0.7 (0.666, 0.741)   0.083 (0.045, 0.114)   \n",
       "48   0.458 (0.421, 0.492) 0.541 (0.502, 0.583) 0.083 (0.033, 0.125)   \n",
       "49   0.614 (0.606, 0.623) 0.695 (0.688, 0.704) 0.082 (0.073, 0.089)   \n",
       "50   0.615 (0.596, 0.638) 0.698 (0.679, 0.719) 0.082 (0.06, 0.11)     \n",
       "51   0.523 (0.504, 0.549) 0.608 (0.59, 0.628)  0.082 (0.058, 0.105)   \n",
       "52   0.498 (0.458, 0.536) 0.576 (0.543, 0.631) 0.081 (0.035, 0.136)   \n",
       "53   0.63 (0.621, 0.637)  0.708 (0.697, 0.714) 0.079 (0.071, 0.086)   \n",
       "54   0.545 (0.536, 0.554) 0.624 (0.617, 0.631) 0.079 (0.069, 0.086)   \n",
       "55   0.482 (0.465, 0.498) 0.56 (0.538, 0.579)  0.079 (0.053, 0.104)   \n",
       "56   0.553 (0.516, 0.592) 0.634 (0.6, 0.673)   0.079 (0.042, 0.123)   \n",
       "57   0.382 (0.339, 0.427) 0.459 (0.421, 0.503) 0.079 (0.029, 0.133)   \n",
       "58   0.554 (0.545, 0.565) 0.632 (0.621, 0.639) 0.077 (0.066, 0.085)   \n",
       "59   0.555 (0.544, 0.563) 0.631 (0.62, 0.639)  0.076 (0.068, 0.084)   \n",
       "60   0.633 (0.617, 0.648) 0.709 (0.685, 0.728) 0.076 (0.061, 0.09)    \n",
       "61   0.538 (0.504, 0.585) 0.616 (0.574, 0.67)  0.076 (0.023, 0.134)   \n",
       "62   0.445 (0.424, 0.476) 0.523 (0.499, 0.549) 0.075 (0.043, 0.109)   \n",
       "63   0.48 (0.455, 0.51)   0.56 (0.528, 0.595)  0.075 (0.041, 0.123)   \n",
       "64   0.511 (0.506, 0.516) 0.585 (0.58, 0.589)  0.074 (0.067, 0.08)    \n",
       "65   0.497 (0.489, 0.505) 0.572 (0.564, 0.579) 0.074 (0.062, 0.087)   \n",
       "66   0.548 (0.521, 0.575) 0.622 (0.594, 0.649) 0.074 (0.038, 0.107)   \n",
       "67   0.516 (0.476, 0.558) 0.587 (0.539, 0.638) 0.074 (0.011, 0.13)    \n",
       "68   0.479 (0.441, 0.514) 0.55 (0.517, 0.587)  0.073 (0.039, 0.109)   \n",
       "69   0.512 (0.506, 0.517) 0.584 (0.58, 0.59)   0.072 (0.066, 0.079)   \n",
       "70   0.546 (0.538, 0.554) 0.618 (0.61, 0.625)  0.072 (0.063, 0.078)   \n",
       "71   0.517 (0.509, 0.528) 0.589 (0.579, 0.598) 0.072 (0.057, 0.084)   \n",
       "72   0.498 (0.481, 0.513) 0.571 (0.552, 0.591) 0.072 (0.055, 0.097)   \n",
       "73   0.591 (0.585, 0.599) 0.662 (0.657, 0.667) 0.071 (0.063, 0.077)   \n",
       "74   0.636 (0.603, 0.66)  0.705 (0.678, 0.737) 0.071 (0.05, 0.1)      \n",
       "75   0.438 (0.398, 0.481) 0.508 (0.468, 0.55)  0.071 (0.022, 0.119)   \n",
       "76   0.593 (0.586, 0.597) 0.662 (0.657, 0.668) 0.07 (0.063, 0.076)    \n",
       "77   0.515 (0.485, 0.542) 0.587 (0.551, 0.611) 0.07 (0.044, 0.099)    \n",
       "78   0.49 (0.449, 0.531)  0.564 (0.512, 0.597) 0.07 (0.016, 0.113)    \n",
       "79   0.549 (0.543, 0.556) 0.619 (0.613, 0.624) 0.069 (0.062, 0.077)   \n",
       "80   0.564 (0.556, 0.575) 0.633 (0.625, 0.641) 0.069 (0.061, 0.076)   \n",
       "81   0.635 (0.601, 0.66)  0.702 (0.669, 0.733) 0.069 (0.041, 0.095)   \n",
       "82   0.418 (0.369, 0.452) 0.484 (0.439, 0.535) 0.069 (0.018, 0.118)   \n",
       "83   0.646 (0.601, 0.681) 0.713 (0.672, 0.749) 0.068 (0.038, 0.098)   \n",
       "84   0.537 (0.498, 0.571) 0.603 (0.562, 0.642) 0.068 (0.021, 0.099)   \n",
       "85   0.503 (0.466, 0.541) 0.57 (0.533, 0.606)  0.067 (0.015, 0.1)     \n",
       "86   0.538 (0.53, 0.545)  0.605 (0.596, 0.613) 0.066 (0.058, 0.074)   \n",
       "87   0.759 (0.736, 0.784) 0.824 (0.806, 0.846) 0.064 (0.045, 0.086)   \n",
       "88   0.531 (0.497, 0.559) 0.592 (0.554, 0.631) 0.064 (0.015, 0.1)     \n",
       "89   0.535 (0.498, 0.585) 0.598 (0.567, 0.634) 0.063 (0.029, 0.102)   \n",
       "90   0.744 (0.736, 0.754) 0.805 (0.799, 0.814) 0.062 (0.054, 0.067)   \n",
       "91   0.568 (0.558, 0.581) 0.63 (0.618, 0.643)  0.062 (0.048, 0.072)   \n",
       "92   0.487 (0.449, 0.526) 0.546 (0.494, 0.598) 0.062 (0.016, 0.096)   \n",
       "93   0.745 (0.735, 0.751) 0.806 (0.799, 0.812) 0.061 (0.055, 0.069)   \n",
       "94   0.571 (0.565, 0.578) 0.631 (0.624, 0.64)  0.06 (0.052, 0.067)    \n",
       "95   0.525 (0.513, 0.535) 0.585 (0.573, 0.596) 0.06 (0.043, 0.072)    \n",
       "96   0.551 (0.513, 0.581) 0.611 (0.574, 0.645) 0.06 (0.023, 0.091)    \n",
       "97   0.715 (0.707, 0.725) 0.775 (0.769, 0.784) 0.059 (0.052, 0.066)   \n",
       "98   0.52 (0.495, 0.546)  0.579 (0.544, 0.616) 0.059 (0.029, 0.093)   \n",
       "99   0.631 (0.587, 0.674) 0.692 (0.655, 0.736) 0.058 (0.023, 0.107)   \n",
       "100  0.516 (0.491, 0.542) 0.573 (0.551, 0.602) 0.057 (0.036, 0.084)   \n",
       "101  0.551 (0.523, 0.59)  0.61 (0.575, 0.639)  0.056 (0.038, 0.071)   \n",
       "102  0.595 (0.568, 0.622) 0.652 (0.621, 0.677) 0.056 (0.034, 0.079)   \n",
       "103  0.504 (0.477, 0.523) 0.559 (0.541, 0.583) 0.056 (0.03, 0.081)    \n",
       "104  0.457 (0.422, 0.49)  0.512 (0.473, 0.552) 0.056 (0.005, 0.102)   \n",
       "105  0.632 (0.624, 0.637) 0.687 (0.68, 0.693)  0.055 (0.051, 0.06)    \n",
       "106  0.701 (0.688, 0.717) 0.755 (0.741, 0.768) 0.055 (0.041, 0.067)   \n",
       "107  0.59 (0.56, 0.622)   0.645 (0.621, 0.681) 0.055 (0.03, 0.082)    \n",
       "108  0.546 (0.537, 0.551) 0.6 (0.594, 0.607)   0.054 (0.049, 0.063)   \n",
       "109  0.582 (0.554, 0.603) 0.637 (0.613, 0.658) 0.054 (0.032, 0.081)   \n",
       "110  0.455 (0.432, 0.488) 0.51 (0.48, 0.541)   0.054 (0.023, 0.087)   \n",
       "111  0.473 (0.427, 0.5)   0.525 (0.485, 0.561) 0.054 (0.021, 0.101)   \n",
       "112  0.732 (0.728, 0.736) 0.784 (0.781, 0.789) 0.053 (0.049, 0.055)   \n",
       "113  0.563 (0.556, 0.571) 0.616 (0.608, 0.625) 0.053 (0.046, 0.06)    \n",
       "114  0.653 (0.635, 0.672) 0.708 (0.691, 0.727) 0.053 (0.036, 0.068)   \n",
       "115  0.553 (0.52, 0.584)  0.606 (0.569, 0.633) 0.053 (0.033, 0.072)   \n",
       "116  0.513 (0.495, 0.527) 0.566 (0.546, 0.585) 0.053 (0.032, 0.077)   \n",
       "117  0.618 (0.585, 0.655) 0.673 (0.639, 0.701) 0.053 (0.023, 0.093)   \n",
       "118  0.579 (0.551, 0.614) 0.632 (0.589, 0.674) 0.052 (0.016, 0.095)   \n",
       "119  0.595 (0.582, 0.605) 0.646 (0.632, 0.656) 0.051 (0.041, 0.062)   \n",
       "120  0.624 (0.601, 0.64)  0.676 (0.653, 0.693) 0.051 (0.035, 0.069)   \n",
       "121  0.494 (0.457, 0.527) 0.545 (0.496, 0.586) 0.051 (0.014, 0.092)   \n",
       "122  0.508 (0.487, 0.531) 0.559 (0.539, 0.577) 0.05 (0.023, 0.073)    \n",
       "123  0.519 (0.512, 0.531) 0.569 (0.56, 0.581)  0.049 (0.039, 0.061)   \n",
       "124  0.67 (0.655, 0.685)  0.719 (0.703, 0.734) 0.049 (0.037, 0.062)   \n",
       "125  0.482 (0.45, 0.512)  0.532 (0.499, 0.562) 0.049 (0.012, 0.085)   \n",
       "126  0.588 (0.58, 0.595)  0.635 (0.628, 0.643) 0.048 (0.041, 0.053)   \n",
       "127  0.66 (0.637, 0.673)  0.706 (0.684, 0.721) 0.048 (0.031, 0.066)   \n",
       "128  0.645 (0.617, 0.675) 0.698 (0.663, 0.726) 0.048 (0.023, 0.08)    \n",
       "129  0.508 (0.486, 0.54)  0.557 (0.532, 0.577) 0.048 (0.015, 0.073)   \n",
       "130  0.564 (0.532, 0.611) 0.618 (0.584, 0.654) 0.048 (0.012, 0.089)   \n",
       "131  0.527 (0.515, 0.539) 0.574 (0.563, 0.584) 0.047 (0.035, 0.059)   \n",
       "132  0.555 (0.524, 0.582) 0.599 (0.578, 0.631) 0.047 (0.013, 0.068)   \n",
       "133  0.568 (0.559, 0.576) 0.614 (0.608, 0.622) 0.046 (0.039, 0.055)   \n",
       "134  0.509 (0.494, 0.525) 0.557 (0.54, 0.569)  0.046 (0.033, 0.064)   \n",
       "135  0.633 (0.604, 0.668) 0.679 (0.643, 0.723) 0.046 (0.021, 0.075)   \n",
       "136  0.648 (0.618, 0.688) 0.697 (0.662, 0.726) 0.046 (0.013, 0.08)    \n",
       "137  0.557 (0.515, 0.604) 0.603 (0.558, 0.643) 0.046 (0.001, 0.088)   \n",
       "138  0.502 (0.475, 0.531) 0.547 (0.523, 0.568) 0.044 (0.021, 0.074)   \n",
       "139  0.537 (0.501, 0.572) 0.579 (0.548, 0.615) 0.044 (0.011, 0.076)   \n",
       "140  0.697 (0.677, 0.712) 0.738 (0.719, 0.755) 0.043 (0.026, 0.055)   \n",
       "141  0.527 (0.501, 0.557) 0.57 (0.544, 0.59)   0.043 (0.012, 0.069)   \n",
       "142  0.517 (0.491, 0.555) 0.562 (0.531, 0.588) 0.042 (0.012, 0.068)   \n",
       "143  0.717 (0.702, 0.739) 0.759 (0.741, 0.779) 0.041 (0.028, 0.055)   \n",
       "144  0.67 (0.649, 0.691)  0.712 (0.69, 0.735)  0.041 (0.024, 0.058)   \n",
       "145  0.672 (0.643, 0.697) 0.71 (0.684, 0.735)  0.041 (0.02, 0.057)    \n",
       "146  0.544 (0.506, 0.584) 0.587 (0.535, 0.622) 0.041 (0.011, 0.077)   \n",
       "147  0.555 (0.507, 0.603) 0.594 (0.559, 0.642) 0.041 (0.011, 0.07)    \n",
       "148  0.581 (0.57, 0.59)   0.621 (0.613, 0.629) 0.04 (0.031, 0.048)    \n",
       "149  0.544 (0.524, 0.563) 0.584 (0.566, 0.602) 0.04 (0.026, 0.057)    \n",
       "150  0.667 (0.651, 0.687) 0.708 (0.691, 0.724) 0.04 (0.025, 0.052)    \n",
       "151  0.559 (0.531, 0.597) 0.598 (0.567, 0.633) 0.04 (0.014, 0.07)     \n",
       "152  0.475 (0.437, 0.499) 0.513 (0.481, 0.558) 0.04 (0.014, 0.068)    \n",
       "153  0.627 (0.587, 0.671) 0.668 (0.627, 0.712) 0.04 (-0.01, 0.081)    \n",
       "154  0.508 (0.5, 0.517)   0.547 (0.54, 0.556)  0.039 (0.031, 0.047)   \n",
       "155  0.513 (0.504, 0.522) 0.552 (0.54, 0.56)   0.039 (0.027, 0.051)   \n",
       "156  0.668 (0.656, 0.683) 0.707 (0.693, 0.72)  0.039 (0.027, 0.048)   \n",
       "157  0.726 (0.697, 0.76)  0.764 (0.739, 0.795) 0.039 (0.015, 0.057)   \n",
       "158  0.527 (0.5, 0.546)   0.565 (0.541, 0.591) 0.039 (0.014, 0.066)   \n",
       "159  0.532 (0.501, 0.559) 0.568 (0.542, 0.596) 0.039 (0.013, 0.058)   \n",
       "160  0.512 (0.458, 0.55)  0.554 (0.505, 0.585) 0.039 (-0.001, 0.092)  \n",
       "161  0.666 (0.658, 0.674) 0.704 (0.697, 0.711) 0.038 (0.033, 0.046)   \n",
       "162  0.598 (0.587, 0.611) 0.637 (0.627, 0.649) 0.038 (0.029, 0.05)    \n",
       "163  0.53 (0.52, 0.542)   0.567 (0.559, 0.576) 0.038 (0.029, 0.045)   \n",
       "164  0.501 (0.493, 0.51)  0.539 (0.532, 0.548) 0.038 (0.028, 0.048)   \n",
       "165  0.683 (0.667, 0.699) 0.72 (0.707, 0.737)  0.038 (0.027, 0.052)   \n",
       "166  0.681 (0.666, 0.697) 0.72 (0.705, 0.735)  0.038 (0.027, 0.048)   \n",
       "167  0.651 (0.626, 0.676) 0.689 (0.668, 0.712) 0.038 (0.016, 0.064)   \n",
       "168  0.504 (0.466, 0.538) 0.543 (0.514, 0.58)  0.038 (0.008, 0.074)   \n",
       "169  0.581 (0.575, 0.587) 0.618 (0.612, 0.624) 0.037 (0.031, 0.044)   \n",
       "170  0.512 (0.497, 0.526) 0.548 (0.533, 0.563) 0.037 (0.022, 0.055)   \n",
       "171  0.512 (0.498, 0.528) 0.549 (0.537, 0.562) 0.037 (0.022, 0.054)   \n",
       "172  0.654 (0.622, 0.692) 0.694 (0.66, 0.724)  0.037 (0.008, 0.072)   \n",
       "173  0.653 (0.643, 0.661) 0.689 (0.678, 0.697) 0.036 (0.028, 0.043)   \n",
       "174  0.54 (0.528, 0.554)  0.577 (0.565, 0.59)  0.036 (0.025, 0.05)    \n",
       "175  0.594 (0.57, 0.623)  0.629 (0.604, 0.664) 0.036 (0.016, 0.059)   \n",
       "176  0.67 (0.649, 0.691)  0.703 (0.688, 0.724) 0.036 (0.016, 0.05)    \n",
       "177  0.559 (0.533, 0.585) 0.595 (0.568, 0.616) 0.036 (0.012, 0.052)   \n",
       "178  0.542 (0.527, 0.558) 0.578 (0.565, 0.591) 0.035 (0.022, 0.051)   \n",
       "179  0.682 (0.657, 0.717) 0.72 (0.683, 0.749)  0.035 (0.009, 0.061)   \n",
       "180  0.646 (0.604, 0.683) 0.684 (0.646, 0.721) 0.035 (0.007, 0.089)   \n",
       "181  0.558 (0.528, 0.598) 0.592 (0.555, 0.647) 0.035 (-0.013, 0.078)  \n",
       "182  0.535 (0.529, 0.54)  0.568 (0.563, 0.573) 0.034 (0.027, 0.039)   \n",
       "183  0.51 (0.499, 0.52)   0.545 (0.532, 0.555) 0.034 (0.019, 0.048)   \n",
       "184  0.661 (0.636, 0.684) 0.694 (0.666, 0.714) 0.034 (0.016, 0.052)   \n",
       "185  0.606 (0.598, 0.615) 0.638 (0.631, 0.647) 0.033 (0.022, 0.041)   \n",
       "186  0.679 (0.665, 0.697) 0.714 (0.697, 0.726) 0.033 (0.021, 0.045)   \n",
       "187  0.533 (0.507, 0.558) 0.566 (0.536, 0.591) 0.033 (0.004, 0.064)   \n",
       "188  0.619 (0.61, 0.629)  0.651 (0.641, 0.66)  0.032 (0.026, 0.038)   \n",
       "189  0.616 (0.603, 0.631) 0.648 (0.636, 0.66)  0.032 (0.023, 0.042)   \n",
       "190  0.599 (0.581, 0.611) 0.631 (0.613, 0.647) 0.032 (0.021, 0.047)   \n",
       "191  0.592 (0.578, 0.606) 0.622 (0.609, 0.638) 0.032 (0.019, 0.042)   \n",
       "192  0.624 (0.599, 0.643) 0.656 (0.632, 0.675) 0.032 (0.017, 0.046)   \n",
       "193  0.524 (0.511, 0.541) 0.557 (0.543, 0.573) 0.032 (0.014, 0.046)   \n",
       "194  0.7 (0.67, 0.737)    0.732 (0.699, 0.768) 0.032 (0.009, 0.059)   \n",
       "195  0.608 (0.585, 0.63)  0.639 (0.611, 0.662) 0.032 (0.005, 0.054)   \n",
       "196  0.506 (0.477, 0.538) 0.54 (0.499, 0.57)   0.032 (-0.009, 0.078)  \n",
       "197  0.488 (0.477, 0.497) 0.52 (0.51, 0.53)    0.031 (0.023, 0.042)   \n",
       "198  0.532 (0.512, 0.55)  0.564 (0.544, 0.577) 0.031 (0.018, 0.049)   \n",
       "199  0.557 (0.542, 0.57)  0.587 (0.575, 0.602) 0.031 (0.018, 0.044)   \n",
       "200  0.505 (0.491, 0.521) 0.535 (0.52, 0.549)  0.031 (0.012, 0.05)    \n",
       "201  0.519 (0.498, 0.538) 0.55 (0.532, 0.567)  0.031 (0.008, 0.052)   \n",
       "202  0.574 (0.547, 0.593) 0.603 (0.569, 0.631) 0.031 (0.006, 0.052)   \n",
       "203  0.508 (0.466, 0.556) 0.54 (0.502, 0.574)  0.031 (-0.006, 0.071)  \n",
       "204  0.695 (0.685, 0.708) 0.726 (0.716, 0.737) 0.03 (0.024, 0.041)    \n",
       "205  0.521 (0.514, 0.528) 0.551 (0.545, 0.557) 0.03 (0.023, 0.037)    \n",
       "206  0.482 (0.474, 0.491) 0.514 (0.504, 0.523) 0.03 (0.021, 0.043)    \n",
       "207  0.546 (0.528, 0.565) 0.577 (0.558, 0.596) 0.03 (0.017, 0.049)    \n",
       "208  0.567 (0.545, 0.586) 0.598 (0.578, 0.617) 0.03 (0.015, 0.048)    \n",
       "209  0.594 (0.577, 0.617) 0.625 (0.602, 0.643) 0.03 (0.01, 0.045)     \n",
       "210  0.619 (0.591, 0.645) 0.647 (0.618, 0.673) 0.03 (0.007, 0.053)    \n",
       "211  0.52 (0.501, 0.541)  0.55 (0.528, 0.572)  0.03 (0.007, 0.047)    \n",
       "212  0.541 (0.511, 0.564) 0.567 (0.546, 0.598) 0.03 (0.003, 0.061)    \n",
       "213  0.55 (0.5, 0.589)    0.581 (0.546, 0.622) 0.03 (-0.004, 0.075)   \n",
       "214  0.506 (0.502, 0.511) 0.536 (0.532, 0.542) 0.029 (0.024, 0.035)   \n",
       "215  0.505 (0.499, 0.512) 0.534 (0.529, 0.541) 0.029 (0.023, 0.036)   \n",
       "216  0.573 (0.563, 0.582) 0.602 (0.593, 0.611) 0.029 (0.021, 0.037)   \n",
       "217  0.73 (0.717, 0.744)  0.759 (0.745, 0.773) 0.029 (0.019, 0.04)    \n",
       "218  0.72 (0.69, 0.745)   0.748 (0.712, 0.773) 0.029 (0.011, 0.046)   \n",
       "219  0.5 (0.489, 0.51)    0.528 (0.517, 0.537) 0.029 (0.011, 0.04)    \n",
       "220  0.547 (0.523, 0.566) 0.576 (0.554, 0.596) 0.029 (0.01, 0.055)    \n",
       "221  0.647 (0.624, 0.673) 0.678 (0.658, 0.697) 0.029 (0.008, 0.05)    \n",
       "222  0.576 (0.552, 0.603) 0.604 (0.58, 0.629)  0.029 (0.004, 0.053)   \n",
       "223  0.55 (0.54, 0.56)    0.578 (0.569, 0.589) 0.028 (0.019, 0.037)   \n",
       "224  0.677 (0.657, 0.689) 0.704 (0.689, 0.714) 0.028 (0.013, 0.04)    \n",
       "225  0.545 (0.528, 0.563) 0.575 (0.552, 0.594) 0.028 (0.011, 0.052)   \n",
       "226  0.676 (0.651, 0.708) 0.705 (0.682, 0.738) 0.028 (0.009, 0.046)   \n",
       "227  0.542 (0.518, 0.562) 0.568 (0.539, 0.592) 0.028 (0.005, 0.044)   \n",
       "228  0.502 (0.484, 0.522) 0.531 (0.508, 0.548) 0.028 (0.004, 0.047)   \n",
       "229  0.566 (0.533, 0.602) 0.595 (0.564, 0.629) 0.028 (0, 0.07)        \n",
       "230  0.525 (0.476, 0.568) 0.549 (0.518, 0.595) 0.028 (-0.03, 0.077)   \n",
       "231  0.472 (0.442, 0.512) 0.501 (0.461, 0.532) 0.028 (-0.024, 0.066)  \n",
       "232  0.544 (0.509, 0.589) 0.57 (0.535, 0.611)  0.028 (-0.014, 0.063)  \n",
       "233  0.622 (0.608, 0.633) 0.648 (0.636, 0.658) 0.027 (0.019, 0.036)   \n",
       "234  0.597 (0.583, 0.609) 0.624 (0.608, 0.64)  0.027 (0.018, 0.037)   \n",
       "235  0.52 (0.512, 0.53)   0.548 (0.537, 0.556) 0.027 (0.018, 0.035)   \n",
       "236  0.531 (0.52, 0.541)  0.558 (0.547, 0.569) 0.027 (0.014, 0.038)   \n",
       "237  0.624 (0.605, 0.652) 0.651 (0.631, 0.671) 0.027 (0.013, 0.042)   \n",
       "238  0.672 (0.653, 0.695) 0.701 (0.679, 0.722) 0.027 (0.012, 0.042)   \n",
       "239  0.619 (0.599, 0.644) 0.647 (0.624, 0.671) 0.027 (0.011, 0.047)   \n",
       "240  0.65 (0.626, 0.674)  0.675 (0.655, 0.695) 0.027 (0.011, 0.042)   \n",
       "241  0.641 (0.611, 0.675) 0.668 (0.633, 0.702) 0.027 (0.01, 0.046)    \n",
       "242  0.635 (0.608, 0.663) 0.662 (0.635, 0.693) 0.027 (0.004, 0.049)   \n",
       "243  0.512 (0.483, 0.545) 0.537 (0.509, 0.57)  0.027 (0, 0.049)       \n",
       "244  0.566 (0.533, 0.597) 0.594 (0.563, 0.63)  0.027 (-0.005, 0.066)  \n",
       "245  0.544 (0.54, 0.55)   0.571 (0.565, 0.576) 0.026 (0.021, 0.03)    \n",
       "246  0.513 (0.508, 0.519) 0.539 (0.533, 0.543) 0.026 (0.02, 0.031)    \n",
       "247  0.502 (0.496, 0.508) 0.529 (0.523, 0.536) 0.026 (0.019, 0.034)   \n",
       "248  0.578 (0.568, 0.585) 0.604 (0.595, 0.614) 0.026 (0.018, 0.034)   \n",
       "249  0.612 (0.593, 0.629) 0.638 (0.622, 0.654) 0.026 (0.015, 0.041)   \n",
       "250  0.554 (0.539, 0.569) 0.579 (0.566, 0.601) 0.026 (0.012, 0.041)   \n",
       "251  0.585 (0.566, 0.602) 0.611 (0.594, 0.627) 0.026 (0.012, 0.041)   \n",
       "252  0.721 (0.705, 0.737) 0.746 (0.733, 0.761) 0.026 (0.011, 0.038)   \n",
       "253  0.513 (0.493, 0.534) 0.537 (0.522, 0.563) 0.026 (0.01, 0.04)     \n",
       "254  0.496 (0.455, 0.552) 0.524 (0.476, 0.566) 0.026 (-0.021, 0.073)  \n",
       "255  0.528 (0.497, 0.565) 0.556 (0.523, 0.589) 0.026 (-0.009, 0.061)  \n",
       "256  0.601 (0.56, 0.653)  0.629 (0.573, 0.676) 0.026 (-0.003, 0.056)  \n",
       "257  0.566 (0.531, 0.599) 0.595 (0.563, 0.632) 0.026 (-0.003, 0.052)  \n",
       "258  0.593 (0.56, 0.623)  0.618 (0.585, 0.651) 0.026 (-0.002, 0.051)  \n",
       "259  0.533 (0.527, 0.54)  0.558 (0.553, 0.564) 0.025 (0.02, 0.031)    \n",
       "260  0.543 (0.534, 0.553) 0.568 (0.561, 0.578) 0.025 (0.016, 0.034)   \n",
       "261  0.503 (0.486, 0.52)  0.53 (0.506, 0.545)  0.025 (0.012, 0.04)    \n",
       "262  0.536 (0.521, 0.551) 0.561 (0.545, 0.576) 0.025 (0.012, 0.037)   \n",
       "263  0.547 (0.529, 0.563) 0.572 (0.556, 0.586) 0.025 (0.011, 0.038)   \n",
       "264  0.721 (0.697, 0.74)  0.744 (0.725, 0.766) 0.025 (0.008, 0.041)   \n",
       "265  0.559 (0.53, 0.584)  0.583 (0.55, 0.61)   0.025 (0.001, 0.052)   \n",
       "266  0.587 (0.559, 0.62)  0.612 (0.573, 0.656) 0.025 (-0.017, 0.057)  \n",
       "267  0.508 (0.482, 0.537) 0.534 (0.506, 0.563) 0.025 (-0.016, 0.055)  \n",
       "268  0.472 (0.441, 0.5)   0.496 (0.471, 0.524) 0.025 (-0.01, 0.057)   \n",
       "269  0.599 (0.575, 0.627) 0.621 (0.587, 0.654) 0.025 (-0.007, 0.054)  \n",
       "270  0.552 (0.546, 0.559) 0.577 (0.57, 0.582)  0.024 (0.017, 0.029)   \n",
       "271  0.542 (0.534, 0.552) 0.566 (0.555, 0.577) 0.024 (0.013, 0.034)   \n",
       "272  0.667 (0.65, 0.685)  0.692 (0.669, 0.712) 0.024 (0.01, 0.041)    \n",
       "273  0.582 (0.563, 0.597) 0.605 (0.586, 0.621) 0.024 (0.009, 0.042)   \n",
       "274  0.627 (0.606, 0.648) 0.652 (0.628, 0.673) 0.024 (0.009, 0.041)   \n",
       "275  0.592 (0.566, 0.617) 0.614 (0.594, 0.64)  0.024 (0.008, 0.039)   \n",
       "276  0.621 (0.603, 0.646) 0.647 (0.625, 0.668) 0.024 (0.008, 0.039)   \n",
       "277  0.5 (0.487, 0.513)   0.524 (0.512, 0.537) 0.024 (0.008, 0.038)   \n",
       "278  0.598 (0.571, 0.624) 0.625 (0.594, 0.646) 0.024 (0.006, 0.045)   \n",
       "279  0.536 (0.52, 0.554)  0.559 (0.539, 0.58)  0.024 (0.003, 0.044)   \n",
       "280  0.687 (0.653, 0.712) 0.71 (0.676, 0.739)  0.024 (0.002, 0.047)   \n",
       "281  0.722 (0.687, 0.754) 0.745 (0.71, 0.781)  0.024 (-0.004, 0.048)  \n",
       "282  0.53 (0.52, 0.538)   0.553 (0.543, 0.563) 0.023 (0.016, 0.029)   \n",
       "283  0.612 (0.604, 0.618) 0.634 (0.626, 0.643) 0.023 (0.016, 0.028)   \n",
       "284  0.566 (0.542, 0.596) 0.591 (0.558, 0.617) 0.023 (0.002, 0.049)   \n",
       "285  0.516 (0.473, 0.552) 0.538 (0.502, 0.576) 0.023 (-0.008, 0.061)  \n",
       "286  0.612 (0.604, 0.619) 0.635 (0.627, 0.642) 0.022 (0.017, 0.029)   \n",
       "287  0.513 (0.508, 0.518) 0.535 (0.529, 0.538) 0.022 (0.017, 0.027)   \n",
       "288  0.587 (0.572, 0.605) 0.607 (0.591, 0.624) 0.022 (0.012, 0.032)   \n",
       "289  0.592 (0.571, 0.608) 0.614 (0.601, 0.629) 0.022 (0.01, 0.035)    \n",
       "290  0.587 (0.575, 0.599) 0.609 (0.595, 0.621) 0.022 (0.01, 0.031)    \n",
       "291  0.543 (0.527, 0.558) 0.565 (0.553, 0.578) 0.022 (0.009, 0.035)   \n",
       "292  0.555 (0.535, 0.569) 0.577 (0.559, 0.597) 0.022 (0.008, 0.041)   \n",
       "293  0.535 (0.52, 0.55)   0.559 (0.539, 0.577) 0.022 (0.006, 0.045)   \n",
       "294  0.56 (0.538, 0.586)  0.582 (0.559, 0.611) 0.022 (0.004, 0.041)   \n",
       "295  0.655 (0.624, 0.692) 0.678 (0.647, 0.716) 0.022 (0.002, 0.046)   \n",
       "296  0.623 (0.59, 0.653)  0.643 (0.603, 0.68)  0.022 (-0.01, 0.052)   \n",
       "297  0.64 (0.61, 0.671)   0.661 (0.633, 0.694) 0.022 (-0.009, 0.047)  \n",
       "298  0.538 (0.533, 0.543) 0.559 (0.554, 0.564) 0.021 (0.016, 0.026)   \n",
       "299  0.705 (0.696, 0.711) 0.725 (0.718, 0.731) 0.021 (0.014, 0.028)   \n",
       "300  0.593 (0.57, 0.616)  0.614 (0.587, 0.638) 0.021 (0.005, 0.033)   \n",
       "301  0.496 (0.485, 0.507) 0.516 (0.503, 0.526) 0.021 (0.004, 0.032)   \n",
       "302  0.596 (0.566, 0.632) 0.615 (0.58, 0.652)  0.021 (-0.007, 0.046)  \n",
       "303  0.663 (0.643, 0.685) 0.686 (0.663, 0.707) 0.021 (-0.002, 0.045)  \n",
       "304  0.54 (0.531, 0.547)  0.559 (0.551, 0.567) 0.02 (0.015, 0.025)    \n",
       "305  0.577 (0.567, 0.588) 0.598 (0.587, 0.608) 0.02 (0.012, 0.028)    \n",
       "306  0.536 (0.527, 0.548) 0.557 (0.546, 0.567) 0.02 (0.011, 0.033)    \n",
       "307  0.687 (0.677, 0.697) 0.708 (0.697, 0.717) 0.02 (0.011, 0.029)    \n",
       "308  0.541 (0.531, 0.551) 0.561 (0.551, 0.569) 0.02 (0.01, 0.029)     \n",
       "309  0.592 (0.58, 0.604)  0.612 (0.598, 0.624) 0.02 (0.01, 0.027)     \n",
       "310  0.645 (0.634, 0.658) 0.666 (0.655, 0.678) 0.02 (0.009, 0.031)    \n",
       "311  0.589 (0.572, 0.603) 0.608 (0.591, 0.623) 0.02 (0.003, 0.033)    \n",
       "312  0.581 (0.561, 0.606) 0.601 (0.577, 0.621) 0.02 (0.002, 0.041)    \n",
       "313  0.632 (0.596, 0.666) 0.652 (0.617, 0.685) 0.02 (-0.009, 0.055)   \n",
       "314  0.563 (0.543, 0.584) 0.584 (0.558, 0.606) 0.02 (-0.009, 0.042)   \n",
       "315  0.572 (0.539, 0.603) 0.594 (0.565, 0.617) 0.02 (-0.006, 0.046)   \n",
       "316  0.498 (0.48, 0.516)  0.516 (0.496, 0.537) 0.02 (-0.006, 0.04)    \n",
       "317  0.492 (0.482, 0.5)   0.511 (0.501, 0.518) 0.019 (0.007, 0.029)   \n",
       "318  0.75 (0.732, 0.763)  0.769 (0.753, 0.783) 0.019 (0.007, 0.029)   \n",
       "319  0.579 (0.56, 0.596)  0.597 (0.58, 0.612)  0.019 (0.002, 0.031)   \n",
       "320  0.543 (0.527, 0.559) 0.563 (0.545, 0.575) 0.019 (0.001, 0.04)    \n",
       "321  0.55 (0.524, 0.575)  0.568 (0.545, 0.599) 0.019 (-0.01, 0.048)   \n",
       "322  0.53 (0.511, 0.546)  0.549 (0.528, 0.567) 0.019 (-0.001, 0.038)  \n",
       "323  0.565 (0.554, 0.573) 0.583 (0.575, 0.593) 0.018 (0.011, 0.027)   \n",
       "324  0.578 (0.57, 0.586)  0.596 (0.587, 0.604) 0.018 (0.011, 0.026)   \n",
       "325  0.536 (0.529, 0.543) 0.554 (0.546, 0.561) 0.018 (0.01, 0.025)    \n",
       "326  0.544 (0.533, 0.553) 0.561 (0.553, 0.572) 0.018 (0.008, 0.029)   \n",
       "327  0.585 (0.565, 0.603) 0.604 (0.586, 0.62)  0.018 (0.006, 0.032)   \n",
       "328  0.627 (0.607, 0.65)  0.647 (0.622, 0.672) 0.018 (0.004, 0.039)   \n",
       "329  0.596 (0.583, 0.613) 0.615 (0.602, 0.628) 0.018 (0.004, 0.03)    \n",
       "330  0.581 (0.57, 0.596)  0.599 (0.585, 0.614) 0.018 (0.003, 0.03)    \n",
       "331  0.642 (0.622, 0.66)  0.66 (0.635, 0.679)  0.018 (0.002, 0.037)   \n",
       "332  0.612 (0.594, 0.638) 0.633 (0.609, 0.654) 0.018 (0.001, 0.039)   \n",
       "333  0.521 (0.499, 0.55)  0.537 (0.507, 0.562) 0.018 (-0.016, 0.045)  \n",
       "334  0.517 (0.512, 0.522) 0.534 (0.529, 0.538) 0.017 (0.011, 0.022)   \n",
       "335  0.599 (0.588, 0.611) 0.617 (0.601, 0.63)  0.017 (0.008, 0.027)   \n",
       "336  0.608 (0.591, 0.618) 0.625 (0.609, 0.641) 0.017 (0.006, 0.028)   \n",
       "337  0.591 (0.577, 0.604) 0.607 (0.594, 0.624) 0.017 (0.003, 0.03)    \n",
       "338  0.586 (0.566, 0.601) 0.602 (0.589, 0.62)  0.017 (0.003, 0.029)   \n",
       "339  0.563 (0.548, 0.582) 0.58 (0.562, 0.603)  0.017 (0.002, 0.033)   \n",
       "340  0.465 (0.437, 0.497) 0.483 (0.455, 0.51)  0.017 (-0.019, 0.051)  \n",
       "341  0.544 (0.513, 0.57)  0.56 (0.525, 0.586)  0.017 (-0.015, 0.041)  \n",
       "342  0.58 (0.557, 0.613)  0.596 (0.569, 0.626) 0.017 (-0.011, 0.044)  \n",
       "343  0.709 (0.681, 0.737) 0.726 (0.696, 0.759) 0.017 (-0.002, 0.04)   \n",
       "344  0.605 (0.583, 0.623) 0.622 (0.601, 0.639) 0.017 (-0.002, 0.036)  \n",
       "345  0.626 (0.623, 0.63)  0.642 (0.638, 0.646) 0.016 (0.014, 0.019)   \n",
       "346  0.626 (0.622, 0.63)  0.642 (0.638, 0.647) 0.016 (0.014, 0.019)   \n",
       "347  0.57 (0.565, 0.575)  0.586 (0.581, 0.591) 0.016 (0.013, 0.02)    \n",
       "348  0.559 (0.555, 0.563) 0.575 (0.572, 0.579) 0.016 (0.013, 0.02)    \n",
       "349  0.518 (0.513, 0.522) 0.534 (0.529, 0.537) 0.016 (0.012, 0.02)    \n",
       "350  0.588 (0.579, 0.595) 0.605 (0.596, 0.613) 0.016 (0.011, 0.024)   \n",
       "351  0.528 (0.522, 0.535) 0.544 (0.537, 0.55)  0.016 (0.01, 0.021)    \n",
       "352  0.695 (0.684, 0.704) 0.711 (0.7, 0.721)   0.016 (0.009, 0.025)   \n",
       "353  0.647 (0.639, 0.656) 0.662 (0.655, 0.671) 0.016 (0.009, 0.023)   \n",
       "354  0.544 (0.537, 0.552) 0.56 (0.554, 0.567)  0.016 (0.009, 0.022)   \n",
       "355  0.555 (0.547, 0.562) 0.571 (0.563, 0.58)  0.016 (0.009, 0.022)   \n",
       "356  0.58 (0.57, 0.591)   0.597 (0.587, 0.608) 0.016 (0.008, 0.024)   \n",
       "357  0.606 (0.595, 0.617) 0.621 (0.611, 0.635) 0.016 (0.007, 0.026)   \n",
       "358  0.638 (0.624, 0.655) 0.655 (0.643, 0.668) 0.016 (0.005, 0.029)   \n",
       "359  0.534 (0.523, 0.543) 0.55 (0.538, 0.563)  0.016 (0.005, 0.027)   \n",
       "360  0.534 (0.521, 0.547) 0.549 (0.539, 0.562) 0.016 (0.003, 0.028)   \n",
       "361  0.675 (0.627, 0.723) 0.689 (0.64, 0.742)  0.016 (-0.034, 0.061)  \n",
       "362  0.506 (0.474, 0.536) 0.521 (0.491, 0.552) 0.016 (-0.017, 0.053)  \n",
       "363  0.562 (0.535, 0.592) 0.578 (0.556, 0.602) 0.016 (-0.004, 0.04)   \n",
       "364  0.553 (0.545, 0.563) 0.569 (0.562, 0.578) 0.015 (0.01, 0.023)    \n",
       "365  0.665 (0.657, 0.671) 0.68 (0.672, 0.687)  0.015 (0.01, 0.021)    \n",
       "366  0.554 (0.547, 0.562) 0.57 (0.562, 0.576)  0.015 (0.01, 0.02)     \n",
       "367  0.613 (0.601, 0.628) 0.629 (0.616, 0.643) 0.015 (0.009, 0.024)   \n",
       "368  0.624 (0.612, 0.633) 0.638 (0.626, 0.648) 0.015 (0.009, 0.021)   \n",
       "369  0.675 (0.667, 0.683) 0.689 (0.681, 0.699) 0.015 (0.008, 0.022)   \n",
       "370  0.64 (0.629, 0.655)  0.655 (0.642, 0.672) 0.015 (0.004, 0.026)   \n",
       "371  0.55 (0.536, 0.561)  0.565 (0.553, 0.578) 0.015 (0.003, 0.028)   \n",
       "372  0.61 (0.593, 0.631)  0.626 (0.61, 0.641)  0.015 (0.001, 0.029)   \n",
       "373  0.525 (0.508, 0.539) 0.54 (0.524, 0.551)  0.015 (0, 0.03)        \n",
       "374  0.507 (0.478, 0.527) 0.522 (0.501, 0.543) 0.015 (-0.005, 0.034)  \n",
       "375  0.532 (0.508, 0.552) 0.546 (0.527, 0.564) 0.015 (-0.005, 0.034)  \n",
       "376  0.543 (0.53, 0.559)  0.559 (0.542, 0.572) 0.015 (-0.001, 0.029)  \n",
       "377  0.55 (0.543, 0.555)  0.565 (0.56, 0.57)   0.014 (0.01, 0.019)    \n",
       "378  0.541 (0.534, 0.545) 0.554 (0.547, 0.56)  0.014 (0.009, 0.017)   \n",
       "379  0.544 (0.537, 0.553) 0.559 (0.551, 0.567) 0.014 (0.008, 0.019)   \n",
       "380  0.555 (0.547, 0.565) 0.57 (0.56, 0.58)    0.014 (0.006, 0.024)   \n",
       "381  0.541 (0.53, 0.551)  0.555 (0.544, 0.566) 0.014 (0.006, 0.022)   \n",
       "382  0.535 (0.527, 0.544) 0.548 (0.539, 0.556) 0.014 (0.005, 0.02)    \n",
       "383  0.586 (0.576, 0.595) 0.598 (0.589, 0.61)  0.014 (0.005, 0.019)   \n",
       "384  0.545 (0.533, 0.556) 0.558 (0.548, 0.57)  0.014 (0.003, 0.022)   \n",
       "385  0.609 (0.582, 0.648) 0.621 (0.584, 0.657) 0.014 (-0.022, 0.038)  \n",
       "386  0.595 (0.552, 0.627) 0.611 (0.566, 0.659) 0.014 (-0.012, 0.056)  \n",
       "387  0.523 (0.493, 0.548) 0.537 (0.508, 0.561) 0.014 (-0.011, 0.036)  \n",
       "388  0.68 (0.649, 0.712)  0.692 (0.663, 0.725) 0.014 (-0.01, 0.04)    \n",
       "389  0.54 (0.521, 0.57)   0.557 (0.533, 0.583) 0.014 (-0.006, 0.036)  \n",
       "390  0.692 (0.667, 0.72)  0.707 (0.683, 0.729) 0.014 (-0.003, 0.036)  \n",
       "391  0.524 (0.51, 0.535)  0.538 (0.525, 0.548) 0.014 (-0.001, 0.028)  \n",
       "392  0.527 (0.522, 0.531) 0.54 (0.537, 0.544)  0.013 (0.01, 0.016)    \n",
       "393  0.52 (0.516, 0.525)  0.532 (0.527, 0.538) 0.013 (0.009, 0.016)   \n",
       "394  0.536 (0.529, 0.544) 0.549 (0.541, 0.556) 0.013 (0.007, 0.018)   \n",
       "395  0.679 (0.666, 0.694) 0.692 (0.682, 0.706) 0.013 (0.005, 0.022)   \n",
       "396  0.657 (0.646, 0.672) 0.67 (0.657, 0.685)  0.013 (0.005, 0.022)   \n",
       "397  0.573 (0.561, 0.587) 0.586 (0.573, 0.6)   0.013 (0.004, 0.022)   \n",
       "398  0.588 (0.578, 0.601) 0.601 (0.586, 0.611) 0.013 (0.004, 0.02)    \n",
       "399  0.623 (0.602, 0.643) 0.637 (0.616, 0.653) 0.013 (0.003, 0.025)   \n",
       "400  0.559 (0.543, 0.577) 0.574 (0.554, 0.587) 0.013 (0.003, 0.024)   \n",
       "401  0.625 (0.614, 0.639) 0.637 (0.625, 0.652) 0.013 (0.003, 0.023)   \n",
       "402  0.523 (0.51, 0.536)  0.536 (0.525, 0.549) 0.013 (0.002, 0.029)   \n",
       "403  0.657 (0.641, 0.68)  0.672 (0.654, 0.689) 0.013 (0.002, 0.024)   \n",
       "404  0.548 (0.529, 0.566) 0.561 (0.55, 0.579)  0.013 (0, 0.028)       \n",
       "405  0.627 (0.587, 0.67)  0.638 (0.604, 0.692) 0.013 (-0.036, 0.054)  \n",
       "406  0.569 (0.536, 0.6)   0.583 (0.554, 0.617) 0.013 (-0.019, 0.046)  \n",
       "407  0.555 (0.537, 0.58)  0.57 (0.546, 0.594)  0.013 (-0.012, 0.038)  \n",
       "408  0.602 (0.574, 0.632) 0.615 (0.589, 0.649) 0.013 (-0.011, 0.041)  \n",
       "409  0.571 (0.547, 0.601) 0.585 (0.563, 0.607) 0.013 (-0.01, 0.038)   \n",
       "410  0.581 (0.558, 0.611) 0.597 (0.574, 0.619) 0.013 (-0.01, 0.032)   \n",
       "411  0.584 (0.558, 0.605) 0.595 (0.575, 0.617) 0.013 (-0.008, 0.03)   \n",
       "412  0.607 (0.578, 0.638) 0.622 (0.597, 0.651) 0.013 (-0.005, 0.037)  \n",
       "413  0.58 (0.563, 0.605)  0.593 (0.568, 0.619) 0.013 (-0.005, 0.029)  \n",
       "414  0.599 (0.594, 0.605) 0.612 (0.606, 0.616) 0.012 (0.009, 0.016)   \n",
       "415  0.527 (0.524, 0.531) 0.539 (0.535, 0.543) 0.012 (0.009, 0.015)   \n",
       "416  0.561 (0.555, 0.569) 0.573 (0.566, 0.579) 0.012 (0.007, 0.016)   \n",
       "417  0.547 (0.543, 0.551) 0.559 (0.554, 0.565) 0.012 (0.007, 0.016)   \n",
       "418  0.636 (0.627, 0.643) 0.648 (0.64, 0.656)  0.012 (0.006, 0.019)   \n",
       "419  0.662 (0.648, 0.675) 0.674 (0.661, 0.684) 0.012 (0.003, 0.021)   \n",
       "420  0.519 (0.51, 0.533)  0.531 (0.519, 0.543) 0.012 (0.002, 0.022)   \n",
       "421  0.599 (0.561, 0.639) 0.614 (0.567, 0.653) 0.012 (-0.013, 0.042)  \n",
       "422  0.615 (0.583, 0.654) 0.626 (0.601, 0.651) 0.012 (-0.012, 0.039)  \n",
       "423  0.598 (0.593, 0.602) 0.609 (0.604, 0.613) 0.011 (0.009, 0.013)   \n",
       "424  0.641 (0.636, 0.647) 0.652 (0.646, 0.659) 0.011 (0.008, 0.014)   \n",
       "425  0.581 (0.575, 0.588) 0.592 (0.585, 0.599) 0.011 (0.007, 0.016)   \n",
       "426  0.556 (0.552, 0.561) 0.567 (0.563, 0.573) 0.011 (0.007, 0.015)   \n",
       "427  0.55 (0.545, 0.556)  0.561 (0.556, 0.566) 0.011 (0.006, 0.017)   \n",
       "428  0.61 (0.603, 0.617)  0.621 (0.614, 0.631) 0.011 (0.006, 0.017)   \n",
       "429  0.546 (0.54, 0.553)  0.557 (0.55, 0.563)  0.011 (0.006, 0.016)   \n",
       "430  0.568 (0.561, 0.575) 0.579 (0.572, 0.588) 0.011 (0.005, 0.016)   \n",
       "431  0.717 (0.707, 0.726) 0.727 (0.72, 0.735)  0.011 (0.004, 0.016)   \n",
       "432  0.519 (0.507, 0.533) 0.531 (0.52, 0.541)  0.011 (0.003, 0.022)   \n",
       "433  0.6 (0.589, 0.612)   0.612 (0.599, 0.623) 0.011 (0.003, 0.02)    \n",
       "434  0.496 (0.489, 0.503) 0.506 (0.499, 0.514) 0.011 (0.002, 0.02)    \n",
       "435  0.5 (0.49, 0.508)    0.511 (0.501, 0.521) 0.011 (0, 0.021)       \n",
       "436  0.57 (0.537, 0.602)  0.585 (0.552, 0.616) 0.011 (-0.016, 0.04)   \n",
       "437  0.532 (0.506, 0.555) 0.542 (0.517, 0.564) 0.011 (-0.015, 0.03)   \n",
       "438  0.632 (0.594, 0.657) 0.642 (0.609, 0.674) 0.011 (-0.011, 0.041)  \n",
       "439  0.546 (0.522, 0.574) 0.558 (0.534, 0.592) 0.011 (-0.011, 0.032)  \n",
       "440  0.611 (0.583, 0.641) 0.624 (0.591, 0.652) 0.011 (-0.01, 0.04)    \n",
       "441  0.578 (0.557, 0.599) 0.59 (0.565, 0.609)  0.011 (-0.006, 0.03)   \n",
       "442  0.598 (0.578, 0.616) 0.606 (0.588, 0.626) 0.011 (-0.006, 0.024)  \n",
       "443  0.501 (0.485, 0.517) 0.513 (0.498, 0.534) 0.011 (-0.004, 0.034)  \n",
       "444  0.573 (0.552, 0.592) 0.585 (0.561, 0.605) 0.011 (-0.003, 0.027)  \n",
       "445  0.603 (0.588, 0.621) 0.615 (0.598, 0.633) 0.011 (-0.002, 0.021)  \n",
       "446  0.683 (0.663, 0.699) 0.692 (0.676, 0.712) 0.011 (-0.001, 0.024)  \n",
       "447  0.655 (0.648, 0.664) 0.666 (0.658, 0.674) 0.01 (0.008, 0.013)    \n",
       "448  0.599 (0.595, 0.603) 0.609 (0.605, 0.614) 0.01 (0.008, 0.012)    \n",
       "449  0.524 (0.52, 0.528)  0.534 (0.53, 0.539)  0.01 (0.007, 0.013)    \n",
       "450  0.707 (0.702, 0.714) 0.718 (0.712, 0.723) 0.01 (0.006, 0.014)    \n",
       "451  0.737 (0.731, 0.748) 0.747 (0.739, 0.756) 0.01 (0.005, 0.016)    \n",
       "452  0.73 (0.716, 0.743)  0.739 (0.726, 0.752) 0.01 (0.004, 0.015)    \n",
       "453  0.522 (0.517, 0.529) 0.532 (0.525, 0.538) 0.01 (0.004, 0.015)    \n",
       "454  0.58 (0.57, 0.593)   0.59 (0.58, 0.604)   0.01 (0.002, 0.02)     \n",
       "455  0.547 (0.536, 0.556) 0.557 (0.548, 0.568) 0.01 (0.001, 0.022)    \n",
       "456  0.563 (0.549, 0.578) 0.574 (0.56, 0.589)  0.01 (0.001, 0.02)     \n",
       "457  0.533 (0.497, 0.576) 0.543 (0.507, 0.576) 0.01 (-0.024, 0.039)   \n",
       "458  0.524 (0.495, 0.56)  0.533 (0.51, 0.567)  0.01 (-0.02, 0.042)    \n",
       "459  0.657 (0.631, 0.689) 0.667 (0.636, 0.699) 0.01 (-0.018, 0.033)   \n",
       "460  0.646 (0.619, 0.681) 0.657 (0.628, 0.692) 0.01 (-0.017, 0.038)   \n",
       "461  0.575 (0.546, 0.6)   0.586 (0.554, 0.611) 0.01 (-0.014, 0.034)   \n",
       "462  0.547 (0.523, 0.573) 0.556 (0.531, 0.584) 0.01 (-0.008, 0.028)   \n",
       "463  0.599 (0.577, 0.618) 0.609 (0.593, 0.632) 0.01 (-0.005, 0.026)   \n",
       "464  0.486 (0.479, 0.496) 0.497 (0.489, 0.506) 0.01 (-0.003, 0.021)   \n",
       "465  0.608 (0.589, 0.629) 0.62 (0.598, 0.641)  0.01 (-0.002, 0.026)   \n",
       "466  0.643 (0.634, 0.652) 0.652 (0.643, 0.661) 0.009 (0.006, 0.013)   \n",
       "467  0.652 (0.646, 0.659) 0.66 (0.654, 0.668)  0.009 (0.006, 0.011)   \n",
       "468  0.558 (0.552, 0.564) 0.567 (0.56, 0.575)  0.009 (0.005, 0.013)   \n",
       "469  0.534 (0.529, 0.54)  0.543 (0.539, 0.548) 0.009 (0.005, 0.013)   \n",
       "470  0.524 (0.52, 0.529)  0.533 (0.529, 0.537) 0.009 (0.005, 0.013)   \n",
       "471  0.528 (0.525, 0.531) 0.537 (0.533, 0.541) 0.009 (0.005, 0.013)   \n",
       "472  0.558 (0.551, 0.564) 0.567 (0.559, 0.573) 0.009 (0.004, 0.014)   \n",
       "473  0.565 (0.558, 0.571) 0.574 (0.568, 0.58)  0.009 (0.004, 0.014)   \n",
       "474  0.57 (0.564, 0.574)  0.578 (0.573, 0.584) 0.009 (0.004, 0.014)   \n",
       "475  0.56 (0.552, 0.568)  0.569 (0.56, 0.578)  0.009 (0.004, 0.013)   \n",
       "476  0.716 (0.705, 0.726) 0.725 (0.717, 0.734) 0.009 (0.003, 0.016)   \n",
       "477  0.56 (0.55, 0.569)   0.569 (0.56, 0.578)  0.009 (0.003, 0.014)   \n",
       "478  0.542 (0.531, 0.556) 0.552 (0.541, 0.563) 0.009 (0.002, 0.019)   \n",
       "479  0.555 (0.547, 0.564) 0.563 (0.553, 0.571) 0.009 (0.001, 0.015)   \n",
       "480  0.646 (0.622, 0.673) 0.656 (0.629, 0.684) 0.009 (-0.017, 0.033)  \n",
       "481  0.596 (0.578, 0.619) 0.605 (0.578, 0.627) 0.009 (-0.017, 0.031)  \n",
       "482  0.682 (0.651, 0.712) 0.691 (0.662, 0.72)  0.009 (-0.013, 0.024)  \n",
       "483  0.686 (0.653, 0.731) 0.695 (0.663, 0.739) 0.009 (-0.012, 0.029)  \n",
       "484  0.665 (0.634, 0.687) 0.673 (0.645, 0.707) 0.009 (-0.008, 0.03)   \n",
       "485  0.595 (0.579, 0.612) 0.604 (0.589, 0.618) 0.009 (-0.004, 0.018)  \n",
       "486  0.52 (0.503, 0.535)  0.531 (0.514, 0.541) 0.009 (-0.002, 0.018)  \n",
       "487  0.591 (0.576, 0.609) 0.601 (0.583, 0.617) 0.009 (-0.001, 0.023)  \n",
       "488  0.614 (0.611, 0.618) 0.623 (0.619, 0.627) 0.008 (0.006, 0.011)   \n",
       "489  0.613 (0.609, 0.617) 0.621 (0.616, 0.626) 0.008 (0.006, 0.01)    \n",
       "490  0.541 (0.535, 0.548) 0.55 (0.544, 0.556)  0.008 (0.005, 0.012)   \n",
       "491  0.584 (0.579, 0.59)  0.591 (0.587, 0.597) 0.008 (0.005, 0.012)   \n",
       "492  0.606 (0.602, 0.612) 0.615 (0.61, 0.62)   0.008 (0.005, 0.011)   \n",
       "493  0.586 (0.579, 0.594) 0.594 (0.586, 0.603) 0.008 (0.003, 0.013)   \n",
       "494  0.555 (0.549, 0.56)  0.563 (0.558, 0.568) 0.008 (0.003, 0.012)   \n",
       "495  0.645 (0.633, 0.657) 0.653 (0.641, 0.666) 0.008 (0.001, 0.015)   \n",
       "496  0.537 (0.525, 0.551) 0.545 (0.532, 0.558) 0.008 (0, 0.014)       \n",
       "497  0.564 (0.542, 0.584) 0.571 (0.545, 0.594) 0.008 (-0.016, 0.031)  \n",
       "498  0.675 (0.65, 0.698)  0.683 (0.659, 0.712) 0.008 (-0.008, 0.027)  \n",
       "499  0.529 (0.512, 0.545) 0.537 (0.511, 0.557) 0.008 (-0.008, 0.024)  \n",
       "500  0.689 (0.668, 0.709) 0.697 (0.679, 0.715) 0.008 (-0.008, 0.02)   \n",
       "501  0.724 (0.706, 0.745) 0.732 (0.714, 0.751) 0.008 (-0.005, 0.021)  \n",
       "502  0.721 (0.696, 0.743) 0.73 (0.702, 0.751)  0.008 (-0.003, 0.019)  \n",
       "503  0.528 (0.518, 0.543) 0.538 (0.525, 0.55)  0.008 (-0.002, 0.022)  \n",
       "504  0.54 (0.53, 0.557)   0.55 (0.54, 0.563)   0.008 (-0.002, 0.02)   \n",
       "505  0.594 (0.585, 0.603) 0.601 (0.595, 0.613) 0.008 (-0.002, 0.018)  \n",
       "506  0.687 (0.677, 0.702) 0.696 (0.682, 0.708) 0.008 (-0.001, 0.017)  \n",
       "507  0.526 (0.523, 0.53)  0.533 (0.529, 0.536) 0.007 (0.004, 0.009)   \n",
       "508  0.526 (0.523, 0.53)  0.533 (0.53, 0.536)  0.007 (0.004, 0.009)   \n",
       "509  0.672 (0.665, 0.682) 0.679 (0.671, 0.686) 0.007 (0.003, 0.011)   \n",
       "510  0.521 (0.517, 0.525) 0.528 (0.524, 0.531) 0.007 (0.003, 0.01)    \n",
       "511  0.701 (0.693, 0.708) 0.707 (0.7, 0.715)   0.007 (0.003, 0.01)    \n",
       "512  0.682 (0.672, 0.691) 0.688 (0.679, 0.696) 0.007 (0.002, 0.014)   \n",
       "513  0.663 (0.652, 0.672) 0.671 (0.66, 0.682)  0.007 (0.001, 0.013)   \n",
       "514  0.707 (0.699, 0.715) 0.715 (0.707, 0.723) 0.007 (0.001, 0.012)   \n",
       "515  0.539 (0.534, 0.547) 0.546 (0.54, 0.553)  0.007 (0.001, 0.012)   \n",
       "516  0.704 (0.692, 0.715) 0.711 (0.7, 0.721)   0.007 (0, 0.014)       \n",
       "517  0.549 (0.537, 0.559) 0.555 (0.544, 0.567) 0.007 (0, 0.013)       \n",
       "518  0.504 (0.499, 0.509) 0.511 (0.506, 0.517) 0.007 (0, 0.012)       \n",
       "519  0.697 (0.667, 0.722) 0.703 (0.677, 0.73)  0.007 (-0.017, 0.026)  \n",
       "520  0.626 (0.591, 0.658) 0.634 (0.6, 0.663)   0.007 (-0.016, 0.033)  \n",
       "521  0.605 (0.574, 0.644) 0.611 (0.576, 0.646) 0.007 (-0.015, 0.023)  \n",
       "522  0.642 (0.619, 0.662) 0.65 (0.626, 0.67)   0.007 (-0.013, 0.026)  \n",
       "523  0.604 (0.588, 0.623) 0.611 (0.593, 0.629) 0.007 (-0.006, 0.019)  \n",
       "524  0.609 (0.595, 0.621) 0.615 (0.6, 0.632)   0.007 (-0.005, 0.019)  \n",
       "525  0.502 (0.494, 0.511) 0.509 (0.5, 0.517)   0.007 (-0.005, 0.017)  \n",
       "526  0.622 (0.604, 0.647) 0.629 (0.613, 0.65)  0.007 (-0.003, 0.015)  \n",
       "527  0.709 (0.697, 0.72)  0.715 (0.705, 0.729) 0.007 (-0.002, 0.015)  \n",
       "528  0.695 (0.683, 0.706) 0.702 (0.692, 0.712) 0.007 (-0.001, 0.017)  \n",
       "529  0.666 (0.655, 0.676) 0.673 (0.663, 0.683) 0.007 (-0.001, 0.014)  \n",
       "530  0.569 (0.562, 0.574) 0.574 (0.569, 0.581) 0.006 (0.002, 0.011)   \n",
       "531  0.645 (0.634, 0.658) 0.651 (0.641, 0.663) 0.006 (0.002, 0.011)   \n",
       "532  0.537 (0.531, 0.542) 0.543 (0.538, 0.55)  0.006 (0.002, 0.01)    \n",
       "533  0.706 (0.698, 0.716) 0.712 (0.702, 0.722) 0.006 (0.002, 0.01)    \n",
       "534  0.572 (0.566, 0.582) 0.579 (0.572, 0.587) 0.006 (0.001, 0.012)   \n",
       "535  0.584 (0.577, 0.593) 0.59 (0.581, 0.597)  0.006 (0.001, 0.01)    \n",
       "536  0.632 (0.62, 0.641)  0.638 (0.626, 0.647) 0.006 (0.001, 0.009)   \n",
       "537  0.572 (0.56, 0.583)  0.579 (0.568, 0.59)  0.006 (0, 0.014)       \n",
       "538  0.522 (0.516, 0.53)  0.528 (0.522, 0.535) 0.006 (0, 0.012)       \n",
       "539  0.536 (0.501, 0.578) 0.54 (0.498, 0.59)   0.006 (-0.042, 0.055)  \n",
       "540  0.541 (0.497, 0.591) 0.546 (0.501, 0.589) 0.006 (-0.031, 0.041)  \n",
       "541  0.625 (0.599, 0.651) 0.628 (0.608, 0.66)  0.006 (-0.022, 0.028)  \n",
       "542  0.541 (0.516, 0.57)  0.548 (0.52, 0.581)  0.006 (-0.019, 0.038)  \n",
       "543  0.586 (0.558, 0.62)  0.594 (0.567, 0.617) 0.006 (-0.018, 0.031)  \n",
       "544  0.724 (0.695, 0.752) 0.73 (0.705, 0.758)  0.006 (-0.014, 0.029)  \n",
       "545  0.65 (0.626, 0.676)  0.658 (0.635, 0.675) 0.006 (-0.012, 0.026)  \n",
       "546  0.567 (0.55, 0.586)  0.575 (0.557, 0.591) 0.006 (-0.009, 0.024)  \n",
       "547  0.728 (0.709, 0.748) 0.733 (0.713, 0.756) 0.006 (-0.009, 0.022)  \n",
       "548  0.531 (0.505, 0.552) 0.538 (0.519, 0.562) 0.006 (-0.008, 0.027)  \n",
       "549  0.582 (0.565, 0.601) 0.588 (0.567, 0.607) 0.006 (-0.008, 0.015)  \n",
       "550  0.519 (0.505, 0.528) 0.524 (0.511, 0.535) 0.006 (-0.007, 0.018)  \n",
       "551  0.584 (0.569, 0.6)   0.591 (0.575, 0.606) 0.006 (-0.006, 0.019)  \n",
       "552  0.546 (0.535, 0.559) 0.552 (0.54, 0.564)  0.006 (-0.006, 0.017)  \n",
       "553  0.539 (0.525, 0.549) 0.545 (0.529, 0.557) 0.006 (-0.003, 0.013)  \n",
       "554  0.553 (0.54, 0.566)  0.559 (0.543, 0.574) 0.006 (-0.002, 0.017)  \n",
       "555  0.507 (0.499, 0.513) 0.513 (0.507, 0.519) 0.006 (-0.002, 0.016)  \n",
       "556  0.51 (0.502, 0.521)  0.516 (0.507, 0.525) 0.006 (-0.002, 0.015)  \n",
       "557  0.627 (0.609, 0.652) 0.635 (0.616, 0.657) 0.006 (-0.002, 0.015)  \n",
       "558  0.687 (0.677, 0.699) 0.694 (0.682, 0.706) 0.006 (-0.001, 0.016)  \n",
       "559  0.579 (0.57, 0.587)  0.583 (0.577, 0.593) 0.006 (-0.001, 0.012)  \n",
       "560  0.553 (0.549, 0.557) 0.558 (0.554, 0.563) 0.005 (0.003, 0.007)   \n",
       "561  0.569 (0.562, 0.576) 0.574 (0.569, 0.582) 0.005 (0.002, 0.01)    \n",
       "562  0.55 (0.543, 0.558)  0.556 (0.549, 0.564) 0.005 (0.002, 0.009)   \n",
       "563  0.609 (0.604, 0.616) 0.614 (0.609, 0.621) 0.005 (0.002, 0.009)   \n",
       "564  0.59 (0.585, 0.597)  0.596 (0.59, 0.602)  0.005 (0.002, 0.009)   \n",
       "565  0.548 (0.544, 0.553) 0.553 (0.549, 0.558) 0.005 (0.002, 0.008)   \n",
       "566  0.604 (0.6, 0.608)   0.609 (0.604, 0.614) 0.005 (0.002, 0.008)   \n",
       "567  0.61 (0.602, 0.617)  0.615 (0.608, 0.622) 0.005 (0.001, 0.01)    \n",
       "568  0.704 (0.697, 0.711) 0.709 (0.701, 0.715) 0.005 (0.001, 0.009)   \n",
       "569  0.564 (0.558, 0.572) 0.569 (0.564, 0.576) 0.005 (0.001, 0.009)   \n",
       "570  0.718 (0.701, 0.729) 0.724 (0.706, 0.734) 0.005 (0.001, 0.009)   \n",
       "571  0.569 (0.561, 0.575) 0.573 (0.566, 0.582) 0.005 (0, 0.011)       \n",
       "572  0.602 (0.593, 0.61)  0.607 (0.598, 0.614) 0.005 (0, 0.011)       \n",
       "573  0.703 (0.696, 0.71)  0.707 (0.701, 0.714) 0.005 (0, 0.008)       \n",
       "574  0.561 (0.554, 0.566) 0.566 (0.558, 0.571) 0.005 (0, 0.008)       \n",
       "575  0.492 (0.456, 0.524) 0.498 (0.464, 0.539) 0.005 (-0.031, 0.057)  \n",
       "576  0.57 (0.543, 0.594)  0.573 (0.551, 0.608) 0.005 (-0.025, 0.03)   \n",
       "577  0.51 (0.48, 0.543)   0.519 (0.486, 0.546) 0.005 (-0.021, 0.041)  \n",
       "578  0.458 (0.434, 0.477) 0.463 (0.447, 0.482) 0.005 (-0.013, 0.03)   \n",
       "579  0.719 (0.677, 0.749) 0.723 (0.683, 0.769) 0.005 (-0.012, 0.03)   \n",
       "580  0.578 (0.561, 0.597) 0.583 (0.563, 0.602) 0.005 (-0.012, 0.019)  \n",
       "581  0.538 (0.522, 0.56)  0.542 (0.524, 0.566) 0.005 (-0.011, 0.021)  \n",
       "582  0.658 (0.635, 0.679) 0.665 (0.644, 0.684) 0.005 (-0.005, 0.019)  \n",
       "583  0.574 (0.558, 0.591) 0.58 (0.567, 0.593)  0.005 (-0.005, 0.016)  \n",
       "584  0.586 (0.574, 0.597) 0.591 (0.579, 0.605) 0.005 (-0.004, 0.019)  \n",
       "585  0.536 (0.528, 0.547) 0.541 (0.533, 0.551) 0.005 (-0.004, 0.013)  \n",
       "586  0.716 (0.695, 0.743) 0.721 (0.699, 0.744) 0.005 (-0.004, 0.011)  \n",
       "587  0.527 (0.516, 0.536) 0.532 (0.522, 0.54)  0.005 (-0.002, 0.014)  \n",
       "588  0.755 (0.741, 0.765) 0.758 (0.747, 0.772) 0.005 (-0.002, 0.012)  \n",
       "589  0.564 (0.557, 0.571) 0.569 (0.561, 0.576) 0.005 (-0.002, 0.01)   \n",
       "590  0.534 (0.524, 0.546) 0.539 (0.531, 0.55)  0.005 (-0.001, 0.013)  \n",
       "591  0.689 (0.679, 0.696) 0.693 (0.686, 0.701) 0.005 (-0.001, 0.01)   \n",
       "592  0.786 (0.782, 0.791) 0.791 (0.786, 0.795) 0.004 (0.003, 0.006)   \n",
       "593  0.536 (0.532, 0.541) 0.541 (0.537, 0.545) 0.004 (0.002, 0.007)   \n",
       "594  0.69 (0.683, 0.695)  0.694 (0.687, 0.699) 0.004 (0.001, 0.008)   \n",
       "595  0.698 (0.691, 0.704) 0.702 (0.695, 0.71)  0.004 (0.001, 0.008)   \n",
       "596  0.601 (0.595, 0.607) 0.606 (0.599, 0.612) 0.004 (0.001, 0.008)   \n",
       "597  0.634 (0.628, 0.64)  0.638 (0.632, 0.644) 0.004 (0.001, 0.007)   \n",
       "598  0.582 (0.577, 0.586) 0.586 (0.581, 0.59)  0.004 (0.001, 0.007)   \n",
       "599  0.652 (0.646, 0.659) 0.656 (0.65, 0.664)  0.004 (0.001, 0.006)   \n",
       "600  0.716 (0.704, 0.726) 0.72 (0.709, 0.73)   0.004 (0, 0.008)       \n",
       "601  0.716 (0.704, 0.727) 0.72 (0.708, 0.734)  0.004 (0, 0.008)       \n",
       "602  0.561 (0.555, 0.567) 0.566 (0.558, 0.573) 0.004 (0, 0.008)       \n",
       "603  0.64 (0.634, 0.648)  0.644 (0.638, 0.653) 0.004 (0, 0.007)       \n",
       "604  0.598 (0.553, 0.638) 0.598 (0.565, 0.643) 0.004 (-0.029, 0.042)  \n",
       "605  0.719 (0.685, 0.752) 0.725 (0.678, 0.76)  0.004 (-0.022, 0.028)  \n",
       "606  0.745 (0.724, 0.761) 0.747 (0.725, 0.768) 0.004 (-0.013, 0.023)  \n",
       "607  0.592 (0.572, 0.613) 0.597 (0.58, 0.618)  0.004 (-0.01, 0.023)   \n",
       "608  0.628 (0.603, 0.651) 0.631 (0.604, 0.651) 0.004 (-0.01, 0.012)   \n",
       "609  0.582 (0.545, 0.613) 0.586 (0.553, 0.615) 0.004 (-0.009, 0.018)  \n",
       "610  0.678 (0.651, 0.7)   0.68 (0.656, 0.703)  0.004 (-0.008, 0.016)  \n",
       "611  0.603 (0.587, 0.616) 0.607 (0.59, 0.62)   0.004 (-0.008, 0.016)  \n",
       "612  0.642 (0.626, 0.656) 0.645 (0.63, 0.661)  0.004 (-0.008, 0.015)  \n",
       "613  0.585 (0.573, 0.599) 0.589 (0.577, 0.603) 0.004 (-0.008, 0.013)  \n",
       "614  0.503 (0.493, 0.514) 0.507 (0.497, 0.515) 0.004 (-0.007, 0.016)  \n",
       "615  0.621 (0.608, 0.64)  0.626 (0.611, 0.642) 0.004 (-0.007, 0.015)  \n",
       "616  0.666 (0.649, 0.68)  0.669 (0.654, 0.684) 0.004 (-0.006, 0.016)  \n",
       "617  0.587 (0.569, 0.609) 0.593 (0.573, 0.613) 0.004 (-0.006, 0.014)  \n",
       "618  0.605 (0.589, 0.63)  0.608 (0.593, 0.633) 0.004 (-0.006, 0.011)  \n",
       "619  0.621 (0.606, 0.636) 0.625 (0.608, 0.643) 0.004 (-0.005, 0.015)  \n",
       "620  0.639 (0.626, 0.652) 0.642 (0.627, 0.657) 0.004 (-0.005, 0.014)  \n",
       "621  0.527 (0.518, 0.54)  0.53 (0.52, 0.544)   0.004 (-0.005, 0.013)  \n",
       "622  0.575 (0.567, 0.585) 0.578 (0.57, 0.59)   0.004 (-0.004, 0.012)  \n",
       "623  0.575 (0.563, 0.588) 0.579 (0.567, 0.595) 0.004 (-0.004, 0.011)  \n",
       "624  0.738 (0.723, 0.755) 0.743 (0.727, 0.759) 0.004 (-0.003, 0.011)  \n",
       "625  0.662 (0.648, 0.676) 0.666 (0.654, 0.68)  0.004 (-0.002, 0.011)  \n",
       "626  0.663 (0.655, 0.671) 0.667 (0.66, 0.674)  0.004 (-0.001, 0.011)  \n",
       "627  0.532 (0.525, 0.538) 0.536 (0.53, 0.544)  0.004 (-0.001, 0.01)   \n",
       "628  0.594 (0.586, 0.605) 0.599 (0.589, 0.611) 0.004 (-0.001, 0.009)  \n",
       "629  0.597 (0.588, 0.605) 0.601 (0.594, 0.608) 0.004 (-0.001, 0.008)  \n",
       "630  0.593 (0.58, 0.609)  0.597 (0.585, 0.61)  0.004 (-0.001, 0.008)  \n",
       "631  0.584 (0.577, 0.592) 0.588 (0.581, 0.594) 0.004 (-0.001, 0.007)  \n",
       "632  0.612 (0.609, 0.616) 0.615 (0.612, 0.619) 0.003 (0.002, 0.004)   \n",
       "633  0.589 (0.583, 0.593) 0.592 (0.586, 0.597) 0.003 (0.001, 0.006)   \n",
       "634  0.622 (0.616, 0.627) 0.625 (0.62, 0.63)   0.003 (0.001, 0.005)   \n",
       "635  0.746 (0.74, 0.753)  0.748 (0.743, 0.755) 0.003 (0.001, 0.005)   \n",
       "636  0.611 (0.603, 0.617) 0.614 (0.607, 0.62)  0.003 (0.001, 0.005)   \n",
       "637  0.585 (0.576, 0.59)  0.588 (0.579, 0.594) 0.003 (0, 0.008)       \n",
       "638  0.684 (0.677, 0.692) 0.688 (0.681, 0.693) 0.003 (0, 0.007)       \n",
       "639  0.59 (0.584, 0.596)  0.593 (0.587, 0.598) 0.003 (0, 0.006)       \n",
       "640  0.571 (0.566, 0.576) 0.575 (0.569, 0.58)  0.003 (0, 0.006)       \n",
       "641  0.611 (0.572, 0.669) 0.615 (0.584, 0.66)  0.003 (-0.025, 0.035)  \n",
       "642  0.532 (0.516, 0.552) 0.535 (0.518, 0.555) 0.003 (-0.022, 0.019)  \n",
       "643  0.716 (0.693, 0.746) 0.719 (0.695, 0.739) 0.003 (-0.02, 0.019)   \n",
       "644  0.553 (0.53, 0.575)  0.555 (0.527, 0.582) 0.003 (-0.019, 0.023)  \n",
       "645  0.741 (0.723, 0.758) 0.745 (0.726, 0.764) 0.003 (-0.012, 0.02)   \n",
       "646  0.642 (0.623, 0.664) 0.646 (0.625, 0.668) 0.003 (-0.012, 0.016)  \n",
       "647  0.663 (0.638, 0.679) 0.665 (0.644, 0.682) 0.003 (-0.012, 0.015)  \n",
       "648  0.632 (0.618, 0.646) 0.634 (0.616, 0.65)  0.003 (-0.01, 0.014)   \n",
       "649  0.655 (0.631, 0.675) 0.657 (0.638, 0.678) 0.003 (-0.01, 0.013)   \n",
       "650  0.646 (0.631, 0.666) 0.649 (0.635, 0.664) 0.003 (-0.009, 0.012)  \n",
       "651  0.667 (0.652, 0.683) 0.67 (0.656, 0.692)  0.003 (-0.008, 0.016)  \n",
       "652  0.644 (0.632, 0.653) 0.645 (0.637, 0.658) 0.003 (-0.008, 0.01)   \n",
       "653  0.641 (0.623, 0.655) 0.644 (0.628, 0.66)  0.003 (-0.007, 0.015)  \n",
       "654  0.502 (0.491, 0.511) 0.506 (0.496, 0.513) 0.003 (-0.004, 0.013)  \n",
       "655  0.69 (0.677, 0.703)  0.692 (0.679, 0.706) 0.003 (-0.004, 0.01)   \n",
       "656  0.583 (0.575, 0.593) 0.587 (0.575, 0.596) 0.003 (-0.003, 0.01)   \n",
       "657  0.565 (0.555, 0.576) 0.569 (0.556, 0.578) 0.003 (-0.003, 0.009)  \n",
       "658  0.551 (0.542, 0.559) 0.553 (0.545, 0.562) 0.003 (-0.003, 0.008)  \n",
       "659  0.65 (0.643, 0.659)  0.654 (0.646, 0.661) 0.003 (-0.003, 0.008)  \n",
       "660  0.608 (0.598, 0.617) 0.61 (0.602, 0.62)   0.003 (-0.003, 0.007)  \n",
       "661  0.612 (0.602, 0.621) 0.616 (0.606, 0.624) 0.003 (-0.002, 0.009)  \n",
       "662  0.644 (0.637, 0.652) 0.648 (0.64, 0.654)  0.003 (-0.002, 0.007)  \n",
       "663  0.585 (0.576, 0.591) 0.588 (0.579, 0.595) 0.003 (-0.001, 0.008)  \n",
       "664  0.564 (0.558, 0.571) 0.567 (0.56, 0.574)  0.003 (-0.001, 0.008)  \n",
       "665  0.577 (0.571, 0.584) 0.58 (0.574, 0.587)  0.003 (-0.001, 0.007)  \n",
       "666  0.622 (0.615, 0.629) 0.625 (0.618, 0.633) 0.003 (-0.001, 0.007)  \n",
       "667  0.528 (0.522, 0.532) 0.531 (0.525, 0.536) 0.003 (-0.001, 0.006)  \n",
       "668  0.535 (0.529, 0.538) 0.538 (0.533, 0.542) 0.003 (-0.001, 0.006)  \n",
       "669  0.71 (0.706, 0.716)  0.712 (0.708, 0.718) 0.002 (0.001, 0.003)   \n",
       "670  0.731 (0.722, 0.737) 0.733 (0.725, 0.74)  0.002 (0, 0.006)       \n",
       "671  0.63 (0.625, 0.636)  0.632 (0.627, 0.638) 0.002 (0, 0.005)       \n",
       "672  0.579 (0.571, 0.584) 0.581 (0.575, 0.585) 0.002 (0, 0.005)       \n",
       "673  0.741 (0.734, 0.747) 0.743 (0.737, 0.748) 0.002 (0, 0.004)       \n",
       "674  0.722 (0.713, 0.729) 0.723 (0.714, 0.73)  0.002 (0, 0.003)       \n",
       "675  0.567 (0.546, 0.589) 0.568 (0.546, 0.586) 0.002 (-0.023, 0.018)  \n",
       "676  0.555 (0.534, 0.57)  0.556 (0.54, 0.571)  0.002 (-0.017, 0.024)  \n",
       "677  0.678 (0.649, 0.707) 0.68 (0.645, 0.711)  0.002 (-0.013, 0.015)  \n",
       "678  0.63 (0.613, 0.652)  0.635 (0.613, 0.652) 0.002 (-0.012, 0.02)   \n",
       "679  0.738 (0.719, 0.757) 0.74 (0.722, 0.758)  0.002 (-0.012, 0.018)  \n",
       "680  0.589 (0.569, 0.61)  0.591 (0.57, 0.615)  0.002 (-0.012, 0.017)  \n",
       "681  0.729 (0.711, 0.744) 0.731 (0.715, 0.748) 0.002 (-0.011, 0.017)  \n",
       "682  0.605 (0.589, 0.62)  0.605 (0.59, 0.625)  0.002 (-0.011, 0.012)  \n",
       "683  0.547 (0.533, 0.559) 0.549 (0.537, 0.562) 0.002 (-0.01, 0.015)   \n",
       "684  0.637 (0.615, 0.673) 0.641 (0.617, 0.67)  0.002 (-0.01, 0.011)   \n",
       "685  0.578 (0.566, 0.592) 0.579 (0.564, 0.595) 0.002 (-0.01, 0.01)    \n",
       "686  0.558 (0.545, 0.572) 0.558 (0.543, 0.573) 0.002 (-0.008, 0.011)  \n",
       "687  0.625 (0.613, 0.64)  0.626 (0.616, 0.642) 0.002 (-0.005, 0.01)   \n",
       "688  0.718 (0.705, 0.73)  0.721 (0.708, 0.732) 0.002 (-0.005, 0.008)  \n",
       "689  0.644 (0.633, 0.659) 0.646 (0.636, 0.66)  0.002 (-0.004, 0.009)  \n",
       "690  0.702 (0.693, 0.711) 0.704 (0.694, 0.713) 0.002 (-0.004, 0.008)  \n",
       "691  0.56 (0.552, 0.568)  0.562 (0.554, 0.571) 0.002 (-0.003, 0.009)  \n",
       "692  0.56 (0.552, 0.568)  0.562 (0.555, 0.569) 0.002 (-0.003, 0.007)  \n",
       "693  0.557 (0.551, 0.564) 0.559 (0.552, 0.566) 0.002 (-0.003, 0.006)  \n",
       "694  0.62 (0.611, 0.627)  0.622 (0.613, 0.629) 0.002 (-0.002, 0.006)  \n",
       "695  0.602 (0.595, 0.609) 0.604 (0.596, 0.611) 0.002 (-0.002, 0.006)  \n",
       "696  0.731 (0.726, 0.736) 0.733 (0.728, 0.739) 0.002 (-0.001, 0.005)  \n",
       "697  0.57 (0.563, 0.578)  0.571 (0.564, 0.579) 0.002 (-0.001, 0.005)  \n",
       "698  0.593 (0.587, 0.6)   0.595 (0.589, 0.601) 0.002 (-0.001, 0.005)  \n",
       "699  0.597 (0.589, 0.605) 0.598 (0.589, 0.607) 0.001 (0, 0.003)       \n",
       "700  0.686 (0.681, 0.691) 0.687 (0.682, 0.692) 0.001 (0, 0.002)       \n",
       "701  0.638 (0.633, 0.643) 0.638 (0.634, 0.643) 0.001 (0, 0.002)       \n",
       "702  0.559 (0.556, 0.564) 0.561 (0.557, 0.565) 0.001 (0, 0.002)       \n",
       "703  0.59 (0.585, 0.595)  0.591 (0.586, 0.596) 0.001 (0, 0.001)       \n",
       "704  0.556 (0.528, 0.578) 0.554 (0.529, 0.582) 0.001 (-0.026, 0.028)  \n",
       "705  0.656 (0.628, 0.702) 0.657 (0.619, 0.698) 0.001 (-0.025, 0.022)  \n",
       "706  0.567 (0.531, 0.595) 0.569 (0.535, 0.599) 0.001 (-0.023, 0.022)  \n",
       "707  0.569 (0.552, 0.59)  0.571 (0.548, 0.588) 0.001 (-0.02, 0.021)   \n",
       "708  0.658 (0.63, 0.688)  0.661 (0.632, 0.689) 0.001 (-0.018, 0.024)  \n",
       "709  0.553 (0.529, 0.58)  0.553 (0.534, 0.58)  0.001 (-0.016, 0.023)  \n",
       "710  0.539 (0.518, 0.561) 0.539 (0.519, 0.566) 0.001 (-0.014, 0.021)  \n",
       "711  0.603 (0.58, 0.629)  0.602 (0.578, 0.631) 0.001 (-0.014, 0.015)  \n",
       "712  0.558 (0.542, 0.577) 0.559 (0.542, 0.573) 0.001 (-0.012, 0.014)  \n",
       "713  0.583 (0.566, 0.605) 0.584 (0.567, 0.607) 0.001 (-0.012, 0.013)  \n",
       "714  0.592 (0.576, 0.605) 0.592 (0.579, 0.607) 0.001 (-0.011, 0.015)  \n",
       "715  0.584 (0.565, 0.605) 0.585 (0.565, 0.604) 0.001 (-0.011, 0.013)  \n",
       "716  0.599 (0.583, 0.611) 0.6 (0.585, 0.613)   0.001 (-0.01, 0.012)   \n",
       "717  0.738 (0.722, 0.748) 0.738 (0.723, 0.748) 0.001 (-0.01, 0.01)    \n",
       "718  0.595 (0.576, 0.619) 0.598 (0.575, 0.62)  0.001 (-0.009, 0.017)  \n",
       "719  0.693 (0.67, 0.712)  0.694 (0.676, 0.712) 0.001 (-0.009, 0.01)   \n",
       "720  0.566 (0.554, 0.575) 0.566 (0.555, 0.574) 0.001 (-0.007, 0.006)  \n",
       "721  0.697 (0.685, 0.709) 0.697 (0.685, 0.709) 0.001 (-0.006, 0.007)  \n",
       "722  0.639 (0.625, 0.655) 0.641 (0.627, 0.655) 0.001 (-0.005, 0.008)  \n",
       "723  0.822 (0.811, 0.834) 0.824 (0.81, 0.836)  0.001 (-0.005, 0.007)  \n",
       "724  0.677 (0.666, 0.69)  0.678 (0.667, 0.69)  0.001 (-0.005, 0.006)  \n",
       "725  0.619 (0.608, 0.628) 0.62 (0.61, 0.629)   0.001 (-0.004, 0.007)  \n",
       "726  0.804 (0.795, 0.813) 0.805 (0.796, 0.813) 0.001 (-0.004, 0.006)  \n",
       "727  0.535 (0.529, 0.542) 0.536 (0.529, 0.543) 0.001 (-0.004, 0.005)  \n",
       "728  0.651 (0.643, 0.66)  0.652 (0.644, 0.663) 0.001 (-0.004, 0.005)  \n",
       "729  0.587 (0.576, 0.597) 0.587 (0.576, 0.596) 0.001 (-0.004, 0.005)  \n",
       "730  0.561 (0.556, 0.566) 0.562 (0.556, 0.567) 0.001 (-0.003, 0.006)  \n",
       "731  0.662 (0.655, 0.667) 0.663 (0.657, 0.669) 0.001 (-0.001, 0.003)  \n",
       "732  0.922 (0.916, 0.935) 0.923 (0.917, 0.936) 0.001 (-0.001, 0.002)  \n",
       "733  0.788 (0.783, 0.794) 0.788 (0.783, 0.794) 0 (0, 0.001)           \n",
       "734  0.547 (0.512, 0.59)  0.547 (0.517, 0.575) 0 (-0.037, 0.035)      \n",
       "735  0.617 (0.566, 0.665) 0.618 (0.582, 0.646) 0 (-0.032, 0.035)      \n",
       "736  0.59 (0.565, 0.618)  0.59 (0.568, 0.614)  0 (-0.022, 0.022)      \n",
       "737  0.606 (0.579, 0.637) 0.606 (0.582, 0.63)  0 (-0.02, 0.015)       \n",
       "738  0.56 (0.533, 0.58)   0.559 (0.534, 0.582) 0 (-0.019, 0.022)      \n",
       "739  0.734 (0.708, 0.758) 0.733 (0.712, 0.753) 0 (-0.018, 0.014)      \n",
       "740  0.649 (0.626, 0.671) 0.649 (0.62, 0.673)  0 (-0.017, 0.018)      \n",
       "741  0.738 (0.718, 0.76)  0.737 (0.715, 0.754) 0 (-0.015, 0.015)      \n",
       "742  0.585 (0.569, 0.606) 0.586 (0.567, 0.602) 0 (-0.015, 0.014)      \n",
       "743  0.558 (0.538, 0.578) 0.558 (0.54, 0.573)  0 (-0.011, 0.01)       \n",
       "744  0.7 (0.684, 0.72)    0.698 (0.683, 0.721) 0 (-0.01, 0.007)       \n",
       "745  0.519 (0.51, 0.531)  0.52 (0.508, 0.532)  0 (-0.009, 0.01)       \n",
       "746  0.526 (0.514, 0.539) 0.527 (0.511, 0.538) 0 (-0.009, 0.009)      \n",
       "747  0.578 (0.563, 0.594) 0.578 (0.561, 0.592) 0 (-0.009, 0.009)      \n",
       "748  0.622 (0.597, 0.64)  0.623 (0.599, 0.642) 0 (-0.009, 0.008)      \n",
       "749  0.598 (0.584, 0.613) 0.598 (0.586, 0.609) 0 (-0.009, 0.008)      \n",
       "750  0.587 (0.575, 0.597) 0.587 (0.575, 0.597) 0 (-0.008, 0.007)      \n",
       "751  0.618 (0.605, 0.628) 0.618 (0.605, 0.627) 0 (-0.008, 0.006)      \n",
       "752  0.562 (0.548, 0.577) 0.562 (0.55, 0.572)  0 (-0.007, 0.007)      \n",
       "753  0.734 (0.71, 0.756)  0.733 (0.711, 0.754) 0 (-0.007, 0.005)      \n",
       "754  0.595 (0.584, 0.608) 0.595 (0.585, 0.605) 0 (-0.007, 0.005)      \n",
       "755  0.683 (0.674, 0.695) 0.683 (0.674, 0.694) 0 (-0.007, 0.004)      \n",
       "756  0.763 (0.756, 0.773) 0.764 (0.757, 0.772) 0 (-0.006, 0.008)      \n",
       "757  0.615 (0.603, 0.628) 0.615 (0.602, 0.629) 0 (-0.006, 0.007)      \n",
       "758  0.564 (0.551, 0.573) 0.565 (0.553, 0.574) 0 (-0.005, 0.007)      \n",
       "759  0.687 (0.671, 0.707) 0.687 (0.67, 0.705)  0 (-0.005, 0.006)      \n",
       "760  0.647 (0.634, 0.66)  0.648 (0.634, 0.661) 0 (-0.005, 0.005)      \n",
       "761  0.788 (0.777, 0.797) 0.788 (0.778, 0.796) 0 (-0.005, 0.004)      \n",
       "762  0.544 (0.538, 0.551) 0.545 (0.538, 0.55)  0 (-0.005, 0.004)      \n",
       "763  0.657 (0.641, 0.674) 0.657 (0.642, 0.675) 0 (-0.004, 0.006)      \n",
       "764  0.66 (0.651, 0.666)  0.659 (0.651, 0.668) 0 (-0.004, 0.005)      \n",
       "765  0.611 (0.603, 0.621) 0.611 (0.605, 0.62)  0 (-0.004, 0.004)      \n",
       "766  0.709 (0.697, 0.72)  0.71 (0.697, 0.72)   0 (-0.004, 0.004)      \n",
       "767  0.649 (0.64, 0.661)  0.649 (0.638, 0.661) 0 (-0.004, 0.003)      \n",
       "768  0.533 (0.529, 0.538) 0.534 (0.53, 0.538)  0 (-0.003, 0.004)      \n",
       "769  0.749 (0.733, 0.764) 0.749 (0.734, 0.766) 0 (-0.003, 0.004)      \n",
       "770  0.603 (0.597, 0.612) 0.603 (0.596, 0.612) 0 (-0.003, 0.003)      \n",
       "771  0.871 (0.863, 0.878) 0.87 (0.863, 0.879)  0 (-0.003, 0.002)      \n",
       "772  0.535 (0.53, 0.54)   0.535 (0.53, 0.54)   0 (-0.003, 0.002)      \n",
       "773  0.562 (0.558, 0.566) 0.562 (0.559, 0.566) 0 (-0.002, 0.003)      \n",
       "774  0.697 (0.692, 0.702) 0.698 (0.692, 0.701) 0 (-0.002, 0.002)      \n",
       "775  0.581 (0.573, 0.588) 0.58 (0.574, 0.588)  0 (-0.002, 0.002)      \n",
       "776  0.834 (0.827, 0.841) 0.834 (0.828, 0.841) 0 (-0.002, 0.002)      \n",
       "777  0.761 (0.756, 0.765) 0.76 (0.756, 0.765)  0 (-0.001, 0)          \n",
       "778  0.889 (0.883, 0.895) 0.889 (0.883, 0.896) 0 (-0.001, 0.002)      \n",
       "779  0.877 (0.873, 0.885) 0.878 (0.874, 0.884) 0 (-0.001, 0.002)      \n",
       "780  0.878 (0.873, 0.883) 0.879 (0.873, 0.883) 0 (-0.001, 0.002)      \n",
       "781  0.638 (0.629, 0.645) 0.638 (0.629, 0.645) 0 (-0.001, 0.002)      \n",
       "782  0.664 (0.659, 0.669) 0.664 (0.659, 0.669) 0 (-0.001, 0.001)      \n",
       "783  0.716 (0.704, 0.723) 0.715 (0.704, 0.723) 0 (-0.001, 0.001)      \n",
       "784  0.766 (0.761, 0.771) 0.767 (0.761, 0.772) 0 (-0.001, 0.001)      \n",
       "785  0.624 (0.619, 0.629) 0.624 (0.619, 0.629) 0 (-0.001, 0.001)      \n",
       "786  0.715 (0.71, 0.72)   0.715 (0.71, 0.72)   0 (-0.001, 0.001)      \n",
       "787  0.642 (0.634, 0.65)  0.642 (0.634, 0.65)  0 (-0.001, 0.001)      \n",
       "788  0.643 (0.635, 0.651) 0.643 (0.635, 0.65)  0 (-0.001, 0.001)      \n",
       "789  0.896 (0.886, 0.901) 0.896 (0.886, 0.902) 0 (-0.001, 0.001)      \n",
       "790  0.645 (0.641, 0.65)  0.645 (0.641, 0.649) 0 (-0.001, 0.001)      \n",
       "791  0.547 (0.517, 0.585) 0.406 (0.368, 0.442) -0.139 (-0.203, -0.096)\n",
       "792  0.602 (0.56, 0.642)  0.47 (0.425, 0.514)  -0.128 (-0.192, -0.06) \n",
       "793  0.69 (0.655, 0.718)  0.612 (0.576, 0.652) -0.076 (-0.105, -0.042)\n",
       "794  0.574 (0.547, 0.616) 0.508 (0.464, 0.561) -0.072 (-0.136, 0.003) \n",
       "795  0.708 (0.674, 0.738) 0.659 (0.623, 0.697) -0.048 (-0.09, -0.002) \n",
       "796  0.573 (0.54, 0.619)  0.527 (0.499, 0.57)  -0.046 (-0.063, -0.029)\n",
       "797  0.569 (0.532, 0.599) 0.525 (0.49, 0.565)  -0.042 (-0.064, -0.019)\n",
       "798  0.669 (0.637, 0.705) 0.632 (0.597, 0.671) -0.037 (-0.059, -0.009)\n",
       "799  0.607 (0.566, 0.642) 0.574 (0.523, 0.611) -0.036 (-0.068, 0.001) \n",
       "800  0.69 (0.64, 0.734)   0.655 (0.618, 0.696) -0.036 (-0.059, -0.001)\n",
       "801  0.623 (0.593, 0.662) 0.591 (0.559, 0.627) -0.036 (-0.055, -0.017)\n",
       "802  0.627 (0.591, 0.654) 0.591 (0.56, 0.62)   -0.036 (-0.05, -0.018) \n",
       "803  0.634 (0.603, 0.661) 0.597 (0.56, 0.622)  -0.035 (-0.052, -0.016)\n",
       "804  0.623 (0.583, 0.677) 0.587 (0.536, 0.638) -0.034 (-0.066, -0.005)\n",
       "805  0.593 (0.553, 0.632) 0.559 (0.516, 0.599) -0.034 (-0.054, -0.009)\n",
       "806  0.552 (0.506, 0.583) 0.519 (0.478, 0.557) -0.033 (-0.07, -0.003) \n",
       "807  0.609 (0.574, 0.644) 0.579 (0.539, 0.61)  -0.033 (-0.058, -0.015)\n",
       "808  0.588 (0.556, 0.626) 0.556 (0.527, 0.594) -0.033 (-0.05, -0.014) \n",
       "809  0.571 (0.531, 0.62)  0.542 (0.506, 0.591) -0.032 (-0.067, 0.008) \n",
       "810  0.693 (0.652, 0.729) 0.658 (0.618, 0.702) -0.032 (-0.055, -0.004)\n",
       "811  0.649 (0.617, 0.683) 0.62 (0.578, 0.648)  -0.031 (-0.056, -0.003)\n",
       "812  0.61 (0.565, 0.657)  0.582 (0.541, 0.62)  -0.029 (-0.06, -0.006) \n",
       "813  0.645 (0.599, 0.687) 0.616 (0.566, 0.668) -0.029 (-0.048, -0.013)\n",
       "814  0.543 (0.507, 0.576) 0.518 (0.478, 0.552) -0.028 (-0.058, 0.009) \n",
       "815  0.549 (0.526, 0.58)  0.523 (0.501, 0.555) -0.027 (-0.05, -0.006) \n",
       "816  0.562 (0.535, 0.591) 0.532 (0.507, 0.567) -0.027 (-0.049, -0.009)\n",
       "817  0.58 (0.556, 0.611)  0.555 (0.531, 0.586) -0.027 (-0.045, -0.008)\n",
       "818  0.692 (0.664, 0.723) 0.664 (0.636, 0.694) -0.027 (-0.044, -0.011)\n",
       "819  0.674 (0.648, 0.696) 0.647 (0.618, 0.665) -0.027 (-0.043, -0.009)\n",
       "820  0.639 (0.584, 0.685) 0.61 (0.571, 0.65)   -0.026 (-0.059, 0.008) \n",
       "821  0.612 (0.565, 0.648) 0.584 (0.546, 0.621) -0.026 (-0.048, -0.007)\n",
       "822  0.622 (0.594, 0.655) 0.597 (0.561, 0.631) -0.026 (-0.043, -0.011)\n",
       "823  0.577 (0.548, 0.608) 0.553 (0.517, 0.594) -0.024 (-0.044, -0.003)\n",
       "824  0.709 (0.685, 0.734) 0.683 (0.66, 0.714)  -0.024 (-0.037, -0.015)\n",
       "825  0.593 (0.563, 0.631) 0.572 (0.538, 0.606) -0.023 (-0.049, 0.003) \n",
       "826  0.598 (0.557, 0.644) 0.572 (0.53, 0.622)  -0.023 (-0.044, -0.003)\n",
       "827  0.637 (0.611, 0.663) 0.619 (0.58, 0.653)  -0.022 (-0.057, 0.017) \n",
       "828  0.59 (0.551, 0.627)  0.565 (0.533, 0.603) -0.022 (-0.047, 0.001) \n",
       "829  0.624 (0.598, 0.649) 0.602 (0.576, 0.634) -0.022 (-0.043, 0)     \n",
       "830  0.675 (0.65, 0.702)  0.652 (0.625, 0.687) -0.022 (-0.043, -0.001)\n",
       "831  0.66 (0.636, 0.69)   0.639 (0.606, 0.671) -0.022 (-0.035, -0.005)\n",
       "832  0.543 (0.502, 0.579) 0.52 (0.477, 0.571)  -0.021 (-0.057, 0.025) \n",
       "833  0.54 (0.5, 0.582)    0.524 (0.484, 0.559) -0.02 (-0.063, 0.032)  \n",
       "834  0.548 (0.509, 0.581) 0.527 (0.492, 0.569) -0.02 (-0.051, 0.007)  \n",
       "835  0.606 (0.581, 0.631) 0.585 (0.558, 0.616) -0.02 (-0.033, -0.005) \n",
       "836  0.717 (0.694, 0.744) 0.697 (0.676, 0.728) -0.02 (-0.031, -0.009) \n",
       "837  0.543 (0.508, 0.586) 0.527 (0.491, 0.569) -0.019 (-0.051, 0.026) \n",
       "838  0.588 (0.548, 0.627) 0.568 (0.53, 0.615)  -0.019 (-0.051, 0.013) \n",
       "839  0.635 (0.607, 0.674) 0.617 (0.587, 0.653) -0.019 (-0.048, 0.009) \n",
       "840  0.698 (0.673, 0.726) 0.679 (0.65, 0.709)  -0.019 (-0.043, 0)     \n",
       "841  0.672 (0.637, 0.715) 0.654 (0.613, 0.707) -0.019 (-0.041, 0.003) \n",
       "842  0.683 (0.659, 0.709) 0.664 (0.628, 0.691) -0.019 (-0.039, -0.004)\n",
       "843  0.608 (0.573, 0.647) 0.592 (0.553, 0.626) -0.019 (-0.031, -0.007)\n",
       "844  0.607 (0.569, 0.648) 0.589 (0.546, 0.636) -0.018 (-0.054, 0.019) \n",
       "845  0.537 (0.507, 0.58)  0.518 (0.491, 0.553) -0.018 (-0.046, 0.008) \n",
       "846  0.612 (0.58, 0.645)  0.595 (0.554, 0.633) -0.018 (-0.04, 0.002)  \n",
       "847  0.683 (0.647, 0.722) 0.665 (0.631, 0.707) -0.018 (-0.04, 0.001)  \n",
       "848  0.525 (0.491, 0.56)  0.509 (0.476, 0.544) -0.018 (-0.038, 0.01)  \n",
       "849  0.591 (0.561, 0.625) 0.573 (0.548, 0.606) -0.018 (-0.037, 0.002) \n",
       "850  0.601 (0.562, 0.655) 0.585 (0.54, 0.627)  -0.018 (-0.035, 0.011) \n",
       "851  0.689 (0.668, 0.709) 0.67 (0.649, 0.686)  -0.018 (-0.031, -0.008)\n",
       "852  0.616 (0.59, 0.657)  0.602 (0.575, 0.639) -0.018 (-0.027, -0.001)\n",
       "853  0.669 (0.643, 0.692) 0.653 (0.621, 0.675) -0.017 (-0.039, 0.006) \n",
       "854  0.515 (0.489, 0.542) 0.5 (0.481, 0.522)   -0.016 (-0.042, 0.016) \n",
       "855  0.611 (0.577, 0.657) 0.598 (0.558, 0.635) -0.016 (-0.041, 0.017) \n",
       "856  0.655 (0.622, 0.686) 0.639 (0.606, 0.679) -0.016 (-0.037, 0.008) \n",
       "857  0.706 (0.673, 0.735) 0.689 (0.657, 0.718) -0.016 (-0.035, 0.003) \n",
       "858  0.733 (0.7, 0.771)   0.717 (0.678, 0.75)  -0.016 (-0.035, -0.002)\n",
       "859  0.735 (0.695, 0.775) 0.718 (0.683, 0.766) -0.016 (-0.035, -0.001)\n",
       "860  0.729 (0.694, 0.763) 0.712 (0.679, 0.743) -0.016 (-0.028, -0.002)\n",
       "861  0.609 (0.571, 0.65)  0.593 (0.551, 0.635) -0.016 (-0.027, -0.004)\n",
       "862  0.564 (0.531, 0.601) 0.554 (0.505, 0.584) -0.015 (-0.058, 0.019) \n",
       "863  0.664 (0.624, 0.71)  0.65 (0.613, 0.692)  -0.015 (-0.032, 0.004) \n",
       "864  0.683 (0.651, 0.714) 0.666 (0.637, 0.696) -0.015 (-0.031, 0)     \n",
       "865  0.624 (0.597, 0.648) 0.61 (0.582, 0.628)  -0.015 (-0.03, 0)      \n",
       "866  0.602 (0.581, 0.624) 0.585 (0.565, 0.61)  -0.015 (-0.03, -0.002) \n",
       "867  0.582 (0.556, 0.616) 0.567 (0.537, 0.597) -0.015 (-0.027, -0.005)\n",
       "868  0.555 (0.536, 0.57)  0.54 (0.52, 0.554)   -0.015 (-0.024, -0.005)\n",
       "869  0.667 (0.653, 0.679) 0.652 (0.637, 0.665) -0.015 (-0.023, -0.006)\n",
       "870  0.662 (0.633, 0.703) 0.65 (0.61, 0.684)   -0.014 (-0.046, 0.007) \n",
       "871  0.487 (0.459, 0.53)  0.477 (0.441, 0.516) -0.014 (-0.044, 0.014) \n",
       "872  0.595 (0.565, 0.627) 0.579 (0.545, 0.61)  -0.014 (-0.044, 0.006) \n",
       "873  0.521 (0.501, 0.562) 0.511 (0.481, 0.541) -0.014 (-0.037, 0.009) \n",
       "874  0.688 (0.656, 0.729) 0.673 (0.65, 0.708)  -0.014 (-0.036, 0.006) \n",
       "875  0.618 (0.598, 0.64)  0.605 (0.584, 0.625) -0.014 (-0.03, 0)      \n",
       "876  0.726 (0.706, 0.751) 0.711 (0.692, 0.732) -0.014 (-0.027, -0.004)\n",
       "877  0.68 (0.66, 0.703)   0.665 (0.646, 0.687) -0.014 (-0.026, -0.002)\n",
       "878  0.659 (0.643, 0.681) 0.647 (0.626, 0.665) -0.014 (-0.025, -0.002)\n",
       "879  0.653 (0.618, 0.704) 0.642 (0.61, 0.682)  -0.013 (-0.036, 0.007) \n",
       "880  0.537 (0.502, 0.563) 0.523 (0.492, 0.549) -0.013 (-0.031, 0.003) \n",
       "881  0.667 (0.643, 0.691) 0.654 (0.629, 0.68)  -0.013 (-0.03, 0.004)  \n",
       "882  0.752 (0.725, 0.784) 0.741 (0.713, 0.775) -0.013 (-0.029, 0.003) \n",
       "883  0.678 (0.651, 0.7)   0.663 (0.638, 0.684) -0.013 (-0.029, 0.002) \n",
       "884  0.612 (0.581, 0.634) 0.599 (0.569, 0.623) -0.013 (-0.027, 0.001) \n",
       "885  0.666 (0.649, 0.685) 0.653 (0.635, 0.672) -0.013 (-0.026, -0.001)\n",
       "886  0.659 (0.629, 0.7)   0.646 (0.616, 0.684) -0.013 (-0.023, -0.005)\n",
       "887  0.603 (0.573, 0.637) 0.592 (0.557, 0.627) -0.012 (-0.044, 0.015) \n",
       "888  0.499 (0.468, 0.525) 0.489 (0.461, 0.515) -0.012 (-0.043, 0.023) \n",
       "889  0.549 (0.526, 0.574) 0.537 (0.509, 0.56)  -0.012 (-0.039, 0.007) \n",
       "890  0.575 (0.539, 0.61)  0.563 (0.53, 0.595)  -0.012 (-0.037, 0.009) \n",
       "891  0.59 (0.55, 0.625)   0.577 (0.532, 0.613) -0.012 (-0.036, 0.013) \n",
       "892  0.735 (0.71, 0.759)  0.721 (0.697, 0.746) -0.012 (-0.028, 0)     \n",
       "893  0.658 (0.631, 0.683) 0.646 (0.626, 0.668) -0.012 (-0.026, 0.005) \n",
       "894  0.731 (0.707, 0.758) 0.718 (0.689, 0.751) -0.012 (-0.026, 0.003) \n",
       "895  0.631 (0.6, 0.655)   0.617 (0.592, 0.64)  -0.012 (-0.025, 0.006) \n",
       "896  0.611 (0.596, 0.635) 0.599 (0.581, 0.622) -0.012 (-0.024, 0)     \n",
       "897  0.677 (0.653, 0.7)   0.665 (0.643, 0.686) -0.012 (-0.024, 0.003) \n",
       "898  0.51 (0.496, 0.526)  0.499 (0.483, 0.513) -0.012 (-0.022, -0.001)\n",
       "899  0.576 (0.555, 0.592) 0.564 (0.544, 0.581) -0.012 (-0.019, -0.005)\n",
       "900  0.585 (0.546, 0.627) 0.575 (0.535, 0.614) -0.011 (-0.039, 0.023) \n",
       "901  0.553 (0.523, 0.58)  0.543 (0.516, 0.577) -0.011 (-0.036, 0.021) \n",
       "902  0.566 (0.533, 0.592) 0.554 (0.529, 0.576) -0.011 (-0.035, 0.007) \n",
       "903  0.538 (0.518, 0.559) 0.528 (0.5, 0.548)   -0.011 (-0.034, 0.009) \n",
       "904  0.726 (0.702, 0.748) 0.716 (0.681, 0.738) -0.011 (-0.032, 0.009) \n",
       "905  0.64 (0.604, 0.665)  0.63 (0.591, 0.659)  -0.011 (-0.031, 0.016) \n",
       "906  0.546 (0.517, 0.571) 0.533 (0.512, 0.558) -0.011 (-0.031, 0.009) \n",
       "907  0.556 (0.526, 0.581) 0.543 (0.518, 0.576) -0.011 (-0.029, 0.007) \n",
       "908  0.57 (0.553, 0.589)  0.558 (0.537, 0.581) -0.011 (-0.029, 0.002) \n",
       "909  0.612 (0.59, 0.635)  0.601 (0.58, 0.623)  -0.011 (-0.027, 0)     \n",
       "910  0.646 (0.627, 0.669) 0.635 (0.618, 0.665) -0.011 (-0.024, 0.003) \n",
       "911  0.633 (0.614, 0.654) 0.623 (0.605, 0.642) -0.011 (-0.024, 0.003) \n",
       "912  0.682 (0.646, 0.721) 0.672 (0.636, 0.715) -0.011 (-0.022, 0.001) \n",
       "913  0.536 (0.52, 0.557)  0.525 (0.508, 0.549) -0.011 (-0.021, 0.003) \n",
       "914  0.531 (0.519, 0.544) 0.52 (0.505, 0.537)  -0.011 (-0.018, -0.001)\n",
       "915  0.706 (0.69, 0.721)  0.695 (0.678, 0.711) -0.011 (-0.016, -0.005)\n",
       "916  0.631 (0.615, 0.648) 0.62 (0.605, 0.637)  -0.011 (-0.015, -0.007)\n",
       "917  0.537 (0.505, 0.569) 0.523 (0.495, 0.562) -0.01 (-0.04, 0.013)   \n",
       "918  0.639 (0.605, 0.674) 0.628 (0.595, 0.667) -0.01 (-0.039, 0.011)  \n",
       "919  0.575 (0.535, 0.615) 0.568 (0.532, 0.603) -0.01 (-0.038, 0.015)  \n",
       "920  0.626 (0.597, 0.664) 0.618 (0.583, 0.647) -0.01 (-0.031, 0.016)  \n",
       "921  0.584 (0.559, 0.616) 0.572 (0.537, 0.608) -0.01 (-0.03, 0.009)   \n",
       "922  0.557 (0.532, 0.585) 0.549 (0.524, 0.579) -0.01 (-0.029, 0.008)  \n",
       "923  0.62 (0.602, 0.641)  0.609 (0.592, 0.628) -0.01 (-0.026, 0.001)  \n",
       "924  0.526 (0.508, 0.54)  0.517 (0.492, 0.537) -0.01 (-0.025, 0.011)  \n",
       "925  0.651 (0.625, 0.676) 0.641 (0.615, 0.666) -0.01 (-0.024, 0)      \n",
       "926  0.687 (0.66, 0.714)  0.675 (0.654, 0.704) -0.01 (-0.024, 0.001)  \n",
       "927  0.62 (0.604, 0.635)  0.61 (0.593, 0.625)  -0.01 (-0.021, 0.001)  \n",
       "928  0.595 (0.576, 0.617) 0.587 (0.563, 0.608) -0.01 (-0.019, 0.004)  \n",
       "929  0.575 (0.556, 0.593) 0.565 (0.542, 0.582) -0.01 (-0.017, -0.003) \n",
       "930  0.787 (0.766, 0.81)  0.778 (0.754, 0.801) -0.01 (-0.015, -0.004) \n",
       "931  0.615 (0.555, 0.653) 0.605 (0.554, 0.649) -0.009 (-0.047, 0.034) \n",
       "932  0.559 (0.532, 0.591) 0.553 (0.514, 0.588) -0.009 (-0.046, 0.019) \n",
       "933  0.621 (0.591, 0.653) 0.613 (0.588, 0.636) -0.009 (-0.031, 0.015) \n",
       "934  0.663 (0.63, 0.699)  0.652 (0.624, 0.683) -0.009 (-0.029, 0.008) \n",
       "935  0.534 (0.515, 0.553) 0.525 (0.504, 0.542) -0.009 (-0.026, 0.008) \n",
       "936  0.684 (0.64, 0.722)  0.676 (0.629, 0.714) -0.009 (-0.023, 0.008) \n",
       "937  0.6 (0.575, 0.618)   0.59 (0.57, 0.611)   -0.009 (-0.021, 0.005) \n",
       "938  0.623 (0.605, 0.648) 0.615 (0.595, 0.638) -0.009 (-0.021, 0.002) \n",
       "939  0.677 (0.662, 0.692) 0.668 (0.651, 0.684) -0.009 (-0.021, 0.002) \n",
       "940  0.546 (0.53, 0.574)  0.538 (0.522, 0.558) -0.009 (-0.02, 0.007)  \n",
       "941  0.63 (0.617, 0.647)  0.621 (0.608, 0.637) -0.009 (-0.019, -0.001)\n",
       "942  0.779 (0.761, 0.794) 0.768 (0.751, 0.783) -0.009 (-0.018, -0.002)\n",
       "943  0.722 (0.71, 0.737)  0.713 (0.7, 0.729)   -0.009 (-0.017, -0.004)\n",
       "944  0.533 (0.518, 0.546) 0.525 (0.513, 0.537) -0.009 (-0.017, -0.001)\n",
       "945  0.802 (0.788, 0.815) 0.794 (0.778, 0.807) -0.009 (-0.016, 0)     \n",
       "946  0.536 (0.525, 0.546) 0.527 (0.518, 0.537) -0.009 (-0.016, 0.002) \n",
       "947  0.69 (0.671, 0.715)  0.682 (0.66, 0.705)  -0.009 (-0.016, -0.003)\n",
       "948  0.597 (0.585, 0.612) 0.587 (0.576, 0.602) -0.009 (-0.014, -0.003)\n",
       "949  0.598 (0.583, 0.615) 0.589 (0.574, 0.605) -0.009 (-0.013, -0.002)\n",
       "950  0.629 (0.604, 0.66)  0.623 (0.597, 0.648) -0.008 (-0.031, 0.023) \n",
       "951  0.643 (0.608, 0.691) 0.632 (0.595, 0.673) -0.008 (-0.031, 0.023) \n",
       "952  0.661 (0.634, 0.687) 0.653 (0.626, 0.678) -0.008 (-0.027, 0.01)  \n",
       "953  0.587 (0.561, 0.611) 0.577 (0.55, 0.606)  -0.008 (-0.024, 0.008) \n",
       "954  0.622 (0.595, 0.649) 0.615 (0.588, 0.642) -0.008 (-0.022, 0.007) \n",
       "955  0.603 (0.582, 0.619) 0.594 (0.575, 0.613) -0.008 (-0.021, 0.007) \n",
       "956  0.555 (0.53, 0.584)  0.547 (0.523, 0.573) -0.008 (-0.021, 0.005) \n",
       "957  0.606 (0.589, 0.629) 0.598 (0.578, 0.617) -0.008 (-0.021, 0.004) \n",
       "958  0.682 (0.657, 0.705) 0.675 (0.65, 0.693)  -0.008 (-0.019, 0.003) \n",
       "959  0.62 (0.602, 0.635)  0.613 (0.595, 0.63)  -0.008 (-0.018, 0.003) \n",
       "960  0.629 (0.616, 0.641) 0.621 (0.607, 0.634) -0.008 (-0.016, -0.001)\n",
       "961  0.724 (0.709, 0.74)  0.716 (0.698, 0.731) -0.008 (-0.015, -0.002)\n",
       "962  0.647 (0.629, 0.665) 0.64 (0.622, 0.656)  -0.008 (-0.012, -0.003)\n",
       "963  0.674 (0.646, 0.71)  0.665 (0.634, 0.702) -0.007 (-0.035, 0.015) \n",
       "964  0.628 (0.607, 0.652) 0.622 (0.599, 0.646) -0.007 (-0.032, 0.02)  \n",
       "965  0.496 (0.478, 0.52)  0.492 (0.47, 0.512)  -0.007 (-0.029, 0.021) \n",
       "966  0.689 (0.668, 0.713) 0.683 (0.657, 0.704) -0.007 (-0.026, 0.009) \n",
       "967  0.551 (0.526, 0.57)  0.543 (0.519, 0.564) -0.007 (-0.024, 0.009) \n",
       "968  0.677 (0.647, 0.714) 0.67 (0.642, 0.708)  -0.007 (-0.015, 0)     \n",
       "969  0.598 (0.582, 0.611) 0.592 (0.576, 0.606) -0.007 (-0.015, 0.001) \n",
       "970  0.634 (0.608, 0.652) 0.628 (0.603, 0.645) -0.007 (-0.015, 0.001) \n",
       "971  0.723 (0.713, 0.737) 0.717 (0.701, 0.73)  -0.007 (-0.014, 0)     \n",
       "972  0.641 (0.627, 0.657) 0.634 (0.617, 0.649) -0.007 (-0.014, 0)     \n",
       "973  0.764 (0.751, 0.782) 0.756 (0.743, 0.775) -0.007 (-0.014, -0.001)\n",
       "974  0.645 (0.62, 0.674)  0.638 (0.612, 0.667) -0.007 (-0.013, -0.001)\n",
       "975  0.592 (0.577, 0.612) 0.585 (0.571, 0.605) -0.007 (-0.012, -0.001)\n",
       "976  0.533 (0.527, 0.541) 0.528 (0.521, 0.536) -0.007 (-0.011, -0.001)\n",
       "977  0.648 (0.638, 0.663) 0.64 (0.631, 0.656)  -0.007 (-0.01, -0.003) \n",
       "978  0.603 (0.565, 0.633) 0.595 (0.559, 0.628) -0.006 (-0.034, 0.019) \n",
       "979  0.536 (0.503, 0.556) 0.53 (0.502, 0.552)  -0.006 (-0.029, 0.016) \n",
       "980  0.608 (0.589, 0.63)  0.603 (0.586, 0.622) -0.006 (-0.021, 0.008) \n",
       "981  0.718 (0.693, 0.743) 0.712 (0.684, 0.735) -0.006 (-0.021, 0.007) \n",
       "982  0.553 (0.538, 0.567) 0.545 (0.53, 0.564)  -0.006 (-0.019, 0.004) \n",
       "983  0.633 (0.615, 0.648) 0.626 (0.61, 0.645)  -0.006 (-0.018, 0.007) \n",
       "984  0.526 (0.503, 0.547) 0.519 (0.499, 0.542) -0.006 (-0.018, 0.006) \n",
       "985  0.661 (0.646, 0.673) 0.654 (0.638, 0.668) -0.006 (-0.017, 0.005) \n",
       "986  0.75 (0.724, 0.781)  0.745 (0.721, 0.771) -0.006 (-0.016, 0.008) \n",
       "987  0.651 (0.624, 0.676) 0.646 (0.616, 0.667) -0.006 (-0.016, 0.006) \n",
       "988  0.577 (0.564, 0.595) 0.572 (0.559, 0.588) -0.006 (-0.014, 0)     \n",
       "989  0.739 (0.725, 0.753) 0.732 (0.718, 0.747) -0.006 (-0.013, 0)     \n",
       "990  0.621 (0.602, 0.639) 0.616 (0.594, 0.635) -0.006 (-0.013, 0.004) \n",
       "991  0.677 (0.659, 0.696) 0.672 (0.656, 0.692) -0.006 (-0.013, 0.003) \n",
       "992  0.571 (0.558, 0.583) 0.565 (0.551, 0.578) -0.006 (-0.013, 0.002) \n",
       "993  0.523 (0.512, 0.534) 0.517 (0.506, 0.53)  -0.006 (-0.013, 0.002) \n",
       "994  0.589 (0.573, 0.606) 0.583 (0.566, 0.599) -0.006 (-0.013, -0.001)\n",
       "995  0.602 (0.581, 0.613) 0.596 (0.574, 0.609) -0.006 (-0.012, 0.002) \n",
       "996  0.648 (0.636, 0.66)  0.642 (0.628, 0.654) -0.006 (-0.012, -0.001)\n",
       "997  0.592 (0.58, 0.605)  0.586 (0.575, 0.599) -0.006 (-0.011, 0)     \n",
       "998  0.6 (0.592, 0.606)   0.593 (0.587, 0.6)   -0.006 (-0.01, -0.002) \n",
       "999  0.69 (0.668, 0.711)  0.683 (0.663, 0.705) -0.006 (-0.009, -0.002)\n",
       "1000 0.605 (0.571, 0.641) 0.599 (0.56, 0.641)  -0.005 (-0.036, 0.026) \n",
       "1001 0.576 (0.551, 0.602) 0.57 (0.544, 0.597)  -0.005 (-0.034, 0.019) \n",
       "1002 0.608 (0.57, 0.645)  0.604 (0.563, 0.643) -0.005 (-0.032, 0.029) \n",
       "1003 0.667 (0.625, 0.701) 0.662 (0.616, 0.695) -0.005 (-0.031, 0.027) \n",
       "1004 0.552 (0.524, 0.582) 0.546 (0.519, 0.575) -0.005 (-0.029, 0.028) \n",
       "1005 0.652 (0.614, 0.677) 0.646 (0.611, 0.673) -0.005 (-0.025, 0.019) \n",
       "1006 0.546 (0.527, 0.567) 0.543 (0.519, 0.563) -0.005 (-0.025, 0.018) \n",
       "1007 0.627 (0.598, 0.668) 0.621 (0.592, 0.656) -0.005 (-0.022, 0.016) \n",
       "1008 0.595 (0.58, 0.622)  0.592 (0.574, 0.613) -0.005 (-0.02, 0.01)   \n",
       "1009 0.505 (0.493, 0.52)  0.501 (0.484, 0.515) -0.005 (-0.019, 0.007) \n",
       "1010 0.599 (0.585, 0.616) 0.594 (0.58, 0.613)  -0.005 (-0.018, 0.009) \n",
       "1011 0.6 (0.581, 0.615)   0.595 (0.578, 0.61)  -0.005 (-0.017, 0.005) \n",
       "1012 0.738 (0.709, 0.771) 0.734 (0.704, 0.767) -0.005 (-0.013, 0.005) \n",
       "1013 0.723 (0.712, 0.733) 0.717 (0.707, 0.728) -0.005 (-0.013, 0.003) \n",
       "1014 0.696 (0.684, 0.713) 0.691 (0.679, 0.705) -0.005 (-0.013, 0.002) \n",
       "1015 0.754 (0.732, 0.774) 0.748 (0.727, 0.767) -0.005 (-0.013, 0.001) \n",
       "1016 0.635 (0.608, 0.658) 0.631 (0.604, 0.657) -0.005 (-0.012, 0.003) \n",
       "1017 0.596 (0.586, 0.602) 0.59 (0.582, 0.599)  -0.005 (-0.011, 0)     \n",
       "1018 0.616 (0.606, 0.632) 0.611 (0.6, 0.629)   -0.005 (-0.011, 0)     \n",
       "1019 0.706 (0.694, 0.717) 0.702 (0.689, 0.714) -0.005 (-0.011, 0.002) \n",
       "1020 0.58 (0.568, 0.594)  0.575 (0.563, 0.59)  -0.005 (-0.011, 0.001) \n",
       "1021 0.542 (0.527, 0.555) 0.538 (0.522, 0.551) -0.005 (-0.01, 0)      \n",
       "1022 0.633 (0.623, 0.642) 0.627 (0.617, 0.64)  -0.005 (-0.01, 0)      \n",
       "1023 0.587 (0.572, 0.6)   0.582 (0.57, 0.595)  -0.005 (-0.01, 0.001)  \n",
       "1024 0.687 (0.667, 0.702) 0.682 (0.664, 0.699) -0.005 (-0.01, 0.001)  \n",
       "1025 0.801 (0.79, 0.813)  0.796 (0.783, 0.808) -0.005 (-0.01, -0.002) \n",
       "1026 0.788 (0.776, 0.802) 0.783 (0.772, 0.796) -0.005 (-0.01, -0.001) \n",
       "1027 0.623 (0.612, 0.635) 0.619 (0.607, 0.631) -0.005 (-0.01, -0.001) \n",
       "1028 0.618 (0.609, 0.624) 0.613 (0.604, 0.62)  -0.005 (-0.009, -0.002)\n",
       "1029 0.576 (0.564, 0.587) 0.571 (0.561, 0.582) -0.005 (-0.008, 0)     \n",
       "1030 0.515 (0.465, 0.567) 0.509 (0.458, 0.563) -0.004 (-0.05, 0.04)   \n",
       "1031 0.56 (0.526, 0.592)  0.553 (0.526, 0.59)  -0.004 (-0.038, 0.018) \n",
       "1032 0.654 (0.631, 0.676) 0.648 (0.621, 0.669) -0.004 (-0.024, 0.013) \n",
       "1033 0.551 (0.531, 0.573) 0.546 (0.525, 0.572) -0.004 (-0.019, 0.011) \n",
       "1034 0.8 (0.774, 0.823)   0.795 (0.771, 0.819) -0.004 (-0.018, 0.009) \n",
       "1035 0.648 (0.627, 0.668) 0.645 (0.622, 0.665) -0.004 (-0.017, 0.008) \n",
       "1036 0.585 (0.562, 0.599) 0.58 (0.564, 0.594)  -0.004 (-0.016, 0.009) \n",
       "1037 0.69 (0.664, 0.713)  0.685 (0.66, 0.71)   -0.004 (-0.013, 0.006) \n",
       "1038 0.629 (0.61, 0.645)  0.625 (0.607, 0.642) -0.004 (-0.013, 0.006) \n",
       "1039 0.634 (0.612, 0.655) 0.63 (0.606, 0.65)   -0.004 (-0.013, 0.003) \n",
       "1040 0.534 (0.523, 0.548) 0.531 (0.517, 0.545) -0.004 (-0.012, 0.009) \n",
       "1041 0.613 (0.597, 0.63)  0.609 (0.59, 0.626)  -0.004 (-0.012, 0.002) \n",
       "1042 0.612 (0.598, 0.627) 0.608 (0.596, 0.623) -0.004 (-0.011, 0.007) \n",
       "1043 0.734 (0.718, 0.756) 0.73 (0.711, 0.753)  -0.004 (-0.011, 0.005) \n",
       "1044 0.584 (0.57, 0.598)  0.579 (0.562, 0.593) -0.004 (-0.011, 0.003) \n",
       "1045 0.579 (0.566, 0.591) 0.575 (0.561, 0.589) -0.004 (-0.011, 0.003) \n",
       "1046 0.894 (0.882, 0.908) 0.891 (0.879, 0.902) -0.004 (-0.01, 0.004)  \n",
       "1047 0.75 (0.74, 0.763)   0.747 (0.735, 0.76)  -0.004 (-0.01, 0.001)  \n",
       "1048 0.549 (0.537, 0.561) 0.545 (0.534, 0.556) -0.004 (-0.009, 0.003) \n",
       "1049 0.512 (0.505, 0.519) 0.508 (0.502, 0.514) -0.004 (-0.008, 0.001) \n",
       "1050 0.581 (0.57, 0.593)  0.577 (0.567, 0.588) -0.004 (-0.008, 0.001) \n",
       "1051 0.722 (0.715, 0.73)  0.718 (0.71, 0.726)  -0.004 (-0.007, 0)     \n",
       "1052 0.594 (0.582, 0.604) 0.591 (0.579, 0.603) -0.004 (-0.007, 0.001) \n",
       "1053 0.658 (0.647, 0.67)  0.654 (0.644, 0.666) -0.004 (-0.007, -0.001)\n",
       "1054 0.572 (0.562, 0.583) 0.569 (0.56, 0.579)  -0.004 (-0.007, -0.001)\n",
       "1055 0.584 (0.573, 0.595) 0.581 (0.569, 0.592) -0.004 (-0.006, -0.001)\n",
       "1056 0.54 (0.513, 0.57)   0.539 (0.501, 0.574) -0.003 (-0.036, 0.027) \n",
       "1057 0.568 (0.532, 0.602) 0.565 (0.526, 0.6)   -0.003 (-0.036, 0.025) \n",
       "1058 0.585 (0.558, 0.619) 0.582 (0.546, 0.609) -0.003 (-0.034, 0.026) \n",
       "1059 0.657 (0.621, 0.709) 0.65 (0.62, 0.704)   -0.003 (-0.034, 0.023) \n",
       "1060 0.561 (0.526, 0.596) 0.56 (0.53, 0.591)   -0.003 (-0.03, 0.025)  \n",
       "1061 0.697 (0.678, 0.72)  0.695 (0.676, 0.719) -0.003 (-0.029, 0.016) \n",
       "1062 0.569 (0.535, 0.597) 0.565 (0.528, 0.593) -0.003 (-0.026, 0.015) \n",
       "1063 0.656 (0.641, 0.673) 0.655 (0.639, 0.671) -0.003 (-0.016, 0.013) \n",
       "1064 0.603 (0.588, 0.62)  0.599 (0.581, 0.619) -0.003 (-0.016, 0.008) \n",
       "1065 0.592 (0.576, 0.607) 0.589 (0.574, 0.605) -0.003 (-0.015, 0.01)  \n",
       "1066 0.55 (0.536, 0.568)  0.547 (0.533, 0.563) -0.003 (-0.014, 0.014) \n",
       "1067 0.539 (0.521, 0.552) 0.536 (0.519, 0.549) -0.003 (-0.014, 0.007) \n",
       "1068 0.63 (0.616, 0.642)  0.626 (0.614, 0.641) -0.003 (-0.014, 0.005) \n",
       "1069 0.652 (0.636, 0.671) 0.65 (0.634, 0.668)  -0.003 (-0.013, 0.009) \n",
       "1070 0.585 (0.568, 0.603) 0.582 (0.565, 0.603) -0.003 (-0.013, 0.005) \n",
       "1071 0.562 (0.546, 0.578) 0.559 (0.545, 0.577) -0.003 (-0.012, 0.008) \n",
       "1072 0.661 (0.649, 0.672) 0.658 (0.647, 0.669) -0.003 (-0.01, 0.003)  \n",
       "1073 0.626 (0.61, 0.638)  0.623 (0.606, 0.636) -0.003 (-0.009, 0.006) \n",
       "1074 0.712 (0.698, 0.731) 0.71 (0.695, 0.729)  -0.003 (-0.009, 0.006) \n",
       "1075 0.672 (0.663, 0.683) 0.669 (0.659, 0.68)  -0.003 (-0.009, 0.002) \n",
       "1076 0.685 (0.673, 0.699) 0.682 (0.672, 0.696) -0.003 (-0.008, 0.002) \n",
       "1077 0.797 (0.779, 0.812) 0.795 (0.779, 0.809) -0.003 (-0.008, 0.001) \n",
       "1078 0.712 (0.705, 0.72)  0.709 (0.702, 0.718) -0.003 (-0.007, 0.002) \n",
       "1079 0.812 (0.798, 0.826) 0.809 (0.796, 0.822) -0.003 (-0.007, 0.002) \n",
       "1080 0.657 (0.642, 0.672) 0.655 (0.638, 0.67)  -0.003 (-0.007, 0.002) \n",
       "1081 0.554 (0.543, 0.564) 0.55 (0.54, 0.563)   -0.003 (-0.007, 0.001) \n",
       "1082 0.607 (0.599, 0.617) 0.604 (0.596, 0.613) -0.003 (-0.007, 0.001) \n",
       "1083 0.62 (0.615, 0.625)  0.618 (0.612, 0.622) -0.003 (-0.006, 0)     \n",
       "1084 0.636 (0.625, 0.646) 0.632 (0.623, 0.643) -0.003 (-0.006, 0)     \n",
       "1085 0.544 (0.537, 0.554) 0.542 (0.533, 0.552) -0.003 (-0.006, 0.001) \n",
       "1086 0.577 (0.569, 0.587) 0.575 (0.566, 0.586) -0.003 (-0.006, 0.001) \n",
       "1087 0.564 (0.557, 0.571) 0.561 (0.554, 0.568) -0.003 (-0.006, -0.001)\n",
       "1088 0.753 (0.747, 0.76)  0.75 (0.743, 0.756)  -0.003 (-0.006, -0.001)\n",
       "1089 0.595 (0.586, 0.606) 0.593 (0.584, 0.603) -0.003 (-0.005, 0)     \n",
       "1090 0.618 (0.606, 0.629) 0.614 (0.603, 0.627) -0.003 (-0.005, 0)     \n",
       "1091 0.685 (0.674, 0.693) 0.682 (0.672, 0.69)  -0.003 (-0.005, -0.001)\n",
       "1092 0.694 (0.686, 0.703) 0.691 (0.683, 0.701) -0.003 (-0.005, -0.001)\n",
       "1093 0.579 (0.57, 0.588)  0.576 (0.567, 0.586) -0.003 (-0.004, -0.001)\n",
       "1094 0.561 (0.531, 0.591) 0.553 (0.526, 0.591) -0.002 (-0.035, 0.022) \n",
       "1095 0.61 (0.575, 0.644)  0.613 (0.57, 0.641)  -0.002 (-0.026, 0.034) \n",
       "1096 0.651 (0.627, 0.687) 0.651 (0.619, 0.682) -0.002 (-0.026, 0.02)  \n",
       "1097 0.518 (0.502, 0.539) 0.517 (0.498, 0.532) -0.002 (-0.019, 0.014) \n",
       "1098 0.635 (0.617, 0.655) 0.633 (0.619, 0.651) -0.002 (-0.018, 0.012) \n",
       "1099 0.656 (0.638, 0.68)  0.652 (0.634, 0.674) -0.002 (-0.017, 0.01)  \n",
       "1100 0.64 (0.619, 0.669)  0.639 (0.618, 0.66)  -0.002 (-0.015, 0.015) \n",
       "1101 0.62 (0.596, 0.638)  0.616 (0.598, 0.642) -0.002 (-0.015, 0.009) \n",
       "1102 0.636 (0.621, 0.655) 0.633 (0.617, 0.654) -0.002 (-0.01, 0.005)  \n",
       "1103 0.561 (0.548, 0.574) 0.56 (0.549, 0.573)  -0.002 (-0.009, 0.008) \n",
       "1104 0.65 (0.632, 0.664)  0.649 (0.633, 0.666) -0.002 (-0.009, 0.008) \n",
       "1105 0.722 (0.706, 0.735) 0.719 (0.706, 0.734) -0.002 (-0.009, 0.007) \n",
       "1106 0.598 (0.585, 0.613) 0.597 (0.583, 0.611) -0.002 (-0.008, 0.004) \n",
       "1107 0.539 (0.525, 0.549) 0.536 (0.523, 0.547) -0.002 (-0.008, 0.004) \n",
       "1108 0.58 (0.569, 0.593)  0.578 (0.568, 0.59)  -0.002 (-0.008, 0.004) \n",
       "1109 0.608 (0.596, 0.623) 0.608 (0.592, 0.623) -0.002 (-0.007, 0.005) \n",
       "1110 0.655 (0.646, 0.664) 0.653 (0.644, 0.663) -0.002 (-0.007, 0.004) \n",
       "1111 0.686 (0.664, 0.703) 0.684 (0.663, 0.702) -0.002 (-0.007, 0.003) \n",
       "1112 0.547 (0.537, 0.557) 0.544 (0.534, 0.554) -0.002 (-0.007, 0.003) \n",
       "1113 0.734 (0.725, 0.745) 0.733 (0.722, 0.745) -0.002 (-0.007, 0.003) \n",
       "1114 0.586 (0.578, 0.595) 0.584 (0.576, 0.593) -0.002 (-0.007, 0.002) \n",
       "1115 0.63 (0.62, 0.64)    0.628 (0.618, 0.638) -0.002 (-0.007, 0.001) \n",
       "1116 0.664 (0.655, 0.672) 0.661 (0.654, 0.672) -0.002 (-0.006, 0.002) \n",
       "1117 0.59 (0.58, 0.602)   0.588 (0.576, 0.601) -0.002 (-0.006, 0.002) \n",
       "1118 0.611 (0.6, 0.622)   0.609 (0.597, 0.621) -0.002 (-0.006, 0.002) \n",
       "1119 0.801 (0.788, 0.818) 0.799 (0.787, 0.816) -0.002 (-0.006, 0.002) \n",
       "1120 0.588 (0.584, 0.593) 0.586 (0.581, 0.59)  -0.002 (-0.005, 0)     \n",
       "1121 0.603 (0.593, 0.613) 0.602 (0.592, 0.612) -0.002 (-0.005, 0)     \n",
       "1122 0.561 (0.555, 0.566) 0.558 (0.553, 0.565) -0.002 (-0.005, 0)     \n",
       "1123 0.591 (0.585, 0.6)   0.589 (0.582, 0.597) -0.002 (-0.005, 0.001) \n",
       "1124 0.596 (0.588, 0.606) 0.594 (0.585, 0.603) -0.002 (-0.005, 0.001) \n",
       "1125 0.635 (0.629, 0.643) 0.633 (0.626, 0.639) -0.002 (-0.005, 0.001) \n",
       "1126 0.558 (0.551, 0.565) 0.556 (0.549, 0.562) -0.002 (-0.005, 0.001) \n",
       "1127 0.632 (0.626, 0.638) 0.629 (0.624, 0.636) -0.002 (-0.004, 0)     \n",
       "1128 0.588 (0.583, 0.592) 0.586 (0.582, 0.59)  -0.002 (-0.004, 0)     \n",
       "1129 0.578 (0.57, 0.585)  0.576 (0.568, 0.583) -0.002 (-0.004, 0)     \n",
       "1130 0.584 (0.579, 0.589) 0.583 (0.577, 0.588) -0.002 (-0.004, 0.001) \n",
       "1131 0.735 (0.726, 0.744) 0.733 (0.724, 0.741) -0.002 (-0.004, 0.001) \n",
       "1132 0.607 (0.597, 0.618) 0.606 (0.594, 0.616) -0.002 (-0.004, 0.001) \n",
       "1133 0.577 (0.571, 0.582) 0.574 (0.568, 0.58)  -0.002 (-0.004, -0.001)\n",
       "1134 0.667 (0.66, 0.675)  0.665 (0.658, 0.674) -0.002 (-0.003, 0)     \n",
       "1135 0.59 (0.548, 0.629)  0.589 (0.545, 0.63)  -0.001 (-0.043, 0.049) \n",
       "1136 0.584 (0.54, 0.61)   0.581 (0.548, 0.611) -0.001 (-0.022, 0.023) \n",
       "1137 0.717 (0.689, 0.742) 0.713 (0.689, 0.741) -0.001 (-0.018, 0.014) \n",
       "1138 0.596 (0.574, 0.619) 0.592 (0.571, 0.617) -0.001 (-0.014, 0.011) \n",
       "1139 0.666 (0.635, 0.696) 0.666 (0.632, 0.692) -0.001 (-0.013, 0.013) \n",
       "1140 0.602 (0.582, 0.626) 0.603 (0.583, 0.625) -0.001 (-0.012, 0.016) \n",
       "1141 0.617 (0.601, 0.63)  0.616 (0.599, 0.63)  -0.001 (-0.012, 0.008) \n",
       "1142 0.72 (0.691, 0.746)  0.72 (0.692, 0.746)  -0.001 (-0.009, 0.009) \n",
       "1143 0.611 (0.595, 0.626) 0.61 (0.595, 0.627)  -0.001 (-0.009, 0.006) \n",
       "1144 0.71 (0.693, 0.724)  0.709 (0.692, 0.724) -0.001 (-0.008, 0.007) \n",
       "1145 0.716 (0.705, 0.724) 0.714 (0.706, 0.723) -0.001 (-0.008, 0.006) \n",
       "1146 0.59 (0.577, 0.605)  0.59 (0.574, 0.606)  -0.001 (-0.008, 0.006) \n",
       "1147 0.677 (0.667, 0.692) 0.676 (0.664, 0.692) -0.001 (-0.008, 0.005) \n",
       "1148 0.727 (0.716, 0.734) 0.726 (0.714, 0.734) -0.001 (-0.008, 0.003) \n",
       "1149 0.57 (0.563, 0.581)  0.569 (0.561, 0.58)  -0.001 (-0.007, 0.005) \n",
       "1150 0.617 (0.609, 0.624) 0.617 (0.609, 0.624) -0.001 (-0.006, 0.004) \n",
       "1151 0.709 (0.692, 0.719) 0.708 (0.692, 0.717) -0.001 (-0.006, 0.003) \n",
       "1152 0.626 (0.609, 0.647) 0.625 (0.607, 0.646) -0.001 (-0.005, 0.004) \n",
       "1153 0.575 (0.568, 0.581) 0.575 (0.568, 0.582) -0.001 (-0.005, 0.004) \n",
       "1154 0.637 (0.626, 0.649) 0.635 (0.625, 0.646) -0.001 (-0.005, 0.002) \n",
       "1155 0.57 (0.563, 0.578)  0.569 (0.562, 0.575) -0.001 (-0.004, 0)     \n",
       "1156 0.662 (0.65, 0.672)  0.661 (0.649, 0.671) -0.001 (-0.004, 0.003) \n",
       "1157 0.638 (0.631, 0.646) 0.637 (0.629, 0.645) -0.001 (-0.004, 0.002) \n",
       "1158 0.847 (0.836, 0.857) 0.846 (0.835, 0.859) -0.001 (-0.004, 0.002) \n",
       "1159 0.636 (0.629, 0.645) 0.635 (0.627, 0.643) -0.001 (-0.003, 0)     \n",
       "1160 0.685 (0.675, 0.693) 0.684 (0.674, 0.692) -0.001 (-0.003, 0)     \n",
       "1161 0.689 (0.683, 0.697) 0.688 (0.681, 0.696) -0.001 (-0.003, 0)     \n",
       "1162 0.597 (0.59, 0.604)  0.596 (0.589, 0.604) -0.001 (-0.003, 0.003) \n",
       "1163 0.53 (0.524, 0.539)  0.529 (0.524, 0.538) -0.001 (-0.003, 0.002) \n",
       "1164 0.587 (0.581, 0.594) 0.586 (0.58, 0.593)  -0.001 (-0.003, 0.001) \n",
       "1165 0.649 (0.639, 0.657) 0.647 (0.638, 0.655) -0.001 (-0.003, -0.001)\n",
       "1166 0.792 (0.783, 0.801) 0.791 (0.782, 0.8)   -0.001 (-0.002, 0)     \n",
       "1167 0.824 (0.819, 0.829) 0.823 (0.818, 0.828) -0.001 (-0.002, 0)     \n",
       "1168 0.649 (0.636, 0.66)  0.648 (0.635, 0.659) -0.001 (-0.002, 0)     \n",
       "1169 0.644 (0.639, 0.649) 0.643 (0.638, 0.648) -0.001 (-0.002, 0.001) \n",
       "1170 0.663 (0.653, 0.675) 0.662 (0.652, 0.675) -0.001 (-0.002, 0.001) \n",
       "1171 0.748 (0.74, 0.755)  0.747 (0.739, 0.753) -0.001 (-0.002, -0.001)\n",
       "     epic_agesex          epic_agesexretina    epic_delta             \n",
       "1                                                                     \n",
       "2                                                                     \n",
       "3                                                                     \n",
       "4                                                                     \n",
       "5                                                                     \n",
       "6                                                                     \n",
       "7                                                                     \n",
       "8                                                                     \n",
       "9                                                                     \n",
       "10                                                                    \n",
       "11                                                                    \n",
       "12                                                                    \n",
       "13                                                                    \n",
       "14                                                                    \n",
       "15                                                                    \n",
       "16                                                                    \n",
       "17                                                                    \n",
       "18                                                                    \n",
       "19                                                                    \n",
       "20                                                                    \n",
       "21                                                                    \n",
       "22                                                                    \n",
       "23                                                                    \n",
       "24                                                                    \n",
       "25                                                                    \n",
       "26                                                                    \n",
       "27                                                                    \n",
       "28                                                                    \n",
       "29                                                                    \n",
       "30                                                                    \n",
       "31                                                                    \n",
       "32                                                                    \n",
       "33                                                                    \n",
       "34                                                                    \n",
       "35                                                                    \n",
       "36                                                                    \n",
       "37                                                                    \n",
       "38                                                                    \n",
       "39                                                                    \n",
       "40                                                                    \n",
       "41                                                                    \n",
       "42                                                                    \n",
       "43                                                                    \n",
       "44                                                                    \n",
       "45                                                                    \n",
       "46                                                                    \n",
       "47                                                                    \n",
       "48                                                                    \n",
       "49                                                                    \n",
       "50                                                                    \n",
       "51                                                                    \n",
       "52                                                                    \n",
       "53                                                                    \n",
       "54   0.62 (0.606, 0.644)  0.631 (0.617, 0.652) 0.012 (0.007, 0.017)   \n",
       "55                                                                    \n",
       "56                                                                    \n",
       "57                                                                    \n",
       "58   0.607 (0.594, 0.62)  0.619 (0.6, 0.634)   0.011 (0.005, 0.016)   \n",
       "59   0.62 (0.598, 0.641)  0.632 (0.607, 0.647) 0.009 (0.005, 0.016)   \n",
       "60                                                                    \n",
       "61                                                                    \n",
       "62                                                                    \n",
       "63                                                                    \n",
       "64                                                                    \n",
       "65                                                                    \n",
       "66                                                                    \n",
       "67                                                                    \n",
       "68                                                                    \n",
       "69   0.462 (0.429, 0.496) 0.503 (0.483, 0.535) 0.048 (0.018, 0.063)   \n",
       "70   0.619 (0.6, 0.624)   0.626 (0.613, 0.641) 0.012 (0.004, 0.019)   \n",
       "71                                                                    \n",
       "72                                                                    \n",
       "73   0.604 (0.595, 0.621) 0.637 (0.625, 0.643) 0.029 (0.018, 0.041)   \n",
       "74                                                                    \n",
       "75                                                                    \n",
       "76   0.608 (0.591, 0.627) 0.635 (0.622, 0.654) 0.028 (0.013, 0.04)    \n",
       "77                                                                    \n",
       "78                                                                    \n",
       "79                                                                    \n",
       "80   0.625 (0.61, 0.635)  0.634 (0.622, 0.65)  0.011 (0.008, 0.016)   \n",
       "81                                                                    \n",
       "82                                                                    \n",
       "83                                                                    \n",
       "84                                                                    \n",
       "85                                                                    \n",
       "86   0.541 (0.517, 0.563) 0.634 (0.609, 0.664) 0.095 (0.062, 0.134)   \n",
       "87                                                                    \n",
       "88                                                                    \n",
       "89                                                                    \n",
       "90                                                                    \n",
       "91                                                                    \n",
       "92                                                                    \n",
       "93                                                                    \n",
       "94                                                                    \n",
       "95                                                                    \n",
       "96                                                                    \n",
       "97                                                                    \n",
       "98                                                                    \n",
       "99                                                                    \n",
       "100                                                                   \n",
       "101                                                                   \n",
       "102                                                                   \n",
       "103                                                                   \n",
       "104                                                                   \n",
       "105  0.685 (0.67, 0.696)  0.741 (0.721, 0.763) 0.059 (0.037, 0.069)   \n",
       "106                                                                   \n",
       "107                                                                   \n",
       "108  0.549 (0.502, 0.569) 0.63 (0.61, 0.647)   0.089 (0.064, 0.111)   \n",
       "109                                                                   \n",
       "110                                                                   \n",
       "111                                                                   \n",
       "112  0.711 (0.708, 0.72)  0.762 (0.755, 0.765) 0.049 (0.042, 0.054)   \n",
       "113  0.621 (0.6, 0.636)   0.629 (0.608, 0.642) 0.007 (0.005, 0.012)   \n",
       "114                                                                   \n",
       "115                                                                   \n",
       "116                                                                   \n",
       "117                                                                   \n",
       "118                                                                   \n",
       "119                                                                   \n",
       "120                                                                   \n",
       "121                                                                   \n",
       "122                                                                   \n",
       "123                                                                   \n",
       "124                                                                   \n",
       "125                                                                   \n",
       "126  0.636 (0.622, 0.653) 0.645 (0.631, 0.659) 0.008 (0.005, 0.01)    \n",
       "127                                                                   \n",
       "128                                                                   \n",
       "129                                                                   \n",
       "130                                                                   \n",
       "131                                                                   \n",
       "132                                                                   \n",
       "133  0.548 (0.52, 0.572)  0.633 (0.615, 0.661) 0.088 (0.075, 0.103)   \n",
       "134                                                                   \n",
       "135                                                                   \n",
       "136                                                                   \n",
       "137                                                                   \n",
       "138                                                                   \n",
       "139                                                                   \n",
       "140  0.689 (0.671, 0.741) 0.714 (0.701, 0.754) 0.027 (0.01, 0.04)     \n",
       "141                                                                   \n",
       "142                                                                   \n",
       "143                                                                   \n",
       "144                                                                   \n",
       "145                                                                   \n",
       "146                                                                   \n",
       "147                                                                   \n",
       "148                                                                   \n",
       "149                                                                   \n",
       "150                                                                   \n",
       "151                                                                   \n",
       "152                                                                   \n",
       "153                                                                   \n",
       "154                                                                   \n",
       "155                                                                   \n",
       "156                                                                   \n",
       "157                                                                   \n",
       "158                                                                   \n",
       "159                                                                   \n",
       "160                                                                   \n",
       "161  0.696 (0.661, 0.711) 0.719 (0.694, 0.736) 0.027 (0.017, 0.038)   \n",
       "162                                                                   \n",
       "163                                                                   \n",
       "164                                                                   \n",
       "165                                                                   \n",
       "166                                                                   \n",
       "167                                                                   \n",
       "168                                                                   \n",
       "169                                                                   \n",
       "170                                                                   \n",
       "171                                                                   \n",
       "172                                                                   \n",
       "173                                                                   \n",
       "174                                                                   \n",
       "175                                                                   \n",
       "176                                                                   \n",
       "177                                                                   \n",
       "178                                                                   \n",
       "179                                                                   \n",
       "180                                                                   \n",
       "181                                                                   \n",
       "182                                                                   \n",
       "183                                                                   \n",
       "184                                                                   \n",
       "185                                                                   \n",
       "186                                                                   \n",
       "187                                                                   \n",
       "188  0.633 (0.622, 0.638) 0.696 (0.69, 0.701)  0.065 (0.057, 0.073)   \n",
       "189                                                                   \n",
       "190                                                                   \n",
       "191                                                                   \n",
       "192                                                                   \n",
       "193                                                                   \n",
       "194                                                                   \n",
       "195                                                                   \n",
       "196                                                                   \n",
       "197                                                                   \n",
       "198                                                                   \n",
       "199                                                                   \n",
       "200                                                                   \n",
       "201                                                                   \n",
       "202                                                                   \n",
       "203                                                                   \n",
       "204  0.771 (0.749, 0.787) 0.781 (0.761, 0.797) 0.01 (0.008, 0.012)    \n",
       "205                                                                   \n",
       "206                                                                   \n",
       "207                                                                   \n",
       "208                                                                   \n",
       "209  0.588 (0.576, 0.6)   0.586 (0.573, 0.597) -0.003 (-0.003, -0.002)\n",
       "210                                                                   \n",
       "211                                                                   \n",
       "212                                                                   \n",
       "213                                                                   \n",
       "214                                                                   \n",
       "215                                                                   \n",
       "216                                                                   \n",
       "217                                                                   \n",
       "218                                                                   \n",
       "219                                                                   \n",
       "220                                                                   \n",
       "221                                                                   \n",
       "222                                                                   \n",
       "223                                                                   \n",
       "224                                                                   \n",
       "225                                                                   \n",
       "226                                                                   \n",
       "227                                                                   \n",
       "228                                                                   \n",
       "229                                                                   \n",
       "230                                                                   \n",
       "231                                                                   \n",
       "232                                                                   \n",
       "233                                                                   \n",
       "234                                                                   \n",
       "235  0.501 (0.49, 0.525)  0.532 (0.518, 0.547) 0.032 (0.02, 0.038)    \n",
       "236                                                                   \n",
       "237                                                                   \n",
       "238  0.66 (0.636, 0.7)    0.69 (0.663, 0.721)  0.026 (0.009, 0.046)   \n",
       "239                                                                   \n",
       "240                                                                   \n",
       "241                                                                   \n",
       "242                                                                   \n",
       "243                                                                   \n",
       "244                                                                   \n",
       "245  0.613 (0.595, 0.635) 0.619 (0.6, 0.644)   0.006 (0.001, 0.014)   \n",
       "246  0.546 (0.512, 0.561) 0.559 (0.532, 0.577) 0.015 (0.006, 0.028)   \n",
       "247                                                                   \n",
       "248                                                                   \n",
       "249                                                                   \n",
       "250                                                                   \n",
       "251                                                                   \n",
       "252  0.787 (0.766, 0.814) 0.792 (0.766, 0.822) 0.004 (-0.003, 0.012)  \n",
       "253                                                                   \n",
       "254                                                                   \n",
       "255                                                                   \n",
       "256                                                                   \n",
       "257                                                                   \n",
       "258                                                                   \n",
       "259                                                                   \n",
       "260                                                                   \n",
       "261                                                                   \n",
       "262                                                                   \n",
       "263                                                                   \n",
       "264                                                                   \n",
       "265                                                                   \n",
       "266                                                                   \n",
       "267                                                                   \n",
       "268                                                                   \n",
       "269                                                                   \n",
       "270  0.715 (0.694, 0.733) 0.716 (0.695, 0.734) 0.001 (0, 0.004)       \n",
       "271                                                                   \n",
       "272                                                                   \n",
       "273                                                                   \n",
       "274                                                                   \n",
       "275                                                                   \n",
       "276                                                                   \n",
       "277                                                                   \n",
       "278                                                                   \n",
       "279                                                                   \n",
       "280                                                                   \n",
       "281                                                                   \n",
       "282                                                                   \n",
       "283                                                                   \n",
       "284                                                                   \n",
       "285                                                                   \n",
       "286                                                                   \n",
       "287                                                                   \n",
       "288                                                                   \n",
       "289                                                                   \n",
       "290                                                                   \n",
       "291                                                                   \n",
       "292                                                                   \n",
       "293                                                                   \n",
       "294                                                                   \n",
       "295                                                                   \n",
       "296                                                                   \n",
       "297                                                                   \n",
       "298  0.668 (0.64, 0.684)  0.667 (0.642, 0.678) 0 (-0.006, 0.004)      \n",
       "299  0.74 (0.727, 0.749)  0.748 (0.734, 0.752) 0.007 (0.004, 0.009)   \n",
       "300                                                                   \n",
       "301                                                                   \n",
       "302                                                                   \n",
       "303                                                                   \n",
       "304                                                                   \n",
       "305                                                                   \n",
       "306                                                                   \n",
       "307                                                                   \n",
       "308                                                                   \n",
       "309  0.59 (0.566, 0.617)  0.6 (0.578, 0.636)   0.01 (0.004, 0.019)    \n",
       "310                                                                   \n",
       "311                                                                   \n",
       "312                                                                   \n",
       "313                                                                   \n",
       "314                                                                   \n",
       "315                                                                   \n",
       "316                                                                   \n",
       "317                                                                   \n",
       "318  0.802 (0.783, 0.817) 0.802 (0.784, 0.818) 0 (-0.002, 0.004)      \n",
       "319                                                                   \n",
       "320                                                                   \n",
       "321                                                                   \n",
       "322                                                                   \n",
       "323                                                                   \n",
       "324                                                                   \n",
       "325                                                                   \n",
       "326                                                                   \n",
       "327                                                                   \n",
       "328                                                                   \n",
       "329                                                                   \n",
       "330                                                                   \n",
       "331                                                                   \n",
       "332                                                                   \n",
       "333                                                                   \n",
       "334                                                                   \n",
       "335                                                                   \n",
       "336                                                                   \n",
       "337                                                                   \n",
       "338  0.527 (0.51, 0.538)  0.524 (0.507, 0.535) -0.003 (-0.005, -0.001)\n",
       "339                                                                   \n",
       "340                                                                   \n",
       "341                                                                   \n",
       "342                                                                   \n",
       "343                                                                   \n",
       "344                                                                   \n",
       "345  0.639 (0.631, 0.647) 0.648 (0.64, 0.656)  0.009 (0.006, 0.01)    \n",
       "346  0.641 (0.631, 0.648) 0.648 (0.642, 0.653) 0.009 (0.005, 0.011)   \n",
       "347  0.596 (0.564, 0.629) 0.627 (0.589, 0.649) 0.019 (0.002, 0.041)   \n",
       "348  0.717 (0.7, 0.736)   0.724 (0.704, 0.741) 0.006 (0.004, 0.01)    \n",
       "349  0.572 (0.556, 0.602) 0.573 (0.557, 0.605) 0.001 (-0.001, 0.003)  \n",
       "350                                                                   \n",
       "351  0.475 (0.452, 0.5)   0.474 (0.448, 0.51)  0.004 (-0.011, 0.016)  \n",
       "352                                                                   \n",
       "353  0.778 (0.75, 0.795)  0.774 (0.747, 0.793) -0.002 (-0.005, -0.001)\n",
       "354  0.512 (0.494, 0.527) 0.526 (0.506, 0.538) 0.012 (-0.002, 0.02)   \n",
       "355                                                                   \n",
       "356                                                                   \n",
       "357                                                                   \n",
       "358                                                                   \n",
       "359                                                                   \n",
       "360                                                                   \n",
       "361                                                                   \n",
       "362                                                                   \n",
       "363                                                                   \n",
       "364                                                                   \n",
       "365  0.73 (0.719, 0.748)  0.735 (0.722, 0.752) 0.004 (0.001, 0.005)   \n",
       "366                                                                   \n",
       "367  0.715 (0.68, 0.735)  0.715 (0.686, 0.732) 0.003 (-0.009, 0.012)  \n",
       "368                                                                   \n",
       "369                                                                   \n",
       "370  0.641 (0.621, 0.671) 0.639 (0.621, 0.673) 0 (-0.007, 0.003)      \n",
       "371                                                                   \n",
       "372                                                                   \n",
       "373                                                                   \n",
       "374                                                                   \n",
       "375                                                                   \n",
       "376                                                                   \n",
       "377  0.541 (0.523, 0.556) 0.542 (0.523, 0.56)  0.004 (-0.01, 0.012)   \n",
       "378                                                                   \n",
       "379                                                                   \n",
       "380                                                                   \n",
       "381                                                                   \n",
       "382                                                                   \n",
       "383                                                                   \n",
       "384                                                                   \n",
       "385                                                                   \n",
       "386                                                                   \n",
       "387  0.546 (0.519, 0.55)  0.543 (0.516, 0.548) -0.003 (-0.004, -0.001)\n",
       "388                                                                   \n",
       "389                                                                   \n",
       "390                                                                   \n",
       "391                                                                   \n",
       "392  0.709 (0.686, 0.722) 0.716 (0.697, 0.726) 0.007 (0.001, 0.01)    \n",
       "393  0.6 (0.562, 0.611)   0.593 (0.556, 0.609) -0.003 (-0.02, 0.005)  \n",
       "394                                                                   \n",
       "395                                                                   \n",
       "396  0.655 (0.623, 0.692) 0.705 (0.676, 0.75)  0.045 (0.032, 0.068)   \n",
       "397                                                                   \n",
       "398                                                                   \n",
       "399                                                                   \n",
       "400                                                                   \n",
       "401                                                                   \n",
       "402                                                                   \n",
       "403                                                                   \n",
       "404                                                                   \n",
       "405                                                                   \n",
       "406                                                                   \n",
       "407                                                                   \n",
       "408                                                                   \n",
       "409                                                                   \n",
       "410                                                                   \n",
       "411                                                                   \n",
       "412                                                                   \n",
       "413                                                                   \n",
       "414                                                                   \n",
       "415                                                                   \n",
       "416                                                                   \n",
       "417                                                                   \n",
       "418  0.751 (0.735, 0.782) 0.748 (0.73, 0.778)  -0.004 (-0.005, -0.002)\n",
       "419  0.728 (0.707, 0.746) 0.728 (0.706, 0.744) 0 (-0.002, 0.001)      \n",
       "420                                                                   \n",
       "421                                                                   \n",
       "422                                                                   \n",
       "423  0.586 (0.549, 0.611) 0.57 (0.533, 0.598)  -0.015 (-0.018, -0.009)\n",
       "424  0.571 (0.556, 0.584) 0.582 (0.572, 0.596) 0.013 (0.005, 0.02)    \n",
       "425  0.712 (0.701, 0.724) 0.715 (0.702, 0.726) 0.002 (0, 0.003)       \n",
       "426                                                                   \n",
       "427                                                                   \n",
       "428                                                                   \n",
       "429                                                                   \n",
       "430  0.65 (0.631, 0.658)  0.653 (0.629, 0.663) 0.003 (-0.002, 0.005)  \n",
       "431                                                                   \n",
       "432                                                                   \n",
       "433  0.628 (0.623, 0.648) 0.627 (0.623, 0.647) -0.001 (-0.003, 0)     \n",
       "434                                                                   \n",
       "435                                                                   \n",
       "436                                                                   \n",
       "437                                                                   \n",
       "438                                                                   \n",
       "439                                                                   \n",
       "440                                                                   \n",
       "441                                                                   \n",
       "442                                                                   \n",
       "443                                                                   \n",
       "444                                                                   \n",
       "445                                                                   \n",
       "446                                                                   \n",
       "447  0.625 (0.606, 0.633) 0.623 (0.604, 0.632) -0.002 (-0.003, -0.001)\n",
       "448                                                                   \n",
       "449  0.676 (0.666, 0.692) 0.68 (0.673, 0.699)  0.007 (-0.001, 0.01)   \n",
       "450  0.733 (0.705, 0.784) 0.727 (0.701, 0.773) -0.006 (-0.015, 0.008) \n",
       "451  0.767 (0.757, 0.778) 0.768 (0.759, 0.78)  0.002 (0, 0.004)       \n",
       "452                                                                   \n",
       "453                                                                   \n",
       "454                                                                   \n",
       "455  0.561 (0.549, 0.58)  0.561 (0.539, 0.573) -0.002 (-0.014, 0.01)  \n",
       "456                                                                   \n",
       "457                                                                   \n",
       "458                                                                   \n",
       "459                                                                   \n",
       "460                                                                   \n",
       "461                                                                   \n",
       "462                                                                   \n",
       "463                                                                   \n",
       "464                                                                   \n",
       "465                                                                   \n",
       "466                                                                   \n",
       "467                                                                   \n",
       "468                                                                   \n",
       "469                                                                   \n",
       "470                                                                   \n",
       "471                                                                   \n",
       "472                                                                   \n",
       "473  0.571 (0.552, 0.583) 0.57 (0.55, 0.582)   -0.001 (-0.001, -0.001)\n",
       "474                                                                   \n",
       "475                                                                   \n",
       "476  0.773 (0.759, 0.78)  0.77 (0.756, 0.779)  -0.002 (-0.006, 0)     \n",
       "477                                                                   \n",
       "478                                                                   \n",
       "479                                                                   \n",
       "480                                                                   \n",
       "481                                                                   \n",
       "482                                                                   \n",
       "483                                                                   \n",
       "484                                                                   \n",
       "485                                                                   \n",
       "486                                                                   \n",
       "487  0.596 (0.576, 0.613) 0.59 (0.577, 0.616)  0.002 (-0.012, 0.012)  \n",
       "488                                                                   \n",
       "489                                                                   \n",
       "490                                                                   \n",
       "491                                                                   \n",
       "492                                                                   \n",
       "493                                                                   \n",
       "494  0.566 (0.56, 0.58)   0.565 (0.559, 0.58)  -0.001 (-0.001, 0)     \n",
       "495                                                                   \n",
       "496                                                                   \n",
       "497                                                                   \n",
       "498                                                                   \n",
       "499                                                                   \n",
       "500                                                                   \n",
       "501                                                                   \n",
       "502                                                                   \n",
       "503                                                                   \n",
       "504                                                                   \n",
       "505  0.672 (0.637, 0.69)  0.677 (0.649, 0.7)   0.009 (0.002, 0.015)   \n",
       "506                                                                   \n",
       "507                                                                   \n",
       "508  0.63 (0.609, 0.662)  0.634 (0.613, 0.662) 0.004 (-0.004, 0.014)  \n",
       "509  0.662 (0.648, 0.669) 0.662 (0.649, 0.671) 0.001 (-0.002, 0.005)  \n",
       "510  0.675 (0.664, 0.683) 0.68 (0.671, 0.693)  0.006 (0.004, 0.01)    \n",
       "511  0.78 (0.758, 0.796)  0.782 (0.768, 0.8)   0.004 (-0.001, 0.01)   \n",
       "512  0.647 (0.629, 0.659) 0.65 (0.635, 0.661)  0.004 (0.002, 0.011)   \n",
       "513  0.683 (0.652, 0.698) 0.682 (0.654, 0.696) 0.001 (-0.002, 0.003)  \n",
       "514  0.711 (0.694, 0.728) 0.714 (0.701, 0.731) 0.004 (0, 0.006)       \n",
       "515                                                                   \n",
       "516  0.723 (0.704, 0.727) 0.721 (0.702, 0.726) 0 (-0.003, 0.005)      \n",
       "517                                                                   \n",
       "518  0.47 (0.432, 0.496)  0.491 (0.455, 0.514) 0.018 (0.013, 0.028)   \n",
       "519                                                                   \n",
       "520                                                                   \n",
       "521                                                                   \n",
       "522                                                                   \n",
       "523                                                                   \n",
       "524                                                                   \n",
       "525                                                                   \n",
       "526                                                                   \n",
       "527  0.676 (0.656, 0.685) 0.684 (0.658, 0.693) 0.007 (0, 0.011)       \n",
       "528  0.711 (0.701, 0.738) 0.711 (0.699, 0.74)  -0.001 (-0.003, 0.004) \n",
       "529  0.678 (0.671, 0.692) 0.679 (0.673, 0.696) 0.002 (-0.001, 0.004)  \n",
       "530  0.566 (0.548, 0.582) 0.569 (0.55, 0.588)  0.003 (-0.001, 0.007)  \n",
       "531                                                                   \n",
       "532                                                                   \n",
       "533  0.78 (0.753, 0.805)  0.78 (0.757, 0.804)  0 (-0.003, 0.008)      \n",
       "534  0.569 (0.536, 0.581) 0.565 (0.534, 0.577) -0.003 (-0.006, -0.001)\n",
       "535                                                                   \n",
       "536                                                                   \n",
       "537                                                                   \n",
       "538                                                                   \n",
       "539                                                                   \n",
       "540                                                                   \n",
       "541                                                                   \n",
       "542                                                                   \n",
       "543                                                                   \n",
       "544                                                                   \n",
       "545                                                                   \n",
       "546                                                                   \n",
       "547                                                                   \n",
       "548                                                                   \n",
       "549                                                                   \n",
       "550                                                                   \n",
       "551                                                                   \n",
       "552                                                                   \n",
       "553                                                                   \n",
       "554  0.549 (0.526, 0.578) 0.544 (0.526, 0.575) -0.003 (-0.005, -0.001)\n",
       "555                                                                   \n",
       "556                                                                   \n",
       "557                                                                   \n",
       "558                                                                   \n",
       "559  0.572 (0.545, 0.597) 0.573 (0.542, 0.596) -0.002 (-0.005, 0.003) \n",
       "560  0.613 (0.587, 0.626) 0.607 (0.58, 0.618)  -0.006 (-0.008, -0.006)\n",
       "561  0.566 (0.549, 0.579) 0.57 (0.557, 0.586)  0.004 (-0.005, 0.01)   \n",
       "562                                                                   \n",
       "563                                                                   \n",
       "564                                                                   \n",
       "565  0.553 (0.543, 0.564) 0.55 (0.54, 0.561)   -0.003 (-0.005, -0.003)\n",
       "566                                                                   \n",
       "567  0.803 (0.79, 0.813)  0.803 (0.791, 0.813) 0 (0, 0.001)           \n",
       "568                                                                   \n",
       "569                                                                   \n",
       "570                                                                   \n",
       "571                                                                   \n",
       "572                                                                   \n",
       "573                                                                   \n",
       "574                                                                   \n",
       "575                                                                   \n",
       "576                                                                   \n",
       "577                                                                   \n",
       "578                                                                   \n",
       "579  0.747 (0.721, 0.779) 0.75 (0.723, 0.783)  0.002 (-0.004, 0.004)  \n",
       "580  0.601 (0.546, 0.64)  0.598 (0.549, 0.649) 0.002 (-0.007, 0.013)  \n",
       "581  0.602 (0.578, 0.654) 0.61 (0.585, 0.662)  0.008 (0, 0.012)       \n",
       "582                                                                   \n",
       "583                                                                   \n",
       "584                                                                   \n",
       "585                                                                   \n",
       "586                                                                   \n",
       "587                                                                   \n",
       "588                                                                   \n",
       "589                                                                   \n",
       "590                                                                   \n",
       "591  0.707 (0.692, 0.737) 0.707 (0.693, 0.735) -0.001 (-0.002, 0.001) \n",
       "592                                                                   \n",
       "593                                                                   \n",
       "594  0.68 (0.664, 0.689)  0.68 (0.665, 0.692)  0.001 (0, 0.004)       \n",
       "595  0.73 (0.7, 0.748)    0.73 (0.702, 0.748)  0 (-0.003, 0.003)      \n",
       "596                                                                   \n",
       "597                                                                   \n",
       "598  0.708 (0.655, 0.732) 0.713 (0.66, 0.733)  0.006 (-0.004, 0.009)  \n",
       "599  0.649 (0.634, 0.683) 0.648 (0.633, 0.682) -0.001 (-0.002, 0)     \n",
       "600                                                                   \n",
       "601                                                                   \n",
       "602                                                                   \n",
       "603                                                                   \n",
       "604                                                                   \n",
       "605                                                                   \n",
       "606                                                                   \n",
       "607                                                                   \n",
       "608                                                                   \n",
       "609                                                                   \n",
       "610                                                                   \n",
       "611                                                                   \n",
       "612                                                                   \n",
       "613                                                                   \n",
       "614                                                                   \n",
       "615                                                                   \n",
       "616                                                                   \n",
       "617                                                                   \n",
       "618                                                                   \n",
       "619                                                                   \n",
       "620                                                                   \n",
       "621  0.544 (0.514, 0.573) 0.55 (0.527, 0.591)  0.012 (0, 0.019)       \n",
       "622  0.613 (0.606, 0.628) 0.611 (0.606, 0.628) -0.001 (-0.004, 0.003) \n",
       "623                                                                   \n",
       "624                                                                   \n",
       "625                                                                   \n",
       "626  0.723 (0.71, 0.745)  0.724 (0.711, 0.746) 0.001 (-0.001, 0.003)  \n",
       "627                                                                   \n",
       "628                                                                   \n",
       "629  0.476 (0.463, 0.499) 0.481 (0.466, 0.503) 0.004 (-0.01, 0.015)   \n",
       "630                                                                   \n",
       "631  0.628 (0.614, 0.642) 0.626 (0.611, 0.644) -0.002 (-0.005, 0.004) \n",
       "632  0.588 (0.577, 0.608) 0.589 (0.575, 0.607) 0 (-0.003, 0.003)      \n",
       "633  0.584 (0.565, 0.596) 0.583 (0.563, 0.594) -0.002 (-0.002, -0.001)\n",
       "634  0.568 (0.558, 0.577) 0.564 (0.551, 0.577) -0.003 (-0.007, 0)     \n",
       "635  0.752 (0.731, 0.762) 0.756 (0.737, 0.769) 0.005 (0.002, 0.008)   \n",
       "636  0.565 (0.541, 0.581) 0.576 (0.563, 0.596) 0.013 (0.007, 0.028)   \n",
       "637  0.624 (0.604, 0.635) 0.621 (0.602, 0.631) -0.003 (-0.007, 0)     \n",
       "638  0.742 (0.733, 0.758) 0.745 (0.734, 0.76)  0.002 (0, 0.004)       \n",
       "639  0.593 (0.578, 0.606) 0.592 (0.575, 0.603) -0.001 (-0.004, 0.002) \n",
       "640                                                                   \n",
       "641                                                                   \n",
       "642                                                                   \n",
       "643                                                                   \n",
       "644                                                                   \n",
       "645                                                                   \n",
       "646                                                                   \n",
       "647                                                                   \n",
       "648                                                                   \n",
       "649                                                                   \n",
       "650                                                                   \n",
       "651                                                                   \n",
       "652                                                                   \n",
       "653                                                                   \n",
       "654                                                                   \n",
       "655                                                                   \n",
       "656                                                                   \n",
       "657  0.536 (0.514, 0.563) 0.564 (0.544, 0.589) 0.025 (-0.007, 0.061)  \n",
       "658                                                                   \n",
       "659  0.598 (0.565, 0.619) 0.593 (0.559, 0.608) -0.006 (-0.012, -0.001)\n",
       "660                                                                   \n",
       "661                                                                   \n",
       "662  0.774 (0.752, 0.777) 0.774 (0.754, 0.777) 0 (-0.001, 0.001)      \n",
       "663  0.622 (0.607, 0.639) 0.62 (0.604, 0.636)  -0.004 (-0.005, 0.001) \n",
       "664                                                                   \n",
       "665                                                                   \n",
       "666  0.62 (0.593, 0.651)  0.627 (0.603, 0.655) 0.005 (0.002, 0.012)   \n",
       "667  0.625 (0.616, 0.637) 0.634 (0.626, 0.644) 0.009 (-0.002, 0.015)  \n",
       "668                                                                   \n",
       "669                                                                   \n",
       "670                                                                   \n",
       "671                                                                   \n",
       "672  0.581 (0.55, 0.592)  0.588 (0.549, 0.599) 0.005 (-0.004, 0.01)   \n",
       "673  0.746 (0.733, 0.776) 0.75 (0.735, 0.776)  0.003 (0, 0.006)       \n",
       "674                                                                   \n",
       "675                                                                   \n",
       "676                                                                   \n",
       "677                                                                   \n",
       "678  0.631 (0.612, 0.664) 0.634 (0.605, 0.668) 0.001 (-0.008, 0.007)  \n",
       "679                                                                   \n",
       "680                                                                   \n",
       "681                                                                   \n",
       "682                                                                   \n",
       "683                                                                   \n",
       "684                                                                   \n",
       "685                                                                   \n",
       "686                                                                   \n",
       "687  0.565 (0.544, 0.598) 0.584 (0.551, 0.614) 0.02 (0.006, 0.036)    \n",
       "688  0.739 (0.732, 0.751) 0.74 (0.729, 0.753)  0.001 (-0.004, 0.005)  \n",
       "689                                                                   \n",
       "690  0.708 (0.686, 0.73)  0.715 (0.693, 0.734) 0.005 (0.002, 0.008)   \n",
       "691                                                                   \n",
       "692                                                                   \n",
       "693  0.543 (0.527, 0.552) 0.544 (0.529, 0.557) 0.001 (-0.009, 0.009)  \n",
       "694  0.588 (0.559, 0.618) 0.596 (0.57, 0.616)  0.005 (-0.009, 0.019)  \n",
       "695                                                                   \n",
       "696  0.701 (0.692, 0.712) 0.704 (0.696, 0.713) 0.002 (0, 0.005)       \n",
       "697                                                                   \n",
       "698                                                                   \n",
       "699                                                                   \n",
       "700                                                                   \n",
       "701  0.659 (0.648, 0.682) 0.658 (0.646, 0.681) -0.001 (-0.004, 0.001) \n",
       "702                                                                   \n",
       "703                                                                   \n",
       "704                                                                   \n",
       "705                                                                   \n",
       "706                                                                   \n",
       "707                                                                   \n",
       "708                                                                   \n",
       "709                                                                   \n",
       "710                                                                   \n",
       "711                                                                   \n",
       "712                                                                   \n",
       "713                                                                   \n",
       "714  0.525 (0.516, 0.536) 0.568 (0.539, 0.61)  0.044 (0.016, 0.084)   \n",
       "715                                                                   \n",
       "716                                                                   \n",
       "717                                                                   \n",
       "718                                                                   \n",
       "719                                                                   \n",
       "720  0.423 (0.407, 0.436) 0.398 (0.383, 0.419) -0.023 (-0.032, -0.015)\n",
       "721                                                                   \n",
       "722                                                                   \n",
       "723                                                                   \n",
       "724                                                                   \n",
       "725  0.587 (0.564, 0.604) 0.581 (0.565, 0.598) -0.005 (-0.009, 0.003) \n",
       "726                                                                   \n",
       "727                                                                   \n",
       "728                                                                   \n",
       "729  0.65 (0.618, 0.672)  0.646 (0.615, 0.674) -0.001 (-0.005, 0.004) \n",
       "730  0.545 (0.53, 0.555)  0.539 (0.525, 0.55)  -0.006 (-0.009, -0.004)\n",
       "731  0.627 (0.618, 0.635) 0.625 (0.617, 0.634) -0.001 (-0.003, 0)     \n",
       "732                                                                   \n",
       "733  0.717 (0.701, 0.732) 0.714 (0.7, 0.73)    -0.002 (-0.011, 0.001) \n",
       "734                                                                   \n",
       "735                                                                   \n",
       "736                                                                   \n",
       "737                                                                   \n",
       "738                                                                   \n",
       "739                                                                   \n",
       "740                                                                   \n",
       "741                                                                   \n",
       "742                                                                   \n",
       "743                                                                   \n",
       "744                                                                   \n",
       "745                                                                   \n",
       "746                                                                   \n",
       "747                                                                   \n",
       "748                                                                   \n",
       "749                                                                   \n",
       "750                                                                   \n",
       "751                                                                   \n",
       "752                                                                   \n",
       "753                                                                   \n",
       "754                                                                   \n",
       "755                                                                   \n",
       "756                                                                   \n",
       "757                                                                   \n",
       "758                                                                   \n",
       "759                                                                   \n",
       "760                                                                   \n",
       "761                                                                   \n",
       "762                                                                   \n",
       "763                                                                   \n",
       "764                                                                   \n",
       "765                                                                   \n",
       "766                                                                   \n",
       "767                                                                   \n",
       "768                                                                   \n",
       "769                                                                   \n",
       "770  0.593 (0.582, 0.607) 0.591 (0.579, 0.606) -0.001 (-0.003, 0)     \n",
       "771                                                                   \n",
       "772                                                                   \n",
       "773                                                                   \n",
       "774  0.708 (0.697, 0.721) 0.71 (0.698, 0.723)  0.001 (-0.001, 0.004)  \n",
       "775                                                                   \n",
       "776                                                                   \n",
       "777                                                                   \n",
       "778                                                                   \n",
       "779                                                                   \n",
       "780                                                                   \n",
       "781                                                                   \n",
       "782  0.613 (0.598, 0.629) 0.609 (0.594, 0.626) -0.003 (-0.005, -0.002)\n",
       "783                                                                   \n",
       "784                                                                   \n",
       "785  0.604 (0.587, 0.618) 0.602 (0.585, 0.618) -0.002 (-0.003, 0.001) \n",
       "786  0.674 (0.647, 0.69)  0.682 (0.666, 0.696) 0.008 (0.005, 0.02)    \n",
       "787                                                                   \n",
       "788                                                                   \n",
       "789                                                                   \n",
       "790                                                                   \n",
       "791                                                                   \n",
       "792                                                                   \n",
       "793                                                                   \n",
       "794                                                                   \n",
       "795                                                                   \n",
       "796                                                                   \n",
       "797                                                                   \n",
       "798                                                                   \n",
       "799                                                                   \n",
       "800                                                                   \n",
       "801                                                                   \n",
       "802                                                                   \n",
       "803                                                                   \n",
       "804                                                                   \n",
       "805                                                                   \n",
       "806                                                                   \n",
       "807                                                                   \n",
       "808                                                                   \n",
       "809                                                                   \n",
       "810                                                                   \n",
       "811                                                                   \n",
       "812                                                                   \n",
       "813                                                                   \n",
       "814                                                                   \n",
       "815                                                                   \n",
       "816                                                                   \n",
       "817                                                                   \n",
       "818                                                                   \n",
       "819                                                                   \n",
       "820                                                                   \n",
       "821                                                                   \n",
       "822                                                                   \n",
       "823                                                                   \n",
       "824                                                                   \n",
       "825                                                                   \n",
       "826                                                                   \n",
       "827                                                                   \n",
       "828                                                                   \n",
       "829                                                                   \n",
       "830                                                                   \n",
       "831                                                                   \n",
       "832                                                                   \n",
       "833                                                                   \n",
       "834                                                                   \n",
       "835                                                                   \n",
       "836                                                                   \n",
       "837                                                                   \n",
       "838                                                                   \n",
       "839                                                                   \n",
       "840                                                                   \n",
       "841                                                                   \n",
       "842                                                                   \n",
       "843                                                                   \n",
       "844                                                                   \n",
       "845                                                                   \n",
       "846                                                                   \n",
       "847                                                                   \n",
       "848                                                                   \n",
       "849                                                                   \n",
       "850                                                                   \n",
       "851                                                                   \n",
       "852                                                                   \n",
       "853                                                                   \n",
       "854                                                                   \n",
       "855                                                                   \n",
       "856                                                                   \n",
       "857                                                                   \n",
       "858                                                                   \n",
       "859                                                                   \n",
       "860                                                                   \n",
       "861                                                                   \n",
       "862                                                                   \n",
       "863                                                                   \n",
       "864                                                                   \n",
       "865                                                                   \n",
       "866                                                                   \n",
       "867                                                                   \n",
       "868                                                                   \n",
       "869  0.635 (0.61, 0.653)  0.633 (0.606, 0.652) -0.002 (-0.004, 0)     \n",
       "870                                                                   \n",
       "871                                                                   \n",
       "872                                                                   \n",
       "873                                                                   \n",
       "874                                                                   \n",
       "875                                                                   \n",
       "876                                                                   \n",
       "877                                                                   \n",
       "878                                                                   \n",
       "879                                                                   \n",
       "880                                                                   \n",
       "881                                                                   \n",
       "882                                                                   \n",
       "883                                                                   \n",
       "884                                                                   \n",
       "885                                                                   \n",
       "886                                                                   \n",
       "887                                                                   \n",
       "888                                                                   \n",
       "889                                                                   \n",
       "890                                                                   \n",
       "891                                                                   \n",
       "892                                                                   \n",
       "893                                                                   \n",
       "894                                                                   \n",
       "895                                                                   \n",
       "896                                                                   \n",
       "897                                                                   \n",
       "898                                                                   \n",
       "899                                                                   \n",
       "900                                                                   \n",
       "901                                                                   \n",
       "902                                                                   \n",
       "903                                                                   \n",
       "904                                                                   \n",
       "905                                                                   \n",
       "906                                                                   \n",
       "907                                                                   \n",
       "908                                                                   \n",
       "909                                                                   \n",
       "910                                                                   \n",
       "911                                                                   \n",
       "912                                                                   \n",
       "913                                                                   \n",
       "914                                                                   \n",
       "915                                                                   \n",
       "916                                                                   \n",
       "917                                                                   \n",
       "918                                                                   \n",
       "919                                                                   \n",
       "920                                                                   \n",
       "921                                                                   \n",
       "922                                                                   \n",
       "923                                                                   \n",
       "924                                                                   \n",
       "925                                                                   \n",
       "926                                                                   \n",
       "927                                                                   \n",
       "928                                                                   \n",
       "929                                                                   \n",
       "930                                                                   \n",
       "931                                                                   \n",
       "932                                                                   \n",
       "933                                                                   \n",
       "934                                                                   \n",
       "935                                                                   \n",
       "936                                                                   \n",
       "937                                                                   \n",
       "938                                                                   \n",
       "939                                                                   \n",
       "940  0.43 (0.321, 0.494)  0.436 (0.33, 0.501)  0.005 (-0.012, 0.011)  \n",
       "941                                                                   \n",
       "942  0.814 (0.801, 0.826) 0.813 (0.799, 0.825) -0.001 (-0.003, 0)     \n",
       "943                                                                   \n",
       "944                                                                   \n",
       "945                                                                   \n",
       "946                                                                   \n",
       "947                                                                   \n",
       "948                                                                   \n",
       "949                                                                   \n",
       "950                                                                   \n",
       "951                                                                   \n",
       "952                                                                   \n",
       "953                                                                   \n",
       "954                                                                   \n",
       "955                                                                   \n",
       "956                                                                   \n",
       "957                                                                   \n",
       "958                                                                   \n",
       "959                                                                   \n",
       "960                                                                   \n",
       "961                                                                   \n",
       "962                                                                   \n",
       "963                                                                   \n",
       "964                                                                   \n",
       "965                                                                   \n",
       "966                                                                   \n",
       "967                                                                   \n",
       "968                                                                   \n",
       "969                                                                   \n",
       "970                                                                   \n",
       "971  0.651 (0.634, 0.671) 0.657 (0.642, 0.677) 0.007 (-0.006, 0.01)   \n",
       "972                                                                   \n",
       "973                                                                   \n",
       "974                                                                   \n",
       "975                                                                   \n",
       "976                                                                   \n",
       "977                                                                   \n",
       "978                                                                   \n",
       "979                                                                   \n",
       "980                                                                   \n",
       "981                                                                   \n",
       "982                                                                   \n",
       "983                                                                   \n",
       "984                                                                   \n",
       "985                                                                   \n",
       "986                                                                   \n",
       "987                                                                   \n",
       "988                                                                   \n",
       "989                                                                   \n",
       "990                                                                   \n",
       "991  0.583 (0.563, 0.601) 0.618 (0.591, 0.649) 0.034 (0.02, 0.06)     \n",
       "992                                                                   \n",
       "993                                                                   \n",
       "994                                                                   \n",
       "995                                                                   \n",
       "996                                                                   \n",
       "997                                                                   \n",
       "998  0.666 (0.645, 0.686) 0.668 (0.645, 0.685) 0 (-0.001, 0.003)      \n",
       "999                                                                   \n",
       "1000                                                                  \n",
       "1001                                                                  \n",
       "1002                                                                  \n",
       "1003                                                                  \n",
       "1004                                                                  \n",
       "1005                                                                  \n",
       "1006                                                                  \n",
       "1007                                                                  \n",
       "1008                                                                  \n",
       "1009                                                                  \n",
       "1010                                                                  \n",
       "1011                                                                  \n",
       "1012                                                                  \n",
       "1013 0.648 (0.632, 0.692) 0.653 (0.634, 0.692) 0.005 (-0.006, 0.01)   \n",
       "1014                                                                  \n",
       "1015                                                                  \n",
       "1016                                                                  \n",
       "1017 0.622 (0.611, 0.649) 0.621 (0.605, 0.645) -0.004 (-0.009, 0.004) \n",
       "1018                                                                  \n",
       "1019 0.579 (0.558, 0.594) 0.565 (0.553, 0.589) -0.007 (-0.021, 0.01)  \n",
       "1020                                                                  \n",
       "1021                                                                  \n",
       "1022                                                                  \n",
       "1023                                                                  \n",
       "1024 0.601 (0.588, 0.626) 0.6 (0.581, 0.618)   -0.006 (-0.011, 0.002) \n",
       "1025                                                                  \n",
       "1026 0.805 (0.795, 0.812) 0.804 (0.794, 0.811) -0.001 (-0.002, 0)     \n",
       "1027                                                                  \n",
       "1028                                                                  \n",
       "1029                                                                  \n",
       "1030                                                                  \n",
       "1031                                                                  \n",
       "1032                                                                  \n",
       "1033                                                                  \n",
       "1034                                                                  \n",
       "1035                                                                  \n",
       "1036                                                                  \n",
       "1037                                                                  \n",
       "1038                                                                  \n",
       "1039                                                                  \n",
       "1040                                                                  \n",
       "1041                                                                  \n",
       "1042                                                                  \n",
       "1043 0.716 (0.705, 0.731) 0.718 (0.706, 0.734) 0.001 (-0.003, 0.003)  \n",
       "1044                                                                  \n",
       "1045                                                                  \n",
       "1046                                                                  \n",
       "1047                                                                  \n",
       "1048                                                                  \n",
       "1049                                                                  \n",
       "1050                                                                  \n",
       "1051 0.751 (0.731, 0.757) 0.75 (0.73, 0.756)   -0.001 (-0.002, 0)     \n",
       "1052                                                                  \n",
       "1053                                                                  \n",
       "1054                                                                  \n",
       "1055                                                                  \n",
       "1056                                                                  \n",
       "1057                                                                  \n",
       "1058                                                                  \n",
       "1059                                                                  \n",
       "1060                                                                  \n",
       "1061                                                                  \n",
       "1062                                                                  \n",
       "1063                                                                  \n",
       "1064                                                                  \n",
       "1065                                                                  \n",
       "1066                                                                  \n",
       "1067                                                                  \n",
       "1068 0.537 (0.499, 0.55)  0.544 (0.512, 0.565) 0.006 (-0.013, 0.031)  \n",
       "1069                                                                  \n",
       "1070                                                                  \n",
       "1071                                                                  \n",
       "1072                                                                  \n",
       "1073                                                                  \n",
       "1074                                                                  \n",
       "1075 0.623 (0.595, 0.63)  0.622 (0.594, 0.627) -0.002 (-0.003, 0)     \n",
       "1076 0.596 (0.57, 0.627)  0.596 (0.57, 0.628)  0 (-0.001, 0.001)      \n",
       "1077                                                                  \n",
       "1078 0.696 (0.667, 0.714) 0.696 (0.672, 0.719) 0.003 (-0.003, 0.008)  \n",
       "1079 0.756 (0.722, 0.801) 0.752 (0.716, 0.797) -0.004 (-0.006, -0.002)\n",
       "1080                                                                  \n",
       "1081                                                                  \n",
       "1082 0.685 (0.651, 0.695) 0.688 (0.657, 0.7)   0.003 (0.002, 0.007)   \n",
       "1083                                                                  \n",
       "1084                                                                  \n",
       "1085                                                                  \n",
       "1086                                                                  \n",
       "1087                                                                  \n",
       "1088 0.706 (0.7, 0.718)   0.705 (0.699, 0.726) 0.002 (-0.015, 0.02)   \n",
       "1089                                                                  \n",
       "1090                                                                  \n",
       "1091                                                                  \n",
       "1092                                                                  \n",
       "1093                                                                  \n",
       "1094                                                                  \n",
       "1095                                                                  \n",
       "1096                                                                  \n",
       "1097                                                                  \n",
       "1098                                                                  \n",
       "1099                                                                  \n",
       "1100                                                                  \n",
       "1101                                                                  \n",
       "1102                                                                  \n",
       "1103                                                                  \n",
       "1104                                                                  \n",
       "1105                                                                  \n",
       "1106                                                                  \n",
       "1107                                                                  \n",
       "1108                                                                  \n",
       "1109                                                                  \n",
       "1110 0.587 (0.578, 0.609) 0.586 (0.577, 0.609) -0.001 (-0.001, 0)     \n",
       "1111                                                                  \n",
       "1112                                                                  \n",
       "1113                                                                  \n",
       "1114 0.542 (0.518, 0.582) 0.549 (0.523, 0.582) 0.003 (-0.005, 0.025)  \n",
       "1115                                                                  \n",
       "1116                                                                  \n",
       "1117                                                                  \n",
       "1118                                                                  \n",
       "1119                                                                  \n",
       "1120 0.652 (0.631, 0.677) 0.649 (0.628, 0.675) -0.004 (-0.005, -0.001)\n",
       "1121                                                                  \n",
       "1122                                                                  \n",
       "1123 0.525 (0.485, 0.555) 0.536 (0.5, 0.556)   0.009 (-0.002, 0.025)  \n",
       "1124 0.54 (0.498, 0.562)  0.553 (0.53, 0.59)   0.018 (0, 0.038)       \n",
       "1125 0.649 (0.641, 0.668) 0.651 (0.642, 0.668) 0.001 (-0.001, 0.005)  \n",
       "1126                                                                  \n",
       "1127 0.641 (0.631, 0.662) 0.642 (0.635, 0.66)  0.003 (-0.003, 0.005)  \n",
       "1128 0.637 (0.617, 0.652) 0.637 (0.615, 0.651) -0.001 (-0.002, 0)     \n",
       "1129                                                                  \n",
       "1130 0.713 (0.705, 0.72)  0.713 (0.706, 0.721) 0 (0, 0.002)           \n",
       "1131 0.727 (0.719, 0.742) 0.727 (0.718, 0.742) 0 (-0.001, 0)          \n",
       "1132                                                                  \n",
       "1133 0.697 (0.69, 0.71)   0.696 (0.69, 0.71)   0 (-0.001, 0)          \n",
       "1134                                                                  \n",
       "1135                                                                  \n",
       "1136                                                                  \n",
       "1137                                                                  \n",
       "1138                                                                  \n",
       "1139                                                                  \n",
       "1140                                                                  \n",
       "1141 0.463 (0.431, 0.486) 0.45 (0.425, 0.48)   -0.008 (-0.024, 0.001) \n",
       "1142                                                                  \n",
       "1143                                                                  \n",
       "1144 0.703 (0.672, 0.723) 0.705 (0.676, 0.73)  0.004 (-0.001, 0.007)  \n",
       "1145                                                                  \n",
       "1146                                                                  \n",
       "1147                                                                  \n",
       "1148 0.722 (0.7, 0.746)   0.723 (0.702, 0.749) 0.002 (-0.001, 0.004)  \n",
       "1149                                                                  \n",
       "1150                                                                  \n",
       "1151                                                                  \n",
       "1152                                                                  \n",
       "1153 0.616 (0.603, 0.632) 0.615 (0.602, 0.629) 0 (-0.005, 0.001)      \n",
       "1154                                                                  \n",
       "1155                                                                  \n",
       "1156                                                                  \n",
       "1157                                                                  \n",
       "1158                                                                  \n",
       "1159                                                                  \n",
       "1160 0.534 (0.496, 0.565) 0.525 (0.486, 0.553) -0.009 (-0.014, -0.005)\n",
       "1161 0.523 (0.495, 0.544) 0.517 (0.485, 0.539) -0.008 (-0.012, -0.005)\n",
       "1162                                                                  \n",
       "1163                                                                  \n",
       "1164                                                                  \n",
       "1165                                                                  \n",
       "1166                                                                  \n",
       "1167                                                                  \n",
       "1168                                                                  \n",
       "1169 0.612 (0.598, 0.616) 0.612 (0.597, 0.615) -0.001 (-0.001, 0)     \n",
       "1170                                                                  \n",
       "1171                                                                  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "st4_clean"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [],
   "source": [
    "st4_clean %>% write_csv(\"outputs/SupplTable4_ukbepic_merged.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<table class=\"dataframe\">\n",
       "<caption>A tibble: 6 × 19</caption>\n",
       "<thead>\n",
       "\t<tr><th scope=col>endpoint</th><th scope=col>model</th><th scope=col>iteration</th><th scope=col>time</th><th scope=col>n_epic</th><th scope=col>eligable</th><th scope=col>n</th><th scope=col>freq</th><th scope=col>phecode</th><th scope=col>phecode_string</th><th scope=col>phecode_category</th><th scope=col>sex</th><th scope=col>Age+Sex</th><th scope=col>Retina</th><th scope=col>Age+Sex+Retina</th><th scope=col>id</th><th scope=col>delta</th><th scope=col>pos</th><th scope=col>highlight</th></tr>\n",
       "\t<tr><th scope=col>&lt;fct&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;fct&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;int&gt;</th><th scope=col>&lt;dbl&gt;</th><th scope=col>&lt;chr&gt;</th><th scope=col>&lt;chr&gt;</th></tr>\n",
       "</thead>\n",
       "<tbody>\n",
       "\t<tr><td>OMOP_4306655</td><td>RetinaUKB</td><td>0</td><td>10</td><td>111</td><td>61256</td><td>3548</td><td>0.05792086</td><td>4306655</td><td>All-Cause Death                           </td><td>Death    </td><td>Both</td><td>0.7489679</td><td>0.6828011</td><td>0.7455266</td><td> 1</td><td>-0.0034413682</td><td>neg</td><td>YES</td></tr>\n",
       "\t<tr><td>phecode_101 </td><td>RetinaUKB</td><td>0</td><td>10</td><td>243</td><td>60713</td><td>1652</td><td>0.02720999</td><td>    101</td><td>Malignant neoplasm of the digestive organs</td><td>Neoplasms</td><td>Both</td><td>0.6286183</td><td>0.5829767</td><td>0.6268683</td><td>15</td><td>-0.0017499574</td><td>neg</td><td>YES</td></tr>\n",
       "\t<tr><td>phecode_102 </td><td>RetinaUKB</td><td>0</td><td>10</td><td> NA</td><td>   NA</td><td>  NA</td><td>        NA</td><td>     NA</td><td>NA                                        </td><td>NA       </td><td>NA  </td><td>0.6354517</td><td>0.6245727</td><td>0.6481125</td><td>22</td><td> 0.0126607788</td><td>pos</td><td>YES</td></tr>\n",
       "\t<tr><td>phecode_103 </td><td>RetinaUKB</td><td>0</td><td>10</td><td>651</td><td>59332</td><td>3620</td><td>0.06101261</td><td>    103</td><td>Malignant neoplasm of the skin            </td><td>Neoplasms</td><td>Both</td><td>0.6237659</td><td>0.5820031</td><td>0.6228162</td><td>24</td><td>-0.0009496536</td><td>neg</td><td>YES</td></tr>\n",
       "\t<tr><td>phecode_164 </td><td>RetinaUKB</td><td>0</td><td>10</td><td>648</td><td>57646</td><td>4945</td><td>0.08578219</td><td>    164</td><td>Anemia                                    </td><td>Blood    </td><td>Both</td><td>0.6389622</td><td>0.6175132</td><td>0.6458954</td><td>64</td><td> 0.0069331670</td><td>pos</td><td>YES</td></tr>\n",
       "\t<tr><td>phecode_202 </td><td>RetinaUKB</td><td>0</td><td>10</td><td>620</td><td>57936</td><td>4259</td><td>0.07351215</td><td>    202</td><td>Diabetes mellitus                         </td><td>Endo     </td><td>Both</td><td>0.6074612</td><td>0.6305492</td><td>0.6360661</td><td>76</td><td> 0.0286048722</td><td>pos</td><td>YES</td></tr>\n",
       "</tbody>\n",
       "</table>\n"
      ],
      "text/latex": [
       "A tibble: 6 × 19\n",
       "\\begin{tabular}{lllllllllllllllllll}\n",
       " endpoint & model & iteration & time & n\\_epic & eligable & n & freq & phecode & phecode\\_string & phecode\\_category & sex & Age+Sex & Retina & Age+Sex+Retina & id & delta & pos & highlight\\\\\n",
       " <fct> & <chr> & <int> & <int> & <int> & <dbl> & <dbl> & <dbl> & <dbl> & <chr> & <fct> & <chr> & <dbl> & <dbl> & <dbl> & <int> & <dbl> & <chr> & <chr>\\\\\n",
       "\\hline\n",
       "\t OMOP\\_4306655 & RetinaUKB & 0 & 10 & 111 & 61256 & 3548 & 0.05792086 & 4306655 & All-Cause Death                            & Death     & Both & 0.7489679 & 0.6828011 & 0.7455266 &  1 & -0.0034413682 & neg & YES\\\\\n",
       "\t phecode\\_101  & RetinaUKB & 0 & 10 & 243 & 60713 & 1652 & 0.02720999 &     101 & Malignant neoplasm of the digestive organs & Neoplasms & Both & 0.6286183 & 0.5829767 & 0.6268683 & 15 & -0.0017499574 & neg & YES\\\\\n",
       "\t phecode\\_102  & RetinaUKB & 0 & 10 &  NA &    NA &   NA &         NA &      NA & NA                                         & NA        & NA   & 0.6354517 & 0.6245727 & 0.6481125 & 22 &  0.0126607788 & pos & YES\\\\\n",
       "\t phecode\\_103  & RetinaUKB & 0 & 10 & 651 & 59332 & 3620 & 0.06101261 &     103 & Malignant neoplasm of the skin             & Neoplasms & Both & 0.6237659 & 0.5820031 & 0.6228162 & 24 & -0.0009496536 & neg & YES\\\\\n",
       "\t phecode\\_164  & RetinaUKB & 0 & 10 & 648 & 57646 & 4945 & 0.08578219 &     164 & Anemia                                     & Blood     & Both & 0.6389622 & 0.6175132 & 0.6458954 & 64 &  0.0069331670 & pos & YES\\\\\n",
       "\t phecode\\_202  & RetinaUKB & 0 & 10 & 620 & 57936 & 4259 & 0.07351215 &     202 & Diabetes mellitus                          & Endo      & Both & 0.6074612 & 0.6305492 & 0.6360661 & 76 &  0.0286048722 & pos & YES\\\\\n",
       "\\end{tabular}\n"
      ],
      "text/markdown": [
       "\n",
       "A tibble: 6 × 19\n",
       "\n",
       "| endpoint &lt;fct&gt; | model &lt;chr&gt; | iteration &lt;int&gt; | time &lt;int&gt; | n_epic &lt;int&gt; | eligable &lt;dbl&gt; | n &lt;dbl&gt; | freq &lt;dbl&gt; | phecode &lt;dbl&gt; | phecode_string &lt;chr&gt; | phecode_category &lt;fct&gt; | sex &lt;chr&gt; | Age+Sex &lt;dbl&gt; | Retina &lt;dbl&gt; | Age+Sex+Retina &lt;dbl&gt; | id &lt;int&gt; | delta &lt;dbl&gt; | pos &lt;chr&gt; | highlight &lt;chr&gt; |\n",
       "|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|\n",
       "| OMOP_4306655 | RetinaUKB | 0 | 10 | 111 | 61256 | 3548 | 0.05792086 | 4306655 | All-Cause Death                            | Death     | Both | 0.7489679 | 0.6828011 | 0.7455266 |  1 | -0.0034413682 | neg | YES |\n",
       "| phecode_101  | RetinaUKB | 0 | 10 | 243 | 60713 | 1652 | 0.02720999 |     101 | Malignant neoplasm of the digestive organs | Neoplasms | Both | 0.6286183 | 0.5829767 | 0.6268683 | 15 | -0.0017499574 | neg | YES |\n",
       "| phecode_102  | RetinaUKB | 0 | 10 |  NA |    NA |   NA |         NA |      NA | NA                                         | NA        | NA   | 0.6354517 | 0.6245727 | 0.6481125 | 22 |  0.0126607788 | pos | YES |\n",
       "| phecode_103  | RetinaUKB | 0 | 10 | 651 | 59332 | 3620 | 0.06101261 |     103 | Malignant neoplasm of the skin             | Neoplasms | Both | 0.6237659 | 0.5820031 | 0.6228162 | 24 | -0.0009496536 | neg | YES |\n",
       "| phecode_164  | RetinaUKB | 0 | 10 | 648 | 57646 | 4945 | 0.08578219 |     164 | Anemia                                     | Blood     | Both | 0.6389622 | 0.6175132 | 0.6458954 | 64 |  0.0069331670 | pos | YES |\n",
       "| phecode_202  | RetinaUKB | 0 | 10 | 620 | 57936 | 4259 | 0.07351215 |     202 | Diabetes mellitus                          | Endo      | Both | 0.6074612 | 0.6305492 | 0.6360661 | 76 |  0.0286048722 | pos | YES |\n",
       "\n"
      ],
      "text/plain": [
       "  endpoint     model     iteration time n_epic eligable n    freq       phecode\n",
       "1 OMOP_4306655 RetinaUKB 0         10   111    61256    3548 0.05792086 4306655\n",
       "2 phecode_101  RetinaUKB 0         10   243    60713    1652 0.02720999     101\n",
       "3 phecode_102  RetinaUKB 0         10    NA       NA      NA         NA      NA\n",
       "4 phecode_103  RetinaUKB 0         10   651    59332    3620 0.06101261     103\n",
       "5 phecode_164  RetinaUKB 0         10   648    57646    4945 0.08578219     164\n",
       "6 phecode_202  RetinaUKB 0         10   620    57936    4259 0.07351215     202\n",
       "  phecode_string                             phecode_category sex  Age+Sex  \n",
       "1 All-Cause Death                            Death            Both 0.7489679\n",
       "2 Malignant neoplasm of the digestive organs Neoplasms        Both 0.6286183\n",
       "3 NA                                         NA               NA   0.6354517\n",
       "4 Malignant neoplasm of the skin             Neoplasms        Both 0.6237659\n",
       "5 Anemia                                     Blood            Both 0.6389622\n",
       "6 Diabetes mellitus                          Endo             Both 0.6074612\n",
       "  Retina    Age+Sex+Retina id delta         pos highlight\n",
       "1 0.6828011 0.7455266       1 -0.0034413682 neg YES      \n",
       "2 0.5829767 0.6268683      15 -0.0017499574 neg YES      \n",
       "3 0.6245727 0.6481125      22  0.0126607788 pos YES      \n",
       "4 0.5820031 0.6228162      24 -0.0009496536 neg YES      \n",
       "5 0.6175132 0.6458954      64  0.0069331670 pos YES      \n",
       "6 0.6305492 0.6360661      76  0.0286048722 pos YES      "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plot_width = 8.25; plot_height=2; plot_res = 320\n",
    "options(repr.plot.width = plot_width, repr.plot.height = plot_height, repr.plot.res=plot_res)\n",
    "\n",
    "scores_plot = c(\"Retina\", \"Age+Sex\", \"Age+Sex+Retina\")#, \"AgeSexRetina\")\n",
    "\n",
    "temp = benchmark_endpoints %>% \n",
    "    filter(score %in% scores_plot) %>% \n",
    "    mutate(score = factor(score, levels=scores_plot)) %>%\n",
    "    mutate(endpoint = factor(endpoint, levels=endpoints_sorted)) %>%\n",
    "    group_by(endpoint, score, phecode_string, phecode_category) %>%\n",
    "    ungroup() %>%\n",
    "    pivot_wider(names_from=score, values_from=cindex) %>% \n",
    "    mutate(id = row_number()) %>%\n",
    "    mutate(delta = `Age+Sex+Retina`-`Age+Sex`) %>%\n",
    "    #mutate(delta_int = `Age+Sex+Retina`-`Age+Sex+Retina`) %>%\n",
    "    mutate(pos = case_when(delta>=0 ~ \"pos\", delta < 0 ~\"neg\")) %>%\n",
    "    mutate(endpoint = fct_reorder(endpoint, delta)) %>%\n",
    "    mutate(highlight = case_when(endpoint %in% endpoint_selection ~ \"YES\", TRUE ~ \"NO\")) %>%# %>% filter(endpoint %in% endpoint_sample)\n",
    "    mutate(phecode_category = factor(phecode_category, levels=categories_sorted)) %>%\n",
    "    filter(endpoint %in% endpoint_selection)\n",
    "    #%>%\n",
    "    #summarise(cindex = mean(cindex)) \n",
    "temp %>% head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "library(ggdist)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {
    "tags": []
   },
   "outputs": [],
   "source": [
    "base_size = 8\n",
    "title_size = 10\n",
    "facet_size = 9\n",
    "geom_text_size=3\n",
    "theme_set(theme_classic(base_size = base_size) + \n",
    "          theme(strip.background = element_blank(), plot.title=element_text(size=title_size, hjust=0), \n",
    "                strip.text.x = element_text(size = facet_size),axis.title=element_text(size=10), axis.text=element_text(size=8, color=\"black\"),\n",
    "                legend.position=\"bottom\", axis.line = element_line(size = 0.2), axis.ticks=element_line(size=0.2), panel.grid.major=element_line()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "tags": []
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>\n",
       ".list-inline {list-style: none; margin:0; padding: 0}\n",
       ".list-inline>li {display: inline-block}\n",
       ".list-inline>li:not(:last-child)::after {content: \"\\00b7\"; padding: 0 .5ex}\n",
       "</style>\n",
       "<ol class=list-inline><li>'phecode_202'</li><li>'phecode_401'</li><li>'phecode_404'</li><li>'phecode_404-1'</li><li>'phecode_431-11'</li><li>'phecode_424'</li><li>'phecode_059-1'</li><li>'phecode_468'</li><li>'phecode_474'</li><li>'phecode_286-2'</li><li>'phecode_324-11'</li><li>'phecode_328'</li><li>'phecode_164'</li><li>'phecode_726-1'</li><li>'phecode_371'</li><li>'phecode_374-42'</li><li>'phecode_374-5'</li><li>'phecode_375-1'</li><li>'phecode_103'</li><li>'phecode_101'</li><li>'phecode_102'</li><li>'phecode_583'</li><li>'phecode_542'</li><li>'OMOP_4306655'</li></ol>\n"
      ],
      "text/latex": [
       "\\begin{enumerate*}\n",
       "\\item 'phecode\\_202'\n",
       "\\item 'phecode\\_401'\n",
       "\\item 'phecode\\_404'\n",
       "\\item 'phecode\\_404-1'\n",
       "\\item 'phecode\\_431-11'\n",
       "\\item 'phecode\\_424'\n",
       "\\item 'phecode\\_059-1'\n",
       "\\item 'phecode\\_468'\n",
       "\\item 'phecode\\_474'\n",
       "\\item 'phecode\\_286-2'\n",
       "\\item 'phecode\\_324-11'\n",
       "\\item 'phecode\\_328'\n",
       "\\item 'phecode\\_164'\n",
       "\\item 'phecode\\_726-1'\n",
       "\\item 'phecode\\_371'\n",
       "\\item 'phecode\\_374-42'\n",
       "\\item 'phecode\\_374-5'\n",
       "\\item 'phecode\\_375-1'\n",
       "\\item 'phecode\\_103'\n",
       "\\item 'phecode\\_101'\n",
       "\\item 'phecode\\_102'\n",
       "\\item 'phecode\\_583'\n",
       "\\item 'phecode\\_542'\n",
       "\\item 'OMOP\\_4306655'\n",
       "\\end{enumerate*}\n"
      ],
      "text/markdown": [
       "1. 'phecode_202'\n",
       "2. 'phecode_401'\n",
       "3. 'phecode_404'\n",
       "4. 'phecode_404-1'\n",
       "5. 'phecode_431-11'\n",
       "6. 'phecode_424'\n",
       "7. 'phecode_059-1'\n",
       "8. 'phecode_468'\n",
       "9. 'phecode_474'\n",
       "10. 'phecode_286-2'\n",
       "11. 'phecode_324-11'\n",
       "12. 'phecode_328'\n",
       "13. 'phecode_164'\n",
       "14. 'phecode_726-1'\n",
       "15. 'phecode_371'\n",
       "16. 'phecode_374-42'\n",
       "17. 'phecode_374-5'\n",
       "18. 'phecode_375-1'\n",
       "19. 'phecode_103'\n",
       "20. 'phecode_101'\n",
       "21. 'phecode_102'\n",
       "22. 'phecode_583'\n",
       "23. 'phecode_542'\n",
       "24. 'OMOP_4306655'\n",
       "\n",
       "\n"
      ],
      "text/plain": [
       " [1] \"phecode_202\"    \"phecode_401\"    \"phecode_404\"    \"phecode_404-1\" \n",
       " [5] \"phecode_431-11\" \"phecode_424\"    \"phecode_059-1\"  \"phecode_468\"   \n",
       " [9] \"phecode_474\"    \"phecode_286-2\"  \"phecode_324-11\" \"phecode_328\"   \n",
       "[13] \"phecode_164\"    \"phecode_726-1\"  \"phecode_371\"    \"phecode_374-42\"\n",
       "[17] \"phecode_374-5\"  \"phecode_375-1\"  \"phecode_103\"    \"phecode_101\"   \n",
       "[21] \"phecode_102\"    \"phecode_583\"    \"phecode_542\"    \"OMOP_4306655\"  "
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "endpoint_selection "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "hide_input": false,
  "kernelspec": {
   "display_name": "R",
   "language": "R",
   "name": "ir"
  },
  "language_info": {
   "codemirror_mode": "r",
   "file_extension": ".r",
   "mimetype": "text/x-r-source",
   "name": "R",
   "pygments_lexer": "r",
   "version": "4.2.1"
  },
  "toc-autonumbering": false
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
